Sentence,class,file
"This is an Open Access article distributed under the  terms of the Creative Commons Attribution Non-Com - mercial License (http://creativecommons.org/licenses/by-nc/3.0) which permits unrestricted non-commercial use, distribution, and reproduction in any medium, pro - vided the original work is properly cited.KOREAN  VACCINE  SOCIETY KOREAN  VACCINE  SOCIETYKOREAN  ACCINE  OCIETYV S http://www.ecevr.org/Clin Exp Vaccine Res 2013;2:34-39 http://dx.doi.org/10.7774/cevr.2013.2.1.34pISSN 2287-3651 • eISSN 2287-366X  Kee-Jong Hong1, Pil-Gu Park1,  Sang-Hwan Seo1, Gi-eun Rhie1,  Kyuh-Jam Hwang2  1Division of High-Risk Pathogen Research, Center  for Infectious Diseases, 2Division of Zoonoses,  Center for Immunology and Pathology, Korea  National Institute of Health, Cheongwon, Korea Received: November 28, 2012 Revised: December 20, 2012 Accepted: December 29, 2012 Corresponding author: Kyuh-Jam Hwang, PhD Division of Zoonoses, Center for Immunology   and Pathology, Korea National Institute of Health,  Osong Health Technology Administration   Complex, 187 Osongsaengmyeong 2-ro,   Osong-eup, Cheongwon 363-951, Korea Tel: +82-43-719-8641, Fax: +82-43-719-8309 E-mail: kyuhwang@nih.go.kr  No potential conflict of interest relevant to this  article was reported.Tularemia is a high-risk infectious disease caused by Gram-negative bacterium Francisella tu - larensis .",Non-OADS,/arxiv_data1/oa_pdf/b2/86/cevr-2-34.PMC3623498.pdf
Kee-Jong Hong et al • Tularemia vaccine development 35 http://www.ecevr.org/ http://dx.doi.org/10.7774/cevr.2013.2.1.34ties because it is known as a nonpathogenic in human [4].,Non-OADS,/arxiv_data1/oa_pdf/b2/86/cevr-2-34.PMC3623498.pdf
"Kee-Jong Hong et al • Tularemia vaccine development 36 http://www.ecevr.org/ http://dx.doi.org/10.7774/cevr.2013.2.1.34 tinuously reported in North America, and Eurasia, especially  in the regions with cold winter [12].",Non-OADS,/arxiv_data1/oa_pdf/b2/86/cevr-2-34.PMC3623498.pdf
Kee-Jong Hong et al • Tularemia vaccine development 37 http://www.ecevr.org/ http://dx.doi.org/10.7774/cevr.2013.2.1.34sible in F .,Non-OADS,/arxiv_data1/oa_pdf/b2/86/cevr-2-34.PMC3623498.pdf
"Kee-Jong Hong et al • Tularemia vaccine development 38 http://www.ecevr.org/ http://dx.doi.org/10.7774/cevr.2013.2.1.34 suggest any successful results of vaccination efficacies either,  and the continuous failure of subunit vaccine trials from Fos - hay’s split vaccine raises the assumption; it should be required that host system could recognize the multiple antigens to in - duce combined immune responses including cellular immu - nity.",Non-OADS,/arxiv_data1/oa_pdf/b2/86/cevr-2-34.PMC3623498.pdf
Kee-Jong Hong et al • Tularemia vaccine development 39 http://www.ecevr.org/ http://dx.doi.org/10.7774/cevr.2013.2.1.34logical warfare: a historical perspective.,Non-OADS,/arxiv_data1/oa_pdf/b2/86/cevr-2-34.PMC3623498.pdf
"This is an Open Access article distributed under the  terms of the Creative Commons Attribution Non-Com - mercial License (http://creativecommons.org/licenses/by-nc/3.0) which permits unrestricted non-commercial use, distribution, and reproduction in any medium, pro - vided the original work is properly cited.KOREAN  VACCINE  SOCIETY KOREAN  VACCINE  SOCIETYKOREAN  ACCINE  OCIETYV S http://www.ecevr.org/Clin Exp Vaccine Res 2013;2:4-7 http://dx.doi.org/10.7774/cevr.2013.2.1.4pISSN 2287-3651 • eISSN 2287-366X  Christian Loucq International Vaccine Institute, Seoul, Korea Received: November 20, 2012 Revised: November 30, 2012Accepted: December 1, 2012  Corresponding author: Christian Loucq, MD International Vaccine Institute, SNU Research Park, 1 Gwanak-ro, Gwanak-gu, Seoul 151-191, KoreaTel: +82-2-881-1100, Fax: +82-2-872-2803E-mail:  cloucq@ivi.int No potential conflict of interest relevant to this  article was reported.Vaccines are considered as one of the major contributions of the 20th century and one of  the most cost effective public health interventions.",Non-OADS,/arxiv_data1/oa_pdf/c5/70/cevr-2-4.PMC3623499.pdf
"Christian Loucq • Vaccines today, tomorrow, and a perspective 5 http://www.ecevr.org/ http://dx.doi.org/10.7774/cevr.2013.2.1.4in vaccine design, development and introduction, addressing  the needs of people in developing countries.",Non-OADS,/arxiv_data1/oa_pdf/c5/70/cevr-2-4.PMC3623499.pdf
"Christian Loucq • Vaccines today, tomorrow, and a perspective 6 http://www.ecevr.org/ http://dx.doi.org/10.7774/cevr.2013.2.1.4 ically advanced malaria vaccine made of fusion protein com ­ prising of the repeat ANAP region of the circumsporozoite  protein of the sporozoite ( Plasmodium falciparum ) and the  hepatitis B surface antigen expressed in Escherichia coli  mixed  hepatitis B surface antigen and used with a proprietary adju ­ vant of GlaxoSmithKline Biologicals.",Non-OADS,/arxiv_data1/oa_pdf/c5/70/cevr-2-4.PMC3623499.pdf
"Christian Loucq • Vaccines today, tomorrow, and a perspective 7 http://www.ecevr.org/ http://dx.doi.org/10.7774/cevr.2013.2.1.4will guide the design of new vaccines that prove more diffi ­ cult to develop.",Non-OADS,/arxiv_data1/oa_pdf/c5/70/cevr-2-4.PMC3623499.pdf
Available  from: http://www.ivi.int.,Non-OADS,/arxiv_data1/oa_pdf/c5/70/cevr-2-4.PMC3623499.pdf
Avail ­ able from: http://www.polioeradication.org/Dataand monitoring/Poliothisweek.aspx.,Non-OADS,/arxiv_data1/oa_pdf/c5/70/cevr-2-4.PMC3623499.pdf
Available from: http://www.who.int/vaccine_safety/initiative/en/.,Non-OADS,/arxiv_data1/oa_pdf/c5/70/cevr-2-4.PMC3623499.pdf
Available from: http://www.dovcollaboration.,Non-OADS,/arxiv_data1/oa_pdf/c5/70/cevr-2-4.PMC3623499.pdf
Available from: http://www.ga  tesfoun­ dation.org/global ­health/Documents/global ­heal th­stra­ tegy­overview.pdf.,Non-OADS,/arxiv_data1/oa_pdf/c5/70/cevr-2-4.PMC3623499.pdf
Available from: http://www.who.int/vaccine_research/diseases/influenza/Ce ­ cil_Czerkinsky_3rdBroadspectrum.pdf.,Non-OADS,/arxiv_data1/oa_pdf/c5/70/cevr-2-4.PMC3623499.pdf
"This is an Open Access article distributed under the  terms of the Creative Commons Attribution Non-Com - mercial License (http://creativecommons.org/licenses/by-nc/3.0) which permits unrestricted non-commercial use, distribution, and reproduction in any medium, pro - vided the original work is properly cited.KOREAN  VACCINE  SOCIETY KOREAN  VACCINE  SOCIETYKOREAN  ACCINE  OCIETYV S http://www.ecevr.org/Clin Exp Vaccine Res 2013;2:40-45 http://dx.doi.org/10.7774/cevr.2013.2.1.40pISSN 2287-3651 • eISSN 2287-366X  Young June Choe, Geun-Ryang Bae Division of Vaccine Preventable Disease Control  and National Immunization Program, Korea Centers for Disease Control and Prevention, Cheongwon, Korea Received: September 27, 2012 Revised: October 31, 2012Accepted: November 5, 2012 Corresponding author: Geun-Ryang Bae, MD, PhD Division of Vaccine Preventable Disease Control and National Immunization Program, Korea   Centers for Disease Control and Prevention, Osong Health Technology Administration  Complex, 187 Osongsaengmyeong 2-ro,  Osong-eup, Cheongwon 363-951, KoreaTel: +82-43-719-7340, Fax: +82-43-719-7379E-mail: bgr824@cdc.go.kr No potential conflict of interest relevant to this  article was reported.Although vaccination is regarded as one of the most effective public health measure to pre - vent and control infectious diseases, no vaccine is perfectly safe.",Non-OADS,/arxiv_data1/oa_pdf/d5/27/cevr-2-40.PMC3623500.pdf
"Young June Choe et al • Vaccine safety management in Korea 41 http://www.ecevr.org/ http://dx.doi.org/10.7774/cevr.2013.2.1.40reactive responses are postulated to occur because of egg-re - lated antigen (measles, mumps, and rubella [MMR] and in - fluenza vaccine), mercury (hepatitis B vaccine, diphtheria,  tetanus, pertussis vaccine [DTaP], Japanese encephalitis vac - cine, and influenza vaccine), vaccine stabilizer (MMR), or an - tibiotics included in the live-attenuated virus vaccine (MMR); however, these mechanisms are not clearly explained, often [1-4].",Non-OADS,/arxiv_data1/oa_pdf/d5/27/cevr-2-40.PMC3623500.pdf
Young June Choe et al • Vaccine safety management in Korea 42 http://www.ecevr.org/ http://dx.doi.org/10.7774/cevr.2013.2.1.40 Fig.,Non-OADS,/arxiv_data1/oa_pdf/d5/27/cevr-2-40.PMC3623500.pdf
Young June Choe et al • Vaccine safety management in Korea 43 http://www.ecevr.org/ http://dx.doi.org/10.7774/cevr.2013.2.1.40AEFI.,Non-OADS,/arxiv_data1/oa_pdf/d5/27/cevr-2-40.PMC3623500.pdf
"When an AEFI has occurred, the vaccinees or their guard - ians may report the suspected AEFI through telephone to the local public health center; or by accessing website at http://nip.cdc.go.kr; and the healthcare professionals may report through telephone to the local public health center; or by ac - cessing website at http://is.cdc.go.kr.",Non-OADS,/arxiv_data1/oa_pdf/d5/27/cevr-2-40.PMC3623500.pdf
Young June Choe et al • Vaccine safety management in Korea 44 http://www.ecevr.org/ http://dx.doi.org/10.7774/cevr.2013.2.1.40 sated (48.6%).,OADS,/arxiv_data1/oa_pdf/d5/27/cevr-2-40.PMC3623500.pdf
Young June Choe et al • Vaccine safety management in Korea 45 http://www.ecevr.org/ http://dx.doi.org/10.7774/cevr.2013.2.1.40siderations.,Non-OADS,/arxiv_data1/oa_pdf/d5/27/cevr-2-40.PMC3623500.pdf
"This is an Open Access article distributed under the  terms of the Creative Commons Attribution Non-Com - mercial License (http://creativecommons.org/licenses/by-nc/3.0) which permits unrestricted non-commercial use, distribution, and reproduction in any medium, pro - vided the original work is properly cited.KOREAN  VACCINE  SOCIETY KOREAN  VACCINE  SOCIETYKOREAN  ACCINE  OCIETYV S http://www.ecevr.org/Clin Exp Vaccine Res 2013;2:46-52 http://dx.doi.org/10.7774/cevr.2013.2.1.46pISSN 2287-3651 • eISSN 2287-366X  Jahyang Cho, Bo Bae Kim,   Chong-Woo Bae, Sung-Ho Cha Department of Pediatrics, Kyung Hee University School of Medicine, Seoul, Korea Received: November 7, 2012 Revised: November 22, 2012Accepted: November 27, 2012 Corresponding author: Chong-Woo Bae, MD  Department of Pediatrics, Kyung Hee University Hospital at Gangdong, Kyung Hee University School of Medicine, 892 Dongnam-ro,  Gangdong-gu, Seoul 134-727, Korea Tel: +82-2-440-6130, Fax: +82-2-440-7175E-mail: baecw@khnmc.or.kr  No potential conflict of interest relevant to this  article was reported.Purpose:  PubMed is not only includes international medical journals but also has a registra - tion site for the ongoing clinical trials, such as ClinicalTrials.gov, under the supervision of US  National Institutes of Health.",Non-OADS,/arxiv_data1/oa_pdf/c1/c8/cevr-2-46.PMC3623501.pdf
Jahyang Cho et al • Vaccine clinical trials conducted by Korean investigators in ClinicalTrials.gov  47 http://www.ecevr.org/ http://dx.doi.org/10.7774/cevr.2013.2.1.46sion of US National Institutes of Health [3].,OADS,/arxiv_data1/oa_pdf/c1/c8/cevr-2-46.PMC3623501.pdf
"Published papers related key words of vaccine, Korea, and clinical trials in PubMed database of US National Library of Medicine 109 Published papers related key words of vaccine, Korea, and clinical study in PubMed database of US National Library of Medicine 171 Registry of clinical trials related key words of vaccine and Korea (conducted by Korean investigators) in ClinicalTrials.gova) database of US National     Institutes of Health (A)  72 Registry of clinical trials related key words of vaccine in ClinicalTrials.gova) database of US National Institutes of Health (B) 4,480 A/B (%) 1.6 a)http://clinicaltrials.gov/ [3].",OADS,/arxiv_data1/oa_pdf/c1/c8/cevr-2-46.PMC3623501.pdf
Jahyang Cho et al • Vaccine clinical trials conducted by Korean investigators in ClinicalTrials.gov  48 http://www.ecevr.org/ http://dx.doi.org/10.7774/cevr.2013.2.1.46 Table 2.,OADS,/arxiv_data1/oa_pdf/c1/c8/cevr-2-46.PMC3623501.pdf
a)http://clinicaltrials.gov/ [3].,Non-OADS,/arxiv_data1/oa_pdf/c1/c8/cevr-2-46.PMC3623501.pdf
Jahyang Cho et al • Vaccine clinical trials conducted by Korean investigators in ClinicalTrials.gov  49 http://www.ecevr.org/ http://dx.doi.org/10.7774/cevr.2013.2.1.46Table 3.,Non-OADS,/arxiv_data1/oa_pdf/c1/c8/cevr-2-46.PMC3623501.pdf
Jahyang Cho et al • Vaccine clinical trials conducted by Korean investigators in ClinicalTrials.gov  50 http://www.ecevr.org/ http://dx.doi.org/10.7774/cevr.2013.2.1.46 Table 4.,OADS,/arxiv_data1/oa_pdf/c1/c8/cevr-2-46.PMC3623501.pdf
"Completed 37 Recruiting 17 Active, not recruiting 11 Not yet recruiting   2 Enrolling by invitation   1 Terminated   1 Unknown   3 Total 72 a)http://clinicaltrials.gov/ [3].No.",Non-OADS,/arxiv_data1/oa_pdf/c1/c8/cevr-2-46.PMC3623501.pdf
a)http://clinicaltrials.gov [3].Table 3.,Non-OADS,/arxiv_data1/oa_pdf/c1/c8/cevr-2-46.PMC3623501.pdf
Jahyang Cho et al • Vaccine clinical trials conducted by Korean investigators in ClinicalTrials.gov  51 http://www.ecevr.org/ http://dx.doi.org/10.7774/cevr.2013.2.1.46Table 5.,Non-OADS,/arxiv_data1/oa_pdf/c1/c8/cevr-2-46.PMC3623501.pdf
"Asan Medical Center 2 Binex 1 Boryung Pharmaceutical Co., Ltd. 1 Bukwang Pharmaceutical 1 Chung-Ang University 1 CJ Cheiljedang Corporation 4 EMD Serono 2 EuBiologics Co., Ltd. 1 Ewha Womans University 3 Gachon University Gil Medical Center 1 Genexine Co., Ltd. 2 GlaxoSmithKline 23 Green Cross Corporation 4 Inha University Hospital 1 Inje University 2 Inovio Pharmaceuticals 2 Instituto Universitario IVI 1 International Vaccine Institute 1 Konkuk University Hospital 1 Korea Cancer Center Hospital 1 Korea University 1 Korean Center for Disease Control and Prevention 1 Kosin University Gospel Hospital 1 Kyunghee University Medical Center 1 LG Life Sciences 2 MedImmune LLC 1 Merck 7 Merck KGaA 2 National Cancer Center, Korea 1 Novartis 3 Novartis Vaccines 3 Pfizer 1 Samsung Medical Center 2 Sanofi-Aventis 7 Seoul National University Hospital 6 Severance Hospital 2 Soonchunhyang University Hospital 1 Tehran University of Medical Sciences 1 The Catholic University of Korea 2 VGX International, Inc. 1 Wonkwang University 1 Wyeth is now a wholly owned subsidiary of Pfizer 2 Yonsei University 2 a)http://clinicaltrials.gov/ [3].hypocalcemia (5), inflammatory bowel diseases (2), influen - za in birds (2), influenza, human (14), intestinal diseases (3)  intestinal neoplasms (1), Japanese encephalitis (2), joint dis - eases (1), kidney diseases (1), kidney failure, chronic (1), liver diseases (6), lung diseases (4), lung neoplasms (2), measles (3), meningitis (2), meningitis, bacterial (1), meningitis, me - ningococcal (1), meningococcal infections (2), menopause (1), metabolic diseases (5), mouth diseases (3), mumps (3), musculoskeletal diseases (1), myelitis (7), Neisseria meningit - idis infection (2), neisseriaceae infections (2), neoplasms,  glandular and epithelial (2), neurologic manifestations (5), neuromuscular diseases (7), non-small cell lung cancer (2), orthomyxoviridae infections (14), papilloma (2), papilloma - virus infections (1), paramyxoviridae infections (3), parotitis (3), cicornaviridae infections (13), pneumococcal infections (1), pneumonia (2), poliomyelitis (7), poxviridae infections (4), precancerous conditions (1), prostatic diseases (1), pros - tatic neoplasms (1), rectal diseases (1), renal insufficiency (1), renal insufficiency, chronic (1), respiratory tract diseases (23), respiratory tract infections (21), respiratory tract neoplasms (2), rheumatic diseases (1), RNA virus infections (31), rotavi - rus infections (1), rubella (3), salivary gland diseases (3), sial - adenitis (3), skin diseases (1), smallpox (4), spinal cord dis - eases (7), stomatognathic diseases (3), streptococcal infec - tions (1), tetanus (12), tetany (12), thoracic neoplasms (2), tu - mor virus infections (1), ulcer (1), urogenital neoplasms (1), urologic diseases (1), uterine cervical diseases (1), uterine cervical dysplasia (1), uterine cervical neoplasms (3), uterine diseases (1), vaccina (1), vibrio infections (1), virus diseases (41), and whooping cough (9).",Non-OADS,/arxiv_data1/oa_pdf/c1/c8/cevr-2-46.PMC3623501.pdf
Jahyang Cho et al • Vaccine clinical trials conducted by Korean investigators in ClinicalTrials.gov  52 http://www.ecevr.org/ http://dx.doi.org/10.7774/cevr.2013.2.1.46 progress.,OADS,/arxiv_data1/oa_pdf/c1/c8/cevr-2-46.PMC3623501.pdf
Available from: http://www.ncbi.nlm.nih.gov/sites/entrez/.,OADS,/arxiv_data1/oa_pdf/c1/c8/cevr-2-46.PMC3623501.pdf
Available from: http://clinicaltrials.gov/.,Non-OADS,/arxiv_data1/oa_pdf/c1/c8/cevr-2-46.PMC3623501.pdf
"This is an Open Access article distributed under the  terms of the Creative Commons Attribution Non-Com - mercial License (http://creativecommons.org/licenses/by-nc/3.0) which permits unrestricted non-commercial use, distribution, and reproduction in any medium, pro - vided the original work is properly cited.KOREAN  VACCINE  SOCIETY KOREAN  VACCINE  SOCIETYKOREAN  ACCINE  OCIETYV S http://www.ecevr.org/Clin Exp Vaccine Res 2013;2:53-57 http://dx.doi.org/10.7774/cevr.2013.2.1.53pISSN 2287-3651 • eISSN 2287-366X  Dae Sun Jo1,2, Jung Soo Kim1,2  1Department of Pediatrics, Chonbuk National  University Medical School; 2Biomedical Research  Institute, Chonbuk National University Hospital,  Chonbuk National University Medical School,  Jeonju, Korea Received: November 27, 2012 Revised: December 20, 2012 Accepted: December 29, 2012 Corresponding author: Jung Soo Kim, MD Department of Pediatrics, Chonbuk National University Hospital, Chonbuk National University Medical School, 20 Geonji-ro, Deokjin-gu,   Jeonju 561-712, Korea Tel: +82-63-250-1468, Fax: +82-63-250-1464 E-mail: kimjsp@chonbuk.ac.kr No potential conflict of interest relevant to this  article was reported.",Non-OADS,/arxiv_data1/oa_pdf/07/c4/cevr-2-53.PMC3623502.pdf
Dae Sun Jo et al • Pediatrician’s perspectives on vaccine injury compensation program in Korea 54 http://www.ecevr.org/ http://dx.doi.org/10.7774/cevr.2013.2.1.53 the field.,Non-OADS,/arxiv_data1/oa_pdf/07/c4/cevr-2-53.PMC3623502.pdf
"Dae Sun Jo et al • Pediatrician’s perspectives on vaccine injury compensation program in Korea 55 http://www.ecevr.org/ http://dx.doi.org/10.7774/cevr.2013.2.1.53Report criteria for inactivated polio vaccine, hepatitis B vaccine,  varicella vaccine, influenza vaccine, and typhoid vaccineFifty-three percent of responders agreed with the present cri - teria, i.e., criteria for diphtheria and tetanus toxoids and acel - lular pertussis vaccine (DTaP).",Non-OADS,/arxiv_data1/oa_pdf/07/c4/cevr-2-53.PMC3623502.pdf
Dae Sun Jo et al • Pediatrician’s perspectives on vaccine injury compensation program in Korea 56 http://www.ecevr.org/ http://dx.doi.org/10.7774/cevr.2013.2.1.53 they are not accepted as standards by authority.,Non-OADS,/arxiv_data1/oa_pdf/07/c4/cevr-2-53.PMC3623502.pdf
Dae Sun Jo et al • Pediatrician’s perspectives on vaccine injury compensation program in Korea 57 http://www.ecevr.org/ http://dx.doi.org/10.7774/cevr.2013.2.1.5310.,Non-OADS,/arxiv_data1/oa_pdf/07/c4/cevr-2-53.PMC3623502.pdf
"This is an Open Access article distributed under the  terms of the Creative Commons Attribution Non-Com - mercial License (http://creativecommons.org/licenses/by-nc/3.0) which permits unrestricted non-commercial use, distribution, and reproduction in any medium, pro - vided the original work is properly cited.KOREAN  VACCINE  SOCIETY KOREAN  VACCINE  SOCIETYKOREAN  ACCINE  OCIETYV S http://www.ecevr.org/Clin Exp Vaccine Res 2013;2:58-65 http://dx.doi.org/10.7774/cevr.2013.2.1.58pISSN 2287-3651 • eISSN 2287-366X  Sang-Yoon Choi1, Thao Dang-Hien Tran1, David E. Briles1,2,  Dong-Kwon Rhee1 1Sungkyunkwan University School of Pharmacy,  Suwon, Korea; 2Department of Microbiology,  University of Alabama at Birmingham,  Birmingham, AL, USA Received: October 31, 2012 Revised: November 9, 2012Accepted: November 15, 2012 Corresponding author: Dong-Kwon Rhee, PhD 2066 Seobu-ro, Jangan-gu, Sungkyunkwan University School of Pharmacy, Suwon 440-746, KoreaTel: +82-31-290-7707, Fax: +82-31-290-7727E-mail: dkrhee@skku.edu No potential conflict of interest relevant to this  article was reported.",Non-OADS,/arxiv_data1/oa_pdf/4c/fc/cevr-2-58.PMC3623503.pdf
"Sang-Yoon Choi et al • Inactivated markerless pep27  mutant as a mucosal vaccine 59 http://www.ecevr.org/ http://dx.doi.org/10.7774/cevr.2013.2.1.58to elicit protective mucosal immunity [9,10].",OADS,/arxiv_data1/oa_pdf/4c/fc/cevr-2-58.PMC3623503.pdf
Sang-Yoon Choi et al • Inactivated markerless pep27  mutant as a mucosal vaccine 60 http://www.ecevr.org/ http://dx.doi.org/10.7774/cevr.2013.2.1.58 ny was confirmed by PCR using the following primers: 5´- TCT CTA TCG GCC TCA AGC AG-3´ and 5´-CTG CGA GGC TTG CAC TGT AG-3´.,Non-OADS,/arxiv_data1/oa_pdf/4c/fc/cevr-2-58.PMC3623503.pdf
Sang-Yoon Choi et al • Inactivated markerless pep27  mutant as a mucosal vaccine 61 http://www.ecevr.org/ http://dx.doi.org/10.7774/cevr.2013.2.1.58sistance markers (Fig.,OADS,/arxiv_data1/oa_pdf/4c/fc/cevr-2-58.PMC3623503.pdf
Sang-Yoon Choi et al • Inactivated markerless pep27  mutant as a mucosal vaccine 62 http://www.ecevr.org/ http://dx.doi.org/10.7774/cevr.2013.2.1.58  When the immunized mice were challenged i.n.,Non-OADS,/arxiv_data1/oa_pdf/4c/fc/cevr-2-58.PMC3623503.pdf
Sang-Yoon Choi et al • Inactivated markerless pep27  mutant as a mucosal vaccine 63 http://www.ecevr.org/ http://dx.doi.org/10.7774/cevr.2013.2.1.58this strain may have the potential to revert back to the virulent  wild-type during colonization.,Non-OADS,/arxiv_data1/oa_pdf/4c/fc/cevr-2-58.PMC3623503.pdf
Sang-Yoon Choi et al • Inactivated markerless pep27  mutant as a mucosal vaccine 64 http://www.ecevr.org/ http://dx.doi.org/10.7774/cevr.2013.2.1.58 References 1.,Non-OADS,/arxiv_data1/oa_pdf/4c/fc/cevr-2-58.PMC3623503.pdf
Sang-Yoon Choi et al • Inactivated markerless pep27  mutant as a mucosal vaccine 65 http://www.ecevr.org/ http://dx.doi.org/10.7774/cevr.2013.2.1.58sulated strain of Streptococcus pneumoniae.,Non-OADS,/arxiv_data1/oa_pdf/4c/fc/cevr-2-58.PMC3623503.pdf
"This is an Open Access article distributed under the  terms of the Creative Commons Attribution Non-Com - mercial License (http://creativecommons.org/licenses/by-nc/3.0) which permits unrestricted non-commercial use, distribution, and reproduction in any medium, pro - vided the original work is properly cited.KOREAN  VACCINE  SOCIETY KOREAN  VACCINE  SOCIETYKOREAN  ACCINE  OCIETYV S http://www.ecevr.org/Clin Exp Vaccine Res 2013;2:66-68 http://dx.doi.org/10.7774/cevr.2013.2.1.66pISSN 2287-3651 • eISSN 2287-366X  Minki Hong1,2*, Bokyu Kang3*,   Woonsung Na1,2, Dongjun An4,  Hyoungjoon Moon3, Doo-Jin Kim1,  Jinsik Oh5, Seong-Jun Park1,  Haryoung Poo1,2, Jeong-Ki Kim6,  Jongman Kim3, Daesub Song1,2 1Viral Infectious Disease Research Center,  Korea Research Institute of Bioscience and  Biotechnology, Daejeon; 2University of Science  and Technology, Daejeon; 3Research Unit, Green  Cross Veterinary Products, Yongin; 4National  Veterinary Research and Quarantine Service, Anyang;  5Bionote Inc., Suwon; 6College of  Pharmacy, Korea University, Sejong, Korea Received: October 31, 2012 Revised: November 9, 2012Accepted: November 15, 2012 Corresponding author: Daesub Song, PhD Viral Infectious Disease Research Center, Korea Research Institute of Bioscience and  Biotechnology, 125 Gwahak-ro, Yuseong-gu, Daejeon 305-806, KoreaTel:+82-42-879-8273, Fax: +82-42-879-8498E-mail: sds1@kribb.re.kr  *Theses authors contributed equally to this work.",Non-OADS,/arxiv_data1/oa_pdf/70/95/cevr-2-66.PMC3623504.pdf
Minki Hong et al • Prolonged shedding of the CIV in immunocompromised dogs 67 http://www.ecevr.org/ http://dx.doi.org/10.7774/cevr.2013.2.1.66nosuppressive response occurs at 2.0-4.0 mg/kg/day.,Non-OADS,/arxiv_data1/oa_pdf/70/95/cevr-2-66.PMC3623504.pdf
"Minki Hong et al • Prolonged shedding of the CIV in immunocompromised dogs 68 http://www.ecevr.org/ http://dx.doi.org/10.7774/cevr.2013.2.1.66 ing, severe cough, and nasal discharge -were observed in  both groups at 2-8 dpi.",Non-OADS,/arxiv_data1/oa_pdf/70/95/cevr-2-66.PMC3623504.pdf
"This is an Open Access article distributed under the  terms of the Creative Commons Attribution Non-Com - mercial License (http://creativecommons.org/licenses/by-nc/3.0) which permits unrestricted non-commercial use, distribution, and reproduction in any medium, pro - vided the original work is properly cited.KOREAN  VACCINE  SOCIETY KOREAN  VACCINE  SOCIETYKOREAN  ACCINE  OCIETYV S http://www.ecevr.org/Clin Exp Vaccine Res 2013;2:69-70 http://dx.doi.org/10.7774/cevr.2013.2.1.69pISSN 2287-3651 • eISSN 2287-366X  Seog-Youn Kang Biologics Division, Korea Food and Drug  Administration, Cheongwon, Korea Received: November 9, 2012 Revised: November 23, 2012Accepted: November 27, 2012 Corresponding author: Seog-Youn Kang, PhD Korea Food and Drug Administration, Osong Health Technology Administration  Complex, 187 Osongsaengmyeong 2-ro,  Osong-eup, Cheongwon 363-700, Korea Tel: +82-43-719-3461, Fax: +82-43-719-3450E-mail: ksy1205@kfda.go.kr No potential conflict of interest relevant to this  article was reported.Based on the action plan “Ensuring a stable supply of National Immunization Program vac - cines and sovereignty of biopharmaceutical products,” Korea Food and Drug Administration  (KFDA) has made efforts to develop vaccines in the context of self reliance and to protect public health.",Non-OADS,/arxiv_data1/oa_pdf/e6/e7/cevr-2-69.PMC3623505.pdf
Seog-Youn Kang • Clinical trials for vaccine development in Korea 70 http://www.ecevr.org/ http://dx.doi.org/10.7774/cevr.2013.2.1.69 most exported item in 2011.,Non-OADS,/arxiv_data1/oa_pdf/e6/e7/cevr-2-69.PMC3623505.pdf
Avail - able from: http://www.kfda.go.kr/index.kfda?mid=96&pageNo=1&seq=12217&cmd=v.T otal LocalMultinational15 10 5 0 	 2006	 2007	 2008	 2009	 2010	 201 1 Year Fig.,Non-OADS,/arxiv_data1/oa_pdf/e6/e7/cevr-2-69.PMC3623505.pdf
"This is an Open Access article distributed under the  terms of the Creative Commons Attribution Non-Com - mercial License (http://creativecommons.org/licenses/by-nc/3.0) which permits unrestricted non-commercial use, distribution, and reproduction in any medium, pro - vided the original work is properly cited.KOREAN  VACCINE  SOCIETY KOREAN  VACCINE  SOCIETYKOREAN  ACCINE  OCIETYV S http://www.ecevr.org/Clin Exp Vaccine Res 2013;2:8-18 http://dx.doi.org/10.7774/cevr.2013.2.1.8pISSN 2287-3651 • eISSN 2287-366X  Jong-Hyeon Park Animal, Plant, and Fisheries Quarantine and  Inspection Agency, Anyang, Korea Received: October 23, 2012 Revised: November 12, 2012Accepted: November 20, 2012 Corresponding author: Jong-Hyeon Park, PhD Animal, Plant and Fisheries Quarantine and Inspection Agency, 175 Anyang-ro, Manan-gu, Anyang 430-757, Korea Tel:  +82-31-467-1719, Fax: +82-31-463-4516E-mail: parkjhvet@korea.kr No potential conflict of interest relevant to this  article was reported.",Non-OADS,/arxiv_data1/oa_pdf/f7/e0/cevr-2-8.PMC3623506.pdf
Jong-Hyeon Park • Improvement of foot-and-mouth disease vaccines  9 http://www.ecevr.org/ http://dx.doi.org/10.7774/cevr.2013.2.1.8vaccinations with O1 Manisa vaccine (at least 6PD 50) among  of cows and pigs [3] which made FMD cases to decline until it  was completely suppressed the following year (the last case reported was in April 2011).,Non-OADS,/arxiv_data1/oa_pdf/f7/e0/cevr-2-8.PMC3623506.pdf
"Jong-Hyeon Park • Improvement of foot-and-mouth disease vaccines  10 http://www.ecevr.org/ http://dx.doi.org/10.7774/cevr.2013.2.1.8 (W/O), and ISA25 (oil-in-water [O/W]).",Non-OADS,/arxiv_data1/oa_pdf/f7/e0/cevr-2-8.PMC3623506.pdf
"Jong-Hyeon Park • Improvement of foot-and-mouth disease vaccines  11 http://www.ecevr.org/ http://dx.doi.org/10.7774/cevr.2013.2.1.8mals for five days, 21 days after the administration of vaccines  with high antigen doses, could clinically protect themselves from infection.",Non-OADS,/arxiv_data1/oa_pdf/f7/e0/cevr-2-8.PMC3623506.pdf
"Jong-Hyeon Park • Improvement of foot-and-mouth disease vaccines  12 http://www.ecevr.org/ http://dx.doi.org/10.7774/cevr.2013.2.1.8 viruses remain, and a high level of biosafety is required dur - ing production process.",Non-OADS,/arxiv_data1/oa_pdf/f7/e0/cevr-2-8.PMC3623506.pdf
"Jong-Hyeon Park • Improvement of foot-and-mouth disease vaccines  13 http://www.ecevr.org/ http://dx.doi.org/10.7774/cevr.2013.2.1.8Among these, some methods have shown fairly successful re - sults, including the protective effects of replication-defective  systems, such as human adenoviruses [44-53].",Non-OADS,/arxiv_data1/oa_pdf/f7/e0/cevr-2-8.PMC3623506.pdf
"Jong-Hyeon Park • Improvement of foot-and-mouth disease vaccines  14 http://www.ecevr.org/ http://dx.doi.org/10.7774/cevr.2013.2.1.8 cificity of NSP ELISA tests was 99.05% (n=12,804) in non-vac - cinations, 98.49% (n=3,500) in single vaccinations, 97.90%  (n=79,649) in multiple vaccinated cattle under two years old, and 95.20% (n=2,517) in multiple vaccinated cattle two years old or older.",OADS,/arxiv_data1/oa_pdf/f7/e0/cevr-2-8.PMC3623506.pdf
Jong-Hyeon Park • Improvement of foot-and-mouth disease vaccines  15 http://www.ecevr.org/ http://dx.doi.org/10.7774/cevr.2013.2.1.8advanced control of vaccines from the stage of vaccine pro - duction so as not to create NSP antibodies in the field are all  essential requirements.,Non-OADS,/arxiv_data1/oa_pdf/f7/e0/cevr-2-8.PMC3623506.pdf
Jong-Hyeon Park • Improvement of foot-and-mouth disease vaccines  16 http://www.ecevr.org/ http://dx.doi.org/10.7774/cevr.2013.2.1.8 16.,Non-OADS,/arxiv_data1/oa_pdf/f7/e0/cevr-2-8.PMC3623506.pdf
Jong-Hyeon Park • Improvement of foot-and-mouth disease vaccines  17 http://www.ecevr.org/ http://dx.doi.org/10.7774/cevr.2013.2.1.8deleted strategy to the serotype O1 virus.,Non-OADS,/arxiv_data1/oa_pdf/f7/e0/cevr-2-8.PMC3623506.pdf
Jong-Hyeon Park • Improvement of foot-and-mouth disease vaccines  18 http://www.ecevr.org/ http://dx.doi.org/10.7774/cevr.2013.2.1.8 agnostic tests and vaccines for terres  trial animals.,Non-OADS,/arxiv_data1/oa_pdf/f7/e0/cevr-2-8.PMC3623506.pdf
"This is an Open Access article distributed under the  terms of the Creative Commons Attribution Non-Com - mercial License (http://creativecommons.org/licenses/by-nc/3.0) which permits unrestricted non-commercial use, distribution, and reproduction in any medium, pro - vided the original work is properly cited.KOREAN  VACCINE  SOCIETY KOREAN  VACCINE  SOCIETYKOREAN  ACCINE  OCIETYV S http://www.ecevr.org/Clin Exp Vaccine Res 2012;1:1-2 http://dx.doi.org/10.7774/cevr.2012.1.1.1pISSN 2287-3651 • eISSN 2287-366X  Received: May 10, 2012 Revised: June 1, 2012Accepted: June 15, 2012We welcome you to submit your manuscript now and join our authors who have published with  Clin Exp Vaccine Res",Non-OADS,/arxiv_data1/oa_pdf/0a/e0/cevr-1-1.PMC3623507.pdf
"Jung Soo Kim et al • We welcome you to submit your manuscript in CEVR 2 http://www.ecevr.org/ http://dx.doi.org/10.7774/cevr.2012.1.1.1 to exchanging ideas and share new discoveries in vaccine research, to building  the infrastructure connecting basic science to real-life programs, and to making frameworks to collaborate among researchers.",Non-OADS,/arxiv_data1/oa_pdf/0a/e0/cevr-1-1.PMC3623507.pdf
"This is an Open Access article distributed under the  terms of the Creative Commons Attribution Non-Com - mercial License (http://creativecommons.org/licenses/by-nc/3.0) which permits unrestricted non-commercial use, distribution, and reproduction in any medium, pro - vided the original work is properly cited.KOREAN  VACCINE  SOCIETY KOREAN  VACCINE  SOCIETYKOREAN  ACCINE  OCIETYV S http://www.ecevr.org/Clin Exp Vaccine Res 2012;1:18-34 http://dx.doi.org/10.7774/cevr.2012.1.1.18pISSN 2287-3651 • eISSN 2287-366X  Nak-Hyung Lee, Jung-Ah Lee,  Seung-Yong Park, Chang-Seon Song, In-Soo Choi, Joong-Bok Lee Department of Veterinary Infectious Diseases, College of Veterinary Medicine, Konkuk University, Seoul, Korea Received: April 25, 2012 Revised: May 20, 2012Accepted: June 15, 2012 Corresponding author: Joong-Bok Lee, PhD Department of Veterinary Infectious Diseases, College of Veterinary Medicine, Konkuk  University, 120 Neundong-ro, Gwangjin-gu,  Seoul 143-701, Korea Tel: +82-2-450-3714, Fax: +82-2-3437-1960E-mail: virus@konkuk.ac.kr No potential conflict of interest relevant to this  article was reported.Vaccination has proven to be the most cost-effective strategy for controlling a wide variety of  infectious diseases in humans and animals.",Non-OADS,/arxiv_data1/oa_pdf/60/f0/cevr-1-18.PMC3623508.pdf
Nak-Hyung Lee et al • Research and development of veterinary vaccines in Korea 19 http://www.ecevr.org/ http://dx.doi.org/10.7774/cevr.2012.1.1.18pathogen and destroy it when infection occurs later.,Non-OADS,/arxiv_data1/oa_pdf/60/f0/cevr-1-18.PMC3623508.pdf
"Nak-Hyung Lee et al • Research and development of veterinary vaccines in Korea 20 http://www.ecevr.org/ http://dx.doi.org/10.7774/cevr.2012.1.1.18 produced by adding necessary additions to viruses that were  propagated in suitable materials, such as cell cultures, tissues, chicken embryos, or live animals where no other means are available.",Non-OADS,/arxiv_data1/oa_pdf/60/f0/cevr-1-18.PMC3623508.pdf
Nak-Hyung Lee et al • Research and development of veterinary vaccines in Korea 21 http://www.ecevr.org/ http://dx.doi.org/10.7774/cevr.2012.1.1.18protective immunity within a short period of time and may  be promising in controlling LPAI H9N2 [12].,Non-OADS,/arxiv_data1/oa_pdf/60/f0/cevr-1-18.PMC3623508.pdf
"Nak-Hyung Lee et al • Research and development of veterinary vaccines in Korea 22 http://www.ecevr.org/ http://dx.doi.org/10.7774/cevr.2012.1.1.18 consequently, animal vaccines have been developed using  this system.",Non-OADS,/arxiv_data1/oa_pdf/60/f0/cevr-1-18.PMC3623508.pdf
Nak-Hyung Lee et al • Research and development of veterinary vaccines in Korea 23 http://www.ecevr.org/ http://dx.doi.org/10.7774/cevr.2012.1.1.18cell invasion by virulent virus and prevents establishment of  a persistent carrier status.,Non-OADS,/arxiv_data1/oa_pdf/60/f0/cevr-1-18.PMC3623508.pdf
"Nak-Hyung Lee et al • Research and development of veterinary vaccines in Korea 24 http://www.ecevr.org/ http://dx.doi.org/10.7774/cevr.2012.1.1.18 of intact antigen, the problem associated with the reversion  of virulence can be minimized.",Non-OADS,/arxiv_data1/oa_pdf/60/f0/cevr-1-18.PMC3623508.pdf
Nak-Hyung Lee et al • Research and development of veterinary vaccines in Korea 25 http://www.ecevr.org/ http://dx.doi.org/10.7774/cevr.2012.1.1.18that VLP vaccine would be a promising vaccine candidate  against AIV .,Non-OADS,/arxiv_data1/oa_pdf/60/f0/cevr-1-18.PMC3623508.pdf
"Nak-Hyung Lee et al • Research and development of veterinary vaccines in Korea 26 http://www.ecevr.org/ http://dx.doi.org/10.7774/cevr.2012.1.1.18 ing a target gene with various genetic techniques, including  gene-insertion, deletion, disruption, replacement, and point mutation.",Non-OADS,/arxiv_data1/oa_pdf/60/f0/cevr-1-18.PMC3623508.pdf
"Nak-Hyung Lee et al • Research and development of veterinary vaccines in Korea 27 http://www.ecevr.org/ http://dx.doi.org/10.7774/cevr.2012.1.1.18including genetics, biochemistry, and molecular biology to  identify proper antigenic epitopes and corresponding pep - tides as candidate vaccine antigens.",OADS,/arxiv_data1/oa_pdf/60/f0/cevr-1-18.PMC3623508.pdf
"Nak-Hyung Lee et al • Research and development of veterinary vaccines in Korea 28 http://www.ecevr.org/ http://dx.doi.org/10.7774/cevr.2012.1.1.18 anthrax, and cholera.",Non-OADS,/arxiv_data1/oa_pdf/60/f0/cevr-1-18.PMC3623508.pdf
"Nak-Hyung Lee et al • Research and development of veterinary vaccines in Korea 29 http://www.ecevr.org/ http://dx.doi.org/10.7774/cevr.2012.1.1.18been mainly focused on the control of infectious diseases of  animals, the current status of development of effective vaccines to reduce foodborne pathogen loads in livestock is highlighted in this section.",Non-OADS,/arxiv_data1/oa_pdf/60/f0/cevr-1-18.PMC3623508.pdf
Nak-Hyung Lee et al • Research and development of veterinary vaccines in Korea 30 http://www.ecevr.org/ http://dx.doi.org/10.7774/cevr.2012.1.1.18 tamination problem of meat processing in slaughter houses.,Non-OADS,/arxiv_data1/oa_pdf/60/f0/cevr-1-18.PMC3623508.pdf
"Nak-Hyung Lee et al • Research and development of veterinary vaccines in Korea 31 http://www.ecevr.org/ http://dx.doi.org/10.7774/cevr.2012.1.1.18pre-existing antibody, malnutrition, environment extremes,  and stress conditions), resulting in adverse effects and poor immune responses.",Non-OADS,/arxiv_data1/oa_pdf/60/f0/cevr-1-18.PMC3623508.pdf
Nak-Hyung Lee et al • Research and development of veterinary vaccines in Korea 32 http://www.ecevr.org/ http://dx.doi.org/10.7774/cevr.2012.1.1.18 Curr Opin Mol Ther 2000;2:94-9.,Non-OADS,/arxiv_data1/oa_pdf/60/f0/cevr-1-18.PMC3623508.pdf
http://dx.doi.org/ 10.1111/j.1750-2659.2012.00396.x.,Non-OADS,/arxiv_data1/oa_pdf/60/f0/cevr-1-18.PMC3623508.pdf
"Nak-Hyung Lee et al • Research and development of veterinary vaccines in Korea 33 http://www.ecevr.org/ http://dx.doi.org/10.7774/cevr.2012.1.1.18ratory syndrome virus GP5 on virus infectivity, antigenic - ity, and ability to induce neutralizing antibodies.",OADS,/arxiv_data1/oa_pdf/60/f0/cevr-1-18.PMC3623508.pdf
http://dx.doi.org/10.1016/j.rvsc.2012.02.012.,OADS,/arxiv_data1/oa_pdf/60/f0/cevr-1-18.PMC3623508.pdf
Nak-Hyung Lee et al • Research and development of veterinary vaccines in Korea 34 http://www.ecevr.org/ http://dx.doi.org/10.7774/cevr.2012.1.1.18 callus.,Non-OADS,/arxiv_data1/oa_pdf/60/f0/cevr-1-18.PMC3623508.pdf
"This is an Open Access article distributed under the  terms of the Creative Commons Attribution Non-Com - mercial License (http://creativecommons.org/licenses/by-nc/3.0) which permits unrestricted non-commercial use, distribution, and reproduction in any medium, pro - vided the original work is properly cited.KOREAN  VACCINE  SOCIETY KOREAN  VACCINE  SOCIETYKOREAN  ACCINE  OCIETYV S http://www.ecevr.org/Clin Exp Vaccine Res 2012;1:3-8 http://dx.doi.org/10.7774/cevr.2012.1.1.3pISSN 2287-3651 • eISSN 2287-366X  Sung-Ho Cha Department of Pediatrics, Kyung Hee University  Hospital, Kyung Hee University School of Medicine, Seoul, Korea Received: May 15, 2012 Revised: May 30, 2012Accepted: June 15, 2012 Corresponding author: Sung-Ho Cha, MD, PhD Department of Pediatrics, Kyung Hee University Hospital, Kyung Hee University School of  Medicine, 26 Kyungheedae-ro, Dongdaemun-gu, Seoul 130-702, Korea Tel: +82-2-958-8303, Fax: +82-2-958-8304E-mail: sunghocha@khu.ac.kr No potential conflict of interest relevant to this  article was reported.There may be many reasons for the significant decrease in the incidence of the pediatric infec - tious diseases in modern Korea; this could be due to the improvement of sanitary facilities, sig - nificant growth of Korean economy, improvement of nutrition, development and dissemination  of antibiotics and implantation of vaccination, and overall improvement of medical technology.",Non-OADS,/arxiv_data1/oa_pdf/62/64/cevr-1-3.PMC3623509.pdf
Sung-Ho Cha • History of vaccination and current vaccination policies in Korea 4 http://www.ecevr.org/ http://dx.doi.org/10.7774/cevr.2012.1.1.3 Joseon Dynasty and cover vaccination-related works in Korea  in modern history and review the objectives and directions of current vaccination policies in South Korea.,Non-OADS,/arxiv_data1/oa_pdf/62/64/cevr-1-3.PMC3623509.pdf
"Sung-Ho Cha • History of vaccination and current vaccination policies in Korea 5 http://www.ecevr.org/ http://dx.doi.org/10.7774/cevr.2012.1.1.3this period [6,7].",Non-OADS,/arxiv_data1/oa_pdf/62/64/cevr-1-3.PMC3623509.pdf
"Sung-Ho Cha • History of vaccination and current vaccination policies in Korea 6 http://www.ecevr.org/ http://dx.doi.org/10.7774/cevr.2012.1.1.3 so unified national vaccination service seemed to be possible  [6,12].",Non-OADS,/arxiv_data1/oa_pdf/62/64/cevr-1-3.PMC3623509.pdf
"Sung-Ho Cha • History of vaccination and current vaccination policies in Korea 7 http://www.ecevr.org/ http://dx.doi.org/10.7774/cevr.2012.1.1.3increased number of infectious diseases or occurring new  emerging infectious disease in the community, temporary vaccination would be given based on the article (e.g., nation - wide measles vaccination in 2001) [12].",Non-OADS,/arxiv_data1/oa_pdf/62/64/cevr-1-3.PMC3623509.pdf
"Sung-Ho Cha • History of vaccination and current vaccination policies in Korea 8 http://www.ecevr.org/ http://dx.doi.org/10.7774/cevr.2012.1.1.3 tion, antigen and antibody tests for hepatitis B to prevent ver - tical infection from infected mothers.",Non-OADS,/arxiv_data1/oa_pdf/62/64/cevr-1-3.PMC3623509.pdf
Available from: http://encykorea.aks.ac.kr.,Non-OADS,/arxiv_data1/oa_pdf/62/64/cevr-1-3.PMC3623509.pdf
Available from: http://www.archives.go.kr.,Non-OADS,/arxiv_data1/oa_pdf/62/64/cevr-1-3.PMC3623509.pdf
"This is an Open Access article distributed under the  terms of the Creative Commons Attribution Non-Com - mercial License (http://creativecommons.org/licenses/by-nc/3.0) which permits unrestricted non-commercial use, distribution, and reproduction in any medium, pro - vided the original work is properly cited.KOREAN  VACCINE  SOCIETY KOREAN  VACCINE  SOCIETYKOREAN  ACCINE  OCIETYV S http://www.ecevr.org/Clin Exp Vaccine Res 2012;1:35-49 http://dx.doi.org/10.7774/cevr.2012.1.1.35pISSN 2287-3651 • eISSN 2287-366X  Yo Han Jang1, Baik-Lin Seong1,2 1Laboratory of Molecular Medicine, Department  of Biotechnology, College of Life Science and  Biotechnology, 2Translational Research Center for  Protein Function Control, Yonsei University, Seoul, Korea Received: May 5, 2012  Revised: May 23, 2012Accepted: June 10, 2012 Corresponding author: Baik-Lin Seong, PhD Department of Biotechnology, College of Life Science and Biotechnology, Yonsei University, 50 Yonsei-ro, Seodaemun-gu, Seoul 120-749, KoreaTel: +82-2-2123-2885, Fax: +82-2-362-7265 E-mail: blseong@yonsei.ac.kr No potential conflict of interest relevant to this  article was reported.",Non-OADS,/arxiv_data1/oa_pdf/7e/82/cevr-1-35.PMC3623510.pdf
"Yo Han Jang et al • Principles of live attenuated influenza vaccine 36 http://www.ecevr.org/ http://dx.doi.org/10.7774/cevr.2012.1.1.35 with each other, resulting in substantial changes in its anti - genicity (antigenic shift).",Non-OADS,/arxiv_data1/oa_pdf/7e/82/cevr-1-35.PMC3623510.pdf
Yo Han Jang et al • Principles of live attenuated influenza vaccine 37 http://www.ecevr.org/ http://dx.doi.org/10.7774/cevr.2012.1.1.35that became possible by the recent considerable advances in  our understanding of the molecular virology of the influenza virus.,Non-OADS,/arxiv_data1/oa_pdf/7e/82/cevr-1-35.PMC3623510.pdf
"Yo Han Jang et al • Principles of live attenuated influenza vaccine 38 http://www.ecevr.org/ http://dx.doi.org/10.7774/cevr.2012.1.1.35 live attenuated vaccines [27,28], unlike other previous strate - gies.",Non-OADS,/arxiv_data1/oa_pdf/7e/82/cevr-1-35.PMC3623510.pdf
Yo Han Jang et al • Principles of live attenuated influenza vaccine 39 http://www.ecevr.org/ http://dx.doi.org/10.7774/cevr.2012.1.1.35variant strain.,Non-OADS,/arxiv_data1/oa_pdf/7e/82/cevr-1-35.PMC3623510.pdf
"Yo Han Jang et al • Principles of live attenuated influenza vaccine 40 http://www.ecevr.org/ http://dx.doi.org/10.7774/cevr.2012.1.1.35 and 2’ ,5’-oligoadenylate synthetase/RNase L [75-78].",Non-OADS,/arxiv_data1/oa_pdf/7e/82/cevr-1-35.PMC3623510.pdf
Yo Han Jang et al • Principles of live attenuated influenza vaccine 41 http://www.ecevr.org/ http://dx.doi.org/10.7774/cevr.2012.1.1.35attenuation of the mutant virus in mice due to the decreased  translation of viral proteins.,Non-OADS,/arxiv_data1/oa_pdf/7e/82/cevr-1-35.PMC3623510.pdf
Yo Han Jang et al • Principles of live attenuated influenza vaccine 42 http://www.ecevr.org/ http://dx.doi.org/10.7774/cevr.2012.1.1.35 tenuated by the reduced translation efficiency of mutated  proteins.,Non-OADS,/arxiv_data1/oa_pdf/7e/82/cevr-1-35.PMC3623510.pdf
Yo Han Jang et al • Principles of live attenuated influenza vaccine 43 http://www.ecevr.org/ http://dx.doi.org/10.7774/cevr.2012.1.1.35cold-adapted strain at nonpermissive temperatures.,Non-OADS,/arxiv_data1/oa_pdf/7e/82/cevr-1-35.PMC3623510.pdf
Yo Han Jang et al • Principles of live attenuated influenza vaccine 44 http://www.ecevr.org/ http://dx.doi.org/10.7774/cevr.2012.1.1.35 The growing body of information on influenza virology to - gether with the RG technique rendered the design of attenu - ated live vaccine candidates relatively easy.,Non-OADS,/arxiv_data1/oa_pdf/7e/82/cevr-1-35.PMC3623510.pdf
Yo Han Jang et al • Principles of live attenuated influenza vaccine 45 http://www.ecevr.org/ http://dx.doi.org/10.7774/cevr.2012.1.1.35combinants made from A/PR/8/34 (H0 N1) and wild H3  N2 influenza viruses.,Non-OADS,/arxiv_data1/oa_pdf/7e/82/cevr-1-35.PMC3623510.pdf
Yo Han Jang et al • Principles of live attenuated influenza vaccine 46 http://www.ecevr.org/ http://dx.doi.org/10.7774/cevr.2012.1.1.35 tenuation phenotype conferred by the M gene of the influ - enza A/Ann Arbor/6/60 cold-adapted virus (H2N2) on the  A/Korea/82 (H3N2) reassortant virus results from a gene constellation effect.,Non-OADS,/arxiv_data1/oa_pdf/7e/82/cevr-1-35.PMC3623510.pdf
Yo Han Jang et al • Principles of live attenuated influenza vaccine 47 http://www.ecevr.org/ http://dx.doi.org/10.7774/cevr.2012.1.1.35bases for broad-spectrum neutralization of avian and hu - man influenza A viruses.,Non-OADS,/arxiv_data1/oa_pdf/7e/82/cevr-1-35.PMC3623510.pdf
Yo Han Jang et al • Principles of live attenuated influenza vaccine 48 http://www.ecevr.org/ http://dx.doi.org/10.7774/cevr.2012.1.1.35 H5N1 influenza vaccine.,Non-OADS,/arxiv_data1/oa_pdf/7e/82/cevr-1-35.PMC3623510.pdf
Yo Han Jang et al • Principles of live attenuated influenza vaccine 49 http://www.ecevr.org/ http://dx.doi.org/10.7774/cevr.2012.1.1.35113.,Non-OADS,/arxiv_data1/oa_pdf/7e/82/cevr-1-35.PMC3623510.pdf
"This is an Open Access article distributed under the  terms of the Creative Commons Attribution Non-Com - mercial License (http://creativecommons.org/licenses/by-nc/3.0) which permits unrestricted non-commercial use, distribution, and reproduction in any medium, pro - vided the original work is properly cited.KOREAN  VACCINE  SOCIETY KOREAN  VACCINE  SOCIETYKOREAN  ACCINE  OCIETYV S http://www.ecevr.org/Clin Exp Vaccine Res 2012;1:50-63 http://dx.doi.org/10.7774/cevr.2012.1.1.50pISSN 2287-3651 • eISSN 2287-366X  Joon Haeng Rhee1,2, Shee Eun Lee1,3,  Soo Young Kim1,4 1Clinical Vaccine R&D Center, Chonnam National  University Hwasun Hospital, Chonnam National  University Medical School, Hwasun; 2Department  of Microbiology and Research Institute of Vibrio Infections, Chonnam National University Medical School, Gwangju;  3Department of Pharmacology  and Dental Therapeutics, School of Dentistry, Chonnam National University, Gwangju;  4Fraunhofer Korea Center for Biopharmaceutical  Research, Hwasun, Korea Received: April 20, 2012 Revised: May 25, 2012Accepted: June 15, 2012 Corresponding author: Joon Haeng Rhee, MD Clinical Vaccine R&D Center, Chonnam National University Hwasun Hospital, Chonnam National  University Medical School, 322 Seoyang-ro,  Hwasun 519-763, Korea Tel: +82-61-379-8479, Fax: +82-61-379-8455E-mail: jhrhee@chonnam.ac.kr  No potential conflict of interest relevant to this  article was reported.Mucosal vaccination, capable of inducing protective immune responses both in the mucosal  and systemic immune compartments, has many advantages and is regarded as a blue ocean in the vaccine industry.",Non-OADS,/arxiv_data1/oa_pdf/4b/2f/cevr-1-50.PMC3623511.pdf
"Joon Haeng Rhee et al • Mucosal vaccine adjuvants update 51 http://www.ecevr.org/ http://dx.doi.org/10.7774/cevr.2012.1.1.50ease of administration, higher patient compliance, needle-free  administration, and a higher capacity for mass immuniza - tions during pandemic situations [4].",Non-OADS,/arxiv_data1/oa_pdf/4b/2f/cevr-1-50.PMC3623511.pdf
"Joon Haeng Rhee et al • Mucosal vaccine adjuvants update 52 http://www.ecevr.org/ http://dx.doi.org/10.7774/cevr.2012.1.1.50 apparently via DCs, can also affect the nature of CD4 T helper  (Th), CD8 T cell, and B cell responses, with some adjuvants promoting Th1-related responses and others preferentially inducing Th2-biased effects.",Non-OADS,/arxiv_data1/oa_pdf/4b/2f/cevr-1-50.PMC3623511.pdf
Joon Haeng Rhee et al • Mucosal vaccine adjuvants update 53 http://www.ecevr.org/ http://dx.doi.org/10.7774/cevr.2012.1.1.50motif for PAMP recognition and cytoplasmic Toll/interleu - kin-1 receptor signaling domain [15].,OADS,/arxiv_data1/oa_pdf/4b/2f/cevr-1-50.PMC3623511.pdf
"Joon Haeng Rhee et al • Mucosal vaccine adjuvants update 54 http://www.ecevr.org/ http://dx.doi.org/10.7774/cevr.2012.1.1.50 alarming the immune system [38,39].",Non-OADS,/arxiv_data1/oa_pdf/4b/2f/cevr-1-50.PMC3623511.pdf
Joon Haeng Rhee et al • Mucosal vaccine adjuvants update 55 http://www.ecevr.org/ http://dx.doi.org/10.7774/cevr.2012.1.1.50and B cells activated by antigen at one place to appear as ef - fector cells in distant mucosal sites [52].,OADS,/arxiv_data1/oa_pdf/4b/2f/cevr-1-50.PMC3623511.pdf
"Joon Haeng Rhee et al • Mucosal vaccine adjuvants update 56 http://www.ecevr.org/ http://dx.doi.org/10.7774/cevr.2012.1.1.50 number of Bell’s palsy was reported in vaccinees, which was  proposed to associated with the high affinity binding of the enterotoxin to GM1 ganglioside moieties of olfactory nerves [6,81].",OADS,/arxiv_data1/oa_pdf/4b/2f/cevr-1-50.PMC3623511.pdf
"Joon Haeng Rhee et al • Mucosal vaccine adjuvants update 57 http://www.ecevr.org/ http://dx.doi.org/10.7774/cevr.2012.1.1.50TLR ligands Recognition of PAMP by TLR triggers a signaling pathway resulting in the production of pro-inflammatory cytokines and up-regulation in expression of co-stimulatory molecules, thereby activating not only innate immunity but ultimately also acquired immune responses (Fig.",Non-OADS,/arxiv_data1/oa_pdf/4b/2f/cevr-1-50.PMC3623511.pdf
Joon Haeng Rhee et al • Mucosal vaccine adjuvants update 58 http://www.ecevr.org/ http://dx.doi.org/10.7774/cevr.2012.1.1.50 could be developed as mucosal vaccines.,Non-OADS,/arxiv_data1/oa_pdf/4b/2f/cevr-1-50.PMC3623511.pdf
Joon Haeng Rhee et al • Mucosal vaccine adjuvants update 59 http://www.ecevr.org/ http://dx.doi.org/10.7774/cevr.2012.1.1.50and enhance B cell proliferation and IgA production [110].,OADS,/arxiv_data1/oa_pdf/4b/2f/cevr-1-50.PMC3623511.pdf
Joon Haeng Rhee et al • Mucosal vaccine adjuvants update 60 http://www.ecevr.org/ http://dx.doi.org/10.7774/cevr.2012.1.1.50 leading to enhanced adaptive immunity.,OADS,/arxiv_data1/oa_pdf/4b/2f/cevr-1-50.PMC3623511.pdf
Joon Haeng Rhee et al • Mucosal vaccine adjuvants update 61 http://www.ecevr.org/ http://dx.doi.org/10.7774/cevr.2012.1.1.50diated mucosal immunity.,OADS,/arxiv_data1/oa_pdf/4b/2f/cevr-1-50.PMC3623511.pdf
http://dx.doi.org/10.1517/17425247.2012.697455.,Non-OADS,/arxiv_data1/oa_pdf/4b/2f/cevr-1-50.PMC3623511.pdf
Joon Haeng Rhee et al • Mucosal vaccine adjuvants update 62 http://www.ecevr.org/ http://dx.doi.org/10.7774/cevr.2012.1.1.50 peptide antigens.,OADS,/arxiv_data1/oa_pdf/4b/2f/cevr-1-50.PMC3623511.pdf
Joon Haeng Rhee et al • Mucosal vaccine adjuvants update 63 http://www.ecevr.org/ http://dx.doi.org/10.7774/cevr.2012.1.1.50response followed by dendritic and natural killer cell  activation and recruitment in the mouse lung.,Non-OADS,/arxiv_data1/oa_pdf/4b/2f/cevr-1-50.PMC3623511.pdf
"This is an Open Access article distributed under the  terms of the Creative Commons Attribution Non-Com - mercial License (http://creativecommons.org/licenses/by-nc/3.0) which permits unrestricted non-commercial use, distribution, and reproduction in any medium, pro - vided the original work is properly cited.KOREAN  VACCINE  SOCIETY KOREAN  VACCINE  SOCIETYKOREAN  ACCINE  OCIETYV S http://www.ecevr.org/Clin Exp Vaccine Res 2012;1:64-69 http://dx.doi.org/10.7774/cevr.2012.1.1.64pISSN 2287-3651 • eISSN 2287-366X  Myung Hee Han1, Hee Young Ju1,  Kyung Suk Lee1, Sung-Ho Cha1,  Young-Jin Lee2, Chong-Woo Bae1 1Department of Pediatrics, 2Medical Library,  Kyung Hee University Hospital at Gangdong,  Kyung Hee University School of Medicine,  Seoul, Korea Received: May 7, 2012 Revised: May 25, 2012Accepted: June 10, 2012 Corresponding author: Chong-Woo Bae, MD Department of Pediatrics, Kyung Hee University Hospital at Gangdong, Kyung Hee University School of Medicine, 892 Dongnam-ro,  Gangdong-gu, Seoul 134-727, Korea Tel: +82-2-440-6130, Fax: +82-2-440-7175E-mail: baecw@khnmc.or.kr No potential conflict of interest relevant to this  article was reported.Purpose:  T o describe the present status and changing patterns of medical papers related to  keywords of vaccine and vaccination published in Korea over the last 50 years, and provide  basic data for future studies.",Non-OADS,/arxiv_data1/oa_pdf/59/6c/cevr-1-64.PMC3623512.pdf
Myung Hee Han et al • Medical papers related to vaccine and vaccination in Korea 65 http://www.ecevr.org/ http://dx.doi.org/10.7774/cevr.2012.1.1.64increasing since 1993.,OADS,/arxiv_data1/oa_pdf/59/6c/cevr-1-64.PMC3623512.pdf
"of medical papers (abstract) with keywords of “vaccine and/or vaccination” in KoreaMed database (B) 1,089 (B)/(A) (%) 0.58 a)KoreaMed: KoreaMed search system provides access not only to the KoreaMed database of bibliographic information but also medical journal information, is  established by the Korean Association of Medical Journal Editors (http://www.koreamed.org).",OADS,/arxiv_data1/oa_pdf/59/6c/cevr-1-64.PMC3623512.pdf
Myung Hee Han et al • Medical papers related to vaccine and vaccination in Korea  66 http://www.ecevr.org/ http://dx.doi.org/10.7774/cevr.2012.1.1.64 or vaccination and various minor keywords were searched  is organized in Table 2.,OADS,/arxiv_data1/oa_pdf/59/6c/cevr-1-64.PMC3623512.pdf
"Acceptability 1 Detection 27 Infection 215 Purification 50 Accuracy 7 Development 118 Inflammatory 14 Rash 4 Activated 12 Diarrhea 16 Injection 39 Reaction 67 Active 36 Distribution 34 Intramuscular 10 Receptor 11 Adult 95 DNA 82 Investigation 24 Recommendation 21 Adverse reaction 12 Dose 69 Investigator 2 Research 188 Analysis 106 Effect 87 Isolation 30 Response 126 Animal 60 Efficacy 92 Knowledge 20 Review 111 Antibody 149 Enzyme 47 Live-attenuated 28 RNA 23 Anti-cancer 6 Epidemiology 69 Manifestation 8 Safety 70 Antigen 103 Etiology 8 Measurement 6 Schedule 33 Anti-tumor 13 Expression 57 Mechanism 15 Sequence 40 Application 14 Factor 33 Monitor 4 Sero-conversion 37 Bacteria 21 Fever 55 Need 49 Sero-epidemiology 6 Cancer 93 Follow up 29 Novel 25 Serology 2 Case 64 Genetics 56 Oral 35 Serotype 27 Case report 34 Genotype 12 Organism 6 Surveillance 15 Cell 147 Guideline 11 Outbreak 26 Shock 12 Characteristics 32 Health care 23 Parasite 8 Side effect 6 Children 160 Heterogeneity 3 Passive 6 Site 39 Classification 9 Host 31 Past 32 Status 53 Clinical   183 Human 134 Pathogenesis 11 Storage 5 Clinical trial 39 Identification 18 Pattern 22 Strategy 27 Cloning 13 Immune 140 PCR 46 Structure 8 Cohort 4 Immunity 98 Peptide 20 Study 311 Colony 17 Immunization 171 Post-marketing 1 Survival 28 Combination 17 Immunoassay 13 Potency 4 Therapy 1 Combined 17 Immunogenecity 10 Practice 18 Toxicity 6 Complication 19 Immunology 129 Prediction 2 Trans-cutaneous 2 Concept 5 Immunotherapy 32 Prevalence 46 Treatment 93 Content 4 Impact 13 Prevention 135 Trial 51 Control 174 In vitro 29 Production 53 Tumor 63 Cost 21 In vivo 32 Prophylaxis 2 Update 7 Coverage 31 Inactivated 44 Prospects 3 Validity 4 Current issue 1 Incidence 75 Protection 60 Viral 106 Cytotoxic 28 Indication 4 Protective effect 16 Virus 189 Defense 2 Industry 7 Protein 111 Volunteer 1 a)KoreaMed: KoreaMed search system provides access not only to the KoreaMed database of bibliographic information but also medical journal information, is  established by the Korean Association of Medical Journal Editors (http://www.koreamed.org).",Non-OADS,/arxiv_data1/oa_pdf/59/6c/cevr-1-64.PMC3623512.pdf
Myung Hee Han et al • Medical papers related to vaccine and vaccination in Korea 67 http://www.ecevr.org/ http://dx.doi.org/10.7774/cevr.2012.1.1.64Table 3.,OADS,/arxiv_data1/oa_pdf/59/6c/cevr-1-64.PMC3623512.pdf
"of papers % Cumulative % 1962-1969 1 0.1 0.1 1970-1979 24 2.2 2.3 1980-1989 46 4.2 6.5 1990-1999 242 22.2 28.7 2000-2009 585 53.8 82.5 2010-Apr 2012 191 27.5 100.0 Total 1,089 100.0 100.0 a)KoreaMed: KoreaMed search system provides access not only to the  KoreaMed database of bibliographic information but also medical journal  information, is established by the Korean Association of Me  dical Journal  Editors (KAMJE) (http://www.koreamed.org).",OADS,/arxiv_data1/oa_pdf/59/6c/cevr-1-64.PMC3623512.pdf
"Myung Hee Han et al • Medical papers related to vaccine and vaccination in Korea  68 http://www.ecevr.org/ http://dx.doi.org/10.7774/cevr.2012.1.1.64 11.5% of clinical trials, 6.9% of complications.",OADS,/arxiv_data1/oa_pdf/59/6c/cevr-1-64.PMC3623512.pdf
"Myung Hee Han et al • Medical papers related to vaccine and vaccination in Korea 69 http://www.ecevr.org/ http://dx.doi.org/10.7774/cevr.2012.1.1.64Discussion  In Medline/PubMed baseline database [5,6], a database of  biomedical papers managed by the US National Library of Medicine, approximately 23,000 articles are updated everyday and about 20 million records are contained up to the present May, 2012.",OADS,/arxiv_data1/oa_pdf/59/6c/cevr-1-64.PMC3623512.pdf
Available from: http://thomsonreuters.com/products_services/sci - ence/.,OADS,/arxiv_data1/oa_pdf/59/6c/cevr-1-64.PMC3623512.pdf
Available from: http://www.koreamed.org.,OADS,/arxiv_data1/oa_pdf/59/6c/cevr-1-64.PMC3623512.pdf
Available from: http://www.nlm.nih.gov/databases/journal.html.,OADS,/arxiv_data1/oa_pdf/59/6c/cevr-1-64.PMC3623512.pdf
Available from: http://www.nlm.nih.gov/bsd/serfile_addedinfo.html.,Non-OADS,/arxiv_data1/oa_pdf/59/6c/cevr-1-64.PMC3623512.pdf
"This is an Open Access article distributed under the  terms of the Creative Commons Attribution Non-Com - mercial License (http://creativecommons.org/licenses/by-nc/3.0) which permits unrestricted non-commercial use, distribution, and reproduction in any medium, pro - vided the original work is properly cited.KOREAN  VACCINE  SOCIETY KOREAN  VACCINE  SOCIETYKOREAN  ACCINE  OCIETYV S http://www.ecevr.org/Clin Exp Vaccine Res 2012;1:70-76 http://dx.doi.org/10.7774/cevr.2012.1.1.70pISSN 2287-3651 • eISSN 2287-366X  Seon Ah Park, Seung-Yong Park,  Chang-Seon Song, In-Soo Choi,  Hwi Yool Kim, Joong-Bok Lee,  Nak-Hyung Lee Department of Veterinary Infectious Diseases, College of Veterinary Medicine, Konkuk University, Seoul, Korea  Received: April 30, 2012 Revised: May 10, 2012Accepted: June 10, 2012 Corresponding author: Nak-Hyung Lee, PhD Department of Veterinary Infectious Diseases, College of Veterinary Medicine, Konkuk  University, 120 Neungdong-ro, Gwangjin-gu,  Seoul 143-701, Korea Tel: +82-2-450-3714, Fax: +82-2-3437-1960   E-mail: nhlee21@gmail.com No potential conflict of interest relevant to this  article was reported.Purpose:  In spite of an extensive vaccination program, parvoviral infections still pose a major  threat to the health of dogs.",Non-OADS,/arxiv_data1/oa_pdf/fe/5d/cevr-1-70.PMC3623513.pdf
"Seon Ah Park et al • A novel vaccine against canine parvovirus infection 71 http://www.ecevr.org/ http://dx.doi.org/10.7774/cevr.2012.1.1.70(Val), respectively [11].",OADS,/arxiv_data1/oa_pdf/fe/5d/cevr-1-70.PMC3623513.pdf
"Seon Ah Park et al • A novel vaccine against canine parvovirus infection 72 http://www.ecevr.org/ http://dx.doi.org/10.7774/cevr.2012.1.1.70 allocated to 3 groups: group I, group II, and group III, which  comprised 2, 2, and 3 dogs, respectively.",OADS,/arxiv_data1/oa_pdf/fe/5d/cevr-1-70.PMC3623513.pdf
Seon Ah Park et al • A novel vaccine against canine parvovirus infection 73 http://www.ecevr.org/ http://dx.doi.org/10.7774/cevr.2012.1.1.70Table 1.,Non-OADS,/arxiv_data1/oa_pdf/fe/5d/cevr-1-70.PMC3623513.pdf
Seon Ah Park et al • A novel vaccine against canine parvovirus infection 74 http://www.ecevr.org/ http://dx.doi.org/10.7774/cevr.2012.1.1.70 Fig.,OADS,/arxiv_data1/oa_pdf/fe/5d/cevr-1-70.PMC3623513.pdf
Seon Ah Park et al • A novel vaccine against canine parvovirus infection 75 http://www.ecevr.org/ http://dx.doi.org/10.7774/cevr.2012.1.1.70epidemiological studies on CPV strains in the domestic dog  population are urgently needed because they will improve the management of infections resulting from the swift evolu - tion of the continually progressing CPV strains.,Non-OADS,/arxiv_data1/oa_pdf/fe/5d/cevr-1-70.PMC3623513.pdf
Seon Ah Park et al • A novel vaccine against canine parvovirus infection 76 http://www.ecevr.org/ http://dx.doi.org/10.7774/cevr.2012.1.1.70 13.,Non-OADS,/arxiv_data1/oa_pdf/fe/5d/cevr-1-70.PMC3623513.pdf
"This is an Open Access article distributed under the  terms of the Creative Commons Attribution Non-Com - mercial License (http://creativecommons.org/licenses/by-nc/3.0) which permits unrestricted non-commercial use, distribution, and reproduction in any medium, pro - vided the original work is properly cited.KOREAN  VACCINE  SOCIETY KOREAN  VACCINE  SOCIETYKOREAN  ACCINE  OCIETYV S http://www.ecevr.org/Clin Exp Vaccine Res 2012;1:77-82 http://dx.doi.org/10.7774/cevr.2012.1.1.77pISSN 2287-3651 • eISSN 2287-366X  Jae-Min Song1, Kwang-Hee Lee2,  Baik-Lin Seong2 1Department of Global Medical Science, College  of Nursing, Sungshin Women’s University, Seoul;  2Department of Biotechnology, College of Life  Science and Biotechnology, Yonsei University,  Seoul, Korea Received: May 20, 2012 Revised: June 8, 2012Accepted: June 15, 2012 Corresponding author: Jae-Min Song, PhD  Department of Global Medical Science,  College of Nursing, Sungshin Women’s University, 55 Dobong-ro 76da-gil, Gangbuk-gu,  Seoul 142-732, KoreaTel: +82-2-920-7289, Fax: +82-2-920-2027E-mail: jmsong@sungshin.ac.kr No potential conflict of interest relevant to this  article was reported.Purpose:  Neuraminidase (NA) of influenza virus contains stalk region that shows a great deal  of variability in both amino acid sequence and length.",Non-OADS,/arxiv_data1/oa_pdf/62/0c/cevr-1-77.PMC3623514.pdf
Jae-Min Song et al • Recombinant influenza vaccines expressing HBV epitope 78 http://www.ecevr.org/ http://dx.doi.org/10.7774/cevr.2012.1.1.77 T lymphocytes as well of humoral immunity [8-11].,OADS,/arxiv_data1/oa_pdf/62/0c/cevr-1-77.PMC3623514.pdf
Jae-Min Song et al • Recombinant influenza vaccines expressing HBV epitope 79 http://www.ecevr.org/ http://dx.doi.org/10.7774/cevr.2012.1.1.77then incubated at 37°C for 1 hour in 0.1% bovine serum albu - min–PBS to block the remaining binding sites.,Non-OADS,/arxiv_data1/oa_pdf/62/0c/cevr-1-77.PMC3623514.pdf
Jae-Min Song et al • Recombinant influenza vaccines expressing HBV epitope 80 http://www.ecevr.org/ http://dx.doi.org/10.7774/cevr.2012.1.1.77 virus (7.4 log 10 PFU/mL) (Fig.,OADS,/arxiv_data1/oa_pdf/62/0c/cevr-1-77.PMC3623514.pdf
Jae-Min Song et al • Recombinant influenza vaccines expressing HBV epitope 81 http://www.ecevr.org/ http://dx.doi.org/10.7774/cevr.2012.1.1.77formation comparing wild type of parental virus in vitro .,OADS,/arxiv_data1/oa_pdf/62/0c/cevr-1-77.PMC3623514.pdf
Jae-Min Song et al • Recombinant influenza vaccines expressing HBV epitope 82 http://www.ecevr.org/ http://dx.doi.org/10.7774/cevr.2012.1.1.77 67:759-64.,OADS,/arxiv_data1/oa_pdf/62/0c/cevr-1-77.PMC3623514.pdf
"This is an Open Access article distributed under the  terms of the Creative Commons Attribution Non-Com - mercial License (http://creativecommons.org/licenses/by-nc/3.0) which permits unrestricted non-commercial use, distribution, and reproduction in any medium, pro - vided the original work is properly cited.KOREAN  VACCINE  SOCIETY KOREAN  VACCINE  SOCIETYKOREAN  ACCINE  OCIETYV S http://www.ecevr.org/Clin Exp Vaccine Res 2012;1:83-87 http://dx.doi.org/10.7774/cevr.2012.1.1.83pISSN 2287-3651 • eISSN 2287-366X  Pil-Gu Park1*, Min-Hee Cho1*,  Gi-eun Rhie1, Haeseul Jeong1,  Hyewon Youn2,3, Kee-Jong Hong1 1Division of High-Risk Pathogen Research, Center  for Infectious Diseases, Korea National Institute  of Health, Cheongwon; 2Laboratory of Molecular  Imaging and Therapy, Cancer Research Institute, Seoul National University College of Medicine, Seoul;  3Department of Nuclear Medicine, Cancer  Imaging Center, Seoul National University Hospital, Seoul, Korea Received: May 15, 2012 Revised: June 5, 2012Accepted: June 10, 2012 Corresponding author: Kee-Jong Hong, PhD Division of High-Risk Pathogen Research,   Center for Infectious Diseases, Korea National Institute of Health, Osong Health Technology Administration Complex, 187 Osongsaengmyeong 2-ro, Osong-eup, Cheongwon 363-951, KoreaTel: +82-43-719-8271, Fax: +82-43-719-8309E-mail: khong@nih.go.kr  *Both authors equally contributed to this research.",Non-OADS,/arxiv_data1/oa_pdf/33/5d/cevr-1-83.PMC3623515.pdf
"Pil-Gu Park et al • GFP-tagged E. coli  shows pathogen distribution 84 http://www.ecevr.org/ http://dx.doi.org/10.7774/cevr.2012.1.1.83 the pathogens in organism level, pathogen can overcome the  limitation of conventional analysis and biological and patho - logical process and be monitored.",OADS,/arxiv_data1/oa_pdf/33/5d/cevr-1-83.PMC3623515.pdf
Pil-Gu Park et al • GFP-tagged E. coli  shows pathogen distribution 85 http://www.ecevr.org/ http://dx.doi.org/10.7774/cevr.2012.1.1.83suggesting fluorescent signal can be pass through skin of ani - mal and be detected.,OADS,/arxiv_data1/oa_pdf/33/5d/cevr-1-83.PMC3623515.pdf
Pil-Gu Park et al • GFP-tagged E. coli  shows pathogen distribution 86 http://www.ecevr.org/ http://dx.doi.org/10.7774/cevr.2012.1.1.83 also evaluation of vaccine efficacy.,Non-OADS,/arxiv_data1/oa_pdf/33/5d/cevr-1-83.PMC3623515.pdf
"Pil-Gu Park et al • GFP-tagged E. coli  shows pathogen distribution 87 http://www.ecevr.org/ http://dx.doi.org/10.7774/cevr.2012.1.1.83pathogens, especially for chronic infection diseases without  exponential replication such as acquired immunodeficiency syndrome or tuberculosis.",Non-OADS,/arxiv_data1/oa_pdf/33/5d/cevr-1-83.PMC3623515.pdf
"This is an Open Access article distributed under the  terms of the Creative Commons Attribution Non-Com - mercial License (http://creativecommons.org/licenses/by-nc/3.0) which permits unrestricted non-commercial use, distribution, and reproduction in any medium, pro - vided the original work is properly cited.KOREAN  VACCINE  SOCIETY KOREAN  VACCINE  SOCIETYKOREAN  ACCINE  OCIETYV S http://www.ecevr.org/Clin Exp Vaccine Res 2012;1:88-94 http://dx.doi.org/10.7774/cevr.2012.1.1.88pISSN 2287-3651 • eISSN 2287-366X  In Seon Kim1, Yu Bin Seo1,  Kyung-Wook Hong1, Ji Yoon Noh1,  Won Suk Choi1, Joon Young Song1,  Geum Joon Cho2, Min Jeong Oh2,  Hai Joong Kim2, Soon Choul Hong2,  Jang Wook Sohn1, Hee Jin Cheong1,  Woo Joo Kim1 1Division of Infectious Diseases, Department of  Internal Medicine, 2Department of Obstetrics  and Gynecology, Korea University College of  Medicine, Seoul, Korea Received: May 20, 2012 Revised: June 10, 2012Accepted: June 15, 2012 Corresponding author: Hee Jin Cheong, MD Division of Infectious Diseases, Department of Internal Medicine, Korea University Guro  Hospital, Korea University College of Medicine, 148 Gurodong-ro, Guro-gu, Seoul 152-703, Korea Tel: +82-2-2626-3050, Fax: +82-2-2626-1105E-mail: heejinmd@medimail.co.kr No potential conflict of interest relevant to this  article was reported.Purpose:  Women who are pregnant, planning to become pregnant in the influenza season or  caring for infant 6-59 months of age are identified as priority groups for influenza vaccination.",Non-OADS,/arxiv_data1/oa_pdf/50/f8/cevr-1-88.PMC3623516.pdf
In Seon Kim et al • Perception on influenza vaccination in Korean women 89 http://www.ecevr.org/ http://dx.doi.org/10.7774/cevr.2012.1.1.88group for influenza vaccination.,Non-OADS,/arxiv_data1/oa_pdf/50/f8/cevr-1-88.PMC3623516.pdf
"In Seon Kim et al • Perception on influenza vaccination in Korean women 90 http://www.ecevr.org/ http://dx.doi.org/10.7774/cevr.2012.1.1.88 of the respondents, women experienced at least one pregnan - cy were 236 (37.2%) and if including the current pregnancy,  293 (58.6%) experienced pregnancy.",OADS,/arxiv_data1/oa_pdf/50/f8/cevr-1-88.PMC3623516.pdf
In Seon Kim et al • Perception on influenza vaccination in Korean women 91 http://www.ecevr.org/ http://dx.doi.org/10.7774/cevr.2012.1.1.88Factors associated with vaccination during pregnancy One hundred ninety of respondents (38.0%) responded that they were going to receive influenza vaccination during preg - nancy in the future (Table 3).,Non-OADS,/arxiv_data1/oa_pdf/50/f8/cevr-1-88.PMC3623516.pdf
In Seon Kim et al • Perception on influenza vaccination in Korean women 92 http://www.ecevr.org/ http://dx.doi.org/10.7774/cevr.2012.1.1.88 responded that they had a concern about harmful effect to  their fetus.,Non-OADS,/arxiv_data1/oa_pdf/50/f8/cevr-1-88.PMC3623516.pdf
In Seon Kim et al • Perception on influenza vaccination in Korean women 93 http://www.ecevr.org/ http://dx.doi.org/10.7774/cevr.2012.1.1.88fluenza vaccine: rationale and experience.,Non-OADS,/arxiv_data1/oa_pdf/50/f8/cevr-1-88.PMC3623516.pdf
In Seon Kim et al • Perception on influenza vaccination in Korean women 94 http://www.ecevr.org/ http://dx.doi.org/10.7774/cevr.2012.1.1.88 Supplement 1.,Non-OADS,/arxiv_data1/oa_pdf/50/f8/cevr-1-88.PMC3623516.pdf
"This is an Open Access article distributed under the  terms of the Creative Commons Attribution Non-Com - mercial License (http://creativecommons.org/licenses/by-nc/3.0) which permits unrestricted non-commercial use, distribution, and reproduction in any medium, pro - vided the original work is properly cited.KOREAN  VACCINE  SOCIETY KOREAN  VACCINE  SOCIETYKOREAN  ACCINE  OCIETYV S http://www.ecevr.org/Clin Exp Vaccine Res 2012;1:9-17 http://dx.doi.org/10.7774/cevr.2012.1.1.9pISSN 2287-3651 • eISSN 2287-366X  Myoung-don Oh1, Jong-Koo Lee2 Departments of 1Internal Medicine and 2Family  Medicine, Seoul National University College of  Medicine, Seoul, Korea  Received: May 13, 2012  Revised: June 8, 2012Accepted: June 15, 2012 Corresponding author: Jong-Koo Lee, MD Department of Family Medicine, Seoul National University College of Medicine, 101 Daehak-ro, Jongno-gu, Seoul 110-744, KoreaTel: +82-2-2072-2215, Fax: +82-2-2072-0318E-mail: docmohw@snu.ac.kr No potential conflict of interest relevant to this  article was reported.Vaccination is one of the most effective and cost-benefit interventions that reduced the mor - tality.",Non-OADS,/arxiv_data1/oa_pdf/61/01/cevr-1-9.PMC3623517.pdf
"Myoung-don Oh et al • History of adult vaccination in Korea 10 http://www.ecevr.org/ http://dx.doi.org/10.7774/cevr.2012.1.1.9 was discontinued in 1979, one year before the declaration of  smallpox eradication by World Health Organization.",Non-OADS,/arxiv_data1/oa_pdf/61/01/cevr-1-9.PMC3623517.pdf
"Myoung-don Oh et al • History of adult vaccination in Korea 11 http://www.ecevr.org/ http://dx.doi.org/10.7774/cevr.2012.1.1.9Year Target diseases Events 1995 Hepatitis B Immunization against hepatitis B removed from supplementary immunization activity, and included into     National Immunization Program  1995 Typhoid fever Inactivated vaccine replaced with purified Vi polysaccharide vaccine 1997 Measles, mumps, rubella Second dose recommended at the age of 4-6 years 1997 Influenza Immunization introduced as a supplementary immunization activity 1997 Leptospirosis Excluded from supplementary immunization activity 1997 Hemorrhagic fever with renal syndrome Immunization recommended only to high risk group 1997 Typhoid fever Immunization recommended only to high risk group 2000 Mumps, rubella Immunization included into National Immunization Program 2000 Measles, mumps, rubella MMR vaccines containing Hoshino and Urabe strains were discontinued 2001 Polio Inactivated polio vaccine introduced 2001 Measles Measles immunization catch-up campaign with MR vaccine launched as a part of the     “5-Year Measles Elimination Program”  2002 Measles, mumps, rubella MMR vaccines containing Rubini strain discontinued according to the WHO recommendation 2002 Japanese B encephalitis Live attenuated vaccine introduced 2004 Tetanus, diphtheria Td vaccine introduced 2004 Polio OPV replaced with IPV  2005 Chickenpox Immunization included into National Immunization Program 2005 Tetanus, diphtheria Td immunization included into National Immunization Program 2006 Measles Measles elimination declared  2008 Hepatitis B WHO granted certification of control of vertical transmission of hepatitis B virus 2009 Influenza Egg-based vaccine against 2009 H1N1 influenza produced by a domestic pharmaceutical company;     This vaccine was licensed by Korea FDA and used for immunization campaign for pandemic influenza 2009 2012 Tuberculosis, hepatitis B, diphtheria,     tetanus, pertussis, polio, measles, mumps,   rubella, varicella, Japanese B encephalitisImmunization cost for the 10 vaccines (BCG [intradermal], HepB, DTaP , Td, Tdap, IPV , DTaP-IPV , MMR, Var, JEV)     reimbursed when the vaccines were given according to the National Immunization Program (January 1, 2012) 2012 Meningococcal infection Mandatory vaccination against meningococcal infection introduced for military recruits  BCG, Bacillus Calmette-Guérin; DPT, diphtheria, pertussis, tetanus; MMR, measles-mumps-rubella; MR, measles-rubella; WHO, World Health Organization; Td, tetanus and diphtheria toxoid; OPV, oral polio vaccine; IPV, inactivated polio vaccine; FDA, Food and Drug Administration; HepB, hepatitis B; DTaP , diphtheria, tetanus, acellular pertussis; Tdap, tetanus, reduced diphtheria, acellular pertussis; JEV, Japanese encephalitis virus.Source: adapted and modified from Korea Centers for Disease Control and Prevention [3].Table 2.",Non-OADS,/arxiv_data1/oa_pdf/61/01/cevr-1-9.PMC3623517.pdf
Myoung-don Oh et al • History of adult vaccination in Korea 12 http://www.ecevr.org/ http://dx.doi.org/10.7774/cevr.2012.1.1.9 non-vaccinated controls.,Non-OADS,/arxiv_data1/oa_pdf/61/01/cevr-1-9.PMC3623517.pdf
"Myoung-don Oh et al • History of adult vaccination in Korea 13 http://www.ecevr.org/ http://dx.doi.org/10.7774/cevr.2012.1.1.9Cross, Boryong, Hankook Vaccine, CJ Pharmaceutical, and  SK Chemical) produced inactivated vaccines.",Non-OADS,/arxiv_data1/oa_pdf/61/01/cevr-1-9.PMC3623517.pdf
"Myoung-don Oh et al • History of adult vaccination in Korea 14 http://www.ecevr.org/ http://dx.doi.org/10.7774/cevr.2012.1.1.9                           Age group Vaccine19-29 30-39 40-49 50-64 ≥65 Te tanus-diphtheria-   pertussis1-time dose of Tdap for Td booster;   then boost with Td every 10 yr (strength I)  First dose with Tdap, Td at 1-, and 6-mo; then Td booster   every 10 yr (strength I) (Tdap only for age of 65 or less) Influenza 1 dose annually (strength III) 1 dose annually (strength I) Hepatitis A 2 doses (at 0 and   6 mo) (strength II)For seronegative, 2 doses   (at 0 and 6 mo) (strength II)For high-risk groupa), seronegative,  2 doses (at 0 and 6 mo) (strength II) Hepatitis B When 3 doses of immunization uncertain,   check HBsAb and vaccinate seronegatives (strength III)For high-risk groupb) with uncertain immunization  history, check HBsAb and vaccinate seronegative  (strength III) Measles-mumps-rubella For high-risk groupc), at least 1 dose;  check rubella IgG for women who is   planning pregnancy (strength III) Varicella For high-risk groupd), check serology;  2 doses for seronegatives (strength II) Human papillomavirus Female (strength II) Meningococcal For high-risk groupe), 1 or 2 doses Pneumococcal For high-risk groupf), 1 dose (strength I) 1 dose (strength I) Zoster 1 dose (strength U) 1 dose (strength III) Strength of recommendation   I.",Non-OADS,/arxiv_data1/oa_pdf/61/01/cevr-1-9.PMC3623517.pdf
Myoung-don Oh et al • History of adult vaccination in Korea 15 http://www.ecevr.org/ http://dx.doi.org/10.7774/cevr.2012.1.1.9Table 5.,Non-OADS,/arxiv_data1/oa_pdf/61/01/cevr-1-9.PMC3623517.pdf
"Accessed on 5  July 2012 (Visit http://www.kfda.go.kr/index.kfda?searchkey=title:contents& mid=70&searchword= 백신&cd=&pageNo=1&seq=12836&cmd=v).or greater was observed in 55.9% of children 6 months to <3  years of age, 69.5% of children 3 years to <9 years of age, and 90.5% of subjects 9 years to <18 years of age.",Non-OADS,/arxiv_data1/oa_pdf/61/01/cevr-1-9.PMC3623517.pdf
Myoung-don Oh et al • History of adult vaccination in Korea 16 http://www.ecevr.org/ http://dx.doi.org/10.7774/cevr.2012.1.1.9 10.,Non-OADS,/arxiv_data1/oa_pdf/61/01/cevr-1-9.PMC3623517.pdf
"Myoung-don Oh et al • History of adult vaccination in Korea 17 http://www.ecevr.org/ http://dx.doi.org/10.7774/cevr.2012.1.1.9of reported pandemic influenza (A/H1N1 2009) virus in - fections in Korea: from April, 2009 through August, 2010.",Non-OADS,/arxiv_data1/oa_pdf/61/01/cevr-1-9.PMC3623517.pdf
"pISSN: 2287-4208 / eISSN: 2287-4690 World J Mens Health  2012 August  30(2): 108-113  http://dx.doi.org/10.5534/wjmh.2012.30.2.108 Review Articl e Received: Aug 3, 2012; Revised: Aug 6, 2012; Accepted: Aug 9, 2 012 Correspondence to: Ju Tae Seo Department of Urology, Cheil General Hospital, Kwandong Univers ity College of Medicine, 17, Seoae-ro 1-gil, Jung-gu,  Seoul 100-380, Korea.",Non-OADS,/arxiv_data1/oa_pdf/26/f4/wjmh-30-108.PMC3623518.pdf
"pISSN: 2287-4208 / eISSN: 2287-4690 World J Mens Health  2012 August  30(2): 114-122 http://dx.doi.org/10.5534/wjmh.2012.30.2.114 Original Articl e Received: Jul 2, 2012; Revised: Aug 15, 2012; Accepted: Aug 16,  2012 Correspondence to: Soo Woong Kim D e p a r t m e n t  o f  U r o l o g y ,  S e o u l  N a t i o n a l  U n i v e r s i t y  H o s p i t a l ,  1 0 1 ,  Daehak-ro, Jongno-gu, Seoul 110-744, Korea.",Non-OADS,/arxiv_data1/oa_pdf/14/5e/wjmh-30-114.PMC3623519.pdf
"pISSN: 2287-4208 / eISSN: 2287-4690 World J Mens Health  2012 August  30(2): 123-130 http://dx.doi.org/10.5534/wjmh.2012.30.2.123 Original Articl e Received: May 25, 2012; Revised: Jun 19, 2012; Accepted: Jun 28 , 2012 Correspondence to: Yun Seob Song Department of Urology, Soon Chun Hyang University Seoul Hospita l, Soon Chun Hyang University College of Medicine, 59, Daesagwan-ro, Yongsan-gu, Seoul 140-743, Korea.",Non-OADS,/arxiv_data1/oa_pdf/2e/aa/wjmh-30-123.PMC3623520.pdf
"pISSN: 2287-4208 / eISSN: 2287-4690 World J Mens Health  2012 August  30(2): 131-137 http://dx.doi.org/10.5534/wjmh.2012.30.2.131 Original Articl e Received: Jul 26, 2012; Revised: Aug 18, 2012; Accepted: Aug 20 , 2012 Correspondence to: Sung Dae Kim Department of Urology, Jeju National University School of Medic ine, 102, Jejudaehak-ro, Jeju 690-756, Korea.",Non-OADS,/arxiv_data1/oa_pdf/e3/6b/wjmh-30-131.PMC3623521.pdf
"pISSN: 2287-4208 / eISSN: 2287-4690 World J Mens Health  2012 August  30(2): 138-140 http://dx.doi.org/10.5534/wjmh.2012.30.2.138 Case Repor t Received: May 25, 2012; Revised: (1st) Jun 27, 2012, (2nd) Jul 19, 2012; Accepted: Jul 23, 2012 Correspondence to: Yun Seob Song Department of Urology, Soon Chun Hyang University Seoul Hospita l, Soon Chun Hyang University College of Medicine, 59, Daesagwan-ro, Yongsan-gu, Seoul 140-743, Korea.",Non-OADS,/arxiv_data1/oa_pdf/01/6a/wjmh-30-138.PMC3623522.pdf
"pISSN: 2287-4208 / eISSN: 2287-4690 World J Mens Health  2012 August  30(2): 141-145 http://dx.doi.org/10.5534/wjmh.2012.30.2.141 Case Repor t Received: Jun 4, 2012; Revised: Jul 20, 2012; Accepted: Jul 26,  2012 Correspondence to: Jae Young Park D e p a r t m e n t  o f  U r o l o g y ,  K o r e a  U n i v e r s i t y  A n s a n  H o s p i t a l ,  1 2 3 ,  J e okgeum-ro, Danwon-gu, Ansan 425-707, Korea.",Non-OADS,/arxiv_data1/oa_pdf/c0/ea/wjmh-30-141.PMC3623523.pdf
"pISSN: 2287-4208 / eISSN: 2287-4690 World J Mens Health  2012 August  30(2): 146-149 http://dx.doi.org/10.5534/wjmh.2012.30.2.146 Case Repor t Received: Jul 26, 2012; Revised: Aug 13, 2012; Accepted: Aug 14 , 2012 Correspondence to: Sung Dae Kim Department of Urology, School of Medicine, Jeju National Univer sity, 102, Jejudaehak-ro, Jeju 690-756, Korea.",Non-OADS,/arxiv_data1/oa_pdf/b7/7c/wjmh-30-146.PMC3623524.pdf
"pISSN: 2287-4208 / eISSN: 2287-4690 World J Mens Health  2012 August  30(2): 150-152 http://dx.doi.org/10.5534/wjmh.2012.30.2.150 Case Repor t Received: Jun 7, 2012; Revised: Jun 27, 2012; Accepted: Jul 4, 2012 Correspondence to: Jong Kil Nam Department of Urology, Pusan National University Yangsan Hospit al, Pusan National University School of Medicine, 20,  Geumo-ro, Mulgeum-eup, Yangsan 626-770, Korea.",Non-OADS,/arxiv_data1/oa_pdf/58/f5/wjmh-30-150.PMC3623525.pdf
"pISSN: 2287-4208 / eISSN: 2287-4690 World J Mens Health  2012 August  30(2): 93-98  http://dx.doi.org/10.5534/wjmh.2012.30.2.93 Review Articl e Received: Jul 26, 2012; Revised: Jul 31, 2012; Accepted: Aug 3,  2012 Correspondence to: Jun-Kyu Suh Department of Urology, National Research Center for Sexual Medi cine, Inha University School of Medicine, 27, Inhang-ro , Jung-gu, Incheon 400-711, Korea.",Non-OADS,/arxiv_data1/oa_pdf/25/ab/wjmh-30-93.PMC3623526.pdf
"pISSN: 2287-4208 / eISSN: 2287-4690 World J Mens Health  2012 August  30(2): 99-107 http://dx.doi.org/10.5534/wjmh.2012.30.2.99 Review Articl e Received: Jul 31, 2012; Revised: Aug 6, 2012; Accepted: Aug 11,  2012 Correspondence to: Jae Saog Hyun Department of Urology, Gyeongsang National University Hospital,  Gyeongsang National University School of Medicine, 79, Gangnam-ro, Jinju 660-702, Korea.",Non-OADS,/arxiv_data1/oa_pdf/24/42/wjmh-30-99.PMC3623527.pdf
"pISSN: 2287-4208 / eISSN: 2287-4690 World J Mens Health 2012 December 30(3): 153-159 http://dx.doi.org/10.5534/wjmh.2012.30.3.153 Review Articl e Received: Oct 4, 2012; Revised: (1st) Nov 24, 2012, (2nd) Nov 2 7, 2012; Accepted: Nov 27, 2012 Correspondence to: Jun Ho Lee Department of Urology, National Police Hospital, 123, Songi-ro,  Songpa-gu, Seoul 138-708, Korea.",Non-OADS,/arxiv_data1/oa_pdf/c8/35/wjmh-30-153.PMC3623530.pdf
"pISSN: 2287-4208 / eISSN: 2287-4690 World J Mens Health 2012 December 30(3): 160-165 http://dx.doi.org/10.5534/wjmh.2012.30.3.160 Original Articl e Received: Oct 21, 2012; Revised: Nov 22, 2012; Accepted: Nov 26 , 2012 Correspondence to: Sung Won Lee Depar t ment  of  Ur ol ogy,  Samsung Medi cal  Cent er ,  Sungkyunkwan Uni versity School of Medicine, 50, Irwon-dong, Gangnam-gu, Seoul 135-710, Korea.",Non-OADS,/arxiv_data1/oa_pdf/d7/85/wjmh-30-160.PMC3623531.pdf
The URL is http://www.clinicaltrials.gov.,Non-OADS,/arxiv_data1/oa_pdf/d7/85/wjmh-30-160.PMC3623531.pdf
"pISSN: 2287-4208 / eISSN: 2287-4690 World J Mens Health 2012 December 30(3): 166-171 http://dx.doi.org/10.5534/wjmh.2012.30.3.166 Original Articl e Received: Aug 10, 2012; Revised: Nov 18, 2012; Accepted: Nov 26 , 2012 Correspondence to: Dae Yul Yang  Department of Urology, Hallym University Kangdong Sacred Heart Hospital, 150, Seongan-ro, Gangdong-gu, Seoul  134-701, Korea.",Non-OADS,/arxiv_data1/oa_pdf/27/8b/wjmh-30-166.PMC3623532.pdf
"pISSN: 2287-4208 / eISSN: 2287-4690 World J Mens Health 2012 December 30(3): 172-176 http://dx.doi.org/10.5534/wjmh.2012.30.3.172 Original Articl e Received: Jul 2, 2012; Revised: (1st) Aug 23, 2012, (2nd) Sep 1 2, 2012; Accepted: Sep 21, 2012 Correspondence to: Du Geon Moon Department of Urology, Korea University Medical Center, 97, Gur odong-gil, Guro-gu, Seoul 152-703, Korea.",Non-OADS,/arxiv_data1/oa_pdf/4c/0e/wjmh-30-172.PMC3623533.pdf
pISSN: 2287-4208 / eISSN: 2287-4690 World J Mens Health 2012 December 30(3): 177-182 http://dx.doi.org/10.5534/wjmh.2012.30.3.177 Original Articl e Yu Seob Shin and Sang Deuk Kim contributed equally to this work.,Non-OADS,/arxiv_data1/oa_pdf/37/f6/wjmh-30-177.PMC3623534.pdf
"pISSN: 2287-4208 / eISSN: 2287-4690 World J Mens Health 2012 December 30(3): 183-188 http://dx.doi.org/10.5534/wjmh.2012.30.3.183 Original Articl e Received: Nov 3, 2012; Revised: Nov 24, 2012; Accepted: Nov 26,  2012 Correspondence to: Jun Ho Lee Department of Urology, National Police Hospital, 123, Songi-ro,  Songpa-gu, Seoul 138-708, Korea.",Non-OADS,/arxiv_data1/oa_pdf/27/59/wjmh-30-183.PMC3623535.pdf
"pISSN: 2287-4208 / eISSN: 2287-4690 World J Mens Health 2012 December 30(3): 189-191 http://dx.doi.org/10.5534/wjmh.2012.30.3.189 Case Repor t Received: Jul 23, 2012; Revised: Aug 30, 2012; Accepted: Sep 21 , 2012 C o r r e s p o n d e n c e  t o :  D o n g  S o o  R y u Department of Urology, Samsung Changwon Hospital, Sungkyunkwan University School of Medicine, 158, Paryong-ro, Masanhoewon-gu, Changwon 630-723, Korea.",Non-OADS,/arxiv_data1/oa_pdf/78/3a/wjmh-30-189.PMC3623536.pdf
"pISSN: 2287-4208 / eISSN: 2287-4690 World J Mens Health 2012 December 30(3): 192-194 http://dx.doi.org/10.5534/wjmh.2012.30.3.192 Case Repor t Received: Aug 10, 2012; Revised: Sep 4, 2012; Accepted: Oct 22,  2012 Correspondence to: Jong Kwan Park Department of Urology, Chonbuk National University Medical Scho ol, 20, Geonji-ro, Deokjin-gu, Jeonju 561-712, Korea .",Non-OADS,/arxiv_data1/oa_pdf/81/b6/wjmh-30-192.PMC3623537.pdf
"pISSN: 2287-4208 / eISSN: 2287-4690 World J Mens Health 2012 December 30(3): 195-197 http://dx.doi.org/10.5534/wjmh.2012.30.3.195 Case Repor t Received: Oct 22, 2012; Revised: Nov 20, 2012; Accepted: Nov 23 , 2012 Correspondence to: Hong Koo Ha D e p a r t m e n t  o f  U r o l o g y ,  P u s a n  N a t i o n a l  U n i v e r s i t y  H o s p i t a l ,  3 0 5 ,  Gudeok-ro, Seo-gu, Busan 602-739, Korea.",Non-OADS,/arxiv_data1/oa_pdf/d6/1d/wjmh-30-195.PMC3623538.pdf
"pISSN: 2287-4208 / eISSN: 2287-4690 World J Mens Health 2012 December 30(3): 198-201 http://dx.doi.org/10.5534/wjmh.2012.30.3.198 Case Repor t Received: Jul 16, 2012; Revised: Nov 18, 2012; Accepted: Nov 26 , 2012 Correspondence to: Jae Hyun Bae Department of Urology, Korea University Ansan Hospital, Korea U niversity College of Medicine, 123, Jeokgeum-ro,  Danwon-gu, Ansan 425-707, Korea.",Non-OADS,/arxiv_data1/oa_pdf/1e/b9/wjmh-30-198.PMC3623539.pdf
Two months after publication it is available to  the public under an Attribution–Noncommercial–Share Alike 3.0 Unported Cre - ative Commons License (http://creativecommons.org/licenses/by-nc-sa/3.0).,Non-OADS,/arxiv_data1/oa_pdf/1a/1d/1095.PMC3623630.pdf
Two months after publication it is available to  the public under an Attribution–Noncommercial–Share Alike 3.0 Unported Cre - ative Commons License (http://creativecommons.org/licenses/by-nc-sa/3.0).,Non-OADS,/arxiv_data1/oa_pdf/33/1c/1099.PMC3623631.pdf
Two months after publication it  is available to the public under an Attribution–Noncommercial–Share Alike 3.0  Unported Creative Commons License (http://creativecommons.org/licenses/by- nc-sa/3.0).,Non-OADS,/arxiv_data1/oa_pdf/cc/df/1103.PMC3623632.pdf
Two months after publication it is available  to the public under an Attribution–Noncommercial–Share Alike 3.0 Unported  Creative Commons License (http://creativecommons.org/licenses/by-nc-sa/3.0).,Non-OADS,/arxiv_data1/oa_pdf/f6/51/1111.PMC3623633.pdf
Two months after publication it is available  to the public under an Attribution–Noncommercial–Share Alike 3.0 Unported  Creative Commons License (http://creativecommons.org/licenses/by-nc-sa/3.0).,Non-OADS,/arxiv_data1/oa_pdf/c7/41/1122.PMC3623634.pdf
Two months after publication it is avail - able to the public under an Attribution–Noncommercial–Share Alike 3.0 Unported  Creative Commons License (http://creativecommons.org/licenses/by-nc-sa/3.0).,Non-OADS,/arxiv_data1/oa_pdf/b6/8e/1134.PMC3623635.pdf
"Sequence analysis and criteria for protein identification Mass spectra were extracted and analyzed using BioWorks SeQuest  Analysis Software package, SeQuest version SRF v. 27, revision 13  (ThermoFisher Scientific, San Jose, CA) against Chlamydomonas   sequences at National Center for Biotechnology Information or the  Chlamydomonas  genome database (version 3.0; http://genome.jgi   -psf.org/Chlre/Chlre3.home.html) for protein identification.",OADS,/arxiv_data1/oa_pdf/b6/8e/1134.PMC3623635.pdf
Searches were performed against the  Chlamydomonas  version 3 database (translated from genomic se - quences; http://genome.jgi-psf.org/Chlre3/Chlre3.home.html) plus  common lab contaminant proteins (www.thegpm.org/crap/index   .html).,OADS,/arxiv_data1/oa_pdf/b6/8e/1134.PMC3623635.pdf
Two months after publication it is available  to the public under an Attribution–Noncommercial–Share Alike 3.0 Unported  Creative Commons License (http://creativecommons.org/licenses/by-nc-sa/3.0).,Non-OADS,/arxiv_data1/oa_pdf/fb/76/1153.PMC3623636.pdf
Two months after publication it is available to  the public under an Attribution–Noncommercial–Share Alike 3.0 Unported Cre - ative Commons License (http://creativecommons.org/licenses/by-nc-sa/3.0).,Non-OADS,/arxiv_data1/oa_pdf/9d/aa/1163.PMC3623637.pdf
Two months after publication it is available to  the public under an Attribution–Noncommercial–Share Alike 3.0 Unported Cre - ative Commons License (http://creativecommons.org/licenses/by-nc-sa/3.0).,Non-OADS,/arxiv_data1/oa_pdf/fe/71/1176.PMC3623638.pdf
Two months after publication it is avail - able to the public under an Attribution–Noncommercial–Share Alike 3.0 Unported  Creative Commons License (http://creativecommons.org/licenses/by-nc-sa/3.0).,Non-OADS,/arxiv_data1/oa_pdf/6e/d4/1185.PMC3623639.pdf
Two months after publication it is avail - able to the public under an Attribution–Noncommercial–Share Alike 3.0 Unported  Creative Commons License (http://creativecommons.org/licenses/by-nc-sa/3.0).,Non-OADS,/arxiv_data1/oa_pdf/92/9d/1196.PMC3623640.pdf
Two months after publication it is avail - able to the public under an Attribution–Noncommercial–Share Alike 3.0 Unported  Creative Commons License (http://creativecommons.org/licenses/by-nc-sa/3.0).,Non-OADS,/arxiv_data1/oa_pdf/7b/46/1208.PMC3623641.pdf
Two months after publication it is avail - able to the public under an Attribution–Noncommercial–Share Alike 3.0 Unported  Creative Commons License (http://creativecommons.org/licenses/by-nc-sa/3.0).,Non-OADS,/arxiv_data1/oa_pdf/a7/35/1222.PMC3623642.pdf
Two months after publication it is avail - able to the public under an Attribution–Noncommercial–Share Alike 3.0 Unported  Creative Commons License (http://creativecommons.org/licenses/by-nc-sa/3.0).,Non-OADS,/arxiv_data1/oa_pdf/41/2a/1232.PMC3623643.pdf
"This procedure was repeated to find zyxin-family proteins in the  proteomes of D. rerio  (RefSeq), B. floridae  (UniProt), A. suum   (WormBase, version 233), D. melanogaster  (RefSeq), and C. gigas   (http://gigadb.org/pacific_oyster/).",OADS,/arxiv_data1/oa_pdf/41/2a/1232.PMC3623643.pdf
"The sequencingdata were visualised using the FinchTV 1.4.0 software (Geospiza, Inc., Seattle, USA; http://www.geospiza.com ).",OADS,/arxiv_data1/oa_pdf/cc/d9/428_2013_Article_1376.PMC3624006.pdf
http://dx.doi.org/10.1371/journal.pone.0008946 .,Non-OADS,/arxiv_data1/oa_pdf/63/e1/mBio.00362-12.PMC3624510.pdf
http://dx.doi.org/10.1371 /journal.ppat.1001289 .,Non-OADS,/arxiv_data1/oa_pdf/1f/a7/mBio.00418-12.PMC3624511.pdf
http://dx.doi.org /10.1371/journal.pone.0000631 .,Non-OADS,/arxiv_data1/oa_pdf/1f/a7/mBio.00418-12.PMC3624511.pdf
http://dx.doi.org/10 .1371/journal.ppat.1002675 .,Non-OADS,/arxiv_data1/oa_pdf/1f/a7/mBio.00418-12.PMC3624511.pdf
http://dx.doi.org/10.1371/journal.ppat.1000110 .,Non-OADS,/arxiv_data1/oa_pdf/1f/a7/mBio.00418-12.PMC3624511.pdf
5:22.http://dx.doi.org/10.1186/1471-2180-5 -22.,Non-OADS,/arxiv_data1/oa_pdf/1f/a7/mBio.00418-12.PMC3624511.pdf
http://dx.doi.org/10.1128/mBio .00495-12 .,Non-OADS,/arxiv_data1/oa_pdf/5e/8c/mBio.00034-13.PMC3624514.pdf
http://dx.doi.org/10.1128/mBio.00118-12 .,Non-OADS,/arxiv_data1/oa_pdf/de/4d/mBio.00066-13.PMC3624515.pdf
http://dx.doi.org/10 .1128/mBio.00280-12 .,Non-OADS,/arxiv_data1/oa_pdf/de/4d/mBio.00066-13.PMC3624515.pdf
http://dx.doi .org/10.1128/mBio.00452-12 .,Non-OADS,/arxiv_data1/oa_pdf/de/4d/mBio.00066-13.PMC3624515.pdf
http://dx.doi.org/10.1371/journal.pone .0033971 .,Non-OADS,/arxiv_data1/oa_pdf/de/4d/mBio.00066-13.PMC3624515.pdf
http://dx.doi.org/10.1111/j.1600 -0463.2012.02957.x .,Non-OADS,/arxiv_data1/oa_pdf/de/4d/mBio.00066-13.PMC3624515.pdf
Available FREE in open access from: http://www.jpathinformatics.org/text.asp?2013/4/1/1/106682 INTRODUCTION The use of complex instruments has become commonplace  in the clinical laboratory.,Non-OADS,/arxiv_data1/oa_pdf/a7/d2/JPI-4-1.PMC3624702.pdf
"J Pathol Inform 2013, 1:1  http://www.jpathinformatics.org/content/4/1/1therapeutic drug monitoring and steroid analysis.",Non-OADS,/arxiv_data1/oa_pdf/a7/d2/JPI-4-1.PMC3624702.pdf
"J Pathol Inform 2013, 1:1  http://www.jpathinformatics.org/content/4/1/1format of the LIS, but is not supplied with the data  management software.",OADS,/arxiv_data1/oa_pdf/a7/d2/JPI-4-1.PMC3624702.pdf
"J Pathol Inform 2013, 1:1  http://www.jpathinformatics.org/content/4/1/1T able 1: Key to the purpose of each line of the source code that was used to pre‑process the data output  file from the liquid chromatography‑tandem mass spectrometry system Line number Purpose 1‑6 Specify modules that are used in the script 8‑14 Specify constants that are used in the script body 16 T ext that is not programming code called a “comment” that is included to clarify or document the script/ program (Perl comments begin with the pound character “#” and can start at the beginning of a line or  afterwards.",Non-OADS,/arxiv_data1/oa_pdf/a7/d2/JPI-4-1.PMC3624702.pdf
"J Pathol Inform 2013, 1:1  http://www.jpathinformatics.org/content/4/1/1accessed (after a delay to allow Sunquest® to perform its  periodic scan of the stipulated upload location for the data)  to determine if the QC results and patient assay results had  indeed been transferred via FTP , and that the calibrator  results were essentially ignored by the pre‑processor.",Non-OADS,/arxiv_data1/oa_pdf/a7/d2/JPI-4-1.PMC3624702.pdf
Available from: http://www.datainnovations.com/sites/default/files/ Connectivity Solution_0.pdf.,OADS,/arxiv_data1/oa_pdf/a7/d2/JPI-4-1.PMC3624702.pdf
Available from: http://www.ietf.org/rfc/rfc959.,Non-OADS,/arxiv_data1/oa_pdf/a7/d2/JPI-4-1.PMC3624702.pdf
Available FREE in open access from: http://www.jpathinformatics.org/text.asp?2013/4/1/4/108542 Access this article online Website:   www.jpathinformatics.org DOI: 10.4103/2153-3539.108542 Quick Response Code:,Non-OADS,/arxiv_data1/oa_pdf/b6/d4/JPI-4-4.PMC3624703.pdf
"J Pathol Inform 2013, 1:4  http://www.jpathinformatics.org/content/4/1/4technology  (IT) infrastructure including individual  workstations, servers, and networks.",OADS,/arxiv_data1/oa_pdf/b6/d4/JPI-4-4.PMC3624703.pdf
"J Pathol Inform 2013, 1:4  http://www.jpathinformatics.org/content/4/1/4T able  1: Glossary of basic terms related to information securitya Glossary Adware Software that automatically renders advertisements in order to generate revenue for its author Anonymization Process that removes or replaces identity information from a communication or record Antivirus Software used to prevent, detect, and remove malware Audit Evaluation process of a person, organization, system, process, enterprise, project or product Authentication Process of verification or confirmation of a user’s identity Backup Process of copying and archiving computer data that can be used to restore the original after a data loss event Bandwidth Amount of data that can be transmitted in a fixed amount of time, usually expressed in bits per second  (bps) Biometrics Unique, measurable characteristics of a human being that allow automatic recognition or identity verification Certificate  (key) Data construct or alphanumeric string that serves as the basis for establishing a secure connection over the internet  or a local network Cloud computing Use of computing resources  (hardware and software) that are delivered as a service over a network  (Internet) Computer virus Parasitic computer program that can replicate by infecting other computer files and spread from one computer to another; it almost always modifies and corrupts files on the targeted computers Computer worm Stand‑alone computer program that replicates itself in order to spread to other computers, usually using computer networks, and has a direct effect on band‑width Confidentiality Protection from unauthorized disclosure Contingency plan Plan designed for an outcome other than the usual  (expected) plan Covered entity Group or organization that creates, transmits, receives, and maintains electronic protected health  information  (e.g., health‑care plans, health‑care billing companies, health‑care providers) Data integrity Maintenance and assurance for the accuracy and consistency of data over its entire life‑cycle Data recovery Process of salvaging data from damaged, failed, corrupted, or inaccessible storage media when it cannot be normally accessed De‑identification Process by which a collection of data is stripped of information, that could allow identification  of data source Denial‑of‑service Attempt to make a machine or network resource unavailable to its intended users Disaster recovery Process, policies, and procedures that are related to preparation for recovery or continuation of technology infrastructure after a disaster Domain integrity Pools of values from which actual values appearing in the columns of a table are drawn Downtime A period of time when a system is unavailable or when a system fails to provide or perform its primary function Encryption Process of changing readable text into a set of characters and numbers based on mathematical algorithms  Endpoint security Methodologies and software that prevent workstations and other data access terminals from becoming  unintended sources for unauthorized extraction of data by individuals authorized for review‑only access.",Non-OADS,/arxiv_data1/oa_pdf/b6/d4/JPI-4-4.PMC3624703.pdf
"J Pathol Inform 2013, 1:4  http://www.jpathinformatics.org/content/4/1/4review.",Non-OADS,/arxiv_data1/oa_pdf/b6/d4/JPI-4-4.PMC3624703.pdf
"J Pathol Inform 2013, 1:4  http://www.jpathinformatics.org/content/4/1/4the laboratory  (LIS, middleware, instrument software,  etc.)",OADS,/arxiv_data1/oa_pdf/b6/d4/JPI-4-4.PMC3624703.pdf
"J Pathol Inform 2013, 1:4  http://www.jpathinformatics.org/content/4/1/4to temporarily maintain power to computers in the event  of a power outage.",Non-OADS,/arxiv_data1/oa_pdf/b6/d4/JPI-4-4.PMC3624703.pdf
"J Pathol Inform 2013, 1:4  http://www.jpathinformatics.org/content/4/1/4Automated logout policies can be implemented so  that after a certain period of inactivity the session is automatically disconnected from the system.",OADS,/arxiv_data1/oa_pdf/b6/d4/JPI-4-4.PMC3624703.pdf
"J Pathol Inform 2013, 1:4  http://www.jpathinformatics.org/content/4/1/4DATA SECURITY MEASURES Apart from the aforementioned security measures,  there are many other factors that need to be considered when dealing with data in the pathology laboratory.",Non-OADS,/arxiv_data1/oa_pdf/b6/d4/JPI-4-4.PMC3624703.pdf
"J Pathol Inform 2013, 1:4  http://www.jpathinformatics.org/content/4/1/4medium.",Non-OADS,/arxiv_data1/oa_pdf/b6/d4/JPI-4-4.PMC3624703.pdf
"J Pathol Inform 2013, 1:4  http://www.jpathinformatics.org/content/4/1/4and file scanning.",OADS,/arxiv_data1/oa_pdf/b6/d4/JPI-4-4.PMC3624703.pdf
"J Pathol Inform 2013, 1:4  http://www.jpathinformatics.org/content/4/1/4in the health‑care industry.",Non-OADS,/arxiv_data1/oa_pdf/b6/d4/JPI-4-4.PMC3624703.pdf
"J Pathol Inform 2013, 1:4  http://www.jpathinformatics.org/content/4/1/4business relationship  (with this often referred to as a  “need‑to‑know” basis), and therefore, are authorized to  access that patient’s medical record.",Non-OADS,/arxiv_data1/oa_pdf/b6/d4/JPI-4-4.PMC3624703.pdf
"J Pathol Inform 2013, 1:4  http://www.jpathinformatics.org/content/4/1/42009 and November 2012 there have been 511  security  breaches of this type reported in the U.S, affecting  over 21 million individuals in total.",Non-OADS,/arxiv_data1/oa_pdf/b6/d4/JPI-4-4.PMC3624703.pdf
"J Pathol Inform 2013, 1:4  http://www.jpathinformatics.org/content/4/1/4time of loss has been overwhelmingly on paper  (25.29%)  or on a laptop  (25.06%).",OADS,/arxiv_data1/oa_pdf/b6/d4/JPI-4-4.PMC3624703.pdf
"J Pathol Inform 2013, 1:4  http://www.jpathinformatics.org/content/4/1/4and procedures for each standard implementation, and  to periodically review and update them.",OADS,/arxiv_data1/oa_pdf/b6/d4/JPI-4-4.PMC3624703.pdf
http://www.healthit.gov; 2012. p.  9.,Non-OADS,/arxiv_data1/oa_pdf/b6/d4/JPI-4-4.PMC3624703.pdf
"J Pathol Inform 2013, 1:4  http://www.jpathinformatics.org/content/4/1/42008;79:60‑1.",Non-OADS,/arxiv_data1/oa_pdf/b6/d4/JPI-4-4.PMC3624703.pdf
"Kr oll  K. Fighting Fires In Data Centers, 2007. http://www.facilitiesnet.",OADS,/arxiv_data1/oa_pdf/b6/d4/JPI-4-4.PMC3624703.pdf
Available from: http://www.facilitiesnet.com/datacenters/article/ Fighting‑Fires‑in‑Data‑Centers‑‑6657.,OADS,/arxiv_data1/oa_pdf/b6/d4/JPI-4-4.PMC3624703.pdf
Available  from: http://csrc.nist.gov/publications/nistpubs/800‑63‑1/SP‑800‑63‑1.pdf.,Non-OADS,/arxiv_data1/oa_pdf/b6/d4/JPI-4-4.PMC3624703.pdf
Available from: http://www.clsi.org.39.,Non-OADS,/arxiv_data1/oa_pdf/b6/d4/JPI-4-4.PMC3624703.pdf
Available from: http://www.fda.gov/downloads/ MedicalDevices/DeviceRegulationandGuidance/GuidanceDocuments/ ucm077823.pdf.,Non-OADS,/arxiv_data1/oa_pdf/b6/d4/JPI-4-4.PMC3624703.pdf
Available from: http://www.cms.gov/Regulations‑and‑Guidance/ HIPAA‑Administrative‑Simplification/HIPAAGenInfo/downloads/hipaalaw.,Non-OADS,/arxiv_data1/oa_pdf/b6/d4/JPI-4-4.PMC3624703.pdf
Available from: http://www.hhs.gov/ocr/ privacy/hipaa/administrative/enforcementrule/enfifr.pdf.,Non-OADS,/arxiv_data1/oa_pdf/b6/d4/JPI-4-4.PMC3624703.pdf
Available from: http://www.ncbi.nlm.nih.gov/pmc/articles/ PMC2781727/.,Non-OADS,/arxiv_data1/oa_pdf/b6/d4/JPI-4-4.PMC3624703.pdf
Available from: http://www.hhs.gov/ocr/privacy/hipaa/administrative/,OADS,/arxiv_data1/oa_pdf/b6/d4/JPI-4-4.PMC3624703.pdf
"J Pathol Inform 2013, 1:4  http://www.jpathinformatics.org/content/4/1/4breachnotificationrule/breachtool.html.",Non-OADS,/arxiv_data1/oa_pdf/b6/d4/JPI-4-4.PMC3624703.pdf
Available  from: http://www.hhs.gov/ohrp/policy/ohrpregulations.pdf.,Non-OADS,/arxiv_data1/oa_pdf/b6/d4/JPI-4-4.PMC3624703.pdf
Available from: http://www.gpo.gov/fdsys/pkg/FR‑2013‑01‑25/ pdf/2013‑01073.pdf.,Non-OADS,/arxiv_data1/oa_pdf/b6/d4/JPI-4-4.PMC3624703.pdf
Available FREE in open access from: http://www.jpathinformatics.org/text.asp?2013/4/1/3/108540,Non-OADS,/arxiv_data1/oa_pdf/7a/8f/JPI-4-3.PMC3624704.pdf
"J Pathol Inform 2013, 1:3  http://www.jpathinformatics.org/content/4/1/3consultation, quality assurance, archiving, education,  conferences, and research.",OADS,/arxiv_data1/oa_pdf/7a/8f/JPI-4-3.PMC3624704.pdf
"J Pathol Inform 2013, 1:3  http://www.jpathinformatics.org/content/4/1/3pathology, responses included the possibility of image  manipulation, technologic limitations of institutions, poor inter‑observer variability, time to scan/digitize slides  and issues regarding billing/payment for consultation  services.",Non-OADS,/arxiv_data1/oa_pdf/7a/8f/JPI-4-3.PMC3624704.pdf
"J Pathol Inform 2013, 1:3  http://www.jpathinformatics.org/content/4/1/3Supplementary T able  1: Survey Level of practice Resident Pathologist with 0‑5  years of practice Pathologist with 6‑10  years of practice 1 Pathologist with 1‑20  years of practice Pathologist with >20 years of practice  How do you define telepathologyIs telepathology used in your practice?",Non-OADS,/arxiv_data1/oa_pdf/7a/8f/JPI-4-3.PMC3624704.pdf
"J Pathol Inform 2013, 1:3  http://www.jpathinformatics.org/content/4/1/3Supplementary T able  1: Contd... N/A Other  (please specify): In your opinion what are the disadvantages in using digital images  (choose all that apply)?",Non-OADS,/arxiv_data1/oa_pdf/7a/8f/JPI-4-3.PMC3624704.pdf
"J Pathol Inform 2013, 1:3  http://www.jpathinformatics.org/content/4/1/3Supplementary T able  2: Responses to survey question 2 Gross or microscopic pathology images on monitor for the purpose of diagnosis and consultation Usually, it is the review of anatomic pathology microscopic slides through an electronic connection Visual capture of pathology images for transmission electronically Digital pathology which may be used for remote consultationA fad that will soon passComputers to transmit images Use of digitalized slides for remote diagnosis Using digitally recorded pathology materials to make a diagnosisPrimary diagnosis by digital pathology from a distance Viewing slides remotely Internet imaging Consult and review at a distance by academics.",Non-OADS,/arxiv_data1/oa_pdf/7a/8f/JPI-4-3.PMC3624704.pdf
"J Pathol Inform 2013, 1:3  http://www.jpathinformatics.org/content/4/1/3Supplementary T able  2: Contd... Pathologic assessment performed remotely through the use of digital images or scanned slides Any technology or mechanism that makes use of a virtual slide or image and a computer Histological diagnosis from virtual images, can be from a distant site Digitalized scanned slides based evaluationThe use of digital and virtual imaging for histopathological diagnosis on national and international consults designsElectronic transmission of digital slides Digital images based on scanning of slides.",Non-OADS,/arxiv_data1/oa_pdf/7a/8f/JPI-4-3.PMC3624704.pdf
"J Pathol Inform 2013, 1:3  http://www.jpathinformatics.org/content/4/1/3examination in pathology.",Non-OADS,/arxiv_data1/oa_pdf/7a/8f/JPI-4-3.PMC3624704.pdf
"J Pathol Inform 2013, 1:3  http://www.jpathinformatics.org/content/4/1/3Natl Med J India 2004;17:17‑9.",Non-OADS,/arxiv_data1/oa_pdf/7a/8f/JPI-4-3.PMC3624704.pdf
Available from: http://canada.com/health/ Pathology+Facts/3680272/story.html.,Non-OADS,/arxiv_data1/oa_pdf/7a/8f/JPI-4-3.PMC3624704.pdf
Available FREE in open access from: http://www.jpathinformatics.org/text.asp?2013/4/1/2/107953,Non-OADS,/arxiv_data1/oa_pdf/6a/bc/JPI-4-2.PMC3624705.pdf
"J Pathol Inform 2013, 1:2  http://www.jpathinformatics.org/content/4/1/2within the pathology report may indicate the specific  slide or diagnostic AOI containing particularly  notable findings, in most situations today, there is  no automated linkage between the slide AOI and the  pathologist’s interpretation embedded within the report.",Non-OADS,/arxiv_data1/oa_pdf/6a/bc/JPI-4-2.PMC3624705.pdf
"J Pathol Inform 2013, 1:2  http://www.jpathinformatics.org/content/4/1/2to each reference point are known.",OADS,/arxiv_data1/oa_pdf/6a/bc/JPI-4-2.PMC3624705.pdf
"J Pathol Inform 2013, 1:2  http://www.jpathinformatics.org/content/4/1/2To assess the accuracy of markup placement on each  subsequent WSI of the same slide, a specific, readily  identifiable tissue landmark (e.g., a small blood vessel  or a unique tissue formation) was located within each  image and the distance from the landmark to the  edges of the markup boundary was measured in the  x  and y axis.",OADS,/arxiv_data1/oa_pdf/6a/bc/JPI-4-2.PMC3624705.pdf
"J Pathol Inform 2013, 1:2  http://www.jpathinformatics.org/content/4/1/2RESULTS Vendor image markup and annotation tools were  employed to annotate histology slides scanned at ×20  from two different organ systems including kidney and  breast.",OADS,/arxiv_data1/oa_pdf/6a/bc/JPI-4-2.PMC3624705.pdf
"J Pathol Inform 2013, 1:2  http://www.jpathinformatics.org/content/4/1/2was not accurately relocated in newly scanned images  of the same slide.",Non-OADS,/arxiv_data1/oa_pdf/6a/bc/JPI-4-2.PMC3624705.pdf
"J Pathol Inform 2013, 1:2  http://www.jpathinformatics.org/content/4/1/2differential diagnoses given mock‑up case scenarios and  presentations.",Non-OADS,/arxiv_data1/oa_pdf/6a/bc/JPI-4-2.PMC3624705.pdf
"Silver  Springs, MD: US Food and Drug Administration; 2012 Available from:  http://www.fda.gov/MedicalDevices/ProductsandMedicalProcedures/ DeviceApprovalsandClearances/Recently‑ApprovedDevices/default.",Non-OADS,/arxiv_data1/oa_pdf/6a/bc/JPI-4-2.PMC3624705.pdf
Available from: http://www.itl.nist.gov/div898/handbook/ eda/section3/eda359.htm.,Non-OADS,/arxiv_data1/oa_pdf/6a/bc/JPI-4-2.PMC3624705.pdf
Available FREE in open access from: http://www.jpathinformatics.org/text.asp?2013/4/1/5/108543,Non-OADS,/arxiv_data1/oa_pdf/07/a4/JPI-4-5.PMC3624706.pdf
"J Pathol Inform 2013, 1:5  http://www.jpathinformatics.org/content/4/1/5INTRODUCTION Digital microscopy for pathology study has recently  become a popular research area where a large number  of computer ‑ based image analysis tools are developed  to support not only disease diagnosis but also treatment efficacy evaluation in clinical and research settings.",Non-OADS,/arxiv_data1/oa_pdf/07/a4/JPI-4-5.PMC3624706.pdf
"J Pathol Inform 2013, 1:5  http://www.jpathinformatics.org/content/4/1/5and query requirements arising from large volumes of  image data and analysis results.",OADS,/arxiv_data1/oa_pdf/07/a4/JPI-4-5.PMC3624706.pdf
"J Pathol Inform 2013, 1:5  http://www.jpathinformatics.org/content/4/1/5provenance information are represented and managed in  a database;  (3) the results are queried for comparisons  of objects and features extracted by the algorithms–for  example, to find the overlap‑to‑intersection ratio and  centroid distance of intersected markups; and (4) for algorithm consolidation, analysis results are either filtered or aggregated based on certain criteria, and for algorithm  sensitivity study, changes in results are recorded and stored as algorithm parameters are tuned.",OADS,/arxiv_data1/oa_pdf/07/a4/JPI-4-5.PMC3624706.pdf
"J Pathol Inform 2013, 1:5  http://www.jpathinformatics.org/content/4/1/5by  ==∑1hh h H ii iNnn Ns s, where Nh is the sample size for  stratum h, n is the total sample size, Nh is the total size  for stratum h, and σh is the standard deviation of stratum  h (obtained from pilot data).",OADS,/arxiv_data1/oa_pdf/07/a4/JPI-4-5.PMC3624706.pdf
"J Pathol Inform 2013, 1:5  http://www.jpathinformatics.org/content/4/1/5model consists of 62 Unified Modeling Language  (UML)  classes, representing information on markups  (spatial  shapes representing regions, cellular or subcellular  objects), annotations  (including calculated features  or observations such as classifications associated with  markups), and provenance  (image references, analysis,  algorithm and parameters).",OADS,/arxiv_data1/oa_pdf/07/a4/JPI-4-5.PMC3624706.pdf
"J Pathol Inform 2013, 1:5  http://www.jpathinformatics.org/content/4/1/5and same image, and regions contain markups.",OADS,/arxiv_data1/oa_pdf/07/a4/JPI-4-5.PMC3624706.pdf
"J Pathol Inform 2013, 1:5  http://www.jpathinformatics.org/content/4/1/5parameters.",OADS,/arxiv_data1/oa_pdf/07/a4/JPI-4-5.PMC3624706.pdf
"J Pathol Inform 2013, 1:5  http://www.jpathinformatics.org/content/4/1/5intersections of markups in spatial joins.",OADS,/arxiv_data1/oa_pdf/07/a4/JPI-4-5.PMC3624706.pdf
"J Pathol Inform 2013, 1:5  http://www.jpathinformatics.org/content/4/1/5the file for spatial objects twice–once for counting the objects  and once for loading the objects to the database.",OADS,/arxiv_data1/oa_pdf/07/a4/JPI-4-5.PMC3624706.pdf
"J Pathol Inform 2013, 1:5  http://www.jpathinformatics.org/content/4/1/5utilization could accelerate spatial computation and  boost the performance.",OADS,/arxiv_data1/oa_pdf/07/a4/JPI-4-5.PMC3624706.pdf
"J Pathol Inform 2013, 1:5  http://www.jpathinformatics.org/content/4/1/5language, without any need of programming.",Non-OADS,/arxiv_data1/oa_pdf/07/a4/JPI-4-5.PMC3624706.pdf
Available from: http://web.cci.emory.edu/confluence/display/ INSILICO/.,OADS,/arxiv_data1/oa_pdf/07/a4/JPI-4-5.PMC3624706.pdf
Available from:  http://www.dclunie.com/papers/AVT ‑RSNA‑2008‑RC730‑DAC2.pdf.,Non-OADS,/arxiv_data1/oa_pdf/07/a4/JPI-4-5.PMC3624706.pdf
Available from: http://www.opengeospatial.org/ standards/sfs.,OADS,/arxiv_data1/oa_pdf/07/a4/JPI-4-5.PMC3624706.pdf
Available from: http://www.opencv.org/.,Non-OADS,/arxiv_data1/oa_pdf/07/a4/JPI-4-5.PMC3624706.pdf
Available from: http://www.aperio.com.,Non-OADS,/arxiv_data1/oa_pdf/07/a4/JPI-4-5.PMC3624706.pdf
Available  from: https://web.cci.emory.edu/confluence/display/PAIS.,OADS,/arxiv_data1/oa_pdf/07/a4/JPI-4-5.PMC3624706.pdf
Available from: http://www.ibm.com/software/data/ spatial/db2spatial/.,OADS,/arxiv_data1/oa_pdf/07/a4/JPI-4-5.PMC3624706.pdf
Available from: http://code.google.com/p/ openpais/.,OADS,/arxiv_data1/oa_pdf/07/a4/JPI-4-5.PMC3624706.pdf
Available from: http://www.boost.org/.,Non-OADS,/arxiv_data1/oa_pdf/07/a4/JPI-4-5.PMC3624706.pdf
Available  from: http://www.angusj.com/delphi/clipper.php.,Non-OADS,/arxiv_data1/oa_pdf/07/a4/JPI-4-5.PMC3624706.pdf
"(Accessed September 27, 2012, at http://www.usaid.",Non-OADS,/arxiv_data1/oa_pdf/6e/bf/NAJMS-5-102.PMC3624709.pdf
"(Accessed  August 3, 2012, at http://www.jhsph.edu/research/ affiliated‑programs/medical‑outcomes‑study‑HIV/User_ manual/index.html).",Non-OADS,/arxiv_data1/oa_pdf/6e/bf/NAJMS-5-102.PMC3624709.pdf
Start a QR-code reading  software (see list of free applications from http://tinyurl.com/yzlh2tc) and point the camera to the QR-code printed in the  journal.,Non-OADS,/arxiv_data1/oa_pdf/b4/b9/NAJMS-5-119.PMC3624712.pdf
See http://tinyurl.com/2bw7fn3 or http://tinyurl.com/3ysr3me for the free applications.Announcementpeople in a Caribbean society N Am J Med Sci 2010;2:381‑8.,Non-OADS,/arxiv_data1/oa_pdf/b4/b9/NAJMS-5-119.PMC3624712.pdf
The application can be downloaded from http://itunes.apple.com/us/app/medknow-journals/id458064375?ls=1&mt=8.,Non-OADS,/arxiv_data1/oa_pdf/cf/ba/NAJMS-5-134.PMC3624715.pdf
The application can be downloaded  from https://market.android.com/details?id=comm.app.medknow.,Non-OADS,/arxiv_data1/oa_pdf/c6/a6/NAJMS-5-145.PMC3624717.pdf
"(Accessed June 28, 2012, at http://www.qcnet.com/ UnityInterlab/tabid/201/language/en‑US/Default.aspx.)",Non-OADS,/arxiv_data1/oa_pdf/d8/71/NAJMS-5-82.PMC3624724.pdf
Author Help: Online submission of the manuscripts Articles can be submitted online from http://www.journalonweb.com.,Non-OADS,/arxiv_data1/oa_pdf/d8/71/NAJMS-5-82.PMC3624724.pdf
Available from:  http://www.constructioncloudcomputing.com/2010/08/14/ cloud-computing-history/[Last accessed on 2012 Jul 27].,Non-OADS,/arxiv_data1/oa_pdf/de/52/IJRI-22-150.PMC3624735.pdf
Available from: http://en.wikipedia.org/ wiki/Cloud_computing.,OADS,/arxiv_data1/oa_pdf/de/52/IJRI-22-150.PMC3624735.pdf
Available from: http://microreviews.org/ types-of-cloud-computing/[Last accessed on 2012 Mar 31].,OADS,/arxiv_data1/oa_pdf/de/52/IJRI-22-150.PMC3624735.pdf
Available from: http://www.techknowtimes.com/  computing/cloud -computing/cloud -computing-increases -  effectiveness-and-efficiency/[Last accessed on 2012 Mar 31].,Non-OADS,/arxiv_data1/oa_pdf/de/52/IJRI-22-150.PMC3624735.pdf
Available from: http://www.ebizq.net/blogs/ saasweek/2008/03/distinguishing_cloud_computing/[Last accessed  on 2012 Mar 31].,Non-OADS,/arxiv_data1/oa_pdf/de/52/IJRI-22-150.PMC3624735.pdf
Available from: http://en.wikipedia.org/ wiki/Software_as_a_service [Last accessed on 2012 Mar 31].,OADS,/arxiv_data1/oa_pdf/de/52/IJRI-22-150.PMC3624735.pdf
Available from: http://www.networkworld.com/ news/2009/042709-burning-security-cloud-computing.html [Last  accessed on 2009 Apr 27].,OADS,/arxiv_data1/oa_pdf/de/52/IJRI-22-150.PMC3624735.pdf
The application can be downloaded from http://itunes.apple.com/us/app/medknow-journals/ id458064375?ls=1&mt=8.,Non-OADS,/arxiv_data1/oa_pdf/de/52/IJRI-22-150.PMC3624735.pdf
Start a QR-code reading software (see list of free applications from http://tinyurl.com/ yzlh2tc) and point the camera to the QR-code printed in the journal.,Non-OADS,/arxiv_data1/oa_pdf/56/01/IJRI-22-170.PMC3624738.pdf
See http://tinyurl.com/2bw7fn3 or http://tinyurl.com/3ysr3me for the free  applications.Announcement,Non-OADS,/arxiv_data1/oa_pdf/56/01/IJRI-22-170.PMC3624738.pdf
Author Help: Online submission of the manuscripts Articles can be submitted online from http://www.journalonweb.com.,Non-OADS,/arxiv_data1/oa_pdf/1d/8a/IJRI-22-178.PMC3624739.pdf
"This is an Open Access article distributed under the terms of the Creative Commons Attribution Non-Commercial License (http://creativecommons.or g/licenses/by-nc/3.0), which permits unrestricted non-commercial use, distribution, and reproduction in any medium, provided the original work is properly cited.",Non-OADS,/arxiv_data1/oa_pdf/1c/f8/nss013.PMC3624952.pdf
"Talairach coordinates were converted into MNI co- ordinates using the algorithm for nonlinear transformation as described in http://www.mrc-cbu.cam.ac.uk/Imaging/mnispace.html.For whole-brain analyses, a threshold of P< 0.001, uncorrected for multiple comparisons and cluster size /C2110 voxels was applied; the threshold for ROI analyses was set to P< 0.05, familywise error cor- rected (FWE).",OADS,/arxiv_data1/oa_pdf/1c/f8/nss013.PMC3624952.pdf
"pISSN 2287-9714   eISSN 2287-9722 www.coloproctol.orgAnnals of Coloproctology www.coloproctol.org 28Rectal Perforation Caused by Anal Stricture After   Hemorrhoid Treatment Yong Joon Suh, Heon-Kyun Ha, Heung-Kwon Oh, Rumi Shin, Seung-Yong Jeong, Kyu Joo Park Department of Surgery, Seoul National University College of Medicine, Seoul, Korea Case Report Ann Coloproctol 2013;29(1):28-30 http://dx.doi.org/10.3393/ac.2013.29.1.28 Inappropriate therapies for hemorrhoids can lead to various complications including anorectal stricture.",Non-OADS,/arxiv_data1/oa_pdf/08/84/ac-29-28.PMC3624977.pdf
"Department of Surgery, Seoul National University College of Medicine,   103 Daehak-ro, Jongno-gu, Seoul 1 10-744, Korea Tel: +82-2-2072-2901, Fax: +82-2-766-3975  E-mail: kjparkmd@plaza.snu.ac.kr © 2013 The Korean Society of Coloproctology This is an open-access article distributed under the terms of the Creative Commons Attribution Non- Commercial License (http://creativecommons.org/licenses/by-nc/3.0) which permits unrestricted non- commercial use, distribution, and reproduction in any medium, provided the original work is properly cited.",Non-OADS,/arxiv_data1/oa_pdf/08/84/ac-29-28.PMC3624977.pdf
"pISSN 2287-9714   eISSN 2287-9722 www.coloproctol.orgAnnals of Coloproctology www.coloproctol.org 12Laparoscopic Versus an Open Colectomy in an Emergency  Setting: A Case-Controlled Study Frederick H. Koh1,2, Ker-Kan Tan1,2, Charles B. Tsang1,2, Dean C. Koh1,2 1Division of Colorectal Surgery, University Surgical Cluster, National University Health System, Singapore; 2Department of Surgery, Yong Loo  Lin School of Medicine, National University of Singapore, SingaporeOriginal Article Ann Coloproctol 2013;29(1):12-16 http://dx.doi.org/10.3393/ac.2013.29.1.12 Purpose:  Laparoscopy continues to be increasingly adopted for elective colorectal resections.",Non-OADS,/arxiv_data1/oa_pdf/36/73/ac-29-12.PMC3624978.pdf
"© 2013 The Korean Society of Coloproctology This is an open-access article distributed under the terms of the Creative Commons Attribution Non- Commercial License (http://creativecommons.org/licenses/by-nc/3.0) which permits unrestricted non- commercial use, distribution, and reproduction in any medium, provided the original work is properly cited.",Non-OADS,/arxiv_data1/oa_pdf/36/73/ac-29-12.PMC3624978.pdf
"www.coloproctol.org 1pISSN 2287-9714   eISSN 2287-9722 www.coloproctol.orgAnnals of Coloproctology Colorectal Cancer Epidemic in Korea Dong-Hyun Kim Department of Social and Preventive Medicine, Hallym University College of Medicine, Chuncheon, KoreaEditorial  Ann Coloproctol 2013;29(1):1-4 http://dx.doi.org/10.3393/ac.2013.29.1.1 tal cancer incidence rates among Koreans are also reported in  the California Regional Cancer Registry.",Non-OADS,/arxiv_data1/oa_pdf/eb/c1/ac-29-1.PMC3624979.pdf
"Department of Social and Preventive Medicine, Hallym University College of  Medicine, 1 Hallimdaehak-gil, Chuncheon 200-702, Korea Tel: +82-33-248-2660, Fax: +82-33-256-1675 E-mail: dhkims@hallym.ac.kr © 2013 The Korean Society of Coloproctology This is an open-access article distributed under the terms of the Creative Commons Attribution Non- Commercial License (http://creativecommons.org/licenses/by-nc/3.0) which permits unrestricted non- commercial use, distribution, and reproduction in any medium, provided the original work is properly cited.",Non-OADS,/arxiv_data1/oa_pdf/eb/c1/ac-29-1.PMC3624979.pdf
Available from: http://www.ncc.re.kr/english/programs/proga - rms02.jsp.,Non-OADS,/arxiv_data1/oa_pdf/eb/c1/ac-29-1.PMC3624979.pdf
Available from: http://www.iarc.fr/en/publications/pdfs-online/epi/sp160/ index.php.,Non-OADS,/arxiv_data1/oa_pdf/eb/c1/ac-29-1.PMC3624979.pdf
"pISSN 2287-9714   eISSN 2287-9722 www.coloproctol.orgAnnals of Coloproctology www.coloproctol.org 34Unusual Case of Solitary Perineal Subcutaneous Metastasis  From Sigmoid Colon Cancer Taek-Gu Lee, Sang-Jeon Lee Department of Surgery, Chungbuk National University College of Medicine, Cheongju, KoreaCase Report Ann Coloproctol 2013;29(1):34-37 http://dx.doi.org/10.3393/ac.2013.29.1.34 Subcutaneous metastasis from colorectal cancer is an unusual presentation.",Non-OADS,/arxiv_data1/oa_pdf/87/3d/ac-29-34.PMC3624980.pdf
"Department of Surgery, Chungbuk National University College of Medicine,  52 Naesudong-ro, Heungdeok-gu, Cheongju 361-804, Korea  Tel: +82-43-269-6360, Fax: +82-43-266-6037 E-mail: colon@chungbuk.ac.kr  © 2013 The Korean Society of Coloproctology This is an open-access article distributed under the terms of the Creative Commons Attribution Non- Commercial License (http://creativecommons.org/licenses/by-nc/3.0) which permits unrestricted non- commercial use, distribution, and reproduction in any medium, provided the original work is properly cited.",Non-OADS,/arxiv_data1/oa_pdf/87/3d/ac-29-34.PMC3624980.pdf
"pISSN 2287-9714   eISSN 2287-9722 www.coloproctol.orgAnnals of Coloproctology www.coloproctol.org 17Feasibility of Hand-Assisted Laparoscopic Surgery as  Compared to Open Surgery for Sigmoid Colon Cancer:   A Case-Controlled Study Sang Eun Nam, Eun-Joo Jung, Chun-Geun Ryu, Jin Hee Paik, Dae-Yong Hwang Department of Surgery, Colorectal Cancer Center, Konkuk University Medical Center, Konkuk University School of Medicine, Seoul, KoreaOriginal Article Ann Coloproctol 2013;29(1):17-21 http://dx.doi.org/10.3393/ac.2013.29.1.17 Purpose:  The aim of this study was to evaluate short-term clinical outcomes by comparing hand-assisted laparoscopic sur - gery (HALS) with open surgery for sigmoid colon cancer.",Non-OADS,/arxiv_data1/oa_pdf/18/02/ac-29-17.PMC3624981.pdf
"© 2013 The Korean Society of Coloproctology This is an open-access article distributed under the terms of the Creative Commons Attribution Non- Commercial License (http://creativecommons.org/licenses/by-nc/3.0) which permits unrestricted non- commercial use, distribution, and reproduction in any medium, provided the original work is properly cited.",Non-OADS,/arxiv_data1/oa_pdf/18/02/ac-29-17.PMC3624981.pdf
Available from: http://www.nccn.org/profes - sionals/physician_gls/f_guidelines.asp.,Non-OADS,/arxiv_data1/oa_pdf/18/02/ac-29-17.PMC3624981.pdf
"pISSN 2287-9714   eISSN 2287-9722 www.coloproctol.orgAnnals of Coloproctology www.coloproctol.org 31A Large Polypoid Vascular Ectasia Removed by Using   a Polypectomy With a Detachable Snare in an Asymptomatic  Patient Byung Hyun Yu, Sung Jae Shin, Kwang Wook Lee, Kyoung Ho Ryoo, Jeong Ook Wi, Joon Hwan Yoo,   Jeong Woo Choi Department of Gastroenterology, Ajou University School of Medicine, Suwon, KoreaCase Report Ann Coloproctol 2013;29(1):31-33 http://dx.doi.org/10.3393/ac.2013.29.1.31 Vascular ectasia is a well-known cause of lower gastrointestinal bleeding in the elderly.",Non-OADS,/arxiv_data1/oa_pdf/0b/a3/ac-29-31.PMC3624982.pdf
"A peduncu - Received: April 13, 2012   •   Accepted: August 27, 2012 Correspondence to: Sung-Jae Shin, Ph.D.    Department of Gastroenterology, Ajou University School of Medicine,   206 World cup-ro, Yeongtong-gu, Suwon 443-721, Korea Tel: +82-31-219-6939, Fax: +82-31-219-5999 E-mail: shsj9128@ajou.ac.kr © 2013 The Korean Society of Coloproctology This is an open-access article distributed under the terms of the Creative Commons Attribution Non- Commercial License (http://creativecommons.org/licenses/by-nc/3.0) which permits unrestricted non- commercial use, distribution, and reproduction in any medium, provided the original work is properly cited.",Non-OADS,/arxiv_data1/oa_pdf/0b/a3/ac-29-31.PMC3624982.pdf
"www.coloproctol.org 5pISSN 2287-9714   eISSN 2287-9722 www.coloproctol.orgAnnals of Coloproctology Functional New Sphincter Ani Reconstruction by Using  Neurovascualr Antropylorus Transposition After   an Anorectal Excision Bong Hwa Lee, Min Jung Kim, Hyoung Chul Park Department of Surgery, Hallym University Sacred Heart Hospital, Hallym University College of Medicine, Anyang, KoreaEditorial  Ann Coloproctol 2013;29(1):5-6 http://dx.doi.org/10.3393/ac.2013.29.1.5 tum, especially in the cases of gracilis muscle transfer.",Non-OADS,/arxiv_data1/oa_pdf/18/6f/ac-29-5.PMC3624983.pdf
"Department of Surgery, Hallym University Sacred Heart Hospital, Hallym  University College of Medicine, 22 Gwanpyeong-ro 170beon-gil, Dongan-gu,  Anyang 431-796, Korea Tel: +82-31-380-3772, Fax: +82-31-380-41 18 E-mail: bshlee@hallym.ac.kr © 2013 The Korean Society of Coloproctology This is an open-access article distributed under the terms of the Creative Commons Attribution Non- Commercial License (http://creativecommons.org/licenses/by-nc/3.0) which permits unrestricted non- commercial use, distribution, and reproduction in any medium, provided the original work is properly cited.",Non-OADS,/arxiv_data1/oa_pdf/18/6f/ac-29-5.PMC3624983.pdf
"pISSN 2287-9714   eISSN 2287-9722 www.coloproctol.orgAnnals of Coloproctology www.coloproctol.org 22Safety and Feasibility of a Laparoscopic Colorectal Cancer  Resection in Elderly Patients Duck Hyoun Jeong, Hyuk Hur, Byung Soh Min, Seung Hyuk Baik, Nam Kyu Kim Department of Surgery, Yonsei University College of Medicine, Seoul, Korea Original Article Ann Coloproctol 2013;29(1):22-27 http://dx.doi.org/10.3393/ac.2013.29.1.22 Purpose:  The aim of this study is to assess the effects of age on the short-term outcomes of a laparoscopic resection of  colorectal cancer in elderly (≥75 years old), as compared with younger (<75 years old), patients.",Non-OADS,/arxiv_data1/oa_pdf/85/67/ac-29-22.PMC3624984.pdf
"Department of Surgery, Yonsei University College of Medicine, 50 Yonsei-ro,  Seodaemun-gu, Seoul 120-749, Korea  Tel: +82-2-2228-2105, Fax: +82-2-313-8289 E-mail: namkyuk@yuhs.ac © 2013 The Korean Society of Coloproctology This is an open-access article distributed under the terms of the Creative Commons Attribution Non- Commercial License (http://creativecommons.org/licenses/by-nc/3.0) which permits unrestricted non- commercial use, distribution, and reproduction in any medium, provided the original work is properly cited.",Non-OADS,/arxiv_data1/oa_pdf/85/67/ac-29-22.PMC3624984.pdf
Available  form: http://kosis.kr.,Non-OADS,/arxiv_data1/oa_pdf/85/67/ac-29-22.PMC3624984.pdf
"pISSN 2287-9714   eISSN 2287-9722 www.coloproctol.orgAnnals of Coloproctology www.coloproctol.org 7Feasibility of Neurovascular Antropylorus Perineal Transposition  With Pudendal Nerve Anastomosis Following Anorectal  Excision: A Cadaveric Study for Neoanal Reconstruction Abhijit Chandra, Ashok Kumar, M Noushif, Nitish Gupta, Vijay Kumar1, Navneet Kumar Chauhan2,  Vishal Gupta Departments of Surgical Gastroenterology, 1Plastic Surgery, and 2Anatomy, Chhatrapati Shahuji Maharaj Medical University (King George’s  Medical University), Lucknow, IndiaOriginal Article Ann Coloproctol 2013;29(1):7-11 http://dx.doi.org/10.3393/ac.2013.29.1.7 Purpose:  Perineal transposition of the antropyloric valve following an anorectal excision as a substitute for a permanent  colostomy has recently been reported in humans.",Non-OADS,/arxiv_data1/oa_pdf/f5/0b/ac-29-7.PMC3624985.pdf
"PN reinnervation of skeletal mus - cles has been performed in order to attain voluntary neosphincter INTRODUCTION Fecal continence results from an intact anal sphincter innervated  by the pudendal nerve (PN), which causes its tonic contraction in  Received: July 25, 2012   •   Accepted: October 28, 2012 Correspondence to: Abhijit Chandra, MS, MCh Department of Surgical Gastroenterology, Chhatrapati Shahuji Maharaj  Medical University (King George’s Medical University), Chowk, Lucknow  226003, India Tel: +91-522-2740068, Fax: +91-522-22561 16 E-mail: abhijitchandra@hotmail.com © 2013 The Korean Society of Coloproctology This is an open-access article distributed under the terms of the Creative Commons Attribution Non- Commercial License (http://creativecommons.org/licenses/by-nc/3.0) which permits unrestricted non- commercial use, distribution, and reproduction in any medium, provided the original work is properly cited.",Non-OADS,/arxiv_data1/oa_pdf/f5/0b/ac-29-7.PMC3624985.pdf
http://dx.doi.org/ 10.1016/j.jss.2012.03.053.,OADS,/arxiv_data1/oa_pdf/f5/0b/ac-29-7.PMC3624985.pdf
"This is an Open Access article distributed under the terms of the Creative Commons Attribution Non-Commercial License (http://c reativecommons.org/licenses/by-nc/3.0 ) which permits unrestricted non-commercial use, distribution, and re production in any medium, provided the original work is prop erly cited.BLOOD RESEARCHVOLUME 48 ㆍNUMBER 1 March 2013ORIGINAL  ARTICLE The prevalence and clinical characteristics of cancer among anemia  patients treated at an outpatient clinic Soo Jeong Kim, So Young Ha, Bo Mi Choi, Mi Yeong Lee, Jong Youl Jin, Soo Jeong Yeom, Tae Wan Kim,  Young Min Kim, Keehyun Lee Department of Internal Medicine, Bucheon St. Mary's Hosp ital, The Catholic University  of Korea, Bucheon, Korea p-ISSN 2287-979X / e-ISSN 2288-0011 http://dx.doi.org/10.5045/br.2013.48.1.46Blood Res 2013;48:46-50.",Non-OADS,/arxiv_data1/oa_pdf/54/df/br-48-46.PMC3624994.pdf
"This is an Open Access article distributed under the terms of the Creative Commons Attribution Non-Commercial License (http://c reativecommons.org/licenses/by-nc/3.0 ) which permits unrestricted non-commercial use, distribution, and re production in any medium, provided the original work is prop erly cited.BLOOD RESEARCHVOLUME 48 ㆍNUMBER 1 March 2013ORIGINAL  ARTICLE The prevalence of vitamin D deficiency in iron-deficient and normal  children under the age of 24 months Hyun Joo Jin, Jun Ho Lee, Moon Kyu Kim Department of Pediatrics, CHA Univer sity School of Medicine, CHA Bund ang Medical Center, Seongnam, Korea p-ISSN 2287-979X / e-ISSN 2288-0011 http://dx.doi.org/10.5045/br.2013.48.1.40Blood Res 2013;48:40-5.",Non-OADS,/arxiv_data1/oa_pdf/15/19/br-48-40.PMC3624995.pdf
"1 This is an Open Access article distributed under the terms of the Creative Commons Attribution Non-Commercial License (http://c reativecommons.org/licenses/by-nc/3.0 ) which permits unrestricted non-commercial use, distribution, and reproduction in any medium, provided the original work is prop erly cited.BLOOD RESEARCH Volume 48 ㆍNumber 1 ㆍMarch 2013 http://dx.doi.org/10.5045/br.2013.48.1.1 Editorial Blood Research: hematology and beyond David F. Stroncek, M.D.",Non-OADS,/arxiv_data1/oa_pdf/f7/a0/br-48-1.PMC3624996.pdf
"This is an Open Access article distributed under the terms of the Creative Commons Attribution Non-Commercial License (http://c reativecommons.org/licenses/by-nc/3.0 ) which permits unrestricted non-commercial use, distribution, and re production in any medium, provided the original work is prop erly cited.BLOOD RESEARCHVOLUME 48 ㆍNUMBER 1 March 2013REVIEW  ARTICLE Role of hepcidin in the pathophysiology and diagnosis of anemia Guido D’Angelo Ematologia/Coagulazione, Laboratorio di Ch imica-Clinica, Ematologia e Microbiologia, Azienda Ospedaliera S.Antonio Abate di  Callarate, Varese, Italy p-ISSN 2287-979X / e-ISSN 2288-0011 http://dx.doi.org/10.5045/br.2013.48.1.10Blood Res 2013;48:10-5.",Non-OADS,/arxiv_data1/oa_pdf/b4/16/br-48-10.PMC3624997.pdf
"This is an Open Access article distributed under the terms of the Creative Commons Attribution Non-Commercial License (http://c reativecommons.org/licenses/by-nc/3.0 ) which permits unrestricted non-commercial use, distribution, and re production in any medium, provided the original work is prop erly cited.BLOOD RESEARCHVOLUME 48 ㆍNUMBER 1 March 2013CASE  REPORT Characterization of anti-factor VIII antibody in a patient with acquired  hemophilia A Jisu Oh1, Yeongmin Lim1, Moon Ju Jang1, Ji Young Huh2, Midori Shima3, Doyeun Oh1 Departments of  1Internal Medicine, 2Laboratory Medicine, CHA University Sc hool of Medicine, Seongnam, Korea, 3Department of  Pediatrics, Nara Medical University  School of Medicine, Nara, Japan p-ISSN 2287-979X / e-ISSN 2288-0011 http://dx.doi.org/10.5045/br.2013.48.1.58Blood Res 2013;48:58-62.",Non-OADS,/arxiv_data1/oa_pdf/c8/47/br-48-58.PMC3624998.pdf
"This is an Open Access article distributed under the terms of the Creative Commons Attribution Non-Commercial License (http://c reativecommons.org/licenses/by-nc/3.0 ) which permits unrestricted non-commercial use, distribution, and re production in any medium, provided the original work is prop erly cited.BLOOD RESEARCHVOLUME 48 ㆍNUMBER 1 March 2013ORIGINAL  ARTICLE Karyotypic change between diagnosis and relapse as a predictor of  salvage therapy outcome in AML patients Yundeok Kim, Jieun Jang, Shin Yong Hyun, Do hyu Hwang, Soo Jeong Kim, Jin Seok Kim,  Jun-Won Cheong, Yoo Hong Min Department of Internal Medicine, Yonsei Un iversity College of Medicine, Seoul, Korea p-ISSN 2287-979X / e-ISSN 2288-0011 http://dx.doi.org/10.5045/br.2013.48.1.24Blood Res 2013;48:24-30.",Non-OADS,/arxiv_data1/oa_pdf/97/90/br-48-24.PMC3624999.pdf
"This is an Open Access article distributed under the terms of the Creative Commons Attribution Non-Commercial License (http://c reativecommons.org/licenses/by-nc/3.0 ) which permits unrestricted non-commercial use, distribution, and re production in any medium, provided the original work is prop erly cited.BLOOD RESEARCHVOLUME 48 ㆍNUMBER 1 March 2013ORIGINAL  ARTICLE Poor prognostic significance of Mycobacterium tuberculosis  infection  during bortezomib-containing chemotherapy in patients with multiple myeloma Jae-Sook Ahn1*, Sung Yoon Rew1*, Deok-Hwan Yang1, Sung-Hoon Jung1, Seung-Ji Kang2, Mi-Young  Kim1, Seung-Shin Lee1, Yeo-Kyeoung Kim1, Hyeoung-Joon Kim1, Je-Jung Lee1,3 Departments of  1Hematology-Oncology and 2Infectious Disease, Chon nam National University Hwasun Hospital, Hwasun, 3The  Brain Korea 21 Project, Center for Bi omedical Human Resources at Chonnam National University, Gwangju, Korea p-ISSN 2287-979X / e-ISSN 2288-0011 http://dx.doi.org/10.5045/br.2013.48.1.35Blood Res 2013;48:35-9.",Non-OADS,/arxiv_data1/oa_pdf/e0/41/br-48-35.PMC3625000.pdf
"This is an Open Access article distributed under the terms of the Creative Commons Attribution Non-Commercial License (http://c reativecommons.org/licenses/by-nc/3.0 ) which permits unrestricted non-commercial use, distribution, and re production in any medium, provided the original work is prop erly cited.BLOOD RESEARCHVOLUME 48 ㆍNUMBER 1 March 2013ORIGINAL   ARTICLE Blood group phenotype frequencies in  blood donors from a tertiary  care hospital in north India Nitin Agarwal, Rakesh Mohan Thapliyal, Kabita Chatterjee Department of Transfusion Medicine, All India In stitute of Medical Sciences, New Delhi, India p-ISSN 2287-979X / e-ISSN 2288-0011 http://dx.doi.org/10.5045/br.2013.48.1.51Blood Res 2013;48:51-4.",Non-OADS,/arxiv_data1/oa_pdf/20/dc/br-48-51.PMC3625001.pdf
"68 This is an Open Access article distributed under the terms of the Creative Commons Attribution Non-Commercial License (http://c reativecommons.org/licenses/by-nc/3.0 ) which permits unrestricted non-commercial use, distribution, and reproduction in any medium, provided the original work is prop erly cited.BLOOD RESEARCH Volume 48 ㆍNumber 1 ㆍMarch 2013 http://dx.doi.org/10.5045/br.2013.48.1.68 Letter to the Editor Ruxolitinib changes the natural  course of myelofibrosis and its  transplant outcome THE AUTHORÊS REPLY:  In his letter referring to “Will JAK1/2  inhibitors change the standard of care for myelofibrosis (MF)?”, Dr. Raut raised two important issues about rux-olitinib: (1) its mechanism of action and (2) its beneficial effect on the outcome of he matopoietic stem cell trans- plantation (HSCT) in MF pati ents.",Non-OADS,/arxiv_data1/oa_pdf/3c/41/br-48-68.PMC3625002.pdf
"5 This is an Open Access article distributed under the terms of the Creative Commons Attribution Non-Commercial License (http://c reativecommons.org/licenses/by-nc/3.0 ) which permits unrestricted non-commercial use, distribution, and reproduction in any medium, provided the original work is prop erly cited.BLOOD RESEARCH Volume 48 ㆍNumber 1 ㆍMarch 2013 http://dx.doi.org/10.5045/br.2013.48.1.5 Perspective A proposal for improvement in  the utilization rate of banked cord blood Young-Ho Lee, M.D., Ph.D.1, Ji Yoon Kim, M.D.,  Ph.D.2, Yeung-Chul Mun, M.D., Ph.D.3, Hong  Hoe Koo, M.D., Ph.D.4 Department of Pediatrics, 1Hanyang University Medical  Center, Hanyang University College of Medicine, Seoul,  2Keimyung University Dongsan Medical Center, Keimyung  University School of Medicine, Daegu, 3Department of Internal  Medicine, Ewha Womans Univer sity School of Medicine,  4Department of Pediatrics, Samsung Medical Center,  Sungkyunkwan Universi ty School of Medicine, Seoul, Korea Cord blood (CB) has been used as an alternative source  for unrelated stem cell transplantation (SCT) for patients with hematologic malignances, bone marrow failure synd-romes, and immune deficiencies .",Non-OADS,/arxiv_data1/oa_pdf/be/49/br-48-5.PMC3625003.pdf
"3 This is an Open Access article distributed under the terms of the Creative Commons Attribution Non-Commercial License (http://c reativecommons.org/licenses/by-nc/3.0 ) which permits unrestricted non-commercial use, distribution, and reproduction in any medium, provided the original work is prop erly cited.BLOOD RESEARCH Volume 48 ㆍNumber 1 ㆍMarch 2013 http://dx.doi.org/10.5045/br.2013.48.1.3 Perspective Blood Research: a new journey  of passion with harmony beyond Asia onto the world Hong Hoe Koo, M.D., Ph.D. Department of Pediatrics, Samsung Medical Center,  Sungkyunkwan Universi ty School of Medicine, Seoul, Korea Experts from the diverse ar eas of hematology, in re- cognizing the growing volume o f  m e d i c a l  r e s e a r c h  i n  t h e   field, came together and founded the Korean Society of Hematology (KSH) on June 11, 1958.",Non-OADS,/arxiv_data1/oa_pdf/a4/9e/br-48-3.PMC3625004.pdf
"This is an Open Access article distributed under the terms of the Creative Commons Attribution Non-Commercial License (http://c reativecommons.org/licenses/by-nc/3.0 ) which permits unrestricted non-commercial use, distribution, and re production in any medium, provided the original work is prop erly cited.BLOOD RESEARCHVOLUME 48 ㆍNUMBER 1 March 2013ORIGINAL  ARTICLE Expression of SOCS1  and SOCS3  genes in human graft-versus-host  disease after allogeneic hematopoietic stem cell transplantation Tae Hyang Lee, Ji Yoon Lee, Sohye Park, Seun g Hwan Shin, Seung-Ah Yahng, Jae-Ho Yoon,  Sung-Eun Lee, Byung-Sik Cho,  Yoo-Jin Kim, Seok Lee, Ch ang-Ki Min, Dong-Wook Kim,  Jong-Wook Lee, Woo-Sung Min, Chong-Won Park, Hee-Je Kim Division of Hematology, Department of In ternal Medicine, Catholic Blood and Marrow Transplantation Center, Seoul St. Mary’s  Hospital, College of Medicine, The Cathol ic University of Korea, Seoul, Korea p-ISSN 2287-979X / e-ISSN 2288-0011 http://dx.doi.org/10.5045/br.2013.48.1.16Blood Res 2013;48:16-23.",Non-OADS,/arxiv_data1/oa_pdf/d2/d6/br-48-16.PMC3625005.pdf
"This is an Open Access article distributed under the terms of the Creative Commons Attribution Non-Commercial License (http://c reativecommons.org/licenses/by-nc/3.0 ) which permits unrestricted non-commercial use, distribution, and re production in any medium, provided the original work is prop erly cited.BLOOD RESEARCHVOLUME 48 ㆍNUMBER 1 March 2013ORIGINAL  ARTICLE Current routine practice and clinico-pathological characteristics  associated with acute promyelocytic leukemia in Korea Sunhyun Ahn1, Joon Seong Park2, Seong Hyun Jeong2, Hyun Woo Lee2, Jun Eun Park3, Mi Hyang Kim4,  Yang Soo Kim5, Ho Sup Lee5, Tae Sung Park6, Eunkyoung You6, Insoo Rheem7, Joowon Park7,  JI Young Huh8, Myung Seo Kang8, Sung Ran Cho1 Departments of  1Laboratory Medicine, 2Hematology-Oncology, and  3Pediatrics, Ajou University School of Medicine, Suwon,  Departments of  4Laboratory Medicine and  5Internal Medicine, Kosin University Gospel Hospital, Busan, Depa rtment of Laborator y  Medicine, 6School of Medicine, Kyun g Hee University, Seoul, 7Dankook University College of Medicine, Cheonan, and  8CHA  Bundang Medical Center, CHA University, Seongnam, Korea p-ISSN 2287-979X / e-ISSN 2288-0011 http://dx.doi.org/10.5045/br.2013.48.1.31Blood Res 2013;48:31-4.",Non-OADS,/arxiv_data1/oa_pdf/ad/86/br-48-31.PMC3625006.pdf
"9 This is an Open Access article distributed under the terms of the Creative Commons Attribution Non-Commercial License (http://c reativecommons.org/licenses/by-nc/3.0) which permits unrestricted non-commercial us e, distribution, and reproduction in any medium, provided the original work is prop erly cited.Blood Research Educational Material BLOOD RESEARCH Volume 48 ㆍNumber 1 ㆍMarch 2013 http://dx.doi.org/10.5045/br.2013.48.1.9 Bone marrow aspirate showing Leishmania donovani  in  polymorphs Harish Chandra, Smita Chandra Department of Pathology, Hi malayan Institute of Medica l Sciences, Dehradun, India A 41-year-old man who was a permanen t resident of Uttarakhand, a nort h Himalayan and sub-Himalayan state  of India, presented with bilateral pedal edema and backache.",Non-OADS,/arxiv_data1/oa_pdf/59/17/br-48-9.PMC3625007.pdf
"8 This is an Open Access article distributed under the terms of the Creative Commons Attribution Non-Commercial License (http://c reativecommons.org/licenses/by-nc/3.0) which permits unrestricted non-commercial us e, distribution, and reproduction in any medium, provided the original work is prop erly cited.Blood Research Educational Material BLOOD RESEARCH Volume 48 ㆍNumber 1 ㆍMarch 2013 http://dx.doi.org/10.5045/br.2013.48.1.8 WaldenstromÊs macroglobulinemia associated with eosinophilia Eunkyoung You1, Kyung Sam Cho2, Tae Sung Park1 Departments of  1Laboratory Medicine and 2Hematology-Oncology, Kyung Hee University School of  Medicine, Seoul, Korea A 73-year-old man with a history of diab etes and hypertension was referred to our hospital on suspicion of multiple  myeloma.",Non-OADS,/arxiv_data1/oa_pdf/fc/3c/br-48-8.PMC3625008.pdf
"This is an Open Access article distributed under the terms of the Creative Commons Attribution Non-Commercial License (http://c reativecommons.org/licenses/by-nc/3.0 ) which permits unrestricted non-commercial use, distribution, and re production in any medium, provided the original work is prop erly cited.BLOOD RESEARCHVOLUME 48 ㆍNUMBER 1 March 2013CASE  REPORT Hepatic veno-occlusive disease resulting in tacrolimus toxicity after  allogeneic hematopoietic stem cell transplantation Seung-Hwan Shin, Seung-Ah Yahng, Jae-Ho Yoon , Sung-Eun Lee, Byung-Sik Cho, Yoo-Jin Kim Catholic Blood and Marrow  Transplantation Center, College of Medicine, The Catholic University of Korea, Seoul, Korea p-ISSN 2287-979X / e-ISSN 2288-0011 http://dx.doi.org/10.5045/br.2013.48.1.55Blood Res 2013;48:55-7.",Non-OADS,/arxiv_data1/oa_pdf/5a/f1/br-48-55.PMC3625009.pdf
"This is an Open Access article distributed under the terms of the Creative Commons Attribution Non-Commercial License (http://c reativecommons.org/licenses/by-nc/3.0 ) which permits unrestricted non-commercial use, distribution, and re production in any medium, provided the original work is prop erly cited.BLOOD RESEARCHVOLUME 48 ㆍNUMBER 1 March 2013CASE  REPORT Acute pyelonephritis with anaplastic thyroid carcinoma producing  granulocyte colony-stimulating factor Keunhee Kang, Joo Hee Park, Ja Young Ryu, Sang Yup Lee, Gang Jee Ko, Young Joo Kwon Department of Internal Medicine, Korea Univ ersity College of Medicine, Seoul, Korea p-ISSN 2287-979X / e-ISSN 2288-0011 http://dx.doi.org/10.5045/br.2013.48.1.63Blood Res 2013;48:63-6.",Non-OADS,/arxiv_data1/oa_pdf/31/2e/br-48-63.PMC3625010.pdf
"67 This is an Open Access article distributed under the terms of the Creative Commons Attribution Non-Commercial License (http://c reativecommons.org/licenses/by-nc/3.0 ) which permits unrestricted non-commercial use, distribution, and reproduction in any medium, provided the original work is prop erly cited.BLOOD RESEARCH Volume 48 ㆍNumber 1 ㆍMarch 2013 http://dx.doi.org/10.5045/br.2013.48.1.67 Letter to the Editor Many questions raised by a ques- tion on JAK1/2 inhibitors in pri- mary myelofibrosis TO THE EDITOR:  Firstly, I congratulate Chul Won Jung  for the perspectives on the ro le of JAK1/2 inhibitors in  the management of primary myelofibrosis (PMF) [1].",Non-OADS,/arxiv_data1/oa_pdf/47/b4/br-48-67.PMC3625011.pdf
"We can see yet anotherexample in autophagy: Bif-1 (Bax-inter-acting factor 1)/endophilin B1 associates *Correspondence to: Daniel J. Klionsky; Email: klionsky@umich.edu Submitted: 04/27/12; Accepted: 04/27/12 http://dx.doi.org/10.4161/auto.20665EDITOR'S CORNER Autophagy 8:8, 1165 –1167; August 2012; G2012 Landes Bioscience www.landesbioscience.com Autophagy 1165",Non-OADS,/arxiv_data1/oa_pdf/fd/8c/auto-8-1165.PMC3625114.pdf
Moreinformation on the rationale behind aunified nomenclature can be found at theHGNC website (http://www.genenames.,OADS,/arxiv_data1/oa_pdf/fd/8c/auto-8-1165.PMC3625114.pdf
Nomenclature guidelines and gene search/database URLs Human http://www.genenames.org/guidelines.html http://www.genenames.org/ Mouse http://www.informatics.jax.org/mgihome/nomen/gene.shtml http://www.informatics.jax.org/ Rat http://www.informatics.jax.org/mgihome/nomen/gene.shtml http://rgd.mcw.edu/ Chicken http://projects.roslin.ac.uk/chickmap/nomenclature.html http://www.agnc.msstate.edu/ Xenopus http://www.xenbase.org/gene/static/geneNomenclature.jsp http://www.xenbase.org/ Zebrafish https://wiki.zfin.org/display/general/ZFIN+Zebrafish+Nomenclature+Guidelines http://zfin.org/ Arabidopsis http://www.arabidopsis.org/portals/nomenclature/guidelines.jsp http://www.arabidopsis.org/ Caenorhabditis http://www.wormbase.org/about/userguide/nomenclature http://www.wormbase.org/ Yeast http://www.yeastgenome.org/help/community/nomenclature-conventions http://www.yeastgenome.org/ 1166 Autophagy Volume 8 Issue 8,Non-OADS,/arxiv_data1/oa_pdf/fd/8c/auto-8-1165.PMC3625114.pdf
Dev Cell 2003; 5:539-45; http://dx.doi.org/10.1016/S1534-5807(03)00296-X2.,OADS,/arxiv_data1/oa_pdf/fd/8c/auto-8-1165.PMC3625114.pdf
BMC Bioinformatics 2011; 12:175; PMID:21595960; http://dx.doi.org/10.1186/1471-2105-12-1753.,OADS,/arxiv_data1/oa_pdf/fd/8c/auto-8-1165.PMC3625114.pdf
http://www.mc.,Non-OADS,/arxiv_data1/oa_pdf/d8/f5/134_2013_Article_2830.PMC3625407.pdf
"This is an Open Access article distributed under the terms of the Creative Commons Attribution License (http://creativecommons.org/licenses/by-nc/3.0/), which permits non-commercial reuse, distribution, and reproduction in any medium, provided the original work is properly cited.",Non-OADS,/arxiv_data1/oa_pdf/48/b9/dks507.PMC3625431.pdf
"http://www.dndi.org/diseases/vl.html (26 November 2012, date last accessed).",Non-OADS,/arxiv_data1/oa_pdf/48/b9/dks507.PMC3625431.pdf
"This is an Open Access article distributed under the terms of the Creative Commons Attribution License (http://creativecommons.org/licenses/by-nc/3.0/), which permits non-commercial reuse, distribution, and reproduction in any medium, provided the original work is properly cited.",Non-OADS,/arxiv_data1/oa_pdf/44/33/dks528.PMC3625434.pdf
"Bacterial lipopolysaccharides: a remarkable family of bioactive macroamphiphiles .EcoSal Chapter 69. http://ecosal.org (29 November, 2012, date last accessed).Yamasaki et al .",OADS,/arxiv_data1/oa_pdf/44/33/dks528.PMC3625434.pdf
"http://ejbc.kr  |  pISSN 1738-6756   eISSN 2092-9900 This is an Open Access article distributed under the terms of the Creative Commons Attribution Non-Commercial License (http://creativecommons.org/   licenses/by-nc/3.0) which permits unrestricted non-commercial use, distribution, and reproduction in any medium, provided the original work is properly cited.INTRODUCTION  The aims of modern breast cancer surgery are to obtain   local and regional control of the cancer and gather sufficient  evidence to detect/predict the risk of distant metastases in   order to guide systemic therapy.",Non-OADS,/arxiv_data1/oa_pdf/30/45/jbc-16-1.PMC3625755.pdf
"Second, most DTCs/ CTCs are nonproliferating (that is, Ki-67 negative) and resis -Potential Applications of Quantum Dots in Mapping Sentinel Lymph Node  and Detection of Micrometastases in Breast Carcinoma Feroz Alam, Neha Y adav Department of Pathology, Jawaharlal Nehru Medical College, Aligarh Muslim University, Aligarh, IndiaREVIEW ARTICLEJ Breast Cancer 2013 March; 16(1): 1-11  http://dx.doi.org/10.4048/jbc.2013.16.1.1 Breast cancer cure aims at complete elimination of malignant cells  and essentially requires detection and treatment of any microme - tastases.",Non-OADS,/arxiv_data1/oa_pdf/30/45/jbc-16-1.PMC3625755.pdf
"http://ejbc.kr  http://dx.doi.org/10.4048/jbc.2013.16.1.1tant to chemotherapy, and they can persist in the bone marrow  of patients with breast cancer many years after primary surgery.",Non-OADS,/arxiv_data1/oa_pdf/30/45/jbc-16-1.PMC3625755.pdf
"Quantum Dots inBreast Carcinoma 3 http://dx.doi.org/10.4048/jbc.2013.16.1.1  http://ejbc.krcytokeratin and epithelial membrane antigen IHC screening  reported micrometastases in 9% to 30% of those cases, in  which the lymph nodes were earlier declared negative on   histopathology [28-30].",Non-OADS,/arxiv_data1/oa_pdf/30/45/jbc-16-1.PMC3625755.pdf
http://ejbc.kr  http://dx.doi.org/10.4048/jbc.2013.16.1.1tion) enabling investigations to be carried out over time.,Non-OADS,/arxiv_data1/oa_pdf/30/45/jbc-16-1.PMC3625755.pdf
Quantum Dots inBreast Carcinoma 5 http://dx.doi.org/10.4048/jbc.2013.16.1.1  http://ejbc.kr[50].,Non-OADS,/arxiv_data1/oa_pdf/30/45/jbc-16-1.PMC3625755.pdf
"http://ejbc.kr  http://dx.doi.org/10.4048/jbc.2013.16.1.1In vitro real time detection  Cell dynamics, molecular signaling mechanisms, confor - mational changes of proteins etc.",OADS,/arxiv_data1/oa_pdf/30/45/jbc-16-1.PMC3625755.pdf
"Quantum Dots inBreast Carcinoma 7 http://dx.doi.org/10.4048/jbc.2013.16.1.1  http://ejbc.krhigh contrast between autofluorescence and emission signal,  allowing minimal surgical incision for removal of the positive  sentinel node [64].",Non-OADS,/arxiv_data1/oa_pdf/30/45/jbc-16-1.PMC3625755.pdf
"http://ejbc.kr  http://dx.doi.org/10.4048/jbc.2013.16.1.1ing efficient anticancer activity in HER2 overexpressing breast  cancer cells, and enabling tumor cell imaging.",Non-OADS,/arxiv_data1/oa_pdf/30/45/jbc-16-1.PMC3625755.pdf
Quantum Dots inBreast Carcinoma 9 http://dx.doi.org/10.4048/jbc.2013.16.1.1  http://ejbc.krof potential subsequent relapses.,Non-OADS,/arxiv_data1/oa_pdf/30/45/jbc-16-1.PMC3625755.pdf
http://ejbc.kr  http://dx.doi.org/10.4048/jbc.2013.16.1.13669-74.,Non-OADS,/arxiv_data1/oa_pdf/30/45/jbc-16-1.PMC3625755.pdf
http://www.cancer - screening.nhs.uk/breastscreen/publications/nhsbsp58-low-resolution.,Non-OADS,/arxiv_data1/oa_pdf/30/45/jbc-16-1.PMC3625755.pdf
Quantum Dots inBreast Carcinoma 11 http://dx.doi.org/10.4048/jbc.2013.16.1.1  http://ejbc.krtor-mediated 	signal 	transduction.,OADS,/arxiv_data1/oa_pdf/30/45/jbc-16-1.PMC3625755.pdf
"http://ejbc.kr  |  pISSN 1738-6756   eISSN 2092-9900 This is an Open Access article distributed under the terms of the Creative Commons Attribution Non-Commercial License (http://creativecommons.org/   licenses/by-nc/3.0) which permits unrestricted non-commercial use, distribution, and reproduction in any medium, provided the original work is properly cited.INTRODUCTION Due to screening programs and advances in oncologic treat - ment, it has been possible to achieve a survival rate of over  80% at 5-year follow-up for breast cancers [1].",Non-OADS,/arxiv_data1/oa_pdf/f9/79/jbc-16-104.PMC3625756.pdf
"Having a better perspective  of how these patients undergo this complex period of transi -Evolution of Health-Related Quality of Life in Breast Cancer Patients during  the First Y ear of Follow-Up David Moro-Valdezate, Salvador Peiró1, Elvira Buch-Villa2, Antonio Caballero-Gárate, M. Dolores Morales-Monsalve3,  Ángel Martínez-Agulló, Félix Checa-Ayet2, Joaquín Ortega-Serrano Department of Surgery, Hospital Clínico Universitario de V alencia, V alencia; 1Health Services Research Unit, Centro Superior de Investigación en Salud  Pública (CSISP), V alencia; 2Department of Surgery, Hospital de Sagunto, V alencia; 3Department of Surgery, Hospital Universitario Doctor Peset de V alencia,  V alencia, Spain ORIGINAL ARTICLEJ Breast Cancer 2013 March; 16(1): 104-111  http://dx.doi.org/10.4048/jbc.2013.16.1.104 Purpose:  The objective of this study was to describe the evolu - tion of health-related quality of life (HRQOL) in a cohort of breast  cancer patients over 1 year after surgery and to analyse the   predictive ability of HRQOL measurement instruments.",Non-OADS,/arxiv_data1/oa_pdf/f9/79/jbc-16-104.PMC3625756.pdf
"Evolution of Quality of Life in Breast Cancer 105 http://dx.doi.org/10.4048/jbc.2013.16.1.104  http://ejbc.krtion, as well as obtaining early detection of alterations in the  HRQOL, may help to make specific interventions to improve  HRQOL in the long run.",Non-OADS,/arxiv_data1/oa_pdf/f9/79/jbc-16-104.PMC3625756.pdf
"http://ejbc.kr  http://dx.doi.org/10.4048/jbc.2013.16.1.104RESULTS Of the 551 patients invited to participate in the study, 105  (19.06%) did not respond to the first survey, 76 (17.04%) did  not respond at 6 months, and 40 patients (10.81%) declined to  participate in the third survey.",Non-OADS,/arxiv_data1/oa_pdf/f9/79/jbc-16-104.PMC3625756.pdf
Evolution of Quality of Life in Breast Cancer 107 http://dx.doi.org/10.4048/jbc.2013.16.1.104  http://ejbc.krsimplify the data comprehension.,Non-OADS,/arxiv_data1/oa_pdf/f9/79/jbc-16-104.PMC3625756.pdf
"http://ejbc.kr  http://dx.doi.org/10.4048/jbc.2013.16.1.104of women at 1 month, and 0.91 for the upper tertile, with the  latter group showing the fewest adverse side effects ( p=0.0001).",Non-OADS,/arxiv_data1/oa_pdf/f9/79/jbc-16-104.PMC3625756.pdf
"Evolution of Quality of Life in Breast Cancer 109 http://dx.doi.org/10.4048/jbc.2013.16.1.104  http://ejbc.krevolved over 1-year follow-up, using questionnaires that were  simple, standardised and had been widely internationally vali - dated.",OADS,/arxiv_data1/oa_pdf/f9/79/jbc-16-104.PMC3625756.pdf
http://ejbc.kr  http://dx.doi.org/10.4048/jbc.2013.16.1.104in terms of long-term HRQOL.,OADS,/arxiv_data1/oa_pdf/f9/79/jbc-16-104.PMC3625756.pdf
Evolution of Quality of Life in Breast Cancer 111 http://dx.doi.org/10.4048/jbc.2013.16.1.104  http://ejbc.kr8.,Non-OADS,/arxiv_data1/oa_pdf/f9/79/jbc-16-104.PMC3625756.pdf
"http://ejbc.kr  |  pISSN 1738-6756   eISSN 2092-9900 This is an Open Access article distributed under the terms of the Creative Commons Attribution Non-Commercial License (http://creativecommons.org/   licenses/by-nc/3.0) which permits unrestricted non-commercial use, distribution, and reproduction in any medium, provided the original work is properly cited.INTRODUCTION Granulocytic sarcoma is a rare extramedullary tumor com - posed of undifferentiated myeloid cells.",Non-OADS,/arxiv_data1/oa_pdf/fe/12/jbc-16-112.PMC3625757.pdf
"The patient had an admission history for petechiae and easy Granulocytic Sarcoma in Breast after Bone Marrow Transplantation Seung Jin Kim*, Woo Sung Hong1,*, Sung Hyun Jun, Seong Hyun Jeong2, Seok Y oun Kang2, Tae Hee Kim3,  Doo Kyoung Kang3, Hyun Ee Yim4, Y ong Sik Jung1, Ku Sang Kim1,5 Special Study Module for Breast, Departments of   1Surgery, 2Hematology-Oncology, 3Radiology, 4Pathology, and 5Biomedical Informatics, Ajou University  School of Medicine, Suwon, KoreaCASE REPORTJ Breast Cancer 2013 March; 16(1): 112-116  http://dx.doi.org/10.4048/jbc.2013.16.1.112 Granulocytic sarcoma is a localized extramedullary solid tumor  composed of immature myeloid cell and is usually associated  with acute myeloid leukemia or myelodysplastic syndrome.",Non-OADS,/arxiv_data1/oa_pdf/fe/12/jbc-16-112.PMC3625757.pdf
Granulocytic Sarcoma in Breast 113 http://dx.doi.org/10.4048/jbc.2013.16.1.112  http://ejbc.krbruises along the whole body 4 years previously.,Non-OADS,/arxiv_data1/oa_pdf/fe/12/jbc-16-112.PMC3625757.pdf
http://ejbc.kr  http://dx.doi.org/10.4048/jbc.2013.16.1.112row were infiltrated diffusely and cellularity was increased to  more than 90% by bone marrow examination.,Non-OADS,/arxiv_data1/oa_pdf/fe/12/jbc-16-112.PMC3625757.pdf
"Granulocytic Sarcoma in Breast 115 http://dx.doi.org/10.4048/jbc.2013.16.1.112  http://ejbc.kr(MEC543: mitoxantrone 10 mg/m2/day for 3 days, etoposide  100 mg/m2/day for 4 days, and cytarabine 2,000 mg/m2/day  for 5 days) and almost complete clinical remission after re - ceiving radiation therapy at the remaining breast tumor for   2 months.",Non-OADS,/arxiv_data1/oa_pdf/fe/12/jbc-16-112.PMC3625757.pdf
"http://ejbc.kr  http://dx.doi.org/10.4048/jbc.2013.16.1.112granulocytic 	sarcoma 	(chloroma) 	in	patients 	with	myelogenous 	leuke - mia,	Hiroshima-Nagasaki 	1949-1969.",Non-OADS,/arxiv_data1/oa_pdf/fe/12/jbc-16-112.PMC3625757.pdf
"http://ejbc.kr  |  pISSN 1738-6756   eISSN 2092-9900 This is an Open Access article distributed under the terms of the Creative Commons Attribution Non-Commercial License (http://creativecommons.org/   licenses/by-nc/3.0) which permits unrestricted non-commercial use, distribution, and reproduction in any medium, provided the original work is properly cited.INTRODUCTION Breast cancer is the second most prevalent cancer in women  in South Korea.",Non-OADS,/arxiv_data1/oa_pdf/71/41/jbc-16-117.PMC3625758.pdf
"An histopathological   examination revealed invasive ductal carcinoma with nuclear Skeletal Muscle Metastases from Breast Cancer: Two Case Reports Y oung Woo Kim, Kyung Jin Seo1, Su Lim Lee2, Ki Wook Kwon, Joon Hur, Ho Jung An, Y oon Ho Ko, Jeong Soo Kim3,  Hye Sung Won Departments of   Internal Medicine, 1Hospital Pathology, 2Radiology, and 3Surgery, Uijeongbu St. Mary’ s Hospital, The Catholic University of Korea College of  Medicine, Uijeongbu, KoreaCASE REPORTJ Breast Cancer 2013 March; 16(1): 117-121  http://dx.doi.org/10.4048/jbc.2013.16.1.117 The skeletal muscle is an unusual site for metastasis from breast  cancer.",Non-OADS,/arxiv_data1/oa_pdf/71/41/jbc-16-117.PMC3625758.pdf
http://ejbc.kr  http://dx.doi.org/10.4048/jbc.2013.16.1.117grade 2 and lymphovascular invasion.,Non-OADS,/arxiv_data1/oa_pdf/71/41/jbc-16-117.PMC3625758.pdf
Skeletal Muscle Metastases from Breast Cancer 119 http://dx.doi.org/10.4048/jbc.2013.16.1.117  http://ejbc.krauthority stopped taking tamoxifen and ceased regular surveil - lance.,Non-OADS,/arxiv_data1/oa_pdf/71/41/jbc-16-117.PMC3625758.pdf
"http://ejbc.kr  http://dx.doi.org/10.4048/jbc.2013.16.1.117and pelvis CT scans showed no notable findings, but PET/CT  showed multiple new enlarged lymph nodes with increased  FDG uptake (SUVmax, 15.4) in the right iliac chain and a  nodular lesion of about 2.5 cm in diameter (SUVmax, 20.1)   in the right gluteus maximus muscle.",Non-OADS,/arxiv_data1/oa_pdf/71/41/jbc-16-117.PMC3625758.pdf
"Skeletal Muscle Metastases from Breast Cancer 121 http://dx.doi.org/10.4048/jbc.2013.16.1.117  http://ejbc.krbecause it has high cost, long scanning times, and a limited  field of view.",Non-OADS,/arxiv_data1/oa_pdf/71/41/jbc-16-117.PMC3625758.pdf
DOI: 	http://dx.doi.org/10.1007/ s12282-012-0352-3.,Non-OADS,/arxiv_data1/oa_pdf/71/41/jbc-16-117.PMC3625758.pdf
"http://ejbc.kr  |  pISSN 1738-6756   eISSN 2092-9900 This is an Open Access article distributed under the terms of the Creative Commons Attribution Non-Commercial License (http://creativecommons.org/   licenses/by-nc/3.0) which permits unrestricted non-commercial use, distribution, and reproduction in any medium, provided the original work is properly cited.INTRODUCTION The microtubules, formed by the polyerization of the cellular  protein tubulin, play a crucial role in the cell division process  hence any interference in the function of this protein can result  in cell separation disruption and causes cellular death by apopto ­ sis which can be used as a cancer treatment modality [1].",Non-OADS,/arxiv_data1/oa_pdf/d0/e4/jbc-16-12.PMC3625759.pdf
"In the Eribulin for Advanced Breast Cancer: A Drug Evaluation Alaaeldin Shablak Department of Medical Oncology, Bradford Royal Infirmary, Bradford, UKREVIEW ARTICLEJ Breast Cancer 2013 March; 16(1): 12-15  http://dx.doi.org/10.4048/jbc.2013.16.1.12 Eribulin is a synthetic microtubule dynamics inhibitor that was  developed from a marine natural product halichondrin B.",Non-OADS,/arxiv_data1/oa_pdf/d0/e4/jbc-16-12.PMC3625759.pdf
"Eribulin: Drug Evaluation 13 http://dx.doi.org/10.4048/jbc.2013.16.1.12  http://ejbc.kr3­weekly study 21 patients received doses from 0.25 to 4 mg/m2,  with DLT consisting of neutropenia in all three patients treated  at 4 mg/m2, and in two of three patients at 2.8 mg/m2.",Non-OADS,/arxiv_data1/oa_pdf/d0/e4/jbc-16-12.PMC3625759.pdf
14  Alaaeldin Shablak http://ejbc.kr  http://dx.doi.org/10.4048/jbc.2013.16.1.12it was rejected by NICE in the United Kingdom based on its  cost effectiveness.,Non-OADS,/arxiv_data1/oa_pdf/d0/e4/jbc-16-12.PMC3625759.pdf
Eribulin: Drug Evaluation 15 http://dx.doi.org/10.4048/jbc.2013.16.1.12  http://ejbc.kret	al.,Non-OADS,/arxiv_data1/oa_pdf/d0/e4/jbc-16-12.PMC3625759.pdf
http://www.access - data.fda.gov/drugsatfda_docs/label/2010/201532lbl.pdf.,Non-OADS,/arxiv_data1/oa_pdf/d0/e4/jbc-16-12.PMC3625759.pdf
http://www.nice.org.uk/nicemedia/live/13238/ 	 57079/57079.pdf.,Non-OADS,/arxiv_data1/oa_pdf/d0/e4/jbc-16-12.PMC3625759.pdf
"http://ejbc.kr  |  pISSN 1738-6756   eISSN 2092-9900 This is an Open Access article distributed under the terms of the Creative Commons Attribution Non-Commercial License (http://creativecommons.org/   licenses/by-nc/3.0) which permits unrestricted non-commercial use, distribution, and reproduction in any medium, provided the original work is properly cited.INTRODUCTION Central nervous system (CNS) metastases are a significant  cause of morbidity and mortality in breast cancer patients.",Non-OADS,/arxiv_data1/oa_pdf/8a/a7/jbc-16-122.PMC3625760.pdf
"Accordingly, the patient was staged pT4b pN3a  pM1.Prolonged Regression of Metastatic Leptomeningeal Breast Cancer That Has  Failed Conventional Therapy: A Case Report and Review of the Literature Andrew Vincent, Glenn Lesser1, Doris Brown, Tamara Vern-Gross, Linda Metheny-Barlow, Julia Lawrence, Michael Chan Department of Radiation Oncology and 1Division on Hematology-Oncology, Wake Forest School of Medicine, Winston-Salem, USACASE REPORTJ Breast Cancer 2013 March; 16(1): 122-126  http://dx.doi.org/10.4048/jbc.2013.16.1.122 Approximately 5% of breast cancer patients develop leptome­ ningeal metastases over the course of their disease.",Non-OADS,/arxiv_data1/oa_pdf/8a/a7/jbc-16-122.PMC3625760.pdf
"Leptomeningeal Breast Cancer Case 123 http://dx.doi.org/10.4048/jbc.2013.16.1.122  http://ejbc.krShe began chemotherapy April 2005 consisting of weekly  paclitaxel (45 mg/m2), carboplatin (2 mg/mL/min), and  trastuzumab (2 mg/kg).",Non-OADS,/arxiv_data1/oa_pdf/8a/a7/jbc-16-122.PMC3625760.pdf
http://ejbc.kr  http://dx.doi.org/10.4048/jbc.2013.16.1.122overall worsening of performance status.,Non-OADS,/arxiv_data1/oa_pdf/8a/a7/jbc-16-122.PMC3625760.pdf
Leptomeningeal Breast Cancer Case 125 http://dx.doi.org/10.4048/jbc.2013.16.1.122  http://ejbc.krcal methotrexate results in cytologic and clinical improvement  in about half of patients with breast cancer leptomeningeal  metastases.,Non-OADS,/arxiv_data1/oa_pdf/8a/a7/jbc-16-122.PMC3625760.pdf
http://ejbc.kr  http://dx.doi.org/10.4048/jbc.2013.16.1.122variable and long-term response is uncommon.,Non-OADS,/arxiv_data1/oa_pdf/8a/a7/jbc-16-122.PMC3625760.pdf
"http://ejbc.kr  |  pISSN 1738-6756   eISSN 2092-9900 This is an Open Access article distributed under the terms of the Creative Commons Attribution Non-Commercial License (http://creativecommons.org/   licenses/by-nc/3.0) which permits unrestricted non-commercial use, distribution, and reproduction in any medium, provided the original work is properly cited.Indigo carmine (sodium indigotindisulfonate) was intro - duced in 1904 and is commonly used for locating the ureteral  orifice, a severed ureter, or a fistula [1].",Non-OADS,/arxiv_data1/oa_pdf/dc/a6/jbc-16-127.PMC3625761.pdf
"Sentinel lymph node biopsy in breast cancer provides a  means of reducing postoperative morbidity and improving Profound Hypotension after an Intradermal Injection of Indigo Carmine for  Sentinel Node Mapping Y oun Yi Jo, Mi Geum Lee, Soon Y oung Yun, Kyung Cheon Lee Department of Anesthesiology and Pain Medicine, Gachon University Gil Medical Center, Incheon, KoreaBRIEF COMMUNICATIONJ Breast Cancer 2013 March; 16(1): 127-128  http://dx.doi.org/10.4048/jbc.2013.16.1.127 Intradermal injections of indigo carmine for sentinel node map - ping are considered safe and no report of an adverse reaction  has been published.",Non-OADS,/arxiv_data1/oa_pdf/dc/a6/jbc-16-127.PMC3625761.pdf
http://ejbc.kr  http://dx.doi.org/10.4048/jbc.2013.16.1.127quality of life by preventing excessive axillary dissection.,Non-OADS,/arxiv_data1/oa_pdf/dc/a6/jbc-16-127.PMC3625761.pdf
"http://ejbc.kr  |  pISSN 1738-6756   eISSN 2092-9900 This is an Open Access article distributed under the terms of the Creative Commons Attribution Non-Commercial License (http://creativecommons.org/   licenses/by-nc/3.0) which permits unrestricted non-commercial use, distribution, and reproduction in any medium, provided the original work is properly cited.T o the Editor:  High fat diet has long been considered as an important   etiological factor in the development of breast cancer as per  the principal dietary hypothesis [1].",Non-OADS,/arxiv_data1/oa_pdf/a1/41/jbc-16-129.PMC3625762.pdf
"Forty-seven Total Cholesterol and Triglyceride Levels in Patients with Breast Cancer Umesh Kapil, Ajeet Singh Bhadoria, Neha Sareen, Preeti Singh, Sada N. Dwivedi1 Departments of Human Nutrition and 1Biostatistics, All India Institute of Medical Sciences, New Delhi, IndiaLETTER TO THE EDITORJ Breast Cancer 2013 March; 16(1): 129-130  http://dx.doi.org/10.4048/jbc.2013.16.1.129 Correspondence to:  Umesh Kapil Department of Human Nutrition, All India Institute of Medical Sciences,  Ansari Nagar, New Delhi 110029, India Tel: +91-11-2659-3383, Fax: +91-11-2686 2663 E- mail: umeshkapil@gmail.com  This study was funded by Indian Council of Medical Research, New Delhi,  India.",Non-OADS,/arxiv_data1/oa_pdf/a1/41/jbc-16-129.PMC3625762.pdf
http://ejbc.kr  http://dx.doi.org/10.4048/jbc.2013.16.1.129percent of the patients and 65.0% of the controls belonged to  upper lower socioeconomic status.,Non-OADS,/arxiv_data1/oa_pdf/a1/41/jbc-16-129.PMC3625762.pdf
"http://ejbc.kr  |  pISSN 1738-6756   eISSN 2092-9900 This is an Open Access article distributed under the terms of the Creative Commons Attribution Non-Commercial License (http://creativecommons.org/   licenses/by-nc/3.0) which permits unrestricted non-commercial use, distribution, and reproduction in any medium, provided the original work is properly cited.T o the Editor:  Breast cancer is the most commonly seen cancer in women  and rates increase with advancing age [1].",Non-OADS,/arxiv_data1/oa_pdf/c1/14/jbc-16-131.PMC3625763.pdf
"Enis Özkaya, Vakkas Korkmaz1, Tuncay Kucukozkan1, Fadil Kara1 Department of Obstetrics and Gynecology, Giresun University Hospital, Giresun; 1Department of Obstetrics and Gynecology, Dr. Sami Ulus Maternity and  Women’ s Health Training and Research Hospital, Ankara, TurkeyLETTER TO THE EDITORJ Breast Cancer 2013 March; 16(1): 131  http://dx.doi.org/10.4048/jbc.2013.16.1.131 Correspondence to:  Enis Ozkaya Department of Obstetrics and Gynecology, Giresun University Hospital, Nizamiye Region, Orhan Yılmaz, Mumcular Street, N:1/1 Giresun, Turkey Tel: +90-505-474-2459, Fax: +90-454-310-1699 E-mail: enozkaya1979@gmail.com Received:  December 2, 2012  Accepted:  December 23, 2012Journal of         BreastCancer",Non-OADS,/arxiv_data1/oa_pdf/c1/14/jbc-16-131.PMC3625763.pdf
"http://ejbc.kr  |  pISSN 1738-6756   eISSN 2092-9900 This is an Open Access article distributed under the terms of the Creative Commons Attribution Non-Commercial License (http://creativecommons.org/   licenses/by-nc/3.0) which permits unrestricted non-commercial use, distribution, and reproduction in any medium, provided the original work is properly cited.J Breast Cancer 2013 March; 16(1): 132  http://dx.doi.org/10.4048/jbc.2013.16.1.132 Journal of         BreastCancer Erratum to:  J Breast Cancer 2012;15(1):15-23.",Non-OADS,/arxiv_data1/oa_pdf/6e/53/jbc-16-132.PMC3625764.pdf
(http://dx.doi.org/10.4048/jbc.2012.15.1.15) This article was initially published on Journal of Breast Cancer with misspelled title of the article.,Non-OADS,/arxiv_data1/oa_pdf/6e/53/jbc-16-132.PMC3625764.pdf
"http://ejbc.kr  |  pISSN 1738-6756   eISSN 2092-9900 This is an Open Access article distributed under the terms of the Creative Commons Attribution Non-Commercial License (http://creativecommons.org/   licenses/by-nc/3.0) which permits unrestricted non-commercial use, distribution, and reproduction in any medium, provided the original work is properly cited.INTRODUCTION Although the advances in the early detection and the treat - ment modalities of breast cancer have achieved the improved  survival, there is still a significant number of mortalities.",Non-OADS,/arxiv_data1/oa_pdf/2c/1c/jbc-16-16.PMC3625765.pdf
"For example, the mismatch repair  genes hMLH1  and hMSH2  are mutated in breast cancer [6];  and the retinoic acid beta 2 (RARβ2) receptor is methylated The Role of the CDH1  Promoter Hypermethylation in the Axillary Lymph  Node Metastasis and Prognosis Seung Pil Jung, Sangmin Kim1, Seok Jin Nam1, Insun Kim2, Jeoung Won Bae Division of Breast and Endocrine Surgery, Department of Surgery, Korea University Hospital, Korea University College of Medicine, Seoul; 1Division of  Breast and Endocrine Surgery, Department of Surgery, Samsung Medical Center, Sungkyunkwan University School of Medicine, Seoul; 2Department of  Pathology, Korea University Hospital, Korea University College of Medicine, Seoul, KoreaORIGINAL ARTICLEJ Breast Cancer 2013 March; 16(1): 16-22  http://dx.doi.org/10.4048/jbc.2013.16.1.16 Purpose:  Hypermethylation of the tumor suppressor genes is  frequently observed in the tumor development and progression.",Non-OADS,/arxiv_data1/oa_pdf/2c/1c/jbc-16-16.PMC3625765.pdf
"Clinical Implication of CDH1  Methylation in Axillary Metastasis and Prognosis 17 http://dx.doi.org/10.4048/jbc.2013.16.1.16  http://ejbc.krand silenced in a fraction of breast cancers, which leads to the  breast cancer progression [7].",Non-OADS,/arxiv_data1/oa_pdf/2c/1c/jbc-16-16.PMC3625765.pdf
"http://ejbc.kr  http://dx.doi.org/10.4048/jbc.2013.16.1.16sion at 72°C for 1 minute, according to the manufacturer’s   indication.",Non-OADS,/arxiv_data1/oa_pdf/2c/1c/jbc-16-16.PMC3625765.pdf
Clinical Implication of CDH1  Methylation in Axillary Metastasis and Prognosis 19 http://dx.doi.org/10.4048/jbc.2013.16.1.16  http://ejbc.krreceptor and HER-2 status were assessed in all primary tumors.,OADS,/arxiv_data1/oa_pdf/2c/1c/jbc-16-16.PMC3625765.pdf
"http://ejbc.kr  http://dx.doi.org/10.4048/jbc.2013.16.1.16of chemotherapy, and use of hormone therapy using multi - variate analysis.",Non-OADS,/arxiv_data1/oa_pdf/2c/1c/jbc-16-16.PMC3625765.pdf
"Clinical Implication of CDH1  Methylation in Axillary Metastasis and Prognosis 21 http://dx.doi.org/10.4048/jbc.2013.16.1.16  http://ejbc.krcomplications including pain, numbness, lymphedema and a  limitation of the arm movement [19], an alternative less inva - sive method to detect the ALN metastasis is necessary.",Non-OADS,/arxiv_data1/oa_pdf/2c/1c/jbc-16-16.PMC3625765.pdf
http://ejbc.kr  http://dx.doi.org/10.4048/jbc.2013.16.1.167.,Non-OADS,/arxiv_data1/oa_pdf/2c/1c/jbc-16-16.PMC3625765.pdf
"http://ejbc.kr  |  pISSN 1738-6756   eISSN 2092-9900 This is an Open Access article distributed under the terms of the Creative Commons Attribution Non-Commercial License (http://creativecommons.org/   licenses/by-nc/3.0) which permits unrestricted non-commercial use, distribution, and reproduction in any medium, provided the original work is properly cited.INTRODUCTION DNA hypermethylation plays an important role in silencing  the tumor suppressor genes being one of the most consistent  hallmarks of the human cancers, and the phenomenon is of a  comparable significance to classic genetic mutations [1].",Non-OADS,/arxiv_data1/oa_pdf/f3/78/jbc-16-23.PMC3625766.pdf
"MCBPs, such as  MeCP2, methyl-CpG binding domain 1 (MBD1), and MBD2, Expression of DNA Methyltransferases in Breast Cancer Patients and to  Analyze the Effect of Natural Compounds on DNA Methyltransferases and  Associated Proteins Sameer Mirza1,*, Gayatri Sharma1,2*, Rajinder Parshad3, Sidhartha Datta Gupta4, Pranav Pandya2, Ranju Ralhan1,5,6,7,8 1Department of Biochemistry, All India Institute of Medical Sciences, New Delhi; 2Dev Sanskriti Vishwa Vidhyalaya, Hardwar; Departments of 3Surgery  and 4Pathology, All India Institute of Medical Sciences, New Delhi, India; 5Alex and Simona Shnaider Laboratory of Molecular Oncology, 6Department of  Pathology and Laboratory Medicine, 7Sonshine Family Centre for Head & Neck Diseases, and 8Department of Otolaryngology, Mount Sinai Hospital,  Toronto, CanadaORIGINAL ARTICLEJ Breast Cancer 2013 March; 16(1): 23-31  http://dx.doi.org/10.4048/jbc.2013.16.1.23 Purpose:  The DNA methylation mediated by specific DNA meth - yltransferases (DNMTs), results in the epigenetic silencing of  multiple genes which are implicated in human breast cancer.",Non-OADS,/arxiv_data1/oa_pdf/f3/78/jbc-16-23.PMC3625766.pdf
"http://ejbc.kr  http://dx.doi.org/10.4048/jbc.2013.16.1.23specifically bind to CpG methylated DNA and are associated  with the histone deacetylase (HDAC)-containing complexes,  to “erase” the transcription-activating histone acetyl marks.",Non-OADS,/arxiv_data1/oa_pdf/f3/78/jbc-16-23.PMC3625766.pdf
Expression ofDNAMethyltransferases inBreast Cancer Patients andtoAnalyze theEffect ofNatural Compounds onDNMTs  25 http://dx.doi.org/10.4048/jbc.2013.16.1.23  http://ejbc.krcrystals were dissolved in acidic isopropanol and the absor - bance was measured at 540 nm.,OADS,/arxiv_data1/oa_pdf/f3/78/jbc-16-23.PMC3625766.pdf
"http://ejbc.kr  http://dx.doi.org/10.4048/jbc.2013.16.1.23lated using the following formula: Fold change in gene expres - sion, 2-∆∆Ct=2-[∆Ct (natural compound treated samples)- ∆Ct (untreated control)], where ∆Ct=Ct (detected genes)-Ct  (18S rRNA) and Ct represent the threshold cycle number.",OADS,/arxiv_data1/oa_pdf/f3/78/jbc-16-23.PMC3625766.pdf
Expression ofDNAMethyltransferases inBreast Cancer Patients andtoAnalyze theEffect ofNatural Compounds onDNMTs  27 http://dx.doi.org/10.4048/jbc.2013.16.1.23  http://ejbc.krFigure 2.,Non-OADS,/arxiv_data1/oa_pdf/f3/78/jbc-16-23.PMC3625766.pdf
"http://ejbc.kr  http://dx.doi.org/10.4048/jbc.2013.16.1.23Effect of EGCG, genistein, curcumin, resveratrol, withaferin A,  and guggulsterone on the methylation status of the panel of  genes For evaluation of the ability of the tested natural compounds  to reactivate the silenced genes, the methylation status of the  promoter regions of ERα, PRB, TMS1, Cyclin D2, MGMT , and   Maspin  genes in MDA MB 231 and RARβ2  and SLIT2  in MCF  7 cells were assessed (Figure 3).",OADS,/arxiv_data1/oa_pdf/f3/78/jbc-16-23.PMC3625766.pdf
Expression ofDNAMethyltransferases inBreast Cancer Patients andtoAnalyze theEffect ofNatural Compounds onDNMTs  29 http://dx.doi.org/10.4048/jbc.2013.16.1.23  http://ejbc.kr DNMT1 HDAC1 MeCP2 MBD2 β actinp21WAF1Untreated Decitabine EGCG Genistein Curcumin Resveratrol Witheferin A GuggulsteroneMCF 7 190 kDa 60 kDa 56kDa 49 kDa 21 kDa 42 kDaUntreated Decitabine EGCG Genistein Curcumin Resveratrol Witheferin A GuggulsteroneMDA MB 231 Figure 5.,Non-OADS,/arxiv_data1/oa_pdf/f3/78/jbc-16-23.PMC3625766.pdf
http://ejbc.kr  http://dx.doi.org/10.4048/jbc.2013.16.1.23post translational histone modifications are important epigene - tic events in the regulation of gene expression and maintenance  of cellular function which may contribute to cancer develop - ment [23].,Non-OADS,/arxiv_data1/oa_pdf/f3/78/jbc-16-23.PMC3625766.pdf
Expression ofDNAMethyltransferases inBreast Cancer Patients andtoAnalyze theEffect ofNatural Compounds onDNMTs  31 http://dx.doi.org/10.4048/jbc.2013.16.1.23  http://ejbc.krACKNOWLEDGEMENTS S.M.,Non-OADS,/arxiv_data1/oa_pdf/f3/78/jbc-16-23.PMC3625766.pdf
"http://ejbc.kr  |  pISSN 1738-6756   eISSN 2092-9900 This is an Open Access article distributed under the terms of the Creative Commons Attribution Non-Commercial License (http://creativecommons.org/   licenses/by-nc/3.0) which permits unrestricted non-commercial use, distribution, and reproduction in any medium, provided the original work is properly cited.INTRODUCTION Neoadjuvant chemotherapy is the treatment of choice for  patients with locally advanced breast cancer and is increasingly  used to treat those with operable breast cancer who are not  candidates for breast-conserving surgery or who have proven  lymph node metastases [1,2].",Non-OADS,/arxiv_data1/oa_pdf/ce/61/jbc-16-32.PMC3625767.pdf
"Medullary breast carcinoma is characterized by the   development of more prominent lymphocytic infiltrates than  are seen when other types of breast cancer are present, and is  associated with a relatively better prognosis, despite the lack  Tumor-Associated Lymphocytes Predict Response to Neoadjuvant  Chemotherapy in Breast Cancer Patients Hee Jin Lee*, Jin-Y oung Seo1,*, Jin-Hee Ahn2, Sei-Hyun Ahn3, Gyungyub Gong Department of Pathology, Asan Medical Center, University of Ulsan College of Medicine, Seoul; 1Department of Surgery, Changwon Fatima Hospital,  Changwon; 2Department of Oncology and 3Division of Breast and Endocrine Surgery, Asan Medical Center, University of Ulsan College of Medicine, Seoul,  KoreaORIGINAL ARTICLEJ Breast Cancer 2013 March; 16(1): 32-39  http://dx.doi.org/10.4048/jbc.2013.16.1.32 Purpose:  Tumor-associated lymphocyte numbers in breast  cancer have been suggested as a new independent predictor   of response to neoadjuvant chemotherapy in breast cancer   patients.",Non-OADS,/arxiv_data1/oa_pdf/ce/61/jbc-16-32.PMC3625767.pdf
Tumor-Associated Lymphocytes 33 http://dx.doi.org/10.4048/jbc.2013.16.1.32  http://ejbc.krof ER expression and poor histologic grade [12].,Non-OADS,/arxiv_data1/oa_pdf/ce/61/jbc-16-32.PMC3625767.pdf
http://ejbc.kr  http://dx.doi.org/10.4048/jbc.2013.16.1.32as those with scores of 3+ or 2+ after fluorescence in situ  hybrid - ization amplification [19].,OADS,/arxiv_data1/oa_pdf/ce/61/jbc-16-32.PMC3625767.pdf
Tumor-Associated Lymphocytes 35 http://dx.doi.org/10.4048/jbc.2013.16.1.32  http://ejbc.krters.,Non-OADS,/arxiv_data1/oa_pdf/ce/61/jbc-16-32.PMC3625767.pdf
"http://ejbc.kr  http://dx.doi.org/10.4048/jbc.2013.16.1.32high-grade tumors, and ER/PR-negative but HER2-positive  tumors.",Non-OADS,/arxiv_data1/oa_pdf/ce/61/jbc-16-32.PMC3625767.pdf
"Tumor-Associated Lymphocytes 37 http://dx.doi.org/10.4048/jbc.2013.16.1.32  http://ejbc.krlates not only with the aspects of the tumor phenotype, such  as small tumor size and HER2 overexpression, but also with  the increased LI; these findings are in good agreement with  those of previous studies [15,21].",Non-OADS,/arxiv_data1/oa_pdf/ce/61/jbc-16-32.PMC3625767.pdf
"http://ejbc.kr  http://dx.doi.org/10.4048/jbc.2013.16.1.32T-cell by chemotherapy might reduce the FOXP3-dependent  suppression of antitumor immunity, thus resulting in an elevated  antitumor immunity leading to a high-pCR rate [27].",Non-OADS,/arxiv_data1/oa_pdf/ce/61/jbc-16-32.PMC3625767.pdf
Tumor-Associated Lymphocytes 39 http://dx.doi.org/10.4048/jbc.2013.16.1.32  http://ejbc.krthelial 	ovarian 	cancer.,Non-OADS,/arxiv_data1/oa_pdf/ce/61/jbc-16-32.PMC3625767.pdf
"http://ejbc.kr  |  pISSN 1738-6756   eISSN 2092-9900 This is an Open Access article distributed under the terms of the Creative Commons Attribution Non-Commercial License (http://creativecommons.org/   licenses/by-nc/3.0) which permits unrestricted non-commercial use, distribution, and reproduction in any medium, provided the original work is properly cited.INTRODUCTION Breast cancer, as an increasing incidence malignancy, is the  most common lethal disease in females [1].",Non-OADS,/arxiv_data1/oa_pdf/17/39/jbc-16-40.PMC3625768.pdf
"In general, vascular  endothelial growth factor (VEGF)-C and -D have been defined STAT3, a Poor Survival Predicator, Is Associated with Lymph Node Metastasis  from Breast Cancer Yujuan Chen, Jing Wang, Xiaodong Wang, Xuejuan Liu, Hongjiang Li, Qing Lv, Jingqiang Zhu, Bing Wei, Ying Tang Department of Thyroid and Breast Surgery, Western China Hospital of Sichuan University, Chengdu, ChinaORIGINAL ARTICLEJ Breast Cancer 2013 March; 16(1): 40-49  http://dx.doi.org/10.4048/jbc.2013.16.1.40 Purpose:  The aim of this study is to explore signal transducer  and activator of transcription 3 (STAT3) expression in breast can - cer and to analyze the detailed mechanism that STAT3 contributes  to the progression of breast cancer.",Non-OADS,/arxiv_data1/oa_pdf/17/39/jbc-16-40.PMC3625768.pdf
"STAT3 and Nodal Metastasis 41 http://dx.doi.org/10.4048/jbc.2013.16.1.40  http://ejbc.kras lymphangiogenic growth factors and play an important role  in tumor lymphangiogenesis via activation of the VEGF recep - tor (VEGFR)-3, which is expressed in lymphatic endothelial  cells [8,9].",OADS,/arxiv_data1/oa_pdf/17/39/jbc-16-40.PMC3625768.pdf
http://ejbc.kr  http://dx.doi.org/10.4048/jbc.2013.16.1.40sidered potentially positive if there was membraneous staining.,Non-OADS,/arxiv_data1/oa_pdf/17/39/jbc-16-40.PMC3625768.pdf
"STAT3 and Nodal Metastasis 43 http://dx.doi.org/10.4048/jbc.2013.16.1.40  http://ejbc.krUnivariate and multivariate survival analysis With univariate analysis (Kaplan-Meier method), we found  five clinicopathological variables and biomarkers’ expression  had significant associations with the OS of breast cancer   patients after curative resection.",OADS,/arxiv_data1/oa_pdf/17/39/jbc-16-40.PMC3625768.pdf
http://ejbc.kr  http://dx.doi.org/10.4048/jbc.2013.16.1.40 Figure 1.,Non-OADS,/arxiv_data1/oa_pdf/17/39/jbc-16-40.PMC3625768.pdf
"STAT3 and Nodal Metastasis 45 http://dx.doi.org/10.4048/jbc.2013.16.1.40  http://ejbc.krlines recommend completion ALND when lymph node   involvement is identified by SLNB [4], although the need for  completion ALND has been questioned [2].",Non-OADS,/arxiv_data1/oa_pdf/17/39/jbc-16-40.PMC3625768.pdf
"http://ejbc.kr  http://dx.doi.org/10.4048/jbc.2013.16.1.40(including VEGF-C expression, VEGF-D expression, and   Ki-67 expression) that had statistically significant associations  with lymph node metastasis from breast cancer, the STAT3  expression was the most important predicator of lymph node  metastasis from breast cancer by using the multinomial logis -tical regression model analysis rather than other variables.",OADS,/arxiv_data1/oa_pdf/17/39/jbc-16-40.PMC3625768.pdf
STAT3 and Nodal Metastasis 47 http://dx.doi.org/10.4048/jbc.2013.16.1.40  http://ejbc.krFigure 5.,Non-OADS,/arxiv_data1/oa_pdf/17/39/jbc-16-40.PMC3625768.pdf
http://ejbc.kr  http://dx.doi.org/10.4048/jbc.2013.16.1.40Table 3.,Non-OADS,/arxiv_data1/oa_pdf/17/39/jbc-16-40.PMC3625768.pdf
STAT3 and Nodal Metastasis 49 http://dx.doi.org/10.4048/jbc.2013.16.1.40  http://ejbc.kr4.,Non-OADS,/arxiv_data1/oa_pdf/17/39/jbc-16-40.PMC3625768.pdf
"http://ejbc.kr  |  pISSN 1738-6756   eISSN 2092-9900 This is an Open Access article distributed under the terms of the Creative Commons Attribution Non-Commercial License (http://creativecommons.org/   licenses/by-nc/3.0) which permits unrestricted non-commercial use, distribution, and reproduction in any medium, provided the original work is properly cited.INTRODUCTION China is a multiple ethnic country comprising 56 ethnic  groups.",Non-OADS,/arxiv_data1/oa_pdf/25/2e/jbc-16-50.PMC3625769.pdf
"We  believe it is of great significance to have an overview of these  two genes among the Chinese high-risk breast cancer patients  in multiple ethnic regions of China, so as to develop genetic  screening guidelines for the Chinese women.Prevalence of BRCA1  and BRCA2  Germline Mutations in Breast Cancer  Women of Multiple Ethnic Region in Northwest China Jianghua Ou1,2, Tao Wu1, Rolf Sijmons3, Duo Ni1, Wenting Xu1, Halmurat Upur4  1Department of Breast Surgery, Xinjiang Cancer Institute & Hospital, Xinjiang Medical University, Urumqi, 2Postdoctoral Research Station of Clinical  Medicine, Xinjiang Medical University, Urumqi, China; 3Department of Genetics, Medical Center of Groningen University, Groningen, The Netherlands;  4Xinjiang Medical University, Urumqi, ChinaORIGINAL ARTICLEJ Breast Cancer 2013 March; 16(1): 50-54  http://dx.doi.org/10.4048/jbc.2013.16.1.50 Purpose:  The aim of this study is to further understand the status  of BRCA1  and BRCA2  mutation among Chinese high-risk breast  cancer patients in multiple-ethnic regions of China.",Non-OADS,/arxiv_data1/oa_pdf/25/2e/jbc-16-50.PMC3625769.pdf
"BRCA1  and BRCA2  mutations in breast cancer 51 http://dx.doi.org/10.4048/jbc.2013.16.1.50  http://ejbc.krMETHODS Subjects  All patient cases were recruited from the Xinjiang Cancer  Institute and Hospital of Xinjiang Medical University, Xinjiang,  China.",Non-OADS,/arxiv_data1/oa_pdf/25/2e/jbc-16-50.PMC3625769.pdf
"http://ejbc.kr  http://dx.doi.org/10.4048/jbc.2013.16.1.50either frameshift or nonsense mutations, which resulted in  premature truncation of the BRCA1/2  protein (Table 1).",Non-OADS,/arxiv_data1/oa_pdf/25/2e/jbc-16-50.PMC3625769.pdf
BRCA1  and BRCA2  mutations in breast cancer 53 http://dx.doi.org/10.4048/jbc.2013.16.1.50  http://ejbc.krwith a family history of breast cancer or other malignancies.,Non-OADS,/arxiv_data1/oa_pdf/25/2e/jbc-16-50.PMC3625769.pdf
It is also supported in the recent National  Comprehensive Cancer Network (NCCN) guidelines published  in March 2011: ‘woman with breast cancer who was diagnosed  up to age 45 years with or without triple negative breast cancer’  (http://www.jnccn.org/content/8/5/562.full).,Non-OADS,/arxiv_data1/oa_pdf/25/2e/jbc-16-50.PMC3625769.pdf
http://ejbc.kr  http://dx.doi.org/10.4048/jbc.2013.16.1.50en	with	familial 	breast 	cancer.,Non-OADS,/arxiv_data1/oa_pdf/25/2e/jbc-16-50.PMC3625769.pdf
http://research.nhgri.nih.gov/bic/Member/index.shtml.,OADS,/arxiv_data1/oa_pdf/25/2e/jbc-16-50.PMC3625769.pdf
DOI: 	http://dx.doi.org/10.1111/j.1759-7714.2012.,Non-OADS,/arxiv_data1/oa_pdf/25/2e/jbc-16-50.PMC3625769.pdf
"http://ejbc.kr  |  pISSN 1738-6756   eISSN 2092-9900 This is an Open Access article distributed under the terms of the Creative Commons Attribution Non-Commercial License (http://creativecommons.org/   licenses/by-nc/3.0) which permits unrestricted non-commercial use, distribution, and reproduction in any medium, provided the original work is properly cited.INTRODUCTION Human breast cancers are diverse in their natural history  and responsiveness to treatments [1].",Non-OADS,/arxiv_data1/oa_pdf/0d/3e/jbc-16-55.PMC3625770.pdf
"METHODS Patients We retrospectively identified patients who were diagnosed  with primary breast cancer and completed all phases of their  primary treatment for breast cancer at the Wonju Severance Usefulness of Pretreatment Neutrophil to Lymphocyte Ratio in Predicting  Disease-Specific Survival in Breast Cancer Patients Hany Noh, Minseob Eomm1, Airi Han Departments of Surgery and 1Pathology, Y onsei University Wonju College of Medicine, Wonju, KoreaORIGINAL ARTICLEJ Breast Cancer 2013 March; 16(1): 55-59  http://dx.doi.org/10.4048/jbc.2013.16.1.55 Purpose:  The purpose of this study was to investigate the prog - nostic impact of pretreatment neutrophil to lymphocyte ratio  (NLR) on breast cancer in view of disease-specific survival and  the intrinsic subtype.",Non-OADS,/arxiv_data1/oa_pdf/0d/3e/jbc-16-55.PMC3625770.pdf
http://ejbc.kr  http://dx.doi.org/10.4048/jbc.2013.16.1.55Christian Hospital from 2000 to 2010 with Institutional Review  Board approval (2011-77).,Non-OADS,/arxiv_data1/oa_pdf/0d/3e/jbc-16-55.PMC3625770.pdf
Neutrophil toLymphocyte Ratio inBreast Cancer 57 http://dx.doi.org/10.4048/jbc.2013.16.1.55  http://ejbc.krTable 1.,Non-OADS,/arxiv_data1/oa_pdf/0d/3e/jbc-16-55.PMC3625770.pdf
"http://ejbc.kr  http://dx.doi.org/10.4048/jbc.2013.16.1.55Cox proportional multivariate hazard model for disease-specific  mortality revealed that higher NLR along with negative ER  status and positive nodal status were independently correlated  with poor prognosis, with hazard ratio 4.08 (95% confidence  interval [CI], 1.62-10.28), 9.93 (95% CI, 3.51-28.13), and 11.23  (95% CI, 3.34-37.83), respectively (Table 3).",OADS,/arxiv_data1/oa_pdf/0d/3e/jbc-16-55.PMC3625770.pdf
Neutrophil toLymphocyte Ratio inBreast Cancer 59 http://dx.doi.org/10.4048/jbc.2013.16.1.55  http://ejbc.krnal A subtype.,Non-OADS,/arxiv_data1/oa_pdf/0d/3e/jbc-16-55.PMC3625770.pdf
"http://ejbc.kr  |  pISSN 1738-6756   eISSN 2092-9900 This is an Open Access article distributed under the terms of the Creative Commons Attribution Non-Commercial License (http://creativecommons.org/   licenses/by-nc/3.0) which permits unrestricted non-commercial use, distribution, and reproduction in any medium, provided the original work is properly cited.INTRODUCTION Male breast cancer (MBC) is rare, accounting for less than  1% of all breast cancer and less than 1% of all cancer cases,  with less than 0.5% of all cancer deaths in men, annually [1].",Non-OADS,/arxiv_data1/oa_pdf/0c/88/jbc-16-60.PMC3625771.pdf
"Whereas the data supporting adjuvant Male Breast Cancer: 37-Y ear Data Study at a Single Experience Center in  Turkey Fatih Selcukbiricik, Deniz Tural, Fatih Aydoğan1, Nuran Beşe2, Evin Büyükünal, Süheyla Serdengeçti Departments of Medical Oncology, 1Surgery, and 2Radiation Oncology, Cerrahpasa Medical School, Istanbul, T urkeyORIGINAL ARTICLEJ Breast Cancer 2013 March; 16(1): 60-65  http://dx.doi.org/10.4048/jbc.2013.16.1.60 Purpose:  The aim of this study is to evaluate the effects of prog - nostic factors on the overall survival (OS) and locoregional   control (LC) among male breast cancer (MBC) patients treated at  Cerrahpasa Medical School Hospital, along with a review of the  related literature.",Non-OADS,/arxiv_data1/oa_pdf/0c/88/jbc-16-60.PMC3625771.pdf
"Male Breast Cancer 61 http://dx.doi.org/10.4048/jbc.2013.16.1.60  http://ejbc.krchemotherapy in women is strong, there is little information  on the effectiveness of adjuvant chemotherapy for MBC [7].",Non-OADS,/arxiv_data1/oa_pdf/0c/88/jbc-16-60.PMC3625771.pdf
"http://ejbc.kr  http://dx.doi.org/10.4048/jbc.2013.16.1.60age at presentation was 62 years (range, 35-90 years).",Non-OADS,/arxiv_data1/oa_pdf/0c/88/jbc-16-60.PMC3625771.pdf
Male Breast Cancer 63 http://dx.doi.org/10.4048/jbc.2013.16.1.60  http://ejbc.krysis (Table 2).,Non-OADS,/arxiv_data1/oa_pdf/0c/88/jbc-16-60.PMC3625771.pdf
"http://ejbc.kr  http://dx.doi.org/10.4048/jbc.2013.16.1.60pression of c-erbB-2 has been associated with shortened sur - vival in some studies [24]; however, others have failed to dem - onstrate a similar correlation [25,26].",Non-OADS,/arxiv_data1/oa_pdf/0c/88/jbc-16-60.PMC3625771.pdf
Male Breast Cancer 65 http://dx.doi.org/10.4048/jbc.2013.16.1.60  http://ejbc.krin	male	and	female 	breast 	carcinoma.,Non-OADS,/arxiv_data1/oa_pdf/0c/88/jbc-16-60.PMC3625771.pdf
"http://ejbc.kr  |  pISSN 1738-6756   eISSN 2092-9900 This is an Open Access article distributed under the terms of the Creative Commons Attribution Non-Commercial License (http://creativecommons.org/   licenses/by-nc/3.0) which permits unrestricted non-commercial use, distribution, and reproduction in any medium, provided the original work is properly cited.INTRODUCTION Endocrine therapy is a well-established standard treatment  in postmenopausal women with hormone receptor-positive  metastatic breast cancer (MBC) that has shown good efficacy  and tolerability [1].",Non-OADS,/arxiv_data1/oa_pdf/43/87/jbc-16-66.PMC3625772.pdf
"The efficacy and toxicity profile of  exemestane in the Evaluation of Faslodex versus Exemestane Efficacy of Exemestane in Korean Patients with Metastatic Breast Cancer  after Failure of Nonsteroidal Aromatase Inhibitors June Koo Lee1, Seock-Ah Im1,2, Daewon Lee1, Ji-Y eon Kim1, Y oojoo Lim1, Eunyoung Lee1, Hyeong-Gon Moon2,3,  Tae-Y ong Kim1,2, Sae-Won Han1,2, Do-Y oun Oh1,2, Se-Hoon Lee1,2, Wonshik Han2,3, Dong-Wan Kim1,2, Tae-Y ou Kim1,2,  Dong-Y oung Noh2,3 1Department of Internal Medicine, Seoul National University Hospital, Seoul; 2Cancer Research Institute, Seoul National University College of Medicine,  Seoul; 3Department of Surgery, Seoul National University Hospital, Seoul, KoreaORIGINAL ARTICLEJ Breast Cancer 2013 March; 16(1): 66-71  http://dx.doi.org/10.4048/jbc.2013.16.1.66 Purpose:  Exemestane has shown good efficacy and tolerability  in postmenopausal women with hormone receptor-positive   metastatic breast cancer.",Non-OADS,/arxiv_data1/oa_pdf/43/87/jbc-16-66.PMC3625772.pdf
Exemestane in Korean Breast Cancer Patients 67 http://dx.doi.org/10.4048/jbc.2013.16.1.66  http://ejbc.krClinical Trial (EFECT) study was comparable to that of fulves - trant in patients whose disease had progressed after treatment  with a nonsteroidal AI (NSAI) [6].,Non-OADS,/arxiv_data1/oa_pdf/43/87/jbc-16-66.PMC3625772.pdf
http://ejbc.kr  http://dx.doi.org/10.4048/jbc.2013.16.1.66and six (5.4%) were ER-negative/PR-positive.,OADS,/arxiv_data1/oa_pdf/43/87/jbc-16-66.PMC3625772.pdf
Exemestane in Korean Breast Cancer Patients 69 http://dx.doi.org/10.4048/jbc.2013.16.1.66  http://ejbc.krFigure 1.,Non-OADS,/arxiv_data1/oa_pdf/43/87/jbc-16-66.PMC3625772.pdf
"http://ejbc.kr  http://dx.doi.org/10.4048/jbc.2013.16.1.66shorter PFS (hazard ratio, 3.611; 95% CI, 1.904-6.848; p< 0.001).",OADS,/arxiv_data1/oa_pdf/43/87/jbc-16-66.PMC3625772.pdf
Exemestane in Korean Breast Cancer Patients 71 http://dx.doi.org/10.4048/jbc.2013.16.1.66  http://ejbc.krprovided efficacy data for exemestane use in Korean women.,Non-OADS,/arxiv_data1/oa_pdf/43/87/jbc-16-66.PMC3625772.pdf
"http://ejbc.kr  |  pISSN 1738-6756   eISSN 2092-9900 This is an Open Access article distributed under the terms of the Creative Commons Attribution Non-Commercial License (http://creativecommons.org/   licenses/by-nc/3.0) which permits unrestricted non-commercial use, distribution, and reproduction in any medium, provided the original work is properly cited.INTRODUCTION Breast cancer was one of the most common cancers in 2008  and overtook stomach cancer as the cancer with the highest  incidence in Korean women in 2001 [1].",Non-OADS,/arxiv_data1/oa_pdf/16/54/jbc-16-72.PMC3625773.pdf
"The search terms used were: (“Breast Neo -Citrus Fruit Intake and Breast Cancer Risk: A Quantitative Systematic Review Jung-Kook Song, Jong-Myon Bae Department of Preventive Medicine, Jeju National University School of Medicine, Jeju, KoreaORIGINAL ARTICLEJ Breast Cancer 2013 March; 16(1): 72-76  http://dx.doi.org/10.4048/jbc.2013.16.1.72 Purpose:  We investigated the association between dietary intake  of citrus fruits and breast cancer risk.",Non-OADS,/arxiv_data1/oa_pdf/16/54/jbc-16-72.PMC3625773.pdf
Citrus Fruits and Breast Cancer Risk 73 http://dx.doi.org/10.4048/jbc.2013.16.1.72  http://ejbc.krplasms/diet therapy”[Majr] OR “Breast Neoplasms/epidemi - ology”[Majr] OR “Breast Neoplasms/etiology”[Majr] OR  “Breast Neoplasms/prevention and control”[Majr]) AND  (“Fruit” [Mesh] OR “Citrus”[Mesh]) AND (“humans”[MeSH  Terms] AND Comparative Study[ptyp] AND “adult”[MeSH  Terms]) for PubMed; and breast AND [(neoplasm) OR (can - cer)] AND [(FRUIT) OR (CITRUS)] AND [(PREVENTION)  OR (RISK) OR (ETIOLOGY)] for EMBASE.,Non-OADS,/arxiv_data1/oa_pdf/16/54/jbc-16-72.PMC3625773.pdf
http://ejbc.kr  http://dx.doi.org/10.4048/jbc.2013.16.1.72the selected studies are shown in Table 1.,Non-OADS,/arxiv_data1/oa_pdf/16/54/jbc-16-72.PMC3625773.pdf
"Citrus Fruits and Breast Cancer Risk 75 http://dx.doi.org/10.4048/jbc.2013.16.1.72  http://ejbc.krHeterogeneity and pooled results There was no significant heterogeneity among the study   results ( I 2=0, p=0.48).",OADS,/arxiv_data1/oa_pdf/16/54/jbc-16-72.PMC3625773.pdf
http://ejbc.kr  http://dx.doi.org/10.4048/jbc.2013.16.1.72the risk of breast cancer.,Non-OADS,/arxiv_data1/oa_pdf/16/54/jbc-16-72.PMC3625773.pdf
http://knhanes.cdc.go.kr.,Non-OADS,/arxiv_data1/oa_pdf/16/54/jbc-16-72.PMC3625773.pdf
"http://ejbc.kr  |  pISSN 1738-6756   eISSN 2092-9900 This is an Open Access article distributed under the terms of the Creative Commons Attribution Non-Commercial License (http://creativecommons.org/   licenses/by-nc/3.0) which permits unrestricted non-commercial use, distribution, and reproduction in any medium, provided the original work is properly cited.INTRODUCTION   Multifocal (MF) breast cancer and multicentric (MC) breast  cancer are historically deﬁned as two or more synchronous  ipsilateral neoplasms, separated by benign tissue located with  in the same quadrant or different quadrants of the breast [1-4].",Non-OADS,/arxiv_data1/oa_pdf/70/84/jbc-16-77.PMC3625774.pdf
"More - over, the extent of breast tissue sampling also plays an impor - tant role in the variability, as some investigators may sample  the suspicious macroscopic areas, whereas the others would Clinical and Pathologic Features of Multifocal and Multicentric Breast Cancer  in Chinese Women: A Retrospective Cohort Study Mei-rong Zhou, Zhong-hua Tang1, Jing Li2, Jin-Hu Fan2, Yi Pang2,3, Hong-jian Y ang4, Shan Zheng5, Jing-qiao Bai6, Ning Lv5,  Y ou-Lin Qiao2, Hai-zhi Qi, Feng Xu1* Departments of General Surgery and 1Breast-Thyroid Surgery, Xiangya Second Hospital, Central South University, Changsha; 2Department of Cancer  Epidemiology, Cancer Institute & Hospital, Chinese Academy of Medical Sciences & Peking Union Medical College, Beijing; 3Department of Epidemiology,  West China School of Public Health, Sichuan University, Chengdu; 4Department of Breast Surgery, Zhejiang Cancer Hospital, Hangzhou; 5Department of  Pathology and 6State Key Laboratory of Molecular Oncology, Department of Etiology and Carcinogenesis, Cancer Institute & Hospital, Chinese Academy of  Medical Sciences & Peking Union Medical College, Beijing, China ORIGINAL ARTICLEJ Breast Cancer 2013 March; 16(1): 77-83  http://dx.doi.org/10.4048/jbc.2013.16.1.77 Purpose:  This study aims to analyze the clinical-pathological  characteristics of multifocal and multicentric breast cancer  (MMBC) in Chinese women.",Non-OADS,/arxiv_data1/oa_pdf/70/84/jbc-16-77.PMC3625774.pdf
http://ejbc.kr  http://dx.doi.org/10.4048/jbc.2013.16.1.77extensively use the whole mount sections [4].,Non-OADS,/arxiv_data1/oa_pdf/70/84/jbc-16-77.PMC3625774.pdf
"Clinicopathologic Characteristics ofMultifocal andMulticentric Breast Cancer inChina 79 http://dx.doi.org/10.4048/jbc.2013.16.1.77  http://ejbc.krdence of MMBC in breast cancer in 2001 was 3.18%, which  was the highest in all the 10 years, while the lowest incidence  was 0.40% occurring in 2008.",Non-OADS,/arxiv_data1/oa_pdf/70/84/jbc-16-77.PMC3625774.pdf
http://ejbc.kr  http://dx.doi.org/10.4048/jbc.2013.16.1.77there were 38 MMBC patients undertaking breast-conserving   surgery (Table 5).,OADS,/arxiv_data1/oa_pdf/70/84/jbc-16-77.PMC3625774.pdf
"Clinicopathologic Characteristics ofMultifocal andMulticentric Breast Cancer inChina 81 http://dx.doi.org/10.4048/jbc.2013.16.1.77  http://ejbc.krunifocal group, while the two groups were similar in terms   of age, tumor size and grade.",Non-OADS,/arxiv_data1/oa_pdf/70/84/jbc-16-77.PMC3625774.pdf
"http://ejbc.kr  http://dx.doi.org/10.4048/jbc.2013.16.1.77patients underwent mastectomy and only one received breast- conserving treatment, the possible reason could be that the  breast of Chinese women is much smaller than that of the  Western population; therefore, it is very difficult to reach   an ideal cosmetic result if enough breast tissue is surgically   excised from Chinese MMBC patient in order to achieve the  negative margin.",Non-OADS,/arxiv_data1/oa_pdf/70/84/jbc-16-77.PMC3625774.pdf
Clinicopathologic Characteristics ofMultifocal andMulticentric Breast Cancer inChina 83 http://dx.doi.org/10.4048/jbc.2013.16.1.77  http://ejbc.kr16.,Non-OADS,/arxiv_data1/oa_pdf/70/84/jbc-16-77.PMC3625774.pdf
"http://ejbc.kr  |  pISSN 1738-6756   eISSN 2092-9900 This is an Open Access article distributed under the terms of the Creative Commons Attribution Non-Commercial License (http://creativecommons.org/   licenses/by-nc/3.0) which permits unrestricted non-commercial use, distribution, and reproduction in any medium, provided the original work is properly cited.INTRODUCTION  Since breast-conserving surgery (BCS) followed by whole  breast irradiation has become accepted as the standard treat - ment [1,2], the rate of conserving surgery in Korea has gradu - ally increased to 50% of breast cancer surgery [3].",Non-OADS,/arxiv_data1/oa_pdf/92/dd/jbc-16-84.PMC3625775.pdf
"The objective of  the current study was to investigate the influence of radio - therapy on the cosmetic outcome after immediate breast  The Suitability of Absorbable Mesh Insertion for Oncoplastic Breast Surgery  in Patients with Breast Cancer Scheduled to Be Irradiated Taehyun Kim, Heunglae Cho1 Departments of Surgery and 1Radiation Oncology, Inje University Pusan Paik Hospital, Inje University College of Medicine, Busan, KoreaORIGINAL ARTICLEJ Breast Cancer 2013 March; 16(1): 84-89  http://dx.doi.org/10.4048/jbc.2013.16.1.84 Purpose:  The objective of this study was to investigate the influ - ence of radiotherapy on the cosmetic outcome after immediate  breast reconstruction using an absorbable mesh in breast cancer.",Non-OADS,/arxiv_data1/oa_pdf/92/dd/jbc-16-84.PMC3625775.pdf
Influence of Radiotherapy on the Cosmetic Outcome Using Mesh 85 http://dx.doi.org/10.4048/jbc.2013.16.1.84  http://ejbc.krreconstruction using an absorbable mesh in breast cancer.,Non-OADS,/arxiv_data1/oa_pdf/92/dd/jbc-16-84.PMC3625775.pdf
http://ejbc.kr  http://dx.doi.org/10.4048/jbc.2013.16.1.84tangential fields with subsequent electron boost to the tumor  bed at a total dose ranging from 50.4 to 66.6 Gy.,Non-OADS,/arxiv_data1/oa_pdf/92/dd/jbc-16-84.PMC3625775.pdf
"Influence of Radiotherapy on the Cosmetic Outcome Using Mesh 87 http://dx.doi.org/10.4048/jbc.2013.16.1.84  http://ejbc.krAmong the seven patients (20%) who had to be reoperated  on due to mesh complication, partial mastectomy for mesh  removal was performed in two patients due to severe inflam - mation and seroma at around 6 months  postoperation (Table  4).",Non-OADS,/arxiv_data1/oa_pdf/92/dd/jbc-16-84.PMC3625775.pdf
"http://ejbc.kr  http://dx.doi.org/10.4048/jbc.2013.16.1.84this study was 18 months, which provided a longer window  for observation of the later side effect induced by mesh and  radiotherapy.",OADS,/arxiv_data1/oa_pdf/92/dd/jbc-16-84.PMC3625775.pdf
"Influence of Radiotherapy on the Cosmetic Outcome Using Mesh 89 http://dx.doi.org/10.4048/jbc.2013.16.1.84  http://ejbc.krup may be required to present guidelines designed minimize  the unexpected adverse effects of mesh insertion, which is not  confirmed as being safe for use in oncoplastic reconstruction.",Non-OADS,/arxiv_data1/oa_pdf/92/dd/jbc-16-84.PMC3625775.pdf
"http://ejbc.kr  |  pISSN 1738-6756   eISSN 2092-9900 This is an Open Access article distributed under the terms of the Creative Commons Attribution Non-Commercial License (http://creativecommons.org/   licenses/by-nc/3.0) which permits unrestricted non-commercial use, distribution, and reproduction in any medium, provided the original work is properly cited.INTRODUCTION Breast cancer is the most commonly diagnosed cancer in  women and is the most common cause of cancer death in  women [1].",Non-OADS,/arxiv_data1/oa_pdf/be/f5/jbc-16-90.PMC3625776.pdf
"Most digital mammography systems have an automatic  beam quality selection mode (automatic optimization of   parameters, AOP) with an automatic exposure control (AEC),  which automatically selects kVp, milliampere-seconds (mAs),  target material, and filter, in order to control for the appropriate  amount of radiation for an acceptable low dose and an increased Dose Reduction in Automatic Optimization Parameter of Full Field Digital  Mammography: Breast Phantom Study  Myung-Su Ko, Hak Hee Kim1, Joo Hee Cha1, Hee Jung Shin1, Jeoung Hyun Kim2, Min Jeong Kim Health Screening and Promotion Center, Asan Medical Center, Seoul; 1Department of Radiology and Research Institute of Radiology, Asan Medical Center,  University of Ulsan College of Medicine, Seoul; 2Department of Radiology, Kyung Hee University Hospital at Gangdong, Kyung Hee University College of  Medicine, Seoul, KoreaORIGINAL ARTICLEJ Breast Cancer 2013 March; 16(1): 90-96  http://dx.doi.org/10.4048/jbc.2013.16.1.90 Purpose:  We evaluated the impact of three automatic optimiza ­ tion of parameters (AOP) modes of digital mammography on the  dose and image quality.",Non-OADS,/arxiv_data1/oa_pdf/be/f5/jbc-16-90.PMC3625776.pdf
"Dose Reduction in Automatic Optimization Parameter of Full Field Digital Mammography 91 http://dx.doi.org/10.4048/jbc.2013.16.1.90  http://ejbc.krcontrast, according to breast thickness and composition, in  terms of glandularity, i.e., the average fraction of glandular   tissue, as well as the preadjustment of settings for the lowest  possible dose or highest possible image contrast, according to  user preference.",Non-OADS,/arxiv_data1/oa_pdf/be/f5/jbc-16-90.PMC3625776.pdf
"http://ejbc.kr  http://dx.doi.org/10.4048/jbc.2013.16.1.90The phantom breast detail component consists of 12 CaCO 3  specks groups of varying sizes, seven hemispheric masses of  varying diameters, and five nylon fibers of varying diameters.",Non-OADS,/arxiv_data1/oa_pdf/be/f5/jbc-16-90.PMC3625776.pdf
"Dose Reduction in Automatic Optimization Parameter of Full Field Digital Mammography 93 http://dx.doi.org/10.4048/jbc.2013.16.1.90  http://ejbc.krscore of specks was lowest in the 50% glandular breast tissue  group ( p=0.002); yet, no difference was found between the  20-21% and 30% glandular breast tissue groups ( p=0.224).",OADS,/arxiv_data1/oa_pdf/be/f5/jbc-16-90.PMC3625776.pdf
http://ejbc.kr  http://dx.doi.org/10.4048/jbc.2013.16.1.90Table 5.,Non-OADS,/arxiv_data1/oa_pdf/be/f5/jbc-16-90.PMC3625776.pdf
"Dose Reduction in Automatic Optimization Parameter of Full Field Digital Mammography 95 http://dx.doi.org/10.4048/jbc.2013.16.1.90  http://ejbc.krwere significantly different among the three modes (both, p< 0.001).",Non-OADS,/arxiv_data1/oa_pdf/be/f5/jbc-16-90.PMC3625776.pdf
"http://ejbc.kr  http://dx.doi.org/10.4048/jbc.2013.16.1.90STD mode in practice, in addition to the lowest radiation  dose; moreover, the DOSE mode can be routinely used in   patient examinations.",Non-OADS,/arxiv_data1/oa_pdf/be/f5/jbc-16-90.PMC3625776.pdf
"http://ejbc.kr  |  pISSN 1738-6756   eISSN 2092-9900 This is an Open Access article distributed under the terms of the Creative Commons Attribution Non-Commercial License (http://creativecommons.org/   licenses/by-nc/3.0) which permits unrestricted non-commercial use, distribution, and reproduction in any medium, provided the original work is properly cited.INTRODUCTION Through the past few decades, the numbers of diagnostic  methods and treatment modalities for breast cancer have   increased, and breast cancer survival and recurrence rates  have improved.",Non-OADS,/arxiv_data1/oa_pdf/5c/a2/jbc-16-97.PMC3625777.pdf
"2.0 (http://www.tufts-nemc.org/ibtr)   is a web-based tool that includes 7 prognostic factors (age,   tumor size, tumor grade, margin status, lymphovascular inva - sion [LVI], use of chemotherapy [CTx], and use of hormone  therapy [HTx]) to predict individualized risk of ipsilateral Validation of a Web-Based Tool to Predict the Ipsilateral Breast Tumor  Recurrence (IBTR!",OADS,/arxiv_data1/oa_pdf/5c/a2/jbc-16-97.PMC3625777.pdf
"2.0) after Breast-Conserving Therapy for Korean Patients Seung Pil Jung, Sung Mo Hur1, Se Kyung Lee2, Sangmin Kim2, Min-Y oung Choi2, Soo Y oun Bae2, Jiyoung Kim2,  Min Kuk Kim2, Won Ho Kil2, Jun-Ho Choe2, Jung-Han Kim2, Jee Soo Kim2, Seok Jin Nam2, Jeoung Won Bae, Jeong Eon Lee2 Division of Breast and Endocrine Surgery, Department of Surgery, Korea University Hospital, Korea University College of Medicine, Seoul; 1Department of  Surgery, Soonchunhyang University College of Medicine, Bucheon; 2Division of Breast and Endocrine Surgery, Department of Surgery, Samsung Medical  Center, Sungkyunkwan University School of Medicine, Seoul, KoreaORIGINAL ARTICLEJ Breast Cancer 2013 March; 16(1): 97-103  http://dx.doi.org/10.4048/jbc.2013.16.1.97 Purpose:  IBTR!",Non-OADS,/arxiv_data1/oa_pdf/5c/a2/jbc-16-97.PMC3625777.pdf
http://ejbc.kr  http://dx.doi.org/10.4048/jbc.2013.16.1.97breast tumor recurrence after BCS with or without RTx [8].,Non-OADS,/arxiv_data1/oa_pdf/5c/a2/jbc-16-97.PMC3625777.pdf
"(The R Project for Statistical Computing,   Vienna, Austria, available from http://www.r-project.org).",Non-OADS,/arxiv_data1/oa_pdf/5c/a2/jbc-16-97.PMC3625777.pdf
2.0forKorean Patient 99 http://dx.doi.org/10.4048/jbc.2013.16.1.97  http://ejbc.krThe Kaplan-Meier IBTR values in the entire cohort and the  4 groups are shown in Figure 1.,Non-OADS,/arxiv_data1/oa_pdf/5c/a2/jbc-16-97.PMC3625777.pdf
"http://ejbc.kr  http://dx.doi.org/10.4048/jbc.2013.16.1.97than 3%, there were two cases of IBTR in 124 patients, and the  predicted versus observed IBTR values were 2.25% and 1.80%  (p=0.73), respectively.",Non-OADS,/arxiv_data1/oa_pdf/5c/a2/jbc-16-97.PMC3625777.pdf
2.0forKorean Patient 101 http://dx.doi.org/10.4048/jbc.2013.16.1.97  http://ejbc.krstatistical significance.,Non-OADS,/arxiv_data1/oa_pdf/5c/a2/jbc-16-97.PMC3625777.pdf
http://ejbc.kr  http://dx.doi.org/10.4048/jbc.2013.16.1.97clinical data outside of the North America.,OADS,/arxiv_data1/oa_pdf/5c/a2/jbc-16-97.PMC3625777.pdf
2.0forKorean Patient 103 http://dx.doi.org/10.4048/jbc.2013.16.1.97  http://ejbc.krSoc	2004;67:274-8.,Non-OADS,/arxiv_data1/oa_pdf/5c/a2/jbc-16-97.PMC3625777.pdf
http://kostat.go.kr.,Non-OADS,/arxiv_data1/oa_pdf/5c/a2/jbc-16-97.PMC3625777.pdf
"T h i s  i s  a n  O p e n  A c c e s s  a r t i c l e  d i s t r i b u t e d  u n d e r  t h e   terms of the Creative Commons Attribution Non-  Commercial License (http://creativecommons.org/li-censes/by-nc/3.0)  which permits unrestricted non-  commercial use, distribution, and reproduction in any medium, provided the original work is properly cited.Keywords Aneurysm, Proximal, Anterior cerebral artery, Angiography, Subarachnoid  hemorrhageJournal of Cerebrovascular and Endovascular Neurosurgery ISSN 2234-8565, EISSN 2287-3139, http://dx.doi.org/10.7461/jcen.2013.15.1.13  Original Article INTRODUCTION The proximal segment (A1) of the anterior cerebral  artery (ACA) is located between the bifurcation of the internal carotid artery (I CA) and the anterior commu- nicating artery.",Non-OADS,/arxiv_data1/oa_pdf/18/f5/jcen-15-13.PMC3625815.pdf
"2013 March;15(1):20~25 Received : 16 January 2013 Revised : 14 February 2013 Accepted : 7 March 2013 Correspondence to Sung-Tae Kim   Department of Neurosurgery, Busan Paik  Hospital, School of Medicine, Inje  University, Busan 614-110, Korea Tel : 82-51-890-6144 Fax : 82-51-898-4244 E-mail : kimst015@hanmail.net T h i s  i s  a n  O p e n  A c c e s s  a r t i c l e  d i s t r i b u t e d  u n d e r  t h e   terms of the Creative Commons Attribution Non- Commercial License (http://creativecommons.org/li- censes/by-nc/3.0)  which permits unrestricted non-  commercial use, distribution, and reproduction in any  medium, provided the ori ginal work is properly cited.",Non-OADS,/arxiv_data1/oa_pdf/a7/e6/jcen-15-20.PMC3625816.pdf
"Keywords Chickens, Surgical anastomosi s, Brachial artery, TrainingJournal of Cerebrovascular and Endovascular Neurosurgery ISSN 2234-8565, EISSN 2287-3139, http://dx.doi.org/10.7461/jcen.2013.15.1.20  Original Article INTRODUCTION Cerebral revascularization has been useful in treat- ment of cerebral hemodynamic failure, in skull base surgery, and in complex an eurysm surgery.",Non-OADS,/arxiv_data1/oa_pdf/a7/e6/jcen-15-20.PMC3625816.pdf
"Tel : 82-10-9063-3012 Fax : 82-64-717-1630E-mail : yfound@hanmail.net T h i s  i s  a n  O p e n  A c c e s s  a r t i c l e  d i s t r i b u t e d  u n d e r  t h e   terms of the Creative Commons Attribution Non-  Commercial License (http://creativecommons.org/li- censes/by-nc/3.0)  which permits unrestricted non-  commercial use, distribution, and reproduction in any  medium, provided the ori ginal work is properly cited.Keywords Anterior spinal artery, Aneurysm, Subarachnoid hemorrhageJournal of Cerebrovascular and Endovascular Neurosurgery ISSN 2234-8565, EISSN 2287-3139, http://dx.doi.org/10.7461/jcen.2013.15.1.26  Case Report A  B Fig.",Non-OADS,/arxiv_data1/oa_pdf/ec/d3/jcen-15-26.PMC3625817.pdf
"Department of Neurosurgery, Rush  University Medical Center, 1725 W.  Harrison St. Suite 855, Chicago, IL 60612 USA Tel : 1-312-942-1854 Fax : 1-312-942-2176E-mail : roham_moftakhar@rush.edu T h i s  i s  a n  O p e n  A c c e s s  a r t i c l e  d i s t r i b u t e d  u n d e r  t h e   terms of the Creative Commons Attribution Non-  Commercial License (http://creativecommons.org/li-censes/by-nc/3.0)  which permits unrestricted non-  commercial use, distribution, and reproduction in any  medium, provided the ori ginal work is properly cited.Keywords Fusiform aneurysm, Ruptured aneu rysm, Subarachnoid hemorrhage,  Therapeutic embolization, Vertebrobasilar dolichoectasiaJournal of Cerebrovascular and Endovascular Neurosurgery ISSN 2234-8565, EISSN 2287-3139, http://dx.doi.org/10.7461/jcen.2013.15.1.30  Case Report INTRODUCTION Vertebrobasilar fusiform aneurysm (VFA), also known  as vertebrobasilar dolichoectasia, is a vasculopathy  characterized by pathologically elongated and dilated  vertebral and basilar arteries with estimated incidence of 0.06 - 5.8%.",Non-OADS,/arxiv_data1/oa_pdf/76/4d/jcen-15-30.PMC3625818.pdf
"2013 March;15(1):5~12 Received : 14 February 2013 Revised : 26 February 2013 Accepted : 28 February 2013 Correspondence to Yoon-Soo Lee Department of Neurosurgery, Daegu  Fatima Hospital, 576-31 Sinam-dong,  Dong-gu, Daegu 701-600, Korea Tel : 82-53-940-7330, 7339 Fax : 82-53-954-7417 E-mail : paulyoonsoolee@hanmail.net T h i s  i s  a n  O p e n  A c c e s s  a r t i c l e  d i s t r i b u t e d  u n d e r  t h e   terms of the Creative Commons Attribution Non- Commercial License (http://creativecommons.org/li- censes/by-nc/3.0)  which permits unrestricted non-  commercial use, distribution, and reproduction in any  medium, provided the ori ginal work is properly cited.Keywords Cerebral aneurysm, Craniotomy, Minimally invasive, Mini-pterional,  Supraorbital, Surgical exposureJournal of Cerebrovascular and Endovascular Neurosurgery ISSN 2234-8565, EISSN 2287-3139, http://dx.doi.org/10.7461/jcen.2013.15.1.5  Original Article INTRODUCTION Since the introduction of frontotemporal craniotomy  by Yaşargil et al, so-called ""pterional craniotomy"" (PC) has traditionally been regarded as a standard approach  for clipping of cerebral aneurysms in the anterior circulation.",Non-OADS,/arxiv_data1/oa_pdf/60/ee/jcen-15-5.PMC3625819.pdf
"To view these ﬁles please visit the journal online (http://dx.doi.org/10.1136/sextrans-2012-050605) 1MRC/CSO Social and Public Health Sciences Unit, Medical Research Council, Glasgow, UK 2Department of Psychology and Allied Health Sciences, Schoolof Health and Life Sciences, Glasgow Caledonian University, Glasgow, UK Correspondence to Dr Lisa M McDaid, MRC/CSOSocial and Public Health Sciences Unit, Medical Research Council, 4 Lilybank Gardens,Glasgow G12 8RZ, UK;l.mcdaid@sphsu.mrc.ac.uk Accepted 3 September 2012 Published Online First5 October 2012ABSTRACT Introduction To examine sexually transmitted infection (STI) testing and self-reported diagnoses among menwho have sex with men (MSM), in Scotland.Methods Cross-sectional survey of seven Glasgow gay bars in July 2010 (n=822, 62% response rate); 693 areincluded in the analyses.Results 81.8% reported ever having had an STI test; 37.4% had tested in the previous 6 months; 13.2%reported having an STI in the previous 12 months.",Non-OADS,/arxiv_data1/oa_pdf/48/4a/sextrans-2012-050605.PMC3625820.pdf
See: http://creativecommons.org/licenses/by-nc/3.0/ REFERENCES 1.,Non-OADS,/arxiv_data1/oa_pdf/48/4a/sextrans-2012-050605.PMC3625820.pdf
http://www.emis-project.eu/community-report-2 (accessed 24 Feb 2012).,Non-OADS,/arxiv_data1/oa_pdf/48/4a/sextrans-2012-050605.PMC3625820.pdf
http://www.sigmaresearch.org.uk/gmss/year/yr2010 (accessed 24 Feb 2012).,Non-OADS,/arxiv_data1/oa_pdf/48/4a/sextrans-2012-050605.PMC3625820.pdf
http://www.sigmaresearch.org.uk/gmss/year/yr2010 (accessed 24 Feb 2012).,Non-OADS,/arxiv_data1/oa_pdf/48/4a/sextrans-2012-050605.PMC3625820.pdf
"To view these ﬁles please visit the journal online (http://dx.doi.org/10.1136/sextrans-2012-050655) 1University College London, Medical School, London, UK 2Sexual Health In Practice, Heart of England NHSFoundation Trust, Birmingham, UK 3Research Department of Infection and Population Health,University College London, London, UK 4Killick Street Health Centre, Islington, London, UK Correspondence to Timesh D Pillay, University College London, Medical School, Rockefeller Building,University Street, LondonWC1E 6BT , UK; t.pillay@ucl.ac.uk Accepted 23 August 2012 Published Online First8 October 2012ABSTRACT Background This longitudinal study aimed to evaluate the impact of a multifaceted educational intervention(Sexual Health in Practice, SHIP) on general practice HIVtesting rates in a high prevalence London area.Intervention SHIP offered training in sexual health clinical skills to general practitioners (GPs) and practicenurses (PNs) in Haringey.",Non-OADS,/arxiv_data1/oa_pdf/15/a9/sextrans-2012-050655.PMC3625821.pdf
See: http://creativecommons.org/licenses/by-nc/3.0/ REFERENCES 1.,Non-OADS,/arxiv_data1/oa_pdf/15/a9/sextrans-2012-050655.PMC3625821.pdf
http://www.hpa.org.uk/Topics/InfectiousDiseases/InfectionsAZ/SexualHealth ProﬁlesAndIndex/SexualHealthPro ﬁlesPerformance/ 32.,Non-OADS,/arxiv_data1/oa_pdf/15/a9/sextrans-2012-050655.PMC3625821.pdf
"See: http://creativecommons.org/ licenses/by-nc/3.0/Table 4 Multivariate models of associations with having outside partners among men and women Adjusted OR 95% CI Men Age 0.96** 0.95 to 0.97Education 1.24** 1.11 to 1.37STI 1.16* 1.01 to 1.34 Binge drinking 1.01 0.96 to 1.04 Drank before sex 1.11** 1.08 to 1.13Partner drank before sex 1.20** 1.15 to 1.25Met partner in shebeen 3.62** 2.93 to 4.47Unprotected vaginal Sex 1.02** 1.01 to 1.03Unprotected anal sex 1.04 0.99 to 1.08 Women Age 0.99 0.97 to 1.00Employed 1.21 0.93 to 1.57STI 2.09** 1.62 to 2.69Binge drinking 1.20** 1.06 to 1.36Drank before sex 1.10** 1.06 to 1.15Partner drank before sex 1.08** 1.04 to 1.12Met partners in shebeens 3.80** 2.57 to 5.62Unprotected vaginal sex 1.02** 1.01 to 1.03Unprotected anal sex 1.08* 1.01 to 1.16 Note: Adjusted OR adjusted for all variables in the model; *p<0.05, **p<0.01.",Non-OADS,/arxiv_data1/oa_pdf/a3/f6/sextrans-2012-050569.PMC3625822.pdf
To viewplease visit the journal online(http://dx.doi.org/10.1136/ jmedgenet-2012-101483).,OADS,/arxiv_data1/oa_pdf/01/13/jmedgenet-2012-101483.PMC3625823.pdf
"See: http://creativecommons.org/licenses/by-nc/3.0/ 328 Samuels ME, et al.J Med Genet 2013; 50:324 –329.",Non-OADS,/arxiv_data1/oa_pdf/01/13/jmedgenet-2012-101483.PMC3625823.pdf
"See: http://creativecommons.org/licenses/ by-nc/3.0/To cite Krucien N, Gafni A, Fleury B, et al.Thorax 2013; 68:487–488.",Non-OADS,/arxiv_data1/oa_pdf/09/54/thoraxjnl-2012-202240.PMC3625824.pdf
See: http://creativecommons.org/ licenses/by-nc/3.0/ REFERENCES 1.,Non-OADS,/arxiv_data1/oa_pdf/f5/f4/sextrans-2012-050690.PMC3625825.pdf
To viewplease visit the journal online (http://dx.doi.org/10.1136/ archdischild-2012-302512).,Non-OADS,/arxiv_data1/oa_pdf/6f/57/archdischild-2012-302512.PMC3625826.pdf
"See: http://creativecommons.org/licenses/by-nc/3.0/ REFERENCES 1 Berssenbrugge A, Dempsey J, Iber C, et al.",Non-OADS,/arxiv_data1/oa_pdf/6f/57/archdischild-2012-302512.PMC3625826.pdf
"See: http://creativecommons.org/ licenses/by-nc/3.0/ REFERENCES 1 Levy L, Nasereddin A, Rav-Acha M, et al .",Non-OADS,/arxiv_data1/oa_pdf/c0/01/thoraxjnl-2011-201408.PMC3625827.pdf
To view please visit the journal online(http://dx.doi.org/10.1136/jmedgenet-2012-101442).,Non-OADS,/arxiv_data1/oa_pdf/91/ba/jmedgenet-2012-101442.PMC3625828.pdf
"See: http://creativecommons.org/licenses/by-nc/3.0/ REFERENCES 1 Hinkes BG, Mucha B, Vlangos CN, Gbadegesin R, Liu J, Hasselbacher K, Hangan D, Ozaltin F, Zenker M, Hildebrandt F. Nephrotic syndrome in the ﬁrst year of life: two thirds of cases are caused by mutations in 4 genes (NPHS1, NPHS2, WT1, andLAMB2).",Non-OADS,/arxiv_data1/oa_pdf/91/ba/jmedgenet-2012-101442.PMC3625828.pdf
"See: http://creativecommons.org/licenses/by-nc/3.0/ REFERENCES 1 Zimmerman FJ, Christakis DA.",Non-OADS,/arxiv_data1/oa_pdf/a3/f6/archdischild-2011-301508.PMC3625829.pdf
"SN: 5795, http://dx.doi.org/10.5255/UKDA-SN-5795-1.",Non-OADS,/arxiv_data1/oa_pdf/a3/f6/archdischild-2011-301508.PMC3625829.pdf
"SN: 5350, http://dx.doi.",OADS,/arxiv_data1/oa_pdf/a3/f6/archdischild-2011-301508.PMC3625829.pdf
"SN: 4683, http://dx.doi.",Non-OADS,/arxiv_data1/oa_pdf/a3/f6/archdischild-2011-301508.PMC3625829.pdf
This is an Open Access article distributed under the terms of theCreative Commons Attribution Non-Commercial Share Alike License (http://creativecommons.org/licenses/by-nc-sa/3.0).,Non-OADS,/arxiv_data1/oa_pdf/73/1c/bio-02-04-363.PMC3625863.pdf
"To facilitate the application of thisassay, we developed free software tools for primer selection, which are available at http://ws.g-language.org/TALEN.",Non-OADS,/arxiv_data1/oa_pdf/73/1c/bio-02-04-363.PMC3625863.pdf
"Primer design software tool for LacZ recovery/disruption assay A software tool for designing the primers of this assay is freely available as anonline tool at http://talen.g-language.org, and the source code is available underGNU General Public License.",OADS,/arxiv_data1/oa_pdf/73/1c/bio-02-04-363.PMC3625863.pdf
Off-target effects The effects at potential off-target sites for the designed TALENs were identifiedusing Paired Target Finder (https://tale-nt.cac.cornell.edu/node/add/talef-off-paired).,OADS,/arxiv_data1/oa_pdf/73/1c/bio-02-04-363.PMC3625863.pdf
This is an Open Access article distributed under the terms of the Creative Commons Attribution Non-Commercial Share AlikeLicense (http://creativecommons.org/licenses/by-nc-sa/3.0).,Non-OADS,/arxiv_data1/oa_pdf/a8/1a/bio-02-04-368.PMC3625864.pdf
This is an Open Access article distributed under the terms of the Creative Commons Attribution Non-Commercial Share Alike License (http://creativecommons.org/licenses/by-nc-sa/3.0).,Non-OADS,/arxiv_data1/oa_pdf/aa/32/bio-02-04-373.PMC3625865.pdf
This is an Open Access article distributed under the terms of theCreative Commons Attribution Non-Commercial Share AlikeLicense (http://creativecommons.org/licenses/by-nc-sa/3.0).,Non-OADS,/arxiv_data1/oa_pdf/a3/a3/bio-02-04-379.PMC3625866.pdf
This is an Open Access article distributed under the terms of the Creative Commons Attribution Non-Commercial Share AlikeLicense (http://creativecommons.org/licenses/by-nc-sa/3.0).,Non-OADS,/arxiv_data1/oa_pdf/6d/28/bio-02-04-387.PMC3625867.pdf
This is an Open Access article distributed under the terms of the Creative Commons Attribution Non-Commercial Share Alike License (http://creativecommons.org/licenses/by-nc-sa/3.0).,Non-OADS,/arxiv_data1/oa_pdf/c7/84/bio-02-04-396.PMC3625868.pdf
"Rasband, ImageJ, U.S. National Institutes of Health, Bethesda, Maryland, USA, http://imagej.nih.",OADS,/arxiv_data1/oa_pdf/c7/84/bio-02-04-396.PMC3625868.pdf
"Velocity and directionality values were obtained using the manual tracking (F. Cordelieres, Manual Tracking, Institute Curie, Orsay France, http://rsb.info.nih.gov/ij/plugins/track, 2004) and chemotaxis tool (G.Trapp and E. Horn, Chemotaxis and Migration tool, Munich, Germany, http://ibidi.",OADS,/arxiv_data1/oa_pdf/c7/84/bio-02-04-396.PMC3625868.pdf
This is an Open Access article distributed under the terms of the Creative Commons Attribution Non-Commercial Share AlikeLicense (http://creativecommons.org/licenses/by-nc-sa/3.0).,Non-OADS,/arxiv_data1/oa_pdf/54/f0/bio-02-04-407.PMC3625869.pdf
This is an Open Access article distributed under the terms of the Creative Commons Attribution Non-Commercial Share Alike License (http://creativecommons.org/licenses/by-nc-sa/3.0).,Non-OADS,/arxiv_data1/oa_pdf/90/64/bio-02-04-416.PMC3625870.pdf
"keratinocytes (Adams etal., 2010) and T cells (Ruefli-Brasse et al., 2004), but published microarray analysis of laser captured ureteric bud shows the protein to be absent in this tissue, and indeed absent in all other tissues of the early kidney (later, it becomes detectable only in mature podocytes and glomerular epithelia; see the GUDMAP website (http://www.gudmap.org)).",Non-OADS,/arxiv_data1/oa_pdf/90/64/bio-02-04-416.PMC3625870.pdf
We have made the cell lines themselves freely available to the community (‘free’ except for the cost of shipping) via theGUDMAP website (http://www.gudmap.org; go to the mouse lines and cell lines section).,Non-OADS,/arxiv_data1/oa_pdf/90/64/bio-02-04-416.PMC3625870.pdf
This is an Open Access article distributed under the terms of theCreative Commons Attribution Non-Commercial Share Alike License (http://creativecommons.org/licenses/by-nc-sa/3.0).,Non-OADS,/arxiv_data1/oa_pdf/e9/0b/bio-02-04-424.PMC3625871.pdf
"Seeds of putative T-DNA insertion mutants of AtVOZ1 (atvoz1-1 , WiscDsLox489-492010) and AtVOZ2 (atvoz2-1 , salk_115813c) were obtained from ABRC, Ohio State University (http://www.arabidopsis.org) andhomozygous lines were identified using genomic PCR and RT-PCR with gene- specific and T-DNA-specific primers listed in supplementary material Table S3.",OADS,/arxiv_data1/oa_pdf/e9/0b/bio-02-04-424.PMC3625871.pdf
This is an Open Access article distributed under the terms of theCreative Commons Attribution Non-Commercial Share Alike License (http://creativecommons.org/licenses/by-nc-sa/3.0).,Non-OADS,/arxiv_data1/oa_pdf/d2/fc/bio-02-04-432.PMC3625872.pdf
Available FREE in open access from: http://www.clinicalimagingscience.org/text.asp?2013/3/1/11/107998,Non-OADS,/arxiv_data1/oa_pdf/fe/5c/JCIS-3-11.PMC3625878.pdf
Available FREE in open access from: http://www.clinicalimagingscience.org/text.asp?2013/3/1/10/107995   Aditi Jain,Non-OADS,/arxiv_data1/oa_pdf/a6/66/JCIS-3-10.PMC3625879.pdf
Available FREE in open access from: http://www.clinicalimagingscience.org/text.asp?2013/3/1/8/107912,Non-OADS,/arxiv_data1/oa_pdf/06/13/JCIS-3-8.PMC3625880.pdf
Available FREE in open access from: http://www.clinicalimagingscience.org/text.asp?2013/3/1/5/106620Aditi Jain,Non-OADS,/arxiv_data1/oa_pdf/8f/9b/JCIS-3-5.PMC3625881.pdf
Available FREE in open access from: http://www.clinicalimagingscience.org/text.asp?2013/3/1/4/106618 Guray Oncel,Non-OADS,/arxiv_data1/oa_pdf/8c/31/JCIS-3-4.PMC3625882.pdf
Available FREE in open access from: http://www.clinicalimagingscience.org/text.asp?2013/3/1/1/106613Recieved : 20‑07‑2012 Accepted : 31‑07‑2012 Published : 30‑01‑2013,Non-OADS,/arxiv_data1/oa_pdf/19/9a/JCIS-3-1.PMC3625883.pdf
Available FREE in open access from: http://www.clinicalimagingscience.org/text.asp?2013/3/1/9/107994   Albert Yang,Non-OADS,/arxiv_data1/oa_pdf/84/13/JCIS-3-9.PMC3625884.pdf
Available FREE in open access from: http://www.clinicalimagingscience.org/text.asp?2013/3/1/7/107909,Non-OADS,/arxiv_data1/oa_pdf/4d/89/JCIS-3-7.PMC3625885.pdf
Available FREE in open access from: http://www.clinicalimagingscience.org/text.asp?2013/3/1/2/106614,Non-OADS,/arxiv_data1/oa_pdf/72/03/JCIS-3-2.PMC3625886.pdf
Available FREE in open access from: http://www.clinicalimagingscience.org/text.asp?2013/3/1/3/106616,Non-OADS,/arxiv_data1/oa_pdf/33/33/JCIS-3-3.PMC3625887.pdf
Available FREE in open access from: http://www.clinicalimagingscience.org/text.asp?2013/3/1/6/106621,Non-OADS,/arxiv_data1/oa_pdf/2c/c5/JCIS-3-6.PMC3625888.pdf
A further 50 FFPE melanoma samples were obtained from the Melbourne Melanoma Project (http://melbournemelanomaproject.com/).,Non-OADS,/arxiv_data1/oa_pdf/b9/5d/srep01659.PMC3625889.pdf
"To view a copy of this license, visit http://creativecommons.org/licenses/by-nc-nd/3.0/ How to cite this article: Richter, A. et al.",Non-OADS,/arxiv_data1/oa_pdf/b9/5d/srep01659.PMC3625889.pdf
Additional information Supplementary information accompanies this paper at http://www.nature.com/ scientificreports Competing financial interests: The authors declare no competing financial interests.,Non-OADS,/arxiv_data1/oa_pdf/55/d8/srep01658.PMC3625890.pdf
"To view a copy of this license, visit http://creativecommons.org/licenses/by-nc-nd/3.0/ How to cite this article: Albuschies, J.",Non-OADS,/arxiv_data1/oa_pdf/55/d8/srep01658.PMC3625890.pdf
"Additional information Supplementary information accompanies this paper at http://www.nature.com/ scientificreports Competing financial interests: Dr. Marc Hellerstein receives compensation as a member of the scientific advisory board of KineMed, Inc. and owns stock in the company.",Non-OADS,/arxiv_data1/oa_pdf/c7/4d/srep01656.PMC3625901.pdf
"To view a copy of this license, visit http://creativecommons.org/licenses/by-nc-nd/3.0/ How to cite this article: Louie, K.B.",Non-OADS,/arxiv_data1/oa_pdf/c7/4d/srep01656.PMC3625901.pdf
"To view a copy of this license,visit http://creativecommons.org/licenses/by-nc-nd/3.0/Naturally occurring autoantibodies and cognition D Mengel et al 9 Translational Psychiatry",Non-OADS,/arxiv_data1/oa_pdf/3b/cd/tp2012151a.PMC3625912.pdf
"To view a copy of this license,visit http://creativecommons.org/licenses/by-nc-nd/3.0/Sapropterin metabolism RE Frye et al 9 Translational Psychiatry",Non-OADS,/arxiv_data1/oa_pdf/fe/f6/tp201314a.PMC3625913.pdf
"31Preprocessed time-series data for each individual were analyzed using a multiple regression model corrected for autocorrelation consisting of three anticipation-relatedand two stimulus-related regressors, convolved with empiri- cally derived HRF (http://afni.nimh.nih.gov/pub/dist/doc/pro- gram_help/waver.html), labeled as the Cox special.Anticipation-related regressors modeling the entire anticipa- tion period consisted of: (1) anticipation of moderately painful heat stimulation, that is, high pain anticipation and (2)anticipation of mildly painful heat stimulation, that is, lowpain anticipation.",OADS,/arxiv_data1/oa_pdf/89/da/tp201315a.PMC3625914.pdf
of psychophysiological interaction method introduced by Friston et al.35and adapted for the Analysis of Functional NeuroImages (http://afni.nimh.nih.gov/sscc/gangc/CD-Cor- rAna.html).,OADS,/arxiv_data1/oa_pdf/89/da/tp201315a.PMC3625914.pdf
"To view a copy of this license, visithttp://creativecommons.org/licenses/by-nc-nd/3.0/ Supplementary Information accompanies the paper on the Translational Psychiatry website (http://www.nature.com/tp)Decreased frontal regulation with MDD IA Strigo et al 9 Translational Psychiatry",Non-OADS,/arxiv_data1/oa_pdf/89/da/tp201315a.PMC3625914.pdf
"To view a copy of this license, visit http://creativecommons.org/licenses/by-nc-nd/3.0/ Supplementary Information accompanies the paper on the Translational Psychiatry website (http://www.nature.com/tp)Maternal immune activation and strain speciﬁc interactions JJ Schwartzer et al 9 Translational Psychiatry",Non-OADS,/arxiv_data1/oa_pdf/ad/c7/tp201316a.PMC3625915.pdf
"German Bundestag (Drs.17/7700): Berlin, Germany, 2011; http://dipbt.bundestag.de/dip21/btd/17/077/1707700.pdf.",Non-OADS,/arxiv_data1/oa_pdf/4b/72/tp201317a.PMC3625916.pdf
"Hans Huber: Bern, Switzerland, 2000; http://www.psycontent.com/ content/x271850812557354/.",Non-OADS,/arxiv_data1/oa_pdf/4b/72/tp201317a.PMC3625916.pdf
"To view a copy of this license, visithttp://creativecommons.org/licenses/by-nc-nd/3.0/Analysis of mental health status in Jewish migrants in 3rd generation after the Shoa E Ullmann et al 4 Translational Psychiatry",Non-OADS,/arxiv_data1/oa_pdf/4b/72/tp201317a.PMC3625916.pdf
"To view a copy of this license, visit http://creativecommons.org/licenses/by-nc-nd/3.0/Synaptic plasticity in adolescent development LD Selemon 9 Translational Psychiatry",Non-OADS,/arxiv_data1/oa_pdf/c9/07/tp20137a.PMC3625918.pdf
Additional information Supplementary information accompanies this paper at http://www.nature.com/ scientificreports Competing financial interests: The authors declare no competing financial interests.,Non-OADS,/arxiv_data1/oa_pdf/1d/eb/srep01657.PMC3625919.pdf
"To view a copy of thislicense, visit http://creativecommons.org/licenses/by-nc-sa/3.0/ How to cite this article: Yanagida, T. et al.",Non-OADS,/arxiv_data1/oa_pdf/1d/eb/srep01657.PMC3625919.pdf
The package and pipeline for producing it are available from http://bcb.dfci.harvard.edu/ovariancancer.,Non-OADS,/arxiv_data1/oa_pdf/88/57/bat013.PMC3625954.pdf
"Database URL: http://bcb.dfci.harvard.edu/ovariancancer ............................................................................................................................................................................................................................................................................................. Introduction A wealth of genomic data, in particular microarray data, is publicly available through diverse online resources.",OADS,/arxiv_data1/oa_pdf/88/57/bat013.PMC3625954.pdf
The generation of the package is repro-ducible using the pipeline provided at https://bitbucket.org/lwaldron/curatedovariandata.,OADS,/arxiv_data1/oa_pdf/88/57/bat013.PMC3625954.pdf
"The MIRIAM Registry (http://www.ebi.ac.uk/miriam/) records information about collections of data in the life sciences, as well as where it can be obtained.",OADS,/arxiv_data1/oa_pdf/b8/37/bat017.PMC3625955.pdf
"This information is used, in combination with the resolving infrastructure of Identifiers.org (http://identifiers.org/), to generate globally unique identifiers, in the form of Uniform Resource Identifier.",OADS,/arxiv_data1/oa_pdf/b8/37/bat017.PMC3625955.pdf
"This is an Open Access article distributed under the terms of the Creative Commons Attribution Non-Commercial License (http://creativecommons.org/licenses/by-nc/3.0/), which permits unrestricted non-commercial use, distribution, and reproduction in any medium, provided the original work is properly cited.",Non-OADS,/arxiv_data1/oa_pdf/b8/37/bat017.PMC3625955.pdf
"A project, hosted on SourceForge, provides ways to con- tribute to both the content and the infrastructure: http://sf.net/p/identifiers-org/.",OADS,/arxiv_data1/oa_pdf/b8/37/bat017.PMC3625955.pdf
"So provided with a pro- file, each URI would directly resolve to a single location,through the preference expressed in the creator’s profile.The advantage of user-defined profiles is highlighted by comparing the resolving of one URI using a pro- file (http://identifiers.org/genecards/ABL1?profile=most_reliable) and without any profile information (http://identifiers.org/genecards/ABL1).",OADS,/arxiv_data1/oa_pdf/b8/37/bat017.PMC3625955.pdf
"http://www.ars-grin.gov/cgi-bin/npgs/html/index.pl?language=en (20 March 2013, datelast accessed).",Non-OADS,/arxiv_data1/oa_pdf/b8/37/bat017.PMC3625955.pdf
"W3C website , http://www.w3.org/ DesignIssues/LinkedData.html.",Non-OADS,/arxiv_data1/oa_pdf/b8/37/bat017.PMC3625955.pdf
"Database URL: http://www.malacards.org/ ............................................................................................................................................................................................................................................................................................. Introduction One of the greatest challenges of biomedical research is deciphering the underlying mechanisms of human dis-eases, which requires accurate classification and annota- tion.",OADS,/arxiv_data1/oa_pdf/34/ca/bat018.PMC3625956.pdf
"There are several vocabularies, ranging from class-specific ones, such as the National Cancer Institute (NCI) Dictionary of Cancer Terms (http:// www.cancer.gov/dictionary), NCI Drug Dictionary (http://www.cancer.gov/drugdictionary) and the InfectiousDisease Ontology (IDO) (http://infectiousdiseaseontology.org/page/Main_Page), to more broadly disposed ones,such as the International Classification of Diseases (ICD)(10,11), the Unified Medical Language System (UMLS) (12), the Systematized Nomenclature of Medicine— Clinical Terms (SNOMED-CT) ( 13), the Medical Subject Headings (MeSH) (http://www.nlm.nih.gov/mesh/) and theDisease Ontology (DO) ( 6).",Non-OADS,/arxiv_data1/oa_pdf/34/ca/bat018.PMC3625956.pdf
"MalaCards’ searches use Solr (http://lucene.apache.org/ solr/), a publicly available server based on Apache’sLucene indexing and text search API.",OADS,/arxiv_data1/oa_pdf/34/ca/bat018.PMC3625956.pdf
Examples can be found in theMalaCards search guide (http://www.malacards.org/pages/searchguide).,Non-OADS,/arxiv_data1/oa_pdf/34/ca/bat018.PMC3625956.pdf
The relevance score is as described in the Lucene Similarity class web manual (http://lucene.apache.org).,OADS,/arxiv_data1/oa_pdf/34/ca/bat018.PMC3625956.pdf
"Implementation The data collection and integration process, which runsperiodically (typically every 3–5 months) to ensure ongoingaccess to recent updates, culminates in producing an inte-grated relational database ( Figure 6 ).MalaCards uses MySQL (www.mysql.org) with default MyISAM tables, PHP together with CakePHP (cakephp.org), a rapid development PHP framework with elegant MVC (model/view/controller) conventions and the Lucene search engine (http://lucene.apache.org/) powered by Solr (http://lucene.apache.org/solr/).",OADS,/arxiv_data1/oa_pdf/34/ca/bat018.PMC3625956.pdf
Network images were pro- duced using the Gephi toolkit (https://gephi.org/toolkit/).,OADS,/arxiv_data1/oa_pdf/34/ca/bat018.PMC3625956.pdf
"‘Interferon’ or ‘memory’) are entered into a ‘cheat list’ and removed from the system, with suggestions for improvements ticketed in our Bugzilla databases (http://www.bugzilla.",Non-OADS,/arxiv_data1/oa_pdf/34/ca/bat018.PMC3625956.pdf
"We have previously developed the Allele Frequency Net Database(AFND, http://www.allelefrequencies.net), which captures worldwide frequencies of alleles, genes and haplotypes for sev-eral immune genes, including KIR genes, in healthy populations, covering >4 million individuals.",Non-OADS,/arxiv_data1/oa_pdf/b7/37/bat021.PMC3625957.pdf
Database URL: http://www.allelefrequencies.net/diseases/ ............................................................................................................................................................................................................................................................................................. Introduction Natural killer (NK) cells are bone marrow-derived lympho- cytes that play an active role in the innate immune system by interacting with human leucocyte antigen (HLA) class Imolecules to kill pathogen-infected cells ( 1).,Non-OADS,/arxiv_data1/oa_pdf/b7/37/bat021.PMC3625957.pdf
"The KIR and Diseases Database is part of Allele Frequen- cies Net Database, and can be accessed through Allele Fre- quencies Net homepage (http://www.allelefrequencies.net/)using the menu ‘KIR’ and the submenu ‘KIR and disease as-sociations’ or via a direct URL access at http://www.allelefrequencies.net/diseases/.",OADS,/arxiv_data1/oa_pdf/b7/37/bat021.PMC3625957.pdf
"Discussion In our original search for frequency data in AFND in normalpopulations, we sourced publication data from >65 peer- reviewed journals—a complete list of data sets and journals may be consulted at http://www.allelefrequencies.net/datasets.asp.",OADS,/arxiv_data1/oa_pdf/b7/37/bat021.PMC3625957.pdf
Database URL: http://merops.sanger.ac.uk ............................................................................................................................... ............................................................................................................................... ............................... Introduction Enzymes that act on biopolymers are poorly classified in terms of the reactions they catalyse.,OADS,/arxiv_data1/oa_pdf/83/2e/bat022.PMC3625958.pdf
"This is an Open Access article distributed under the terms of the Creative Commons Attribution Non-Commercial License (http://creativecommons.org/licenses/by-nc/3.0), which permits unrestricted non-commercial use, distribution, and reproduction in any medium, provided the original work is properly cited.",Non-OADS,/arxiv_data1/oa_pdf/83/2e/bat022.PMC3625958.pdf
Database URL: http://lysosome.unipg.it/ ............................................................................................................................... ............................................................................................................................... ............................... Introduction Lysosomes are cellular organelles that play a pivotal role in the cell homeostasis through their involvement in degrad-ation and recycling processes of extracellular material that has been internalized by endocytosis and intracellular com- ponents that have been sequestered by autophagy ( 1).,OADS,/arxiv_data1/oa_pdf/91/70/bat024.PMC3625959.pdf
"This is an Open Access article distributed under the terms of the Creative Commons Attribution Non-Commercial License (http://creativecommons.org/licenses/by-nc/3.0/), which permits unrestricted non-commercial use, distribution, and reproduction in any medium, provided the original work is properly cited.",Non-OADS,/arxiv_data1/oa_pdf/91/70/bat024.PMC3625959.pdf
A total of 3mg of RNA was sent for high-throughput pair-end RNA- sequencing to the Norwegian Sequencing Center at the Ullevål Hospital (http://www.sequencing.uio.no/).,OADS,/arxiv_data1/oa_pdf/55/20/leu2012266a.PMC3626019.pdf
The FASTQC software was used for quality control of the raw sequence data (http://www.bioinformatics.babraham.ac.uk/pro-jects/fastqc/).,OADS,/arxiv_data1/oa_pdf/55/20/leu2012266a.PMC3626019.pdf
We used the fusion discovery software FusionMap(release date 16-04-2012) 2and the pre-built Human B37 and RefGene from the FusionMap website (http://www.omicsoft.com/ fusionmap/).,OADS,/arxiv_data1/oa_pdf/55/20/leu2012266a.PMC3626019.pdf
The NFIA gene encodes a member of the NFI family of transcription factors (http://genome.ucsc.edu).,Non-OADS,/arxiv_data1/oa_pdf/55/20/leu2012266a.PMC3626019.pdf
"An analysis of the hypothetical fusions using theBLAST program (http://blast.ncbi.nlm.nih.gov/Blast.cgi) showed inone of the two genes high-sequence identity with several genes and/or numerous repetitive sequences (for example, SINE).",OADS,/arxiv_data1/oa_pdf/55/20/leu2012266a.PMC3626019.pdf
"( e) Schematic overview of the position of the different domains of the NFIA and CBFA2T3 proteins and the NFIA/CBFA2T3 chimeric protein, according to ensembl (http://www.ensembl.org/index.html).Letters to the Editor 981 &2013 Macmillan Publishers Limited Leukemia (2013) 954 – 995",Non-OADS,/arxiv_data1/oa_pdf/55/20/leu2012266a.PMC3626019.pdf
Available from: URL http://cgap.nci.nih.gov/Chromosomes/Mitelman.,OADS,/arxiv_data1/oa_pdf/55/20/leu2012266a.PMC3626019.pdf
"To view a copy of this license, visit http://creativecommons.org/licenses/by-nc-nd/3.0/ Supplementary Information accompanies the paper on the Leukemia website (http://www.nature.com/leu) Mutations of epigenetic regulators and of the spliceosome machinery in therapy-related myeloid neoplasms and in acute leukemias evolved from chronic myeloproliferative diseases Leukemia (2013) 27,982–985; doi:10.1038/leu.2012.267 Therapy-related myeloid neoplasms (t-MN), including acute myeloid leukemias (t-AML) and myelodysplastic syndromes (t-MDS), indicate myeloid disorders developing in patients treated with radiotherapy and/or chemotherapy for canceror autoimmune diseases.",Non-OADS,/arxiv_data1/oa_pdf/55/20/leu2012266a.PMC3626019.pdf
"To view a copy of this license, visit http://creativecommons.org/licenses/by-nc-nd/3.0/How to manage WM C Buske and V Leblond 772 Leukemia (2013) 762 – 772 &2013 Macmillan Publishers Limited",Non-OADS,/arxiv_data1/oa_pdf/8d/17/leu201336a.PMC3626020.pdf
"To view a copy of this license, visit http://creativecommons.org/licenses/by-nc-nd/3.0/ Supplementary Information accompanies the paper on the Leukemia website (http://www.nature.com/leu)Comparison of unirradiated to irradiated white blood cell transfusions EJ Freireich et al 865 &2013 Macmillan Publishers Limited Leukemia (2013) 861 – 865",Non-OADS,/arxiv_data1/oa_pdf/9c/7d/leu2012301a.PMC3626021.pdf
"This is an Open Access article distributed under the terms of the Creative Commons Attribution Non-Commercial License (http://creativecommons.org/licenses/by-nc/3.0/), which permits unrestricted non-commercial use, distribution, and reproduction in any medium, provided the original work is properly cited.",Non-OADS,/arxiv_data1/oa_pdf/bf/3c/bat011.PMC3626023.pdf
"16. http://vega.sanger.ac.uk/Gorilla_gorilla/Location/Chromosome?r= 6-MHC (26 February 2013, date last accessed).",Non-OADS,/arxiv_data1/oa_pdf/bf/3c/bat011.PMC3626023.pdf
"36. http://www.ebi.ac.uk/imgt/hla/stats.html (26 February 2013, date last accessed).",Non-OADS,/arxiv_data1/oa_pdf/bf/3c/bat011.PMC3626023.pdf
"45. http://www.ebi.ac.uk/ipd/mhc/nhp/index.html (26 February 2013, date last accessed).",Non-OADS,/arxiv_data1/oa_pdf/bf/3c/bat011.PMC3626023.pdf
"70. http://vega.sanger.ac.uk/Pan_troglodytes/Info/Index (26 February 2013, date last accessed).",Non-OADS,/arxiv_data1/oa_pdf/bf/3c/bat011.PMC3626023.pdf
"79. http://www.lpzoo.com/ (26 February 2013, date last accessed).80. http://bacpac.chori.org/library.php?id=127 (26 February 2013, date last accessed).",Non-OADS,/arxiv_data1/oa_pdf/bf/3c/bat011.PMC3626023.pdf
"(1996–2010) http://www.repeat masker.org (26 February 2013, date last accessed).",Non-OADS,/arxiv_data1/oa_pdf/bf/3c/bat011.PMC3626023.pdf
"85. http://blast.advbiocomp.com/ (26 February 2013, date last accessed).",Non-OADS,/arxiv_data1/oa_pdf/bf/3c/bat011.PMC3626023.pdf
"90. http://vega.sanger.ac.uk/ (26 February 2013, date last accessed).91. http://www.sanger.ac.uk/research/projects/vertebrategenome/ havana/ (26 February 2013, date last accessed).",Non-OADS,/arxiv_data1/oa_pdf/bf/3c/bat011.PMC3626023.pdf
"To view a copy of this license, visit http://creativecommons.org/licenses/by-nc-nd/3.0/Aerobic training and arterial stiffness in older adults KM Madden et al 339 &2013 Macmillan Publishers Limited Journal of Human Hypertension (2013) 335 – 339",Non-OADS,/arxiv_data1/oa_pdf/79/c7/jhh201238a.PMC3626024.pdf
"Do not distribute.www.landesbioscience.com  Bacteriophage  183Bac teriophage 1:4, 183-187; July–December 2011; © 2011 Landes BioscienceEDitor’s corn Er  EDitor’s caorn Er EDitor’s corn Er http://dx.doi.org/10.4161/bact.1.4.17624 Fig.",Non-OADS,/arxiv_data1/oa_pdf/61/a9/bact-1-183.PMC3626388.pdf
http://dx.doi.org/10.4161/bact.1.4.17625,Non-OADS,/arxiv_data1/oa_pdf/77/fe/bact-1-186.PMC3626389.pdf
"Do not distribute.Bacteriophage 1:4, 228-230; July–December 2011; © 2011 Landes Bioscience Views an D C ommentaries 228 Bac teriophage  V olume 1 i ssue 4Keywords:  mean free path, phage  adsorption, phage therapy Submitted: 06/27/11Accepted: 07/12/11http://dx.doi.org/10.4161/bact.1.4.17281 Correspondence to: Stephen T. Abedon;   Email: abedon.1@osu.eduIt can be difficult to appreciate just  how small bacteria and phages are or  how large, in comparison, the volumes that they occupy.",Non-OADS,/arxiv_data1/oa_pdf/cc/7c/bact-1-228.PMC3626390.pdf
Curr Pharm Biotechnol 2010; 11:58-68; PMID:20214608; http://dx.doi.org/10.2174/138920110790725429 3.,Non-OADS,/arxiv_data1/oa_pdf/cc/7c/bact-1-228.PMC3626390.pdf
Appl Environ Microbiol 2001; 67:4233-41; PMID:11526028; http://dx.doi.org/10.1128/A EM.67.9.4233- 41.2001 5.,Non-OADS,/arxiv_data1/oa_pdf/cc/7c/bact-1-228.PMC3626390.pdf
Curr Pharm Biotechnol 2010; 11:1; PMID:20214603; http://dx.doi.org/10.2174/138920110790725438 9.,Non-OADS,/arxiv_data1/oa_pdf/cc/7c/bact-1-228.PMC3626390.pdf
Bacteriophage 2011; 1:66-85; http://dx.doi.org/10.4161/bact.1.2.15845 10.,Non-OADS,/arxiv_data1/oa_pdf/cc/7c/bact-1-228.PMC3626390.pdf
Bacteriophage 2011; 1:111-4; http://dx.doi.org/10.4161/bact.1.2.14590,Non-OADS,/arxiv_data1/oa_pdf/cc/7c/bact-1-228.PMC3626390.pdf
Available from: http://www.medicines.org.,Non-OADS,/arxiv_data1/oa_pdf/73/b4/40268_2013_Article_3.PMC3627013.pdf
Available from: http://archive.eahp.eu/Media/Home-page/EJHP- BMJ/EJHP-Practice-archive/Issue-2-2007/10th-EAHP-congress-in- Lisbon/Chemical-and-physical-stability-of-diluted-busulfan-infusio n-solutions .,Non-OADS,/arxiv_data1/oa_pdf/73/b4/40268_2013_Article_3.PMC3627013.pdf
Available from: http://www.ema.europa.eu/docs/en_GB/ document_library/Scientiﬁc_guideline/2009/09/WC500002662.pdf .,Non-OADS,/arxiv_data1/oa_pdf/73/b4/40268_2013_Article_3.PMC3627013.pdf
http://www.ema.europa.eu/docs/en_ GB/document_library/EPAR_-_Product_Information/human/001012/WC500053998.pdf .,Non-OADS,/arxiv_data1/oa_pdf/92/6c/40268_2013_Article_8.PMC3627014.pdf
"ICH harmonised tripartite guide- lines for good clinical practice, 1996. http://www.emea.europa.",Non-OADS,/arxiv_data1/oa_pdf/92/6c/40268_2013_Article_8.PMC3627014.pdf
http://www.wma.net/en/30publications/10policies/b3/ .,Non-OADS,/arxiv_data1/oa_pdf/92/6c/40268_2013_Article_8.PMC3627014.pdf
"Guidance for industry:bioanalytical method validation, 2001. http://www.fda.gov/down loads/Drugs/GuidanceComplianceRegulatoryInformation/Guidanc es/ucm070107.pdf .",Non-OADS,/arxiv_data1/oa_pdf/92/6c/40268_2013_Article_8.PMC3627014.pdf
FDAPAC Mar 2006. http://www.fda.gov/ohrms /dockets/ac06/brieﬁng/ 2006-4210b_14_McNeil%20FDA%20PAC%20March%2006%20 Brieﬁng%20Document.pdf .,OADS,/arxiv_data1/oa_pdf/8e/05/40268_2013_Article_9.PMC3627016.pdf
"aHu- man genome database contig map: http://www.ncbi.nlm.nih.gov/ projects/mapview/maps.cgi?taxid=9606&chr=3 bProbe sets to all four contigs along chromosome 3 were designed, synthesized,labeled, and hybridized to normal human fibroblasts following strand-specific pre-treatment; one probe set to the large NT_005612 contig ( green ) and probe sets to the other three contigs (red) are shown170 F.A.",Non-OADS,/arxiv_data1/oa_pdf/4e/92/10577_2013_Article_9345.PMC3627024.pdf
"Rockville: CDER, 2001 May.http://www.fda.gov/downloads/Drugs/GuidanceComplianceRegul atoryInformation/Guidances/ucm070107.pdf .",Non-OADS,/arxiv_data1/oa_pdf/3d/2f/40268_2012_Article_1.PMC3627029.pdf
2012. http://www.fda.gov/ForConsumers/ ConsumerUpdates/ucm107836.htm .,Non-OADS,/arxiv_data1/oa_pdf/63/42/40268_2013_Article_5.PMC3627035.pdf
http://www.acog.org/ */media/Announcements/20111013 MakenaLtr.pdf .,Non-OADS,/arxiv_data1/oa_pdf/63/42/40268_2013_Article_5.PMC3627035.pdf
2012. http://www.nabp.net/government-affairs/model- pharmacy-act-rules .,Non-OADS,/arxiv_data1/oa_pdf/63/42/40268_2013_Article_5.PMC3627035.pdf
2004. http://www.fda.,Non-OADS,/arxiv_data1/oa_pdf/63/42/40268_2013_Article_5.PMC3627035.pdf
2003. http://www.nytimes.com/ 2003/06/08/magazine/the-toxic-pharmacist.html?pagewanted= all&src=pm .,Non-OADS,/arxiv_data1/oa_pdf/63/42/40268_2013_Article_5.PMC3627035.pdf
2012. http://www.nabp.net/government- affairs/model-actrules/ .,Non-OADS,/arxiv_data1/oa_pdf/63/42/40268_2013_Article_5.PMC3627035.pdf
2011. http://issuu.com/mcmahon group/docs/ppn0611_de .,Non-OADS,/arxiv_data1/oa_pdf/63/42/40268_2013_Article_5.PMC3627035.pdf
2011. http://www.ismp.org/newsletters/ acutecare/articles/20110407.asp .,Non-OADS,/arxiv_data1/oa_pdf/63/42/40268_2013_Article_5.PMC3627035.pdf
2009. http://www.hc-sc.gc.ca/dhp-mps/alt_ formats/hpfb-dgpsa/pdf/compli-conform/pol_0051-eng.pdf .,Non-OADS,/arxiv_data1/oa_pdf/63/42/40268_2013_Article_5.PMC3627035.pdf
2001. http://www.fda.,Non-OADS,/arxiv_data1/oa_pdf/63/42/40268_2013_Article_5.PMC3627035.pdf
2012. http://www.fda.gov/Dr ugs/GuidanceComp lianceRegulatoryInformation/PharmacyCompounding/ucm204237.htm .,Non-OADS,/arxiv_data1/oa_pdf/63/42/40268_2013_Article_5.PMC3627035.pdf
FY2006– 2009. http://pr.mo.gov/pharmacists-compounding.asp .,Non-OADS,/arxiv_data1/oa_pdf/63/42/40268_2013_Article_5.PMC3627035.pdf
2010. http://www.tsbp.state.tx.us/ﬁles_pdf/BN/ Nov10/Additions/Tab 24_Compounde d%20Sample%20Testing.,OADS,/arxiv_data1/oa_pdf/63/42/40268_2013_Article_5.PMC3627035.pdf
2012. http://www.fda.gov/newsevents/newsroom/press announcements/ucm310215.htm .,Non-OADS,/arxiv_data1/oa_pdf/63/42/40268_2013_Article_5.PMC3627035.pdf
2003.http://gao.gov/assets/120/110456.pdf .,OADS,/arxiv_data1/oa_pdf/63/42/40268_2013_Article_5.PMC3627035.pdf
2011. http://www.nytimes.com/2011/08 /31/health/31drug.html?ref= avastindrug .,Non-OADS,/arxiv_data1/oa_pdf/63/42/40268_2013_Article_5.PMC3627035.pdf
2011. http://www.nytimes.com/2011/09/02/business/ more-reports-of-avastin-causi ng-blindness.html?_r=1&ref= avastindrug .,Non-OADS,/arxiv_data1/oa_pdf/63/42/40268_2013_Article_5.PMC3627035.pdf
2012. http://www.cdc.gov/HAI/ outbreaks/laboratory/lab_testing_results.html#labresults .,OADS,/arxiv_data1/oa_pdf/63/42/40268_2013_Article_5.PMC3627035.pdf
2012. http://www.fda.gov/downloads/AboutFDA/Centers Ofﬁces/OfﬁceofGlobalRegulator yOperationsandPolicy/ORA/ ORAElectronicReadingRoom/UCM325980.pdf .,OADS,/arxiv_data1/oa_pdf/63/42/40268_2013_Article_5.PMC3627035.pdf
2012. https://secure.pcab.info/about/ downloads/principles-of-compounding.pdf .,Non-OADS,/arxiv_data1/oa_pdf/63/42/40268_2013_Article_5.PMC3627035.pdf
2013. http://www.amednews.com/article/20130211/profession/130219977/2/ .,Non-OADS,/arxiv_data1/oa_pdf/63/42/40268_2013_Article_5.PMC3627035.pdf
2012. http://www.asrs.org/education/compounding- pharmacies-/background .,Non-OADS,/arxiv_data1/oa_pdf/63/42/40268_2013_Article_5.PMC3627035.pdf
http://www.ich.org/ﬁleadmin/Public_ Web_Site/ICH_Products/Guidelines/Efﬁcacy/E6_R1/Step4/E6_ R1__Guideline.pdf .,Non-OADS,/arxiv_data1/oa_pdf/32/14/40268_2012_Article_2.PMC3627046.pdf
http://www.sda.gov.cn/WS01/CL0053/ 24473.html .,OADS,/arxiv_data1/oa_pdf/32/14/40268_2012_Article_2.PMC3627046.pdf
http://www.fda.gov/downloads/Drugs/GuidanceCompliance RegulatoryInformation/Guidances/ucm070107.pdf .,Non-OADS,/arxiv_data1/oa_pdf/32/14/40268_2012_Article_2.PMC3627046.pdf
http://www.cde.org.cn/zdyz.do?,Non-OADS,/arxiv_data1/oa_pdf/32/14/40268_2012_Article_2.PMC3627046.pdf
http://www.fda.gov/downloads/Drugs/ GuidanceComplianceRegulatoryInformation/Guidances/UCM 070124.pdf .,Non-OADS,/arxiv_data1/oa_pdf/32/14/40268_2012_Article_2.PMC3627046.pdf
To viewplease visit the journal online(http://dx.doi.org/10.1136/ jmedgenet-2012-101284).,OADS,/arxiv_data1/oa_pdf/d6/b6/jmedgenet-2012-101284.PMC3627132.pdf
"16 17The IFT80 protein is part of the IFT-B par- t i c l et h a tc o n s i s t so fa tl e a s t1 4p r o t e i n s ,w h i c hi na s s o -ciation with kinesin-2 mo tors drives anterograde transport from the ciliary base to the tip while IFT139, Open Access Scan to access more free content ▸http://dx.doi.org/10.1136/ jmedgenet-2012-101282 Schmidts M, et al.J Med Genet 2013; 50:309 –323.",Non-OADS,/arxiv_data1/oa_pdf/d6/b6/jmedgenet-2012-101284.PMC3627132.pdf
"Variants anno-tated in dbSNP132, the 1000 Genomes project, the Seattleexome database (http://www.evs.gs.washington.edu) or in ourinhouse databases with an allele frequency above 0.5% wereremoved.",OADS,/arxiv_data1/oa_pdf/d6/b6/jmedgenet-2012-101284.PMC3627132.pdf
"An autosomal recessive inheritance model was appliedfor gene identi ﬁcation, with known JATD and SRPS genes manu- ally analysed using the Integrative Genomics Viewer (http://www.broadinstitute.org/igv/).",OADS,/arxiv_data1/oa_pdf/d6/b6/jmedgenet-2012-101284.PMC3627132.pdf
"ncbi.nlm.nih.gov/Omim) ▸University of California, Santa Cruz (UCSC) Genome Browser (http://www.genome.ucsc.edu) ▸The Consensus CDS (CCDS) project (http://www.ncbi.nlm.",OADS,/arxiv_data1/oa_pdf/d6/b6/jmedgenet-2012-101284.PMC3627132.pdf
nih.gov/projects/CCDS/) ▸PLINK (http://pngu.mgh.harvard.edu/~purcell/plink/) Figure 1 Mutations causing Jeune asphyxiating thoracic dystrophy ( JATD).,Non-OADS,/arxiv_data1/oa_pdf/d6/b6/jmedgenet-2012-101284.PMC3627132.pdf
"▸Copy Number Analyzer for Affymetrix GeneChip (http:// www.genome.umin.jp/) ▸GraphPad, Quick Calcs (http://www.graphpad.com/quickcalcs/ chisquared2.cfm) ▸Polyphen2 (http://genetics.bwh.harvard.edu/pph2/) ▸Mutationtaster (http://www.mutationtaster.org/) ▸Sorting intolerant from tolerant (SIFT) (http://sift.jcvi.org/) ▸Genomic evolutionary rate pro ﬁling (GERP) (http://mendel.",Non-OADS,/arxiv_data1/oa_pdf/d6/b6/jmedgenet-2012-101284.PMC3627132.pdf
"stanford.edu/SidowLab/downloads/gerp) ▸PhyloP (http://genome.ucsc.edu) ▸Alamut (http://www.interactive-biosoftware.com/software/ alamut/features) RESULTS DYNC2H1 mutations are a major genetic cause of JATD In total, we detected causative (biallelic) DYNC2H1 mutations in 29/71 patients (41%) from 19/57 families (33%) with JATD.The patient ’s clinical information is provided in table 1, and the detected mutations are summarised in table 2.",OADS,/arxiv_data1/oa_pdf/d6/b6/jmedgenet-2012-101284.PMC3627132.pdf
"rs137853027: Minor allele frequency (EVS) 3 in 11957 alleles (0.00026 or 0.026%) c.3459-1G>A Exon 24 splice acceptor Het Intron 23 SS JATD-3 c.9817C>T p.E3273* Het Exon 62 WES (Agilent 50 Mb) ∼15% of cilia have bulged tips filled with IFTB proteins, normal cilia length c.7442G>A p.R2481Q Het Exon 46 JATD-4 c.1306G>T p.E436* Het Exon 9 WES (Agilent 50 Mb) c.8457A>G p.I2819M Het Exon 53 JATD-5 c.3682C>A p.L1228I Het Exon 25 WES (Nimblegen V.3) rs189806840 (dbSNP) rs137853027: Minor allele frequency (EVS) 16 in 11820 alleles (0.0013 5 or 0.135%) c.7663G>A p.V2555M Het Exon 47c.7718A>G p.Y2573C Het Exon 48 JATD-6 14kb deletion (g.103191405-103204921)p.G3891_Q4020del Het Del exons 81 –83 SNP microarray CNV analysis and SS c.9044A>G p.D3015G Het Exon 57 SS rs137853027 † rs137853027: minor allele frequency (EVS) 3 in 11957 alleles (0.00026 or 0.026%) c.11437C>T p.R3813C Het Exon 79 SS JATD-7 c.10163C>T p.P3388L Het Exon 67 WES (Agilent 50 Mb) c.12480_13556del(g.103325916-103350592)p.N4160_Q4314del Het Del exons 87 –90 Exome CNV analysis JATD-8 c.3719T>C p.I1240T Het Exon 25 WES (Agilent 50 Mb) rs137853028 † rs137853028: not seen in EVS c.12716T>G p.L4239R Het Exon 89 JATD-9 c. 11560T>G p.W3854G Hom Exon 80 HZ mapping (250 K) then SSJATD-10 c.6910G>A p.A2304T Het Exon 43 SS 3 affected sibs c.8389_8397delCCAGCTTTG p.P2797_L2799del Het Exon 52 WES (Agilent 50 Mb) JATD-11 c.195G>T p.T65T Het Exon 1 splice donor WES (Agilent 50 Mb) c.4135A>G p.M1379V Het Exon 27 JATD-12 c.312_313delTA p.P104PfsX*2 Het Exon 2 WES (Agilent 50 Mb) 3 affected sibs c.5972T>A p.M1991K Het Exon 38 JATD-13 c.4325G>A p.G1442D Het Exon 28 WES (Agilent 50 Mb) c.1953G>A p.K651K Het Exon 13 splice donor JATD-14 c.988C>T p.R330C Hom Exon 6 WES (Agilent 50 Mb) 2 affected sibsJATD-15 c. 7594C>T p.R2532W Hom Exon 47 WES (Agilent 50 Mb)JATD-16 c.7437+3A>G Exon 45 splice donor Het Intron 45 WES (Agilent 50 MB) Normal cilia length c.7539A>T p.G2513G Het Exon 46 splice donor JATD-17 c.6679A>G p.M2227V Hom Exon 42 WES (Agilent 50 Mb) c.12538delC p.L4177Ffs*29 Het Exon 87 JATD-18 c.2346-5T>G Exon 17 splice acceptor Het Intron 16 WES (Agilent 50 Mb) 2 affected sibs c.7085A>G p.N2362S Het Exon 43 JATD-19 c.7919T>C p.I2640T Het Exon 49 WES (Agilent 50 Mb) 2 affected sibs c.2612T>C p.L871P Het Exon 18 †Annotated as pathogenic in dbSNP due to previous publication.13EVS, NHLBI Exome Variant Server (http://evs.gs.washington.edu/EVS/).",Non-OADS,/arxiv_data1/oa_pdf/d6/b6/jmedgenet-2012-101284.PMC3627132.pdf
"See: http://creativecommons.org/ licenses/by-nc/3.0/ REFERENCES 1 Jeune M, Beraud C, Carron R. Asphyxiating thoracic dystrophy with familial characteristics.",Non-OADS,/arxiv_data1/oa_pdf/d6/b6/jmedgenet-2012-101284.PMC3627132.pdf
5. http://www.who.int/mediacentre/news/releases/2003/pr27/en/  6.,Non-OADS,/arxiv_data1/oa_pdf/67/6e/WIITM-8-19693.PMC3627156.pdf
"Obesity and overweight, Factsheet N°311, Updated March 2011, Available at: http://www.who.int/mediacentre/factsheets/ fs311/ en/ index.html  3.",Non-OADS,/arxiv_data1/oa_pdf/16/2d/WIITM-8-19719.PMC3627159.pdf
Additional information Supplementary information accompanies this paper at http://www.nature.com/ scientificreports Competing financial interests: The authors declare no competing financial interests.,Non-OADS,/arxiv_data1/oa_pdf/95/0e/srep01660.PMC3627187.pdf
"To view a copy of thislicense, visit http://creativecommons.org/licenses/by-nc-sa/3.0/ How to cite this article: Zhang, M., Zuo, G., Chen, J., Gao, Y.",Non-OADS,/arxiv_data1/oa_pdf/95/0e/srep01660.PMC3627187.pdf
Additional information Supplementary information accompanies this paper at http://www.nature.com/ scientificreports Competing financial interests: The authors declare no competing financial interests.,Non-OADS,/arxiv_data1/oa_pdf/fd/43/srep01666.PMC3627188.pdf
"To view a copy of this license, visit http://creativecommons.org/licenses/by-nc-nd/3.0/ How to cite this article: Hou, P.P.",Non-OADS,/arxiv_data1/oa_pdf/fd/43/srep01666.PMC3627188.pdf
Additional information Supplementary information accompanies this paper at http://www.nature.com/ scientificreportsCompeting financial interests: The authors declare no competing financial interests.,Non-OADS,/arxiv_data1/oa_pdf/ff/36/srep01667.PMC3627189.pdf
"To view a copy of this license, visit http://creativecommons.org/licenses/by-nc-nd/3.0/ How to cite this article: Zhou, H. et al.",Non-OADS,/arxiv_data1/oa_pdf/ff/36/srep01667.PMC3627189.pdf
"The force field parameters for POPC and POPE were taken from the website of Biocomputing laboratory at the University of Calgary (http://moose.bio.ucalgary.ca/index.php?page 5Structures_and_Topologies), and that for POPG was elaborated based on parameters for the two first.",OADS,/arxiv_data1/oa_pdf/ac/fe/srep01678.PMC3627190.pdf
Lipid-II topologies and initial systems coordinates that we have designed and used in this work are available at our website (http://model.nmr.ru/files/lipid-II_bilayers.zip).,OADS,/arxiv_data1/oa_pdf/ac/fe/srep01678.PMC3627190.pdf
"wrote the manuscript, all authors reviewed the manuscript.Additional information Supplementary information accompanies this paper at http://www.nature.com/ scientificreports Competing financial interests: The authors declare no competing financial interests.",Non-OADS,/arxiv_data1/oa_pdf/ac/fe/srep01678.PMC3627190.pdf
"To view a copy of thislicense, visit http://creativecommons.org/licenses/by-nc-sa/3.0/ How to cite this article: Chugunov, A. et al.",Non-OADS,/arxiv_data1/oa_pdf/ac/fe/srep01678.PMC3627190.pdf
Additional information Supplementary information accompanies this paper at http://www.nature.com/ scientificreports Competing financial interests: The authors declare no competing financial interests.,Non-OADS,/arxiv_data1/oa_pdf/87/69/srep01663.PMC3627191.pdf
"To view a copy of thislicense, visit http://creativecommons.org/licenses/by-nc-nd/3.0/ How to cite this article: Dong, R.H., Zhou, L., Wang, D. & Hao, J.C. Sci.",Non-OADS,/arxiv_data1/oa_pdf/87/69/srep01663.PMC3627191.pdf
Additional information Supplementary information accompanies this paper at http://www.nature.com/ scientificreports Competing financial interests: The authors declare no competing financial interests.,Non-OADS,/arxiv_data1/oa_pdf/44/fa/srep01662.PMC3627192.pdf
"To view a copy of thislicense, visit http://creativecommons.org/licenses/by-nc-nd/3.0/ How to cite this article: Ying, Y. et al.",Non-OADS,/arxiv_data1/oa_pdf/44/fa/srep01662.PMC3627192.pdf
"U. S. Securities and Exchange Commision, U.S. Standard Industrial Classification codes, http://www.sec.gov/info/edgar/siccodes.htm (last accessed 22/03/2012).",OADS,/arxiv_data1/oa_pdf/06/76/srep01665.PMC3627193.pdf
"Wharton Research Data Services, https://wrds-web.wharton.upenn.edu/wrds/, CRSP US Stock Database (last accessed 22/03/2012).",OADS,/arxiv_data1/oa_pdf/06/76/srep01665.PMC3627193.pdf
Additional information Supplementary information accompanies this paper at http://www.nature.com/ scientificreports Competing financial interests: The authors declare no competing financial interests.,Non-OADS,/arxiv_data1/oa_pdf/06/76/srep01665.PMC3627193.pdf
"To view a copy of this license, visit http://creativecommons.org/licenses/by-nc-nd/3.0/ How to cite this article: Pozzi, F., Di Matteo, T. & Aste, T. Spread of risk across financial markets: better to invest in the peripheries.",Non-OADS,/arxiv_data1/oa_pdf/06/76/srep01665.PMC3627193.pdf
"To begin to explore the role of protein palmitoylation in adipocytes, *Correspondence to: Keyong Du; Email: kdu@tuftsmedicalcenter.org Submitted: 08/14/12; Revised: 09/07/12; Accepted: 09/07/12 http://dx.doi.org/10.4161/adip.22117RESEARCH PAPER Adipocyte 2:1, 17 –27; January/February/March 2013; G2013 Landes Bioscience www.landesbioscience.com Adipocyte 17",Non-OADS,/arxiv_data1/oa_pdf/e6/ae/adip-2-17.PMC3627377.pdf
Curr Opin Cell Biol 1997; 9:148-54; PMID: 9069258; http://dx.doi.org/10.1016/S0955-0674(97) 80056-7 2.,OADS,/arxiv_data1/oa_pdf/e6/ae/adip-2-17.PMC3627377.pdf
Biochim Biophys Acta 1999; 1451:1-16; PMID:10446384; http://dx.doi.org/10.1016/S0167- 4889(99)00075-0 4.,OADS,/arxiv_data1/oa_pdf/e6/ae/adip-2-17.PMC3627377.pdf
Prog Lipid Res 2009; 48:117-27; PMID: 19233228; http://dx.doi.org/10.1016/j.plipres.2009.,OADS,/arxiv_data1/oa_pdf/e6/ae/adip-2-17.PMC3627377.pdf
Physiol Rev 2004; 84:623-47; PMID:15044684; http://dx.doi.org/10.1152/physrev.,Non-OADS,/arxiv_data1/oa_pdf/e6/ae/adip-2-17.PMC3627377.pdf
Physiol Rev 2007; 87:507-20; PMID:17429039; http://dx.doi.org/10.1152/physrev.00024.2006 9.,Non-OADS,/arxiv_data1/oa_pdf/e6/ae/adip-2-17.PMC3627377.pdf
Mol Cell Endocrinol 2010; 316:129- 39; PMID:19723556; http://dx.doi.org/10.1016/j.,OADS,/arxiv_data1/oa_pdf/e6/ae/adip-2-17.PMC3627377.pdf
Mol Med 2008; 14:741-51; PMID:19009016; http://dx.doi.org/10.,Non-OADS,/arxiv_data1/oa_pdf/e6/ae/adip-2-17.PMC3627377.pdf
Trends Endocrinol Metab 2011; 22:325-32; PMID: 21561789; http://dx.doi.org/10.1016/j.tem.2011.03.,OADS,/arxiv_data1/oa_pdf/e6/ae/adip-2-17.PMC3627377.pdf
J Lipid Res 2011; 52:393-8; PMID:21044946; http://dx.doi.org/ 10.1194/jlr.D011106 14.,Non-OADS,/arxiv_data1/oa_pdf/e6/ae/adip-2-17.PMC3627377.pdf
J Biol Chem 2004; 279:41168-78; PMID:15262990; http://dx.doi.org/10.,OADS,/arxiv_data1/oa_pdf/e6/ae/adip-2-17.PMC3627377.pdf
J Cell Biol 2009; 186:7-9; PMID:19596846; http://dx.doi.org/10.1083/jcb.,OADS,/arxiv_data1/oa_pdf/e6/ae/adip-2-17.PMC3627377.pdf
J Biol Chem 2012; 287:523-30; PMID: 22081607; http://dx.doi.org/10.1074/jbc.M111.,OADS,/arxiv_data1/oa_pdf/e6/ae/adip-2-17.PMC3627377.pdf
Neuron 2004; 44:977-86; PMID:15603740; http://dx.doi.org/10.,OADS,/arxiv_data1/oa_pdf/e6/ae/adip-2-17.PMC3627377.pdf
J Biol Chem 1996; 271:11541-7; PMID:8626715; http://dx.doi.org/10.1074/jbc.271.19.11541 20.,Non-OADS,/arxiv_data1/oa_pdf/e6/ae/adip-2-17.PMC3627377.pdf
J Biol Chem 2003; 278:19309-16; PMID:12642592; http://dx.doi.org/10.,OADS,/arxiv_data1/oa_pdf/e6/ae/adip-2-17.PMC3627377.pdf
J Biol Chem 2010; 285:24629-38; PMID:20519516; http://dx.doi.org/10.1074/jbc.M110.119289 24.,OADS,/arxiv_data1/oa_pdf/e6/ae/adip-2-17.PMC3627377.pdf
J Neurosci 2010; 30:10784-98; PMID:20702708; http://dx.doi.org/10.1523/JNEUROSCI.0297-10.,Non-OADS,/arxiv_data1/oa_pdf/e6/ae/adip-2-17.PMC3627377.pdf
J Biol Chem 2009; 284:9994- 10003; PMID:19211550; http://dx.doi.org/10.1074/ jbc.M900724200 29.,OADS,/arxiv_data1/oa_pdf/e6/ae/adip-2-17.PMC3627377.pdf
Biochem Biophys Res Commun 1997; 239:650-4; PMID:9367822; http://dx.doi.org/10.1006/bbrc.1997.,OADS,/arxiv_data1/oa_pdf/e6/ae/adip-2-17.PMC3627377.pdf
Traffic 2011; 12:672-81; PMID:21401839; http://dx.doi.org/10.1111/j.1600- 0854.2011.01178.x 31.,OADS,/arxiv_data1/oa_pdf/e6/ae/adip-2-17.PMC3627377.pdf
Traffic 2011; 12:665-71; PMID:21306486; http://dx.doi.org/10.1111/j.1600- 0854.2011.01175.x 32.,OADS,/arxiv_data1/oa_pdf/e6/ae/adip-2-17.PMC3627377.pdf
Mol Cell Biol 2000; 20: 2475-87; PMID:10713171; http://dx.doi.org/10.,OADS,/arxiv_data1/oa_pdf/e6/ae/adip-2-17.PMC3627377.pdf
Biochem Biophys Res Commun 1999; 259: 533-8; PMID:10364453; http://dx.doi.org/10.1006/ bbrc.1999.0811 34.,OADS,/arxiv_data1/oa_pdf/e6/ae/adip-2-17.PMC3627377.pdf
Trends Biochem Sci 2006; 31:215-22; PMID:16540333; http://dx.doi.org/10.1016/j.tibs.2006.02.007 37.,OADS,/arxiv_data1/oa_pdf/e6/ae/adip-2-17.PMC3627377.pdf
Cell Metab 2007; 5:47-57; PMID:17189206; http://dx.doi.org/10.1016/ j.cmet.2006.11.013 38.,OADS,/arxiv_data1/oa_pdf/e6/ae/adip-2-17.PMC3627377.pdf
Biochem J 2001; 354:275-83; PMID:11171104; http://dx.doi.org/10.1042/0264-6021:3540275 39.,Non-OADS,/arxiv_data1/oa_pdf/e6/ae/adip-2-17.PMC3627377.pdf
J Biol Chem 2004; 279:35486-93; PMID:15123646; http://dx.doi.org/10.1074/jbc.M404202200 42.,OADS,/arxiv_data1/oa_pdf/e6/ae/adip-2-17.PMC3627377.pdf
J Biol Chem 2006; 281:38930-40; PMID:17052978; http://dx.doi.org/10.1074/jbc.M607524200 43.,OADS,/arxiv_data1/oa_pdf/e6/ae/adip-2-17.PMC3627377.pdf
J Biol Chem 2006; 281:4024- 34; PMID:16286453; http://dx.doi.org/10.1074/jbc.,OADS,/arxiv_data1/oa_pdf/e6/ae/adip-2-17.PMC3627377.pdf
EMBO J 2003; 22: 537-47; PMID:12554654; http://dx.doi.org/10.1093/ emboj/cdg038 45.,Non-OADS,/arxiv_data1/oa_pdf/e6/ae/adip-2-17.PMC3627377.pdf
J Biol Chem 2002; 277:12067-74; PMID:11815625; http://dx.doi.org/10.1074/jbc.M20001820046.,OADS,/arxiv_data1/oa_pdf/e6/ae/adip-2-17.PMC3627377.pdf
Endocrinology 2004; 145:613-9; PMID:14563701; http://dx.doi.org/10.,Non-OADS,/arxiv_data1/oa_pdf/e6/ae/adip-2-17.PMC3627377.pdf
Nat Methods 2009; 6:135-8; PMID:19137006; http://dx.doi.org/10.1038/ nmeth.1293 48.,OADS,/arxiv_data1/oa_pdf/e6/ae/adip-2-17.PMC3627377.pdf
J Lipid Res 2010; 51:1566-80; PMID:20028662; http://dx.doi.,OADS,/arxiv_data1/oa_pdf/e6/ae/adip-2-17.PMC3627377.pdf
"This is an Open Access article distributed under the terms of the Creative Commons Attribution Non-Commercial License (http://creativecommons.or g/licenses/ by-nc/3.0/), which permits unrestricted non-commercial use, distribution, and reproduction in any medium, provided the original work is properly cited.",Non-OADS,/arxiv_data1/oa_pdf/dd/70/gkt002.PMC3627562.pdf
"This is an Open Access article distributed under the terms of the Creative Commons Attribution Non-Commercial License (http://creativecommons.or g/licenses/ by-nc/3.0/), which permits unrestricted non-commercial use, distribution, and reproduction in any medium, provided the original work is properly cited.",Non-OADS,/arxiv_data1/oa_pdf/88/b6/gkt003.PMC3627563.pdf
The ‘ co-phylog ’ package is available at http://humpopgenfudan.cn/resources/softwares/CO-phylog.tar.gz.,OADS,/arxiv_data1/oa_pdf/88/b6/gkt003.PMC3627563.pdf
"Two other phylogenomictools, CVtree (http://tlife.fudan.edu.cn/cvtree/) and Kr (22) (http://guanine.evolbio.mpg.de/kr2/) were also usedto build trees, and the trees’ accuracies were evaluated in the same way.",OADS,/arxiv_data1/oa_pdf/88/b6/gkt003.PMC3627563.pdf
The symmetric differences were evaluated using the ‘treedist’ program that is contained in the PHYLIPpackage (http://evolution.gs.washington.edu/phylip.html).,OADS,/arxiv_data1/oa_pdf/88/b6/gkt003.PMC3627563.pdf
This alignment was previously produced by the MSA tool progressiveMauve (24) (http://gel.ahabs.wisc.edu/mauve/).,OADS,/arxiv_data1/oa_pdf/88/b6/gkt003.PMC3627563.pdf
"For each organism, we ﬁrst retrieved it s 16S rDNA sequence using the ‘Browsers’ on the Ribosomal Da tabase Project (http://rdp .cme.msu.edu/index.jsp) webs i t e ,a n dt h e nc r e a t e dM S Ao f these 16S rDNAs and built a tree using the ‘Tree Builder’ tools (http://rdp.cme.msu.edu/treebuilderpub/index.jsp) (25).",OADS,/arxiv_data1/oa_pdf/88/b6/gkt003.PMC3627563.pdf
"We there- fore explored the proper value range of Fusing simulated NGS data with sequencing qualities, which were generated using the tool ‘Maq simulation’ in the MAQ package (http://maq.sourceforge.net/).",OADS,/arxiv_data1/oa_pdf/88/b6/gkt003.PMC3627563.pdf
"This is an Open Access article distributed under the terms of the Creative Commons Attribution Non-Commercial License (http://creativecommons.or g/licenses/ by-nc/3.0/), which permits unrestricted non-commercial use, distribution, and reproduction in any medium, provided the original work is properly cited.",Non-OADS,/arxiv_data1/oa_pdf/08/d4/gkt004.PMC3627564.pdf
"This is an Open Access article distributed under the terms of the Creative Commons Attribution Non-Commercial License (http://creativecommons.or g/licenses/ by-nc/3.0/), which permits unrestricted non-commercial use, distribution, and reproduction in any medium, provided the original work is properly cited.",Non-OADS,/arxiv_data1/oa_pdf/68/b6/gkt005.PMC3627565.pdf
It can be downloaded from http://www.seqan.de/projects/masai.,Non-OADS,/arxiv_data1/oa_pdf/68/b6/gkt005.PMC3627565.pdf
"The source code is distributed under the BSD license, andbinaries for Linux, Mac OS X and Windows can be freelydownloaded from http://www.seqan.de/projects/masai.",OADS,/arxiv_data1/oa_pdf/68/b6/gkt005.PMC3627565.pdf
"This is an Open Access article distributed under the terms of the Creative Commons Attribution Non-Commercial License (http://creativecommons.or g/licenses/ by-nc/3.0/), which permits unrestricted non-commercial use, distribution, and reproduction in any medium, provided the original work is properly cited.",Non-OADS,/arxiv_data1/oa_pdf/3a/eb/gkt028.PMC3627566.pdf
"This is an Open Access article distributed under the terms of the Creative Commons Attribution Non-Commercial License (http://creativecommons.or g/licenses/ by-nc/3.0/), which permits unrestricted non-commercial use, distribution, and reproduction in any medium, provided the original work is properly cited.",Non-OADS,/arxiv_data1/oa_pdf/95/23/gkt031.PMC3627567.pdf
"This is an Open Access article distributed under the terms of the Creative Commons Attribution Non-Commercial License (http://creativecommons.or g/licenses/ by-nc/3.0/), which permits unrestricted non-commercial use, distribution, and reproduction in any medium, provided the original work is properly cited.",Non-OADS,/arxiv_data1/oa_pdf/35/f6/gkt048.PMC3627568.pdf
"The Galaxy metaserver (https://main.g2.bx.psu.edu) was used to ‘fetch’ the closest non-overlapping feature for every interval, ‘sub- tract’ intervals present in the ab initio and Agilent 44K oligonucleotide sets and determine the base ‘coverage’ ofall intervals.",OADS,/arxiv_data1/oa_pdf/35/f6/gkt048.PMC3627568.pdf
"(2010) Use of array genomic hybridization technology in constitutional genetic diagnosis in Canada, CCMG epub http://www.ccmg-ccgm.org/policies_guidelines.php.",Non-OADS,/arxiv_data1/oa_pdf/35/f6/gkt048.PMC3627568.pdf
"This is an Open Access article distributed under the terms of the Creative Commons Attribution Non-Commercial License (http://creativecommons.or g/licenses/ by-nc/3.0/), which permits unrestricted non-commercial use, distribution, and reproduction in any medium, provided the original work is properly cited.",Non-OADS,/arxiv_data1/oa_pdf/69/61/gkt054.PMC3627569.pdf
(2011) http://www.broadinstitute.org/gsea/doc/ GSEAUserGuideFrame.html.,Non-OADS,/arxiv_data1/oa_pdf/69/61/gkt054.PMC3627569.pdf
"This is an Open Access article distributed under the terms of the Creative Commons Attribution Non-Commercial License (http://creativecommons.or g/licenses/ by-nc/3.0/), which permits unrestricted non-commercial use, distribution, and reproduction in any medium, provided the original work is properly cited.",Non-OADS,/arxiv_data1/oa_pdf/4b/fb/gkt069.PMC3627570.pdf
The computation was done using MatrixEQTL software (19) and R (http://www.r-project.org/) on ahigh performance linux-based computer cluster.,OADS,/arxiv_data1/oa_pdf/4b/fb/gkt069.PMC3627570.pdf
A user-friendly implementation (PiP Finder) is available at http://bit.ly/pipﬁnder using the ﬁnal variation set deﬁnedhere.,OADS,/arxiv_data1/oa_pdf/4b/fb/gkt069.PMC3627570.pdf
"We have also written a web tool, PiP Finder(http://bit.ly/pipﬁnder), to provide researchers with aneasy-to-use interface to identify this issue in any given eQTL signal.",OADS,/arxiv_data1/oa_pdf/4b/fb/gkt069.PMC3627570.pdf
"This is an Open Access article distributed under the terms of the Creative Commons Attribution Non-Commercial License (http://creativecommons.or g/licenses/ by-nc/3.0/), which permits unrestricted non-commercial use, distribution, and reproduction in any medium, provided the original work is properly cited.",Non-OADS,/arxiv_data1/oa_pdf/d0/98/gkt075.PMC3627571.pdf
"This is an Open Access article distributed under the terms of the Creative Commons Attribution Non-Commercial License (http://creativecommons.or g/licenses/ by-nc/3.0/), which permits unrestricted non-commercial use, distribution, and reproduction in any medium, provided the original work is properly cited.",Non-OADS,/arxiv_data1/oa_pdf/5d/38/gkt077.PMC3627572.pdf
"This is an Open Access article distributed under the terms of the Creative Commons Attribution Non-Commercial License (http://creativecommons.or g/licenses/ by-nc/3.0/), which permits unrestricted non-commercial use, distribution, and reproduction in any medium, provided the original work is properly cited.",Non-OADS,/arxiv_data1/oa_pdf/a1/f5/gkt080.PMC3627573.pdf
"This is an Open Access article distributed under the terms of the Creative Commons Attribution Non-Commercial License (http://creativecommons.or g/licenses/ by-nc/3.0/), which permits unrestricted non-commercial use, distribution, and reproduction in any medium, provided the original work is properly cited.",Non-OADS,/arxiv_data1/oa_pdf/c8/df/gkt081.PMC3627574.pdf
"This is an Open Access article distributed under the terms of the Creative Commons Attribution Non-Commercial License (http://creativecommons.or g/licenses/ by-nc/3.0/), which permits unrestricted non-commercial use, distribution, and reproduction in any medium, provided the original work is properly cited.",Non-OADS,/arxiv_data1/oa_pdf/3e/1c/gkt082.PMC3627575.pdf
"This is an Open Access article distributed under the terms of the Creative Commons Attribution Non-Commercial License (http://creativecommons.or g/licenses/ by-nc/3.0/), which permits unrestricted non-commercial use, distribution, and reproduction in any medium, provided the original work is properly cited.",Non-OADS,/arxiv_data1/oa_pdf/07/87/gkt083.PMC3627576.pdf
"This is an Open Access article distributed under the terms of the Creative Commons Attribution Non-Commercial License (http://creativecommons.or g/licenses/ by-nc/3.0/), which permits unrestricted non-commercial use, distribution, and reproduction in any medium, provided the original work is properly cited.",Non-OADS,/arxiv_data1/oa_pdf/cf/83/gkt084.PMC3627577.pdf
"This is an Open Access article distributed under the terms of the Creative Commons Attribution Non-Commercial License (http://creativecommons.or g/licenses/ by-nc/3.0/), which permits unrestricted non-commercial use, distribution, and reproduction in any medium, provided the original work is properly cited.",Non-OADS,/arxiv_data1/oa_pdf/ce/4f/gkt085.PMC3627578.pdf
"This is an Open Access article distributed under the terms of the Creative Commons Attribution Non-Commercial License (http://creativecommons.or g/licenses/ by-nc/3.0/), which permits unrestricted non-commercial use, distribution, and reproduction in any medium, provided the original work is properly cited.",Non-OADS,/arxiv_data1/oa_pdf/f0/bc/gkt086.PMC3627579.pdf
"This is an Open Access article distributed under the terms of the Creative Commons Attribution Non-Commercial License (http://creativecommons.or g/licenses/ by-nc/3.0/), which permits unrestricted non-commercial use, distribution, and reproduction in any medium, provided the original work is properly cited.",Non-OADS,/arxiv_data1/oa_pdf/03/ff/gkt087.PMC3627580.pdf
Microarray data have been submitted to the ArrayExpress database (http://www.ebi.,OADS,/arxiv_data1/oa_pdf/03/ff/gkt087.PMC3627580.pdf
ACCESSION NUMBERS The microarray data from this publication have been submitted to the ArrayExpress database (http://www.ebi.ac.uk/arrayexpress/) and assigned the identiﬁerE-MTAB-1234.,OADS,/arxiv_data1/oa_pdf/03/ff/gkt087.PMC3627580.pdf
"This is an Open Access article distributed under the terms of the Creative Commons Attribution Non-Commercial License (http://creativecommons.or g/licenses/ by-nc/3.0/), which permits unrestricted non-commercial use, distribution, and reproduction in any medium, provided the original work is properly cited.",Non-OADS,/arxiv_data1/oa_pdf/bd/f0/gkt088.PMC3627581.pdf
RNA-seq data were submitted to the Gene Expression Omnibus database and assigned the identiﬁer GSE39263.Data access Data from this study were submitted to the NCBI Gene Expression Omnibus (http://www.ncbi.nlm.nih.gov/geo)under accession number GSE39263.,OADS,/arxiv_data1/oa_pdf/bd/f0/gkt088.PMC3627581.pdf
"This is an Open Access article distributed under the terms of the Creative Commons Attribution Non-Commercial License (http://creativecommons.or g/licenses/ by-nc/3.0/), which permits unrestricted non-commercial use, distribution, and reproduction in any medium, provided the original work is properly cited.",Non-OADS,/arxiv_data1/oa_pdf/a8/14/gkt090.PMC3627582.pdf
"Assuming mild restrictions on the shape and scale differences between two Gamma-distributed random variables, their sum can be modelled as approximately Gamma-distributed as well (http://ideas.repec.org/p/dgr/kubcen/200770.html).",Non-OADS,/arxiv_data1/oa_pdf/a8/14/gkt090.PMC3627582.pdf
"This is an Open Access article distributed under the terms of the Creative Commons Attribution Non-Commercial License (http://creativecommons.or g/licenses/ by-nc/3.0/), which permits unrestricted non-commercial use, distribution, and reproduction in any medium, provided the original work is properly cited.",Non-OADS,/arxiv_data1/oa_pdf/93/9d/gkt091.PMC3627583.pdf
"This is an Open Access article distributed under the terms of the Creative Commons Attribution Non-Commercial License (http://creativecommons.or g/licenses/ by-nc/3.0/), which permits unrestricted non-commercial use, distribution, and reproduction in any medium, provided the original work is properly cited.",Non-OADS,/arxiv_data1/oa_pdf/41/1f/gkt092.PMC3627584.pdf
"This is an Open Access article distributed under the terms of the Creative Commons Attribution Non-Commercial License (http://creativecommons.or g/licenses/ by-nc/3.0/), which permits unrestricted non-commercial use, distribution, and reproduction in any medium, provided the original work is properly cited.",Non-OADS,/arxiv_data1/oa_pdf/51/8a/gkt093.PMC3627585.pdf
"This is an Open Access article distributed under the terms of the Creative Commons Attribution Non-Commercial License (http://creativecommons.or g/licenses/ by-nc/3.0/), which permits unrestricted non-commercial use, distribution, and reproduction in any medium, provided the original work is properly cited.",Non-OADS,/arxiv_data1/oa_pdf/f9/12/gkt094.PMC3627586.pdf
"This is an Open Access article distributed under the terms of the Creative Commons Attribution Non-Commercial License (http://creativecommons.or g/licenses/ by-nc/3.0/), which permits unrestricted non-commercial use, distribution, and reproduction in any medium, provided the original work is properly cited.",Non-OADS,/arxiv_data1/oa_pdf/88/8d/gkt095.PMC3627587.pdf
"This is an Open Access article distributed under the terms of the Creative Commons Attribution Non-Commercial License (http://creativecommons.or g/licenses/ by-nc/3.0/), which permits unrestricted non-commercial use, distribution, and reproduction in any medium, provided the original work is properly cited.",Non-OADS,/arxiv_data1/oa_pdf/43/46/gkt096.PMC3627588.pdf
"Yeast and bacterial transform-ations, yeast DNA and plasmid DNA preparation, curing of the 2-micron plasmid from [Cir +] strains, culturing of yeast and bacteria and other general procedures wereperformed by following protocols listed on the Jayaram laboratory web page (http://www.sbs.utexas.edu/jayaram/ jayaramlab_ﬁles/Protocols.htm).",OADS,/arxiv_data1/oa_pdf/43/46/gkt096.PMC3627588.pdf
"This is an Open Access article distributed under the terms of the Creative Commons Attribution Non-Commercial License (http://creativecommons.or g/licenses/ by-nc/3.0/), which permits unrestricted non-commercial use, distribution, and reproduction in any medium, provided the original work is properly cited.",Non-OADS,/arxiv_data1/oa_pdf/cc/ea/gkt097.PMC3627589.pdf
"Genomic sequences of the genes in C. elegans , Caenorhabditis brenneri ,Caenorhabditis briggsae , Caenorhabditis japonica andCaenorhabditis remanei were extracted from Wormbase (http://www.wormbase.org/).",OADS,/arxiv_data1/oa_pdf/cc/ea/gkt097.PMC3627589.pdf
Sequence logos were generated by using WebLogo (44) at http://weblogo.threeplusone.,OADS,/arxiv_data1/oa_pdf/cc/ea/gkt097.PMC3627589.pdf
"This is an Open Access article distributed under the terms of the Creative Commons Attribution Non-Commercial License (http://creativecommons.or g/licenses/ by-nc/3.0/), which permits unrestricted non-commercial use, distribution, and reproduction in any medium, provided the original work is properly cited.",Non-OADS,/arxiv_data1/oa_pdf/9d/71/gkt098.PMC3627590.pdf
"This is an Open Access article distributed under the terms of the Creative Commons Attribution Non-Commercial License (http://creativecommons.or g/licenses/ by-nc/3.0/), which permits unrestricted non-commercial use, distribution, and reproduction in any medium, provided the original work is properly cited.",Non-OADS,/arxiv_data1/oa_pdf/f7/eb/gkt099.PMC3627591.pdf
"This is an Open Access article distributed under the terms of the Creative Commons Attribution Non-Commercial License (http://creativecommons.or g/licenses/ by-nc/3.0/), which permits unrestricted non-commercial use, distribution, and reproduction in any medium, provided the original work is properly cited.",Non-OADS,/arxiv_data1/oa_pdf/f3/67/gkt100.PMC3627592.pdf
"This is an Open Access article distributed under the terms of the Creative Commons Attribution Non-Commercial License (http://creativecommons.or g/licenses/ by-nc/3.0/), which permits unrestricted non-commercial use, distribution, and reproduction in any medium, provided the original work is properly cited.",Non-OADS,/arxiv_data1/oa_pdf/3b/f3/gkt101.PMC3627593.pdf
"To do this, CompaRNA queries the Rfam (59) online search engine (http://rfam.sanger.ac.uk/search/) with a target RNA sequence.",OADS,/arxiv_data1/oa_pdf/3b/f3/gkt101.PMC3627593.pdf
CompaRNA relies on the automatic classiﬁcation of RNAs into Rfam families by the Rfam (59) online search engine (http://rfam.sanger.ac.uk/ search).,OADS,/arxiv_data1/oa_pdf/3b/f3/gkt101.PMC3627593.pdf
CompaRNA is available on two mirrors on the Internet: http://comparna.amu.edu.pl/ and http://iimcb.genesilico.pl/comparna/.,OADS,/arxiv_data1/oa_pdf/3b/f3/gkt101.PMC3627593.pdf
"This is an Open Access article distributed under the terms of the Creative Commons Attribution Non-Commercial License (http://creativecommons.or g/licenses/ by-nc/3.0/), which permits unrestricted non-commercial use, distribution, and reproduction in any medium, provided the original work is properly cited.",Non-OADS,/arxiv_data1/oa_pdf/6b/d8/gkt102.PMC3627594.pdf
"This is an Open Access article distributed under the terms of the Creative Commons Attribution Non-Commercial License (http://creativecommons.or g/licenses/ by-nc/3.0/), which permits unrestricted non-commercial use, distribution, and reproduction in any medium, provided the original work is properly cited.",Non-OADS,/arxiv_data1/oa_pdf/4d/bf/gkt103.PMC3627595.pdf
"Molar extinction coefﬁcient was determined using a nearest neighbour approximation (http://www.idtdna.com/analyzer/Applications/OligoAnalyzer), and the calculated molar extinction coefﬁcients of these oligo- nucleotides were listed in Table 1.",OADS,/arxiv_data1/oa_pdf/4d/bf/gkt103.PMC3627595.pdf
"This is an Open Access article distributed under the terms of the Creative Commons Attribution Non-Commercial License (http://creativecommons.or g/licenses/ by-nc/3.0/), which permits unrestricted non-commercial use, distribution, and reproduction in any medium, provided the original work is properly cited.",Non-OADS,/arxiv_data1/oa_pdf/0a/94/gkt104.PMC3627596.pdf
The identiﬁers for the 107 proteins from Table 1 were entered into the STRING database (http://string.embl.de) (33).,OADS,/arxiv_data1/oa_pdf/0a/94/gkt104.PMC3627596.pdf
"This is an Open Access article distributed under the terms of the Creative Commons Attribution Non-Commercial License (http://creativecommons.or g/licenses/ by-nc/3.0/), which permits unrestricted non-commercial use, distribution, and reproduction in any medium, provided the original work is properly cited.",Non-OADS,/arxiv_data1/oa_pdf/f0/8e/gkt125.PMC3627597.pdf
"To overcome this problem, we propose a novel method, Empirical Bayesian mutation Calling(https://github.com/friend1ws/EBCall), for detectingsomatic mutations.",Non-OADS,/arxiv_data1/oa_pdf/d3/e7/gkt126.PMC3627598.pdf
"This is an Open Access article distributed under the terms of the Creative Commons Attribution Non-Commercial License (http://creativecommons.or g/licenses/ by-nc/3.0/), which permits unrestricted non-commercial use, distribution, and reproduction in any medium, provided the original work is properly cited.",Non-OADS,/arxiv_data1/oa_pdf/d3/e7/gkt126.PMC3627598.pdf
Polymerase chain reaction (PCR) duplicationswere eliminated using Picard (http://picard.sourceforge.net/).,Non-OADS,/arxiv_data1/oa_pdf/d3/e7/gkt126.PMC3627598.pdf
"This is an Open Access article distributed under the terms of the Creative Commons Attribution Non-Commercial License (http://creativecommons.or g/licenses/ by-nc/3.0/), which permits unrestricted non-commercial use, distribution, and reproduction in any medium, provided the original work is properly cited.",Non-OADS,/arxiv_data1/oa_pdf/42/1c/gkt127.PMC3627599.pdf
"This is an Open Access article distributed under the terms of the Creative Commons Attribution Non-Commercial License (http://creativecommons.or g/licenses/ by-nc/3.0/), which permits unrestricted non-commercial use, distribution, and reproduction in any medium, provided the original work is properly cited.",Non-OADS,/arxiv_data1/oa_pdf/d1/ae/gkt128.PMC3627600.pdf
"This is an Open Access article distributed under the terms of the Creative Commons Attribution Non-Commercial License (http://creativecommons.or g/licenses/ by-nc/3.0/), which permits unrestricted non-commercial use, distribution, and reproduction in any medium, provided the original work is properly cited.",Non-OADS,/arxiv_data1/oa_pdf/3a/fe/gkt129.PMC3627601.pdf
"This is an Open Access article distributed under the terms of the Creative Commons Attribution Non-Commercial License (http://creativecommons.or g/licenses/ by-nc/3.0/), which permits unrestricted non-commercial use, distribution, and reproduction in any medium, provided the original work is properly cited.",Non-OADS,/arxiv_data1/oa_pdf/76/5b/gkt130.PMC3627602.pdf
"Protein recovery was evaluated by gel analysis by ImageJ software, available free online at the NIH website(http://rsb.info.nih.gov/).4094 Nucleic Acids Research, 2013, Vol.",OADS,/arxiv_data1/oa_pdf/76/5b/gkt130.PMC3627602.pdf
"This is an Open Access article distributed under the terms of the Creative Commons Attribution Non-Commercial License (http://creativecommons.or g/licenses/ by-nc/3.0/), which permits unrestricted non-commercial use, distribution, and reproduction in any medium, provided the original work is properly cited.",Non-OADS,/arxiv_data1/oa_pdf/47/f5/gkt131.PMC3627603.pdf
"This is an Open Access article distributed under the terms of the Creative Commons Attribution Non-Commercial License (http://creativecommons.or g/licenses/ by-nc/3.0/), which permits unrestricted non-commercial use, distribution, and reproduction in any medium, provided the original work is properly cited.",Non-OADS,/arxiv_data1/oa_pdf/e4/1d/gkt132.PMC3627604.pdf
"7102’’ color = 5 20 198 autoScale = on visibility = 2 viewLimits = 1:500 bigDataUrl=http://ucscdatahosting.com/labuser/Tech_Support/rep123.uhr.7102.bw’ in a usertrack window of the UCSC genome browser at http://genome.ucsc.edu/cgi-bin/hgCustom?hgsid=322010991: RT-PCR-transcript validation Remaining total RNA from Sp_D62[Tt], Sp_D64[Tt] and Sp_D66 were reverse-transcribed using SuperScriptIII(Invitrogen, Carlsbad, CA, USA) with either oligo(dT) (Sp_D62 and Sp_D64 [Tt]) or gene-speciﬁc primers (Sp_D66 [Tt]) then ampliﬁed with HotStarTaq (Qiagen,Valencia, CA, USA), as described (28).",OADS,/arxiv_data1/oa_pdf/e4/1d/gkt132.PMC3627604.pdf
"This is an Open Access article distributed under the terms of the Creative Commons Attribution Non-Commercial License (http://creativecommons.or g/licenses/ by-nc/3.0/), which permits unrestricted non-commercial use, distribution, and reproduction in any medium, provided the original work is properly cited.",Non-OADS,/arxiv_data1/oa_pdf/b3/0b/gkt133.PMC3627605.pdf
"This is an Open Access article distributed under the terms of the Creative Commons Attribution Non-Commercial License (http://creativecommons.or g/licenses/ by-nc/3.0/), which permits unrestricted non-commercial use, distribution, and reproduction in any medium, provided the original work is properly cited.",Non-OADS,/arxiv_data1/oa_pdf/43/92/gkt134.PMC3627606.pdf
"However, we wondered whether IR might induce additional FHA-dependent interactionsbetween these proteins, as PARP3 is predicted to have PIKK consensus sites of threonine phosphorylation (http://scansite.mit.edu/).",Non-OADS,/arxiv_data1/oa_pdf/43/92/gkt134.PMC3627606.pdf
"This is an Open Access article distributed under the terms of the Creative Commons Attribution Non-Commercial License (http://creativecommons.or g/licenses/ by-nc/3.0/), which permits unrestricted non-commercial use, distribution, and reproduction in any medium, provided the original work is properly cited.",Non-OADS,/arxiv_data1/oa_pdf/9a/fd/gkt135.PMC3627607.pdf
"www.landesbioscience.com Autophagy 459Autophagy 9:4, 459–475; April 2013; © 2013 Landes BioscienceBAsic ReseAR ch P APeR  BAsic ReseAR ch P APeR *Correspondence to: Vassiliki Karantza; Email: karantva@umdnj.edu Submitted: 10/07/12; Revised: 12/03/12; Accepted: 12/07/12http://dx.doi.org/10.4161/auto.23164involution is the process of post-lactational mammary gland regression to quiescence and it involves secretory epithelial  cell death, stroma remodeling and gland repopulation by adipocytes.",Non-OADS,/arxiv_data1/oa_pdf/7d/7c/auto-9-459.PMC3627664.pdf
Breast Cancer Res 2006; 8:203;  PMID:16677411; http://dx.doi.org/10.1186/bcr1401 2.,Non-OADS,/arxiv_data1/oa_pdf/7d/7c/auto-9-459.PMC3627664.pdf
Development 2008; 135:995- 1003; PMID:18296651; http://dx.doi.org/10.1242/ dev.005439 3.,Non-OADS,/arxiv_data1/oa_pdf/7d/7c/auto-9-459.PMC3627664.pdf
Proc Natl Acad Sci U S A 1997; 94:3425-30; PMID:9096410; http://dx.doi.,OADS,/arxiv_data1/oa_pdf/7d/7c/auto-9-459.PMC3627664.pdf
Bioessays 2005; 27:894-903; PMID:16108064; http://dx.doi.,OADS,/arxiv_data1/oa_pdf/7d/7c/auto-9-459.PMC3627664.pdf
Biol Reprod 2008; 78:586-94;  PMID:18057312; http://dx.doi.org/10.1095/biolre- prod.107.065045 9.,OADS,/arxiv_data1/oa_pdf/7d/7c/auto-9-459.PMC3627664.pdf
Mol Carcinog 2004; 41:207- 20; PMID:15468292; http://dx.doi.org/10.1002/ mc.20058 10.,Non-OADS,/arxiv_data1/oa_pdf/7d/7c/auto-9-459.PMC3627664.pdf
Breast Cancer Res 2004; 6:R75-91;  PMID:14979920; http://dx.doi.org/10.1186/bcr753 11.,Non-OADS,/arxiv_data1/oa_pdf/7d/7c/auto-9-459.PMC3627664.pdf
J  Mammary Gland Biol Neoplasia 2007; 12:71-82;  PMID:17318269; http://dx.doi.org/10.1007/s10911- 007-9039-3 12.,Non-OADS,/arxiv_data1/oa_pdf/7d/7c/auto-9-459.PMC3627664.pdf
J  Mammary Gland Biol Neoplasia 2009; 14:145-57;  PMID:19350209; http://dx.doi.org/10.1007/s10911-009-9118-8 13.,Non-OADS,/arxiv_data1/oa_pdf/7d/7c/auto-9-459.PMC3627664.pdf
Development  2003; 130:3459-68; PMID:12810593; http://dx.doi.,OADS,/arxiv_data1/oa_pdf/7d/7c/auto-9-459.PMC3627664.pdf
Breast Cancer Res 2004; 6:R92-109; PMID:14979921;  http://dx.doi.org/10.1186/bcr754 16.,Non-OADS,/arxiv_data1/oa_pdf/7d/7c/auto-9-459.PMC3627664.pdf
Genes Dev  1999; 13:2604-16; PMID:10521404; http://dx.doi.,OADS,/arxiv_data1/oa_pdf/7d/7c/auto-9-459.PMC3627664.pdf
Endocrinology 2002; 143:3641-50;  PMID:12193580; http://dx.doi.org/10.1210/en.2002-220224 19.,Non-OADS,/arxiv_data1/oa_pdf/7d/7c/auto-9-459.PMC3627664.pdf
J Pathol 2012; 227:106-17; PMID:22081431;  http://dx.doi.org/10.1002/path.3961,Non-OADS,/arxiv_data1/oa_pdf/7d/7c/auto-9-459.PMC3627664.pdf
Nat Cell Biol  2010; 12:823-30; PMID:20811354; http://dx.doi.,OADS,/arxiv_data1/oa_pdf/7d/7c/auto-9-459.PMC3627664.pdf
FEBS Lett 1993; 333:169-74; PMID:8224160;  http://dx.doi.org/10.1016/0014-5793(93)80398-E 55.,OADS,/arxiv_data1/oa_pdf/7d/7c/auto-9-459.PMC3627664.pdf
Microbiology  2009; 155:3816-26; PMID:19778961; http://dx.doi.,Non-OADS,/arxiv_data1/oa_pdf/7d/7c/auto-9-459.PMC3627664.pdf
Science 2003; 301:1387-91; PMID:12958363;  http://dx.doi.org/10.1126/science.1087782 57.,Non-OADS,/arxiv_data1/oa_pdf/7d/7c/auto-9-459.PMC3627664.pdf
Science 2008; 321:117-20; PMID:18599786; http://dx.doi.org/10.1126/science.1154822 58.,Non-OADS,/arxiv_data1/oa_pdf/7d/7c/auto-9-459.PMC3627664.pdf
Nature 2004; 432:1032-6; PMID:15525940; http://dx.doi.,OADS,/arxiv_data1/oa_pdf/7d/7c/auto-9-459.PMC3627664.pdf
J Biol Chem  2008; 283:22847-57; PMID:18524774; http://dx.doi.,OADS,/arxiv_data1/oa_pdf/7d/7c/auto-9-459.PMC3627664.pdf
Cell 2007; 131:1137-48;  PMID:18083103; http://dx.doi.org/10.1016/j.,OADS,/arxiv_data1/oa_pdf/7d/7c/auto-9-459.PMC3627664.pdf
Curr Biol  2009; 19:1741-6; PMID:19818615; http://dx.doi.org/10.1016/j.cub.2009.08.042 65.,OADS,/arxiv_data1/oa_pdf/7d/7c/auto-9-459.PMC3627664.pdf
Curr Opin Cell Biol 2010; 22:206- 11; PMID:20045304; http://dx.doi.org/10.1016/j.ceb.2009.12.00235.,OADS,/arxiv_data1/oa_pdf/7d/7c/auto-9-459.PMC3627664.pdf
Nucleic Acids Res 1997; 25:4323- 30; PMID:9336464; http://dx.doi.org/10.1093/ nar/25.21.4323 36.,Non-OADS,/arxiv_data1/oa_pdf/7d/7c/auto-9-459.PMC3627664.pdf
J Cell Physiol  2009; 219:57-68; PMID:19086032; http://dx.doi.,OADS,/arxiv_data1/oa_pdf/7d/7c/auto-9-459.PMC3627664.pdf
Cell  2005; 120:237-48; PMID:15680329; http://dx.doi.,OADS,/arxiv_data1/oa_pdf/7d/7c/auto-9-459.PMC3627664.pdf
Genes Dev 2007; 21:1621-35; PMID:17606641;  http://dx.doi.org/10.1101/gad.1565707 40.,OADS,/arxiv_data1/oa_pdf/7d/7c/auto-9-459.PMC3627664.pdf
Cancer Cell 2006; 10:51-64; PMID:16843265; http://dx.doi.org/10.1016/j.,OADS,/arxiv_data1/oa_pdf/7d/7c/auto-9-459.PMC3627664.pdf
Cell Death Differ 2008; 15:243-50; PMID:17571081; http://dx.doi.org/10.1038/ sj.cdd.4402184 42.,Non-OADS,/arxiv_data1/oa_pdf/7d/7c/auto-9-459.PMC3627664.pdf
Mol Biol Cell 2005; 16:5528- 37; PMID:16195353; http://dx.doi.org/10.1091/mbc.,OADS,/arxiv_data1/oa_pdf/7d/7c/auto-9-459.PMC3627664.pdf
BMC Dev  Biol 2010; 10:122; PMID:21192804; http://dx.doi.,OADS,/arxiv_data1/oa_pdf/7d/7c/auto-9-459.PMC3627664.pdf
Am J Pathol  2010; 176:1241-55; PMID:20110414; http://dx.doi.,OADS,/arxiv_data1/oa_pdf/7d/7c/auto-9-459.PMC3627664.pdf
Cell  2007; 128:931-46; PMID:17350577; http://dx.doi.org/10.1016/j.cell.2006.12.044 47.,OADS,/arxiv_data1/oa_pdf/7d/7c/auto-9-459.PMC3627664.pdf
J Cell Sci 2005; 118:539-53; PMID:15673687; http://dx.doi.,OADS,/arxiv_data1/oa_pdf/7d/7c/auto-9-459.PMC3627664.pdf
J Mammary Gland Biol Neoplasia 2003; 8:309-19; PMID:14973375; http://dx.doi.,Non-OADS,/arxiv_data1/oa_pdf/7d/7c/auto-9-459.PMC3627664.pdf
Development 2012; 139:269- 75; PMID:22129827; http://dx.doi.org/10.1242/ dev.07169620.,OADS,/arxiv_data1/oa_pdf/7d/7c/auto-9-459.PMC3627664.pdf
Nat Cell Biol  2011; 13:303-9; PMID:21336304; http://dx.doi.,OADS,/arxiv_data1/oa_pdf/7d/7c/auto-9-459.PMC3627664.pdf
Comp Biochem Physiol C  Toxicol Pharmacol 2004; 139:65-75; PMID:15556067;  http://dx.doi.org/10.1016/j.cca.2004.09.006 25.,OADS,/arxiv_data1/oa_pdf/7d/7c/auto-9-459.PMC3627664.pdf
Eur J Cell Biol 2009; 88:117- 30; PMID:19013662; http://dx.doi.org/10.1016/j.,OADS,/arxiv_data1/oa_pdf/7d/7c/auto-9-459.PMC3627664.pdf
Cell Death Differ 2005; 12:107- 14; PMID:15647754; http://dx.doi.org/10.1038/sj.cdd.4401517 28.,Non-OADS,/arxiv_data1/oa_pdf/7d/7c/auto-9-459.PMC3627664.pdf
Methods Mol Biol 2008; 445:119- 24; PMID:18425446; http://dx.doi.org/10.1007/978-1-59745-157-4_7 29.,Non-OADS,/arxiv_data1/oa_pdf/7d/7c/auto-9-459.PMC3627664.pdf
Future Microbiol  2008; 3:517-24; PMID:18811236; http://dx.doi.,Non-OADS,/arxiv_data1/oa_pdf/7d/7c/auto-9-459.PMC3627664.pdf
Nature 2011; 469:323- 35; PMID:21248839; http://dx.doi.org/10.1038/ nature09782 32.,Non-OADS,/arxiv_data1/oa_pdf/7d/7c/auto-9-459.PMC3627664.pdf
Nat Cell Biol 2011; 13:1335-43;  PMID:22002674; http://dx.doi.org/10.1038/ncb2363 33.,OADS,/arxiv_data1/oa_pdf/7d/7c/auto-9-459.PMC3627664.pdf
Autophagy  2011; 7:386-400; PMID:21183797; http://dx.doi.,Non-OADS,/arxiv_data1/oa_pdf/7d/7c/auto-9-459.PMC3627664.pdf
Proc Natl Acad Sci U S A 2011; 108:17396-401; PMID:21969579; http://dx.doi.org/10.1073/ pnas.1113421108,OADS,/arxiv_data1/oa_pdf/7d/7c/auto-9-459.PMC3627664.pdf
Mol Cancer Res 2010; 8:873-84; PMID:20530580;  http://dx.doi.org/10.1158/1541-7786.MCR-09-0494 74.,Non-OADS,/arxiv_data1/oa_pdf/7d/7c/auto-9-459.PMC3627664.pdf
Methods Enzymol  2009; 452:13-23; PMID:19200873; http://dx.doi.,OADS,/arxiv_data1/oa_pdf/7d/7c/auto-9-459.PMC3627664.pdf
Nat Med  2011; 17:1109-15; PMID:21822285; http://dx.doi.,OADS,/arxiv_data1/oa_pdf/7d/7c/auto-9-459.PMC3627664.pdf
Nature  1999; 402:672-6; PMID:10604474; http://dx.doi.,OADS,/arxiv_data1/oa_pdf/7d/7c/auto-9-459.PMC3627664.pdf
J Mammary Gland Biol Neoplasia  1999; 4:221-8; PMID:10426401; http://dx.doi.,Non-OADS,/arxiv_data1/oa_pdf/7d/7c/auto-9-459.PMC3627664.pdf
"www.landesbioscience.com Autophagy 581Autophagy 9:4, 581–594; April 2013; © 2013 Landes BioscienceTrAnsLATionAL  reseArch P APer  TrAnsLATionAL  reseArch P APer *Correspondence to: Paloma B. Liton; Email: paloma.liton@duke.edu Submitted: 06/14/2012; Revised: 01/03/2013; Accepted: 01/10/2013http://dx.doi.org/10.4161/auto.23568Introduction The trabecular meshwork (TM), a tiny tissue located in the ante - rior segment of the eye between the cornea and the sclera, is one  of the tissues involved in maintaining appropriate levels of IOP.",Non-OADS,/arxiv_data1/oa_pdf/98/47/auto-9-581.PMC3627672.pdf
Curr Opin  Ophthalmol 2012; 23:135-43; PMID:22262082;  http://dx.doi.org/10.1097/ICU.0b013e32834ff23e 2.,Non-OADS,/arxiv_data1/oa_pdf/98/47/auto-9-581.PMC3627672.pdf
Am J Ophthalmol 1999; 127:407-12; PMID:10218693;  http://dx.doi.org/10.1016/S0002-9394(98)00436-X 3.,Non-OADS,/arxiv_data1/oa_pdf/98/47/auto-9-581.PMC3627672.pdf
Prog Retin Eye Res 2005; 24:612-37; PMID:15919228; http://dx.doi.,Non-OADS,/arxiv_data1/oa_pdf/98/47/auto-9-581.PMC3627672.pdf
Free Radic Biol Med  2008; 45:367-76; PMID:18489911; http://dx.doi.,Non-OADS,/arxiv_data1/oa_pdf/98/47/auto-9-581.PMC3627672.pdf
Am J Ophthalmol 2004; 137:62-9;  PMID:14700645; http://dx.doi.org/10.1016/S0002- 9394(03)00788-8 7.,Non-OADS,/arxiv_data1/oa_pdf/98/47/auto-9-581.PMC3627672.pdf
Arch Ophthalmol  2005; 123:458-63; PMID:15824217; http://dx.doi.,Non-OADS,/arxiv_data1/oa_pdf/98/47/auto-9-581.PMC3627672.pdf
J Glaucoma 2007; 16:334- 43; PMID:17438430; http://dx.doi.org/10.1097/01.,Non-OADS,/arxiv_data1/oa_pdf/98/47/auto-9-581.PMC3627672.pdf
Exp Eye Res  2007; 84:389-99; PMID:17196589; http://dx.doi.,OADS,/arxiv_data1/oa_pdf/98/47/auto-9-581.PMC3627672.pdf
Invest Ophthalmol Vis Sci 2008; 49:1447-58;  PMID:18385062; http://dx.doi.org/10.1167/iovs.07-1361 13.,Non-OADS,/arxiv_data1/oa_pdf/98/47/auto-9-581.PMC3627672.pdf
Invest Ophthalmol Vis Sci 2009; 50:5251-8;  PMID:19516005; http://dx.doi.org/10.1167/iovs.09- 3871 15.,Non-OADS,/arxiv_data1/oa_pdf/98/47/auto-9-581.PMC3627672.pdf
Antioxid Redox Signal  2006; 8:152-62; PMID:16487049; http://dx.doi.,Non-OADS,/arxiv_data1/oa_pdf/98/47/auto-9-581.PMC3627672.pdf
Antioxid Redox Signal 2012; 16:263-74;  PMID:21923553; http://dx.doi.org/10.1089/ ars.2011.4037 17.,Non-OADS,/arxiv_data1/oa_pdf/98/47/auto-9-581.PMC3627672.pdf
Mol Aspects Med  2006; 27:444-54; PMID:16978688; http://dx.doi.,Non-OADS,/arxiv_data1/oa_pdf/98/47/auto-9-581.PMC3627672.pdf
Curr Opin Cell Biol  2011; 23:198-206; PMID:21030235; http://dx.doi.,OADS,/arxiv_data1/oa_pdf/98/47/auto-9-581.PMC3627672.pdf
Cell 2008; 132:27-42; PMID:18191218;  http://dx.doi.org/10.1016/j.cell.2007.12.018 22.,OADS,/arxiv_data1/oa_pdf/98/47/auto-9-581.PMC3627672.pdf
Cell 2011; 146:682-95; PMID:21884931;  http://dx.doi.org/10.1016/j.cell.2011.07.030 23.,OADS,/arxiv_data1/oa_pdf/98/47/auto-9-581.PMC3627672.pdf
Autophagy  2005; 1:131-40; PMID:16874025; http://dx.doi.,Non-OADS,/arxiv_data1/oa_pdf/98/47/auto-9-581.PMC3627672.pdf
Invest Ophthalmol Vis Sci  2008; 49:3961-9; PMID:18469195; http://dx.doi.org/10.1167/iovs.08-1915 25.,Non-OADS,/arxiv_data1/oa_pdf/98/47/auto-9-581.PMC3627672.pdf
Exp Gerontol 2005; 40:745-8; PMID:16051457; http://dx.doi.org/10.1016/j.,OADS,/arxiv_data1/oa_pdf/98/47/auto-9-581.PMC3627672.pdf
EMBO J 2000; 19:5720- 8; PMID:11060023; http://dx.doi.org/10.1093/ emboj/19.21.5720 27.,Non-OADS,/arxiv_data1/oa_pdf/98/47/auto-9-581.PMC3627672.pdf
J Cell Sci 2004;  117:2805-12; PMID:15169837; http://dx.doi.,OADS,/arxiv_data1/oa_pdf/98/47/auto-9-581.PMC3627672.pdf
Autophagy 2009; 5:585- 9; PMID:19411822; http://dx.doi.org/10.4161/ auto.5.5.8823 29.,Non-OADS,/arxiv_data1/oa_pdf/98/47/auto-9-581.PMC3627672.pdf
Science 2011; 332:1429- 33; PMID:21617040; http://dx.doi.org/10.1126/sci- ence.1204592 33.,OADS,/arxiv_data1/oa_pdf/98/47/auto-9-581.PMC3627672.pdf
Genes Dev 2009; 23:798- 803; PMID:19279323; http://dx.doi.org/10.1101/ gad.519709 34.,Non-OADS,/arxiv_data1/oa_pdf/98/47/auto-9-581.PMC3627672.pdf
Curr Opin Cell Biol  2010; 22:234-40; PMID:20045302; http://dx.doi.,OADS,/arxiv_data1/oa_pdf/98/47/auto-9-581.PMC3627672.pdf
Aging Cell 2006; 5:187-95; PMID:16626397; http://dx.doi.,OADS,/arxiv_data1/oa_pdf/98/47/auto-9-581.PMC3627672.pdf
Eye (Lond)  2006; 20:553-63; PMID:15905869; http://dx.doi.,OADS,/arxiv_data1/oa_pdf/98/47/auto-9-581.PMC3627672.pdf
Curr Opin Ophthalmol  2008; 19:507-11; PMID:18854696; http://dx.doi.,Non-OADS,/arxiv_data1/oa_pdf/98/47/auto-9-581.PMC3627672.pdf
Sci Signal 2012;  5:ra42; PMID:22692423; http://dx.doi.org/10.1126/ scisignal.2002790 44.,OADS,/arxiv_data1/oa_pdf/98/47/auto-9-581.PMC3627672.pdf
EMBO J 2011; 30:3242- 58; PMID:21804531; http://dx.doi.org/10.1038/ emboj.2011.257 45.,Non-OADS,/arxiv_data1/oa_pdf/98/47/auto-9-581.PMC3627672.pdf
Free Radic  Biol Med 1997; 23:215-25; PMID:9199883; http://dx.doi.org/10.1016/S0891-5849(96)00612-038.,Non-OADS,/arxiv_data1/oa_pdf/98/47/auto-9-581.PMC3627672.pdf
Physiol Rev 2010; 90:1383-435;  PMID:20959619; http://dx.doi.org/10.1152/phys- rev.00030.2009 39.,Non-OADS,/arxiv_data1/oa_pdf/98/47/auto-9-581.PMC3627672.pdf
Mol Biol Cell 2008; 19:2092-100; PMID:18321988;  http://dx.doi.org/10.1091/mbc.E07-12-1257 41.,Non-OADS,/arxiv_data1/oa_pdf/98/47/auto-9-581.PMC3627672.pdf
PLoS One  2011; 6:e23367; PMID:21858089; http://dx.doi.org/10.1371/journal.pone.0023367 42.,Non-OADS,/arxiv_data1/oa_pdf/98/47/auto-9-581.PMC3627672.pdf
Nature 2009; 461:654-8; PMID:19794493; http://dx.doi.,Non-OADS,/arxiv_data1/oa_pdf/98/47/auto-9-581.PMC3627672.pdf
"Plant Cell 2012; 24:4621–34; PMID:23144183; http://dx.doi.org/10.1105/tpc.112.105403Keywords:  Arabidopsis, ATG8 lipida - tion, carbon starvation, cysteine desulf - hydrase, cytosolic sulfide, senescence Submitted: 12/13/12Revised: 12/27/12Accepted: 01/02/13http://dx.doi.org/10.4161/auto.23460 *Correspondence to: Cecilia Gotor; Email: gotor@ ibvf.csic.esHydrogen sulfide is already recog - nized as an important signaling  molecule in mammalian systems, and  emerging data suggest that H2S is a sig - naling molecule just as important as nitric oxide (NO) and H 2O2 in plants.",Non-OADS,/arxiv_data1/oa_pdf/8a/48/auto-9-609.PMC3627676.pdf
Rats were randomly divided to four groups: (1)  http://www.jgc301.com; jgc@jgc301.com  | Journal of Geriatric Cardiology,Non-OADS,/arxiv_data1/oa_pdf/dc/d5/jgc-10-01-052.PMC3627702.pdf
"The supernatant was   incubated with 0.6 mL react ion buffer, when iNOS was  determined, combined with the addition of inhibitor 1  mmol/L EGTA (iNOS Ca2+ independent, eNOS Ca2+ de-  http://www.jgc301.com; jgc@mail.sciencep.com  | Journal of Geriatric Cardiology",Non-OADS,/arxiv_data1/oa_pdf/dc/d5/jgc-10-01-052.PMC3627702.pdf
"Compared with Tiro group, eNOS activity  was significantly lower in Tiro + L-NNA group ( P < 0.05),    Journal of Geriatric Cardiology  | jgc@jgc301.com; http://www.jgc301.com",Non-OADS,/arxiv_data1/oa_pdf/dc/d5/jgc-10-01-052.PMC3627702.pdf
"Compared with AMI/R group,   http://www.jgc301.com; jgc@mail.sciencep.com  | Journal of Geriatric Cardiology",Non-OADS,/arxiv_data1/oa_pdf/dc/d5/jgc-10-01-052.PMC3627702.pdf
Journal of Geriatric Cardiology  | jgc@jgc301.com; http://www.jgc301.com,Non-OADS,/arxiv_data1/oa_pdf/dc/d5/jgc-10-01-052.PMC3627702.pdf
"Together, it could be  http://www.jgc301.com; jgc@mail.sciencep.com  | Journal of Geriatric Cardiology",Non-OADS,/arxiv_data1/oa_pdf/dc/d5/jgc-10-01-052.PMC3627702.pdf
Journal of Geriatric Cardiology  | jgc@jgc301.com; http://www.jgc301.com,Non-OADS,/arxiv_data1/oa_pdf/dc/d5/jgc-10-01-052.PMC3627702.pdf
Inclusion criteria were age >  http://www.jgc301.com; jgc@jgc301.com  | Journal of Geriatric Cardiology,Non-OADS,/arxiv_data1/oa_pdf/30/15/jgc-10-01-010.PMC3627703.pdf
http://www.jgc301.com; jgc@mail.sciencep.com  | Journal of Geriatric Cardiology,Non-OADS,/arxiv_data1/oa_pdf/30/15/jgc-10-01-010.PMC3627703.pdf
Journal of Geriatric Cardiology  | jgc@jgc301.com; http://www.jgc301.com,Non-OADS,/arxiv_data1/oa_pdf/30/15/jgc-10-01-010.PMC3627703.pdf
CAE is often viewed as a variant of   http://www.jgc301.com; jgc@mail.sciencep.com  | Journal of Geriatric Cardiology,Non-OADS,/arxiv_data1/oa_pdf/30/15/jgc-10-01-010.PMC3627703.pdf
"Furthermore, laboratory tests concern- ing these diseases and their potential relationship with  Journal of Geriatric Cardiology  | jgc@jgc301.com; http://www.jgc301.com",Non-OADS,/arxiv_data1/oa_pdf/30/15/jgc-10-01-010.PMC3627703.pdf
http://www.jgc301.com; jgc@mail.sciencep.com  | Journal of Geriatric Cardiology,Non-OADS,/arxiv_data1/oa_pdf/30/15/jgc-10-01-010.PMC3627703.pdf
2  Methods  2.1  Patients   Extraction indications were HRS class I and IIa indica- http://www.jgc301.com; jgc@jgc301.com  | Journal of Geriatric Cardiology,Non-OADS,/arxiv_data1/oa_pdf/5e/f4/jgc-10-01-003.PMC3627705.pdf
"Before visiting our center, 29 patients with  Journal of Geriatric Cardiology  | jgc@jgc301.com; http://www.jgc301.com",Non-OADS,/arxiv_data1/oa_pdf/5e/f4/jgc-10-01-003.PMC3627705.pdf
"One patient required cardiothoracic surgery after failed by the transvenous approach, the 56-month lead was  non-coated, passive-fixation, dual-coil, and formed   http://www.jgc301.com; jgc@mail.sciencep.com  | Journal of Geriatric Cardiology",Non-OADS,/arxiv_data1/oa_pdf/5e/f4/jgc-10-01-003.PMC3627705.pdf
One patient   Journal of Geriatric Cardiology  | jgc@jgc301.com; http://www.jgc301.com,Non-OADS,/arxiv_data1/oa_pdf/5e/f4/jgc-10-01-003.PMC3627705.pdf
a  http://www.jgc301.com; jgc@mail.sciencep.com  | Journal of Geriatric Cardiology,Non-OADS,/arxiv_data1/oa_pdf/5e/f4/jgc-10-01-003.PMC3627705.pdf
"During the same period, removal of non-ICD leads (540 leads) showed  Journal of Geriatric Cardiology  | jgc@jgc301.com; http://www.jgc301.com",Non-OADS,/arxiv_data1/oa_pdf/5e/f4/jgc-10-01-003.PMC3627705.pdf
http://www.jgc301.com; jgc@mail.sciencep.com  | Journal of Geriatric Cardiology,Non-OADS,/arxiv_data1/oa_pdf/5e/f4/jgc-10-01-003.PMC3627705.pdf
The choice of stent was at the  http://www.jgc301.com; jgc@jgc301.com  | Journal of Geriatric Cardiology,Non-OADS,/arxiv_data1/oa_pdf/7c/0a/jgc-10-01-016.PMC3627706.pdf
http://www.jgc301.com; jgc@mail.sciencep.com  | Journal of Geriatric Cardiology,Non-OADS,/arxiv_data1/oa_pdf/7c/0a/jgc-10-01-016.PMC3627706.pdf
Journal of Geriatric Cardiology  | jgc@jgc301.com; http://www.jgc301.com,Non-OADS,/arxiv_data1/oa_pdf/7c/0a/jgc-10-01-016.PMC3627706.pdf
Percutaneous  coronary intervention for chronic total occlusions: improved  survival for patients with successful revascularization com- http://www.jgc301.com; jgc@mail.sciencep.com  | Journal of Geriatric Cardiology,Non-OADS,/arxiv_data1/oa_pdf/7c/0a/jgc-10-01-016.PMC3627706.pdf
Journal of Geriatric Cardiology  | jgc@jgc301.com; http://www.jgc301.com,Non-OADS,/arxiv_data1/oa_pdf/7c/0a/jgc-10-01-016.PMC3627706.pdf
http://www.jgc301.com; jgc@jgc301.com  | Journal of Geriatric Cardiology,Non-OADS,/arxiv_data1/oa_pdf/d1/9c/jgc-10-01-001.PMC3627707.pdf
Journal of Geriatric Cardiology  | jgc@jgc301.com; http://www.jgc301.com,Non-OADS,/arxiv_data1/oa_pdf/d1/9c/jgc-10-01-001.PMC3627707.pdf
"In  patients with AMI, a venous blood sample of 5 mL was  http://www.jgc301.com; jgc@jgc301.com  | Journal of Geriatric Cardiology",Non-OADS,/arxiv_data1/oa_pdf/86/d8/jgc-10-01-034.PMC3627710.pdf
http://www.jgc301.com; jgc@mail.sciencep.com  | Journal of Geriatric Cardiology,Non-OADS,/arxiv_data1/oa_pdf/86/d8/jgc-10-01-034.PMC3627710.pdf
4  Discussion   This study demonstrates that circulating miR-214 can be  detected in the blood and is down-regulated in patients with    Journal of Geriatric Cardiology  | jgc@jgc301.com; http://www.jgc301.com,Non-OADS,/arxiv_data1/oa_pdf/86/d8/jgc-10-01-034.PMC3627710.pdf
"In summary, the present study shows that a new circulat- ing microRNA, miR-214, is down regulated in patients with  http://www.jgc301.com; jgc@mail.sciencep.com  | Journal of Geriatric Cardiology",Non-OADS,/arxiv_data1/oa_pdf/86/d8/jgc-10-01-034.PMC3627710.pdf
Journal of Geriatric Cardiology  | jgc@jgc301.com; http://www.jgc301.com,Non-OADS,/arxiv_data1/oa_pdf/86/d8/jgc-10-01-034.PMC3627710.pdf
"[8] reported the first  HCM-causing mutation of β-myosin heavy chain ( β-MyHC)  gene in 1990, a large number of mutations in sarcomeric  protein genes that encode β-MyHC, cardiac troponin T  (cTnT), cardiac troponin I (cTnI), cardiac troponin C   http://www.jgc301.com; jgc@jgc301.com  | Journal of Geriatric Cardiology",Non-OADS,/arxiv_data1/oa_pdf/35/35/jgc-10-01-091.PMC3627712.pdf
"However, they usually  lead to poor prognosis and high incidence of sudden cardiac    Journal of Geriatric Cardiology  | jgc@jgc301.com; http://www.jgc301.com",Non-OADS,/arxiv_data1/oa_pdf/35/35/jgc-10-01-091.PMC3627712.pdf
http://www.jgc301.com; jgc@mail.sciencep.com  | Journal of Geriatric Cardiology,Non-OADS,/arxiv_data1/oa_pdf/35/35/jgc-10-01-091.PMC3627712.pdf
Journal of Geriatric Cardiology  | jgc@jgc301.com; http://www.jgc301.com,Non-OADS,/arxiv_data1/oa_pdf/35/35/jgc-10-01-091.PMC3627712.pdf
"3  Animal models of cardiomyopathies caused  by troponin mutations  In order to determine the significance of the in vitro  findings concerning inherited cardiomyopathies, especially  to validate whether the shift in cardiac myofilament Ca2+-  sensitivity is the most important and a common cause of  http://www.jgc301.com; jgc@mail.sciencep.com  | Journal of Geriatric Cardiology",Non-OADS,/arxiv_data1/oa_pdf/35/35/jgc-10-01-091.PMC3627712.pdf
"[53,90,117,118] To fully understand the pathogenic   Journal of Geriatric Cardiology  | jgc@jgc301.com; http://www.jgc301.com",Non-OADS,/arxiv_data1/oa_pdf/35/35/jgc-10-01-091.PMC3627712.pdf
"21  McNally E, MacLeod H, Dellefa ve L. Arrhythmogenic Right  http://www.jgc301.com; jgc@mail.sciencep.com  | Journal of Geriatric Cardiology",Non-OADS,/arxiv_data1/oa_pdf/35/35/jgc-10-01-091.PMC3627712.pdf
Available at:  http://www.genetests.org.,OADS,/arxiv_data1/oa_pdf/35/35/jgc-10-01-091.PMC3627712.pdf
Correlation of molecular  and functional effects of mutations in cardiac troponin T  Journal of Geriatric Cardiology  | jgc@jgc301.com; http://www.jgc301.com,Non-OADS,/arxiv_data1/oa_pdf/35/35/jgc-10-01-091.PMC3627712.pdf
http://www.jgc301.com; jgc@mail.sciencep.com  | Journal of Geriatric Cardiology,Non-OADS,/arxiv_data1/oa_pdf/35/35/jgc-10-01-091.PMC3627712.pdf
F110I and R278C troponin T mutations that cause familial hypertrophic cardiomyopathy affect muscle contraction in  Journal of Geriatric Cardiology  | jgc@jgc301.com; http://www.jgc301.com,Non-OADS,/arxiv_data1/oa_pdf/35/35/jgc-10-01-091.PMC3627712.pdf
http://www.jgc301.com; jgc@mail.sciencep.com  | Journal of Geriatric Cardiology,Non-OADS,/arxiv_data1/oa_pdf/35/35/jgc-10-01-091.PMC3627712.pdf
The  non-infarcted area of the myocardium exhibits ventricular  arrhythmogenic abnormalities of both conduction and repo- http://www.jgc301.com; jgc@jgc301.com  | Journal of Geriatric Cardiology,Non-OADS,/arxiv_data1/oa_pdf/2f/83/jgc-10-01-039.PMC3627714.pdf
Steady-state activation of Ito was induced by voltage  Journal of Geriatric Cardiology  | jgc@jgc301.com; http://www.jgc301.com,Non-OADS,/arxiv_data1/oa_pdf/2f/83/jgc-10-01-039.PMC3627714.pdf
The density of   http://www.jgc301.com; jgc@mail.sciencep.com  | Journal of Geriatric Cardiology,Non-OADS,/arxiv_data1/oa_pdf/2f/83/jgc-10-01-039.PMC3627714.pdf
"These results proved the lengthening of the APD were more notable after NGF infusion ( P < 0.01, n = 20,    Journal of Geriatric Cardiology  | jgc@jgc301.com; http://www.jgc301.com",Non-OADS,/arxiv_data1/oa_pdf/2f/83/jgc-10-01-039.PMC3627714.pdf
The time constant of  the fast inactivation ( I Kr) in the HMI + NGF cardiomyocytes   http://www.jgc301.com; jgc@mail.sciencep.com  | Journal of Geriatric Cardiology,Non-OADS,/arxiv_data1/oa_pdf/2f/83/jgc-10-01-039.PMC3627714.pdf
"The steady-state activation curve of HMI + NGF cardio- myocytes was negatively shifted, with a shift in V 1/2,act from  -21.6 ± 3.2 mV in the control group, -28.2 ± 2.9 mV in the    Journal of Geriatric Cardiology  | jgc@jgc301.com; http://www.jgc301.com",Non-OADS,/arxiv_data1/oa_pdf/2f/83/jgc-10-01-039.PMC3627714.pdf
http://www.jgc301.com; jgc@mail.sciencep.com  | Journal of Geriatric Cardiology,Non-OADS,/arxiv_data1/oa_pdf/2f/83/jgc-10-01-039.PMC3627714.pdf
"[12,18] NGF signaling within the heart is     Journal of Geriatric Cardiology  | jgc@jgc301.com; http://www.jgc301.com",Non-OADS,/arxiv_data1/oa_pdf/2f/83/jgc-10-01-039.PMC3627714.pdf
The main depolarizing potassium current showed a significant reduction in peak current density with     http://www.jgc301.com; jgc@mail.sciencep.com  | Journal of Geriatric Cardiology,Non-OADS,/arxiv_data1/oa_pdf/2f/83/jgc-10-01-039.PMC3627714.pdf
The combination    Journal of Geriatric Cardiology  | jgc@jgc301.com; http://www.jgc301.com,Non-OADS,/arxiv_data1/oa_pdf/2f/83/jgc-10-01-039.PMC3627714.pdf
[36] demonstrated  http://www.jgc301.com; jgc@mail.sciencep.com  | Journal of Geriatric Cardiology,Non-OADS,/arxiv_data1/oa_pdf/2f/83/jgc-10-01-039.PMC3627714.pdf
Journal of Geriatric Cardiology  | jgc@jgc301.com; http://www.jgc301.com,Non-OADS,/arxiv_data1/oa_pdf/2f/83/jgc-10-01-039.PMC3627714.pdf
http://www.jgc301.com; jgc@mail.sciencep.com  | Journal of Geriatric Cardiology,Non-OADS,/arxiv_data1/oa_pdf/2f/83/jgc-10-01-039.PMC3627714.pdf
"[7] Later, several  studies, but not all, confirme d the relationship between AGT   http://www.jgc301.com; jgc@jgc301.com  | Journal of Geriatric Cardiology",Non-OADS,/arxiv_data1/oa_pdf/90/4c/jgc-10-01-059.PMC3627715.pdf
"Similarly, in the subgroup meta-   Journal of Geriatric Cardiology  | jgc@jgc301.com; http://www.jgc301.com",Non-OADS,/arxiv_data1/oa_pdf/90/4c/jgc-10-01-059.PMC3627715.pdf
http://www.jgc301.com; jgc@mail.sciencep.com  | Journal of Geriatric Cardiology,Non-OADS,/arxiv_data1/oa_pdf/90/4c/jgc-10-01-059.PMC3627715.pdf
Journal of Geriatric Cardiology  | jgc@jgc301.com; http://www.jgc301.com,Non-OADS,/arxiv_data1/oa_pdf/90/4c/jgc-10-01-059.PMC3627715.pdf
http://www.jgc301.com; jgc@mail.sciencep.com  | Journal of Geriatric Cardiology,Non-OADS,/arxiv_data1/oa_pdf/90/4c/jgc-10-01-059.PMC3627715.pdf
Coronary heart dis- Journal of Geriatric Cardiology  | jgc@jgc301.com; http://www.jgc301.com,Non-OADS,/arxiv_data1/oa_pdf/90/4c/jgc-10-01-059.PMC3627715.pdf
http://www.jgc301.com; jgc@mail.sciencep.com  | Journal of Geriatric Cardiology,Non-OADS,/arxiv_data1/oa_pdf/90/4c/jgc-10-01-059.PMC3627715.pdf
It  http://www.jgc301.com; jgc@jgc301.com  | Journal of Geriatric Cardiology,Non-OADS,/arxiv_data1/oa_pdf/5a/5d/jgc-10-01-021.PMC3627718.pdf
Journal of Geriatric Cardiology  | jgc@jgc301.com; http://www.jgc301.com,Non-OADS,/arxiv_data1/oa_pdf/5a/5d/jgc-10-01-021.PMC3627718.pdf
This d  http://www.jgc301.com; jgc@mail.sciencep.com  | Journal of Geriatric Cardiology,Non-OADS,/arxiv_data1/oa_pdf/5a/5d/jgc-10-01-021.PMC3627718.pdf
Journal of Geriatric Cardiology  | jgc@jgc301.com; http://www.jgc301.com,Non-OADS,/arxiv_data1/oa_pdf/5a/5d/jgc-10-01-021.PMC3627718.pdf
http://www.jgc301.com; jgc@mail.sciencep.com  | Journal of Geriatric Cardiology,Non-OADS,/arxiv_data1/oa_pdf/5a/5d/jgc-10-01-021.PMC3627718.pdf
Frequency  and characteristics of aspirin resistance in chilean cardio- Journal of Geriatric Cardiology  | jgc@jgc301.com; http://www.jgc301.com,Non-OADS,/arxiv_data1/oa_pdf/5a/5d/jgc-10-01-021.PMC3627718.pdf
http://www.jgc301.com; jgc@mail.sciencep.com  | Journal of Geriatric Cardiology,Non-OADS,/arxiv_data1/oa_pdf/5a/5d/jgc-10-01-021.PMC3627718.pdf
http://www.jgc301.com; jgc@jgc301.com  | Journal of Geriatric Cardiology,Non-OADS,/arxiv_data1/oa_pdf/cc/5e/jgc-10-01-028.PMC3627720.pdf
"SHBG was associ- ated with the MetS, and was entered into a multivariate   http://www.jgc301.com; jgc@mail.sciencep.com  | Journal of Geriatric Cardiology",Non-OADS,/arxiv_data1/oa_pdf/cc/5e/jgc-10-01-028.PMC3627720.pdf
"4  Discussion  Whether SHBG is a causal factor of the MetS, or merely  represents a marker for primary endocrine abnormalities   Journal of Geriatric Cardiology  | jgc@jgc301.com; http://www.jgc301.com",Non-OADS,/arxiv_data1/oa_pdf/cc/5e/jgc-10-01-028.PMC3627720.pdf
http://www.jgc301.com; jgc@mail.sciencep.com  | Journal of Geriatric Cardiology,Non-OADS,/arxiv_data1/oa_pdf/cc/5e/jgc-10-01-028.PMC3627720.pdf
"Association of  bioavailable, free, and total testosterone with insulin resistance  Journal of Geriatric Cardiology  | jgc@jgc301.com; http://www.jgc301.com",Non-OADS,/arxiv_data1/oa_pdf/cc/5e/jgc-10-01-028.PMC3627720.pdf
http://www.jgc301.com; jgc@mail.sciencep.com  | Journal of Geriatric Cardiology,Non-OADS,/arxiv_data1/oa_pdf/cc/5e/jgc-10-01-028.PMC3627720.pdf
"This is an Open Access article distributed under the terms of the Creative CommonsAttributionNon-Commercial License (http://creativecommons.org/licenses/by-nc/3.0), which permits unrestricted non-commercial use, distribution, and reproduction in any medium, provided the original work is properly cited.",Non-OADS,/arxiv_data1/oa_pdf/35/7a/sbs059.PMC3627767.pdf
"This is an Open Access article distributed under the terms of the Creative Commons Attribution Non-Commercial License (http://creativecommons.or g/licenses/ by-nc/3.0), which permits unrestricted non-commercial use, distribution, and reproduction in any medium, provided the original work is properly c ited.",Non-OADS,/arxiv_data1/oa_pdf/35/7a/sbs059.PMC3627767.pdf
"This is an Open Access article distributed under the terms of the Creative CommonsAttributionNon-Commercial License (http://creativecommons.org/licenses/by-nc/3.0), which permits unrestricted non-commercial use, distribution, and reproduction in any medium, provided the original work is properly cited.",Non-OADS,/arxiv_data1/oa_pdf/84/64/sbr192.PMC3627774.pdf
"This is an Open Access article distributed under the terms of the Creative Commons Attribution Non-Commercial License (http://creativecommons.or g/licenses/ by-nc/3.0), which permits unrestricted non-commercial use, distribution, and reproduction in any medium, provided the original work is properly c ited.",Non-OADS,/arxiv_data1/oa_pdf/84/64/sbr192.PMC3627774.pdf
"Editorial T otally Laparoscopic Surgery for Gastric Cancer  Hoon Hur, and Sang-Uk Han Department of Surgery, Ajou University School of Medicine, Suwon, KoreaJ Gastric Cancer 2013;13(1):1-2  http://dx.doi.org/10.5230/jgc.2013.13.1.1 Correspondence to: Sang-Uk Han Editor in Chief, the Journal of Gastric Cancer Department of Surgery, Ajou University School of Medicine, 206  WorldCup-ro, Yeongtong-gu, Suwon 443-749, Korea Tel: +82-31-219-4384, Fax: +82-31-219-4438 E-mail: hansu@ajou.ac.kr Received March 13, 2013 Accepted March 13, 2013 Copyrights © 2013 by The Korean Gastric Cancer Association www.jgc-online.org This is an open-access article distributed under the terms of the Creative Commons Attribution Non-Commercial License (http://creativecommons.org/ licenses/by-nc/3.0) which permits unrestricted noncommercial use, distribution, and reproduction in any medium, provided the original work is properly cited.Laparoscopic surgery for gastric cancer has become a popular  procedure in East Asian countries such as Korea and Japan,1 and  the advantages of this approach for gastric cancer surgery have  been clearly demonstrated in several clinical studies.2-5 The most  commonly performed laparoscopic procedures for gastric cancer  include the omentectomy and the lymphadenectomy.",Non-OADS,/arxiv_data1/oa_pdf/71/75/jgc-13-1.PMC3627801.pdf
"Key Words:  Laparoscopy; Gastrectomy; Stomach neoplasms; Robotics; Anastomosis, surgicalJ Gastric Cancer 2013;13(1):19-25  http://dx.doi.org/10.5230/jgc.2013.13.1.19 Correspondence to: Ichiro Uyama Division of Upper Gastrointestinal, Department of Surgery, Fujita Health  University, 1-98 Dengakugakubo, Kutsukake, Toyoake, Aichi, 470-1192  Japan Tel: +81-562-93-9254, Fax: +81-562-93-9011 E-mail: iuyama@fujita-hu.ac.jp Received February 19, 2013 Revised March 6, 2013 Accepted March 6, 2013 Copyrights © 2013 by The Korean Gastric Cancer Association www.jgc-online.org This is an open-access article distributed under the terms of the Creative Commons Attribution Non-Commercial License (http://creativecommons.org/ licenses/by-nc/3.0) which permits unrestricted noncommercial use, distribution, and reproduction in any medium, provided the original work is properly cited.Introduction Gastric cancer is the fourth most common cancer and the  second leading cause of cancer-related death worldwide.1 Surgical  resection remains the only curative treatment option, and regional  lymphadenectomy is recommended as part of radical gastrectomy.2  Laparoscopic gastrectomy (LG) is an emerging surgical approach  which offers significant advantages on short-term outcomes when  compared with open surgical procedures for patients with gastric  cancer.3-6 Although laparoscopic surgery is currently being regarded  as the treatment of choice for early gastric cancer (EGC), the  indications and outcomes of LG for advanced gastric cancer (AGC)  remain controversial due to its technical difficulties and the lack of  long-term results.7 This article provides a history of LG and gives updated information on LG for AGC based on our experience  along with a review of the literature.",Non-OADS,/arxiv_data1/oa_pdf/1d/b6/jgc-13-19.PMC3627802.pdf
"Key Words:  Laparoscopy; Stomach neoplasms; Anastomosis; Learning curve; MorbidityJ Gastric Cancer 2013;13(1):26-33  http://dx.doi.org/10.5230/jgc.2013.13.1.26 Correspondence to: Ji-Ho Park Department of Surgery, Gyeongsang National University Hospital, 79  Gangnam-ro, Jinju 660-702, Korea Tel: +82-55-750-8096, Fax: +82-55-750-5442 E-mail: goodgsdr@gmail.com Received January 30, 2013 Revised March 4, 2013 Accepted March 6, 2013 Copyrights © 2013 by The Korean Gastric Cancer Association www.jgc-online.org This is an open-access article distributed under the terms of the Creative Commons Attribution Non-Commercial License (http://creativecommons.org/ licenses/by-nc/3.0) which permits unrestricted noncommercial use, distribution, and reproduction in any medium, provided the original work is properly cited.Introduction The use of laparoscopic gastrectomy to treat early gastric cancer has recently gained acceptance for its minimal invasiveness, mak- ing it a suitable alternative method to an open procedure.1,2 Totally  laparoscopic distal gastrectomy (TLDG) including intracorporeal  gastrointestinal anastomosis for gastric cancer is increasingly per- formed as surgeons gain experience and laparoscopic instruments  continue to evolve.",Non-OADS,/arxiv_data1/oa_pdf/51/c8/jgc-13-26.PMC3627803.pdf
"Key Words:  Gastrointestinal stomal tumors; Surgery; Laparoscopy; Neoadjuvant therapyJ Gastric Cancer 2013;13(1):3-18  http://dx.doi.org/10.5230/jgc.2013.13.1.3 Correspondence to: Han-Kwang Yang Department of Surgery, Cancer Research Institute, Seoul National  University College of Medicine, 101 Daehak-ro, Jongno-gu, Seoul 110- 744, Korea Tel: +82-2-2072-3797, Fax: +82-2-3672-0047 E-mail: hkyang@snu.ac.kr Received March 6, 2013 Revised March 9, 2013 Accepted March 10, 2013 Copyrights © 2013 by The Korean Gastric Cancer Association www.jgc-online.org This is an open-access article distributed under the terms of the Creative Commons Attribution Non-Commercial License (http://creativecommons.org/ licenses/by-nc/3.0) which permits unrestricted noncommercial use, distribution, and reproduction in any medium, provided the original work is properly cited.Introduction Gastrointestinal stromal tumor (GIST) is the most common  mesenchymal tumor in the gastrointestinal tract; it originated from  the interstitial cells of Cajal or their common stem cell.",Non-OADS,/arxiv_data1/oa_pdf/3f/ba/jgc-13-3.PMC3627804.pdf
Available 	from: 	http://www.nccn.org/professionals/ physician_gls/f_guidelines.asp#sarcoma.,Non-OADS,/arxiv_data1/oa_pdf/3f/ba/jgc-13-3.PMC3627804.pdf
"Key Words:  Intracorporeal; Extracorporeal; Billorth I; Billroth II; Roux en YJ Gastric Cancer 2013;13(1):34-43  http://dx.doi.org/10.5230/jgc.2013.13.1.34 Correspondence to: Sang-Uk Han Department of Surgery, Ajou University School of Medicine, San-5,  Woncheon-dong, Yeongtong-gu, Suwon 422-749, Korea Tel: +82-31-219-5195, Fax: +82-31-219-5755 E-mail: hansu@ajou.ac.kr Received May 22, 2012 Revised September 5, 2012 Accepted September 13, 2012 Copyrights © 2013 by The Korean Gastric Cancer Association www.jgc-online.org This is an open-access article distributed under the terms of the Creative Commons Attribution Non-Commercial License (http://creativecommons.org/ licenses/by-nc/3.0) which permits unrestricted noncommercial use, distribution, and reproduction in any medium, provided the original work is properly cited.Introduction The frequency of diagnosis of early gastric cancer has been re- cently increasing due to external influences such as increased need  for health examination.",Non-OADS,/arxiv_data1/oa_pdf/88/4a/jgc-13-34.PMC3627805.pdf
"Key Words:  Stomach neoplasms; Laparoscopy; GastrectomyJ Gastric Cancer 2013;13(1):44-50  http://dx.doi.org/10.5230/jgc.2013.13.1.44 Correspondence to: Jong-Min Park Department of Surgery, National Medical Center, 245 Eulji-ro, Jung-gu,  Seoul 100-799, Korea Tel: +82-2-2260-4883, Fax: +82-2-2269-0750 E-mail: jmparkgs@gmail.com Received February 4, 2013 Revised March 5, 2013 Accepted March 6, 2013 Copyrights © 2013 by The Korean Gastric Cancer Association www.jgc-online.org This is an open-access article distributed under the terms of the Creative Commons Attribution Non-Commercial License (http://creativecommons.org/ licenses/by-nc/3.0) which permits unrestricted noncommercial use, distribution, and reproduction in any medium, provided the original work is properly cited.Introduction Gastric cancer is still one of the most common malignan- cies in Korea1 and the incidence of early gastric cancer (EGC) has  increased due to the implementation of national cancer screening  program.Since the report of Kitano et al.2 about good oncologic out- comes of laparoscopy-assisted gastrectomy (LAG), laparoscopic  gastrectomy for EGC has been widely accepted and performed in  Korea and Japan.",Non-OADS,/arxiv_data1/oa_pdf/96/34/jgc-13-44.PMC3627806.pdf
"Original Article J Gastric Cancer 2013;13(1):51-57  http://dx.doi.org/10.5230/jgc.2013.13.1.51 Correspondence to: Woo Jin Hyung Department of Surgery, Yonsei University College of Medicine, 50,  Yonsei-ro, Seodaemun-gu, Seoul 120-752, Korea  Tel: +82-2-2228-2129, Fax: +82-2-313-8289 E-mail: wjhyung@yuhs.ac Received December 18, 2012 Revised December 20, 2012 Accepted December 21, 2012 Copyrights © 2013 by The Korean Gastric Cancer Association www.jgc-online.org This is an open-access article distributed under the terms of the Creative Commons Attribution Non-Commercial License (http://creativecommons.org/ licenses/by-nc/3.0) which permits unrestricted noncommercial use, distribution, and reproduction in any medium, provided the original work is properly cited.Introduction With the help of widespread health screening and develop- ment of endoscopic technology, early detection of gastric cancer  has been raised where gastric cancer is prevalent such as Korea and Japan.1,2 Endoscopic resection, endoscopic submucosal resection  or endoscopic submucosal dissection has been gaining acceptance  as a useful method to treat early gastric cancer due to its minimal  invasiveness and favorable results in maintaining good quality of  life.3-6 However, additional gastrectomy is needed after endo- scopic resection for early gastric cancer when pathology confirms  any possibility of lymph node metastasis or margin involvement.7,8 While there have been several reports regarding the necessity of  additional surgery after endoscopic resection, no studies depicted  the optimal type of surgery to apply in these patients.",Non-OADS,/arxiv_data1/oa_pdf/25/41/jgc-13-51.PMC3627807.pdf
"Key Words:  Stomach neoplasms; Alpha-fetoproteins; Drug therapy; General surgery; SorafenibJ Gastric Cancer 2013;13(1):58-64  http://dx.doi.org/10.5230/jgc.2013.13.1.58 Correspondence to: Kenji Koneri Department of Gastroenterological Surgery, University of Fukui, 23-3,  Matsuoka Shimoaizuki, Eiheiji-cho, Yoshida-gun, Fukui 910-1193, Japan Tel: +81-776-61-3111, Fax: +81-776-61-8113  E-mail: koneri@hotmail.co.jp Received January 31, 2013 Revised February 13, 2013 Accepted February 13, 2013 Copyrights © 2013 by The Korean Gastric Cancer Association www.jgc-online.org This is an open-access article distributed under the terms of the Creative Commons Attribution Non-Commercial License (http://creativecommons.org/ licenses/by-nc/3.0) which permits unrestricted noncommercial use, distribution, and reproduction in any medium, provided the original work is properly cited.Introduction Alpha-fetoprotein-producing gastric cancer (AFPGC) is a  rare subtype of gastric cancer associated with a poor progno- sis because it readily metastasizes to the liver and lymph nodes.",Non-OADS,/arxiv_data1/oa_pdf/44/63/jgc-13-58.PMC3627808.pdf
"Key Words:  Stomach neoplasms; Early gastric cancer; Rupture spontaneous; Peritonitis; General surgeryJ Gastric Cancer 2013;13(1):65-68  http://dx.doi.org/10.5230/jgc.2013.13.1.65 Correspondence to: Asim Shabbir Department of Surgery, National University Hospital, Singapore NUHS  Tower Block, Level 8, 1E Kent Ridge Road, Singapore 119228 Tel: +65-6772-4240, Fax: +65-6777-8427 E-mail: cfsasim@nus.edu.sg Received September 18, 2012 Revised November 15, 2012 Accepted December 1, 2012 Copyrights © 2013 by The Korean Gastric Cancer Association www.jgc-online.org This is an open-access article distributed under the terms of the Creative Commons Attribution Non-Commercial License (http://creativecommons.org/ licenses/by-nc/3.0) which permits unrestricted noncommercial use, distribution, and reproduction in any medium, provided the original work is properly cited.Introduction Gastric carcinoma rarely presents with perforation.",Non-OADS,/arxiv_data1/oa_pdf/a4/3e/jgc-13-65.PMC3627809.pdf
"Key Words:  Carcinosarcoma; Stomach; ImmunohistochemistryJ Gastric Cancer 2013;13(1):69-72  http://dx.doi.org/10.5230/jgc.2013.13.1.69 Correspondence to: Woo Yong Lee Department of Surgery, Inje University Paik Hospital, Inje University  College of Medicine, 9, Mareunnae-ro, Jung-gu, Seoul 100-032, Korea Tel: +82-2-2270-0247, Fax: +82-2-2270-0250 E-mail: yongaaa5972@naver.com Received August 29, 2012 Revised November 21, 2012 Accepted December 1, 2012 Copyrights © 2013 by The Korean Gastric Cancer Association www.jgc-online.org This is an open-access article distributed under the terms of the Creative Commons Attribution Non-Commercial License (http://creativecommons.org/ licenses/by-nc/3.0) which permits unrestricted noncommercial use, distribution, and reproduction in any medium, provided the original work is properly cited.",Non-OADS,/arxiv_data1/oa_pdf/d3/27/jgc-13-69.PMC3627810.pdf
"S405Surgical Neurology International  SNI: Revista Argentina de Neurocirugia , a supplement to SNIEditor: R. Torino,Hospital Británico, Buenos Aires, ArgentinaOPEN ACCESS For entire Editorial Board visit :    http://www.surgicalneurologyint.comAbstract Background:  Cervical foraminotomy is an operation designed to decompress  a single or multiple cervical nerve roots from a posterior approach.",Non-OADS,/arxiv_data1/oa_pdf/de/2d/SNI-3-405.PMC3627813.pdf
Available FREE in open access from: http://www.surgicalneurologyint.com/text.asp?2012/3/7/405/104406 Copyright: © 2012 Campero A.,Non-OADS,/arxiv_data1/oa_pdf/de/2d/SNI-3-405.PMC3627813.pdf
"S400 Surgical Neurology International Editor: R. Torino,Hospital Británico, Buenos Aires, ArgentinaOPEN ACCESS For entire Editorial Board visit :    http://www.surgicalneurologyint.com SNI: Revista Argentina de Neurocirugia , a supplement to SNIAbstract Background: Hypoglossal‑facial anastomosis is the gold standard treatment for  facial reanimation in those cases where the facial nerve has been damaged near the brainstem.",Non-OADS,/arxiv_data1/oa_pdf/7e/c8/SNI-3-400.PMC3627814.pdf
Available FREE in open access from: http://www.surgicalneurologyint.com/text.asp?2012/3/7/400/104405 Copyright: © 2012 Campero A.,Non-OADS,/arxiv_data1/oa_pdf/7e/c8/SNI-3-400.PMC3627814.pdf
"S395 Surgical Neurology International  SNI: Revista Argentina de Neurocirugia , a supplement to SNIEditor: R. Torino, Hospital Británico, Buenos Aires, ArgentinaOPEN ACCESS For entire Editorial Board visit :    http://www.surgicalneurologyint.comAbstract Background:  Tension pneumocephalus is uncommon after transsphenoidal  surgery.",Non-OADS,/arxiv_data1/oa_pdf/26/52/SNI-3-395.PMC3627815.pdf
Available FREE in open access from: http://www.surgicalneurologyint.com/text.asp?2012/3/7/395/104404 Copyright: © 2012 Campero A.,Non-OADS,/arxiv_data1/oa_pdf/26/52/SNI-3-395.PMC3627815.pdf
"S389 Surgical Neurology International  SNI: Revista Argentina de Neurocirugia , a supplement to SNIEditor: R. Torino, Hospital Británico, Buenos Aires, ArgentinaOPEN ACCESS For entire Editorial Board visit :    http://www.surgicalneurologyint.comAbstract Background:  To explain the technique used and to describe the outcome of the  first 52 patients who underwent endoscopic transnasal surgery to treat pituitary  tumors at our institution.",Non-OADS,/arxiv_data1/oa_pdf/cf/09/SNI-3-389.PMC3627816.pdf
"Available FREE in open access from: http://www.surgicalneurologyint.com/text.asp?2012/3/7/389/104403 Copyright: © 2012 Ajler P. This is an open-access article distributed under the terms of the Creative Commons Attribution License, which permits unrestricted use, distribution,  and reproduction in any medium, provided the original author and source are credited.",Non-OADS,/arxiv_data1/oa_pdf/cf/09/SNI-3-389.PMC3627816.pdf
uni-bonn.de/dtc/pri msurg/index.html :http://www.meb.,Non-OADS,/arxiv_data1/oa_pdf/e6/5e/423_2013_Article_1050.PMC3627856.pdf
On http://www.europe.stryker.com/i-suite .,Non-OADS,/arxiv_data1/oa_pdf/17/7b/423_2013_Article_1059.PMC3627858.pdf
"Nutrition Research and Practice ( Nutr Res Pract ) 2013;7(2):103-108 http://dx.doi.org/10.4162/nrp.2013.7.2.103 pISSN 1976-1457 eISSN 2005-6168 The antidiabetic effects of an herbal formula composed of  Alnus hirsuta , Rosa davurica , Acanthopanax senticosus  and Panax schinseng  in the streptozotocin-induced diabetic  rats Weicheng Hu*, Jin-Hee Yeo*, Yunyao Jiang, Seong-Il Heo and Myeong-Hyeon Wang§ Department of Medical Biotechnology, College of Biomedical Science, Kangwon National University, 192-1 Hyoja-dong,  Chuncheon, Gangwon 200-701, Korea Abstract A folk prescription consisting of  Alnus hirsuta , Rosa davurica , Acanthopanax senticosus  and Panax schinseng  has been used in the treatmen t  of diabetes mellitus.",Non-OADS,/arxiv_data1/oa_pdf/55/86/nrp-7-103.PMC3627926.pdf
"Nutrition Research and Practice ( Nutr Res Pract ) 2013;7(2):109-114 http://dx.doi.org/10.4162/nrp.2013.7.2.109 pISSN 1976-1457 eISSN 2005-6168 Effects of vitamin C and E supplementation on oxidative stress and liver toxicity i n  rats fed a low-fat ethanol diet Soo-Jung Lee, Seon-Young Kim and Hyesun Min§ Department of Food and Nutrition, College of Bio-Nano Science,  Hannam University, 461-6 Jeonmin-dong, Yuseong-gu, Daejeon  305-811, Korea Abstract We compared the preventive capacity of high intakes of vitamin C (VC) and vitamin E (VE) on oxidative stress and liver toxicity  in rats fe d a low-fat ethanol diet.",Non-OADS,/arxiv_data1/oa_pdf/9e/d4/nrp-7-109.PMC3627927.pdf
"Nutrition Research and Practice ( Nutr Res Pract ) 2013;7(2):115-121 http://dx.doi.org/10.4162/nrp.2013.7.2.115 pISSN 1976-1457 eISSN 2005-6168 Characterization of food allergies in patients with atopic dermatitis Jaryoung Kwon1, Jungyun Kim2, Sunheui Cho1, Geunwoong Noh3 and Sang Sun Lee1§ 1Department of Food and Nutrition, Hanyang Unive rsity, 17 Haengdang-dong, Seongdong-gu, Seoul 133-791, Korea 2Department of Food and Nutrition, Seojeong College, Yangju 482-777, Korea 3Division of Allergy and Clinical Immunology, Department of Pediatrics, Chungnam National University Hospital, Daejeon  301-721, Korea  Abstract We examined the characteristics of food allergy prevalence and suggested the basis of dietary guidelines for patients with food  allergies and  atopic dermatitis.",Non-OADS,/arxiv_data1/oa_pdf/20/fd/nrp-7-115.PMC3627928.pdf
"Nutrition Research and Practice ( Nutr Res Pract ) 2013;7(2):122-131 http://dx.doi.org/10.4162/nrp.2013.7.2.122 pISSN 1976-1457 eISSN 2005-6168 Prevalence of child malnutrition in agro-pastoral households in Afar Regional State o f  Ethiopia Rabia Fentaw1, Ayalneh Bogale2§ and Degnet Abebaw3 1Afar Pastoral and Agro-pastoral Research Institute, Samera, Ethiopia 2African Centre for Food Security, University of KwaZul u-Natal, Private Bag X01, Pietermaritzburg, South Africa 3Ethiopian Economic Policy Research Institute, Addis Ababa, Ethiopia Abstract Based on data generated from 180 randomly selected households with children age under five years old in Aysaita district of Afa r region o f Ethiopia, this study explored prevalence of malnutrition and scrutinized household characteristics, maternal characteristics, s pecifics of the child an d economic variables associated with child malnutrition.",Non-OADS,/arxiv_data1/oa_pdf/91/1b/nrp-7-122.PMC3627929.pdf
Available from: http://www.unsystem.org/scn/Publications/UN_Report.PDF.,Non-OADS,/arxiv_data1/oa_pdf/91/1b/nrp-7-122.PMC3627929.pdf
Available from: http://www.answers.com/topic/ malnutrition.,Non-OADS,/arxiv_data1/oa_pdf/91/1b/nrp-7-122.PMC3627929.pdf
"Nutrition Research and Practice ( Nutr Res Pract ) 2013;7(2):132-138 http://dx.doi.org/10.4162/nrp.2013.7.2.132 pISSN 1976-1457 eISSN 2005-6168 Assessing the children’s views on foods and consumption of selected food groups:  outcome from focus group approach Sharifah Intan Zainun Sharif Ishak1, Shamarina Shohaimi1§ and Mirnalini Kandiah2  1Department of Biology, Faculty of Science, Universi ty Putra Malaysia, 43400 UPM Serdang, Selangor, Malaysia 2Department of Food Science and Nutrition, Faculty of Applied Sciences, UCSI University, Malaysia Abstract The food choices in childhood have high a probability of being carried through into their adulthood life, which then contribute s to the risk o f  many non-communicable diseases.",Non-OADS,/arxiv_data1/oa_pdf/17/bc/nrp-7-132.PMC3627930.pdf
"Nutrition Research and Practice ( Nutr Res Pract ) 2013;7(2):139-145 http://dx.doi.org/10.4162/nrp.2013.7.2.139 pISSN 1976-1457 eISSN 2005-6168 Gender specific effect of major dietary patterns on the metabolic syndrome risk i n  Korean pre-pubertal children Soo Jin Park1*, Seung Min Lee2*, Seon Mee Kim3 and Myoungsook Lee2§ 1Department of Oriental Medical Food and Nutrition, Semyung University, Jecheon 390-711, Korea 2Department of Food and Nutrition, Sungshin Women’s Un iversity, 147 Mia-dong, Gangbuk-gu, Seoul 142-732, Korea 3Department of Family Medicine, Korea University, Guro-Hospital, Seoul 136-705, Korea Abstract There is a lack of data on metabolic risk factors during pre-puberty, which is important for identifying the subgroups of youth , at whom earl y interventions should be targeted.",Non-OADS,/arxiv_data1/oa_pdf/51/be/nrp-7-139.PMC3627931.pdf
"Nutrition Research and Practice ( Nutr Res Pract ) 2013;7(2):146 http://dx.doi.org/10.4162/nrp.2013.7.2.146pISSN 1976-1457 eISSN 2005-6168 Erratum: Lutein decreases oxidative stress and inflammation in liver and eyes of guinea pigs fed a hypercholesterolemic diet Jung Eun Kim, Richard M. Clark, Youngki Park, Jiyoung Lee and Maria Luz Fernandez Department of Nutritional Sciences, University of Connecticut, 3624 Horsebarn Rd ext, Storrs, CT 06269, USA http://dx.doi.org/10.4162/nrp.2012.6.2.113 Nutr Res Pract 2012;6:113-119 This article was initially published on Nutrition Research and Practice with mistyped concentration of lutein used in the study .",Non-OADS,/arxiv_data1/oa_pdf/5a/cf/nrp-7-146.PMC3627932.pdf
"Short CommunicationNutrition Research and Practice ( Nutr Res Pract ) 2013;7(2):77-81 http://dx.doi.org/10.4162/nrp.2013.7.2.77 pISSN 1976-1457 eISSN 2005-6168 Short-term impact of sugar consumption on hunger and ad libitum food intake i n  young women Fernanda RO Penaforte1,2§, Camila C Japur1,3, Letícia P Pigatto2, Paula G Chiarello3 and Rosa W Diez-Garcia1,3 1Laboratory of Eating Practices and Behavior (PratiCA), Course of Nutrition and Metabolism, University of São Paulo, Ribeirã o Preto, SP, Brazil 2Department of Nutrition, Federal University of Triângulo Mineiro, Uberaba, MG, Brazil 3Course of Nutrition and Metabolism, University of São Paulo, Ribeirão Preto, SP, Brazil Abstract The hypothesis of this study was that greater sugar consumption at breakfast promotes a stronger sensation of hunger and a late r increase i n energy consumption.",Non-OADS,/arxiv_data1/oa_pdf/38/a4/nrp-7-77.PMC3627933.pdf
"Nutrition Research and Practice ( Nutr Res Pract ) 2013;7(2):82-88 http://dx.doi.org/10.4162/nrp.2013.7.2.82 pISSN 1976-1457 eISSN 2005-6168 Chemical composition of nuts and seeds sold in Korea Keun Hee Chung§*, Kyung Ok Shin*, Hyo Jeong Hwang and Kyung-Soon Choi Department of Food and Nutrition, Sahmyook Universi ty, 815, Hwarang-ro, Nowon-gu, Seoul 139-742, Korea  Abstract Eleven types of nuts and seeds were analyzed to determine their energy (326-733 mg), moisture (1.6-18.3 mg), carbohydrate (8.8- 70.9 mg), protein (4.9-30.5 mg), lipid (2.5-69.8 mg), and ash (1.2-5.5 mg) contents per 100 g of sample.",Non-OADS,/arxiv_data1/oa_pdf/c9/9f/nrp-7-82.PMC3627934.pdf
"Nutrition Research and Practice ( Nutr Res Pract ) 2013;7(2):89-95 http://dx.doi.org/10.4162/nrp.2013.7.2.89 pISSN 1976-1457 eISSN 2005-6168 Inorganic sulfur reduces cell proliferation by inhibiting of ErbB 2 and ErbB 3 protein an d mRNA expression in MDA-MB-231 human breast cancer cells Ae Wha Ha1, Kyung Hee Hong2, Hee Sun Kim2 and Woo Kyoung Kim1§ 1Department of Food Science and Nutrition, Dankook Universi ty, 126 Jukjeon-dong, Suji-gu, Yongin-si, Gyunggi 448-701, Korea 2Department of Food and Nutrition, Beawha Women’s University, Seoul 110-735, Korea Abstract Dietary inorganic sulfur is the minor component in our diet, but some studies suggested that inorganic sulfur is maybe effectiv e to treat cancer  related illness.",Non-OADS,/arxiv_data1/oa_pdf/d7/3b/nrp-7-89.PMC3627935.pdf
"Nutrition Research and Practice ( Nutr Res Pract ) 2013;7(2):96-102 http://dx.doi.org/10.4162/nrp.2013.7.2.96 pISSN 1976-1457 eISSN 2005-6168 Inhibitory effects of Capsicum annuum L. water extracts on lipoprotein lipase activity  in 3T3-L1 cells Jongmi Baek1, Jaesung Lee1, Kyoungkon Kim1, Taewoo Kim2, Daejung Kim2, Cheonan Kim3, Kanazawa Tsutomu4,  Sarangowa Ochir4, Kooyeon Lee1, Cheol Ho Park1, Yong-Jik Lee2 and Myeon Choe1,2,§ 1Divison of Bio-Health Technology, College of Biomedical Science, Kangwon National University, 192-1 Hyoja-dong, Chuncheon-si, Gangwon 200-701, Korea 2Well-Being Bioproducts RIC Center, Kangwon National University, Gangwon 225-874, Korea 3Enzymebio Co., LTD, Chuncheon, Gangwon 200-870, Korea 4Kitami Institute of Technology, 165 Koen-cho, Kitami 090-8507, Japan Abstract Obesity, an intractable metabolic disease, currently has no medical treatment without side effects, so studies have been active ly carried out to  find natural compounds that have anti-obesity activity with minimu m side effects.",Non-OADS,/arxiv_data1/oa_pdf/45/ad/nrp-7-96.PMC3627936.pdf
"Among the five Arabidopsis  MSIL proteins [12-14], MSI2  and MSI3 are related genes, although their functions are not yet known.MSI4  and MSI5 are also related genes, and MSI4 is an allelic gene of FVE , which functions in the autonomous Mycobiology 2013 March, 41(1): 1-12 http://dx.doi.org/10.5941/MYCO.2013.41.1.1 pISSN 1229-8093  eISSN 2092-9323 © The Korean Society of Mycology *Corresponding author E-mail: ysbahn@yonsei.ac.kr †D.-H. Yang and S. Maeng contributed equally to this work.",Non-OADS,/arxiv_data1/oa_pdf/c7/b8/mb-41-1.PMC3627964.pdf
Each fungal MSIL protein sequence was retrieved by protein blast search (blastp) using the Saccharomyces cerevisiae  Msi1 protein sequence as the query in the NCBI database (http://blast.ncbi.nlm.nih.gov/Blast.cgi) and Phanerochaete chrysosporium  database JGI (http://genome.jgi-psf.org/Phchr1/Phchr1.info.html).,OADS,/arxiv_data1/oa_pdf/c7/b8/mb-41-1.PMC3627964.pdf
"Spot test reactions wereconducted to investigate the thalli under a compoundmicroscope, and thin layer chromatography (TLC) wasResearch Article Mycobiology 2013 March, 41(1): 13-17 http://dx.doi.org/10.5941/MYCO.2013.41.1.13pISSN 1229-8093  eISSN 2092-9323 © The Korean Society of Mycology *Corresponding author E-mail: jshur1@sunchon.ac.kr Received  November 15, 2012 Accepted  December 20, 2012 This is an Open Access article distributed under the terms of the Creative Commons Attribution Non-Commercial License (http://creativecommons.org/licenses/by-nc/3.0/) which permits unrestricted non-commercial use, distribution, and reproduction in any medium, provided the original work is properly cited.",Non-OADS,/arxiv_data1/oa_pdf/61/4a/mb-41-13.PMC3627965.pdf
Available from: http://archive.fieldmuseum.org/ticolichen/checklist.html.,Non-OADS,/arxiv_data1/oa_pdf/61/4a/mb-41-13.PMC3627965.pdf
"For surface sterilization, the segmentswere soaked in 95% ethanol for 1 min, then in sodiumhypochlorite (4% available chlorine) for 3 min, and 95%Mycobiology 2013 March, 41(1): 18-24 http://dx.doi.org/10.5941/MYCO.2013.41.1.18 pISSN 1229-8093  eISSN 2092-9323 © The Korean Society of Mycology *Corresponding author E-mail: shunyu@cnu.ac.kr Received  December 7, 2012 Revised  December 28, 2012 Accepted  December 31, 2012 This is an Open Access article distributed under the terms of the Creative Commons Attribution Non-Commercial License (http:// creativecommons.org/licenses/by-nc/3.0/) which permits unrestrictednon-commercial use, distribution, and reproduction in any medium, provided the original work is properly cited.",Non-OADS,/arxiv_data1/oa_pdf/a0/5f/mb-41-18.PMC3627966.pdf
"Thus, a total of 18 species ofMycobiology 2013 March, 41(1): 25-36 http://dx.doi.org/10.5941/MYCO.2013.41.1.25 pISSN 1229-8093  eISSN 2092-9323 © The Korean Society of Mycology *Corresponding author E-mail: jshur1@sunchon.ac.kr Received  November 15, 2012 Revised  December 26, 2012 Accepted  January 8, 2013 This is an Open Access article distributed under the terms of the Creative Commons Attribution Non-Commercial License (http:// creativecommons.org/licenses/by-nc/3.0/) which permits unrestrictednon-commercial use, distribution, and reproduction in any medium, provided the original work is properly cited.",Non-OADS,/arxiv_data1/oa_pdf/7d/e9/mb-41-25.PMC3627967.pdf
"Mycobiology 2013 March, 41(1): 37-41 http://dx.doi.org/10.5941/MYCO.2013.41.1.37 pISSN 1229-8093  eISSN 2092-9323 © The Korean Society of Mycology *Corresponding author E-mail: kanghw2@hknu.ac.kr Received  November 10, 2012 Revised  November 17, 2012 Accepted  January 22, 2013 This is an Open Access article distributed under the terms of the Creative Commons Attribution Non-Commercial License (http:// creativecommons.org/licenses/by-nc/3.0/) which permits unrestrictednon-commercial use, distribution, and reproduction in any medium, provided the original work is properly cited.",Non-OADS,/arxiv_data1/oa_pdf/81/2c/mb-41-37.PMC3627968.pdf
DNAsequences and the deduced protein sequences obtained inthis study were compared using the National Center forBiotechnology Information (NCBI) BLAST network sources (http://www.ncbi.nlm.nih.gov/BLAST).,OADS,/arxiv_data1/oa_pdf/81/2c/mb-41-37.PMC3627968.pdf
"Of them, aputative laccase gene, fvlac7 , was spliced with the mRNA from genomic DNA using an online analysis tools program(http://molbiol-tools.ca/).",OADS,/arxiv_data1/oa_pdf/81/2c/mb-41-37.PMC3627968.pdf
"The FWC was produced by aerobiccomposting using municipal-source separated food wasteMycobiology 2013 March, 41(1): 42-46 http://dx.doi.org/10.5941/MYCO.2013.41.1.42 pISSN 1229-8093  eISSN 2092-9323 © The Korean Society of Mycology *Corresponding author E-mail: johnghwa@kangwon.ac.kr Received  September 28, 2012 Revised  December 13, 2012 Accepted  December 25, 2012 This is an Open Access article distributed under the terms of the Creative Commons Attribution Non-Commercial License (http:// creativecommons.org/licenses/by-nc/3.0/) which permits unrestrictednon-commercial use, distribution, and reproduction in any medium, provided the original work is properly cited.",Non-OADS,/arxiv_data1/oa_pdf/b3/ea/mb-41-42.PMC3627969.pdf
"Recently, the growing concernover the use of pesticides to human health and environmenthas brought increasing interest in the use of alternativescharacterized with negative impact on the environment.Therefore, present activity focuses on finding compounds Mycobiology 2013 March, 41(1): 47-55 http://dx.doi.org/10.5941/MYCO.2013.41.1.47pISSN 1229-8093  eISSN 2092-9323 © The Korean Society of Mycology *Corresponding author E-mail: fowzy_2008@yahoo.com Received  January 14, 2013 Accepted  February 13, 2013 This is an Open Access article distributed under the terms of the Creative Commons Attribution Non-Commercial License (http://creativecommons.org/licenses/by-nc/3.0/) which permits unrestricted non-commercial use, distribution, and reproduction in any medium, provided the original work is properly cited.",Non-OADS,/arxiv_data1/oa_pdf/de/6c/mb-41-47.PMC3627970.pdf
"Ascomata apothecioid, numerous, sessile, small lirellate, mostly scattered,scarcely aggregate, simple or infrequently branched, 1.5~ Mycobiology 2013 March, 41(1): 56-58 http://dx.doi.org/10.5941/MYCO.2013.41.1.56pISSN 1229-8093  eISSN 2092-9323 © The Korean Society of Mycology *Corresponding author E-mail: jshur1@sunchon.ac.kr Received  October 24, 2012 Revised  December 6, 2012 Accepted  December 26, 2012 This is an Open Access article distributed under the terms of the Creative Commons Attribution Non-Commercial License (http:// creativecommons.org/licenses/by-nc/3.0/) which permits unrestrictednon-commercial use, distribution, and reproduction in any medium, provided the original work is properly cited.",Non-OADS,/arxiv_data1/oa_pdf/40/19/mb-41-56.PMC3627971.pdf
"Toaccomplish this, micromorphological characteristics of theisolate DUCC1302 were observed using a phase-contrastmicroscope (Axioskop 40; Carl Zeiss, Jena, Germany), ad i s s e c t i n g  m i c r o s c o p e  ( S Z 2 - I L S T ;  O l y m p u s ,  T o k y o ,  J a p a n ) Mycobiology 2013 March, 41(1): 59-62 http://dx.doi.org/10.5941/MYCO.2013.41.1.59 pISSN 1229-8093  eISSN 2092-9323 © The Korean Society of Mycology *Corresponding author E-mail: piceae@dankook.ac.kr Received  February 17, 2013 Revised  March 6, 2013 Accepted  March 6, 2013 This is an Open Access article distributed under the terms of the Creative Commons Attribution Non-Commercial License (http:// creativecommons.org/licenses/by-nc/3.0/) which permits unrestrictednon-commercial use, distribution, and reproduction in any medium, provided the original work is properly cited.",Non-OADS,/arxiv_data1/oa_pdf/2f/a0/mb-41-59.PMC3627972.pdf
"A BLAST search of the GenBank database(http://www.ncbi.nlm.nih.gov/genbank/) using the determinedsequence revealed that the highest similarity (98%) waswith that of Ophiostoma ips  (Rumbold) Nannf; therefore, we identified DUCC1302 as Ophiostoma ips .",OADS,/arxiv_data1/oa_pdf/2f/a0/mb-41-59.PMC3627972.pdf
"The environmental conditions of the growth chamberMycobiology 2013 March, 41(1): 63-66 http://dx.doi.org/10.5941/MYCO.2013.41.1.63 pISSN 1229-8093  eISSN 2092-9323 © The Korean Society of Mycology *Corresponding author E-mail: plant119@gg.go.kr Received  November 15, 2012 Revised  December 7, 2012 Accepted  January 23, 2013 This is an Open Access article distributed under the terms of the Creative Commons Attribution Non-Commercial License (http:// creativecommons.org/licenses/by-nc/3.0/) which permits unrestrictednon-commercial use, distribution, and reproduction in any medium, provided the original work is properly cited.",Non-OADS,/arxiv_data1/oa_pdf/74/12/mb-41-63.PMC3627973.pdf
All authors analyzed the results and wrote the article Additional information Supplementary information accompanies this paper at http://www.nature.com/ scientificreports Competing financial interests: The authors declare no competing financial interests.,Non-OADS,/arxiv_data1/oa_pdf/70/8a/srep01668.PMC3627974.pdf
"To view a copy of thislicense, visit http://creativecommons.org/licenses/by-nc-nd/3.0/ How to cite this article: Schultz, D., Lu, M., Onuchic, T.S.J.",Non-OADS,/arxiv_data1/oa_pdf/70/8a/srep01668.PMC3627974.pdf
"INJ This is an Open Access article distributed under the terms of the Creative Commons Attri - bution Non-Commercial License (http://creativecommons.org/licenses/by-nc/3.0/) which  permits unrestricted non-commercial use, distribution, and reproduction in any medium,  provided the original work is properly cited.",Non-OADS,/arxiv_data1/oa_pdf/38/99/inj-17-1.PMC3627991.pdf
J Androl 2005;26:664-70.Editorial  http://dx.doi.org/10.5213/inj.2013.17.1.1 pISSN 2093-4777 · eISSN 2093-6931,Non-OADS,/arxiv_data1/oa_pdf/38/99/inj-17-1.PMC3627991.pdf
"INJ This is an Open Access article distributed under the terms of the Creative Commons Attri - bution Non-Commercial License (http://creativecommons.org/licenses/by-nc/3.0/) which  permits unrestricted non-commercial use, distribution, and reproduction in any medium,  provided the original work is properly cited.",Non-OADS,/arxiv_data1/oa_pdf/29/c9/inj-17-11.PMC3627992.pdf
"Bladder training (BT) has been proven to improve urge  urinary incontinence, and resolution rates have been reported Original Article http://dx.doi.org/10.5213/inj.2013.17.1.11 pISSN 2093-4777 · eISSN 2093-6931",Non-OADS,/arxiv_data1/oa_pdf/29/c9/inj-17-11.PMC3627992.pdf
"•  The Effect of Bladder Drill on Overactive Bladder http://dx.doi.org/10.5213/inj.2013.17.1.11INJ to range from 12% to 73%, and improvement rates from 57% to  87% [5].",Non-OADS,/arxiv_data1/oa_pdf/29/c9/inj-17-11.PMC3627992.pdf
The ICIQ questionnaires were previously linguistically  validated by bilingual translators and approved for use by the  International Consultation on Incontinence Modular Ques - tionnaire Advisory Board (http://www.iciq.net/index.html).,Non-OADS,/arxiv_data1/oa_pdf/29/c9/inj-17-11.PMC3627992.pdf
•  The Effect of Bladder Drill on Overactive Bladder http://dx.doi.org/10.5213/inj.2013.17.1.11INJ Table 1.,Non-OADS,/arxiv_data1/oa_pdf/29/c9/inj-17-11.PMC3627992.pdf
•  The Effect of Bladder Drill on Overactive Bladder http://dx.doi.org/10.5213/inj.2013.17.1.11INJ developed originally for the treatment of urge incontinence.,Non-OADS,/arxiv_data1/oa_pdf/29/c9/inj-17-11.PMC3627992.pdf
•  The Effect of Bladder Drill on Overactive Bladder http://dx.doi.org/10.5213/inj.2013.17.1.11INJ Table 3.,Non-OADS,/arxiv_data1/oa_pdf/29/c9/inj-17-11.PMC3627992.pdf
•  The Effect of Bladder Drill on Overactive Bladder http://dx.doi.org/10.5213/inj.2013.17.1.11INJ sessions of BT was obtained by a follow-up telephone interview.,Non-OADS,/arxiv_data1/oa_pdf/29/c9/inj-17-11.PMC3627992.pdf
"•  The Effect of Bladder Drill on Overactive Bladder http://dx.doi.org/10.5213/inj.2013.17.1.11INJ iOAB is effective in improving QoL, work productivity, and  voiding symptoms, and is perceived to be useful in improving  symptoms.",Non-OADS,/arxiv_data1/oa_pdf/29/c9/inj-17-11.PMC3627992.pdf
"INJ This is an Open Access article distributed under the terms of the Creative Commons Attri - bution Non-Commercial License (http://creativecommons.org/licenses/by-nc/3.0/) which  permits unrestricted non-commercial use, distribution, and reproduction in any medium,  provided the original work is properly cited.",Non-OADS,/arxiv_data1/oa_pdf/5d/cd/inj-17-18.PMC3627993.pdf
"Keywords:  Stress urinary incontinence; Suburethral slings; Recurrence  Corresponding author:  Kwang Taek Kim Department of Urology, Gachon University Gil Medical Center,   Gachon University of Medicine and Science, 21 Namdong-daero 774beon-gil,  Namdong-gu, Incheon 405-760, Korea Tel: +82-32-460-3334 / Fax: +82-32-460-8340 / E-mail: shinekkt@gmail.com Co-corresponding author:  Khae Hawn Kim Department of Urology, Gachon University Gil Medical Center,   Gachon University of Medicine and Science, 21 Namdong-daero 774beon-gil,  Namdong-gu, Incheon 405-760, Korea Tel: +82-32-460-3334 / Fax: +82-32-460-8340,   E-mail: kimcho99@gilhospital.com Submitted:  March 7, 2013 / Accepted after revision:  March 26, 2013INTRODUCTION Since Ulmsten described the tension-free vaginal tape (TVT) procedure in 1995, midurethral synthetic sling (MUS) proce - dures, including the transobturator tape (TOT) procedure, have  grown in acceptance and popularity for stress urinary inconti -Original Article http://dx.doi.org/10.5213/inj.2013.17.1.18 pISSN 2093-4777 · eISSN 2093-6931",Non-OADS,/arxiv_data1/oa_pdf/5d/cd/inj-17-18.PMC3627993.pdf
•  Canal Transobturator Tape in Persistent Stress Urinary Incontinence http://dx.doi.org/10.5213/inj.2013.17.1.18INJ nence (SUI) surgery.,Non-OADS,/arxiv_data1/oa_pdf/5d/cd/inj-17-18.PMC3627993.pdf
•  Canal Transobturator Tape in Persistent Stress Urinary Incontinence http://dx.doi.org/10.5213/inj.2013.17.1.18INJ moved and most patients were discharged.,Non-OADS,/arxiv_data1/oa_pdf/5d/cd/inj-17-18.PMC3627993.pdf
•  Canal Transobturator Tape in Persistent Stress Urinary Incontinence http://dx.doi.org/10.5213/inj.2013.17.1.18INJ urethra by its hammock-like supportive layer [5].,Non-OADS,/arxiv_data1/oa_pdf/5d/cd/inj-17-18.PMC3627993.pdf
•  Canal Transobturator Tape in Persistent Stress Urinary Incontinence http://dx.doi.org/10.5213/inj.2013.17.1.18INJ study was 85.90±13.10 cmH 2O.,Non-OADS,/arxiv_data1/oa_pdf/5d/cd/inj-17-18.PMC3627993.pdf
•  Canal Transobturator Tape in Persistent Stress Urinary Incontinence http://dx.doi.org/10.5213/inj.2013.17.1.18INJ patients had TOT surgery and 1 patient had TVT surgery.,Non-OADS,/arxiv_data1/oa_pdf/5d/cd/inj-17-18.PMC3627993.pdf
"INJ This is an Open Access article distributed under the terms of the Creative Commons Attri - bution Non-Commercial License (http://creativecommons.org/licenses/by-nc/3.0/) which  permits unrestricted non-commercial use, distribution, and reproduction in any medium,  provided the original work is properly cited.",Non-OADS,/arxiv_data1/oa_pdf/ed/84/inj-17-2.PMC3627994.pdf
"Besides PDMS, a trans - parent elastomer that has been the main choice of material for  microdevice fabrication owing to easy replicability, PMMA has  also been widely adopted for microfluidic applications such as  DNA separation [30,32,34,37-40], detection [30,40,41], on-chip Review Article http://dx.doi.org/10.5213/inj.2013.17.1.2 pISSN 2093-4777 · eISSN 2093-6931",Non-OADS,/arxiv_data1/oa_pdf/ed/84/inj-17-2.PMC3627994.pdf
"www.einj.org     3 Lee  •  Lab-on-a-Chip for Clinical Diagnoses http://dx.doi.org/10.5213/inj.2013.17.1.2INJ PCR [42,43], and cell culture [44] owing to its particularly sim - ple and versatile fabrication procedures, which include hot em - bossing [45-47], injection molding [48,49], laser ablation [50,51],  reactive ion etching [52], and deep ultraviolet (UV) lithography  [53].",Non-OADS,/arxiv_data1/oa_pdf/ed/84/inj-17-2.PMC3627994.pdf
4    www.einj.orgLee  •  Lab-on-a-Chip for Clinical Diagnoses http://dx.doi.org/10.5213/inj.2013.17.1.2INJ two PDMS substrates in a vertical arrangement [11] (Fig.,Non-OADS,/arxiv_data1/oa_pdf/ed/84/inj-17-2.PMC3627994.pdf
"www.einj.org     5 Lee  •  Lab-on-a-Chip for Clinical Diagnoses http://dx.doi.org/10.5213/inj.2013.17.1.2INJ plify the heating apparatuses, the issue of sample injection or  actuation remains a bottleneck when enhancing the portability  of the device.",Non-OADS,/arxiv_data1/oa_pdf/ed/84/inj-17-2.PMC3627994.pdf
6    www.einj.orgLee  •  Lab-on-a-Chip for Clinical Diagnoses http://dx.doi.org/10.5213/inj.2013.17.1.2INJ MICRODEVICE ASSEMBLY Bonding is one of the critical issues in microfluidic device fabri - cation.,Non-OADS,/arxiv_data1/oa_pdf/ed/84/inj-17-2.PMC3627994.pdf
www.einj.org     7 Lee  •  Lab-on-a-Chip for Clinical Diagnoses http://dx.doi.org/10.5213/inj.2013.17.1.2INJ sizing of the device footprint and replaced the use of bulky and  expensive peripheral accessories such as a pump and heaters.,Non-OADS,/arxiv_data1/oa_pdf/ed/84/inj-17-2.PMC3627994.pdf
8    www.einj.orgLee  •  Lab-on-a-Chip for Clinical Diagnoses http://dx.doi.org/10.5213/inj.2013.17.1.2INJ crochip capillary electrophoresis.,Non-OADS,/arxiv_data1/oa_pdf/ed/84/inj-17-2.PMC3627994.pdf
www.einj.org     9 Lee  •  Lab-on-a-Chip for Clinical Diagnoses http://dx.doi.org/10.5213/inj.2013.17.1.2INJ Enzymatic amplification of beta-globin genomic sequences and re - striction site analysis for diagnosis of sickle cell anemia.,OADS,/arxiv_data1/oa_pdf/ed/84/inj-17-2.PMC3627994.pdf
10    www.einj.orgLee  •  Lab-on-a-Chip for Clinical Diagnoses http://dx.doi.org/10.5213/inj.2013.17.1.2INJ 83.,Non-OADS,/arxiv_data1/oa_pdf/ed/84/inj-17-2.PMC3627994.pdf
"INJ This is an Open Access article distributed under the terms of the Creative Commons Attri - bution Non-Commercial License (http://creativecommons.org/licenses/by-nc/3.0/) which  permits unrestricted non-commercial use, distribution, and reproduction in any medium,  provided the original work is properly cited.",Non-OADS,/arxiv_data1/oa_pdf/c6/95/inj-17-24.PMC3627995.pdf
"Accordingly, a number of mini - mally invasive therapies are being developed as alternative mo - dalities, including transrectal high-intensity focused ultrasound  (HIFU), which is now indicated for patients with localized, low- grade prostate cancer or as salvage therapy in cases of cancer Original Article http://dx.doi.org/10.5213/inj.2013.17.1.24 pISSN 2093-4777 · eISSN 2093-6931",Non-OADS,/arxiv_data1/oa_pdf/c6/95/inj-17-24.PMC3627995.pdf
•  Stricture and Holmium: YAG Laser http://dx.doi.org/10.5213/inj.2013.17.1.24INJ recurrence after radiotherapy [4-6].,Non-OADS,/arxiv_data1/oa_pdf/c6/95/inj-17-24.PMC3627995.pdf
•  Stricture and Holmium: YAG Laser http://dx.doi.org/10.5213/inj.2013.17.1.24INJ ment.,OADS,/arxiv_data1/oa_pdf/c6/95/inj-17-24.PMC3627995.pdf
"•  Stricture and Holmium: YAG Laser http://dx.doi.org/10.5213/inj.2013.17.1.24INJ most well described postoperative complications after surgical  treatment for prostate cancer, strictures of the vesicourethral  anastomosis or urethral strictures also occur frequently, with  reported incidences rate ranging from 0.4% to 32% [7,8,16,17].",Non-OADS,/arxiv_data1/oa_pdf/c6/95/inj-17-24.PMC3627995.pdf
"•  Stricture and Holmium: YAG Laser http://dx.doi.org/10.5213/inj.2013.17.1.24INJ  Routinely follow-up appointments at regular short intervals  were performed soon after the initial treatment with concomi - tant patient counseling, in order to screen for symptoms of re - currence.",Non-OADS,/arxiv_data1/oa_pdf/c6/95/inj-17-24.PMC3627995.pdf
"•  Stricture and Holmium: YAG Laser http://dx.doi.org/10.5213/inj.2013.17.1.24INJ Moreau JL, et al.",OADS,/arxiv_data1/oa_pdf/c6/95/inj-17-24.PMC3627995.pdf
"INJ This is an Open Access article distributed under the terms of the Creative Commons Attri - bution Non-Commercial License (http://creativecommons.org/licenses/by-nc/3.0/) which  permits unrestricted non-commercial use, distribution, and reproduction in any medium,  provided the original work is properly cited.",Non-OADS,/arxiv_data1/oa_pdf/77/cd/inj-17-30.PMC3627996.pdf
"Therefore, we investigated the clini - cal differences between LUTS patients with sympathetic hyper - activity and sympathetic hypoactivity.Original Article http://dx.doi.org/10.5213/inj.2013.17.1.30 pISSN 2093-4777 · eISSN 2093-6931",Non-OADS,/arxiv_data1/oa_pdf/77/cd/inj-17-30.PMC3627996.pdf
•  Imbalance of the ANS and Symptoms of LUTS http://dx.doi.org/10.5213/inj.2013.17.1.30INJ MATERIALS AND METHODS We selected 43 patients who visited an outpatient clinic for  LUTS and 49 healthy volunteers who visited the family medi - cine outpatient clinic for a general health examination.,Non-OADS,/arxiv_data1/oa_pdf/77/cd/inj-17-30.PMC3627996.pdf
•  Imbalance of the ANS and Symptoms of LUTS http://dx.doi.org/10.5213/inj.2013.17.1.30INJ bladder outlet obstruction [9].,Non-OADS,/arxiv_data1/oa_pdf/77/cd/inj-17-30.PMC3627996.pdf
•  Imbalance of the ANS and Symptoms of LUTS http://dx.doi.org/10.5213/inj.2013.17.1.30INJ imbalance in ANS activity may be a factor that cause or pro - gression of diseases in men with LUTS.,Non-OADS,/arxiv_data1/oa_pdf/77/cd/inj-17-30.PMC3627996.pdf
http://dx.doi.org/10.1007/s12529-013-9295-0.,Non-OADS,/arxiv_data1/oa_pdf/77/cd/inj-17-30.PMC3627996.pdf
http://dx.doi.org/10.1007/s12160-013-9476-8.,Non-OADS,/arxiv_data1/oa_pdf/77/cd/inj-17-30.PMC3627996.pdf
"INJ This is an Open Access article distributed under the terms of the Creative Commons Attri - bution Non-Commercial License (http://creativecommons.org/licenses/by-nc/3.0/) which  permits unrestricted non-commercial use, distribution, and reproduction in any medium,  provided the original work is properly cited.",Non-OADS,/arxiv_data1/oa_pdf/fc/88/inj-17-34.PMC3627997.pdf
"Under the spinal anesthesia, patient was placed in the lithot -Case Report http://dx.doi.org/10.5213/inj.2013.17.1.34 pISSN 2093-4777 · eISSN 2093-6931",Non-OADS,/arxiv_data1/oa_pdf/fc/88/inj-17-34.PMC3627997.pdf
•  Unroofed Midline Prostate Cyst Presenting Lower Urinary Tract Symptoms http://dx.doi.org/10.5213/inj.2013.17.1.34INJ omy position.,Non-OADS,/arxiv_data1/oa_pdf/fc/88/inj-17-34.PMC3627997.pdf
•  Unroofed Midline Prostate Cyst Presenting Lower Urinary Tract Symptoms http://dx.doi.org/10.5213/inj.2013.17.1.34INJ voiding symptoms.,Non-OADS,/arxiv_data1/oa_pdf/fc/88/inj-17-34.PMC3627997.pdf
•  Unroofed Midline Prostate Cyst Presenting Lower Urinary Tract Symptoms http://dx.doi.org/10.5213/inj.2013.17.1.34INJ REFERENCES 1.,Non-OADS,/arxiv_data1/oa_pdf/fc/88/inj-17-34.PMC3627997.pdf
"INJ This is an Open Access article distributed under the terms of the Creative Commons Attri - bution Non-Commercial License (http://creativecommons.org/licenses/by-nc/3.0/) which  permits unrestricted non-commercial use, distribution, and reproduction in any medium,  provided the original work is properly cited.",Non-OADS,/arxiv_data1/oa_pdf/99/d3/inj-17-38.PMC3627998.pdf
When the patient was queried about the possibility of self-in -Case Report http://dx.doi.org/10.5213/inj.2013.17.1.38 pISSN 2093-4777 · eISSN 2093-6931,Non-OADS,/arxiv_data1/oa_pdf/99/d3/inj-17-38.PMC3627998.pdf
"www.einj.org     39 Krishna Reddy  •  Unusual Penetrating Injury http://dx.doi.org/10.5213/inj.2013.17.1.38INJ sertion because accidental injury would be unlikely to push the  needle completely through the external genitalia, the patient  was too ashamed to admit the cause and was discharged after 2  days.",Non-OADS,/arxiv_data1/oa_pdf/99/d3/inj-17-38.PMC3627998.pdf
40    www.einj.orgKrishna Reddy  •  Unusual Penetrating Injury http://dx.doi.org/10.5213/inj.2013.17.1.38INJ serted into the genitourinary tract.,Non-OADS,/arxiv_data1/oa_pdf/99/d3/inj-17-38.PMC3627998.pdf
"INJ This is an Open Access article distributed under the terms of the Creative Commons Attri - bution Non-Commercial License (http://creativecommons.org/licenses/by-nc/3.0/) which  permits unrestricted non-commercial use, distribution, and reproduction in any medium,  provided the original work is properly cited.",Non-OADS,/arxiv_data1/oa_pdf/5c/fd/inj-17-41.PMC3627999.pdf
"However  we do it, we need to recognize that bladder failure is still a fron - tier that deserves our attention more than ever.Letter http://dx.doi.org/10.5213/inj.2013.17.1.41 pISSN 2093-4777 · eISSN 2093-6931",Non-OADS,/arxiv_data1/oa_pdf/5c/fd/inj-17-41.PMC3627999.pdf
"INJ This is an Open Access article distributed under the terms of the Creative Commons Attri - bution Non-Commercial License (http://creativecommons.org/licenses/by-nc/3.0/) which  permits unrestricted non-commercial use, distribution, and reproduction in any medium,  provided the original work is properly cited.",Non-OADS,/arxiv_data1/oa_pdf/d8/e3/inj-17-42.PMC3628000.pdf
"Jang Hwan Kim Department of Urology, Y onsei University College of Medicine E-mail: jkim@yuhs.acBook Review http://dx.doi.org/10.5213/inj.2013.17.1.42 pISSN 2093-4777 · eISSN 2093-6931",Non-OADS,/arxiv_data1/oa_pdf/d8/e3/inj-17-42.PMC3628000.pdf
To view thisﬁle please visit the journal online (http://dx.doi.org/10.1136/amiajnl-2011-000735).,Non-OADS,/arxiv_data1/oa_pdf/cc/3e/amiajnl-2011-000735.PMC3628043.pdf
"See: http://creativecommons.org/licenses/by-nc/3.0/ REFERENCES 1 Hoffman J, Doloresco F, Vermeulen L, et al.",Non-OADS,/arxiv_data1/oa_pdf/cc/3e/amiajnl-2011-000735.PMC3628043.pdf
"See: http://creativecommons.org/licenses/by-nc/3.0/ REFERENCES 1 Muller MA, Marincek B, Frauenfelder T. State of the art 3D imaging of abdominal organs.",Non-OADS,/arxiv_data1/oa_pdf/e3/fe/amiajnl-2012-001057.PMC3628048.pdf
http://www.virtualgl.org (accessed 29 Feb 2012).,Non-OADS,/arxiv_data1/oa_pdf/e3/fe/amiajnl-2012-001057.PMC3628048.pdf
Competing interests All authors have completed the Uni ﬁed Competing Interest form at http://www.icmje.org/coi_disclosure.pdf (uploaded through manuscriptcentral) and declare: no support from any organization for the submitted work; no ﬁnancial relationships with any organizations that might have an interest in the submitted work in the previous 3 years; no other relationships or activities that couldappear to have in ﬂuenced the submitted work.,Non-OADS,/arxiv_data1/oa_pdf/19/4f/amiajnl-2012-001241.PMC3628057.pdf
"See: http://creativecommons.org/ licenses/by-nc/3.0/ REFERENCES 1 Aspden P, Wolcott J, Bootman J, et al.Preventing medication errors .",Non-OADS,/arxiv_data1/oa_pdf/19/4f/amiajnl-2012-001241.PMC3628057.pdf
2010. http://edocket.access.,Non-OADS,/arxiv_data1/oa_pdf/19/4f/amiajnl-2012-001241.PMC3628057.pdf
To view please visit the journal online (http://dx.doi.org/10.1136/amiajnl-2012-001272).,Non-OADS,/arxiv_data1/oa_pdf/5e/0e/amiajnl-2012-001272.PMC3628060.pdf
"See: http://creativecommons.org/ licenses/by-nc/3.0/ REFERENCES 1 Viswanathan M, Golin CE, Jones CD, et al.",Non-OADS,/arxiv_data1/oa_pdf/5e/0e/amiajnl-2012-001272.PMC3628060.pdf
September 2012. http://www.effectivehealthcare.ahrq.gov/reports/ ﬁnal.cfm (accessed 13 September 2012).,Non-OADS,/arxiv_data1/oa_pdf/5e/0e/amiajnl-2012-001272.PMC3628060.pdf
Additional information Supplementary information accompanies this paper at http://www.nature.com/ scientificreports Competing financial interests: The authors declare no competing financial interests.,Non-OADS,/arxiv_data1/oa_pdf/01/fe/srep01677.PMC3628075.pdf
"To view a copy of this license, visit http://creativecommons.org/licenses/by-nc-nd/3.0/ How to cite this article: Andersson, M. et al.",Non-OADS,/arxiv_data1/oa_pdf/01/fe/srep01677.PMC3628075.pdf
Additional information Supplementary information accompanies this paper at http://www.nature.com/ scientificreports Competing financial interests: The authors declare no competing financial interests.License: This work is licensed under a Creative Commons Attribution-NonCommercial-NoDerivs 3.0 Unported License.,Non-OADS,/arxiv_data1/oa_pdf/86/a8/srep01673.PMC3628113.pdf
"To view a copy of thislicense, visit http://creativecommons.org/licenses/by-nc-nd/3.0/ How to cite this article: Kaur, S. et al.",Non-OADS,/arxiv_data1/oa_pdf/86/a8/srep01673.PMC3628113.pdf
"Published by Oxford University Press on behalf of the Society for Research on Nicotine and Tobacco.This is an Open Access article distributed under the terms of the Creative Commons Attribution Non-Commercial License  (http://creativecommons.org/licenses/by-nc/3.0/), which permits unrestricted non-commercial use, distribution, and reproduction  in any medium, provided the original work is properly cited.Nicotine & Tobacco Research, Volume 14, Number 7 (July 2012) xxx–8 1Nicotine & Tobacco Research 1doi: 10.1093/ntr/ntr155© The Author 2011.",Non-OADS,/arxiv_data1/oa_pdf/9c/c9/ntr155.PMC3628155.pdf
"Retrieved from http://www.dh.gov.uk/en/Managingyour organisation/Financeandplanning/Programmebudgeting/ DH_075743#_1 Dino, G., Horn, K., Abdulkadri, A., Kalsekar, I., & Branstetter, S.  (2008).",Non-OADS,/arxiv_data1/oa_pdf/9c/c9/ntr155.PMC3628155.pdf
Retrieved from http://www.statistics.gov.uk/statbase/tsdtables1.,OADS,/arxiv_data1/oa_pdf/9c/c9/ntr155.PMC3628155.pdf
"Retrieved from http://www.webcitation.org/query?url=http%  3A%2F%2Fwww.theaa.com%2Fmotoring_advice%2Frunning_costs%2Fpetrol2008.pdf&date=2010-08-24Thomas, R., & Perera, R. (2006).",OADS,/arxiv_data1/oa_pdf/9c/c9/ntr155.PMC3628155.pdf
"Optical Thin-Film Software: The Essential Macleod (Thin Film Center Inc., Version 8.18.0), http://www.thinfilmcenter.com/essential.html (accessed March 25, 2013).",Non-OADS,/arxiv_data1/oa_pdf/29/bf/srep01672.PMC3628165.pdf
"To view a copy of thislicense, visit http://creativecommons.org/licenses/by-nc-nd/3.0/ How to cite this article: Jen, Y. et al.",Non-OADS,/arxiv_data1/oa_pdf/29/bf/srep01672.PMC3628165.pdf
"Our analysis is based on two sets of data from the electronic-only journals JHEP and JSTAT (http://jhep.sissa.it; http://jstat.sissa.it), with 7908 and 2558 review requests leading to a referee report, respectively, each from roughly a three-year period.",OADS,/arxiv_data1/oa_pdf/72/1e/srep01679.PMC3628219.pdf
"To view a copy of thislicense, visit http://creativecommons.org/licenses/by-nc-nd/3.0/How to cite this article: Hartonen, T. & Alava, M.J. How important tasks are performed: peer review.",Non-OADS,/arxiv_data1/oa_pdf/72/1e/srep01679.PMC3628219.pdf
http://www.figaro.co.jp/en/ product/indexphp?mode 5search&kbn 51&type530&id5213010.,OADS,/arxiv_data1/oa_pdf/e3/27/srep01669.PMC3628220.pdf
Additional information Supplementary information accompanies this paper at http://www.nature.com/ scientificreports Competing financial interests: The authors declare no competing financial interests.,Non-OADS,/arxiv_data1/oa_pdf/e3/27/srep01669.PMC3628220.pdf
"To view a copy of thislicense, visit http://creativecommons.org/licenses/by-nc-nd/3.0/ How to cite this article: Dai, Z. et al.",Non-OADS,/arxiv_data1/oa_pdf/e3/27/srep01669.PMC3628220.pdf
Additional information Supplementary information accompanies this paper at http://www.nature.com/ scientificreports Competing financial interests: The authors declare no competing financial interests.,Non-OADS,/arxiv_data1/oa_pdf/b4/6a/srep01675.PMC3628221.pdf
"To view a copy of thislicense, visit http://creativecommons.org/licenses/by-nc-nd/3.0/ How to cite this article: Yu, Y.-C. et al.",Non-OADS,/arxiv_data1/oa_pdf/b4/6a/srep01675.PMC3628221.pdf
Author Help: Online submission of the manuscripts Articles can be submitted online from http://www.journalonweb.com.,Non-OADS,/arxiv_data1/oa_pdf/23/b5/JGID-5-3.PMC3628231.pdf
The application can be downloaded  from http://itunes.apple.com/us/app/medknow-journals/id458064375?ls=1&mt=8.,Non-OADS,/arxiv_data1/oa_pdf/a4/f1/JGID-5-31.PMC3628232.pdf
The application can be downloaded  from https://market.android.com/details?id=comm.app.medknow.,Non-OADS,/arxiv_data1/oa_pdf/cd/69/JGID-5-34b.PMC3628234.pdf
Start a QR-code reading software (see list of free  applications from http://tinyurl.com/yzlh2tc) and point the camera to the QR-code printed in the journal.,Non-OADS,/arxiv_data1/oa_pdf/69/d7/JGID-5-8.PMC3628235.pdf
See http:// tinyurl.com/2bw7fn3 or http://tinyurl.com/3ysr3me for the free applications.Announcement,Non-OADS,/arxiv_data1/oa_pdf/69/d7/JGID-5-8.PMC3628235.pdf
Available from: http://people.bu.edu/wwildman/ WeirdWildWeb/courses/thth/projects/thth_projects_2003_lewis/udda.,Non-OADS,/arxiv_data1/oa_pdf/2c/52/IJNM-27-1.PMC3628253.pdf
Available from: http://www.india.,Non-OADS,/arxiv_data1/oa_pdf/2c/52/IJNM-27-1.PMC3628253.pdf
Available from: http://www.gma.yahoo.com/ readied‑donate‑organs‑21‑old‑emerges‑coma‑204904805.html.,Non-OADS,/arxiv_data1/oa_pdf/2c/52/IJNM-27-1.PMC3628253.pdf
Available  from: http://www.allbusiness.com/health‑care‑social‑assistance/ ambulatory‑healthservices/345938‑1.html.,Non-OADS,/arxiv_data1/oa_pdf/2c/52/IJNM-27-1.PMC3628253.pdf
Available from:  http://www.usatoday.com/news/nation/2008‑11‑03‑99035845_x.,Non-OADS,/arxiv_data1/oa_pdf/2c/52/IJNM-27-1.PMC3628253.pdf
Available from: http://www.articles.nydailynews.com/2008‑03‑24/ news/29432162_1_brain‑scan‑vehicle‑accident‑oklahoma‑city.,Non-OADS,/arxiv_data1/oa_pdf/2c/52/IJNM-27-1.PMC3628253.pdf
Available from: http://www.karmayog.org/publichealth/ publichealth_3204.htm.,Non-OADS,/arxiv_data1/oa_pdf/2c/52/IJNM-27-1.PMC3628253.pdf
Available from: http://www.acr.org/ SecondaryMainMenuCategories/quality_safety/guidelines/nuc_med/ ct_spect_brain_perfusion.aspx.,Non-OADS,/arxiv_data1/oa_pdf/2c/52/IJNM-27-1.PMC3628253.pdf
Available from: http://www.interactive.snm.org/docs/ pg_ch20_0403.pdf.,Non-OADS,/arxiv_data1/oa_pdf/2c/52/IJNM-27-1.PMC3628253.pdf
Author Help: Online submission of the manuscripts Articles can be submitted online from http://www.journalonweb.com.,Non-OADS,/arxiv_data1/oa_pdf/35/85/IJNM-27-10.PMC3628254.pdf
The application can be downloaded  from http://itunes.apple.com/us/app/medknow-journals/id458064375?ls=1&mt=8.,Non-OADS,/arxiv_data1/oa_pdf/40/5f/IJNM-27-35.PMC3628260.pdf
The application can be downloaded  from https://market.android.com/details?id=comm.app.medknow.,Non-OADS,/arxiv_data1/oa_pdf/db/16/IJNM-27-38.PMC3628261.pdf
Start a QR-code reading  software (see list of free applications from http://tinyurl.com/yzlh2tc) and point the camera to the QR-code printed in the  journal.,Non-OADS,/arxiv_data1/oa_pdf/77/16/IJNM-27-45.PMC3628263.pdf
See http://tinyurl.com/2bw7fn3 or http://tinyurl.com/3ysr3me for the free applications.Announcement,Non-OADS,/arxiv_data1/oa_pdf/77/16/IJNM-27-45.PMC3628263.pdf
Tremor Other Hyperkinet Mov 2013;3: http://tremorjournal.org/ article/view/131 * To whom correspondence should be addressed.,Non-OADS,/arxiv_data1/oa_pdf/28/70/tre-03-131-3076-1.PMC3628345.pdf
"2However, the crude prevalence of primary late- onset dystonia ranges from 101 to 430 cases per million in various populations, and age of dystonia onset and sex distribution differFreely available online Tremor and Other Hyperkinetic Movements http://www.tremorjournal.orgThe Center for Digital Research and ScholarshipColumbia University Libraries/Information Services1",Non-OADS,/arxiv_data1/oa_pdf/28/70/tre-03-131-3076-1.PMC3628345.pdf
"24Defazio G, Gigante AF Epidemiology of Primary Dystonia Tremor and Other Hyperkinetic Movements http://www.tremorjournal.orgThe Center for Digital Research and ScholarshipColumbia University Libraries/Information Services2",Non-OADS,/arxiv_data1/oa_pdf/28/70/tre-03-131-3076-1.PMC3628345.pdf
"24The lack of association between late-onset dystonia and a history of psychiatric illnesses oremotionally relevant life events contributes to the large body ofEpidemiology of Primary Dystonia Defazio G, Gigante AF Tremor and Other Hyperkinetic Movements http://www.tremorjournal.orgThe Center for Digital Research and ScholarshipColumbia University Libraries/Information Services3",Non-OADS,/arxiv_data1/oa_pdf/28/70/tre-03-131-3076-1.PMC3628345.pdf
"1Authors provided the OR stratified by 1–2 sore throats per year (OR, 2.9; 95% CI, 1.4–5.7) and 3 sore throats per year (OR, 2.1; 95% CI, 1.0–4.1).Defazio G, Gigante AF Epidemiology of Primary Dystonia Tremor and Other Hyperkinetic Movements http://www.tremorjournal.orgThe Center for Digital Research and ScholarshipColumbia University Libraries/Information Services4",Non-OADS,/arxiv_data1/oa_pdf/28/70/tre-03-131-3076-1.PMC3628345.pdf
"Ann Neurol 1991;29:320–324, doi: http://dx.doi.org/ 10.1002/ana.410290315.",Non-OADS,/arxiv_data1/oa_pdf/28/70/tre-03-131-3076-1.PMC3628345.pdf
"Eur Neurol 1993;33: 345–350, doi: http://dx.doi.org/10.1159/000116969.",Non-OADS,/arxiv_data1/oa_pdf/28/70/tre-03-131-3076-1.PMC3628345.pdf
"Mov Disord 1997;12:1000–1006, doi: http://dx.doi.org/10.",OADS,/arxiv_data1/oa_pdf/28/70/tre-03-131-3076-1.PMC3628345.pdf
"Acta Neurol Scand 2003;107:228–232, doi: http://dx.doi.org/10.1034/j.1600-0404.2003.01362.x.",OADS,/arxiv_data1/oa_pdf/28/70/tre-03-131-3076-1.PMC3628345.pdf
"Mov Disord 2005;20:822–825, doi: http://dx.doi.org/10.1002/mds.20398.",OADS,/arxiv_data1/oa_pdf/28/70/tre-03-131-3076-1.PMC3628345.pdf
"Eur J Neurol 2006;13: 1083–1088, doi: http://dx.doi.org/10.1111/j.1468-1331.2006.01387.x.",OADS,/arxiv_data1/oa_pdf/28/70/tre-03-131-3076-1.PMC3628345.pdf
"Am J Hum Genet 1994;55:468–475.Epidemiology of Primary Dystonia Defazio G, Gigante AF Tremor and Other Hyperkinetic Movements http://www.tremorjournal.orgThe Center for Digital Research and ScholarshipColumbia University Libraries/Information Services5",Non-OADS,/arxiv_data1/oa_pdf/28/70/tre-03-131-3076-1.PMC3628345.pdf
"Nat Genet 2009;41:286–288, doi: http://dx.doi.org/10.1038/ng.304.",OADS,/arxiv_data1/oa_pdf/28/70/tre-03-131-3076-1.PMC3628345.pdf
"Mov Disord 2005;10:1375–1377, doi: http://dx.doi.org/10.",OADS,/arxiv_data1/oa_pdf/28/70/tre-03-131-3076-1.PMC3628345.pdf
"Hum Mol Genet 1996;5:1673–1677, doi: http://dx.doi.org/10.1093/hmg/5.10.1673.",Non-OADS,/arxiv_data1/oa_pdf/28/70/tre-03-131-3076-1.PMC3628345.pdf
"Mov Disord 2002;17:392–397, doi: http://dx.doi.org/10.1002/mds.10077.",OADS,/arxiv_data1/oa_pdf/28/70/tre-03-131-3076-1.PMC3628345.pdf
"Mov Disord 2000;15:954– 959, doi: http://dx.doi.org/10.1002/1531-8257(200009)15:5 ,954::AID- MDS1028 .3.0.CO;2-I.",OADS,/arxiv_data1/oa_pdf/28/70/tre-03-131-3076-1.PMC3628345.pdf
"Familial blepharospasm is inherited as an autosomal dominant trait and relates to a novel unassigned gene.Mov Disord 2003;18:207–212, doi: http://dx.doi.org/10.1002/mds.10314.",Non-OADS,/arxiv_data1/oa_pdf/28/70/tre-03-131-3076-1.PMC3628345.pdf
"Mov Disord 1991;6:310–314, doi: http://dx.doi.org/ 10.1002/mds.870060407.",OADS,/arxiv_data1/oa_pdf/28/70/tre-03-131-3076-1.PMC3628345.pdf
"Mov Disord 2001; 16:714–718, doi: http://dx.doi.org/10.1002/mds.1128.",OADS,/arxiv_data1/oa_pdf/28/70/tre-03-131-3076-1.PMC3628345.pdf
"Mov Disord 1991;6:304–309, doi: http://dx.doi.org/ 10.1002/mds.870060406.",OADS,/arxiv_data1/oa_pdf/28/70/tre-03-131-3076-1.PMC3628345.pdf
"J Neurol Neurosurg Psychiatry 1998;64:25– 32, doi: http://dx.doi.org/10.1136/jnnp.64.1.25.",Non-OADS,/arxiv_data1/oa_pdf/28/70/tre-03-131-3076-1.PMC3628345.pdf
"Brain 2009;132:756–764, doi: http://dx.doi.org/10.1093/brain/awn363.",Non-OADS,/arxiv_data1/oa_pdf/28/70/tre-03-131-3076-1.PMC3628345.pdf
"Case-control study of risk factors for spasmodic dysphonia: A comparison with other voice disorders.Laryngoscope 2012;122:1082–1092, doi: http://dx.doi.org/10.1002/lary.",Non-OADS,/arxiv_data1/oa_pdf/28/70/tre-03-131-3076-1.PMC3628345.pdf
"J Neuroophthalmol 2005;25:280–285, doi: http://dx.doi.org/10.1097/01.wno.",Non-OADS,/arxiv_data1/oa_pdf/28/70/tre-03-131-3076-1.PMC3628345.pdf
"J Neurol Neurosurg Psychiatry 2007;78:260–263, doi: http://dx.doi.org/10.1136/jnnp.2006.103713.29.Jankovic J.",Non-OADS,/arxiv_data1/oa_pdf/28/70/tre-03-131-3076-1.PMC3628345.pdf
"Mov Disord 2001; 16:7–12, doi: http://dx.doi.org/10.1002/1531-8257(200101)16:1 ,7::AID- MDS1005 .3.0.CO;2-0.",OADS,/arxiv_data1/oa_pdf/28/70/tre-03-131-3076-1.PMC3628345.pdf
"Mov Disord 1999;14:492–496, doi: http://dx.doi.org/ 10.1002/1531-8257(199905)14:3 ,492::AID-MDS1018 .3.0.CO;2-4.",OADS,/arxiv_data1/oa_pdf/28/70/tre-03-131-3076-1.PMC3628345.pdf
"Mov Disord 2005;20:1564–1570, doi: http://dx.doi.org/10.1002/mds.20635.",OADS,/arxiv_data1/oa_pdf/28/70/tre-03-131-3076-1.PMC3628345.pdf
"Br J Ophthalmol 1997;81:439–442, doi: http://dx.doi.org/10.1136/bjo.81.6.439.",Non-OADS,/arxiv_data1/oa_pdf/28/70/tre-03-131-3076-1.PMC3628345.pdf
"Mov Disord 2003;18:1196–1198, doi: http://dx.doi.org/10.1002/mds.10480.",OADS,/arxiv_data1/oa_pdf/28/70/tre-03-131-3076-1.PMC3628345.pdf
"Neurology 2011;77:631–637, doi: http://dx.doi.org/10.1212/WNL.",Non-OADS,/arxiv_data1/oa_pdf/28/70/tre-03-131-3076-1.PMC3628345.pdf
"Laryngoscope 2002;112:220–223, doi: http://dx.doi.org/10.1097/00005537-200202000-00004.",Non-OADS,/arxiv_data1/oa_pdf/28/70/tre-03-131-3076-1.PMC3628345.pdf
"Mov Disord 2007;22:576–578, doi: http://dx.doi.org/10.1002/mds.21322.",OADS,/arxiv_data1/oa_pdf/28/70/tre-03-131-3076-1.PMC3628345.pdf
"J Neurol Neurosurg Psychiatry 2007;78:877– 879, doi: http://dx.doi.org/10.1136/jnnp.2007.119891.",Non-OADS,/arxiv_data1/oa_pdf/28/70/tre-03-131-3076-1.PMC3628345.pdf
"Neurology 1996;47:508–520, doi: http://dx.doi.org/10.1212/WNL.47.",Non-OADS,/arxiv_data1/oa_pdf/28/70/tre-03-131-3076-1.PMC3628345.pdf
"Brain 2003;126:2586–2596, doi: http://dx.doi.org/10.1093/brain/awg273.",OADS,/arxiv_data1/oa_pdf/28/70/tre-03-131-3076-1.PMC3628345.pdf
"Enhanced long-term potentiation-like plasticity of the trigeminal blink reflex circuit in blepharospasm.J Neurosci 2006;26:716–721, doi: http://dx.doi.org/10.1523/JNEUROSCI.",Non-OADS,/arxiv_data1/oa_pdf/28/70/tre-03-131-3076-1.PMC3628345.pdf
"J Neural Transm Suppl 2006;70: 485–488, doi: http://dx.doi.org/10.1007/978-3-211-45295-0_72.",Non-OADS,/arxiv_data1/oa_pdf/28/70/tre-03-131-3076-1.PMC3628345.pdf
"Mov Disord 2012;27:305–307, doi: http://dx.doi.org/10.1002/mds.24026.Defazio G, Gigante AF Epidemiology of Primary Dystonia Tremor and Other Hyperkinetic Movements http://www.tremorjournal.orgThe Center for Digital Research and ScholarshipColumbia University Libraries/Information Services6",Non-OADS,/arxiv_data1/oa_pdf/28/70/tre-03-131-3076-1.PMC3628345.pdf
Additional information Supplementary information accompanies this paper at http://www.nature.com/ scientificreports Competing financial interests: The authors declare no competing financial interests.,Non-OADS,/arxiv_data1/oa_pdf/2c/a8/srep01676.PMC3628356.pdf
"To view a copy of this license, visit http://creativecommons.org/licenses/by-nc-nd/3.0/ How to cite this article: Longo, E. et al.",Non-OADS,/arxiv_data1/oa_pdf/2c/a8/srep01676.PMC3628356.pdf
http://www.pref.fukushima.jp/j/ 7houbu0311-0331.pdf (in Japanese: Accessed on 20 February 2013).,Non-OADS,/arxiv_data1/oa_pdf/3b/3b/srep01670.PMC3628369.pdf
http://www.radioactivity.nsr.jo.jp/ja/ contents/5000/4106/24/1304764_0406_01.pdf (in Japanese: Accessed on 20 February 2013).,OADS,/arxiv_data1/oa_pdf/3b/3b/srep01670.PMC3628369.pdf
http://www.pref.fukushima..jp/j/ 20-50km0315-0331.pdf (in Japanese: Accessed on 20 February 2013).,Non-OADS,/arxiv_data1/oa_pdf/3b/3b/srep01670.PMC3628369.pdf
http://www.pref.fukushima.jp/ nuclear/old/kanshi/H22-3.pdf (in Japanese: Accessed on 20 February 2013).,OADS,/arxiv_data1/oa_pdf/3b/3b/srep01670.PMC3628369.pdf
"To view a copy of this license, visit http://creativecommons.org/licenses/by-nc-nd/3.0/ How to cite this article: Akahane, K. et al.",Non-OADS,/arxiv_data1/oa_pdf/3b/3b/srep01670.PMC3628369.pdf
Additional information Supplementary information accompanies this paper at http://www.nature.com/ scientificreports Competing financial interests: The authors declare no competing financial interests.,Non-OADS,/arxiv_data1/oa_pdf/b6/19/srep01674.PMC3628451.pdf
"To view a copy of this license, visit http://creativecommons.org/licenses/by-nc-sa/3.0/ How to cite this article: Yu, H.Q.",Non-OADS,/arxiv_data1/oa_pdf/b6/19/srep01674.PMC3628451.pdf
Available at: http://www.aha.org/aha/ trendwatch/2010/10apr-tw-HITmeanuse.pdf.,Non-OADS,/arxiv_data1/oa_pdf/72/ca/wjem-14-109.PMC3628454.pdf
"2  : March 2013original  rEsEarch  Implementation of Computerized Physician Order Entry for  Critical Patients in an Academic Emergency Department is Not  Associated with a Change in Mortality Rate    Doug D. Brunette, MD Jean Tersteeg, RN Nicholas Brown, MD Valerie Johnson, MD Stephen Dunlop, MD James Karambay, MD James Miner, MD Supervising Section Editor:  James Killeen, MD Submission history:  Submitted June 29, 2010; Revisions received May 16, 2012; Accepted September 6, 2012 Full text available through open access at http://escolarship.org/uc/uciem_westjem DOI: 10.5811/westjem.2012.9.6601Hennepin County Medical Center, Department of Emergency Medicine, Minneapolis,  Minnesota Introduction : There is limited literature on the effect of computerized physician order entry  (CPOE) on mortality.",Non-OADS,/arxiv_data1/oa_pdf/97/5d/wjem-14-114.PMC3628455.pdf
Available at: http://frwebgate.access.gpo.,Non-OADS,/arxiv_data1/oa_pdf/97/5d/wjem-14-114.PMC3628455.pdf
Available at: http://www.uptodate.com/index .,Non-OADS,/arxiv_data1/oa_pdf/9d/ca/wjem-14-123.PMC3628457.pdf
Available at: http://files.medi-cal.ca.gov/pubsdoco/ rates/rates_information.asp?num=18&first=72142&last=79020.,OADS,/arxiv_data1/oa_pdf/9d/ca/wjem-14-123.PMC3628457.pdf
Available at: http://www.acep.org/WorkArea/ DownloadAsset.aspx?id=47823 6.,Non-OADS,/arxiv_data1/oa_pdf/2d/14/wjem-14-137.PMC3628461.pdf
Available at: http://www.theelevatormuseum.,Non-OADS,/arxiv_data1/oa_pdf/b6/22/wjem-14-141.PMC3628462.pdf
Available at: http://www.otisworldwide.com/ pdf/AboutEscalators.pdf.,Non-OADS,/arxiv_data1/oa_pdf/b6/22/wjem-14-141.PMC3628462.pdf
Available at: http://einestages.spiegel.de/static/ topicalbumbackground/4281/kathedralen des kaufrauschs.html.,Non-OADS,/arxiv_data1/oa_pdf/b6/22/wjem-14-141.PMC3628462.pdf
Available at: http://www.webjournal.ch/article.,Non-OADS,/arxiv_data1/oa_pdf/b6/22/wjem-14-141.PMC3628462.pdf
Available at: http://sustainablecities.dk/en/ city-projects/cases/hong-kong-re-discovering-escalators-as-public- transport).,Non-OADS,/arxiv_data1/oa_pdf/b6/22/wjem-14-141.PMC3628462.pdf
Available at http://www.elcosh.org/record/ document/405/d000397.pdf.,Non-OADS,/arxiv_data1/oa_pdf/b6/22/wjem-14-141.PMC3628462.pdf
Available at:  http://www.cpsc.gov/cpscpub/prerel/prhtml08/08264.html.,Non-OADS,/arxiv_data1/oa_pdf/b6/22/wjem-14-141.PMC3628462.pdf
Available at: http://www.kfv.at/kfv/ landesstellen/tirol/presse/presse-details-tirol/artikel/2354/.,Non-OADS,/arxiv_data1/oa_pdf/b6/22/wjem-14-141.PMC3628462.pdf
Available at: http://www.ots.at/presseaussendung/ OTS_20070221_OTS0053/mehr-sicherheit-bei-aufzuegen-und- fahrtreppen-in-oesterreich.,Non-OADS,/arxiv_data1/oa_pdf/b6/22/wjem-14-141.PMC3628462.pdf
Available at: http://www.census.gov/ prod/cen2010/briefs/c2010br-03.pdf.,OADS,/arxiv_data1/oa_pdf/b6/22/wjem-14-141.PMC3628462.pdf
Available at: http://www.pxweb.,Non-OADS,/arxiv_data1/oa_pdf/b6/22/wjem-14-141.PMC3628462.pdf
Available at:  http://www.cdc.gov/injury/wisqars/.,OADS,/arxiv_data1/oa_pdf/b6/22/wjem-14-141.PMC3628462.pdf
Available at: http://www.statcan.gc.ca/pub/82- 625-x/2010002/article/11272-eng.htm.,OADS,/arxiv_data1/oa_pdf/b6/22/wjem-14-141.PMC3628462.pdf
19. http://www.healthyagingprograms.org/resources/Falls Free Review  Paper Final.pdf.,Non-OADS,/arxiv_data1/oa_pdf/b6/22/wjem-14-141.PMC3628462.pdf
Available at: http://www.who.int/ substance abuse/publications/global alcohol report/msbgsruprofiles.,Non-OADS,/arxiv_data1/oa_pdf/b6/22/wjem-14-141.PMC3628462.pdf
Available at: http://www.cec.health.nsw.gov.au/programs/ falls-prevention.,Non-OADS,/arxiv_data1/oa_pdf/b6/22/wjem-14-141.PMC3628462.pdf
Available  at: http://www.who.int/ageing/publications/Fallsprevention7March.pdf.,Non-OADS,/arxiv_data1/oa_pdf/b6/22/wjem-14-141.PMC3628462.pdf
Available at:  http://pubs.niaaa.nih.gov/publications/arh27-1/63-78.htm.,Non-OADS,/arxiv_data1/oa_pdf/b6/22/wjem-14-141.PMC3628462.pdf
Available at: http://www.wheelessonline.com/ortho/ chance_fracture_of_the_spine.,Non-OADS,/arxiv_data1/oa_pdf/3d/e6/wjem-14-147.PMC3628464.pdf
Available at http://www.cdc.gov/h1n1flu/estimates_2009_h1n1.htm.,OADS,/arxiv_data1/oa_pdf/43/51/wjem-14-191.PMC3628481.pdf
Available  at: http://www.cdc.gov/h1n1flu/cdcresponse.htm.,OADS,/arxiv_data1/oa_pdf/43/51/wjem-14-191.PMC3628481.pdf
Available at: http://www.acep.org/practres.aspx?LinkIdentifier =id&id=45423&fid=908&Mo=No.,Non-OADS,/arxiv_data1/oa_pdf/43/51/wjem-14-191.PMC3628481.pdf
Available at http://www.acep.org/WorkArea/ DownloadAsset.aspx?id=45781.,Non-OADS,/arxiv_data1/oa_pdf/43/51/wjem-14-191.PMC3628481.pdf
Available at http://www.cdc.gov/h1n1flu/guidelines_infection_ control.htm.,Non-OADS,/arxiv_data1/oa_pdf/43/51/wjem-14-191.PMC3628481.pdf
Available at http://www.cdc.gov/H1N1flu/HAN/101909.htm.,OADS,/arxiv_data1/oa_pdf/43/51/wjem-14-191.PMC3628481.pdf
Available at http://www.census.gov.,OADS,/arxiv_data1/oa_pdf/e5/72/wjem-14-200.PMC3628482.pdf
Available at  http://www.safekids.org/our-work/research/fact-sheets/drowning- prevention-fact-sheet.html.,Non-OADS,/arxiv_data1/oa_pdf/e5/72/wjem-14-200.PMC3628482.pdf
Available at http://www.uscgboating.org/assets/1/workflow_ staging/AssetManager/512.PDF.,OADS,/arxiv_data1/oa_pdf/e5/72/wjem-14-200.PMC3628482.pdf
Available at http://www.cdc.gov/injury/wisqars/nonfatal.,Non-OADS,/arxiv_data1/oa_pdf/e5/72/wjem-14-200.PMC3628482.pdf
Available at: http://www.jephc.com/ full_article.cfm?content_id=486.,Non-OADS,/arxiv_data1/oa_pdf/cc/a7/wjem-14-204.PMC3628483.pdf
Available at http://www.ada.org/sections/ about/pdfs/anesthesia_guidelines.pdf .,Non-OADS,/arxiv_data1/oa_pdf/cc/a7/wjem-14-204.PMC3628483.pdf
Available at http://www.dbc.ca.gov/formspubs/pub_permitted_duties.,Non-OADS,/arxiv_data1/oa_pdf/cc/a7/wjem-14-204.PMC3628483.pdf
Available at: http://www.msnbc.msn.com/id/38820121/ns/health-health_ care/t/some-ers-post-wait-times-text-billboard .,Non-OADS,/arxiv_data1/oa_pdf/24/fb/wjem-14-77.PMC3628484.pdf
Available at: http://www.msnbc.msn.com/id/42557663/ ns/health-health_care/t/nj-hospital-show-er-wait-times-billboards .,Non-OADS,/arxiv_data1/oa_pdf/24/fb/wjem-14-77.PMC3628484.pdf
Available  at: http://www.ama-assn.org/amednews/2010/10/11/prl21011.htm .,Non-OADS,/arxiv_data1/oa_pdf/24/fb/wjem-14-77.PMC3628484.pdf
There were 9 sites available for viewing and available to the  public on the website http://airnow.ca.gov.2 Daily readings were  available.,Non-OADS,/arxiv_data1/oa_pdf/d2/19/wjem-14-79.PMC3628485.pdf
Available  at: http://www.sdcounty.ca.gov/oes/docs/2007_SanDiego_Fire_AAR_ Main_Document_FINAL.pdf .,OADS,/arxiv_data1/oa_pdf/d2/19/wjem-14-79.PMC3628485.pdf
Available at: http://www.cdc.gov/mmwr/preview/ mmwrhtml/mm5727a2.htm .,OADS,/arxiv_data1/oa_pdf/d2/19/wjem-14-79.PMC3628485.pdf
Available at: http://www.acep.org/content.,Non-OADS,/arxiv_data1/oa_pdf/c7/7c/wjem-14-85.PMC3628486.pdf
Available at: http://www.ihi.org/IHI/Topics/Flow/EmergencyDepartment/ImprovementStories/GettingLeanintheED.,OADS,/arxiv_data1/oa_pdf/c7/7c/wjem-14-85.PMC3628486.pdf
Available at: http://www.vawd.uscourts.gov/OPINIONS/KISER/8- 5MEMOOPINION.PDF.,Non-OADS,/arxiv_data1/oa_pdf/c7/7c/wjem-14-85.PMC3628486.pdf
This article is distributed under the terms of an Attribution– Noncommercial–Share Alike–No Mirror Sites license for the first six months after the pub - lication date (see http://www.rupress.org/terms).,Non-OADS,/arxiv_data1/oa_pdf/35/11/JCB_201211097.PMC3628506.pdf
"After six months it is available under a  Creative Commons License (Attribution–Noncommercial–Share Alike 3.0 Unported license,  as described at http://creativecommons.org/licenses/by-nc-sa/3.0/).THE JOURNAL OF CELL BIOLOGY",Non-OADS,/arxiv_data1/oa_pdf/35/11/JCB_201211097.PMC3628506.pdf
"Array data were  scanned using a G2565BA DNA scanner (Agilent Technologies) with  Agilent Scan Control (version 7.0; http://www.chem.agilent.com/Library/ usermanuals/Public/G2566-90017.pdf) using the software parameters:  5 µm, 61 mm × 21.6 mm, 16-bit TIF images, and no <XDR>.",OADS,/arxiv_data1/oa_pdf/35/11/JCB_201211097.PMC3628506.pdf
The result - ing data were quantitated using Agilent Feature Extraction software (ver - sion 9.5; http://www.chem.agilent.com/Library/usermanuals/Public/   ReferenceGuide_050416.pdf) using the software parameters: ChIP-v1_ 95_May07.,OADS,/arxiv_data1/oa_pdf/35/11/JCB_201211097.PMC3628506.pdf
"The resulting data were loaded into the R statistical environ - ment (version 2.8.1; http://cran.r-project.org/bin/windows/base/old/)  and assessed for spatial and distributional homogeneity; two arrays were  excluded for having highly atypical intensity distributions, leaving six  total biological replicates.",OADS,/arxiv_data1/oa_pdf/35/11/JCB_201211097.PMC3628506.pdf
"Data were preprocessed using the variance- stabilizing normalization algorithm with default parameter settings, as  implemented in the vsn package (version 3.8.0) of the BioConductor open- source library (http://bioconductor.org/packages/2.11/bioc/html/vsn.",OADS,/arxiv_data1/oa_pdf/35/11/JCB_201211097.PMC3628506.pdf
Statistical analysis using a linear model  was then fit to each probe on the array to capture differences between the  enriched and control channels using the limma package (version 2.16.5;  http://bioconductor.org/packages/2.11/bioc/html/limma.html) for the  R statistical environment (version 2.9.0; http://cran.r-project.org/bin/ windows/base/old/).,OADS,/arxiv_data1/oa_pdf/35/11/JCB_201211097.PMC3628506.pdf
"http://dx.doi.org/10.1038/3505719 2 Condemine, W., Y. Takahashi, J. Zhu, F. Puvion-Dutilleul, S. Guegan, A. Janin,  and H. de Thé.",Non-OADS,/arxiv_data1/oa_pdf/35/11/JCB_201211097.PMC3628506.pdf
"http://dx.doi   .org/10.1158/0008-5472.CAN-05-379 2 de Stanchina, E., E. Querido, M. Narita, R.V.",Non-OADS,/arxiv_data1/oa_pdf/35/11/JCB_201211097.PMC3628506.pdf
"http://dx.doi.org/   10.1016/S1097-2765(04)00062- 0 Dellaire, G., and D.P.",OADS,/arxiv_data1/oa_pdf/35/11/JCB_201211097.PMC3628506.pdf
"http://dx.doi   .org/10.1002/bies.2008 9 Dellaire, G., R.W.",Non-OADS,/arxiv_data1/oa_pdf/35/11/JCB_201211097.PMC3628506.pdf
"http://dx.doi.org/   10.1242/jcs.0281 6 Efron, B., and R. Tibshirani.",Non-OADS,/arxiv_data1/oa_pdf/35/11/JCB_201211097.PMC3628506.pdf
"http://dx.doi   .org/10.1002/gepi.112 4 Fogal, V., M. Gostissa, P. Sandy, P. Zacchi, T. Sternsdorf, K. Jensen, P.P.",Non-OADS,/arxiv_data1/oa_pdf/35/11/JCB_201211097.PMC3628506.pdf
"19:6185– 6195. http://dx.doi.org/10.1093/emboj/19.22.618 5 Gialitakis, M., P. Arampatzi, T. Makatounakis, and J. Papamatheakis.",Non-OADS,/arxiv_data1/oa_pdf/35/11/JCB_201211097.PMC3628506.pdf
"http://dx.doi.org/10.1128/MCB.00906-0 9 Ishov, A.M., and G.G.",Non-OADS,/arxiv_data1/oa_pdf/35/11/JCB_201211097.PMC3628506.pdf
"http://dx.doi   .org/10.1083/jcb.134.4.81 5 Kumar, P.P., O. Bischof, P.K.",Non-OADS,/arxiv_data1/oa_pdf/35/11/JCB_201211097.PMC3628506.pdf
"http://dx.doi.org/10.1038/ncb151 6 Misteli, T. 2007.",Non-OADS,/arxiv_data1/oa_pdf/35/11/JCB_201211097.PMC3628506.pdf
"http://dx.doi.org/10.1016/j.cell.2007.01.02 8 Osborne, C.S., L. Chakalova, K.E.",OADS,/arxiv_data1/oa_pdf/35/11/JCB_201211097.PMC3628506.pdf
"http://dx.doi.org/10.1038/ng142 3 Parada, L.A., P.G.",Non-OADS,/arxiv_data1/oa_pdf/35/11/JCB_201211097.PMC3628506.pdf
"http://dx.doi.org/10.1186/   gb-2004-5-7-r4 4 Pickersgill, H., B. Kalverda, E. de Wit, W. Talhout, M. Fornerod, and B. van  Steensel.",Non-OADS,/arxiv_data1/oa_pdf/35/11/JCB_201211097.PMC3628506.pdf
"http://dx.doi   .org/10.1038/ng185 2 Ponzielli, R., P.C.",Non-OADS,/arxiv_data1/oa_pdf/35/11/JCB_201211097.PMC3628506.pdf
"http://dx.doi.org/10   .1093/nar/gkn73 5 Rocke, D.M., and B. Durbin.",OADS,/arxiv_data1/oa_pdf/35/11/JCB_201211097.PMC3628506.pdf
"http://dx.doi.org/10   .1089/10665270175330748 5 Shiels, C., S.A. Islam, R. Vatcheva, P. Sasieni, M.J. Sternberg, P.S.",Non-OADS,/arxiv_data1/oa_pdf/35/11/JCB_201211097.PMC3628506.pdf
"http://dx.doi.org/10.1083/jcb.20030313 1 Smyth, G.K. 2004.",Non-OADS,/arxiv_data1/oa_pdf/35/11/JCB_201211097.PMC3628506.pdf
Online supple - mental material is available at http://www.jcb.org/cgi/content/full/ jcb.201211097/DC1.,Non-OADS,/arxiv_data1/oa_pdf/35/11/JCB_201211097.PMC3628506.pdf
Additional data are available in the JCB Data - Viewer at http://dx.doi.org/10.1083/jcb.201211097.dv.,OADS,/arxiv_data1/oa_pdf/35/11/JCB_201211097.PMC3628506.pdf
"http://dx.doi.org/   10.1128/MCB.00636-0 6 Boisvert, F.M., M.J. Hendzel, and D.P.",Non-OADS,/arxiv_data1/oa_pdf/35/11/JCB_201211097.PMC3628506.pdf
"http://dx.doi.org/10.1083/   jcb.148.2.28 3 Broccardo, C., J. Osorio, M.F.",Non-OADS,/arxiv_data1/oa_pdf/35/11/JCB_201211097.PMC3628506.pdf
"http://dx.doi.org/10.1159/00005691 4 Cao, T., E. Duprez, K.L.",OADS,/arxiv_data1/oa_pdf/35/11/JCB_201211097.PMC3628506.pdf
"http://dx.doi.org/10.1038/ng105 1 Chakalova, L., D. Carter, and P. Fraser.",OADS,/arxiv_data1/oa_pdf/35/11/JCB_201211097.PMC3628506.pdf
http://dx.doi   .org/10.1016/S0076-6879(03)75029- 0,OADS,/arxiv_data1/oa_pdf/35/11/JCB_201211097.PMC3628506.pdf
"http://dx.doi.org/10.1016/S0888-7543(03)00075- 2 Townson, S.M., K. Kang, A.V.",OADS,/arxiv_data1/oa_pdf/35/11/JCB_201211097.PMC3628506.pdf
"http://dx.doi.org/   10.1016/j.bbrc.2006.08.06 3 Trask, B., D. Pinkel, and G. van den Engh.",OADS,/arxiv_data1/oa_pdf/35/11/JCB_201211097.PMC3628506.pdf
"http://dx.doi.org/10.1016/0888-7543(89)90112- 2 Wang, J., C. Shiels, P. Sasieni, P.J.",OADS,/arxiv_data1/oa_pdf/35/11/JCB_201211097.PMC3628506.pdf
"http://dx.doi   .org/10.1083/jcb.20030514 2 Yeager, T.R., A.A. Neumann, A. Englezou, L.I.",OADS,/arxiv_data1/oa_pdf/35/11/JCB_201211097.PMC3628506.pdf
http://dx.doi.org/10.1083/   jcb.130.6.123 9,Non-OADS,/arxiv_data1/oa_pdf/35/11/JCB_201211097.PMC3628506.pdf
This article is distributed under the terms of an Attribution– Noncommercial–Share Alike–No Mirror Sites license for the first six months after the pub - lication date (see http://www.rupress.org/terms).,Non-OADS,/arxiv_data1/oa_pdf/75/05/JCB_201207139.PMC3628507.pdf
"After six months it is available under a  Creative Commons License (Attribution–Noncommercial–Share Alike 3.0 Unported license,  as described at http://creativecommons.org/licenses/by-nc-sa/3.0/).THE JOURNAL OF CELL BIOLOGY",Non-OADS,/arxiv_data1/oa_pdf/75/05/JCB_201207139.PMC3628507.pdf
"Mating experiments and fluorescence microscopy To generate gametes, cells were grown for 10 d on Tris-acetate-phosphate  medium plates (Gorman and Levine, 1965) and resuspended in modified  medium I without nitrogen (8 ml/plate; M-N; http://www.chlamy.org/ SG.html), and the suspension was incubated overnight in constant light  with gentle agitation.",Non-OADS,/arxiv_data1/oa_pdf/75/05/JCB_201207139.PMC3628507.pdf
"63:2145– 2161. http://dx.doi.org/10.1007/s00018-006-6180- x Blacque, O.E., M.J. Reardon, C. Li, J. McCarthy, M.R.",Non-OADS,/arxiv_data1/oa_pdf/75/05/JCB_201207139.PMC3628507.pdf
"http://dx.doi.org/10.1091/mbc.E06-06-057 1 Bloodgood, R.A., and N.L.",OADS,/arxiv_data1/oa_pdf/75/05/JCB_201207139.PMC3628507.pdf
"http://dx.doi.org/10.1083/jcb.127.3.80 3 Brown, J.M., C.G.",OADS,/arxiv_data1/oa_pdf/75/05/JCB_201207139.PMC3628507.pdf
"http://dx.doi.org/10.1242/jcs.10715 1 Cole, D.G., and W.J.",OADS,/arxiv_data1/oa_pdf/75/05/JCB_201207139.PMC3628507.pdf
"http://dx.doi.org/10.1016/j.cell.2009.04.05 3 Cole, D.G., D.R.",OADS,/arxiv_data1/oa_pdf/75/05/JCB_201207139.PMC3628507.pdf
"141:993– 1008. http://dx.doi.org/10.1083/jcb.141.4.99 3 Domire, J.S., J.A.",Non-OADS,/arxiv_data1/oa_pdf/75/05/JCB_201207139.PMC3628507.pdf
"http://dx.doi.org/10.1007/s00018-010-0603- 4 Ejsing, C.S., E. Duchoslav, J. Sampaio, K. Simons, R. Bonner, C. Thiele, K.  Ekroos, and A. Shevchenko.",Non-OADS,/arxiv_data1/oa_pdf/75/05/JCB_201207139.PMC3628507.pdf
"http://dx.doi.org/   10.1021/ac060545 x Firestone, A.J., J.S.",OADS,/arxiv_data1/oa_pdf/75/05/JCB_201207139.PMC3628507.pdf
"http://dx.doi.org/10.1038/nature1093 6 González-Ballester, D., A. de Montaigu, A. Galván, and E. Fernández.",Non-OADS,/arxiv_data1/oa_pdf/75/05/JCB_201207139.PMC3628507.pdf
"http://dx.doi.org/   10.1073/pnas.54.6.166 5 Hou, Y., G.J.",OADS,/arxiv_data1/oa_pdf/75/05/JCB_201207139.PMC3628507.pdf
"http://dx.doi.org/10.1091/mbc.E04-05-037 7 Huang, K., D.R.",Non-OADS,/arxiv_data1/oa_pdf/75/05/JCB_201207139.PMC3628507.pdf
"http://dx.doi.org/10.1083/   jcb.20070406 9 Huang, H., Q. Gao, X. Peng, S.Y.",OADS,/arxiv_data1/oa_pdf/75/05/JCB_201207139.PMC3628507.pdf
"http://dx.doi.org/10.1016/   j.devcel.2011.01.00 4 Hunnicutt, G.R., and W.J.",OADS,/arxiv_data1/oa_pdf/75/05/JCB_201207139.PMC3628507.pdf
"http://dx.doi.org/10.1016/S0012-1606(05)80019- 3 Iomini, C., L. Li, J.M.",OADS,/arxiv_data1/oa_pdf/75/05/JCB_201207139.PMC3628507.pdf
"http://dx.doi.org/10.1016/j.cub.2009.04.01 5 Jin, H., S.R.",OADS,/arxiv_data1/oa_pdf/75/05/JCB_201207139.PMC3628507.pdf
"141:1208– 1219. http://dx.doi.org/10.1016/j.cell.2010.05.01 5 Kee, H.L., J.F.",OADS,/arxiv_data1/oa_pdf/75/05/JCB_201207139.PMC3628507.pdf
http://dx.doi.org/10.1038/ncb245 0electron ionization mass spectrometry was performed using a Quattro II  mass spectrometer (Waters).,OADS,/arxiv_data1/oa_pdf/75/05/JCB_201207139.PMC3628507.pdf
Online supplemental material is avail - able at http://www.jcb.org/cgi/content/full/jcb.201207139/DC1.,Non-OADS,/arxiv_data1/oa_pdf/75/05/JCB_201207139.PMC3628507.pdf
"http://dx.doi.org/10.1016/j.gde   .2005.04.00 6 Berbari, N.F., A.D. Johnson, J.S.",OADS,/arxiv_data1/oa_pdf/75/05/JCB_201207139.PMC3628507.pdf
"http://dx.doi.org/10.1091/mbc.E07-09-094 2 Berbari, N.F., J.S.",Non-OADS,/arxiv_data1/oa_pdf/75/05/JCB_201207139.PMC3628507.pdf
http://dx.doi   .org/10.1078/1434461026045013 6,Non-OADS,/arxiv_data1/oa_pdf/75/05/JCB_201207139.PMC3628507.pdf
"85:23– 61. http://dx.doi.org/10.1016/S0070-2153(08)00802- 8 Piperno, G., E. Siuda, S. Henderson, M. Segil, H. Vaananen, and M. Sassaroli.",OADS,/arxiv_data1/oa_pdf/75/05/JCB_201207139.PMC3628507.pdf
"143:1591– 1601. http://dx.doi.org/10.1083/jcb.143.6.159 1 Qin, H., D.R.",Non-OADS,/arxiv_data1/oa_pdf/75/05/JCB_201207139.PMC3628507.pdf
"http://dx.doi.org/10.1038/nrm95 2 Seo, S., L.M.",OADS,/arxiv_data1/oa_pdf/75/05/JCB_201207139.PMC3628507.pdf
"http://dx.doi.org/10.1038/ncb256 0 Witman, G.B.",Non-OADS,/arxiv_data1/oa_pdf/75/05/JCB_201207139.PMC3628507.pdf
"http://dx.doi.org/10.1016/0076-   6879(86)34096- 5 Witman, G.B.",OADS,/arxiv_data1/oa_pdf/75/05/JCB_201207139.PMC3628507.pdf
"http://dx.doi.org/10.1016/0962-8924(93)90091- E Witman, G.B.",OADS,/arxiv_data1/oa_pdf/75/05/JCB_201207139.PMC3628507.pdf
"http://dx.doi   .org/10.1172/JCI3704 1 Zhang, Q., D. Nishimura, S. Seo, T. Vogel, D.A.",OADS,/arxiv_data1/oa_pdf/75/05/JCB_201207139.PMC3628507.pdf
"http://dx.doi.org/   10.1093/hmg/dds00 4Kim, J., M. Kato, and P.A.",OADS,/arxiv_data1/oa_pdf/75/05/JCB_201207139.PMC3628507.pdf
"http://dx.doi.org/10.1016/   j.cellsig.2009.09.02 6 Kozminski, K.G., K.A.",OADS,/arxiv_data1/oa_pdf/75/05/JCB_201207139.PMC3628507.pdf
"http://dx.doi.org/10.1073/   pnas.90.12.551 9 Kozminski, K.G., P.L.",Non-OADS,/arxiv_data1/oa_pdf/75/05/JCB_201207139.PMC3628507.pdf
"http://dx.doi.org/10   .1083/jcb.131.6.151 7 Lechtreck, K.F., E.C.",Non-OADS,/arxiv_data1/oa_pdf/75/05/JCB_201207139.PMC3628507.pdf
"http://dx.doi   .org/10.1083/jcb.20090918 3 Lefebvre, P.A.",Non-OADS,/arxiv_data1/oa_pdf/75/05/JCB_201207139.PMC3628507.pdf
"http://dx.doi.org/10.1016/S0091-679X(08)   60782- 7 Levental, I., M. Grzybek, and K. Simons.",OADS,/arxiv_data1/oa_pdf/75/05/JCB_201207139.PMC3628507.pdf
"http://dx.doi.org/10.1021/bi100882 y Meijer, H.J., B. ter Riet, J.A.",OADS,/arxiv_data1/oa_pdf/75/05/JCB_201207139.PMC3628507.pdf
"http://dx.doi.org/10.1046/j.1365-313X   .2002.01336. x Mukhopadhyay, S.X., X. Wen, B. Chih, C.D.",OADS,/arxiv_data1/oa_pdf/75/05/JCB_201207139.PMC3628507.pdf
"http://dx.doi.org/   10.1101/gad.196621 0 Munnik, T., H.J.",OADS,/arxiv_data1/oa_pdf/75/05/JCB_201207139.PMC3628507.pdf
http://dx.doi.org/10.1046/j.1365- 313x.2000.00725.,Non-OADS,/arxiv_data1/oa_pdf/75/05/JCB_201207139.PMC3628507.pdf
"129:1201– 1213. http://dx.doi.org/10.1016/j.cell.2007.03.05 3 Nachury, M.V ., E.S.",OADS,/arxiv_data1/oa_pdf/75/05/JCB_201207139.PMC3628507.pdf
"http://dx.doi.org/10.1146/annurev.cellbio.042308.11333 7 Nakamura, S., G. Tanaka, T. Maeda, R. Kamiya, T. Matsunaga, and O. Nikaido.",OADS,/arxiv_data1/oa_pdf/75/05/JCB_201207139.PMC3628507.pdf
"http://dx.doi.org/10.1073/   pnas.040549610 1 Ocbina, P.J., and K.V.",OADS,/arxiv_data1/oa_pdf/75/05/JCB_201207139.PMC3628507.pdf
"http://dx.doi.org/10.1002/dvdy.2155 1 Ou, G., O.E.",Non-OADS,/arxiv_data1/oa_pdf/75/05/JCB_201207139.PMC3628507.pdf
"http://dx.doi.org/10.1038/nature0381 8 Pazour, G.J., B.L.",Non-OADS,/arxiv_data1/oa_pdf/75/05/JCB_201207139.PMC3628507.pdf
"http://dx.doi.org/10.1083/jcb.144.3.47 3 Pedersen, L.B., and S.T.",OADS,/arxiv_data1/oa_pdf/75/05/JCB_201207139.PMC3628507.pdf
http://dx.doi.org/10.1038/ncb256 9,Non-OADS,/arxiv_data1/oa_pdf/75/05/JCB_201207139.PMC3628507.pdf
This article is distributed under the terms of an Attribution–Noncommercial– Share Alike–No Mirror Sites license for the first six months after the publication date (see  http://www.rupress.org/terms).,Non-OADS,/arxiv_data1/oa_pdf/73/9d/JCB_201301005.PMC3628509.pdf
"After six months it is available under a Creative Commons  License (Attribution–Noncommercial–Share Alike 3.0 Unported license, as described at  http://creativecommons.org/licenses/by-nc-sa/3.0/).THE JOURNAL OF CELL BIOLOGY",Non-OADS,/arxiv_data1/oa_pdf/73/9d/JCB_201301005.PMC3628509.pdf
"http://dx.doi.org/10.1053/j.gastro.2009.05.00 2 Krauss, R.S.",OADS,/arxiv_data1/oa_pdf/73/9d/JCB_201301005.PMC3628509.pdf
"http://dx.doi   .org/10.1016/j.yexcr.2010.05.00 8 Lagha, M., T. Sato, L. Bajard, P. Daubas, M. Esner, D. Montarras, F. Relaix, and  M. Buckingham.",OADS,/arxiv_data1/oa_pdf/73/9d/JCB_201301005.PMC3628509.pdf
"http://dx.doi.org/10.1101/sqb.2008.73.00 6 Lepper, C., S.J.",OADS,/arxiv_data1/oa_pdf/73/9d/JCB_201301005.PMC3628509.pdf
"http://dx.doi.org/10.1038/nature0820 9 Litingtung, Y., L. Lei, H. Westphal, and C. Chiang.",Non-OADS,/arxiv_data1/oa_pdf/73/9d/JCB_201301005.PMC3628509.pdf
"http://dx.doi.org/   10.1038/171 7 Lu, M., and R.S.",OADS,/arxiv_data1/oa_pdf/73/9d/JCB_201301005.PMC3628509.pdf
"http://dx.doi.org/   10.1073/pnas.090888310 7 Mulieri, P.J., A. Okada, D.A.",OADS,/arxiv_data1/oa_pdf/73/9d/JCB_201301005.PMC3628509.pdf
"http://dx.doi.org/10.1002/1097-0177(2000)9999:9999<:: AID-DVDY1032>3.0.CO;2- M Park, W., and M.F.",OADS,/arxiv_data1/oa_pdf/73/9d/JCB_201301005.PMC3628509.pdf
http://dx.doi   .org/10.1111/j.1572-0241.2005.41775.,Non-OADS,/arxiv_data1/oa_pdf/73/9d/JCB_201301005.PMC3628509.pdf
"http://dx.doi.org/10.1038/nrg110 9 Patapoutian, A., B.J.",Non-OADS,/arxiv_data1/oa_pdf/73/9d/JCB_201301005.PMC3628509.pdf
"http://dx.doi.org/10.1126/science.270.5243.181 8 Ramalho-Santos, M., D.A.",OADS,/arxiv_data1/oa_pdf/73/9d/JCB_201301005.PMC3628509.pdf
"http://dx.doi.org/10.1002/gene.1019 8 Rishniw, M., P.W.",OADS,/arxiv_data1/oa_pdf/73/9d/JCB_201301005.PMC3628509.pdf
"28:153– 165. http://dx.doi.org/10.1007/s10974-007-9112- y Samarasinghe, D.D.",Non-OADS,/arxiv_data1/oa_pdf/73/9d/JCB_201301005.PMC3628509.pdf
"http://dx.doi.org/   10.1083/jcb.20040205 4 Takaesu, G., J.S.",OADS,/arxiv_data1/oa_pdf/73/9d/JCB_201301005.PMC3628509.pdf
"http://dx.doi.org/10.1083/jcb.20060803 1 Tenzen, T., B.L.",OADS,/arxiv_data1/oa_pdf/73/9d/JCB_201301005.PMC3628509.pdf
"http://dx.doi.org/10.1016/j.devcel.2006.04.00 4 Wang, Y., D. Huso, H. Cahill, D. Ryugo, and J. Nathans.",OADS,/arxiv_data1/oa_pdf/73/9d/JCB_201301005.PMC3628509.pdf
"http://dx.doi.org/10.1002/dvdy.2043 6 Wu, Y., J.Y.",OADS,/arxiv_data1/oa_pdf/73/9d/JCB_201301005.PMC3628509.pdf
"9:397. http://dx.doi.org/10.1186/1471-2164-9-39 7 Zacharias, W.J., B.B.",Non-OADS,/arxiv_data1/oa_pdf/73/9d/JCB_201301005.PMC3628509.pdf
Online supplemental material is available at http://www.jcb   .org/cgi/content/full/jcb.201301005/DC1.,Non-OADS,/arxiv_data1/oa_pdf/73/9d/JCB_201301005.PMC3628509.pdf
"http://dx.doi.org/   10.1242/dev.0011 5 Chakder, S., and S. Rattan.",OADS,/arxiv_data1/oa_pdf/73/9d/JCB_201301005.PMC3628509.pdf
"http://dx.doi   .org/10.1016/S0960-9822(03)00088- 5 Cole, F., W. Zhang, A. Geyra, J.-S. Kang, and R.S.",OADS,/arxiv_data1/oa_pdf/73/9d/JCB_201301005.PMC3628509.pdf
"http://dx.doi   .org/10.1016/j.devcel.2004.10.00 9 Goyal, R.K., and A. Chaudhury.",OADS,/arxiv_data1/oa_pdf/73/9d/JCB_201301005.PMC3628509.pdf
"http://dx.doi.org/10.1097/   MCG.0b013e31816b444 d Goyal, R.K., and A. Chaudhury.",Non-OADS,/arxiv_data1/oa_pdf/73/9d/JCB_201301005.PMC3628509.pdf
"http://dx.doi.org/10.1053/   j.gastro.2010.08.01 3 Kablar, B., S. Tajbakhsh, and M.A.",OADS,/arxiv_data1/oa_pdf/73/9d/JCB_201301005.PMC3628509.pdf
"http://dx.doi.org/10.1083/jcb.143.2.40 3 Kang, J.-S., G.-U.",OADS,/arxiv_data1/oa_pdf/73/9d/JCB_201301005.PMC3628509.pdf
"http://dx.doi.org/10.1083/jcb.20080111 9 Katori, Y., B.H.",OADS,/arxiv_data1/oa_pdf/73/9d/JCB_201301005.PMC3628509.pdf
http://dx.doi.org/10.1016/j.aanat.2009.09.00 7,OADS,/arxiv_data1/oa_pdf/73/9d/JCB_201301005.PMC3628509.pdf
"http://dx.doi.org/10.1016/j.ydbio.2011.04.02 5 Zhang, W., J.-S. Kang, F. Cole, M.J. Yi, and R.S.",OADS,/arxiv_data1/oa_pdf/73/9d/JCB_201301005.PMC3628509.pdf
"http://dx.doi.org/10.1016/j.devcel.2006.04.00 5 Zhang, W., M. Hong, G.-U.",OADS,/arxiv_data1/oa_pdf/73/9d/JCB_201301005.PMC3628509.pdf
"http://dx.doi.org/10.1242/dmm.00574 4 Zhao, W., and G.K. Dhoot.",OADS,/arxiv_data1/oa_pdf/73/9d/JCB_201301005.PMC3628509.pdf
"http://dx.doi.org/10.1002/   1097-0177(2000)9999:9999<::AID-DVDY1019>3.0.CO;2- 3 Zhao, W., and G.K. Dhoot.",OADS,/arxiv_data1/oa_pdf/73/9d/JCB_201301005.PMC3628509.pdf
http://dx.doi.org/10.1002/1097-0177(2000)9999:9999<::AID-   DVDY1029>3.0.CO;2- 2,Non-OADS,/arxiv_data1/oa_pdf/73/9d/JCB_201301005.PMC3628509.pdf
This article is distributed under the terms of an Attribution– Noncommercial–Share Alike–No Mirror Sites license for the first six months after the pub - lication date (see http://www.rupress.org/terms).,Non-OADS,/arxiv_data1/oa_pdf/93/3f/JCB_201211041.PMC3628510.pdf
"After six months it is available under a  Creative Commons License (Attribution–Noncommercial–Share Alike 3.0 Unported license,  as described at http://creativecommons.org/licenses/by-nc-sa/3.0/).THE JOURNAL OF CELL BIOLOGY",Non-OADS,/arxiv_data1/oa_pdf/93/3f/JCB_201211041.PMC3628510.pdf
"http://dx.doi.org/10.1006/dbio.1995   .1280 Eichenlaub-Ritter, U., and I. Boll.",OADS,/arxiv_data1/oa_pdf/93/3f/JCB_201211041.PMC3628510.pdf
"http://dx.doi.org/10.1159/   00013287 1 Ferrell, J.E.",OADS,/arxiv_data1/oa_pdf/93/3f/JCB_201211041.PMC3628510.pdf
"http://dx.doi   .org/10.1126/science.280.5365.89 5 Furuno, N., M. Nishizawa, K. Okazaki, H. Tanaka, J. Iwashita, N. Nakajo, Y.  Ogawa, and N. Sagata.",OADS,/arxiv_data1/oa_pdf/93/3f/JCB_201211041.PMC3628510.pdf
"http://dx.doi.org/10.1016/j.ymeth   .2009.12.01 0 Gerhart, J., M. Wu, and M. Kirschner.",OADS,/arxiv_data1/oa_pdf/93/3f/JCB_201211041.PMC3628510.pdf
"http://dx.doi.org/10.1083/jcb.98.4.124 7 Graf, J.-D., and H.R.",OADS,/arxiv_data1/oa_pdf/93/3f/JCB_201211041.PMC3628510.pdf
"http://dx.doi.org/10.1016/S0091-679X(08)60270- 8 Hara, K., P. Tydeman, and M. Kirschner.",OADS,/arxiv_data1/oa_pdf/93/3f/JCB_201211041.PMC3628510.pdf
"http://dx.doi.org/10.1007/s00412-002-0195- 3 Homer, H.A., A. McDougall, M. Levasseur, A.P.",Non-OADS,/arxiv_data1/oa_pdf/93/3f/JCB_201211041.PMC3628510.pdf
"http://dx.doi.org/10.1530/rep.1.0085 6 Hu, C.K., M. Coughlin, C.M.",Non-OADS,/arxiv_data1/oa_pdf/93/3f/JCB_201211041.PMC3628510.pdf
"http://dx.doi   .org/10.1083/jcb.20071110 5 Kolano, A., S. Brunet, A.D.",OADS,/arxiv_data1/oa_pdf/93/3f/JCB_201211041.PMC3628510.pdf
"http://dx.doi.org/10.1093/molehr/   gar02 6 LeMaire-Adkins, R., K. Radke, and P.A.",OADS,/arxiv_data1/oa_pdf/93/3f/JCB_201211041.PMC3628510.pdf
"http://dx.doi.org/10.1007/978-1-59745-000-3_ 3 Ma, C., C. Cummings, and X.J.",Non-OADS,/arxiv_data1/oa_pdf/93/3f/JCB_201211041.PMC3628510.pdf
"http://dx.doi.org/10.1128/MCB.23.5.1703-   1716.200 3 Ma, C., H.A.",OADS,/arxiv_data1/oa_pdf/93/3f/JCB_201211041.PMC3628510.pdf
"http://dx.doi.org/10.1016/j.cub.2005.11.06 7 Matthews, L.R., P. Carter, D. Thierry-Mieg, and K. Kemphues.",OADS,/arxiv_data1/oa_pdf/93/3f/JCB_201211041.PMC3628510.pdf
"http://dx.doi.org/10.1083/jcb.141.5.115 9 Murray, A.W., and M.W.",Non-OADS,/arxiv_data1/oa_pdf/93/3f/JCB_201211041.PMC3628510.pdf
"http://dx.doi.org/10   .1126/science.268307 7 Musacchio, A., and E.D.",OADS,/arxiv_data1/oa_pdf/93/3f/JCB_201211041.PMC3628510.pdf
"http://dx.doi.org/   10.1038/nrm216 3 Nagaoka, S.I., C.A.",Non-OADS,/arxiv_data1/oa_pdf/93/3f/JCB_201211041.PMC3628510.pdf
"http://dx.doi.org/10.1016/j.cub   .2011.03.00 3 Ohan, N., Y. Agazie, C. Cummings, R. Booth, M. Bayaa, and X.J.",OADS,/arxiv_data1/oa_pdf/93/3f/JCB_201211041.PMC3628510.pdf
Online supplemental material is  available at http://www.jcb.org/cgi/content/full/jcb.201211041/DC1.,Non-OADS,/arxiv_data1/oa_pdf/93/3f/JCB_201211041.PMC3628510.pdf
Additional data are available in the JCB DataViewer at http://dx.doi   .org/10.1083/jcb.201211041.dv.,OADS,/arxiv_data1/oa_pdf/93/3f/JCB_201211041.PMC3628510.pdf
"http://dx.doi.org/10.1139/g11-07 9 Bayaa, M., R.A. Booth, Y .",OADS,/arxiv_data1/oa_pdf/93/3f/JCB_201211041.PMC3628510.pdf
"http://dx.doi   .org/10.1073/pnas.22030259 7 Belloc, E., and R. Méndez.",Non-OADS,/arxiv_data1/oa_pdf/93/3f/JCB_201211041.PMC3628510.pdf
"http://dx.doi   .org/10.1038/nature0680 9 Benink, H.A., and W.M.",OADS,/arxiv_data1/oa_pdf/93/3f/JCB_201211041.PMC3628510.pdf
http://dx.doi.org/10.1083/jcb.146.1.,Non-OADS,/arxiv_data1/oa_pdf/93/3f/JCB_201211041.PMC3628510.pdf
"http://dx.doi.org/10.1083/jcb.126.1.19 9 Clute, P., and Y .",OADS,/arxiv_data1/oa_pdf/93/3f/JCB_201211041.PMC3628510.pdf
"http://dx.doi.org/10.1038/   3505060 7 Pines, J.",Non-OADS,/arxiv_data1/oa_pdf/93/3f/JCB_201211041.PMC3628510.pdf
"http://dx.doi.org/10.1016/j.tcb.2005   .11.00 6 Rieder, C.L., A. Schultz, R. Cole, and G. Sluder.",OADS,/arxiv_data1/oa_pdf/93/3f/JCB_201211041.PMC3628510.pdf
"http://dx.doi.org/10.1083/jcb.127.5.130 1 Rieder, C.L., R.W.",OADS,/arxiv_data1/oa_pdf/93/3f/JCB_201211041.PMC3628510.pdf
"http://dx.doi.org/10.1083/jcb.130.4.94 1 Schultz, R.M., and P.M. Wassarman.",OADS,/arxiv_data1/oa_pdf/93/3f/JCB_201211041.PMC3628510.pdf
"http://dx.doi.org/10.4161/cc.2101 6 Skoufias, D.A., S. DeBonis, Y .",Non-OADS,/arxiv_data1/oa_pdf/93/3f/JCB_201211041.PMC3628510.pdf
"http://dx.doi   .org/10.1074/jbc.M51173520 0 Sluder, G. 1979.",Non-OADS,/arxiv_data1/oa_pdf/93/3f/JCB_201211041.PMC3628510.pdf
"http://dx.doi.org/10.1083/jcb.80.3.67 4 Soewarto, D., H. Schmiady, and U. Eichenlaub-Ritter.",Non-OADS,/arxiv_data1/oa_pdf/93/3f/JCB_201211041.PMC3628510.pdf
"http://dx.doi.org/10.1016/S0960-9822(01)00145- 2 Tian, J., S. Kim, E. Heilig, and J.V.",OADS,/arxiv_data1/oa_pdf/93/3f/JCB_201211041.PMC3628510.pdf
"http://dx.doi.org/10.1073/   pnas.25049219 7 Verlhac, M.H., C. Lefebvre, P. Guillaud, P. Rassinier, and B. Maro.",Non-OADS,/arxiv_data1/oa_pdf/93/3f/JCB_201211041.PMC3628510.pdf
"http://dx.doi.org/10.1016/S0960-9822(00)00753- 3 von Dassow, G., K.J.",OADS,/arxiv_data1/oa_pdf/93/3f/JCB_201211041.PMC3628510.pdf
"http://dx.doi.org/10.1083/jcb.20090709 0 Wassarman, P.M., W.J.",OADS,/arxiv_data1/oa_pdf/93/3f/JCB_201211041.PMC3628510.pdf
"http://dx.doi   .org/10.1016/j.devcel.2008.07.00 5 Zou, H., T.J. McGarry, T. Bernal, and M.W.",OADS,/arxiv_data1/oa_pdf/93/3f/JCB_201211041.PMC3628510.pdf
http://dx.doi.org/10.1126/   science.285.5426.41 8,Non-OADS,/arxiv_data1/oa_pdf/93/3f/JCB_201211041.PMC3628510.pdf
This article is distributed under the terms of an Attribution– Noncommercial–Share Alike–No Mirror Sites license for the first six months after the pub - lication date (see http://www.rupress.org/terms).,Non-OADS,/arxiv_data1/oa_pdf/29/02/JCB_201211155.PMC3628511.pdf
"After six months it is available under a  Creative Commons License (Attribution–Noncommercial–Share Alike 3.0 Unported license,  as described at http://creativecommons.org/licenses/by-nc-sa/3.0/).THE JOURNAL OF CELL BIOLOGY",Non-OADS,/arxiv_data1/oa_pdf/29/02/JCB_201211155.PMC3628511.pdf
Online sup - plemental material is available at http://www.jcb.org/cgi/content/full/ jcb.201211155/DC1.,Non-OADS,/arxiv_data1/oa_pdf/29/02/JCB_201211155.PMC3628511.pdf
Additional data are available in the JCB Data - Viewer at http://dx.doi.org/10.1083/jcb.201211155.dv.,OADS,/arxiv_data1/oa_pdf/29/02/JCB_201211155.PMC3628511.pdf
"http://dx.doi.org/10.1126/science.181.4096.22 3 Appenzeller-Herzog, C., J. Riemer, B. Christensen, E.S.",OADS,/arxiv_data1/oa_pdf/29/02/JCB_201211155.PMC3628511.pdf
"http://dx.doi   .org/10.1038/emboj.2010.20 3 Axten, J.M., J.R. Medina, Y. Feng, A. Shu, S.P.",OADS,/arxiv_data1/oa_pdf/29/02/JCB_201211155.PMC3628511.pdf
"http://dx.doi.org/10.1074/jbc.M112.42898 7 Hatahet, F., and L.W.",Non-OADS,/arxiv_data1/oa_pdf/29/02/JCB_201211155.PMC3628511.pdf
"http://dx.doi.org/10.1089/ars.2009.246 6 Higo, T., M. Hattori, T. Nakamura, T. Natsume, T. Michikawa, and K. Mikoshiba.",OADS,/arxiv_data1/oa_pdf/29/02/JCB_201211155.PMC3628511.pdf
"http://dx.doi.org/10.1016/j.cell.2004.11.04 8 Hoebe, R.A., C.H.",OADS,/arxiv_data1/oa_pdf/29/02/JCB_201211155.PMC3628511.pdf
"http://dx.doi.org/10.1038/nbt127 8 Hwang, C., A.J.",OADS,/arxiv_data1/oa_pdf/29/02/JCB_201211155.PMC3628511.pdf
"http://dx.doi.org/10.1016/   j.freeradbiomed.2007.11.00 8 Kodali, V.K., and C. Thorpe.",OADS,/arxiv_data1/oa_pdf/29/02/JCB_201211155.PMC3628511.pdf
"http://dx.doi.org/10.1089/ars.2010.309 8 Lohman, J.R., and S.J.",OADS,/arxiv_data1/oa_pdf/29/02/JCB_201211155.PMC3628511.pdf
"http://dx.doi   .org/10.1021/bi800498 g Malhotra, J.D., H. Miao, K. Zhang, A. Wolfson, S. Pennathur, S.W.",Non-OADS,/arxiv_data1/oa_pdf/29/02/JCB_201211155.PMC3628511.pdf
"http://dx.doi.org/10.1101/gad.125070 4 McCullough, K.D., J.L.",Non-OADS,/arxiv_data1/oa_pdf/29/02/JCB_201211155.PMC3628511.pdf
"http://dx.doi.org/10.1128/MCB.21.4.1249-1259.200 1 Merksamer, P.I., A. Trusina, and F.R.",OADS,/arxiv_data1/oa_pdf/29/02/JCB_201211155.PMC3628511.pdf
"http://dx.doi.org/10.1016/j.cell.2008.10.01 1 Meyer, A.J., and T.P.",OADS,/arxiv_data1/oa_pdf/29/02/JCB_201211155.PMC3628511.pdf
"http://dx.doi.org/10.1089/ars.2009   .2948 Nguyen, V.D., M.J. Saaranen, A.R.",OADS,/arxiv_data1/oa_pdf/29/02/JCB_201211155.PMC3628511.pdf
"http://dx.doi.org/10.1016/j.jmb.2010.12.03 9 Pagani, M., M. Fabbri, C. Benedetti, A. Fassio, S. Pilati, N.J. Bulleid, A. Cabibbo,  and R. Sitia.",OADS,/arxiv_data1/oa_pdf/29/02/JCB_201211155.PMC3628511.pdf
"http://dx.doi.org/10.1074/jbc   .M00306120 0 Palmer, A.E., C. Jin, J.C. Reed, and R.Y.",OADS,/arxiv_data1/oa_pdf/29/02/JCB_201211155.PMC3628511.pdf
"http://dx.doi.org/10.1002/pro.68 4 Ron, D., and J.F.",OADS,/arxiv_data1/oa_pdf/29/02/JCB_201211155.PMC3628511.pdf
"http://dx.doi.org/10.1101/gad.6.3.43 9 Rubio, C., D. Pincus, A. Korennykh, S. Schuck, H. El-Samad, and P. Walter.",Non-OADS,/arxiv_data1/oa_pdf/29/02/JCB_201211155.PMC3628511.pdf
"http://dx.doi.org/   10.1083/jcb.20100707 7 Ruddock, L.W.",Non-OADS,/arxiv_data1/oa_pdf/29/02/JCB_201211155.PMC3628511.pdf
"http://dx.doi   .org/10.1089/ars.2011.448 17-methyl-5-(1-[3-(trifluoromethyl)phenyl]acetyl-2,3-dihydro-1H-indol-5-yl)-   7H-pyrrolo[2,3-d]pyrimidin-4-amine (GSK2606414), a potent and selec - tive first-in-class inhibitor of protein kinase R (PKR)-like endoplasmic re - ticulum kinase (PERK).",Non-OADS,/arxiv_data1/oa_pdf/29/02/JCB_201211155.PMC3628511.pdf
"http://dx.doi.org/   10.1021/jm300713 s Baker, K.M., S. Chakravarthi, K.P.",Non-OADS,/arxiv_data1/oa_pdf/29/02/JCB_201211155.PMC3628511.pdf
"27:2988– 2997. http://dx.doi.org/10.1038/emboj.2008.23 0 Björnberg, O., H. Ostergaard, and J.R. Winther.",OADS,/arxiv_data1/oa_pdf/29/02/JCB_201211155.PMC3628511.pdf
"http://dx.doi.org/10.1089/ars.2006.8.35 4 Blais, J.D., K.T.",OADS,/arxiv_data1/oa_pdf/29/02/JCB_201211155.PMC3628511.pdf
"http://dx.doi.org/10.1074/jbc   .M110.12659 9 Braakman, I., J. Helenius, and A. Helenius.",Non-OADS,/arxiv_data1/oa_pdf/29/02/JCB_201211155.PMC3628511.pdf
http://dx.doi.org/10.1111/j.1476-5381.1989.tb14609.,Non-OADS,/arxiv_data1/oa_pdf/29/02/JCB_201211155.PMC3628511.pdf
"http://dx.doi.org/10.1038/415092 a Cannon, M.B., and S.J.",OADS,/arxiv_data1/oa_pdf/29/02/JCB_201211155.PMC3628511.pdf
"http://dx.doi.org/10.1038/sj .embor   .740064 5 Chin, K.T., G. Kang, J. Qu, L.B.",OADS,/arxiv_data1/oa_pdf/29/02/JCB_201211155.PMC3628511.pdf
"http://dx.doi   .org/10.1096/fj.11-18462 2 Cross, B.C., P.J.",Non-OADS,/arxiv_data1/oa_pdf/29/02/JCB_201211155.PMC3628511.pdf
"http://dx.doi.org/10.1038/1104 7 Ellgaard, L., and L.W.",OADS,/arxiv_data1/oa_pdf/29/02/JCB_201211155.PMC3628511.pdf
"http://dx.doi.org/10.1038/sj.embor.740031 1 Esposito, A., T. Oggier, H. Gerritsen, F. Lustenberger, and F. Wouters.",Non-OADS,/arxiv_data1/oa_pdf/29/02/JCB_201211155.PMC3628511.pdf
"http://dx.doi.org/10.1364/OPEX.13   .00981 2 Frand, A.R., and C.A.",OADS,/arxiv_data1/oa_pdf/29/02/JCB_201211155.PMC3628511.pdf
"http://dx.doi.org/10.1016/S1097-2765(00)80017- 9 Frank, J.H., A.D. Elder, J. Swartling, A.R.",OADS,/arxiv_data1/oa_pdf/29/02/JCB_201211155.PMC3628511.pdf
http://dx.doi.org/10.1111/j.1365-2818.2007.01803.,Non-OADS,/arxiv_data1/oa_pdf/29/02/JCB_201211155.PMC3628511.pdf
"http://dx.doi   .org/10.1073/pnas.050644810 3 Hanson, G.T., R. Aggeler, D. Oglesbee, M. Cannon, R.A. Capaldi, R.Y.",Non-OADS,/arxiv_data1/oa_pdf/29/02/JCB_201211155.PMC3628511.pdf
"http://dx.doi.org/10.1074/jbc.M31284620 0 Harding, H.P., Y. Zhang, A. Bertolotti, H. Zeng, and D. Ron.",Non-OADS,/arxiv_data1/oa_pdf/29/02/JCB_201211155.PMC3628511.pdf
"http://dx.doi.org/10.1016/   S1097-2765(00)80330- 5 Harding, H.P., Y. Zhang, H. Zeng, I. Novoa, P.D.",OADS,/arxiv_data1/oa_pdf/29/02/JCB_201211155.PMC3628511.pdf
http://dx.doi.org/10.1016/S1097-2765(03)00105- 9,OADS,/arxiv_data1/oa_pdf/29/02/JCB_201211155.PMC3628511.pdf
"http://dx.doi.org/   10.1016/0003-9861(86)90314- 0 Sevier, C.S., H. Qu, N. Heldman, E. Gross, D. Fass, and C.A.",OADS,/arxiv_data1/oa_pdf/29/02/JCB_201211155.PMC3628511.pdf
"http://dx.doi.org/10   .1042/BJ2007142 8 Travers, K.J., C.K.",Non-OADS,/arxiv_data1/oa_pdf/29/02/JCB_201211155.PMC3628511.pdf
"http://dx.doi.org/10.1016/S0092-8674(00)80835- 1 Tu, B.P., S.C. Ho-Schleyer, K.J.",OADS,/arxiv_data1/oa_pdf/29/02/JCB_201211155.PMC3628511.pdf
"http://dx.doi.org/10.1126/science.290.5496.157 1 van Lith, M., S. Tiwari, J. Pediani, G. Milligan, and N.J. Bulleid.",OADS,/arxiv_data1/oa_pdf/29/02/JCB_201211155.PMC3628511.pdf
"http://dx.doi.org/10.1242/jcs.08553 0 Wallrabe, H., and A. Periasamy.",Non-OADS,/arxiv_data1/oa_pdf/29/02/JCB_201211155.PMC3628511.pdf
"http://dx.doi   .org/10.1016/j.copbio.2004.12.00 2 Walter, P., and D. Ron.",OADS,/arxiv_data1/oa_pdf/29/02/JCB_201211155.PMC3628511.pdf
"http://dx.doi.org/   10.1126/science.120903 8 Zhao, H., P.A.",OADS,/arxiv_data1/oa_pdf/29/02/JCB_201211155.PMC3628511.pdf
"http://dx.doi.org/10.1083/   jcb.20091108 6 Zito, E., E.P.",OADS,/arxiv_data1/oa_pdf/29/02/JCB_201211155.PMC3628511.pdf
"http://dx.doi.org/10.1016/j.molcel   .2010.11.01 0 Zito, E., H.G.",OADS,/arxiv_data1/oa_pdf/29/02/JCB_201211155.PMC3628511.pdf
http://dx.doi.org/10   .1016/j.molcel.2012.08.01 0,OADS,/arxiv_data1/oa_pdf/29/02/JCB_201211155.PMC3628511.pdf
This article is distributed under the terms of an Attribution– Noncommercial–Share Alike–No Mirror Sites license for the first six months after the pub - lication date (see http://www.rupress.org/terms).,Non-OADS,/arxiv_data1/oa_pdf/e3/d7/JCB_201205030.PMC3628512.pdf
"After six months it is available under a  Creative Commons License (Attribution–Noncommercial–Share Alike 3.0 Unported license,  as described at http://creativecommons.org/licenses/by-nc-sa/3.0/).THE JOURNAL OF CELL BIOLOGY",Non-OADS,/arxiv_data1/oa_pdf/e3/d7/JCB_201205030.PMC3628512.pdf
"http://dx.doi   .org/10.1172/JCI4477 4 Graus-Porta, D., S. Blaess, M. Senften, A. Littlewood-Evans, C. Damsky, Z.  Huang, P. Orban, R. Klein, J.C. Schittny, and U. Müller.",Non-OADS,/arxiv_data1/oa_pdf/e3/d7/JCB_201205030.PMC3628512.pdf
"http://dx.doi.org/10   .1016/S0896-6273(01)00374- 9 Guertin, D.A., D.M.",OADS,/arxiv_data1/oa_pdf/e3/d7/JCB_201205030.PMC3628512.pdf
"http://dx.doi.org/10.1016/j.devcel   .2006.10.00 7 Guertin, D.A., D.M.",OADS,/arxiv_data1/oa_pdf/e3/d7/JCB_201205030.PMC3628512.pdf
"http://dx.doi.org/   10.1016/j.ccr.2008.12.01 7 Herculano-Houzel, S., and R. Lent.",OADS,/arxiv_data1/oa_pdf/e3/d7/JCB_201205030.PMC3628512.pdf
"http://dx.doi.org/10.1523/JNEUROSCI   .4526-04.200 5 Hietakangas, V., and S.M.",OADS,/arxiv_data1/oa_pdf/e3/d7/JCB_201205030.PMC3628512.pdf
"http://dx.doi   .org/10.1101/gad.41630 7 Hisano, S., K. Sawada, M. Kawano, M. Kanemoto, G. Xiong, K. Mogi, H.  Sakata-Haga, J. Takeda, Y. Fukui, and H. Nogami.",OADS,/arxiv_data1/oa_pdf/e3/d7/JCB_201205030.PMC3628512.pdf
"http://dx.doi.org/10 .1016/   S0169-328X(02)00442- 4 Ikenoue, T., K. Inoki, Q. Yang, X. Zhou, and K.L.",OADS,/arxiv_data1/oa_pdf/e3/d7/JCB_201205030.PMC3628512.pdf
"http://dx.doi.org/10.1038/   emboj.2008.11 9 Jacinto, E., R. Loewith, A. Schmidt, S. Lin, M.A.",OADS,/arxiv_data1/oa_pdf/e3/d7/JCB_201205030.PMC3628512.pdf
"http://dx.doi   .org/10.1038/ncb118 3 Kapfhammer, J.P. 2004.",Non-OADS,/arxiv_data1/oa_pdf/e3/d7/JCB_201205030.PMC3628512.pdf
"http://dx.doi.org/10.1016/j.proghi.2004.07.00 2 Kim, D.H., D.D.",OADS,/arxiv_data1/oa_pdf/e3/d7/JCB_201205030.PMC3628512.pdf
"http://dx.doi.org/10.1016/S0092-   8674(02)00808- 5 Kumar, A., T.E.",OADS,/arxiv_data1/oa_pdf/e3/d7/JCB_201205030.PMC3628512.pdf
"http://dx.doi.org/10.1128/MCB   .01405-0 7 Lamming, D.W., L. Ye, P. Katajisto, M.D.",OADS,/arxiv_data1/oa_pdf/e3/d7/JCB_201205030.PMC3628512.pdf
"http://dx.doi.org/   10.1126/science.121513 5 Laplante, M., and D.M.",OADS,/arxiv_data1/oa_pdf/e3/d7/JCB_201205030.PMC3628512.pdf
"http://dx.doi.org/10.1016/j.cell.2012.03   .017 Larsell, O.",OADS,/arxiv_data1/oa_pdf/e3/d7/JCB_201205030.PMC3628512.pdf
"445:168– 176. http://dx.doi.org/10.1038/nature0545 3 Li, H., G. Chen, B. Zhou, and S. Duan.",OADS,/arxiv_data1/oa_pdf/e3/d7/JCB_201205030.PMC3628512.pdf
"http://dx.doi.org/10.1091/mbc.E08-03-029 4 Loewith, R., E. Jacinto, S. Wullschleger, A. Lorberg, J.L.",Non-OADS,/arxiv_data1/oa_pdf/e3/d7/JCB_201205030.PMC3628512.pdf
http://dx.doi.org/10   .1016/S1097-2765(02)00636- 6Online supplemental material Fig.,Non-OADS,/arxiv_data1/oa_pdf/e3/d7/JCB_201205030.PMC3628512.pdf
Online supplemental material is available at http://www.jcb.org/cgi/   content/full/jcb.201205030/DC1.,Non-OADS,/arxiv_data1/oa_pdf/e3/d7/JCB_201205030.PMC3628512.pdf
"http://dx.doi   .org/10.1016/j.cmet.2008.10.00 2 Boukhtouche, F., S. Janmaat, G. Vodjdani, V. Gautheron, J. Mallet, I. Dusart,  and J. Mariani.",OADS,/arxiv_data1/oa_pdf/e3/d7/JCB_201205030.PMC3628512.pdf
"http://dx.doi.org/10.1523/JNEUROSCI.4636-05.200 6 Calabrese, B., and S. Halpain.",OADS,/arxiv_data1/oa_pdf/e3/d7/JCB_201205030.PMC3628512.pdf
"http://dx.doi.org/10.1086/37388 3 Cole, E.H., O. Johnston, C.L.",Non-OADS,/arxiv_data1/oa_pdf/e3/d7/JCB_201205030.PMC3628512.pdf
"http://dx.doi.org/   10.2215/CJN.0468110 7 Crino, P.B.",Non-OADS,/arxiv_data1/oa_pdf/e3/d7/JCB_201205030.PMC3628512.pdf
"http://dx.doi   .org/10.1016/j.molmed.2011.07.00 8 Cybulski, N., P. Polak, J. Auwerx, M.A.",OADS,/arxiv_data1/oa_pdf/e3/d7/JCB_201205030.PMC3628512.pdf
"http://dx.doi.org/   10.1073/pnas.081132110 6 Easton, R.M., H. Cho, K. Roovers, D.W. Shineman, M. Mizrahi, M.S.",Non-OADS,/arxiv_data1/oa_pdf/e3/d7/JCB_201205030.PMC3628512.pdf
"http://dx.doi.org/10.1128/MCB.25.5   .1869-1878.200 5 Ehninger, D., and A.J.",Non-OADS,/arxiv_data1/oa_pdf/e3/d7/JCB_201205030.PMC3628512.pdf
"http://dx.doi.org/10.1038/   emboj.2008.12 0 Fremeau, R.T. Jr., M.D.",OADS,/arxiv_data1/oa_pdf/e3/d7/JCB_201205030.PMC3628512.pdf
416:375– 385. http://dx.doi.org/10.1042/BJ2008166 8,Non-OADS,/arxiv_data1/oa_pdf/e3/d7/JCB_201205030.PMC3628512.pdf
"132:2943– 2954. http://dx.doi.org/10.1242/dev.0186 4 Wetts, R., and K. Herrup.",OADS,/arxiv_data1/oa_pdf/e3/d7/JCB_201205030.PMC3628512.pdf
"http://dx.doi.org/10.1016/0006-8993(82)   90431- 0 Wierenga, C.J., N. Becker, and T. Bonhoeffer.",OADS,/arxiv_data1/oa_pdf/e3/d7/JCB_201205030.PMC3628512.pdf
"http://dx.doi.org/10.1038/nn.218 0 Wullschleger, S., R. Loewith, and M.N.",OADS,/arxiv_data1/oa_pdf/e3/d7/JCB_201205030.PMC3628512.pdf
"http://dx.doi.org/10.1016/j.cell.2006   .01.01 6Mazei-Robison, M.S., J.W.",OADS,/arxiv_data1/oa_pdf/e3/d7/JCB_201205030.PMC3628512.pdf
"http://dx.doi.org/10.1093/ oxfordjournals.jbchem.a00324 9 Polak, P., N. Cybulski, J.N.",Non-OADS,/arxiv_data1/oa_pdf/e3/d7/JCB_201205030.PMC3628512.pdf
"http://dx.doi   .org/10.1016/j.cmet.2008.09.00 3 Read, D.E., and A.M. Gorman.",OADS,/arxiv_data1/oa_pdf/e3/d7/JCB_201205030.PMC3628512.pdf
"http://dx.doi.org/10.1007/   s00018-009-0057- 8 Richter, J.D., and E. Klann.",OADS,/arxiv_data1/oa_pdf/e3/d7/JCB_201205030.PMC3628512.pdf
"http://dx.doi.org/   10.1083/jcb.20090313 1 Russell, R.C., C. Fang, and K.L.",Non-OADS,/arxiv_data1/oa_pdf/e3/d7/JCB_201205030.PMC3628512.pdf
"http://dx.doi.org/10.1242/dev.05823 0 Saito, H., H. Tsumura, S. Otake, A. Nishida, T. Furukawa, and N. Suzuki.",OADS,/arxiv_data1/oa_pdf/e3/d7/JCB_201205030.PMC3628512.pdf
"http://dx.doi.org/   10.1016/j.bbrc.2005.04.04 3 Sarbassov, D.D., S.M.",OADS,/arxiv_data1/oa_pdf/e3/d7/JCB_201205030.PMC3628512.pdf
"http://dx.doi.org/10.1016/j.cub.2004.06.05 4 Sarbassov, D.D., D.A.",OADS,/arxiv_data1/oa_pdf/e3/d7/JCB_201205030.PMC3628512.pdf
"http://dx.doi.org/10.1126/science.110614 8 Sarbassov, D.D., S.M.",OADS,/arxiv_data1/oa_pdf/e3/d7/JCB_201205030.PMC3628512.pdf
"http://dx.doi   .org/10.1254/jphs.11R04C P Shiota, C., J.T.",OADS,/arxiv_data1/oa_pdf/e3/d7/JCB_201205030.PMC3628512.pdf
"http://dx.doi.org/10.1016/j.devcel.2006.08.01 3 Sidman, R.L., P.W.",OADS,/arxiv_data1/oa_pdf/e3/d7/JCB_201205030.PMC3628512.pdf
"http://dx.doi   .org/10.1126/science.137.3530.61 0 Sillitoe, R.V., and A.L.",OADS,/arxiv_data1/oa_pdf/e3/d7/JCB_201205030.PMC3628512.pdf
"http://dx.doi.org/10.1146/an nurev   .cellbio.23.090506.12323 7 Siuta, M.A., S.D.",OADS,/arxiv_data1/oa_pdf/e3/d7/JCB_201205030.PMC3628512.pdf
http://dx.doi.org/10.1371/journal.,Non-OADS,/arxiv_data1/oa_pdf/e3/d7/JCB_201205030.PMC3628512.pdf
"http://dx.doi.org/10.1007/   s00441000028 9 Tronche, F., C. Kellendonk, O. Kretz, P. Gass, K. Anlag, P.C.",Non-OADS,/arxiv_data1/oa_pdf/e3/d7/JCB_201205030.PMC3628512.pdf
"http://dx.doi.org/10.1038/1270 3 Tschopp, O., Z.Z.",Non-OADS,/arxiv_data1/oa_pdf/e3/d7/JCB_201205030.PMC3628512.pdf
"The original table has been replaced with a corrected version, which is available at http://jcb.rupress.org/content/ suppl/2013/03/18/jcb.201301120.DC1/JCB_201301120_TableS1.xls x.JCB: CorrectionTHE JOURNAL OF CELL BIOLOGY",Non-OADS,/arxiv_data1/oa_pdf/8d/34/JCB_2013011202012c.PMC3628514.pdf
This article is distributed under the terms of an Attribution– Noncommercial–Share Alike–No Mirror Sites license for the first six months after the pub - lication date (see http://www.rupress.org/terms).,Non-OADS,/arxiv_data1/oa_pdf/ac/67/JCB_201211048.PMC3628515.pdf
"After six months it is available under a  Creative Commons License (Attribution–Noncommercial–Share Alike 3.0 Unported license,  as described at http://creativecommons.org/licenses/by-nc-sa/3.0/).THE JOURNAL OF CELL BIOLOGY",Non-OADS,/arxiv_data1/oa_pdf/ac/67/JCB_201211048.PMC3628515.pdf
Online supplemental material is available at http://www.jcb   .org/cgi/content/full/jcb.201211048/DC1.,Non-OADS,/arxiv_data1/oa_pdf/ac/67/JCB_201211048.PMC3628515.pdf
"http://dx.doi   .org/10.1091/mbc.E09-04-027 7 Brokaw, C.J.",Non-OADS,/arxiv_data1/oa_pdf/ac/67/JCB_201211048.PMC3628515.pdf
"http://dx.doi.org/   10.1002/cm.97028030 3 Brokaw, C.J.",Non-OADS,/arxiv_data1/oa_pdf/ac/67/JCB_201211048.PMC3628515.pdf
"http://dx.doi.org/10   .1002/cm.1006 7 Brokaw, C.J.",Non-OADS,/arxiv_data1/oa_pdf/ac/67/JCB_201211048.PMC3628515.pdf
"http://dx.doi.org/10.1002/cm.2031 3 Brokaw, C.J., and R. Kamiya.",OADS,/arxiv_data1/oa_pdf/ac/67/JCB_201211048.PMC3628515.pdf
"http://dx.doi.org/10.1002/cm.97008011 0contained the recognition sites for BamHI, NdeI, and EcoRI (underlined).",OADS,/arxiv_data1/oa_pdf/ac/67/JCB_201211048.PMC3628515.pdf
"http://dx.doi.org/   10.1016/S0074-7696(02)19012- 7 Kamiya, R., E. Kurimoto, and E. Muto.",OADS,/arxiv_data1/oa_pdf/ac/67/JCB_201211048.PMC3628515.pdf
"http://dx.doi.org/10.1083/jcb.112.3.44 1 Kato-Minoura, T., M. Hirono, and R. Kamiya.",OADS,/arxiv_data1/oa_pdf/ac/67/JCB_201211048.PMC3628515.pdf
"http://dx.doi.org/10.1083/jcb.137.3.64 9 Kikushima, K. 2009.",OADS,/arxiv_data1/oa_pdf/ac/67/JCB_201211048.PMC3628515.pdf
"http://dx.doi.org/10.1002/cm.2035 5 Kim, K.S., S. Kustu, and W. Inwood.",Non-OADS,/arxiv_data1/oa_pdf/ac/67/JCB_201211048.PMC3628515.pdf
"http://dx.doi.org/10   .1534/genetics.106.05826 3 King, S.J., and S.K.",OADS,/arxiv_data1/oa_pdf/ac/67/JCB_201211048.PMC3628515.pdf
"http://dx.doi.org/10.1083/jcb.136   .1.17 7 King, S.M., and R. Kamiya.",OADS,/arxiv_data1/oa_pdf/ac/67/JCB_201211048.PMC3628515.pdf
"http://dx.doi   .org/10.1073/pnas.82.14.471 7 Kohno, T., K. Wakabayashi, D.R.",OADS,/arxiv_data1/oa_pdf/ac/67/JCB_201211048.PMC3628515.pdf
"http://dx.doi.org/10.1002/   cm.2050 7 Kotani, N., H. Sakakibara, S.A. Burgess, H. Kojima, and K. Oiwa.",OADS,/arxiv_data1/oa_pdf/ac/67/JCB_201211048.PMC3628515.pdf
"http://dx.doi.org/10.1529/   biophysj.106.10196 4 Kremer, J.R., D.N.",OADS,/arxiv_data1/oa_pdf/ac/67/JCB_201211048.PMC3628515.pdf
"http://dx.doi.org/10.1006/jsbi.1996.001 3 Kwon, Y.J., S.J.",OADS,/arxiv_data1/oa_pdf/ac/67/JCB_201211048.PMC3628515.pdf
"7:20– 33. http://dx.doi.org/10.1097/JTO.0b013e3182307f6 2 Laemmli, U.K. 1970.",Non-OADS,/arxiv_data1/oa_pdf/ac/67/JCB_201211048.PMC3628515.pdf
"http://dx.doi.org/10   .1038/227680a 0 LeDizet, M., and G. Piperno.",OADS,/arxiv_data1/oa_pdf/ac/67/JCB_201211048.PMC3628515.pdf
"http://dx.doi.org/10.1016/   j.gene.2010.11.00 6 Lin, J., D. Tritschler, K. Song, C.F.",OADS,/arxiv_data1/oa_pdf/ac/67/JCB_201211048.PMC3628515.pdf
"http://dx.doi.org/10.1002/   cm.2100 0 Lin, J., T. Heuser, K. Song, X. Fu, and D. Nicastro.",OADS,/arxiv_data1/oa_pdf/ac/67/JCB_201211048.PMC3628515.pdf
"http://dx.doi.org/10.1371/ journal.pone.004649 4 Lindemann, C.B.",Non-OADS,/arxiv_data1/oa_pdf/ac/67/JCB_201211048.PMC3628515.pdf
"http://dx.doi.org/10.1016/B978-0-   12-385065-2.00001- 3 Lindemann, C.B., and K.A.",OADS,/arxiv_data1/oa_pdf/ac/67/JCB_201211048.PMC3628515.pdf
"http://dx.doi.org/   10.1242/jcs.05132 6 Marshall, W.F.",Non-OADS,/arxiv_data1/oa_pdf/ac/67/JCB_201211048.PMC3628515.pdf
"http://dx.doi.org/10.1083/jcb.20071008 5 Mastronarde, D.N.",OADS,/arxiv_data1/oa_pdf/ac/67/JCB_201211048.PMC3628515.pdf
"http://dx.doi.org/10.1016/j.jsb.2005.07.00 7 Mitchison, T.J., and H.M. Mitchison.",OADS,/arxiv_data1/oa_pdf/ac/67/JCB_201211048.PMC3628515.pdf
"http://dx.doi.org/10.1038/463308 aBui, K.H., H. Sakakibara, T. Movassagh, K. Oiwa, and T. Ishikawa.",OADS,/arxiv_data1/oa_pdf/ac/67/JCB_201211048.PMC3628515.pdf
"http://dx.doi.org/10.1083/   jcb.20080805 0 Bui, K.H., H. Sakakibara, T. Movassagh, K. Oiwa, and T. Ishikawa.",OADS,/arxiv_data1/oa_pdf/ac/67/JCB_201211048.PMC3628515.pdf
"http://dx.doi.org/10.1083/jcb   .20090308 2 Bui, K.H., T. Yagi, R. Yamamoto, R. Kamiya, and T. Ishikawa.",OADS,/arxiv_data1/oa_pdf/ac/67/JCB_201211048.PMC3628515.pdf
"http://dx.doi   .org/10.1083/jcb.20120112 0 Drummond, I.A.",Non-OADS,/arxiv_data1/oa_pdf/ac/67/JCB_201211048.PMC3628515.pdf
"http://dx.doi.org/10.1016/j.ceb.2011.12.00 7 Dutcher, S.K.",OADS,/arxiv_data1/oa_pdf/ac/67/JCB_201211048.PMC3628515.pdf
"http://dx.doi.org/10.1016/   S0091-679X(08)60857- 2 Dymek, E.E., T. Heuser, D. Nicastro, and E.F. Smith.",OADS,/arxiv_data1/oa_pdf/ac/67/JCB_201211048.PMC3628515.pdf
"http://dx.doi.org/10.1091/mbc.E11-03-027 1 Elam, C.A., M. Wirschell, R. Yamamoto, L.A. Fox, K. York, R. Kamiya, S.K.",Non-OADS,/arxiv_data1/oa_pdf/ac/67/JCB_201211048.PMC3628515.pdf
"http://dx.doi.org/10.1002/cm.2051 9 Fischer, N., and J.D.",OADS,/arxiv_data1/oa_pdf/ac/67/JCB_201211048.PMC3628515.pdf
"http://dx.doi.org/10.1007/   s00438010048 5 Gardner, L.C., E. O’Toole, C.A.",Non-OADS,/arxiv_data1/oa_pdf/ac/67/JCB_201211048.PMC3628515.pdf
"http://dx.doi.org/10.1083/jcb.127.5.131 1 Gokhale, A., M. Wirschell, and W.S.",Non-OADS,/arxiv_data1/oa_pdf/ac/67/JCB_201211048.PMC3628515.pdf
"http://dx.doi.org/10.1083/jcb   .20090616 8 Habermacher, G., and W.S.",OADS,/arxiv_data1/oa_pdf/ac/67/JCB_201211048.PMC3628515.pdf
"http://dx.doi.org/10.1083/jcb.136.1.16 7 Hayashi, S., and C. Shingyoji.",OADS,/arxiv_data1/oa_pdf/ac/67/JCB_201211048.PMC3628515.pdf
"http://dx.doi.org/10.1242/jcs   .03119 5 Hayashibe, K., C. Shingyoji, and R. Kamiya.",OADS,/arxiv_data1/oa_pdf/ac/67/JCB_201211048.PMC3628515.pdf
"http://dx.doi.org/ 10.1002/(SICI)1097-0169(1997)37:3<232::AID-CM5>3.0.CO;2- 8 Hendrickson, T.W., C.A.",OADS,/arxiv_data1/oa_pdf/ac/67/JCB_201211048.PMC3628515.pdf
"http://dx.doi.org/10.1091/mbc   .E04-08-069 4 Heuser, T., M. Raytchev, J. Krell, M.E.",OADS,/arxiv_data1/oa_pdf/ac/67/JCB_201211048.PMC3628515.pdf
"http://dx.doi.org/   10.1083/jcb.20090806 7 Heuser, T., E.E.",OADS,/arxiv_data1/oa_pdf/ac/67/JCB_201211048.PMC3628515.pdf
"http://dx.doi.org/10.1091/mbc   .E12-05-035 7 Heuser, T., C.F.",Non-OADS,/arxiv_data1/oa_pdf/ac/67/JCB_201211048.PMC3628515.pdf
"http://dx.doi.org/10.1056/NEJMra101017 2 Hirokawa, N., Y. Tanaka, and Y. Okada.",OADS,/arxiv_data1/oa_pdf/ac/67/JCB_201211048.PMC3628515.pdf
"http://dx.doi.org/10.1016/   j.ceb.2012.01.00 2 Hoops, H.J., and G.B.",OADS,/arxiv_data1/oa_pdf/ac/67/JCB_201211048.PMC3628515.pdf
"http://dx.doi.org/10.1083/jcb.97.3.90 2 Jarvik, J.W., and J.L.",OADS,/arxiv_data1/oa_pdf/ac/67/JCB_201211048.PMC3628515.pdf
"http://dx.doi.org/10.1083/jcb.85.2.25 8 Kamiya, R. 2000.",OADS,/arxiv_data1/oa_pdf/ac/67/JCB_201211048.PMC3628515.pdf
http://dx.doi.org/10.1006/meth   .2000.109 0,OADS,/arxiv_data1/oa_pdf/ac/67/JCB_201211048.PMC3628515.pdf
"http://dx.doi   .org/10.1091/mbc.E10-10-080 6 VanderWaal, K.E., R. Yamamoto, K. Wakabayashi, L. Fox, R. Kamiya, S.K.",Non-OADS,/arxiv_data1/oa_pdf/ac/67/JCB_201211048.PMC3628515.pdf
"http://dx.doi.org/10.1091/mbc.E11-03-027 0 Wirschell, M., T. Hendrickson, and W.S.",OADS,/arxiv_data1/oa_pdf/ac/67/JCB_201211048.PMC3628515.pdf
"http://dx.doi.org/10.1002/cm.2021 1 Wirschell, M., C. Yang, P. Yang, L. Fox, H.A.",Non-OADS,/arxiv_data1/oa_pdf/ac/67/JCB_201211048.PMC3628515.pdf
"http://dx.doi.org/10.1091/mbc   .E09-04-027 6 Witman, G.B.",Non-OADS,/arxiv_data1/oa_pdf/ac/67/JCB_201211048.PMC3628515.pdf
"http://dx.doi.org/10.1016/0076-6879   (86)34096- 5 Witman, G.B., K. Carlson, J. Berliner, and J.L.",OADS,/arxiv_data1/oa_pdf/ac/67/JCB_201211048.PMC3628515.pdf
"http://dx.doi   .org/10.1083/jcb.54.3.50 7 Yagi, T., S. Kamimura, and R. Kamiya.",OADS,/arxiv_data1/oa_pdf/ac/67/JCB_201211048.PMC3628515.pdf
"29:177– 185. http://dx.doi.org/10.1002/cm.97029020 9 Yamamoto, R., H.A.",Non-OADS,/arxiv_data1/oa_pdf/ac/67/JCB_201211048.PMC3628515.pdf
"http://dx.doi.org/10.1128/EC.00341-0 7 Yamamoto, R., M. Hirono, and R. Kamiya.",OADS,/arxiv_data1/oa_pdf/ac/67/JCB_201211048.PMC3628515.pdf
"http://dx.doi.org/10.1083/jcb.20100208 1 Yang, P., and W.S.",OADS,/arxiv_data1/oa_pdf/ac/67/JCB_201211048.PMC3628515.pdf
"http://dx.doi.org/   10.1016/j.cub.2004.11.02 8 Myster, S.H., J.A.",OADS,/arxiv_data1/oa_pdf/ac/67/JCB_201211048.PMC3628515.pdf
"http://dx.doi.org/10.1126/science   .112861 8 Oh, E.C., and N. Katsanis.",OADS,/arxiv_data1/oa_pdf/ac/67/JCB_201211048.PMC3628515.pdf
"http://dx.doi.org/10.1242/dev.05005 4 Okagaki, T., and R. Kamiya.",OADS,/arxiv_data1/oa_pdf/ac/67/JCB_201211048.PMC3628515.pdf
"103:1895– 1902. http://dx.doi.org/10.1083/jcb.103.5.189 5 Okita, N., N. Isogai, M. Hirono, R. Kamiya, and K. Yoshimura.",OADS,/arxiv_data1/oa_pdf/ac/67/JCB_201211048.PMC3628515.pdf
"http://dx.doi.org/10.1242/jcs.0163 3 Pazour, G.J., N. Agrin, J. Leszyk, and G.B.",Non-OADS,/arxiv_data1/oa_pdf/ac/67/JCB_201211048.PMC3628515.pdf
"http://dx.doi.org/   10.1083/jcb.20050400 8 Pettersen, E.F., T.D.",OADS,/arxiv_data1/oa_pdf/ac/67/JCB_201211048.PMC3628515.pdf
"http://dx.doi.org/10.1002/jcc.2008 4 Pigino, G., K.H.",Non-OADS,/arxiv_data1/oa_pdf/ac/67/JCB_201211048.PMC3628515.pdf
"http://dx.doi.org/10.1083/jcb.20110612 5 Piperno, G. 1995.",Non-OADS,/arxiv_data1/oa_pdf/ac/67/JCB_201211048.PMC3628515.pdf
"http://dx.doi.org/10.1002/cm   .97032020 6 Porter, M.E.",Non-OADS,/arxiv_data1/oa_pdf/ac/67/JCB_201211048.PMC3628515.pdf
"http://dx.doi.org/10.1083/jcb   .151.5.F3 7 Porter, M.E., J.",OADS,/arxiv_data1/oa_pdf/ac/67/JCB_201211048.PMC3628515.pdf
"http://dx.doi   .org/10.1083/jcb.118.5.116 3 Roy, S. 2009.",Non-OADS,/arxiv_data1/oa_pdf/ac/67/JCB_201211048.PMC3628515.pdf
"http://dx.doi.org/10.1002/bies.20090003 1 Sakato, M. 2009.",Non-OADS,/arxiv_data1/oa_pdf/ac/67/JCB_201211048.PMC3628515.pdf
"http://dx.doi.org/10   .1016/S0091-679X(08)91010- 4 Sanders, M.A., and J.L.",OADS,/arxiv_data1/oa_pdf/ac/67/JCB_201211048.PMC3628515.pdf
"http://dx.doi.org/10   .1016/S0091-679X(08)60805- 5 Satir, P., and S.T.",OADS,/arxiv_data1/oa_pdf/ac/67/JCB_201211048.PMC3628515.pdf
"http://dx.doi.org/10.1146/ annurev.physiol.69.040705.14123 6 Shimogawara, K., S. Fujiwara, A. Grossman, and H. Usuda.",OADS,/arxiv_data1/oa_pdf/ac/67/JCB_201211048.PMC3628515.pdf
"http://dx.doi.org/10.1038/3152 0 Smith, E.F. 2002.",Non-OADS,/arxiv_data1/oa_pdf/ac/67/JCB_201211048.PMC3628515.pdf
"http://dx.doi.org/10.1002/cm   .1003 1 Smith, E.F., and R. Rohatgi.",OADS,/arxiv_data1/oa_pdf/ac/67/JCB_201211048.PMC3628515.pdf
"http://dx.doi.org/10.1126/scisignal.4155mr 1 Smith, E.F., and W.S.",OADS,/arxiv_data1/oa_pdf/ac/67/JCB_201211048.PMC3628515.pdf
"http://dx.doi.org/10.1002/cm.1015 5 Soler Artigas, M., L.V.",Non-OADS,/arxiv_data1/oa_pdf/ac/67/JCB_201211048.PMC3628515.pdf
"http://dx.doi.org/   10.1136/thoraxjnl-2011-20072 4 Taillon, B.E., and J.W.",OADS,/arxiv_data1/oa_pdf/ac/67/JCB_201211048.PMC3628515.pdf
This article is distributed under the terms of an Attribution– Noncommercial–Share Alike–No Mirror Sites license for the first six months after the pub - lication date (see http://www.rupress.org/terms).,Non-OADS,/arxiv_data1/oa_pdf/e6/02/JCB_201209151.PMC3628517.pdf
"After six months it is available under a  Creative Commons License (Attribution–Noncommercial–Share Alike 3.0 Unported license,  as described at http://creativecommons.org/licenses/by-nc-sa/3.0/).THE JOURNAL OF CELL BIOLOGY",Non-OADS,/arxiv_data1/oa_pdf/e6/02/JCB_201209151.PMC3628517.pdf
"http://dx.doi.org/10.1038/nature0802 1 Bravo-Cordero, J.J., L. Hodgson, and J. Condeelis.",OADS,/arxiv_data1/oa_pdf/e6/02/JCB_201209151.PMC3628517.pdf
"http://dx.doi.org/10.1016/j.ceb.2011.12.00 4 Brizel, D.M., S.P.",OADS,/arxiv_data1/oa_pdf/e6/02/JCB_201209151.PMC3628517.pdf
"http://dx.doi.org/10.1016/S1097- 2765   (00)80417- 7 Burgstaller, G., and M. Gimona.",OADS,/arxiv_data1/oa_pdf/e6/02/JCB_201209151.PMC3628517.pdf
"http://dx.doi.org/10.1152/ajpheart   .01002.200 4 Chen, C., N. Pore, A. Behrooz, F. Ismail-Beigi, and A. Maity.",Non-OADS,/arxiv_data1/oa_pdf/e6/02/JCB_201209151.PMC3628517.pdf
"http://dx.doi.org/10.1074/ jbc.M01014420 0 Chen, J., N. Imanaka, J. Chen, and J.D.",OADS,/arxiv_data1/oa_pdf/e6/02/JCB_201209151.PMC3628517.pdf
"http://dx.doi.org/10.1002/jez.140251020 6 Chen, Y., M.A.",OADS,/arxiv_data1/oa_pdf/e6/02/JCB_201209151.PMC3628517.pdf
"http://dx.doi.org/10.1158/0008-5472.CAN-07-122 9 Clark, E.S., A.S. Whigham, W.G.",Non-OADS,/arxiv_data1/oa_pdf/e6/02/JCB_201209151.PMC3628517.pdf
"http://dx.doi.org/10.1158/0008-5472.CAN-06-392 8 Compernolle, V., K. Brusselmans, D. Franco, A. Moorman, M. Dewerchin, D.  Collen, and P. Carmeliet.",Non-OADS,/arxiv_data1/oa_pdf/e6/02/JCB_201209151.PMC3628517.pdf
"http://dx.doi.org/   10.1016/j.cardiores.2003.07.00 3 Dateoka, S., Y. Ohnishi, and K. Kakudo.",OADS,/arxiv_data1/oa_pdf/e6/02/JCB_201209151.PMC3628517.pdf
"http://dx.doi.org/10.1007/s00795-011-0543- 6 De Strooper, B., W. Annaert, P. Cupers, P. Saftig, K. Craessaerts, J.S.",Non-OADS,/arxiv_data1/oa_pdf/e6/02/JCB_201209151.PMC3628517.pdf
"http://dx.doi.org/   10.1038/1908 3 Eckert, M.A., T.M.",OADS,/arxiv_data1/oa_pdf/e6/02/JCB_201209151.PMC3628517.pdf
"http://dx.doi.org/10.1016/   j.ccr.2011.01.03 6 Ellisen, L.W., J. Bird, D.C. West, A.L.",OADS,/arxiv_data1/oa_pdf/e6/02/JCB_201209151.PMC3628517.pdf
"http://dx.doi.org/10.1016/0092-8674(91)90111- B Friedl, P., J. Locker, E. Sahai, and J.E.",OADS,/arxiv_data1/oa_pdf/e6/02/JCB_201209151.PMC3628517.pdf
"http://dx.doi.org/10   .1038/ncb254 8 Fröhlich, C., R. Albrechtsen, L. Dyrskjøt, L. Rudkjaer, T.F.",OADS,/arxiv_data1/oa_pdf/e6/02/JCB_201209151.PMC3628517.pdf
"http://dx.doi.org/10.1158/1078-0432   .CCR-06-106 6 Garber, M.E., O.G.",Non-OADS,/arxiv_data1/oa_pdf/e6/02/JCB_201209151.PMC3628517.pdf
"http://dx.doi.org/   10.1073/pnas.24150079 8 Goishi, K., S. Higashiyama, M. Klagsbrun, N. Nakano, T. Umata, M. Ishikawa,  E. Mekada, and N. Taniguchi.",OADS,/arxiv_data1/oa_pdf/e6/02/JCB_201209151.PMC3628517.pdf
Online supplemental material is available at  http://www.jcb.org/cgi/content/full/jcb.201209151/DC1.,Non-OADS,/arxiv_data1/oa_pdf/e6/02/JCB_201209151.PMC3628517.pdf
Additional  data are available in the JCB DataViewer at http://dx.doi.org/10.1083/ jcb.201209151.dv.,OADS,/arxiv_data1/oa_pdf/e6/02/JCB_201209151.PMC3628517.pdf
"http://dx.doi.org/10.1074/jbc   .M30026720 0 Adelman, D.M., M. Gertsenstein, A. Nagy, M.C.",Non-OADS,/arxiv_data1/oa_pdf/e6/02/JCB_201209151.PMC3628517.pdf
"http://dx.doi.org/10.1101/gad.85370 0 Agrawal, N., M.J. Frederick, C.R.",Non-OADS,/arxiv_data1/oa_pdf/e6/02/JCB_201209151.PMC3628517.pdf
"http://dx.doi.org/10 .1126/   science.120692 3 Albrechtsen, R., D. Stautz, A. Sanjay, M. Kveiborg, and U.M.",OADS,/arxiv_data1/oa_pdf/e6/02/JCB_201209151.PMC3628517.pdf
"317:195– 209. http://dx.doi.org/10.1016/j.yexcr.2010.10.00 3 Amarilio, R., S.V.",OADS,/arxiv_data1/oa_pdf/e6/02/JCB_201209151.PMC3628517.pdf
"http://dx.doi.org/10.1242/dev.00844 1 Asakura, M., M. Kitakaze, S. Takashima, Y. Liao, F. Ishikura, T. Yoshinaka, H.  Ohmoto, K. Node, K. Yoshino, H. Ishiguro, et al.",OADS,/arxiv_data1/oa_pdf/e6/02/JCB_201209151.PMC3628517.pdf
http://dx.doi.org/10.1172/JCI3615 7,Non-OADS,/arxiv_data1/oa_pdf/e6/02/JCB_201209151.PMC3628517.pdf
"http://dx.doi.org/10.1083/jcb.20070109 2 Li, H., E. Solomon, S. Duhachek Muggy, D. Sun, and A. Zolkiewska.",OADS,/arxiv_data1/oa_pdf/e6/02/JCB_201209151.PMC3628517.pdf
"http://dx.doi   .org/10.1158/0008-5472.CAN-06-270 1 Linder, S. 2007.",OADS,/arxiv_data1/oa_pdf/e6/02/JCB_201209151.PMC3628517.pdf
"http://dx.doi.org/   10.1016/j.tcb.2007.01.00 2 Linder, S., D. Nelson, M. Weiss, and M. Aepfelbacher.",OADS,/arxiv_data1/oa_pdf/e6/02/JCB_201209151.PMC3628517.pdf
"http://dx.doi.org/10.1073/   pnas.96.17.964 8 Lucien, F., K. Brochu-Gaudreau, D. Arsenault, K. Harper, and C.M.",Non-OADS,/arxiv_data1/oa_pdf/e6/02/JCB_201209151.PMC3628517.pdf
"http://dx.doi.org/10.1371/journal.pone.002885 1 Maraver, A., P.J.",Non-OADS,/arxiv_data1/oa_pdf/e6/02/JCB_201209151.PMC3628517.pdf
"http://dx.doi   .org/10.1016/j.ccr.2012.06.01 4 Marchisio, P.C., D. Cirillo, L. Naldini, M.V.",OADS,/arxiv_data1/oa_pdf/e6/02/JCB_201209151.PMC3628517.pdf
"http://dx.doi.org/10.1083/jcb.99.5.169 6 Markowski, J., M. Oczko-Wojciechowska, T. Gierek, M. Jarzab, J. Paluch, M.  Kowalska, Z. Wygoda, A. Pfeifer, T. Tyszkiewicz, B. Jarzab, et al.",Non-OADS,/arxiv_data1/oa_pdf/e6/02/JCB_201209151.PMC3628517.pdf
"http://dx.doi.org/10.1002/jso.2131 3 Mitamura, T., S. Higashiyama, N. Taniguchi, M. Klagsbrun, and E. Mekada.",OADS,/arxiv_data1/oa_pdf/e6/02/JCB_201209151.PMC3628517.pdf
"http://dx.doi.org/10.1074/jbc.270.3.101 5 Miyamoto, S., M. Hirata, A. Yamazaki, T. Kageyama, H. Hasuwa, H. Mizushima,  Y. Tanaka, H. Yagi, K. Sonoda, M. Kai, et al.",OADS,/arxiv_data1/oa_pdf/e6/02/JCB_201209151.PMC3628517.pdf
"http://dx.doi.org/10.1158/0008-5472   .CAN-04-081 1 Mumm, J.S., E.H. Schroeter, M.T.",OADS,/arxiv_data1/oa_pdf/e6/02/JCB_201209151.PMC3628517.pdf
"http://dx.doi.org/10.1016/S1097-2765(00)80416- 5 Murphy, D.A., and S.A. Courtneidge.",OADS,/arxiv_data1/oa_pdf/e6/02/JCB_201209151.PMC3628517.pdf
"http://dx.doi.org/10.1038/nrm314 1 Murphy, D.A., B. Diaz, P.A.",OADS,/arxiv_data1/oa_pdf/e6/02/JCB_201209151.PMC3628517.pdf
"http://dx.doi.org/10.1371/journal   .pone.002249 9 Ohh, M., C.W.",OADS,/arxiv_data1/oa_pdf/e6/02/JCB_201209151.PMC3628517.pdf
"http://dx.doi.org/   10.1038/3501705 4 Ongusaha, P.P., J.C. Kwak, A.J.",Non-OADS,/arxiv_data1/oa_pdf/e6/02/JCB_201209151.PMC3628517.pdf
"http://dx.doi.org/10.1038/nrg327 2 Gustafsson, M.V., X. Zheng, T. Pereira, K. Gradin, S. Jin, J. Lundkvist, J.L.",OADS,/arxiv_data1/oa_pdf/e6/02/JCB_201209151.PMC3628517.pdf
"http://dx.doi.org/10.1016/j.devcel.2005.09.01 0 Hanahan, D., and R.A. Weinberg.",OADS,/arxiv_data1/oa_pdf/e6/02/JCB_201209151.PMC3628517.pdf
"http://dx.doi.org/10.1016/j.cell.2011.02.01 3 Higashiyama, S., J.A.",OADS,/arxiv_data1/oa_pdf/e6/02/JCB_201209151.PMC3628517.pdf
"http://dx.doi.org/   10.1126/science.184069 8 Higashiyama, S., R. Iwamoto, K. Goishi, G. Raab, N. Taniguchi, M. Klagsbrun,  and E. Mekada.",OADS,/arxiv_data1/oa_pdf/e6/02/JCB_201209151.PMC3628517.pdf
"http://dx.doi   .org/10.1083/jcb.128.5.92 9 Hiraga, T., S. Kizaka-Kondoh, K. Hirota, M. Hiraoka, and T. Yoneda.",OADS,/arxiv_data1/oa_pdf/e6/02/JCB_201209151.PMC3628517.pdf
"http://dx.doi.org/10   .1371/journal.pone.001031 2 Hu, B., E. Castillo, L. Harewood, P. Ostano, A. Reymond, R. Dummer, W. Raffoul,  W. Hoetzenecker, G.F. Hofbauer, and G.P.",Non-OADS,/arxiv_data1/oa_pdf/e6/02/JCB_201209151.PMC3628517.pdf
"http://dx.doi.org/10.1016/j.cell.2012.03.04 8 Keith, B., and M.C.",OADS,/arxiv_data1/oa_pdf/e6/02/JCB_201209151.PMC3628517.pdf
"http://dx.doi.org/10.1016/j.cell.2007.04.01 9 Kodama, T., E. Ikeda, A. Okada, T. Ohtsuka, M. Shimoda, T. Shiomi, K.  Yoshida, M. Nakada, E. Ohuchi, and Y. Okada.",OADS,/arxiv_data1/oa_pdf/e6/02/JCB_201209151.PMC3628517.pdf
"http://dx.doi.org/10.1016/   S0002-9440(10)63429- 3 Krishnan, J., P. Ahuja, S. Bodenmann, D. Knapik, E. Perriard, W. Krek, and  J.C. Perriard.",OADS,/arxiv_data1/oa_pdf/e6/02/JCB_201209151.PMC3628517.pdf
"http://dx.doi.org/10.1161/01.RES.0000338613.89841.c 1 Kung, A.L., S. Wang, J.M.",OADS,/arxiv_data1/oa_pdf/e6/02/JCB_201209151.PMC3628517.pdf
"http://dx.doi.org/10.1038/8214 6 Kurisaki, T., A. Masuda, K. Sudo, J. Sakagami, S. Higashiyama, Y. Matsuda, A.  Nagabukuro, A. Tsuji, Y. Nabeshima, M. Asano, et al.",OADS,/arxiv_data1/oa_pdf/e6/02/JCB_201209151.PMC3628517.pdf
"http://dx.doi.org/10.1128/MCB.23.1.55-61.200 3 Kveiborg, M., C. Fröhlich, R. Albrechtsen, V. Tischler, N. Dietrich, P. Holck, P.  Kronqvist, F. Rank, A.M. Mercurio, and U.M.",OADS,/arxiv_data1/oa_pdf/e6/02/JCB_201209151.PMC3628517.pdf
"http://dx.doi.org/10.1158/0008-5472.CAN-05-026 2 Landi, M.T., T. Dracheva, M. Rotunno, J.D.",Non-OADS,/arxiv_data1/oa_pdf/e6/02/JCB_201209151.PMC3628517.pdf
"http://dx.doi.org/10.1371/ journal.pone.000165 1 Lendeckel, U., J. Kohl, M. Arndt, S. Carl-McGrath, H. Donat, and C. Röcken.",OADS,/arxiv_data1/oa_pdf/e6/02/JCB_201209151.PMC3628517.pdf
"131:41– 48. http://dx.doi.org/10.1007/s00432-004-0619- y Le Pabic, H., D. Bonnier, U.M.",Non-OADS,/arxiv_data1/oa_pdf/e6/02/JCB_201209151.PMC3628517.pdf
http://dx.doi.org/10.1053/jhep   .2003.5020 5,Non-OADS,/arxiv_data1/oa_pdf/e6/02/JCB_201209151.PMC3628517.pdf
"http://dx.doi.org/10.1016/j.bbrc.2012.05.05 2 Tokumaru, S., S. Higashiyama, T. Endo, T. Nakagawa, J.I.",OADS,/arxiv_data1/oa_pdf/e6/02/JCB_201209151.PMC3628517.pdf
"http://dx.doi.org/10.1083/jcb.151.2.20 9 Vaupel, P., K. Schlenger, C. Knoop, and M. Höckel.",OADS,/arxiv_data1/oa_pdf/e6/02/JCB_201209151.PMC3628517.pdf
"http://dx.doi.org/10.1093/   bioinformatics/bti68 8 Wang, F., C. Sloss, X. Zhang, S.W.",OADS,/arxiv_data1/oa_pdf/e6/02/JCB_201209151.PMC3628517.pdf
"http://dx.doi.org/10.1158/0008-5472.CAN-07-049 8 Wang, G.L., B.H.",OADS,/arxiv_data1/oa_pdf/e6/02/JCB_201209151.PMC3628517.pdf
"http://dx.doi   .org/10.1073/pnas.92.12.551 0 Wang, N.J., Z. Sanborn, K.L.",Non-OADS,/arxiv_data1/oa_pdf/e6/02/JCB_201209151.PMC3628517.pdf
"http://dx.doi   .org/10.1073/pnas.111466910 8 Weaver, A.M. 2006.",OADS,/arxiv_data1/oa_pdf/e6/02/JCB_201209151.PMC3628517.pdf
"http://dx.doi.org/10.1007/   s10585-006-9014- 1 Weng, A.P., A.A. Ferrando, W. Lee, J.P. Morris IV, L.B.",Non-OADS,/arxiv_data1/oa_pdf/e6/02/JCB_201209151.PMC3628517.pdf
"http://dx.doi.org/10.1126/science.110216 0 Wharton, K.A., K.M.",Non-OADS,/arxiv_data1/oa_pdf/e6/02/JCB_201209151.PMC3628517.pdf
"http://dx.doi.org/10.1016/0092-8674(85)90229- 6 Xing, F., H. Okuda, M. Watabe, A. Kobayashi, S.K.",OADS,/arxiv_data1/oa_pdf/e6/02/JCB_201209151.PMC3628517.pdf
"http://dx.doi.org/10.1038/onc.2011.12 2 Xu, K.P., Y. Ding, J. Ling, Z. Dong, and F.S.",OADS,/arxiv_data1/oa_pdf/e6/02/JCB_201209151.PMC3628517.pdf
"http://dx.doi.org/   10.1167/iovs.03-085 1 Yamada, D., K. Ohuchida, K. Mizumoto, S. Ohhashi, J. Yu, T. Egami, H. Fujita,  E. Nagai, and M. Tanaka.",OADS,/arxiv_data1/oa_pdf/e6/02/JCB_201209151.PMC3628517.pdf
"168:441– 452. http://dx.doi.org/10.1083/jcb.20040707 6 Yang, Y., Y.H.",Non-OADS,/arxiv_data1/oa_pdf/e6/02/JCB_201209151.PMC3628517.pdf
"http://dx.doi.org/10.1172/JCI4257 9 Young, S.D., R.S.",OADS,/arxiv_data1/oa_pdf/e6/02/JCB_201209151.PMC3628517.pdf
"http://dx.doi.org/10.1073/   pnas.85.24.953 3 Zavadil, J., L. Cermak, N. Soto-Nieves, and E.P.",Non-OADS,/arxiv_data1/oa_pdf/e6/02/JCB_201209151.PMC3628517.pdf
"http://dx.doi.org/10.1038/   sj.emboj.760006 9 Zeng, Q., S. Li, D.B.",OADS,/arxiv_data1/oa_pdf/e6/02/JCB_201209151.PMC3628517.pdf
http://dx.doi.org/10.1016/j.ccr.2005.06.00 4of tumor growth and angiogenesis.,OADS,/arxiv_data1/oa_pdf/e6/02/JCB_201209151.PMC3628517.pdf
"http://dx.doi.org/10.1038/sj.onc.120953 6 Petcherski, A.G., and J. Kimble.",OADS,/arxiv_data1/oa_pdf/e6/02/JCB_201209151.PMC3628517.pdf
"http://dx.doi.org/10.1016/S0960-   9822(00)00577- 7 Provot, S., D. Zinyk, Y. Gunes, R. Kathri, Q.",OADS,/arxiv_data1/oa_pdf/e6/02/JCB_201209151.PMC3628517.pdf
"http://dx.doi.org/10.1083/jcb.20061202 3 Rocks, N., G. Paulissen, F. Quesada Calvo, M. Polette, M. Gueders, C. Munaut,  J.M.",Non-OADS,/arxiv_data1/oa_pdf/e6/02/JCB_201209151.PMC3628517.pdf
"http://dx.doi.org/10.1074/jbc.M110.21603 6 Rubin, J.S., A.M. Chan, D.P.",Non-OADS,/arxiv_data1/oa_pdf/e6/02/JCB_201209151.PMC3628517.pdf
"http://dx.doi   .org/10.1073/pnas.88.2.41 5 Sahin, U., G. Weskamp, K. Kelly, H.M. Zhou, S. Higashiyama, J. Peschon, D.  Hartmann, P. Saftig, and C.P.",OADS,/arxiv_data1/oa_pdf/e6/02/JCB_201209151.PMC3628517.pdf
"http://dx.doi.org/10.1083/jcb.20030713 7 Sahlgren, C., M.V.",OADS,/arxiv_data1/oa_pdf/e6/02/JCB_201209151.PMC3628517.pdf
"http://dx.doi.org/10   .1073/pnas.080204710 5 Santagata, S., F. Demichelis, A. Riva, S. Varambally, M.D.",Non-OADS,/arxiv_data1/oa_pdf/e6/02/JCB_201209151.PMC3628517.pdf
"http://dx.doi.org/10.1158/0008-5472.CAN-04-250 0 Seals, D.F., and S.A. Courtneidge.",Non-OADS,/arxiv_data1/oa_pdf/e6/02/JCB_201209151.PMC3628517.pdf
"http://dx.doi.org/10.1101/gad.103970 3 Seals, D.F., E.F. Azucena Jr., I.",Non-OADS,/arxiv_data1/oa_pdf/e6/02/JCB_201209151.PMC3628517.pdf
"http://dx.doi   .org/10.1016/j.ccr.2005.01.00 6 Sethi, N., X. Dai, C.G.",OADS,/arxiv_data1/oa_pdf/e6/02/JCB_201209151.PMC3628517.pdf
"http://dx.doi.org/10   .1016/j.ccr.2010.12.02 2 Sjöblom, T., S. Jones, L.D.",OADS,/arxiv_data1/oa_pdf/e6/02/JCB_201209151.PMC3628517.pdf
"http://dx.doi.org/10.1126/science.113342 7 Stautz, D., A. Sanjay, M.T.",Non-OADS,/arxiv_data1/oa_pdf/e6/02/JCB_201209151.PMC3628517.pdf
"316:55– 67. http://dx.doi.org/10.1016/j.yexcr.2009.09.01 7 Stearman, R.S., L. Dwyer-Nield, L. Zerbe, S.A. Blaine, Z. Chan, P.A.",OADS,/arxiv_data1/oa_pdf/e6/02/JCB_201209151.PMC3628517.pdf
"http://dx.doi.org/10.1016/S0002-9440(10)61257- 6 Stransky, N., A.M. Egloff, A.D. Tward, A.D. Kostic, K. Cibulskis, A. Sivachenko,  G.V.",OADS,/arxiv_data1/oa_pdf/e6/02/JCB_201209151.PMC3628517.pdf
"http://dx.doi.org/10.1126/science.120813 0 Su, L.J., C.W.",OADS,/arxiv_data1/oa_pdf/e6/02/JCB_201209151.PMC3628517.pdf
8:140.  http://dx.doi.org/10.1186/1471-2164-8-14 0,Non-OADS,/arxiv_data1/oa_pdf/e6/02/JCB_201209151.PMC3628517.pdf
http://dx.doi.org/10.1083/jcb.201211048)  identify the MIA (modifier of inner arms) complex within  the Chlamydomonas reinhardtii  axoneme that physically  links to a known regulatory structure and provides a sig - naling conduit from the radial spokes to an inner arm dy - nein essential for waveform determination.,OADS,/arxiv_data1/oa_pdf/c4/c7/JCB_201302077.PMC3628518.pdf
"Another key observation is that mutants defective for  the radial spoke head domain (which interacts with the central  pair) and MIA exhibit reduced microtubule sliding velocities  compared with either single mutant alone, suggesting that the A solid-state control system for dynein-based   ciliary/flagellar motility Stephen M. King Department of Molecular, Microbial, and Structural Biology, University of Connecticut Health Center, Farmington, CT 06030 © 2013 King  This article is distributed under the terms of an Attribution–Noncommercial– Share Alike–No Mirror Sites license for the first six months after the publication date (see  http://www.rupress.org/terms).",Non-OADS,/arxiv_data1/oa_pdf/c4/c7/JCB_201302077.PMC3628518.pdf
"After six months it is available under a Creative Commons  License (Attribution–Noncommercial–Share Alike 3.0 Unported license, as described at  http://creativecommons.org/licenses/by-nc-sa/3.0/).THE JOURNAL OF CELL BIOLOGY",Non-OADS,/arxiv_data1/oa_pdf/c4/c7/JCB_201302077.PMC3628518.pdf
"Finally, phylogenetic analysis (Yamamoto et al., 2013) re - vealed that potential orthologues of C. reinhardtii  MIA com - plex components are present in vertebrates, and RNASeq data  from the Human BodyMap 2.0 project (http://rnaseq.crg.es/ project/HBM) indicate they are highly expressed in ciliated/ flagellated tissues, such as testis, ovary, and lung.",OADS,/arxiv_data1/oa_pdf/c4/c7/JCB_201302077.PMC3628518.pdf
"http://dx.doi.org/10.1083/jcb.86.2.44 6 Bui, K.H., T. Yagi, R. Yamamoto, R. Kamiya, and T. Ishikawa.",OADS,/arxiv_data1/oa_pdf/c4/c7/JCB_201302077.PMC3628518.pdf
"http://dx.doi.org/   10.1083/jcb.20120112 0 Gokhale, A., M. Wirschell, and W.S.",OADS,/arxiv_data1/oa_pdf/c4/c7/JCB_201302077.PMC3628518.pdf
http://dx.doi.org/10.1083/   jcb.20090616 8 Figure 1.,Non-OADS,/arxiv_data1/oa_pdf/c4/c7/JCB_201302077.PMC3628518.pdf
"http://dx.doi.org/10.1002/   cm.97032020 7 Hayashibe, K., C. Shingyoji, and R. Kamiya.",OADS,/arxiv_data1/oa_pdf/c4/c7/JCB_201302077.PMC3628518.pdf
"http://dx.doi   .org/10.1002/(SICI)1097-0169(1997)37:3<232::AID-CM5>3.0.CO;2- 8 Heuser, T., E.E.",OADS,/arxiv_data1/oa_pdf/c4/c7/JCB_201302077.PMC3628518.pdf
"http://dx.doi.org/10.1091/mbc.E12-   05-035 7 Ishikawa, T. 2012.",Non-OADS,/arxiv_data1/oa_pdf/c4/c7/JCB_201302077.PMC3628518.pdf
"http://dx.doi.org/10.1083/jcb.136.1.17 7 King, S.M., and R. Kamiya.",OADS,/arxiv_data1/oa_pdf/c4/c7/JCB_201302077.PMC3628518.pdf
"69:1059– 1068. http://dx.doi.org/10.1002/cm.2107 5 Kwon, Y.J., S.J.",OADS,/arxiv_data1/oa_pdf/c4/c7/JCB_201302077.PMC3628518.pdf
"7:20– 33. http://dx.doi.org/10.1097/JTO.0b013e3182307f6 2 Mitchell, D.R., and J.L.",Non-OADS,/arxiv_data1/oa_pdf/c4/c7/JCB_201302077.PMC3628518.pdf
"http://dx.doi.org/10.1126/science   .112861 8 Patel-King, R.S., and S.M.",OADS,/arxiv_data1/oa_pdf/c4/c7/JCB_201302077.PMC3628518.pdf
"http://dx.doi.org/10.1083/jcb.20090508 3 Porter, M.E., and W.S.",OADS,/arxiv_data1/oa_pdf/c4/c7/JCB_201302077.PMC3628518.pdf
"http://dx.doi.org/10.1083/jcb.151.5.F3 7 Smith, E.F., and W.S.",OADS,/arxiv_data1/oa_pdf/c4/c7/JCB_201302077.PMC3628518.pdf
"http://dx.doi.org/   10.1136/thoraxjnl-2011-20072 4 Wakabayashi, K., and S.M.",OADS,/arxiv_data1/oa_pdf/c4/c7/JCB_201302077.PMC3628518.pdf
This article is distributed under the terms of an Attribution– Noncommercial–Share Alike–No Mirror Sites license for the first six months after the pub - lication date (see http://www.rupress.org/terms).,Non-OADS,/arxiv_data1/oa_pdf/03/c3/JCB_201210033.PMC3628519.pdf
"After six months it is available under a  Creative Commons License (Attribution–Noncommercial–Share Alike 3.0 Unported license,  as described at http://creativecommons.org/licenses/by-nc-sa/3.0/).THE JOURNAL OF CELL BIOLOGY",Non-OADS,/arxiv_data1/oa_pdf/03/c3/JCB_201210033.PMC3628519.pdf
Online supplemental material is available at http://www.jcb.org/   cgi/content/full/jcb.201210033/DC1.,Non-OADS,/arxiv_data1/oa_pdf/03/c3/JCB_201210033.PMC3628519.pdf
"http://dx.doi.org/10.1021/jp711222 s Blanc, E., P. Roversi, C. Vonrhein, C. Flensburg, S.M.",Non-OADS,/arxiv_data1/oa_pdf/03/c3/JCB_201210033.PMC3628519.pdf
"http://dx.doi.org/10.1107/S090744490401642 7 Bolanos-Garcia, V.M., S. Beaufils, A. Renault, J.G.",Non-OADS,/arxiv_data1/oa_pdf/03/c3/JCB_201210033.PMC3628519.pdf
"http://dx.doi   .org/10.1529/biophysj.105.06351 1 Bolanos-Garcia, V .M., T. Kiyomitsu, S. D’Arcy, D.Y .",OADS,/arxiv_data1/oa_pdf/03/c3/JCB_201210033.PMC3628519.pdf
"http://dx.doi.org/10.1016/j.str.2008   .10.01 5 Bolanos-Garcia, V.M., T. Lischetti, D. Matak-Vinkovi ć, E. Cota, P.J.",OADS,/arxiv_data1/oa_pdf/03/c3/JCB_201210033.PMC3628519.pdf
"http://dx.doi.org/   10.1016/j.str.2011.09.01 7 Chao, W.C., K. Kulkarni, Z. Zhang, E.H. Kong, and D. Barford.",OADS,/arxiv_data1/oa_pdf/03/c3/JCB_201210033.PMC3628519.pdf
"http://dx.doi   .org/10.1038/nature1089 6 Cowtan, K. 2006.",Non-OADS,/arxiv_data1/oa_pdf/03/c3/JCB_201210033.PMC3628519.pdf
"62:1002– 1011. http://dx.doi.org/10.1107/S090744490602211 6 D’Arcy, S., O.R.",Non-OADS,/arxiv_data1/oa_pdf/03/c3/JCB_201210033.PMC3628519.pdf
"http://dx.doi.org/10.1007/s00412-012-   0378- 5 Krenn, V., A. Wehenkel, X. Li, S. Santaguida, and A. Musacchio.",Non-OADS,/arxiv_data1/oa_pdf/03/c3/JCB_201210033.PMC3628519.pdf
"http://dx.doi   .org/10.1083/jcb.20111001 3 Lan, W., and D.W. Cleveland.",OADS,/arxiv_data1/oa_pdf/03/c3/JCB_201210033.PMC3628519.pdf
"http://dx.doi   .org/10.1083/jcb.20100608 0 Langer, G., S.X.",OADS,/arxiv_data1/oa_pdf/03/c3/JCB_201210033.PMC3628519.pdf
"http://dx.doi.org/10.1038/   nprot.2008.9 1 Lee, S., P. Thebault, L. Freschi, S. Beaufils, T.L.",Non-OADS,/arxiv_data1/oa_pdf/03/c3/JCB_201210033.PMC3628519.pdf
"http://dx.doi.org/10.1074/jbc   .M111.30735 5 Leslie, A.G. 2006.",OADS,/arxiv_data1/oa_pdf/03/c3/JCB_201210033.PMC3628519.pdf
"http://dx.doi.org/10.1107/   S090744490503910 7 Letunic, I., and P. Bork.",OADS,/arxiv_data1/oa_pdf/03/c3/JCB_201210033.PMC3628519.pdf
"http://dx.doi.org/10.1093/bioinformatics/btl52 9 Liu, S.T., G.K. Chan, J.C. Hittle, G. Fujii, E. Lees, and T.J.",OADS,/arxiv_data1/oa_pdf/03/c3/JCB_201210033.PMC3628519.pdf
"http://dx.doi   .org/10.1091/mbc.02-05-007 4 Maciejowski, J., K.A.",OADS,/arxiv_data1/oa_pdf/03/c3/JCB_201210033.PMC3628519.pdf
"http://dx.doi.org/   10.1083/jcb.20100105 0 Martin-Lluesma, S., V.M.",Non-OADS,/arxiv_data1/oa_pdf/03/c3/JCB_201210033.PMC3628519.pdf
"http://dx.doi.org/10.1126/science   .107559 6 McCoy, A.J., R.W.",OADS,/arxiv_data1/oa_pdf/03/c3/JCB_201210033.PMC3628519.pdf
"http://dx.doi.org/10.1107/S002188980702120 6 Meraldi, P., V.M.",Non-OADS,/arxiv_data1/oa_pdf/03/c3/JCB_201210033.PMC3628519.pdf
"http://dx.doi   .org/10.1016/j.devcel.2004.06.00 6 Miller, S.A., M.L.",OADS,/arxiv_data1/oa_pdf/03/c3/JCB_201210033.PMC3628519.pdf
"http://dx.doi.org/10.1016/   j.cub.2008.11.00 7 Morin, V., S. Prieto, S. Melines, S. Hem, M. Rossignol, T. Lorca, J. Espeut,  N. Morin, and A. Abrieu.",OADS,/arxiv_data1/oa_pdf/03/c3/JCB_201210033.PMC3628519.pdf
"22:289– 295. http://dx.doi.org/10.1016/j.cub.2011.12.04 8 Murshudov, G.N., P. Skubák, A.A. Lebedev, N.S.",OADS,/arxiv_data1/oa_pdf/03/c3/JCB_201210033.PMC3628519.pdf
"http://dx.doi.org/10.1107/S090744491100131 4 Musacchio, A., and E.D.",Non-OADS,/arxiv_data1/oa_pdf/03/c3/JCB_201210033.PMC3628519.pdf
"http://dx.doi   .org/10.1038/nrm216 3 Newman, J., D. Egan, T.S.",Non-OADS,/arxiv_data1/oa_pdf/03/c3/JCB_201210033.PMC3628519.pdf
"http://dx.doi.org/10.1107/S090744490502498 4 Oppermann, F.S., F. Gnad, J.V.",Non-OADS,/arxiv_data1/oa_pdf/03/c3/JCB_201210033.PMC3628519.pdf
"http://dx.doi.org/10.1074/ mcp.M800588-MCP20 0 Santaguida, S., A. Tighe, A.M. D’Alise, S.S. Taylor, and A. Musacchio.",Non-OADS,/arxiv_data1/oa_pdf/03/c3/JCB_201210033.PMC3628519.pdf
"http://dx.doi.org/10.1083/jcb.20100103 6 Santaguida, S., C. Vernieri, F. Villa, A. Ciliberto, and A. Musacchio.",Non-OADS,/arxiv_data1/oa_pdf/03/c3/JCB_201210033.PMC3628519.pdf
http://dx.doi   .org/10.1038/emboj.2011.7 0enrichment enables quantitative phosphoproteomics of the kinome  across the cell cycle.,OADS,/arxiv_data1/oa_pdf/03/c3/JCB_201210033.PMC3628519.pdf
"http://dx.doi.org/10.1016/   j.molcel.2008.07.00 7 DeLuca, K.F., S.M.",OADS,/arxiv_data1/oa_pdf/03/c3/JCB_201210033.PMC3628519.pdf
"http://dx.doi.org/10.1242/   jcs.07262 9 Dephoure, N., C. Zhou, J. Villén, S.A. Beausoleil, C.E.",Non-OADS,/arxiv_data1/oa_pdf/03/c3/JCB_201210033.PMC3628519.pdf
"http://dx.doi.org/10.1073/   pnas.080513910 5 Ditchfield, C., V.L.",Non-OADS,/arxiv_data1/oa_pdf/03/c3/JCB_201210033.PMC3628519.pdf
"http://dx.doi.org/10.1083/   jcb.20020809 1 Dulla, K., H. Daub, R. Hornberger, E.A.",OADS,/arxiv_data1/oa_pdf/03/c3/JCB_201210033.PMC3628519.pdf
"http://dx.doi   .org/10.1074/mcp.M900335-MCP20 0 Eddy, S.R.",Non-OADS,/arxiv_data1/oa_pdf/03/c3/JCB_201210033.PMC3628519.pdf
"http://dx.doi.org/10.1371/journal.pcbi.100219 5 Emsley, P., B. Lohkamp, W.G.",OADS,/arxiv_data1/oa_pdf/03/c3/JCB_201210033.PMC3628519.pdf
"http://dx.doi.org/10.1107/S090744491000749 3 Evans, P. 2006.",Non-OADS,/arxiv_data1/oa_pdf/03/c3/JCB_201210033.PMC3628519.pdf
"http://dx.doi.org/10.1107/S090744490503669 3 Guimaraes, G.J., Y. Dong, B.F. McEwen, and J.G.",Non-OADS,/arxiv_data1/oa_pdf/03/c3/JCB_201210033.PMC3628519.pdf
"http://dx.doi.org/10.1016/   j.cub.2008.08.01 2 Hached, K., S.Z.",OADS,/arxiv_data1/oa_pdf/03/c3/JCB_201210033.PMC3628519.pdf
"http://dx.doi   .org/10.1242/dev.06131 7 Hardwick, K.G., R.C.",Non-OADS,/arxiv_data1/oa_pdf/03/c3/JCB_201210033.PMC3628519.pdf
"http://dx.doi.org/10.1083/jcb.20100213 3 Holm, L., and P. Rosenström.",OADS,/arxiv_data1/oa_pdf/03/c3/JCB_201210033.PMC3628519.pdf
"http://dx.doi.org/10   .1093/nar/gkq36 6 Janicki, S.M., T. Tsukamoto, S.E.",OADS,/arxiv_data1/oa_pdf/03/c3/JCB_201210033.PMC3628519.pdf
"http://dx.doi.org/10.1016/S0092-8674   (04)00171- 0 Janssen, A., M. van der Burg, K. Szuhai, G.J.",OADS,/arxiv_data1/oa_pdf/03/c3/JCB_201210033.PMC3628519.pdf
"http://dx.doi.org/   10.1126/science.121021 4 Jelluma, N., A.B.",Non-OADS,/arxiv_data1/oa_pdf/03/c3/JCB_201210033.PMC3628519.pdf
http://dx.doi.org/10.1371/journal.,Non-OADS,/arxiv_data1/oa_pdf/03/c3/JCB_201210033.PMC3628519.pdf
"http://dx.doi.org/10.1016/j.cell.2007.11.04 6 Jelluma, N., T.B.",OADS,/arxiv_data1/oa_pdf/03/c3/JCB_201210033.PMC3628519.pdf
"http://dx.doi.org/10.1083/jcb   .20100303 8 Katoh, K., and D.M.",OADS,/arxiv_data1/oa_pdf/03/c3/JCB_201210033.PMC3628519.pdf
"In press http://dx.doi.org/10.1093/molbev/mst01 0 Kemmler, S., M. Stach, M. Knapp, J. Ortiz, J. Pfannstiel, T. Ruppert, and J.  Lechner.",Non-OADS,/arxiv_data1/oa_pdf/03/c3/JCB_201210033.PMC3628519.pdf
"http://dx.doi   .org/10.1038/emboj.2009.6 2 Klebig, C., D. Korinth, and P. Meraldi.",OADS,/arxiv_data1/oa_pdf/03/c3/JCB_201210033.PMC3628519.pdf
http://dx.doi.org/10.1083/jcb.20090212 8,Non-OADS,/arxiv_data1/oa_pdf/03/c3/JCB_201210033.PMC3628519.pdf
"2:316. http://dx.doi   .org/10.1038/ncomms131 9 Sliedrecht, T., C. Zhang, K.M.",Non-OADS,/arxiv_data1/oa_pdf/03/c3/JCB_201210033.PMC3628519.pdf
"http://dx.doi   .org/10.1371/journal.pone.001025 1 Stamatakis, A., T. Ludwig, and H. Meier.",Non-OADS,/arxiv_data1/oa_pdf/03/c3/JCB_201210033.PMC3628519.pdf
"http://dx.doi.org/10.1093/bioinformatics/   bti19 1 Stucke, V.M., H.H.",OADS,/arxiv_data1/oa_pdf/03/c3/JCB_201210033.PMC3628519.pdf
"http://dx.doi.org/10   .1093/emboj/21.7.172 3 Stucke, V.M., C. Baumann, and E.A.",OADS,/arxiv_data1/oa_pdf/03/c3/JCB_201210033.PMC3628519.pdf
"http://dx.doi.org/10.1007/s00412-004-0288- 2 Sudakin, V., G.K. Chan, and T.J.",OADS,/arxiv_data1/oa_pdf/03/c3/JCB_201210033.PMC3628519.pdf
"http://dx.doi.org/10.1083/jcb   .20010209 3 Suijkerbuijk, S.J., T.J. van Dam, G.E.",Non-OADS,/arxiv_data1/oa_pdf/03/c3/JCB_201210033.PMC3628519.pdf
"http://dx.doi.org/10   .1016/j.devcel.2012.03.00 9 Tighe, A., O.",OADS,/arxiv_data1/oa_pdf/03/c3/JCB_201210033.PMC3628519.pdf
"http://dx.doi.org/10.1083/jcb.20071202 8 Tooley, J., and P.T.",OADS,/arxiv_data1/oa_pdf/03/c3/JCB_201210033.PMC3628519.pdf
"http://dx.doi   .org/10.1007/s10577-010-9180- 5 Vink, M., M. Simonetta, P. Transidico, K. Ferrari, M. Mapelli, A.",Non-OADS,/arxiv_data1/oa_pdf/03/c3/JCB_201210033.PMC3628519.pdf
"http://dx.doi.org/10.1016/   j.cub.2006.03.05 7 Vleugel, M., E. Hoogendoorn, B. Snel, and G.J.",OADS,/arxiv_data1/oa_pdf/03/c3/JCB_201210033.PMC3628519.pdf
"http://dx.doi   .org/10.1016/j.devcel.2012.06.01 3 Vonrhein, C., E. Blanc, P. Roversi, and G. Bricogne.",OADS,/arxiv_data1/oa_pdf/03/c3/JCB_201210033.PMC3628519.pdf
"http://dx.doi.org/10.1091/mbc.E08-03-032 4 Zemp, I., T. Wild, M.F.",OADS,/arxiv_data1/oa_pdf/03/c3/JCB_201210033.PMC3628519.pdf
"http://dx.doi.org/10.1083/jcb.20090404 8 Zwart, P.H., R.W.",OADS,/arxiv_data1/oa_pdf/03/c3/JCB_201210033.PMC3628519.pdf
http://dx.doi.org/   10.1107/S090744490705531 X,Non-OADS,/arxiv_data1/oa_pdf/03/c3/JCB_201210033.PMC3628519.pdf
"Loss of Hook1 also led to an inhibi - tion of cell spreading, implicating a role for Hook1 sorting  of specific CIE cargo proteins away from bulk membrane  and back to the PM.Microtubule-dependent endosomal sorting   of clathrin-independent cargo by Hook1 Lymarie Maldonado-Báez,1 Nelson B. Cole,1 Helmut Krämer,2,3 and Julie G. Donaldson1 1Laboratory of Cell Biology, Cell Biology and Physiology Center, National Heart, Lung and Blood Institute, National Institutes of Health, Bethesda, MD 20892 2Department of Cell Biology and 3Department of Neuroscience, University of Texas Southwestern Medical Center, Dallas, TX 75390 This article is distributed under the terms of an Attribution–Noncommercial–Share Alike–No  Mirror Sites license for the first six months after the publication date (see http://www.rupress   .org/terms).",Non-OADS,/arxiv_data1/oa_pdf/bb/76/JCB_201208172.PMC3628520.pdf
"http://dx.doi.org/10   .1038/ncb165 7 Balklava, Z., S. Pant, H. Fares, and B.D.",OADS,/arxiv_data1/oa_pdf/bb/76/JCB_201208172.PMC3628520.pdf
"http://dx.doi.org/10.1038/ncb162 7 Baron Gaillard, C.L., E. Pallesi-Pocachard, D. Massey-Harroche, F. Richard, J.P.  Arsanto, J.P. Chauvin, P. Lecine, H. Krämer, J.P. Borg, and A.",Non-OADS,/arxiv_data1/oa_pdf/bb/76/JCB_201208172.PMC3628520.pdf
"http://dx.doi.org/10.1091/mbc.E11-05-040 5 Barral, D.C., M. Cavallari, P.J.",Non-OADS,/arxiv_data1/oa_pdf/bb/76/JCB_201208172.PMC3628520.pdf
http://dx.doi   .org/10.1111/j.1600-0854.2008.00781.,Non-OADS,/arxiv_data1/oa_pdf/bb/76/JCB_201208172.PMC3628520.pdf
"http://dx.doi.org/   10.1242/jcs.09604 0 Conner, S.D., and S.L.",OADS,/arxiv_data1/oa_pdf/bb/76/JCB_201208172.PMC3628520.pdf
"http://dx.doi.org/10.1038/nature0145 1 Dai, J., J. Li, E. Bos, M. Porcionatto, R.T. Premont, S. Bourgoin, P.J.",Non-OADS,/arxiv_data1/oa_pdf/bb/76/JCB_201208172.PMC3628520.pdf
"http://dx.doi.org/   10.1016/j.devcel.2004.10.00 2 Deora, A.A., D. Gravotta, G. Kreitzer, J. Hu, D. Bok, and E. Rodriguez- Boulan.",OADS,/arxiv_data1/oa_pdf/bb/76/JCB_201208172.PMC3628520.pdf
"http://dx.doi.org/10.1091/ mbc.E04-01-005 8 Donaldson, J.G., N. Porat-Shliom, and L.A. Cohen.",Non-OADS,/arxiv_data1/oa_pdf/bb/76/JCB_201208172.PMC3628520.pdf
"http://dx.doi.org/10.1016/j.cellsig.2008.06.02 0 Eyster, C.A., J.D.",OADS,/arxiv_data1/oa_pdf/bb/76/JCB_201208172.PMC3628520.pdf
http://dx.doi.org/10.1111/j.1600-0854.2009.00894.,Non-OADS,/arxiv_data1/oa_pdf/bb/76/JCB_201208172.PMC3628520.pdf
"http://dx.doi.org/10.1091/mbc.E10-11-087 4 Gong, Q., M. Weide, C. Huntsman, Z. Xu, L.Y.",OADS,/arxiv_data1/oa_pdf/bb/76/JCB_201208172.PMC3628520.pdf
"http://dx.doi.org/10.1074/jbc.M70076720 0 Grant, B.D., and J.G.",Non-OADS,/arxiv_data1/oa_pdf/bb/76/JCB_201208172.PMC3628520.pdf
"http://dx.doi.org/   10.1038/nrm275 5 Gustafsson, M.G., L. Shao, P.M. Carlton, C.J.",OADS,/arxiv_data1/oa_pdf/bb/76/JCB_201208172.PMC3628520.pdf
"http://dx.doi.org/10.1529/   biophysj.107.12034 5 Hansen, C.G., and B.J.",OADS,/arxiv_data1/oa_pdf/bb/76/JCB_201208172.PMC3628520.pdf
http://dx.doi.org/10   .1242/jcs.03395 1Nocodazole treatment and replating for the cell-spreading assay HeLa cells grown on coverslips were pretreated with 10 µg/ml nocodazole  for 2 h at 37°C.,Non-OADS,/arxiv_data1/oa_pdf/bb/76/JCB_201208172.PMC3628520.pdf
"http://dx.doi.org/10.1091/mbc.E03-06-035 8 Roberts, E.A., J. Chua, G.B.",OADS,/arxiv_data1/oa_pdf/bb/76/JCB_201208172.PMC3628520.pdf
"http://dx.doi.org/10.1083/jcb.20060302 6 Sandvig, K., S. Pust, T. Skotland, and B. van Deurs.",OADS,/arxiv_data1/oa_pdf/bb/76/JCB_201208172.PMC3628520.pdf
"23:413– 420. http://dx.doi.org/10.1016/j.ceb.2011.03.00 7 Song, J., Z. Khachikian, H. Radhakrishna, and J.G.",OADS,/arxiv_data1/oa_pdf/bb/76/JCB_201208172.PMC3628520.pdf
http://dx.doi.org/10.1111/ j.1600-0854.2006.00511.,Non-OADS,/arxiv_data1/oa_pdf/bb/76/JCB_201208172.PMC3628520.pdf
"http://dx.doi.org/   10.1038/nrm275 1 Walenta, J.H., A.J.",OADS,/arxiv_data1/oa_pdf/bb/76/JCB_201208172.PMC3628520.pdf
"http://dx.doi.org/10.1083/jcb   .152.5.92 3 Walseng, E., O. Bakke, and P.A.",OADS,/arxiv_data1/oa_pdf/bb/76/JCB_201208172.PMC3628520.pdf
"283:14717– 14727. http://dx.doi.org/10.1074/jbc.M80107020 0 Weigert, R., A.C. Yeung, J. Li, and J.G.",OADS,/arxiv_data1/oa_pdf/bb/76/JCB_201208172.PMC3628520.pdf
"http://dx.doi.org/10.1091/mbc   .E04-04-034 2 Xu, L., M.E.",OADS,/arxiv_data1/oa_pdf/bb/76/JCB_201208172.PMC3628520.pdf
"http://dx.doi.org/10.1091/mbc.E08-05-047 3 Yan, Y., S. Vasudevan, H.T.",Non-OADS,/arxiv_data1/oa_pdf/bb/76/JCB_201208172.PMC3628520.pdf
"http://dx.doi.org/10.1016/j.bbagen.2008.06.00 7 Zimmermann, P., Z. Zhang, G. Degeest, E. Mortier, I. Leenaerts, C. Coomans,  J. Schulz, F. N’Kuli, P.J.",OADS,/arxiv_data1/oa_pdf/bb/76/JCB_201208172.PMC3628520.pdf
"9:721) http://dx.doi.org/10.1016/j.devcel.2005.07.01 1 Zöller, M. 2011.",OADS,/arxiv_data1/oa_pdf/bb/76/JCB_201208172.PMC3628520.pdf
"http://dx.doi.org/   10.1038/nrc302 3Hashimoto, S., Y. Onodera, A. Hashimoto, M. Tanaka, M. Hamaguchi, A.  Yamada, and H. Sabe.",OADS,/arxiv_data1/oa_pdf/bb/76/JCB_201208172.PMC3628520.pdf
"http://dx.doi   .org/10.1073/pnas.040175310 1 Horgan, C.P., and M.W.",OADS,/arxiv_data1/oa_pdf/bb/76/JCB_201208172.PMC3628520.pdf
"http://dx.doi.org/10.1042/   BST039120 2 Howes, M.T., M. Kirkham, J. Riches, K. Cortese, P.J.",Non-OADS,/arxiv_data1/oa_pdf/bb/76/JCB_201208172.PMC3628520.pdf
"http://dx.doi   .org/10.1083/jcb.20100211 9 Howes, M.T., S. Mayor, and R.G.",Non-OADS,/arxiv_data1/oa_pdf/bb/76/JCB_201208172.PMC3628520.pdf
"http://dx.doi.org/10.1016/j.ceb.2010.04.00 1 Iacono, K.T., A.L.",OADS,/arxiv_data1/oa_pdf/bb/76/JCB_201208172.PMC3628520.pdf
"http://dx.doi.org/10.1016/j.yexmp.2007.08.01 4 Karacsonyi, C., A.S. Miguel, and R. Puertollano.",OADS,/arxiv_data1/oa_pdf/bb/76/JCB_201208172.PMC3628520.pdf
http://dx.doi.org/10.1111/j.1600-0854.2007.00619.,Non-OADS,/arxiv_data1/oa_pdf/bb/76/JCB_201208172.PMC3628520.pdf
"http://dx.doi.org/10.1083/jcb.133.6.120 5 Krämer, H., and M. Phistry.",OADS,/arxiv_data1/oa_pdf/bb/76/JCB_201208172.PMC3628520.pdf
"http://dx.doi   .org/10.1242/jcs.03148 4 Luiro, K., K. Yliannala, L. Ahtiainen, H. Maunu, I. Järvelä, A. Kyttälä, and A.  Jalanko.",OADS,/arxiv_data1/oa_pdf/bb/76/JCB_201208172.PMC3628520.pdf
"http://dx.doi.org/10.1093/hmg/ddh32 1 Magadán, J.G., M.A.",OADS,/arxiv_data1/oa_pdf/bb/76/JCB_201208172.PMC3628520.pdf
"http://dx.doi.org/10.1128/MCB.26.7.2595-2614.200 6 Mayor, S., and R.E.",OADS,/arxiv_data1/oa_pdf/bb/76/JCB_201208172.PMC3628520.pdf
"http://dx.doi.org/10.1038/   nrm221 6 Naslavsky, N., and S. Caplan.",OADS,/arxiv_data1/oa_pdf/bb/76/JCB_201208172.PMC3628520.pdf
"http://dx.doi.org/10.1016/   j.tcb.2010.10.00 3 Naslavsky, N., R. Weigert, and J.G.",OADS,/arxiv_data1/oa_pdf/bb/76/JCB_201208172.PMC3628520.pdf
"http://dx.doi   .org/10.1091/mbc.02-04-005 3 Naslavsky, N., R. Weigert, and J.G.",OADS,/arxiv_data1/oa_pdf/bb/76/JCB_201208172.PMC3628520.pdf
"http://dx.doi.org/10.1091/mbc   .E04-02-015 1 Paterson, A.D., R.G.",Non-OADS,/arxiv_data1/oa_pdf/bb/76/JCB_201208172.PMC3628520.pdf
"http://dx.doi.org/10.1074/jbc.M30008220 0 Ponta, H., L. Sherman, and P.A.",OADS,/arxiv_data1/oa_pdf/bb/76/JCB_201208172.PMC3628520.pdf
"http://dx.doi   .org/10.1038/nrm100 4 Porat-Shliom, N., Y. Kloog, and J.G.",OADS,/arxiv_data1/oa_pdf/bb/76/JCB_201208172.PMC3628520.pdf
"http://dx.doi.org/10.1091/mbc.E07-08-084 1 Powelka, A.M., J.",Non-OADS,/arxiv_data1/oa_pdf/bb/76/JCB_201208172.PMC3628520.pdf
"http://dx.doi.org/10.1111/j.1600- 0854.2004.00150. x Prosser, D.C., T.G.",OADS,/arxiv_data1/oa_pdf/bb/76/JCB_201208172.PMC3628520.pdf
"http://dx.doi   .org/10.1083/jcb.20110404 5 Puthenveedu, M.A., B. Lauffer, P. Temkin, R. Vistein, P. Carlton, K. Thorn, J.  Taunton, O.D.",Non-OADS,/arxiv_data1/oa_pdf/bb/76/JCB_201208172.PMC3628520.pdf
"http://dx.doi.org/10.1016/j.cell.2010.10.00 3 Radhakrishna, H., and J.G.",OADS,/arxiv_data1/oa_pdf/bb/76/JCB_201208172.PMC3628520.pdf
139:49– 61. http://dx.doi.org/10.1083/jcb.139.1.4 9,Non-OADS,/arxiv_data1/oa_pdf/bb/76/JCB_201208172.PMC3628520.pdf
"Here, we review how  these recent advancements are modifying our under - standing of the APC/C.Panta rhei: The APC/C at steady state Ivana Primorac1 and Andrea Musacchio1,2 1Department of Mechanistic Cell Biology, Max Planck Institute of Molecular Physiology, 44227 Dortmund, Germany 2Centre for Medical Biotechnology, Faculty of Biology, University of Duisburg-Essen, 45141 Essen, Germany © 2013 Primorac and Musacchio  This article is distributed under the terms of an Attribution– Noncommercial–Share Alike–No Mirror Sites license for the first six months after the publi - cation date (see http://www.rupress.org/terms).",Non-OADS,/arxiv_data1/oa_pdf/bc/39/JCB_201301130.PMC3628523.pdf
"After six months it is available under a  Creative Commons License (Attribution–Noncommercial–Share Alike 3.0 Unported license,  as described at http://creativecommons.org/licenses/by-nc-sa/3.0/).THE JOURNAL OF CELL BIOLOGY",Non-OADS,/arxiv_data1/oa_pdf/bc/39/JCB_201301130.PMC3628523.pdf
"http://dx.doi.org/10.1101/gad.26760 3 Daum, J.R., J.D.",OADS,/arxiv_data1/oa_pdf/bc/39/JCB_201301130.PMC3628523.pdf
"http://dx.doi.org/10.1016/j.cub.2009.07.01 7 Dawson, I.A., S. Roth, and S. Artavanis ­Tsakonas.",OADS,/arxiv_data1/oa_pdf/bc/39/JCB_201301130.PMC3628523.pdf
"http://dx.doi.org/   10.1083/jcb.129.3.72 5 Di Fiore, B., and J. Pines.",Non-OADS,/arxiv_data1/oa_pdf/bc/39/JCB_201301130.PMC3628523.pdf
"http://dx.doi.org/10   .1083/jcb.20100108 3 Dimova, N.V., N.A.",OADS,/arxiv_data1/oa_pdf/bc/39/JCB_201301130.PMC3628523.pdf
"http://dx.doi.org/10.1038/   ncb242 5 Dong, X., K.H.",OADS,/arxiv_data1/oa_pdf/bc/39/JCB_201301130.PMC3628523.pdf
"http://dx.doi.org/10.1101/gad.11.1.9 4 Dou, H., L. Buetow, G.J.",OADS,/arxiv_data1/oa_pdf/bc/39/JCB_201301130.PMC3628523.pdf
"http://dx.doi   .org/10.1038/nsmb.237 9 Dube, P., F. Herzog, C. Gieffers, B. Sander, D. Riedel, S.A. Müller, A. Engel,  J.­M.",Non-OADS,/arxiv_data1/oa_pdf/bc/39/JCB_201301130.PMC3628523.pdf
"http://dx.doi.org/10.1016/   j.molcel.2005.11.00 8 Elowe, S., K. Dulla, A. Uldschmid, X. Li, Z. Dou, and E.A.",OADS,/arxiv_data1/oa_pdf/bc/39/JCB_201301130.PMC3628523.pdf
"http://dx.doi.org/10.1242/jcs.05650 7 Enquist­Newman, M., M. Sullivan, and D.O.",OADS,/arxiv_data1/oa_pdf/bc/39/JCB_201301130.PMC3628523.pdf
"http://dx.doi.org/10   .1016/j.molcel.2008.04.00 4 Essex, A., A. Dammermann, L. Lewellyn, K. Oegema, and A. Desai.",OADS,/arxiv_data1/oa_pdf/bc/39/JCB_201301130.PMC3628523.pdf
"http://dx.doi.org/10.1091/mbc.E08­10­104 7 Fang, G. 2002.",Non-OADS,/arxiv_data1/oa_pdf/bc/39/JCB_201301130.PMC3628523.pdf
"http://dx.doi.org/   10.1016/j.cell.2011.03.00 6 Foe, I.T., S.A. Foster, S.K.",OADS,/arxiv_data1/oa_pdf/bc/39/JCB_201301130.PMC3628523.pdf
"http://dx.doi   .org/10.1016/j.cub.2011.09.05 1 Foley, E.A., and T.M.",OADS,/arxiv_data1/oa_pdf/bc/39/JCB_201301130.PMC3628523.pdf
"http://dx.doi.org/10.1038/nrm349 4 Foster, S.A., and D.O.",OADS,/arxiv_data1/oa_pdf/bc/39/JCB_201301130.PMC3628523.pdf
"http://dx.doi.org/10.1016/j.molcel.2012.07.03 1 Fraschini, R., A. Beretta, L. Sironi, A. Musacchio, G. Lucchini, and S. Piatti.",Non-OADS,/arxiv_data1/oa_pdf/bc/39/JCB_201301130.PMC3628523.pdf
"http://dx.doi.org/10.1093/emboj/20.23.664 8 Garnett, M.J., J. Mansfeld, C. Godwin, T. Matsusaka, J. Wu, P. Russell, J. Pines,  and A.R.",Non-OADS,/arxiv_data1/oa_pdf/bc/39/JCB_201301130.PMC3628523.pdf
"http://dx.doi.org/10.1038/ncb198 3 Ge, S., J.R. Skaar, and M. Pagano.",OADS,/arxiv_data1/oa_pdf/bc/39/JCB_201301130.PMC3628523.pdf
"8:167– 171. http://dx.doi.org/10.4161/cc.8.1.760 6 Gieffers, C., P. Dube, J.R. Harris, H. Stark, and J.M.",Non-OADS,/arxiv_data1/oa_pdf/bc/39/JCB_201301130.PMC3628523.pdf
"7:907– 913. http://dx.doi.org/10.1016/S1097­2765(01)00234­ 9 Glotzer, M., A.W.",OADS,/arxiv_data1/oa_pdf/bc/39/JCB_201301130.PMC3628523.pdf
"http://dx.doi.org/10   .1038/349132a 0 Hagan, R.S., M.S.",Non-OADS,/arxiv_data1/oa_pdf/bc/39/JCB_201301130.PMC3628523.pdf
"http://dx.doi.org/10.1006/jmbi.2002.539 9 Baboshina, O.V., and A.L.",OADS,/arxiv_data1/oa_pdf/bc/39/JCB_201301130.PMC3628523.pdf
"http://dx.doi   .org/10.1074/jbc.271.5.282 3 Barford, D. 2011a.",Non-OADS,/arxiv_data1/oa_pdf/bc/39/JCB_201301130.PMC3628523.pdf
"http://dx.doi   .org/10.1017/S003358351000025 9 Barford, D. 2011b.",Non-OADS,/arxiv_data1/oa_pdf/bc/39/JCB_201301130.PMC3628523.pdf
"366:3605– 3624. http://dx.doi.org/10.1098/rstb.2011.006 9 Behrends, C., and J.W.",Non-OADS,/arxiv_data1/oa_pdf/bc/39/JCB_201301130.PMC3628523.pdf
"http://dx.doi   .org/10.1038/nsmb.206 6 Burton, J.L., and M.J. Solomon.",OADS,/arxiv_data1/oa_pdf/bc/39/JCB_201301130.PMC3628523.pdf
"http://dx.doi.org/10.1101/gad.151110 7 Burton, J.L., V. Tsakraklides, and M.J. Solomon.",Non-OADS,/arxiv_data1/oa_pdf/bc/39/JCB_201301130.PMC3628523.pdf
"http://dx.doi.org/10.1016/j.molcel   .2005.04.02 2 Buschhorn, B.A., G. Petzold, M. Gálová, P. Dube, C. Kraft, F. Herzog, H. Stark,  and J.­M.",OADS,/arxiv_data1/oa_pdf/bc/39/JCB_201301130.PMC3628523.pdf
"http://dx.doi.org/10.1038/nsmb.197 9 Carroll, C.W., and D.O.",Non-OADS,/arxiv_data1/oa_pdf/bc/39/JCB_201301130.PMC3628523.pdf
"http://dx.doi.org/10.1016/j.cub.2004.12.06 6 Chao, W.C.H., K. Kulkarni, Z. Zhang, E.H. Kong, and D. Barford.",OADS,/arxiv_data1/oa_pdf/bc/39/JCB_201301130.PMC3628523.pdf
"http://dx.doi   .org/10.1038/nature1089 6 Choi, E., J.M.",Non-OADS,/arxiv_data1/oa_pdf/bc/39/JCB_201301130.PMC3628523.pdf
"http://dx.doi.org/10.1074/jbc.M80369520 0 Chung, E., and R.­H.",OADS,/arxiv_data1/oa_pdf/bc/39/JCB_201301130.PMC3628523.pdf
"http://dx.doi.org/10.1101/gad.10.24.308 1 Cooper, K.F., M.J. Mallory, D.B.",OADS,/arxiv_data1/oa_pdf/bc/39/JCB_201301130.PMC3628523.pdf
http://dx.doi.org/10.1038/nature0962 5,Non-OADS,/arxiv_data1/oa_pdf/bc/39/JCB_201301130.PMC3628523.pdf
"http://dx.doi   .org/10.1016/j.molcel.2005.04.02 3 Kramer, E.R., N. Scheuringer, A.V.",OADS,/arxiv_data1/oa_pdf/bc/39/JCB_201301130.PMC3628523.pdf
"http://dx.doi.org/10   .1038/emboj.2012.16 8 Lara­Gonzalez, P., and S.S. Taylor.",OADS,/arxiv_data1/oa_pdf/bc/39/JCB_201301130.PMC3628523.pdf
"http://dx.doi.org/10.1371/journal   .pone.004904 1 Lara­Gonzalez, P., M.I.F.",Non-OADS,/arxiv_data1/oa_pdf/bc/39/JCB_201301130.PMC3628523.pdf
"http://dx.doi.org/10.1242/jcs.09476 3 Lara­Gonzalez, P., F.G. Westhorpe, and S.S. Taylor.",Non-OADS,/arxiv_data1/oa_pdf/bc/39/JCB_201301130.PMC3628523.pdf
"http://dx.doi.org/10.1016/j   .cub.2012.10.00 6 Lau, D.T.C., and A.W.",OADS,/arxiv_data1/oa_pdf/bc/39/JCB_201301130.PMC3628523.pdf
"http://dx.doi.org/10   .1016/j.cub.2011.12.02 9 Leismann, O., and C.F.",OADS,/arxiv_data1/oa_pdf/bc/39/JCB_201301130.PMC3628523.pdf
"http://dx.doi.org/10.1242/   jcs.0041 1 Luo, X., Z. Tang, J. Rizo, and H. Yu.",OADS,/arxiv_data1/oa_pdf/bc/39/JCB_201301130.PMC3628523.pdf
"http://dx.doi.org/10.1016/   S1097 ­2765(01)00435 ­X Ma, H.T., and R.Y.C.",OADS,/arxiv_data1/oa_pdf/bc/39/JCB_201301130.PMC3628523.pdf
"http://dx.doi.org/10.1074/jbc   .M110.20189 7 Malureanu, L.A., K.B.",Non-OADS,/arxiv_data1/oa_pdf/bc/39/JCB_201301130.PMC3628523.pdf
"http://dx.doi.org/10.1016/j.devcel.2008.11.00 4 Mansfeld, J., P. Collin, M.O.",OADS,/arxiv_data1/oa_pdf/bc/39/JCB_201301130.PMC3628523.pdf
"http://dx.doi.org/10.1038/ncb234 7 Mapelli, M., and A. Musacchio.",Non-OADS,/arxiv_data1/oa_pdf/bc/39/JCB_201301130.PMC3628523.pdf
"http://dx.doi.org/10.1016/j.sbi.2007.08.01 1 Mapelli, M., F.V.",OADS,/arxiv_data1/oa_pdf/bc/39/JCB_201301130.PMC3628523.pdf
"http://dx.doi.org/10.1038/   sj.emboj.760103 3 Mapelli, M., L. Massimiliano, S. Santaguida, and A. Musacchio.",Non-OADS,/arxiv_data1/oa_pdf/bc/39/JCB_201301130.PMC3628523.pdf
"http://dx.doi.org/10.1016/   j.cell.2007.08.04 9 Matyskiela, M.E., and D.O.",OADS,/arxiv_data1/oa_pdf/bc/39/JCB_201301130.PMC3628523.pdf
"http://dx.doi.org/10.1016/j.molcel.2009.02.02 7 Matyskiela, M.E., M.C.",OADS,/arxiv_data1/oa_pdf/bc/39/JCB_201301130.PMC3628523.pdf
"8:92.  http://dx.doi.org/10.1186/jbiol18 4 Miller, J.J., M.K.",OADS,/arxiv_data1/oa_pdf/bc/39/JCB_201301130.PMC3628523.pdf
"http://dx.doi.org/10.1101/gad.145400 6 Miniowitz ­Shemtov, S., A. Teichner, D. Sitry ­Shevah, and A. Hershko.",Non-OADS,/arxiv_data1/oa_pdf/bc/39/JCB_201301130.PMC3628523.pdf
"22:4236– 4246. http://dx.doi.org/10.1091/mbc.E11­03­021 6 Hagting, A., N. Den Elzen, H.C. Vodermaier, I.C.",OADS,/arxiv_data1/oa_pdf/bc/39/JCB_201301130.PMC3628523.pdf
"http://dx.doi.org/   10.1083/jcb.20011100 1 Hall, M.C., M.P.",OADS,/arxiv_data1/oa_pdf/bc/39/JCB_201301130.PMC3628523.pdf
"http://dx.doi.org/   10.1074/jbc.M21310920 0 Hardwick, K.G., R.C.",Non-OADS,/arxiv_data1/oa_pdf/bc/39/JCB_201301130.PMC3628523.pdf
"http://dx.doi.org/10.1038/ncb141 0 Hegemann, B., J.R.A.",OADS,/arxiv_data1/oa_pdf/bc/39/JCB_201301130.PMC3628523.pdf
"http://dx.doi.org/10.1126/scisignal.200199 3 Herzog, F.F., I.I.",Non-OADS,/arxiv_data1/oa_pdf/bc/39/JCB_201301130.PMC3628523.pdf
"http://dx.doi.org/10.1126/science.116330 0 Hörmanseder, E., T. Tischer, S. Heubes, O. Stemmann, and T.U.",OADS,/arxiv_data1/oa_pdf/bc/39/JCB_201301130.PMC3628523.pdf
"http://dx.doi.org/10.1038/   embor.2011.3 2 Hwang, L.H., L.F. Lau, D.L.",OADS,/arxiv_data1/oa_pdf/bc/39/JCB_201301130.PMC3628523.pdf
"http://dx.doi.org/10   .1126/science.279.5353.104 1 Izawa, D., and J. Pines.",OADS,/arxiv_data1/oa_pdf/bc/39/JCB_201301130.PMC3628523.pdf
"http://dx.doi.org/10.1038/   ncb216 5 Izawa, D., and J. Pines.",OADS,/arxiv_data1/oa_pdf/bc/39/JCB_201301130.PMC3628523.pdf
"199:27– 37. http://dx.doi.org/10.1083/jcb.20120517 0 Jaspersen, S.L., J.F.",Non-OADS,/arxiv_data1/oa_pdf/bc/39/JCB_201301130.PMC3628523.pdf
"http://dx.doi.org/   10.1016/S0960­9822(99)80111­ 0 Jia, L., B. Li, R.T. Warrington, X. Hao, S. Wang, and H. Yu.",OADS,/arxiv_data1/oa_pdf/bc/39/JCB_201301130.PMC3628523.pdf
"22:4227– 4235. http://dx.doi.org/10.1091/mbc.E11­05­038 9 Jin, L., A. Williamson, S. Banerjee, I. Philipp, and M. Rape.",Non-OADS,/arxiv_data1/oa_pdf/bc/39/JCB_201301130.PMC3628523.pdf
"http://dx.doi.org/10.1016/j.cell.2008.04.01 2 Kim, S.H., D.P.",OADS,/arxiv_data1/oa_pdf/bc/39/JCB_201301130.PMC3628523.pdf
"http://dx.doi.org/10.1126/science.279.5353.104 5 Kimata, Y., J.E.",OADS,/arxiv_data1/oa_pdf/bc/39/JCB_201301130.PMC3628523.pdf
"http://dx.doi.org/10   .1016/j.molcel.2008.09.02 3 Kimata, Y., M. Trickey, D. Izawa, J. Gannon, M. Yamamoto, and H. Yamano.",OADS,/arxiv_data1/oa_pdf/bc/39/JCB_201301130.PMC3628523.pdf
"http://dx.doi.org/10.1016/j.devcel.2007.12.01 0 King, E.M.J., S.J.A.",OADS,/arxiv_data1/oa_pdf/bc/39/JCB_201301130.PMC3628523.pdf
"http://dx.doi.org/10.1371/journal   .pone.000034 2 King, R.W., J.M.",Non-OADS,/arxiv_data1/oa_pdf/bc/39/JCB_201301130.PMC3628523.pdf
"http://dx.doi.org/10.1016/0092­8674(95)90338­ 0 Kops, G.J.P.L., and J.V.",OADS,/arxiv_data1/oa_pdf/bc/39/JCB_201301130.PMC3628523.pdf
"http://dx.doi.org/10.1007/s00412­012­0378­ 5 Kraft, C., F. Herzog, C. Gieffers, K. Mechtler, A. Hagting, J. Pines, and   J.­M.",Non-OADS,/arxiv_data1/oa_pdf/bc/39/JCB_201301130.PMC3628523.pdf
http://dx.doi.org/   10.1093/emboj/cdg62 7,Non-OADS,/arxiv_data1/oa_pdf/bc/39/JCB_201301130.PMC3628523.pdf
"http://dx.doi.org/10.1083/jcb.149.7.137 7 Schreiber, A., F. Stengel, Z. Zhang, R.I. Enchev, E.H. Kong, E.P.",Non-OADS,/arxiv_data1/oa_pdf/bc/39/JCB_201301130.PMC3628523.pdf
"http://dx.doi.org/10.1038/nature0975 6 Schwab, M., A.S. Lutum, and W. Seufert.",OADS,/arxiv_data1/oa_pdf/bc/39/JCB_201301130.PMC3628523.pdf
"http://dx.doi.org/10.1016/   S0092­8674(00)80529­ 2 Schwab, M., M. Neutzner, D. Möcker, and W. Seufert.",OADS,/arxiv_data1/oa_pdf/bc/39/JCB_201301130.PMC3628523.pdf
"http://dx.doi.org/10.1093/emboj/20.18.516 5 Sczaniecka, M., A. Feoktistova, K.M.",Non-OADS,/arxiv_data1/oa_pdf/bc/39/JCB_201301130.PMC3628523.pdf
"32:303– 314. http://dx.doi.org/10.1038/emboj.2012.33 5 Shirayama, M., W. Zachariae, R. Ciosk, and K. Nasmyth.",OADS,/arxiv_data1/oa_pdf/bc/39/JCB_201301130.PMC3628523.pdf
"http://dx.doi.org/10.1093/emboj/17.5.133 6 Shirayama, M., A. Tóth, M. Gálová, and K. Nasmyth.",OADS,/arxiv_data1/oa_pdf/bc/39/JCB_201301130.PMC3628523.pdf
"http://dx.doi.org/10.1038/4608 0 Sironi, L., M. Mapelli, S. Knapp, A.",Non-OADS,/arxiv_data1/oa_pdf/bc/39/JCB_201301130.PMC3628523.pdf
"http://dx.doi.org/10.1093/emboj/21.10.249 6 Skoufias, D.A., P.R.",Non-OADS,/arxiv_data1/oa_pdf/bc/39/JCB_201301130.PMC3628523.pdf
"http://dx.doi.org/10.1371/journal.pone.002296 9 Sudakin, V., D. Ganoth, A. Dahan, H. Heller, J. Hershko, F.C.",Non-OADS,/arxiv_data1/oa_pdf/bc/39/JCB_201301130.PMC3628523.pdf
"http://dx.doi.org/10.1083/   jcb.20010209 3 Summers, M.K., B. Pan, K. Mukhyala, and P.K.",Non-OADS,/arxiv_data1/oa_pdf/bc/39/JCB_201301130.PMC3628523.pdf
"http://dx.doi.org/10.1016/j.molcel.2008.07.01 4 Tang, Z., R. Bharadwaj, B. Li, and H. Yu.",OADS,/arxiv_data1/oa_pdf/bc/39/JCB_201301130.PMC3628523.pdf
"http://dx.doi.org/10.1016/S1534­5807(01)00019­ 3 Tang, Z., H. Shu, D. Oncel, S. Chen, and H. Yu.",OADS,/arxiv_data1/oa_pdf/bc/39/JCB_201301130.PMC3628523.pdf
"http://dx.doi.org/10   .1016/j.molcel.2004.09.03 1 Teichner, A., E. Eytan, D. Sitry­Shevah, S. Miniowitz­Shemtov, E. Dumin, J.  Gromis, and A. Hershko.",OADS,/arxiv_data1/oa_pdf/bc/39/JCB_201301130.PMC3628523.pdf
"http://dx.doi.org/10.1101/gad.139690 6 Tian, W.W., B.B.",Non-OADS,/arxiv_data1/oa_pdf/bc/39/JCB_201301130.PMC3628523.pdf
"http://dx.doi.org/10.1126/science.122839 4Murray, A.W., M.J. Solomon, and M.W.",OADS,/arxiv_data1/oa_pdf/bc/39/JCB_201301130.PMC3628523.pdf
"http://dx.doi.org/10.1038/339280a 0 Musacchio, A., and A. Ciliberto.",Non-OADS,/arxiv_data1/oa_pdf/bc/39/JCB_201301130.PMC3628523.pdf
"http://dx.doi.org/10.1038/ncb179 9 Ohi, M.D., A. Feoktistova, L. Ren, C. Yip, Y. Cheng, J.­S.",OADS,/arxiv_data1/oa_pdf/bc/39/JCB_201301130.PMC3628523.pdf
"http://dx.doi.org/10.1016/j.molcel.2007.10.00 3 Okaz, E., O. Argüello ­Miranda, A. Bogdanova, P.K.",OADS,/arxiv_data1/oa_pdf/bc/39/JCB_201301130.PMC3628523.pdf
"http://dx.doi.org/10   .1016/j.cell.2012.08.04 4 Ostapenko, D., J.L.",OADS,/arxiv_data1/oa_pdf/bc/39/JCB_201301130.PMC3628523.pdf
"http://dx.doi.org/10.1128/MCB.00055­0 8 Pan, J., and R.­H.",OADS,/arxiv_data1/oa_pdf/bc/39/JCB_201301130.PMC3628523.pdf
"http://dx.doi   .org/10.1101/gad.118420 4 Passmore, L.A., and D. Barford.",OADS,/arxiv_data1/oa_pdf/bc/39/JCB_201301130.PMC3628523.pdf
"http://dx.doi.org/10.1038/   sj.embor.740048 2 Passmore, L.A., E.A.",OADS,/arxiv_data1/oa_pdf/bc/39/JCB_201301130.PMC3628523.pdf
"http://dx.doi.org/10.1093/emboj/cdg08 4 Passmore, L.A., C.R.",Non-OADS,/arxiv_data1/oa_pdf/bc/39/JCB_201301130.PMC3628523.pdf
"http://dx.doi.org/10   .1016/j.molcel.2005.11.00 3 Peters, J.­M.",OADS,/arxiv_data1/oa_pdf/bc/39/JCB_201301130.PMC3628523.pdf
"http://dx.doi   .org/10.1038/nrm198 8 Petroski, M.D., and R.J. Deshaies.",Non-OADS,/arxiv_data1/oa_pdf/bc/39/JCB_201301130.PMC3628523.pdf
"http://dx.doi.org/10.1016/j.cell   .2005.09.03 3 Pfleger, C.M., E. Lee, and M.W.",OADS,/arxiv_data1/oa_pdf/bc/39/JCB_201301130.PMC3628523.pdf
"http://dx.doi.org/10.1101/gad.91820 1 Pines, J.",Non-OADS,/arxiv_data1/oa_pdf/bc/39/JCB_201301130.PMC3628523.pdf
"http://dx.doi.org/10.1038/nrm313 2 Plechanovová, A., E.G.",OADS,/arxiv_data1/oa_pdf/bc/39/JCB_201301130.PMC3628523.pdf
"http://dx.doi.org/10.1038/   nature1137 6 Prinz, S., E.S.",OADS,/arxiv_data1/oa_pdf/bc/39/JCB_201301130.PMC3628523.pdf
"http://dx.doi   .org/10.1016/S0960­9822(98)70298­ 2 Pruneda, J.N., P.J.",OADS,/arxiv_data1/oa_pdf/bc/39/JCB_201301130.PMC3628523.pdf
"http://dx.doi.org/10.1016/j.molcel.2012.07.00 1 Reddy, S.K., M. Rape, W.A.",OADS,/arxiv_data1/oa_pdf/bc/39/JCB_201301130.PMC3628523.pdf
"http://dx.doi.org/10.1038/   nature0573 4 Reimann, J.D., E. Freed, J.Y.",OADS,/arxiv_data1/oa_pdf/bc/39/JCB_201301130.PMC3628523.pdf
"http://dx.doi   .org/10.1016/S0092­8674(01)00361­ 0 Robbins, J.A., and F.R.",OADS,/arxiv_data1/oa_pdf/bc/39/JCB_201301130.PMC3628523.pdf
"5:23. http://dx.doi.org/10.1186/1747­1028­5­2 3 Rodrigo­Brenni, M.C., and D.O.",Non-OADS,/arxiv_data1/oa_pdf/bc/39/JCB_201301130.PMC3628523.pdf
"http://dx.doi   .org/10.1016/j.cell.2007.05.02 7 Rodrigo­Brenni, M.C., S.A. Foster, and D.O.",OADS,/arxiv_data1/oa_pdf/bc/39/JCB_201301130.PMC3628523.pdf
http://dx.doi.org/10.1016/j.molcel.2010.07.02 7,OADS,/arxiv_data1/oa_pdf/bc/39/JCB_201301130.PMC3628523.pdf
"http://dx.doi.org/10.1006/bbrc.2000.262 2 Zachariae, W., A. Shevchenko, P.D.",OADS,/arxiv_data1/oa_pdf/bc/39/JCB_201301130.PMC3628523.pdf
"http://dx.doi.org/   10.1126/science.279.5354.121 6 Zachariae, W.W., M.M.",Non-OADS,/arxiv_data1/oa_pdf/bc/39/JCB_201301130.PMC3628523.pdf
"http://dx.doi.org/10.1038/nchembio.80 1 Zeng, X., F. Sigoillot, S. Gaur, S. Choi, K.L.",Non-OADS,/arxiv_data1/oa_pdf/bc/39/JCB_201301130.PMC3628523.pdf
"http://dx.doi.org/10.1016/j.ccr.2010.08.01 0 Zhang, Y., and E. Lees.",OADS,/arxiv_data1/oa_pdf/bc/39/JCB_201301130.PMC3628523.pdf
"http://dx.doi   .org/10.1128/MCB.21.15.5190­5199.200 1 Zhang, Z., K. Kulkarni, S.J.",Non-OADS,/arxiv_data1/oa_pdf/bc/39/JCB_201301130.PMC3628523.pdf
"http://dx.doi.org/10.1038/emboj.2010.24 7 Zhang, Z., S.M.",OADS,/arxiv_data1/oa_pdf/bc/39/JCB_201301130.PMC3628523.pdf
"http://dx.doi.org/10.1016/j.jmb.2010.02.04 5 Zhang, Z., J. Yang, E.H. Kong, W.C. Chao, E.P.",OADS,/arxiv_data1/oa_pdf/bc/39/JCB_201301130.PMC3628523.pdf
"449:365– 371. http://dx.doi.org/10.1042/BJ2012137 4 Zur, A., and M. Brandeis.",Non-OADS,/arxiv_data1/oa_pdf/bc/39/JCB_201301130.PMC3628523.pdf
"21:4500– 4510. http://dx.doi.org/10.1093/emboj/cdf45 2Uzunova, K., B.T.",OADS,/arxiv_data1/oa_pdf/bc/39/JCB_201301130.PMC3628523.pdf
"http://dx.doi.org/10.1038/nsmb.241 2 van Zon, W., J. Ogink, B. ter Riet, R.H. Medema, H. te Riele, and R.M.F.",OADS,/arxiv_data1/oa_pdf/bc/39/JCB_201301130.PMC3628523.pdf
"http://dx.doi.org/10.1083/jcb.20091208 4 Varetti, G., C. Guida, S. Santaguida, E. Chiroli, and A. Musacchio.",Non-OADS,/arxiv_data1/oa_pdf/bc/39/JCB_201301130.PMC3628523.pdf
"http://dx.doi   .org/10.1016/j.molcel.2011.11.01 4 Vink, M., M. Simonetta, P. Transidico, K. Ferrari, M. Mapelli, A.",OADS,/arxiv_data1/oa_pdf/bc/39/JCB_201301130.PMC3628523.pdf
"http://dx.doi.org/10.1016/   j.cub.2006.03.05 7 Visconti, R., L. Palazzo, and D. Grieco.",OADS,/arxiv_data1/oa_pdf/bc/39/JCB_201301130.PMC3628523.pdf
"http://dx.doi.org/10.1126/science.278.5337.46 0 Vodermaier, H.C., C. Gieffers, S. Maurer­Stroh, F. Eisenhaber, and J.­M.",OADS,/arxiv_data1/oa_pdf/bc/39/JCB_201301130.PMC3628523.pdf
"http://dx.doi   .org/10.1016/S0960­9822(03)00581­ 5 Walker, A., C. Acquaviva, T. Matsusaka, L. Koop, and J. Pines.",OADS,/arxiv_data1/oa_pdf/bc/39/JCB_201301130.PMC3628523.pdf
"http://dx.doi.org/10.1242/jcs.03159 1 Wang, J., B.T.",OADS,/arxiv_data1/oa_pdf/bc/39/JCB_201301130.PMC3628523.pdf
"http://dx.doi.org/10.1038/nsmb.164 5 Wendt, K.S., H.C. Vodermaier, U. Jacob, C. Gieffers, M. Gmachl, J.M.",OADS,/arxiv_data1/oa_pdf/bc/39/JCB_201301130.PMC3628523.pdf
"http://dx.doi.org/10.1038/nsb0901­78 4 Westhorpe, F.G., A. Tighe, P. Lara­Gonzalez, and S.S. Taylor.",Non-OADS,/arxiv_data1/oa_pdf/bc/39/JCB_201301130.PMC3628523.pdf
"http://dx.doi.org/10.1242/jcs.09328 6 Wickliffe, K.E., A. Williamson, H.­J.",Non-OADS,/arxiv_data1/oa_pdf/bc/39/JCB_201301130.PMC3628523.pdf
"http://dx.doi.org/10.1016/j.tcb.2011.08.00 8 Wickliffe, K.E., S. Lorenz, D.E.",OADS,/arxiv_data1/oa_pdf/bc/39/JCB_201301130.PMC3628523.pdf
"http://dx.doi.org/10.1016/j.cell.2011.01.03 5 Williamson, A., K.E.",OADS,/arxiv_data1/oa_pdf/bc/39/JCB_201301130.PMC3628523.pdf
"http://dx.doi.org/10 .1016/   j.molcel.2011.04.02 2 Wolthuis, R., L. Clay­Farrace, W. van Zon, M. Yekezare, L. Koop, J. Ogink,  R. Medema, and J. Pines.",OADS,/arxiv_data1/oa_pdf/bc/39/JCB_201301130.PMC3628523.pdf
"http://dx.doi.org/10.1038/   sj.emboj.760032 2 Yang, M., B. Li, D.R.",OADS,/arxiv_data1/oa_pdf/bc/39/JCB_201301130.PMC3628523.pdf
"http://dx.doi.org/10.1016/j.cell.2007.08.04 8 Yu, H., J.M.",OADS,/arxiv_data1/oa_pdf/bc/39/JCB_201301130.PMC3628523.pdf
"http://dx.doi.org/   10.1126/science.279.5354.121 9 Yudkovsky, Y., M. Shteinberg, T. Listovsky, M. Brandeis, and A. Hershko.",Non-OADS,/arxiv_data1/oa_pdf/bc/39/JCB_201301130.PMC3628523.pdf
This article is distributed under the terms of an Attribution– Noncommercial–Share Alike–No Mirror Sites license for the first six months after the pub - lication date (see http://www.rupress.org/terms).,Non-OADS,/arxiv_data1/oa_pdf/2c/e1/JCB_201208098.PMC3628524.pdf
"After six months it is available under a  Creative Commons License (Attribution–Noncommercial–Share Alike 3.0 Unported license,  as described at http://creativecommons.org/licenses/by-nc-sa/3.0/).THE JOURNAL OF CELL BIOLOGY",Non-OADS,/arxiv_data1/oa_pdf/2c/e1/JCB_201208098.PMC3628524.pdf
"http://dx.doi.org/10.1534/genetics.107.07910 3 Blangy, A., H.A.",Non-OADS,/arxiv_data1/oa_pdf/2c/e1/JCB_201208098.PMC3628524.pdf
"http://dx.doi.org/10.1016/0092-8674(95)90142- 6 Bolhy, S., I. Bouhlel, E. Dultz, T. Nayak, M. Zuccolo, X. Gatti, R. Vallee, J.  Ellenberg, and V. Doye.",OADS,/arxiv_data1/oa_pdf/2c/e1/JCB_201208098.PMC3628524.pdf
"http://dx.doi.org/10.1083/jcb.20100711 8 Burkhardt, J.K., C.J.",OADS,/arxiv_data1/oa_pdf/2c/e1/JCB_201208098.PMC3628524.pdf
"http://dx.doi.org/10.1083/jcb.139.2.46 9 Crackower, M.A., D.S.",OADS,/arxiv_data1/oa_pdf/2c/e1/JCB_201208098.PMC3628524.pdf
"http://dx.doi.org/10.1006/geno.1998.566 5 Culver-Hanlon, T.L., S.A. Lex, A.D. Stephens, N.J. Quintyne, and S.J.",OADS,/arxiv_data1/oa_pdf/2c/e1/JCB_201208098.PMC3628524.pdf
"http://dx.doi   .org/10.1016/j.cub.2011.05.03 2 DeBonis, S., D.A.",OADS,/arxiv_data1/oa_pdf/2c/e1/JCB_201208098.PMC3628524.pdf
"http://dx.doi.org/10.1016/S0955-0674(01)00292- 7 Echeverri, C.J., B.M.",OADS,/arxiv_data1/oa_pdf/2c/e1/JCB_201208098.PMC3628524.pdf
"http://dx.doi.org/10.1083/jcb.132.4.61 7 Eckley, D.M., S.R.",OADS,/arxiv_data1/oa_pdf/2c/e1/JCB_201208098.PMC3628524.pdf
"http://dx.doi.org/10.1083/jcb   .147.2.30 7 Egan, M.J., K. Tan, and S.L.",OADS,/arxiv_data1/oa_pdf/2c/e1/JCB_201208098.PMC3628524.pdf
"http://dx.doi.org/10.1038/3504102 0 Ferenz, N.P., R. Paul, C. Fagerstrom, A. Mogilner, and P. Wadsworth.",Non-OADS,/arxiv_data1/oa_pdf/2c/e1/JCB_201208098.PMC3628524.pdf
"http://dx.doi.org/10.1016/j.cub.2009   .09.02 5 Gassmann, R., A. Essex, J.S.",OADS,/arxiv_data1/oa_pdf/2c/e1/JCB_201208098.PMC3628524.pdf
"http://dx.doi   .org/10.1101/gad.168750 8 Gassmann, R., A.J.",OADS,/arxiv_data1/oa_pdf/2c/e1/JCB_201208098.PMC3628524.pdf
"http://dx.doi.org/10.1101/gad   .188681 0 Gill, S.R., T.A.",Non-OADS,/arxiv_data1/oa_pdf/2c/e1/JCB_201208098.PMC3628524.pdf
Online supplemental material is available at  http://www.jcb.org/cgi/content/full/jcb.201208098/DC1.,Non-OADS,/arxiv_data1/oa_pdf/2c/e1/JCB_201208098.PMC3628524.pdf
"http://dx.doi.org/   10.1038/ncb127 3 Liang, Y., W. Yu, Y. Li, L. Yu, Q. Zhang, F. Wang, Z. Yang, J.",Non-OADS,/arxiv_data1/oa_pdf/2c/e1/JCB_201208098.PMC3628524.pdf
"18:2656– 2666. http://dx.doi.org/10.1091/mbc.E06-04-034 5 McKenney, R.J., M. Vershinin, A. Kunwar, R.B.",Non-OADS,/arxiv_data1/oa_pdf/2c/e1/JCB_201208098.PMC3628524.pdf
"http://dx.doi.org/10.1016/j.cell.2010.02.03 5 McKenney, R.J., S.J.",OADS,/arxiv_data1/oa_pdf/2c/e1/JCB_201208098.PMC3628524.pdf
"http://dx.doi.org/10.1074/jbc.M111.28901 7 Melkonian, K.A., K.C.",Non-OADS,/arxiv_data1/oa_pdf/2c/e1/JCB_201208098.PMC3628524.pdf
"http://dx.doi.org/10.1074/jbc.M70000320 0 Mikami, A., S.H.",OADS,/arxiv_data1/oa_pdf/2c/e1/JCB_201208098.PMC3628524.pdf
"http://dx.doi.org/10.1242/jcs.0016 8 Mitchison, T.J., P. Maddox, J. Gaetz, A. Groen, M. Shirasu, A. Desai, E.D.",Non-OADS,/arxiv_data1/oa_pdf/2c/e1/JCB_201208098.PMC3628524.pdf
"http://dx.doi   .org/10.1091/mbc.E05-02-017 4 Muresan, V ., M.C.",Non-OADS,/arxiv_data1/oa_pdf/2c/e1/JCB_201208098.PMC3628524.pdf
"http://dx.doi.org/10.1016/S1097-2765   (01)00165- 4 Nyarko, A., Y.",OADS,/arxiv_data1/oa_pdf/2c/e1/JCB_201208098.PMC3628524.pdf
"http://dx.doi.org/10.1074/jbc.M112.37603 8 Palmer, K.J., H. Hughes, and D.J.",OADS,/arxiv_data1/oa_pdf/2c/e1/JCB_201208098.PMC3628524.pdf
"http://dx.doi.org/10.1091/mbc.E08-12-116 0 Pfarr, C.M., M. Coue, P.M. Grissom, T.S.",Non-OADS,/arxiv_data1/oa_pdf/2c/e1/JCB_201208098.PMC3628524.pdf
"http://dx.doi.org/10.1038/345263a 0 Pfister, K.K., P.R.",Non-OADS,/arxiv_data1/oa_pdf/2c/e1/JCB_201208098.PMC3628524.pdf
"http://dx.doi.org/10.1371/journal   .pgen.002000 1 Poser, I., M. Sarov, J.R. Hutchins, J.K. Hériché, Y. Toyoda, A. Pozniakovsky,  D. Weigl, A. Nitzsche, B. Hegemann, A.W.",Non-OADS,/arxiv_data1/oa_pdf/2c/e1/JCB_201208098.PMC3628524.pdf
"http://dx.doi.org/10.1038/   nmeth.119 9 Quintyne, N.J., S.R.",OADS,/arxiv_data1/oa_pdf/2c/e1/JCB_201208098.PMC3628524.pdf
"http://dx.doi.org/10.1083/   jcb.147.2.32 1 Raaijmakers, J.A., M.E.",OADS,/arxiv_data1/oa_pdf/2c/e1/JCB_201208098.PMC3628524.pdf
http://dx.doi.,Non-OADS,/arxiv_data1/oa_pdf/2c/e1/JCB_201208098.PMC3628524.pdf
"http://dx.doi.org/10.1038/emboj.2012.27 2 Robinson, J.T., E.J.",OADS,/arxiv_data1/oa_pdf/2c/e1/JCB_201208098.PMC3628524.pdf
"http://dx.doi.org/10.1083/jcb.146.3.59 7 Salina, D., K. Bodoor, D.M.",Non-OADS,/arxiv_data1/oa_pdf/2c/e1/JCB_201208098.PMC3628524.pdf
"http://dx.doi.org/10.1016/S0092-8674(01)   00628- 6 Sawin, K.E., K. LeGuellec, M. Philippe, and T.J. Mitchison.",OADS,/arxiv_data1/oa_pdf/2c/e1/JCB_201208098.PMC3628524.pdf
"http://dx.doi.org/10.1038/359540a 0 Schmidt, J.C., T. Kiyomitsu, T. Hori, C.B.",OADS,/arxiv_data1/oa_pdf/2c/e1/JCB_201208098.PMC3628524.pdf
"http://dx.doi.org/10.1083/jcb.20100612 9 Schroer, T.A.",Non-OADS,/arxiv_data1/oa_pdf/2c/e1/JCB_201208098.PMC3628524.pdf
"http://dx.doi.org/10.1083/jcb.115.6.163 9 Gönczy, P., S. Pichler, M. Kirkham, and A.A. Hyman.",OADS,/arxiv_data1/oa_pdf/2c/e1/JCB_201208098.PMC3628524.pdf
"http://dx.doi.org/10.1083/jcb   .147.1.13 5 Goshima, G., F. Nédélec, and R.D.",OADS,/arxiv_data1/oa_pdf/2c/e1/JCB_201208098.PMC3628524.pdf
"http://dx.doi.org/10.1083/jcb.20050510 7 Griffis, E.R., N. Stuurman, and R.D.",OADS,/arxiv_data1/oa_pdf/2c/e1/JCB_201208098.PMC3628524.pdf
"http://dx.doi.org/10.1083/   jcb.20070206 2 Hagan, R.S., M.S.",Non-OADS,/arxiv_data1/oa_pdf/2c/e1/JCB_201208098.PMC3628524.pdf
"http://dx.doi.org/10.1091/mbc.E11-03-021 6 Hall, J., Y.",Non-OADS,/arxiv_data1/oa_pdf/2c/e1/JCB_201208098.PMC3628524.pdf
"http://dx.doi.org/10.1038/382420a 0 Holleran, E.A., L.A. Ligon, M. Tokito, M.C.",OADS,/arxiv_data1/oa_pdf/2c/e1/JCB_201208098.PMC3628524.pdf
"http://dx.doi.org/10.1074/jbc   .M10483820 0 Howell, B.J., B.F. McEwen, J.C. Canman, D.B.",Non-OADS,/arxiv_data1/oa_pdf/2c/e1/JCB_201208098.PMC3628524.pdf
"http://dx.doi.org/10.1016/   j.cell.2012.07.02 2 Jacquot, G., P. Maidou-Peindara, and S. Benichou.",OADS,/arxiv_data1/oa_pdf/2c/e1/JCB_201208098.PMC3628524.pdf
"285:23019– 23031. http://dx.doi.org/10.1074/jbc.M110.10060 2 Johansson, M., N. Rocha, W. Zwart, I. Jordens, L. Janssen, C. Kuijl, V.M.",OADS,/arxiv_data1/oa_pdf/2c/e1/JCB_201208098.PMC3628524.pdf
"http://dx.doi.org/10.1083/   jcb.20060607 7 Kapitein, L.C., E.J.",OADS,/arxiv_data1/oa_pdf/2c/e1/JCB_201208098.PMC3628524.pdf
"http://dx.doi.org/10.1038/   nature0350 3 Kardon, J.R., and R.D.",OADS,/arxiv_data1/oa_pdf/2c/e1/JCB_201208098.PMC3628524.pdf
"http://dx.doi.org/10.1038/nrm280 4 Kardon, J.R., S.L.",OADS,/arxiv_data1/oa_pdf/2c/e1/JCB_201208098.PMC3628524.pdf
"http://dx.doi   .org/10.1073/pnas.090097610 6 Karki, S., and E.L. Holzbaur.",OADS,/arxiv_data1/oa_pdf/2c/e1/JCB_201208098.PMC3628524.pdf
"http://dx.doi   .org/10.1038/379270a 0 King, S.J., and T.A.",OADS,/arxiv_data1/oa_pdf/2c/e1/JCB_201208098.PMC3628524.pdf
"http://dx.doi   .org/10.1038/7133 8 Kiyomitsu, T., and I.M.",OADS,/arxiv_data1/oa_pdf/2c/e1/JCB_201208098.PMC3628524.pdf
"http://dx.doi.org/10.1038/ncb244 0 Kwiatkowski, N., N. Jelluma, P. Filippakopoulos, M. Soundararajan, M.S.",Non-OADS,/arxiv_data1/oa_pdf/2c/e1/JCB_201208098.PMC3628524.pdf
"http://dx.doi.org/10   .1038/nchembio.34 5 Lenz, J.H., I. Schuchardt, A. Straube, and G. Steinberg.",OADS,/arxiv_data1/oa_pdf/2c/e1/JCB_201208098.PMC3628524.pdf
http://dx.doi.org/10.1038/sj.emboj.760111 9,Non-OADS,/arxiv_data1/oa_pdf/2c/e1/JCB_201208098.PMC3628524.pdf
"http://dx.doi.org/10.1083/jcb.112.6.117 7 Vergnolle, M.A., and S.S. Taylor.",OADS,/arxiv_data1/oa_pdf/2c/e1/JCB_201208098.PMC3628524.pdf
"17:1173– 1179. http://dx.doi.org/10.1016/j.cub.2007.05.07 7 Waterman-Storer, C.M., S. Karki, and E.L. Holzbaur.",OADS,/arxiv_data1/oa_pdf/2c/e1/JCB_201208098.PMC3628524.pdf
"http://dx.doi.org/10   .1083/jcb.20080411 4 Wittmann, T., and T. Hyman.",OADS,/arxiv_data1/oa_pdf/2c/e1/JCB_201208098.PMC3628524.pdf
"http://dx.doi.org/10.1016/S0091-679X(08)61978- 0 Wojcik, E., R. Basto, M. Serr, F. Scaërou, R. Karess, and T. Hays.",OADS,/arxiv_data1/oa_pdf/2c/e1/JCB_201208098.PMC3628524.pdf
"http://dx.doi.org/   10.1038/ncb1101-100 1 Yamada, M., S. Toba, Y. Yoshida, K. Haratani, D. Mori, Y. Yano, Y. Mimori- Kiyosue, T. Nakamura, K. Itoh, S. Fushiki, et al.",OADS,/arxiv_data1/oa_pdf/2c/e1/JCB_201208098.PMC3628524.pdf
"http://dx.doi.org/10.1038/emboj.2008.18 2 Zhang, J., G. Han, and X. Xiang.",OADS,/arxiv_data1/oa_pdf/2c/e1/JCB_201208098.PMC3628524.pdf
"http://dx.doi.org/10.1083/   jcb.115.5.130 9 Sharp, D.J., G.C.",OADS,/arxiv_data1/oa_pdf/2c/e1/JCB_201208098.PMC3628524.pdf
"http://dx.doi.org/10.1038/3504657 4 Song, J., R.C.",OADS,/arxiv_data1/oa_pdf/2c/e1/JCB_201208098.PMC3628524.pdf
"http://dx.doi.org/10.1016/j.jmb.2005   .10.01 7 Splinter, D., M.E.",OADS,/arxiv_data1/oa_pdf/2c/e1/JCB_201208098.PMC3628524.pdf
"http://dx.doi.org/10.1371/journal.pbio.100035 0 Splinter, D., D.S.",Non-OADS,/arxiv_data1/oa_pdf/2c/e1/JCB_201208098.PMC3628524.pdf
"http://dx.doi.org/   10.1091/mbc.E12-03-021 0 Starr, D.A., B.C.",Non-OADS,/arxiv_data1/oa_pdf/2c/e1/JCB_201208098.PMC3628524.pdf
"http://dx.doi.org/10.1083/jcb.142.3.76 3 Stehman, S.A., Y. Chen, R.J. McKenney, and R.B.",OADS,/arxiv_data1/oa_pdf/2c/e1/JCB_201208098.PMC3628524.pdf
"http://dx.doi.org/   10.1083/jcb.20061011 2 Steuer, E.R., L. Wordeman, T.A.",OADS,/arxiv_data1/oa_pdf/2c/e1/JCB_201208098.PMC3628524.pdf
"http://dx.doi.org/10.1038/345266a 0 Stevens, D., R. Gassmann, K. Oegema, and A. Desai.",Non-OADS,/arxiv_data1/oa_pdf/2c/e1/JCB_201208098.PMC3628524.pdf
"http://dx.doi.org/10.1371/journal.pone   .002296 9 Susalka, S.J., K. Nikulina, M.W.",OADS,/arxiv_data1/oa_pdf/2c/e1/JCB_201208098.PMC3628524.pdf
"277:32939– 32946. http://dx.doi.org/10.1074/jbc.M20551020 0 Tai, A.W., J.Z.",Non-OADS,/arxiv_data1/oa_pdf/2c/e1/JCB_201208098.PMC3628524.pdf
"http://dx.doi.org/10.1016/S0092-8674(00)80800- 4 Tai, C.Y., D.L.",OADS,/arxiv_data1/oa_pdf/2c/e1/JCB_201208098.PMC3628524.pdf
"http://dx.doi.org/10.1083/jcb.20010904 6 Tanenbaum, M.E., L. Mac ůrek, N. Galjart, and R.H. Medema.",Non-OADS,/arxiv_data1/oa_pdf/2c/e1/JCB_201208098.PMC3628524.pdf
"http://dx.doi   .org/10.1038/emboj.2008.24 2 Tanenbaum, M.E., L. Mac ůrek, A. Janssen, E.F. Geers, M. Alvarez-Fernández,  and R.H. Medema.",Non-OADS,/arxiv_data1/oa_pdf/2c/e1/JCB_201208098.PMC3628524.pdf
"http://dx.doi.org/10.1016/   j.cub.2009.08.02 7 Tanenbaum, M.E., A. Akhmanova, and R.H. Medema.",OADS,/arxiv_data1/oa_pdf/2c/e1/JCB_201208098.PMC3628524.pdf
"EMBO Rep.  11:649. http://dx.doi.org/10.1038/embor   .2010.12 7 Tynan, S.H., A. Purohit, S.J.",OADS,/arxiv_data1/oa_pdf/2c/e1/JCB_201208098.PMC3628524.pdf
"http://dx.doi.org/10   .1074/jbc.M00153620 0 Vaisberg, E.A., M.P.",OADS,/arxiv_data1/oa_pdf/2c/e1/JCB_201208098.PMC3628524.pdf
"http://dx.doi.org/10.1083/jcb.123.4.84 9 Vanneste, D., M. Takagi, N. Imamoto, and I. Vernos.",OADS,/arxiv_data1/oa_pdf/2c/e1/JCB_201208098.PMC3628524.pdf
"http://dx.doi.org/10.1016/j.cub.2009.09.01 9 Varma, D., P. Monzo, S.A. Stehman, and R.B.",OADS,/arxiv_data1/oa_pdf/2c/e1/JCB_201208098.PMC3628524.pdf
"http://dx.doi.org/10.1083/jcb   .20071010 6 Vassilev, L.T., C. Tovar, S. Chen, D. Knezevic, X. Zhao, H. Sun, D.C.  Heimbrook, and L. Chen.",Non-OADS,/arxiv_data1/oa_pdf/2c/e1/JCB_201208098.PMC3628524.pdf
http://dx.doi.org/10.1083/jcb   .131.6.150 7,Non-OADS,/arxiv_data1/oa_pdf/2c/e1/JCB_201208098.PMC3628524.pdf
"The treatment for heart fa-ilure may aggravate the associated arrhythmias, or antiarrhythmic drugs, such as ion channel blockers, and are likely to have proar -Review http://dx.doi.org/10.4070/kcj.2013.43.3.145 Print ISSN 1738-5520 • On-line ISSN 1738-5555 A Memory Molecule, Ca2+/Calmodulin-Dependent Protein Kinase II  and Redox Stress; Key Factors for Arrhythmias in a Diseased Heart Young-Hwan Song, MD Department of Pediatrics, Sanggye Paik Hospital, College of Medicine, Inje University, Seoul, Korea Arrhythmias can develop in various cardiac diseases, such as ischemic heart disease, cardiomyopathy and congenital heart disease.",Non-OADS,/arxiv_data1/oa_pdf/cd/09/kcj-43-145.PMC3629238.pdf
"This is an Open Access article distributed under the terms of the Creative  Commons Attribution Non-Commercial License (http://creativecommons.org/licenses/by-nc/3.0) which permits unrestricted non-commercial use, distribution, and reproduction in any medium, provided the original work is properly cited.rhythmic side effects in a diseased heart.1)2) Therefore, new treat - ments targeting both arrhythmia and heart failure are essential, and  the understanding of cellular and molecular mechanisms that under-lie the pathogenesis of arrhythmias in a diseased heart is thought to be the first step of this development.",Non-OADS,/arxiv_data1/oa_pdf/cd/09/kcj-43-145.PMC3629238.pdf
"146 CaMKII and Redox Stress in Arrhythmias http://dx.doi.org/10.4070/kcj.2013.43.3.145 www.e-kcj.org association domain which directs the assembly of holoenzyme, a  regulatory domain which controls the activation of the enzyme, and a catalytic domain which interacts with the substrates and per - forms kinase functions (Fig.",Non-OADS,/arxiv_data1/oa_pdf/cd/09/kcj-43-145.PMC3629238.pdf
"147 Young-Hwan Song http://dx.doi.org/10.4070/kcj.2013.43.3.145 www.e-kcj.org molecule” in the heart.15) In heart failure, neurohormonal systems, including rennin-angio - tensin-aldosterone system (RAAS) and β-adrenergic system, are kn- own to be activated to increase the blood pressure in order to main - tain tissue perfusion.",Non-OADS,/arxiv_data1/oa_pdf/cd/09/kcj-43-145.PMC3629238.pdf
148 CaMKII and Redox Stress in Arrhythmias http://dx.doi.org/10.4070/kcj.2013.43.3.145 www.e-kcj.org two possible mechanisms to explain these findings.,Non-OADS,/arxiv_data1/oa_pdf/cd/09/kcj-43-145.PMC3629238.pdf
149 Young-Hwan Song http://dx.doi.org/10.4070/kcj.2013.43.3.145 www.e-kcj.org can cause atrial fibrillation.,Non-OADS,/arxiv_data1/oa_pdf/cd/09/kcj-43-145.PMC3629238.pdf
150 CaMKII and Redox Stress in Arrhythmias http://dx.doi.org/10.4070/kcj.2013.43.3.145 www.e-kcj.org 12.,Non-OADS,/arxiv_data1/oa_pdf/cd/09/kcj-43-145.PMC3629238.pdf
151 Young-Hwan Song http://dx.doi.org/10.4070/kcj.2013.43.3.145 www.e-kcj.org ductance calcium-activated potassium channels.,Non-OADS,/arxiv_data1/oa_pdf/cd/09/kcj-43-145.PMC3629238.pdf
"Editorial http://dx.doi.org/10.4070/kcj.2013.43.3.152 Print ISSN 1738-5520 • On-line ISSN 1738-5555 Usefulness of Coronary Computed Tomography Angiography   Evaluating the Clinical Importance of Coronary Artery Calcium and Noncalcified Plaque in Asymptomatic Patients Young Joon Hong, MD Division of Cardiology, Department of Internal Medicine, Chonnam National University Hospital, Gwangju, Korea Correspondence: Young Joon Hong, MD, Division of Cardiology, Depart - ment of Internal Medicine, Chonnam National University Hospital, 42 Jae - bong-ro, Dong-gu, Gwangju 501-757, KoreaTel: 82-62-220-5778, Fax: 82-62-223-3105E-mail: hyj200@hanmail.net • The author has no financial conflicts of interest.",Non-OADS,/arxiv_data1/oa_pdf/5e/25/kcj-43-152.PMC3629239.pdf
"This is an Open Access article distributed under the terms of the Creative  Commons Attribution Non-Commercial License (http://creativecommons.org/licenses/by-nc/3.0) which permits unrestricted non-commercial use, distribution, and reproduction in any medium, provided the original work is properly cited.In this editorial, we summarized the usefulness of CCTA to evaluate  the importance of coronary artery calcium and NCP in asymptomat - ic patients.",Non-OADS,/arxiv_data1/oa_pdf/5e/25/kcj-43-152.PMC3629239.pdf
153 Young Joon Hong http://dx.doi.org/10.4070/kcj.2013.43.3.152  www.e-kcj.orgzero CACS was associated with a 1% 10-year CHD risk.,OADS,/arxiv_data1/oa_pdf/5e/25/kcj-43-152.PMC3629239.pdf
"154 Copyright © 2013 The Korean Society of CardiologyKorean Circulation Journal Introduction Calcifications are present almost solely in relation to atheroscle - rosis in the coronary vessels except for individuals with chronic kid-Original Article http://dx.doi.org/10.4070/kcj.2013.43.3.154 Print ISSN 1738-5520 • On-line ISSN 1738-5555 Prevalence and Prognostic Implication of Non-Calcified Plaque   in Asymptomatic Population with Coronary Artery Calcium Score of Zero Iksung Cho, MD1, Jung-won Suh, MD1, Hyuk-Jae Chang, MD2, Kwang-Il Kim, MD1, Eun Ju Jeon, MD3, Sang Il Choi, MD3,  Young-Seok Cho, MD1, Tae-Jin Youn, MD1, In-Ho Chae, MD1, Cheol-Ho Kim, MD1, and Dong-Ju Choi, MD1 1Department of Internal Medicine, Seoul National University Bundang Hospital, Seongnam, 2Division of Cardiology, Department of Internal Medicine, Yonsei University College of Medicine, Seoul,  3Division of Radiology, Seoul National University Bundang Hospital, Seongnam , Korea Background and Objectives:  Non-calcified plaque (NCP) identified by coronary CT angiography (CCTA) has been reported in up to 10% of  individuals with coronary artery calcium score (CACS) of zero.",Non-OADS,/arxiv_data1/oa_pdf/df/86/kcj-43-154.PMC3629240.pdf
"This is an Open Access article distributed under the terms of the Creative  Commons Attribution Non-Commercial License (http://creativecommons.org/licenses/by-nc/3.0) which permits unrestricted non-commercial use, distribution, and reproduction in any medium, provided the original work is properly cited.ney disease.1) Therefore, coronary artery calcium score (CACS) has  been used as a useful surrogate marker for coronary atherosclerosis  burden.",Non-OADS,/arxiv_data1/oa_pdf/df/86/kcj-43-154.PMC3629240.pdf
"http://dx.doi.org/10.4070/kcj.2013.43.3.154 www.e-kcj.org CACS have not been fully evaluated.19) Therefore, we evaluated the association of standard risk factors  with NCP, and the prognosis of NCP in middle aged asymptomatic  subjects with CACS of zero using CCTA.",Non-OADS,/arxiv_data1/oa_pdf/df/86/kcj-43-154.PMC3629240.pdf
156 Clinical Implication of NCP in Asymptomatic Subjects with Zero CACS http://dx.doi.org/10.4070/kcj.2013.43.3.154 www.e-kcj.org out NCP.,Non-OADS,/arxiv_data1/oa_pdf/df/86/kcj-43-154.PMC3629240.pdf
"http://dx.doi.org/10.4070/kcj.2013.43.3.154 www.e-kcj.org TA, age, male gender, diabetes, hypertension, and dyslipidemia were  independent predictors of NCP.",OADS,/arxiv_data1/oa_pdf/df/86/kcj-43-154.PMC3629240.pdf
158 Clinical Implication of NCP in Asymptomatic Subjects with Zero CACS http://dx.doi.org/10.4070/kcj.2013.43.3.154 www.e-kcj.org (CAD) and ethnicity of study population.,Non-OADS,/arxiv_data1/oa_pdf/df/86/kcj-43-154.PMC3629240.pdf
http://dx.doi.org/10.4070/kcj.2013.43.3.154 www.e-kcj.org Study limitation This study is not without limitations.,Non-OADS,/arxiv_data1/oa_pdf/df/86/kcj-43-154.PMC3629240.pdf
160 Clinical Implication of NCP in Asymptomatic Subjects with Zero CACS http://dx.doi.org/10.4070/kcj.2013.43.3.154 www.e-kcj.org giography characteristics of atherosclerotic plaques subsequently re - sulting in acute coronary syndrome.,Non-OADS,/arxiv_data1/oa_pdf/df/86/kcj-43-154.PMC3629240.pdf
"161 Copyright © 2013 The Korean Society of CardiologyKorean Circulation Journal Introduction Drug-eluting stents (DES) have been reported to reduce angiogra- phic restenosis and the need for repeat revascularization.1-4) How - ever, systematic reviews and long-scale registries have observed a Original Article http://dx.doi.org/10.4070/kcj.2013.43.3.161 Print ISSN 1738-5520 • On-line ISSN 1738-5555 Long-Term Predictors of Clinical Events after Off-Label Use   of Drug-Eluting Stent beyond 1 Year Kyeong Ho Yun, MD, Jum Suk Ko, MD, Sang Jae Rhee, MD, Eun Mi Lee, MD,   Nam Jin Yoo, MD, Nam-Ho Kim, MD, Seok Kyu Oh, MD, and Jin-Won Jeong, MD Department of Cardiovascular Medicine, Regional Cardiovascular Center, Wonkwang University Hospital, Iksan, Korea Background and Objectives:  We evaluated the long-term outcomes and predictors of clinical events after off-label use of drug-eluting  stents (DES) beyond 1 year after procedure.",Non-OADS,/arxiv_data1/oa_pdf/c4/82/kcj-43-161.PMC3629241.pdf
"This is an Open Access article distributed under the terms of the Creative  Commons Attribution Non-Commercial License (http://creativecommons.org/licenses/by-nc/3.0) which permits unrestricted non-commercial use, distribution, and reproduction in any medium, provided the original work is properly cited.similar rate of death and myocardial infarction (MI) in patients tr- eated with either DES or bare-metal stents (BMS) during long-term 5-year follow-up.",Non-OADS,/arxiv_data1/oa_pdf/c4/82/kcj-43-161.PMC3629241.pdf
"162 MACE after Off-Label DES http://dx.doi.org/10.4070/kcj.2013.43.3.161 www.e-kcj.org tation.12-14) Based on these findings, we evaluated the long-term outcomes  and predictors of clinical events after off-label use of DES after  1-year follow-up had elapsed.",OADS,/arxiv_data1/oa_pdf/c4/82/kcj-43-161.PMC3629241.pdf
http://dx.doi.org/10.4070/kcj.2013.43.3.161 www.e-kcj.org tion was 1 179 days (interquartile range 769-1541) after a one year  event-free period.,OADS,/arxiv_data1/oa_pdf/c4/82/kcj-43-161.PMC3629241.pdf
164 MACE after Off-Label DES http://dx.doi.org/10.4070/kcj.2013.43.3.161 www.e-kcj.org Relationship between stent length and clinical outcomes The incidence of MACE according to DES length is shown in Table  4.,Non-OADS,/arxiv_data1/oa_pdf/c4/82/kcj-43-161.PMC3629241.pdf
"http://dx.doi.org/10.4070/kcj.2013.43.3.161 www.e-kcj.org (HR 2.7, log rank p=0.002).",OADS,/arxiv_data1/oa_pdf/c4/82/kcj-43-161.PMC3629241.pdf
"166 MACE after Off-Label DES http://dx.doi.org/10.4070/kcj.2013.43.3.161 www.e-kcj.org In contrast to populations enrolled in randomized controlled tri - als, a large proportion of patients in daily clinical practice receive  DES for off-label indications.",Non-OADS,/arxiv_data1/oa_pdf/c4/82/kcj-43-161.PMC3629241.pdf
http://dx.doi.org/10.4070/kcj.2013.43.3.161 www.e-kcj.org analysis of 4 randomized trials comparing sirolimus-eluting stents  with bare-metal stents.,Non-OADS,/arxiv_data1/oa_pdf/c4/82/kcj-43-161.PMC3629241.pdf
"168 Copyright © 2013 The Korean Society of CardiologyKorean Circulation Journal Introduction Variant angina pectoris (VAP) was first described by Prinzmetal et  al.,1) and is a syndrome of ischemic pain accompanied by ST-segment Original Article http://dx.doi.org/10.4070/kcj.2013.43.3.168 Print ISSN 1738-5520 • On-line ISSN 1738-5555 C-Type Natriuretic Peptide as a Surrogate Marker   in Variant Angina Pectoris Dong-Hyeon Lee, MD, Ho-Joong Youn, MD, Yun-Seok Choi, MD, Jong-Min Lee, MD,   Chul-Soo Park, MD, Hae-Ok Jung, MD, Hui-Kyung Jeon, MD, and Man-Young Lee, MD Division of Cardiology, Department of Internal Medicine, Seoul St. Mary’s Hospital, The Catholic University of Korea College of Medicine, Seoul, Korea Background and Objectives:  The purpose of this study was to assess the value of C-type natriuretic peptide (CNP) as a surrogate marker  for detection of coronary artery spasm in variant angina pectoris (VAP).",Non-OADS,/arxiv_data1/oa_pdf/f6/0e/kcj-43-168.PMC3629242.pdf
"This is an Open Access article distributed under the terms of the Creative  Commons Attribution Non-Commercial License (http://creativecommons.org/licenses/by-nc/3.0) which permits unrestricted non-commercial use, distribution, and reproduction in any medium, provided the original work is properly cited.elevation that occurs at rest and without exertion.",Non-OADS,/arxiv_data1/oa_pdf/f6/0e/kcj-43-168.PMC3629242.pdf
http://dx.doi.org/10.4070/kcj.2013.43.3.168 www.e-kcj.org muscle cell growth.6-8) The contribution of endothelial mediators to  the effects of CNP on the coronary circulation is unclear and poorly  characterized.,Non-OADS,/arxiv_data1/oa_pdf/f6/0e/kcj-43-168.PMC3629242.pdf
170 The Relationships between CNP and VAP http://dx.doi.org/10.4070/kcj.2013.43.3.168 www.e-kcj.org VAP via acetylcholine-induced SPT.,Non-OADS,/arxiv_data1/oa_pdf/f6/0e/kcj-43-168.PMC3629242.pdf
http://dx.doi.org/10.4070/kcj.2013.43.3.168 www.e-kcj.org 68.2% and a specificity of 40.0% for predicting the probability of VAP  presence via SPT (Fig.,OADS,/arxiv_data1/oa_pdf/f6/0e/kcj-43-168.PMC3629242.pdf
"172 The Relationships between CNP and VAP http://dx.doi.org/10.4070/kcj.2013.43.3.168 www.e-kcj.org tion and brief periods of rapid atrial pacing, and that PSVT or elec - trophysiological studies did not change the production and/or re- lease of CNP.",Non-OADS,/arxiv_data1/oa_pdf/f6/0e/kcj-43-168.PMC3629242.pdf
http://dx.doi.org/10.4070/kcj.2013.43.3.168 www.e-kcj.org tients with angina pectoris and normal coronary angiograms.,Non-OADS,/arxiv_data1/oa_pdf/f6/0e/kcj-43-168.PMC3629242.pdf
"174 Copyright © 2013 The Korean Society of CardiologyKorean Circulation Journal Introduction  A growing population are diagnosed with cancers and treated with Original Article http://dx.doi.org/10.4070/kcj.2013.43.3.174 Print ISSN 1738-5520 • On-line ISSN 1738-5555 Evaluation of Short-Term Use of N-Acetylcysteine as a Strategy   for Prevention of Anthracycline-Induced Cardiomyopathy: EPOCH Trial -   A Prospective Randomized Study Sang-Ho Jo, MD1, Lee Su Kim, MD2, Sung-Ai Kim, MD1, Hyun-Sook Kim, MD1,  Sang-Jin Han, MD1, Woo Jung Park, MD1, and Young Jin Choi, MD3 1Division of Cardiology, Department of Internal Medicine and  2Division of Breast and Endocrine Surgery, Hallym University Sacred Heart Hospital, Anyang, 3Division of Cardiology, Department of Internal Medicine, Sejong General Hospital, Bucheon, Korea Background and Objectives:  We investigate to determine whether N-acetylcysteine (NAC) can prevent anthracycline-induced cardiotoxicity.",Non-OADS,/arxiv_data1/oa_pdf/51/78/kcj-43-174.PMC3629243.pdf
"This is an Open Access article distributed under the terms of the Creative  Commons Attribution Non-Commercial License (http://creativecommons.org/licenses/by-nc/3.0) which permits unrestricted non-commercial use, distribution, and reproduction in any medium, provided the original work is properly cited.chemotherapeutic agents.",Non-OADS,/arxiv_data1/oa_pdf/51/78/kcj-43-174.PMC3629243.pdf
"http://dx.doi.org/10.4070/kcj.2013.43.3.174 www.e-kcj.org therapeutic agents may compromise the clinical effectiveness of  chemotherapy, affecting the patient’s survival and quality of life, in - dependently of the prognosis related to the cancer per se.",Non-OADS,/arxiv_data1/oa_pdf/51/78/kcj-43-174.PMC3629243.pdf
176 N-Acetylcysteine and Anthracycline Cardiomyopathy  http://dx.doi.org/10.4070/kcj.2013.43.3.174 www.e-kcj.org cardiac markers and echocardiography.,Non-OADS,/arxiv_data1/oa_pdf/51/78/kcj-43-174.PMC3629243.pdf
http://dx.doi.org/10.4070/kcj.2013.43.3.174 www.e-kcj.org ference is 25% between the 2 groups.,OADS,/arxiv_data1/oa_pdf/51/78/kcj-43-174.PMC3629243.pdf
"178 N-Acetylcysteine and Anthracycline Cardiomyopathy  http://dx.doi.org/10.4070/kcj.2013.43.3.174 www.e-kcj.org tality, HF and re-hospitalization at 1-, 3-, 6- and 12-month in the  NAC and control groups (Fig.",Non-OADS,/arxiv_data1/oa_pdf/51/78/kcj-43-174.PMC3629243.pdf
"http://dx.doi.org/10.4070/kcj.2013.43.3.174 www.e-kcj.org atin, and methotrexate.4)5)13)14) The most beneficial and convenient methods for preventing car - diomyopathy has been found with limitations on the amount of  drugs used, and alternate drug-delivery methods, such as continu - ous infusion rather than rapid bolus injection.",Non-OADS,/arxiv_data1/oa_pdf/51/78/kcj-43-174.PMC3629243.pdf
180 N-Acetylcysteine and Anthracycline Cardiomyopathy  http://dx.doi.org/10.4070/kcj.2013.43.3.174 www.e-kcj.org The first reason of negative results could be attributed to some - what of a short period and small dose of NAC usage.,Non-OADS,/arxiv_data1/oa_pdf/51/78/kcj-43-174.PMC3629243.pdf
http://dx.doi.org/10.4070/kcj.2013.43.3.174 www.e-kcj.org 10.,Non-OADS,/arxiv_data1/oa_pdf/51/78/kcj-43-174.PMC3629243.pdf
The Am- erican Heart Association currently recommends high-dose aspirin Original Article http://dx.doi.org/10.4070/kcj.2013.43.3.182 Print ISSN 1738-5520 • On-line ISSN 1738-5555 Is High-Dose Aspirin Necessary in the Acute Phase   of Kawasaki Disease?,Non-OADS,/arxiv_data1/oa_pdf/70/3d/kcj-43-182.PMC3629244.pdf
"This is an Open Access article distributed under the terms of the Creative  Commons Attribution Non-Commercial License (http://creativecommons.org/licenses/by-nc/3.0) which permits unrestricted non-commercial use, distribution, and reproduction in any medium, provided the original work is properly cited.",Non-OADS,/arxiv_data1/oa_pdf/70/3d/kcj-43-182.PMC3629244.pdf
http://dx.doi.org/10.4070/kcj.2013.43.3.182 www.e-kcj.org the acute phase of KD and thereby determine whether high-dose  aspirin is necessary for the acute therapy of KD in the IVIG era.,Non-OADS,/arxiv_data1/oa_pdf/70/3d/kcj-43-182.PMC3629244.pdf
184 High-Dose Aspirin in Acute Kawasaki Disease http://dx.doi.org/10.4070/kcj.2013.43.3.182 www.e-kcj.org dose of IVIG; and 1 received a second IVIG followed by infliximab  therapy.,Non-OADS,/arxiv_data1/oa_pdf/70/3d/kcj-43-182.PMC3629244.pdf
"http://dx.doi.org/10.4070/kcj.2013.43.3.182 www.e-kcj.org Incidence of coronary artery lesions There was no significant difference in the incidence of CALs be - tween the study and control group {2/43 (4.7%) vs. 3/107 (2.8%), p=  0.625} (Table 4).",OADS,/arxiv_data1/oa_pdf/70/3d/kcj-43-182.PMC3629244.pdf
186 High-Dose Aspirin in Acute Kawasaki Disease http://dx.doi.org/10.4070/kcj.2013.43.3.182 www.e-kcj.org associated with Kawasaki disease.,Non-OADS,/arxiv_data1/oa_pdf/70/3d/kcj-43-182.PMC3629244.pdf
"Case A patient, who had experienced a prior myocardial infarction, par -Case Report http://dx.doi.org/10.4070/kcj.2013.43.3.187 Print ISSN 1738-5520 • On-line ISSN 1738-5555 Electromagnetic Interference of Wireless Local Area Network   on Electrocardiogram Monitoring System: A Case Report Seungmin Chung, MD1, Joohee Yi, BS2, and Seung Woo Park, MD1,2 1Division of Cardiology, Cardiac and Vascular Center, Samsung Medical Center, Sungkyunkwan University School of Medicine, Seoul,  2Department of Information Strategy, Samsung Medical Center, Seoul, Korea Electromagnetic interference (EMI) can affect various medical devices.",Non-OADS,/arxiv_data1/oa_pdf/dd/ad/kcj-43-187.PMC3629245.pdf
"This is an Open Access article distributed under the terms of the Creative  Commons Attribution Non-Commercial License (http://creativecommons.org/licenses/by-nc/3.0) which permits unrestricted non-commercial use, distribution, and reproduction in any medium, provided the original work is properly cited.ticipated in the cardiac rehabilitation program in the sports medicine  center of our hospital, under the wireless ECG monitoring system (Quinton Q-Tel Cardiac Rehabilitation Management System, Cardiac Science, Bothell, WA, USA).",Non-OADS,/arxiv_data1/oa_pdf/dd/ad/kcj-43-187.PMC3629245.pdf
"188 EMI of WLAN on ECG http://dx.doi.org/10.4070/kcj.2013.43.3.187 www.e-kcj.org rect contact to the acquisition module and EMI impairs ECG inter- pretation.8) In addition, it has been shown that magnetic field based  wireless auto identification technology produces hazardous EMI in two 12-lead ECG machines.",OADS,/arxiv_data1/oa_pdf/dd/ad/kcj-43-187.PMC3629245.pdf
"Furth-ermore, a radiofrequency (RF) ablation of the left lateral AP was not successful through a conventional endocardial approach, but it was successful through an intracoronary sinus approach.Case Report http://dx.doi.org/10.4070/kcj.2013.43.3.189 Print ISSN 1738-5520 • On-line ISSN 1738-5555 Successful Ablation of Resistant Left Lateral Accessory Pathway and Coexisting Atypical Atrioventricular Nodal Reentrant Tachycardia June Namgung, MD Division of Cardiology, Department of Internal Medicine, Inje University College of Medicine, Ilsan Paik Hospital, Goyang, Korea A 41-year-old male was presented with drug-resistant supraventricular tachycardia.",Non-OADS,/arxiv_data1/oa_pdf/4c/d6/kcj-43-189.PMC3629246.pdf
"This is an Open Access article distributed under the terms of the Creative  Commons Attribution Non-Commercial License (http://creativecommons.org/licenses/by-nc/3.0) which permits unrestricted non-commercial use, distribution, and reproduction in any medium, provided the original work is properly cited.Case A 41-year-old man had a 5-year history of palpitations with exer- tion, due to a paroxysmal supraventricular tachycardia.",Non-OADS,/arxiv_data1/oa_pdf/4c/d6/kcj-43-189.PMC3629246.pdf
190 AVRT and Atypical AVNRT http://dx.doi.org/10.4070/kcj.2013.43.3.189 www.e-kcj.org tract.,Non-OADS,/arxiv_data1/oa_pdf/4c/d6/kcj-43-189.PMC3629246.pdf
191 June Namgung http://dx.doi.org/10.4070/kcj.2013.43.3.189 www.e-kcj.org sitioned in the intra CS (Fig.,Non-OADS,/arxiv_data1/oa_pdf/4c/d6/kcj-43-189.PMC3629246.pdf
192 AVRT and Atypical AVNRT http://dx.doi.org/10.4070/kcj.2013.43.3.189 www.e-kcj.org ways were unmasked after successful elimination of AP.,Non-OADS,/arxiv_data1/oa_pdf/4c/d6/kcj-43-189.PMC3629246.pdf
"We report a case on Case Report http://dx.doi.org/10.4070/kcj.2013.43.3.193 Print ISSN 1738-5520 • On-line ISSN 1738-5555 Transient J-Wave Appearance in the Inferior-Lateral Leads during Electrical Storm in a Patient with Brugada Syndrome Dong-Hyuk Yang, MD, Hyuk-jeong Kwon, MD, Jin-Chul Kim, MD, Ji-Hun Jang, MD, Sung-Hee Shin, MD,   Jun Kwan, MD, Sung-Il Woo, MD, Keum-Soo Park, MD, and Dae-Hyeok Kim, MD Division of Cardiology, Department of Internal Medicine, Inha University College of Medicine, Incheon, Korea A 67-year-old male patient was admitted with an abrupt sudden cardiac death.",Non-OADS,/arxiv_data1/oa_pdf/8f/9d/kcj-43-193.PMC3629247.pdf
"This is an Open Access article distributed under the terms of the Creative  Commons Attribution Non-Commercial License (http://creativecommons.org/licenses/by-nc/3.0) which permits unrestricted non-commercial use, distribution, and reproduction in any medium, provided the original work is properly cited.the appearance of transient J-wave in the inferior-lateral leads dur- ing electrical storm in a patient with Brugada syndrome.",Non-OADS,/arxiv_data1/oa_pdf/8f/9d/kcj-43-193.PMC3629247.pdf
194 J Wave and Brugada Syndrome http://dx.doi.org/10.4070/kcj.2013.43.3.193 www.e-kcj.org ering spontaneous presence of Brugada ECG patterns in the right  precordial leads during the electrical stimulation (Fig.,Non-OADS,/arxiv_data1/oa_pdf/8f/9d/kcj-43-193.PMC3629247.pdf
http://dx.doi.org/10.4070/kcj.2013.43.3.193 www.e-kcj.org abilized.,Non-OADS,/arxiv_data1/oa_pdf/8f/9d/kcj-43-193.PMC3629247.pdf
"Coronary angiography Case Report http://dx.doi.org/10.4070/kcj.2013.43.3.196 Print ISSN 1738-5520 • On-line ISSN 1738-5555 Coronary Slow Flow Phenomenon Leads to ST   Elevation Myocardial Infarction Taner Sen, MD Department of Cardiology, Kutahya Evliya Celebi Education and Research Hospital, Kutahya, Turkey   The exact etiology of the coronary slow flow phenomenon (CSFP) is not certain.",Non-OADS,/arxiv_data1/oa_pdf/7e/4f/kcj-43-196.PMC3629248.pdf
"This is an Open Access article distributed under the terms of the Creative  Commons Attribution Non-Commercial License (http://creativecommons.org/licenses/by-nc/3.0) which permits unrestricted non-commercial use, distribution, and reproduction in any medium, provided the original work is properly cited.showed slow dye flow and delayed distal vessel clearance in the left  anterior descending coronary artery (LAD) (Fig.",Non-OADS,/arxiv_data1/oa_pdf/7e/4f/kcj-43-196.PMC3629248.pdf
197 Taner Sen http://dx.doi.org/10.4070/kcj.2013.43.3.196 www.e-kcj.org Fig.,Non-OADS,/arxiv_data1/oa_pdf/7e/4f/kcj-43-196.PMC3629248.pdf
"198 Coronary Slow Flow http://dx.doi.org/10.4070/kcj.2013.43.3.196 www.e-kcj.org cardial infarction, which necessitates coronary angiography for a  definite diagnosis.",Non-OADS,/arxiv_data1/oa_pdf/7e/4f/kcj-43-196.PMC3629248.pdf
"2) In 1949, St- ein3) proposed that ergonovine may be clinically useful in the diag -Case Report http://dx.doi.org/10.4070/kcj.2013.43.3.199 Print ISSN 1738-5520 • On-line ISSN 1738-5555 Does a Negative Ergonovine Provocation Test Truly Predict   Freedom from Variant Angina?",Non-OADS,/arxiv_data1/oa_pdf/98/87/kcj-43-199.PMC3629249.pdf
"This is an Open Access article distributed under the terms of the Creative  Commons Attribution Non-Commercial License (http://creativecommons.org/licenses/by-nc/3.0) which permits unrestricted non-commercial use, distribution, and reproduction in any medium, provided the original work is properly cited.nosis of patients with suspected coronary artery vasospasm.",Non-OADS,/arxiv_data1/oa_pdf/98/87/kcj-43-199.PMC3629249.pdf
200 A Case Report of a False Negative Ergonovine Provocation Test http://dx.doi.org/10.4070/kcj.2013.43.3.199 www.e-kcj.org The patient underwent coronary angiography and ergonovine pro- vocation test.,Non-OADS,/arxiv_data1/oa_pdf/98/87/kcj-43-199.PMC3629249.pdf
"http://dx.doi.org/10.4070/kcj.2013.43.3.199 www.e-kcj.org tianginal medication such as nitroglycerine before the ergonovine  provocation test, which would have affected the results of the test.",Non-OADS,/arxiv_data1/oa_pdf/98/87/kcj-43-199.PMC3629249.pdf
"202 A Case Report of a False Negative Ergonovine Provocation Test http://dx.doi.org/10.4070/kcj.2013.43.3.199 www.e-kcj.org left main, left anterior descending, or left circumflex coronary arte- ries (Fig.",Non-OADS,/arxiv_data1/oa_pdf/98/87/kcj-43-199.PMC3629249.pdf
http://dx.doi.org/10.4070/kcj.2013.43.3.199 www.e-kcj.org WC.,Non-OADS,/arxiv_data1/oa_pdf/98/87/kcj-43-199.PMC3629249.pdf
"Case A 27-year-old female was admitted to the hospital because of left Case Report http://dx.doi.org/10.4070/kcj.2013.43.3.204 Print ISSN 1738-5520 • On-line ISSN 1738-5555 A Case of Myopathy, Encephalopathy, Lactic Acidosis and   Stroke-Like Episodes (MEALS) Syndrome with Intracardiac Thrombus Jung-Chul Joo, MD, Myung Do Seol, MD, Jin Won Yoon, MD, Young Soo Lee, MD,   Dong-Keun Kim, MD, Yong Hoon Choi, MD, Hyo Seong Ahn, and Wook Hyun Cho, MD Sahmyook Medical Center Seoul Hospital, Seoul, Korea Myopathy, encephalopathy, lactic acidosis and stroke-like episodes (MELAS) is a multisystem clinical syndrome manifested by mitochon - drial myopathy, encephalopathy, lactic acidosis and recurrent stroke-like episodes.",Non-OADS,/arxiv_data1/oa_pdf/92/9c/kcj-43-204.PMC3629250.pdf
"This is an Open Access article distributed under the terms of the Creative  Commons Attribution Non-Commercial License (http://creativecommons.org/licenses/by-nc/3.0) which permits unrestricted non-commercial use, distribution, and reproduction in any medium, provided the original work is properly cited.hemiplegia and aphasia.",Non-OADS,/arxiv_data1/oa_pdf/92/9c/kcj-43-204.PMC3629250.pdf
http://dx.doi.org/10.4070/kcj.2013.43.3.204 www.e-kcj.org normal range.,OADS,/arxiv_data1/oa_pdf/92/9c/kcj-43-204.PMC3629250.pdf
"206 MELAS with Cardiac Involvement http://dx.doi.org/10.4070/kcj.2013.43.3.204 www.e-kcj.org is one of the most common mitochondrial disorders inherited ma - ternally, and is frequently associated with mitochondrial DNA muta - tion encoding transfer ribonucleic acid (RNA), with the most com - mon mutation occurring in the transfer RNA for leucine.2) As a result  of the disturbed function of their cells’ mitochondria, patients with  MELAS syndrome present with various clinical features, including st-roke like episodes, cardiomegaly, muscle weakness, headache, vo-miting, short stature, dementia, deafness, and endocrine system dysfunction with diabetes mellitus, hypogonadism, and hypopara - thyroidism.",Non-OADS,/arxiv_data1/oa_pdf/92/9c/kcj-43-204.PMC3629250.pdf
"However, a nitinol self-expandable Case Report http://dx.doi.org/10.4070/kcj.2013.43.3.207 Print ISSN 1738-5520 • On-line ISSN 1738-5555 An Adolescent Patient with Coarctation of Aorta Treated   with Self-Expandable Nitinol Stent Woo Sup Shim, MD1, Jin Young Song, MD3, Sang Yun Lee, MD1, Jae Suk Baek, MD1,  So Ick Jang, MD1, Seong Ho Kim, MD1, and Yang Min Kim, MD2 1Departments of Pediatric Cardiology and 2Radiology, Sejong Cardiovascular Center, Sejong General Hospital, Bucheon,  3Department of Pediatric Cardiology, Samsung Medical Center, Seoul, Korea Transcatheter treatment of aortic coarctation, with balloon angioplasty or stent implantation, is now an acceptable alternative to surgical  repair.",Non-OADS,/arxiv_data1/oa_pdf/e2/61/kcj-43-207.PMC3629251.pdf
"This is an Open Access article distributed under the terms of the Creative  Commons Attribution Non-Commercial License (http://creativecommons.org/licenses/by-nc/3.0) which permits unrestricted non-commercial use, distribution, and reproduction in any medium, provided the original work is properly cited.stent, when deployed at the coarctation site, produces low constant  radial force, which may result in a gradual widening (stretching) of the stenotic lesion, instead of tearing vascular wall structures (‘st-retching rather than tearing’), leaving less tissue injury.",Non-OADS,/arxiv_data1/oa_pdf/e2/61/kcj-43-207.PMC3629251.pdf
208 Self-Expandable Nitinol Stent in a Native Aortic Coarctation Patient http://dx.doi.org/10.4070/kcj.2013.43.3.207 www.e-kcj.org posterior shelf lesion was seen (Fig.,Non-OADS,/arxiv_data1/oa_pdf/e2/61/kcj-43-207.PMC3629251.pdf
http://dx.doi.org/10.4070/kcj.2013.43.3.207 www.e-kcj.org mnant waist of the stent.,Non-OADS,/arxiv_data1/oa_pdf/e2/61/kcj-43-207.PMC3629251.pdf
"210 Self-Expandable Nitinol Stent in a Native Aortic Coarctation Patient http://dx.doi.org/10.4070/kcj.2013.43.3.207 www.e-kcj.org be used safely in patients with aortic coarctation, leaving less tissue  injury.",Non-OADS,/arxiv_data1/oa_pdf/e2/61/kcj-43-207.PMC3629251.pdf
"http://dx.doi.org/10.4070/kcj.2013.43.3.207 www.e-kcj.org the stent was reduced to, the stronger the radial force exerted by  the stent was observed.",OADS,/arxiv_data1/oa_pdf/e2/61/kcj-43-207.PMC3629251.pdf
"The patient Images in Cardiovascular Medicine http://dx.doi.org/10.4070/kcj.2013.43.3.212 Print ISSN 1738-5520 • On-line ISSN 1738-5555 Iceberg in Small Pulmonary Embolism Ching-Wei Lee, MD1,2, Fa-Po Chung, MD2, Kang-Ling Wang, MD2, Ching-Lan Wu, MD3, and Tse-Min Lu, MD2 1Division of Cardiology, Department of Internal Medicine, Taipei-Veterans General Hospital, Tao-Yuan Branch, Tao-Yuan, 2Division of Cardiology, Department of Internal Medicine and 2Radiology, Taipei-Veterans General Hospital, Taipei, 3Department of Radiology, Taipei-Veterans Gernal Hospital, Taipei, Taiwan Received:  September 7, 2012 / Revision Received: September 26, 2012 / Accepted: October 4, 2012 Correspondence: Tse-Min Lu, MD, Division of Cardiology, Department of Internal Medicine, Taipei-Veterans General Hospital, No.",Non-OADS,/arxiv_data1/oa_pdf/f8/00/kcj-43-212.PMC3629252.pdf
"This is an Open Access article distributed under the terms of the Creative Commons Attribution Non-Commercial License (http://creativecommons.org/licenses/  by-nc/3.0) which permits unrestricted non-commercial use, distribution, and reproduction in any medium, provided the original work is properly cited.succumbed suddenly with pulseless electrical activity before the  emergent operation.",Non-OADS,/arxiv_data1/oa_pdf/f8/00/kcj-43-212.PMC3629252.pdf
http://dx.doi.org/10.4070/kcj.2013.43.3.212  www.e-kcj.orgFig.,OADS,/arxiv_data1/oa_pdf/f8/00/kcj-43-212.PMC3629252.pdf
"Several large feminist organizations exist in Poland, including eFKa ( www.efka.org.pl ) & Feminoteka (www.feminoteka.pl ), both aiming to support female soli- darity and to counteract gender discrimination, Polish Federation for Women and Family Planning, focusing onreproductive rights ( http://www.federa.org.pl ), and Women ’s March 8th Agreement, organizing annual feminist manifestation Manifa ( www.manifa.org ), among others.",Non-OADS,/arxiv_data1/oa_pdf/21/03/11199_2013_Article_272.PMC3629279.pdf
Retrieved from http://www.latimes.com .,Non-OADS,/arxiv_data1/oa_pdf/21/03/11199_2013_Article_272.PMC3629279.pdf
Retrieved from http://www.nytimes.com .,Non-OADS,/arxiv_data1/oa_pdf/21/03/11199_2013_Article_272.PMC3629279.pdf
Retrieved from http://www.bridgew.edu/SoAS/JIWS/April03/Graff.pdf .,Non-OADS,/arxiv_data1/oa_pdf/21/03/11199_2013_Article_272.PMC3629279.pdf
Retrieved from http://jezebel.com/ #!5548464/5-ways-of-looking-at-sarah-palin-feminism .,Non-OADS,/arxiv_data1/oa_pdf/21/03/11199_2013_Article_272.PMC3629279.pdf
Retrieved from http://www.nytimes.com .,Non-OADS,/arxiv_data1/oa_pdf/21/03/11199_2013_Article_272.PMC3629279.pdf
Retrieved from http://www.slate.com/id/2256340 .,Non-OADS,/arxiv_data1/oa_pdf/21/03/11199_2013_Article_272.PMC3629279.pdf
Retrieved fromhttp://thefbomb.org/2010/10/what-does-christine- o%E2%80%99donnel-mean-for-feminism/ .,Non-OADS,/arxiv_data1/oa_pdf/21/03/11199_2013_Article_272.PMC3629279.pdf
"123 Letters to Editor Iran J Pediatr; Vol 23 (No 1),Feb2013 Published by: Tehran University of Medical Sciences (http://ijp.tums.ac.ir ) Fig.",Non-OADS,/arxiv_data1/oa_pdf/4e/61/IJPD-23-123.PMC3629298.pdf
"124 Lettersto Editor Iran J Pediatr; Vol 23 (No 1),Feb2013 Published by: Tehran University of Medical Scie nces(http://ijp.tums.ac.ir )reliable indicator in assessment and monitoring the maternal and child health program and finding a rational reason for this increasing trend is important[4].",Non-OADS,/arxiv_data1/oa_pdf/4e/61/IJPD-23-123.PMC3629298.pdf
"2: 111-124 pISSN 2005-9159  eISSN 2093-0569http://dx.doi.org/10.3344/kjp.2013.26.2.111 | Review Article | Ultrasound-Guided Pain Interventions – A Review of  Techniques for Peripheral Nerves Toronto Western Hospital, University Health Network, University of Toronto, Canada Neilesh Soneji, MD, FRCPC and Ph ilip Wenn Hsin Peng, MBBS, FRCP C, Founder (Pain Medicine) Ultrasound has emerged to become a commonly used modality in the performance of chronic pain  interventions.",Non-OADS,/arxiv_data1/oa_pdf/9f/33/kjpain-26-111.PMC3629336.pdf
"2: 125-129 pISSN 2005-9159  eISSN 2093-0569http://dx.doi.org/10.3344/kjp.2013.26.2.125 | Original Article | Effects of Palonosetron, a 5-HT3 Receptor Antagonist, on  Mechanical Allodynia in a Rat Model of Postoperative Pain Department of Anesthesiology and Pain Medicine, School of Medicine, Chosun University,  *Medical School, Chonnam National University, Gwangju, Korea Ki Tae Jung, MD, Myung Ha Yoon, MD*, Hyun Young Lee, MD,  Bo Yeon Yu, MD, Dong Kyu Kim, MD, and Kyung Joon Lim, MD Background:  5-hydroxytryptamine 3 (5-HT3) receptors have been known to be associated with the modulation of  nociceptive transmission.",Non-OADS,/arxiv_data1/oa_pdf/5f/7a/kjpain-26-125.PMC3629337.pdf
"2: 130-134 pISSN 2005-9159  eISSN 2093-0569http://dx.doi.org/10.3344/kjp.2013.26.2.130 | Original Article | Anatomic Characteristics of Supraorbital Foramina in  Korean Using Three-Dimensional Model  Department of Anesthesiology and Pain Medicine, Seoul National University Bundang Hospital, Seongnam, Korea,  *Department of Applied Mathematics and Statistics, State University of New York at Stony Brook Sang Woo Woo, MD, Hye Joo Lee, PhD*, Francis Sahngun Nahm, MD,  Pyung Bok Lee, MD, and Eun Joo Choi, MD Background:  The aims of this study were to analyze the anatomic variations of supraorbital foramina/notches in Koreans  and to compare the results with those of previous  studies examining other races.",Non-OADS,/arxiv_data1/oa_pdf/d0/44/kjpain-26-130.PMC3629338.pdf
"2: 135-141 pISSN 2005-9159  eISSN 2093-0569http://dx.doi.org/10.3344/kjp.2013.26.2.135 | Original Article | Effect of Ethyl Pyruvate on Paclitaxel-Induced  Neuropathic Pain in Rats Department of Anesthesiology and Pain Medicine, Asan Medical Center,  University of Ulsan College of Medicine, Seoul, Korea Seong Soo Choi, MD, Won Uk Koh, MD, Jae Sik Nam, MD,  Jin Woo Shin, MD, Jeong Gill Le em, MD, and Jeong Hun Suh, MD Background:   Although paclitaxel is a widely used chemotherapeutic agent for the treatment of solid cancers, side effects  such as neuropathic pain lead to poor compliance and discontinuation of the therapy.",Non-OADS,/arxiv_data1/oa_pdf/56/aa/kjpain-26-135.PMC3629339.pdf
"2: 142-147 pISSN 2005-9159  eISSN 2093-0569http://dx.doi.org/10.3344/kjp.2013.26.2.142 | Original Article | The Survey about the Degree of Damage of  Radiation-Protective Shields in Operation Room Department of Anesthesiology and Pain Medicine, Konkuk University Medical Center, Seoul,  *Jeju National University Hospital, Jeju, Korea Jae Sung Ryu, MD, Seung Woo Baek, MD, Cheol Hee Jung, MD, Suk J u Cho, MD*,  E u  G e n e  J u n g ,  M D ,  H a e  K y o u n g  K i m ,  M D ,  a n d  J a e  H u n  K i m ,  M D Background:  Medical doctors who perform C-arm fluoroscopy-guided procedures are exposed to X-ray radiation.",Non-OADS,/arxiv_data1/oa_pdf/df/52/kjpain-26-142.PMC3629340.pdf
"2: 148-153 pISSN 2005-9159  eISSN 2093-0569http://dx.doi.org/10.3344/kjp.2013.26.2.148 | Original Article | A Randomized Controlled Trial about the Levels of Radiation  Exposure Depends on the Use of Collimation C-arm  Fluoroscopic-guided Medial Branch Block Department of Anesthesiology and Pain Medicine, Konkuk University Medical Center, Seoul, Korea Seung Woo Baek, MD, Jae Sung Ryu, MD, Cheol Hee Jung, MD, Joo H an Lee, MD,  Won Kyoung Kwon, MD, Nam Sik Woo, MD, Hae Kyoung Kim, MD, and J a e  H u n  K i m ,  M D Background:  C-arm fluoroscope has been widely used to promote more effective pain management; however, unwanted  radiation exposure for operators is inevitable.",Non-OADS,/arxiv_data1/oa_pdf/a3/22/kjpain-26-148.PMC3629341.pdf
"2: 154-159 pISSN 2005-9159  eISSN 2093-0569http://dx.doi.org/10.3344/kjp.2013.26.2.154 |C a s e  R e p o r t| Efficacy of Intra-articular Steroid Injection in Patients  with Femoroacetabular Impingement Department of Anesthesiology and Pain Medicine, Seoul National University Bundang Hospital, Seongnam, Korea Jung Sun Park, MD, Young Eun Jang, MD, Francis Sahngun Nahm, MD ,  Pyung Bok Lee, MD, and Eun Joo Choi, MD Femoroacetabular Impingement (FAI) arises from morphological abnormalities between the proximal femur  and acetabulum.",Non-OADS,/arxiv_data1/oa_pdf/db/d5/kjpain-26-154.PMC3629342.pdf
"2: 160-163 pISSN 2005-9159  eISSN 2093-0569http://dx.doi.org/10.3344/kjp.2013.26.2.160 |C a s e  R e p o r t| Concurrence of Malignant Perip heral Nerve Sheath Tumor at  the Site of Complex Regional Pain Syndrome Type 1 - A Case Report - Department of Anesthesiology and Pain Medicine, Seoul National University Bundang Hospital, Seongnam, Korea Yeong Ho Jeong, MD, Eun Joo Choi, MD, and Francis Sahngun Nahm,  M D Malignant peripheral nerve sheath tumors (MPNSTs) ar e very rare sarcomas derived from various cells in  the peripheral nerve sheath.",Non-OADS,/arxiv_data1/oa_pdf/24/32/kjpain-26-160.PMC3629343.pdf
"2: 164-168 pISSN 2005-9159  eISSN 2093-0569http://dx.doi.org/10.3344/kjp.2013.26.2.164 |C a s e  R e p o r t| Searching for Hidden, Painful Osteochondral Lesions of the  Ankle in Patients with Chronic Lower Limb Pain - Two Case Reports - Department of Anesthesiology and Pain Medicine, School of Medicine, Pusan National University, Yangsan, *Chnagwon Samsung Medical Center, Changwon, Korea  Hyun Su Ri, MD, Dong Heon Lee, MD*, and Kyung Hoon Kim, MD It is easy to overlook osteochondral lesions (OCLs) of the ankle in patients with chronic lower limb pain,  such as complex regional pain syndrome (CRPS) or thromboangiitis obliterans (TAO, Buerger’s disease).",Non-OADS,/arxiv_data1/oa_pdf/90/59/kjpain-26-164.PMC3629344.pdf
"2: 169-172 pISSN 2005-9159  eISSN 2093-0569http://dx.doi.org/10.3344/kjp.2013.26.2.169 |C a s e  R e p o r t| Non Surgical Treatment of Eagle ’s Syndrome - A Case Report - Department of Anesthesiology and Pain Medicine, Ajou University College of Medicine, Suwon, Korea Min Kyu Han, MD, Do Wan Kim, MD, and Jong Yeun Yang, MD Eagle’s syndrome is a disease without a clear lesion that is associated with repeated episodes of pharyngalgia,  odynophagia, the sensation of a foreign body in the pharynx, tinnitus, and otalgia in which patients displaying these types of symptoms must be given a differential diagno sis.",Non-OADS,/arxiv_data1/oa_pdf/6f/8f/kjpain-26-169.PMC3629345.pdf
"2: 173-176 pISSN 2005-9159  eISSN 2093-0569http://dx.doi.org/10.3344/kjp.2013.26.2.173 |C a s e  R e p o r t| Symptomatic Hallucal Interphalangeal Sesamoid Bones  Successfully Treated with Ultrasound-guided Injection - A Case Report - Department of Anesthesiology and Pain Medicine, Seoul National University Hospital,  *Korea University Medical Center, †Department of Neuropsychiatry, Seoul National University Hospital, Seoul, Korea Hye Young Shin, MD, Soo Young Park, MD*, Hye Young Kim, MD,  Yoo Sun Jung, MD, Sangbum An, MD, and Do Hyung Kang, MD† The hallucal interphalangeal sesamoid bone is usually asymptomatic, but it is not uncommon for it to be  symptomatic in cases of undue pressure, overuse, or trauma.",Non-OADS,/arxiv_data1/oa_pdf/a2/3a/kjpain-26-173.PMC3629346.pdf
"2: 177-180 pISSN 2005-9159  eISSN 2093-0569http://dx.doi.org/10.3344/kjp.2013.26.2.177 |C a s e  R e p o r t| Secondary Trigeminal Neuralgia Caused by  Pharyngeal Squamous Cell Carcinoma - A Case Report - Department of Anesthesiology and Pain Medicine, Seoul National University Hospital,  *Korea University Medical Center, Seoul, †Gangneung Asan Hospital, Gangneung, Korea Min Seok Kim, MD, Yong Jae Ryu, MD, Soo Young Park, MD*, Hye Yo ung Kim, MD,  Sangbum An, MD, and Sung Woo Kim, MD† Trigeminal neuralgia (TN) is characterized by recurrent paroxysms of unilateral facial pain that typically is  severe, lancinating, and activated with cutaneous stimulation.",Non-OADS,/arxiv_data1/oa_pdf/11/5d/kjpain-26-177.PMC3629347.pdf
"2: 181-185 pISSN 2005-9159  eISSN 2093-0569http://dx.doi.org/10.3344/kjp.2013.26.2.181 |C a s e  R e p o r t| Spondylodiscitis after Cervical Nucleoplasty without Any  Abnormal Laboratory Findings Department of Anesthesiology and Pain Medicine, Seoul National University Bundang Hospital, Seongnam, Korea  Seung Jun Lee, MD, Eun Joo Choi, MD, and Francis Sahngun Nahm, MD Infective spondylodiscitis is a rare complication that can occur after interventional spinal procedures, of  which symptoms are usually back pain and fever.",Non-OADS,/arxiv_data1/oa_pdf/f0/d3/kjpain-26-181.PMC3629348.pdf
"2: 186-190 pISSN 2005-9159  eISSN 2093-0569http://dx.doi.org/10.3344/kjp.2013.26.2.186 |C a s e  R e p o r t| Ultrasound-guided Pulsed Radiofrequency of the  Third Occipital Nerve Department of Anesthesiology and Pain Medicine, The Catholic University of Korea College of Medicine, Seoul, Korea E u n g  D o n  K i m ,  M D ,  Y o u n g  H o o n  K i m ,  M D ,  C h o n g  M i n  P a r k ,  M D ,   Jung Ah Kwak, MD, and Dong Eon Moon, MD A C2-3 zygapophygeal joint is a major source of cerv icogenic headache.",Non-OADS,/arxiv_data1/oa_pdf/7c/c3/kjpain-26-186.PMC3629349.pdf
"2: 191-194 pISSN 2005-9159  eISSN 2093-0569http://dx.doi.org/10.3344/kjp.2013.26.2.191 | Brief Report | Referred Pain in Right Arm from Abdominal Wall  Pseudoaneurysm Department of Anesthesiology and Pain Medicine, Korea University Medical Center,  *Seoul National University Hospital, †Department of Surgery, Seoul National University Hospital, Seoul, Korea Soo Young Park, MD, Seon Kyoung Ahn, MD*, Hye Young Kim, MD*,  J i  Y e o n  S h i n ,  M D * ,  a n d  S a n g i l  M i n ,  M D† Pseudoaneurysm of the abdominal wall is a possible but very rare clinical entity.",Non-OADS,/arxiv_data1/oa_pdf/cf/80/kjpain-26-191.PMC3629350.pdf
"2: 195-198 pISSN 2005-9159  eISSN 2093-0569http://dx.doi.org/10.3344/kjp.2013.26.2.195 | Brief Report | Disseminated Herpes Zoster in an Immunocompetent  Elderly Patient Department of Anesthesiology and Pain Medicine, Daejeon St. Mary's Hospital,  The Catholic University of Korea College of Medicine, Daejeon, Korea Keon Jung Yoon, MD, Su Hwa Kim, MD, Eun Ha Lee, MD, and Ji Hye Choi, MD Herpes zoster is a cutaneous infection that is characterized by an acute vesicobullous rash with ipsilateral  one or two dermatomal distribution and painful allodynia, while predominantly being found in the elderly.",Non-OADS,/arxiv_data1/oa_pdf/c5/aa/kjpain-26-195.PMC3629351.pdf
"2: 199-202 pISSN 2005-9159  eISSN 2093-0569http://dx.doi.org/10.3344/kjp.2013.26.2.199 | Brief Report | Occurrence of Trochlear Nerve Palsy after Epiduroscopic  Laser Discectomy and Neural Decompression Department of Anesthesiology and Pain Medicine, Daejeon St. Mary's Hospital,  The Catholic University of Korea College of Medicine, Daejeon, Korea Keon Jung Yoon, MD, Eun Ha Lee, MD, Su Hwa Kim, MD, and Mi Sun Noh, MD Epiduroscopic laser discectomy and neural decompression (ELND) is known as an effective treatment for  intractable lumbar pain and radiating pain which develo p after lumbar surgery, as well as for herniation of  the intervertebral disk and spinal stenosis.",Non-OADS,/arxiv_data1/oa_pdf/f7/40/kjpain-26-199.PMC3629352.pdf
"2: 203-206 pISSN 2005-9159  eISSN 2093-0569http://dx.doi.org/10.3344/kjp.2013.26.2.203 | Brief Report | Inadvertent Dural Puncture during Caudal Approach by the  Introducer Needle for Epidural Adhesiolysis Caused by  Anatomical Variation Department of Anesthesiology and Pain Medicine, Ajou University College of Medicine, Suwon, Korea Si Gon Kim, MD, Jong Yeun Yang, MD, Do Wan Kim, MD, and Yeon Ju  Lee, MD  There have been reports of abnormalities in the lumbosacral region involving a lower-than-normal termina- tion of the dural sac, which is caused by disease or anatomical variation.",Non-OADS,/arxiv_data1/oa_pdf/b7/82/kjpain-26-203.PMC3629353.pdf
2: 207 pISSN 2005-9159  eISSN 2093-0569http://dx.doi.org/10.3344/kjp.2013.26.2.207 | Letters to Editor | Are Doctors Exposed to Radiation Even When Wearing  Protectors during Fluoroscopic Procedures?,Non-OADS,/arxiv_data1/oa_pdf/58/d0/kjpain-26-207.PMC3629354.pdf
2: 208 pISSN 2005-9159  eISSN 2093-0569http://dx.doi.org/10.3344/kjp.2013.26.2.208 | Letters to Editor | Replay to the Letter: Are Doctors Exposed to Radiation Even  When Wearing Protectors during Fluoroscopic Procedures?,Non-OADS,/arxiv_data1/oa_pdf/6d/81/kjpain-26-208.PMC3629355.pdf
2: 209-210 pISSN 2005-9159  eISSN 2093-0569http://dx.doi.org/10.3344/kjp.2013.26.2.209 | Letters to Editor | Can Vitamin C Be Used as an Adjuvant for Managing  Postoperative Pain?,Non-OADS,/arxiv_data1/oa_pdf/30/14/kjpain-26-209.PMC3629356.pdf
"2: 211 pISSN 2005-9159  eISSN 2093-0569http://dx.doi.org/10.3344/kjp.2013.26.2.211 Erratum: Incorrect Title of the Author Opioid Pharmacotherapy for Chronic  Noncancer Pain: The American Experience C. Richard Chapman, MD, PhD Korean J Pain 2013 January; Vol.",Non-OADS,/arxiv_data1/oa_pdf/de/cd/kjpain-26-211.PMC3629357.pdf
"1: 3-13 pISSN 2005-9159 eISSN 2093-0569 http://dx.doi.org/10.3344/kjp.2013.26.1.3  This is an open-access article distributed under the terms of the Creative Commons Attribution Non-Commercial License (http://   creativecommons.org/licenses/by-nc/3.0/), which permits unrestricted non-commercial use, distribution, and reproduction in any medium,  provided the original work is properly cited.Copyright ⓒThe Korean Pain Society, 2013In this review article, the title of the author was given incorrectly in the editing process.",Non-OADS,/arxiv_data1/oa_pdf/de/cd/kjpain-26-211.PMC3629357.pdf
"2013;45(1):1-14pISSN 1598-2998, eISSN 2005-9256 http://dx.doi.org/10.4143/crt.2013.45.1.1 Kyu-Won Jung,MS1 Young-Joo Won,PhD1 Hyun-Joo Kong,MS1 Chang-Mo Oh,MD1 Hong Gwan Seo,MD, PhD2 Jin-Soo Lee,MD, PhD1 1The Korea Central Cancer Registry,  Division of Cancer Registration  and Surveillance,  2National Cancer Control Institute,  National Cancer Center, Goyang, Korea Correspondence: Young-Joo Won, PhD The Korea Central Cancer Registry,  Division of Cancer Registration and  Surveillance, National Cancer Center,  323 Ilsan-ro, Ilsandong-gu,  Goyang 410-769, Korea Tel: 82-31-920-2015 Fax: 82-31-920-2179 E-mail: astra67@ncc.re.kr Received  February 26, 2013 Accepted  February 27, 2013Purpose This article gives an overview of nationwide cancer statistics, including incidence, mortality, survival and prevalence, and their trends in Korea based on 2010 cancer incidence data.",Non-OADS,/arxiv_data1/oa_pdf/b2/d2/crt-45-1.PMC3629358.pdf
"Details of the history, objectives and  Ȉhttp://www.cancerresearchandtreatment.org Ȉ Ȉhttp://www.e-crt.org Ȉ1 Copyright ˅2013 by  the Korean Cancer Association This is an Open-Access article distributed under the terms of the Creative Commons Attribution Non-Commercial License (http://creativecommons.org/  licenses/by-nc/3.0/)which permits unrestricted non-commercial use, distribution, and reproduction in any medium, provided the original work is properly cited.",Non-OADS,/arxiv_data1/oa_pdf/b2/d2/crt-45-1.PMC3629358.pdf
Available from: http://kostat.go.kr.,Non-OADS,/arxiv_data1/oa_pdf/b2/d2/crt-45-1.PMC3629358.pdf
Avail- able from: http://seer.cancer.gov/seerstat/2010.,Non-OADS,/arxiv_data1/oa_pdf/b2/d2/crt-45-1.PMC3629358.pdf
Available from: http://www.pauldickman.com.14.,Non-OADS,/arxiv_data1/oa_pdf/b2/d2/crt-45-1.PMC3629358.pdf
"2013;45(1):15-21pISSN 1598-2998, eISSN 2005-9256 http://dx.doi.org/10.4143/crt.2013.45.1.15 Kyu-Won Jung,MS1 Young-Joo Won,PhD1 Hyun-Joo Kong,MS1 Chang-Mo Oh,MD1 Hong Gwan Seo,MD, PhD2 Jin-Soo Lee,MD, PhD1 1The Korea Central Cancer Registry,  Division of Cancer Registration  and Surveillance,  2National Cancer Control Institute,  National Cancer Center, Goyang, Korea Correspondence: Young-Joo Won, PhD The Korea Central Cancer Registry,  Division of Cancer Registration and  Surveillance, National Cancer Center,  323 Ilsan-ro, Ilsandong-gu,  Goyang 410-769, Korea Tel: 82-31-920-2015 Fax: 82-31-920-2179 E-mail: astra67@ncc.re.kr Received  February 26, 2013 Accepted  February 27, 2013Purpose To estimate the current cancer burden in Korea, cancer incidence and mortality rates were projected for the year 2013.",Non-OADS,/arxiv_data1/oa_pdf/70/e9/crt-45-15.PMC3629359.pdf
"Ȉhttp://www.cancerresearchandtreatment.org Ȉ Ȉhttp://www.e-crt.org Ȉ15 Copyright ˅2013 by  the Korean Cancer Association This is an Open-Access article distributed under the terms of the Creative Commons Attribution Non-Commercial License (http://creativecommons.org/  licenses/by-nc/3.0/)which permits unrestricted non-commercial use, distribution, and reproduction in any medium, provided the original work is properly cited.",Non-OADS,/arxiv_data1/oa_pdf/70/e9/crt-45-15.PMC3629359.pdf
4.0; http://surveillance.cancer.gov/joinpoint) from the  Surveillance Research Program of the US National Cancer Institute [8].,Non-OADS,/arxiv_data1/oa_pdf/70/e9/crt-45-15.PMC3629359.pdf
Available from: http://kostat.go.kr.,Non-OADS,/arxiv_data1/oa_pdf/70/e9/crt-45-15.PMC3629359.pdf
Available from: http://surveillance.cancer.gov/joinpoint/.,Non-OADS,/arxiv_data1/oa_pdf/70/e9/crt-45-15.PMC3629359.pdf
"2013;45(1):22-30pISSN 1598-2998, eISSN 2005-9256 http://dx.doi.org/10.4143/crt.2013.45.1.22 Joon Suk Park,MD1 Joon Young Choi,MD2 Seung Hwan Moon,MD2 Yong Chan Ahn,MD3 Jeeyun Lee,MD4 Dohun Kim,MD1 Kwhanmien Kim,MD5 Young Mog Shim,MD1 Departments of 1Thoracic Surgery,  2Nuclear Medicine,  and 3Radiation Oncology,  4Division of Hematology-Oncology,  Department of Internal Medicine,  Samsung Medical Center, Sungkyunkwan University School of Medicine, Seoul,  5Department of Thoracic Surgery,  Seoul National Bundang Hospital,  Seoul National University College of  Medicine, Seongnam, Korea Correspondence: Young Mog Shim, MD  Department of Thoracic Surgery,  Samsung Medical Center, Sungkyunkwan  University School of Medicine, 81 Irwon-ro, Gangnam-gu, Seoul 135-710, Korea  Tel: 82-2-3410-3022 Fax: 82-2-3410-3029 E-mail: ymshim@skku.edu  Received  November 6, 2012 Accepted  January 6, 2013 * Joon Suk Park and Joon Young Choi  contributed equally to this work.",Non-OADS,/arxiv_data1/oa_pdf/3f/04/crt-45-22.PMC3629360.pdf
"However, previous examina- Ȉhttp://www.cancerresearchandtreatment.org Ȉ Ȉhttp://www.e-crt.org Ȉ22 Copyright ˅2013 by  the Korean Cancer Association This is an Open-Access article distributed under the terms of the Creative Commons Attribution Non-Commercial License (http://creativecommons.org/  licenses/by-nc/3.0/)which permits unrestricted non-commercial use, distribution, and reproduction in any medium, provided the original work is properly cited.",Non-OADS,/arxiv_data1/oa_pdf/3f/04/crt-45-22.PMC3629360.pdf
"2013;45(1):31-39pISSN 1598-2998, eISSN 2005-9256 http://dx.doi.org/10.4143/crt.2013.45.1.31 Jong Hoon Lee,MD1 Jin Ho Song,MD2 Sang Nam Lee,MD2 Jin Hyoung Kang,MD3 Min Sik Kim,MD4 Dong Il Sun,MD2 Yeon-Sil Kim,MD2 1Department of Radiation Oncology,  St. Vincent’s Hospital,  The Catholic University of  Korea College of Medicine, Suwon,  Departments of 2Radiation Oncology and 3Medical Oncology,  4Head and Neck Surgery Center,  Seoul St. Mary’s Hospital,  The Catholic University of  Korea College of Medicine, Seoul, Korea Correspondence: Yeon-Sil Kim, MD Department of Radiation Oncology,  Seoul St. Mary’s Hospital,  The Catholic University of  Korea College of Medicine, 222 Banpo-daero, Seocho-gu, Seoul 137-701, Korea Tel: 82-2-2258-1501 Fax: 82-2-2258-1532 E-mail: yeonkim7@catholic.ac.kr Received  October 10, 2012 Accepted  December 5, 2012Purpose We wanted to evaluate the role of postoperative chemoradiotherapy (CRT) for patients with locally advanced squamous cell carcinoma of the head and neck (SCCHN).",Non-OADS,/arxiv_data1/oa_pdf/18/39/crt-45-31.PMC3629361.pdf
"The Intergroup Study 0034 evaluated the issue of postoperative chemotherapy in a trial that randomized patients after surgery to three 21-day Ȉhttp://www.cancerresearchandtreatment.org Ȉ Ȉhttp://www.e-crt.org Ȉ31 Copyright ˅2013 by  the Korean Cancer Association This is an Open-Access article distributed under the terms of the Creative Commons Attribution Non-Commercial License (http://creativecommons.org/  licenses/by-nc/3.0/)which permits unrestricted non-commercial use, distribution, and reproduction in any medium, provided the original work is properly cited.",Non-OADS,/arxiv_data1/oa_pdf/18/39/crt-45-31.PMC3629361.pdf
"2013;45(1):40-47pISSN 1598-2998, eISSN 2005-9256 http://dx.doi.org/10.4143/crt.2013.45.1.40 Hee Jun Lee,MD1 Hee Seung Kim,MD1 Noh Hyun Park,MD, PhD1 Hyun Hoon Chung,MD, PhD1 Jae Weon Kim,MD, PhD1 Yong Sang Song,MD, PhD1,2,3 1Department of Obstetrics and Gynecology, 2Cancer Research Institute, Seoul National University College of Medicine,  3Major in Biomodulation,  World Class University,  Seoul National University, Seoul, Korea Correspondence: Noh Hyun Park, MD, PhD Department of Obstetrics and Gynecology,  Seoul National University College of Medicine,  103 Daehak-ro, Jongno-gu, Seoul 110-799, Korea Tel: 82-2-2072-2380 Fax: 82-2-762-3599 E-mail: pnhkhr@snu.ac.kr Received  November 7, 2012 Accepted  January 18, 2013 * Hee Jun Lee and Hee Seung Kim contributed equally to this work.Purpose The purpose of this study is to evaluate the efficacy and toxicity of oxaliplatin, leucov- orin, and 5-fluorouracil (FOLFOX-4) chemotherapy in heavily pretreated patients with recurrent epithelial ovarian cancer (EOC).",Non-OADS,/arxiv_data1/oa_pdf/61/b6/crt-45-40.PMC3629362.pdf
"Patients with platinum-sensitive disease, who relapse later than six months after primary Ȉhttp://www.cancerresearchandtreatment.org Ȉ Ȉhttp://www.e-crt.org Ȉ40 Copyright ˅2013 by  the Korean Cancer Association This is an Open-Access article distributed under the terms of the Creative Commons Attribution Non-Commercial License (http://creativecommons.org/  licenses/by-nc/3.0/)which permits unrestricted non-commercial use, distribution, and reproduction in any medium, provided the original work is properly cited.",Non-OADS,/arxiv_data1/oa_pdf/61/b6/crt-45-40.PMC3629362.pdf
Available from: http://ctep.cancer.,Non-OADS,/arxiv_data1/oa_pdf/61/b6/crt-45-40.PMC3629362.pdf
"2013;45(1):48-54pISSN 1598-2998, eISSN 2005-9256 http://dx.doi.org/10.4143/crt.2013.45.1.48 Bae Kwon Jeong,MD1,2,3 Seung Jae Huh,MD, PhD1 Doo Ho Choi,MD, PhD1 Won Park,MD, PhD1 Duk Soo Bae,MD, PhD4 Byoung-Gie Kim,MD, PhD4 1Department of Radiation Oncology,  Samsung Medical Center, Sungkyunkwan University School of Medicine, Seoul,  2Department of Radiation Oncology, Gyeongsang National  University School of Medicine,  3Institute of Health Science,  Gyeongsang National University, Jinju,  4Department of Obstetrics and Gynecology, Samsung Medical Center, Sungkyunkwan University School of Medicine, Seoul, Korea Correspondence: Doo Ho Choi, MD, PhD Department of Radiation Oncology,  Samsung Medical Center, Sungkyunkwan  University School of Medicine, 81 Irwon-ro, Gangnam-gu, Seoul 135-710, Korea Tel: 82-2-3410-2436 Fax: 82-2-3410-2619 E-mail: doho.choi@samsung.com Received  October 23, 2012 Accepted  January 10, 2013Purpose In some unusual cases, in patients with cervical cancer, an elevation of squamous cell carcinoma antigen (SCC-Ag) was not observed at diagnosis but was observed on recurrence, or vice versa.",Non-OADS,/arxiv_data1/oa_pdf/64/99/crt-45-48.PMC3629363.pdf
"Several methods are available for detection of relapse, which serve as a significant prognostic factor for patients Ȉhttp://www.cancerresearchandtreatment.org Ȉ Ȉhttp://www.e-crt.org Ȉ48 Copyright ˅2013 by  the Korean Cancer Association This is an Open-Access article distributed under the terms of the Creative Commons Attribution Non-Commercial License (http://creativecommons.org/  licenses/by-nc/3.0/)which permits unrestricted non-commercial use, distribution, and reproduction in any medium, provided the original work is properly cited.",Non-OADS,/arxiv_data1/oa_pdf/64/99/crt-45-48.PMC3629363.pdf
"2013;45(1):55-62pISSN 1598-2998, eISSN 2005-9256 http://dx.doi.org/10.4143/crt.2013.45.1.55 Seung Tae Kim,MD, PhD Kyong Hwa Park,MD, PhD Jun Suk Kim,MD, PhD Sang Won Shin,MD, PhD Yeul Hong Kim,MD, PhD Division of Hematology-Oncology,  Department of Medicine,  Korea University College of Medicine,  Seoul, Korea Correspondence: Yeul Hong Kim,MD, PhD Division of Hematology-Oncology,  Department of Medicine, Korea University Anam Hospital, Korea University College  of Medicine, 73 Inchon-ro, Seongbuk-gu,  Seoul 136-705, Korea Tel: 82-2-920-5569 Fax: 82-2-920-6622 E-mail: yhk0215@korea.ac.kr Received  December 4, 2012 Accepted  December 16, 2012Purpose Activating mutation of the KRASoncogene is an established negative predictor for anti-epidermal growth factor receptor (anti-EGFR) therapies in metastatic colorectal cancer (CRC).",Non-OADS,/arxiv_data1/oa_pdf/7e/e9/crt-45-55.PMC3629364.pdf
"Key words KRAS, Anti-EGFR, Colorectal neoplasmsOriginal Article Open Access Impact of KRASMutation Status on Outcomes in  Metastatic Colon Cancer Patients without  Anti-Epidermal Growth Factor Receptor Therapy  Ȉhttp://www.cancerresearchandtreatment.org Ȉ Ȉhttp://www.e-crt.org Ȉ55 Copyright ˅2013 by  the Korean Cancer Association This is an Open-Access article distributed under the terms of the Creative Commons Attribution Non-Commercial License (http://creativecommons.org/  licenses/by-nc/3.0/)which permits unrestricted non-commercial use, distribution, and reproduction in any medium, provided the original work is properly cited.Introduction Colorectal cancer (CRC) has been a significant cause of morbidity and mortality in the world [1].",Non-OADS,/arxiv_data1/oa_pdf/7e/e9/crt-45-55.PMC3629364.pdf
"2013;45(1):63-69pISSN 1598-2998, eISSN 2005-9256 http://dx.doi.org/10.4143/crt.2013.45.1.63 Kyun Woo Park,MD1 Eun-Seon Jung,MD2 Dong-Gu Kim,MD3 Young-Kyung Yoo,MD3 Tae-Ho Hong,MD3 In Seok Lee,MD1 Yoon Ho Koh,MD4 Ji-Hoon Kim,MD5 Myung Ah Lee,MD1 Departments of 1Internal Medicine, 2Pathology, and 3Surgery, Seoul St. Mary’s Hospital, Seoul, 4Department of Internal Medicine,  Uijeongbu St. Mary's Hospital, Uijeongbu, 5Department of Internal Medicine,  St. Vincent's Hospital, Suwon, The Catholic University of  College of Medicine, Korea Correspondence: Myung Ah Lee, MD Department of Internal Medicine, Seoul  St. Mary's Hospital, 222 Banpo-daero,  Seocho-gu, Seoul 137-701, Korea Tel: 82-2-2258-6044  Fax: 82-2-599-3589 E-mail: angelamd@catholic.ac.kr Received  April 19, 2012 Accepted  January 24, 2013Purpose There are three types of bile duct cancer, intrahepatic cholangiocarcinoma (ICC),  hilar cholangiocarcinoma (HC), and extrahepatic cholangiocarcinoma (EHC).",Non-OADS,/arxiv_data1/oa_pdf/0c/a9/crt-45-63.PMC3629365.pdf
"Key words Bile duct neoplasms, ERCC1, PrognosisOriginal Article Open Access ERCC1 Can Be a Prognostic Factor in Hilar Cholangiocarcinoma  and Extrahepatic Bile Duct Cancer, But Not in Intrahepatic  Cholangiocarcinoma  Ȉhttp://www.cancerresearchandtreatment.org Ȉ Ȉhttp://www.e-crt.org Ȉ63 Copyright ˅2013 by  the Korean Cancer Association This is an Open-Access article distributed under the terms of the Creative Commons Attribution Non-Commercial License (http://creativecommons.org/  licenses/by-nc/3.0/)which permits unrestricted non-commercial use, distribution, and reproduction in any medium, provided the original work is properly cited.Introduction There are three types of bile duct cancers (BDCs) according to the anatomical location; these include intrahepatic cholan- giocarcinoma (ICC), hilar cholangiocarcinoma (HC), and  extrahepatic cholangiocarcinoma (EHC).",Non-OADS,/arxiv_data1/oa_pdf/0c/a9/crt-45-63.PMC3629365.pdf
"2013;45(1):70-73pISSN 1598-2998, eISSN 2005-9256 http://dx.doi.org/10.4143/crt.2013.45.1.70 Jin Hyun Cho,MD Nam Jun Kim,MD Sung Min Ko,MD Chunghun Kim,MD Hee Kyung Ahn,MD Jina Yun,MD Yeon Hee Park,MD, PhD Department of Medicine,  Samsung Medical Center,  Sungkyunkwan University School of  Medicine, Seoul, Korea Correspondence: Yeon Hee Park, MD, PhD Division of Hematology-Oncology,  Department of Medicine,  Samsung Medical Center, Sungkyunkwan  University School of Medicine, 81 Irwon-ro, Gangnam-gu, Seoul 135-710, Korea Tel: 82-2-3410-3459 Fax: 82-2-3410-1754 E-mail: yeonh.park@samsung.com Received  May 17, 2011 Accepted  July 13, 2011Paraneoplastic pemphigus is an autoimmune blistering and erosive mucocutaneous syndrome associated with underlying neoplasm.",Non-OADS,/arxiv_data1/oa_pdf/5c/a9/crt-45-70.PMC3629366.pdf
"As for carcinomas, cases of adenocarcinoma of the pancreas, gastrointestinal tract, Ȉhttp://www.cancerresearchandtreatment.org Ȉ Ȉhttp://www.e-crt.org Ȉ70 Copyright ˅2013 by  the Korean Cancer Association This is an Open-Access article distributed under the terms of the Creative Commons Attribution Non-Commercial License (http://creativecommons.org/  licenses/by-nc/3.0/)which permits unrestricted non-commercial use, distribution, and reproduction in any medium, provided the original work is properly cited.",Non-OADS,/arxiv_data1/oa_pdf/5c/a9/crt-45-70.PMC3629366.pdf
"2013;45(1):74-77pISSN 1598-2998, eISSN 2005-9256 http://dx.doi.org/10.4143/crt.2013.45.1.74 Kyeong-Hyun Kim,MD1 Seo-Young Song,MD1 Kyu-Hyoung Lim,MD1 Seon-Sook Han,MD1 Se-Hyun Kim,MD1 Jun Hwi Cho,MD2 Chan Woo Park,MD2 Seoungkoo Lee,MD3 Hui-Young Lee,MD1 Departments of 1Internal Medicine,  2Emergency Medicine, and 3Pathology, Kangwon National University Hospital, Kangwon National University  School of Medicine, Chuncheon, Korea Correspondence: Hui-Young Lee, MD Department of Internal Medicine,  Kangwon National University Hospital,  Kangwon National University School of  Medicine, 1 Gangwondaehak-gil,  Chuncheon 200-701, Korea Tel: 82-33-258-9371 Fax: 82-33-258-2455 E-mail: hylee7@kangwon.ac.kr Received  June 7, 2011 Accepted  August 3, 2011Pemetrexed is approved as a first-line treatment for advanced non-squamous  non-small cell lung cancer (NSCLC) with cisplatin and as a single agent for second- line treatment or for patients who show no disease progression after four cycles of platinum-based doublet induction chemotherapy as maintenance therapy.",Non-OADS,/arxiv_data1/oa_pdf/55/fb/crt-45-74.PMC3629367.pdf
"Ȉhttp://www.cancerresearchandtreatment.org Ȉ Ȉhttp://www.e-crt.org Ȉ74 Copyright ˅2013 by  the Korean Cancer Association This is an Open-Access article distributed under the terms of the Creative Commons Attribution Non-Commercial License (http://creativecommons.org/  licenses/by-nc/3.0/)which permits unrestricted non-commercial use, distribution, and reproduction in any medium, provided the original work is properly cited.",Non-OADS,/arxiv_data1/oa_pdf/55/fb/crt-45-74.PMC3629367.pdf
"Enrichment of poly I:C genes in clinical datasets was determined using  the GSV A algorithm, 9  as implemented in the R software environment  ( http://www.r-project.org/ ).",OADS,/arxiv_data1/oa_pdf/b1/dc/mi201286a.PMC3629368.pdf
"SUPPLEMENTARY MATERIAL   is linked to the online version of the  paper at  http://www.nature.com/mi        ACKNOWLEDGMENTS    We thank Lorena Renteria and Jacob LaStant for their assistance with  the preparation and harvest of the lung tissues, and Justin Guinney for his input on the application of GSVA to this data set.",Non-OADS,/arxiv_data1/oa_pdf/b1/dc/mi201286a.PMC3629368.pdf
"To view a copy of this license, visit http://creativecommons.org/licenses/by-nc-nd/3.0/",Non-OADS,/arxiv_data1/oa_pdf/b1/dc/mi201286a.PMC3629368.pdf
"510 VOLUME 6 NUMBER 3  | MAY 2013  | www.nature.com/miARTICLES     SUPPLEMENTARY MATERIAL   is linked to the online version of the  paper at  http://www.nature.com/mi        ACKNOWLEDGMENTS    We would like to thank Drs B. Jeppson, J. Marsal, U. H å kansson,  G. Baseckas, and O. Patchan (Sk å ne University Hospital, Lund / Malm ö ,  Sweden) for collecting human ileum.",Non-OADS,/arxiv_data1/oa_pdf/b0/7f/mi201289a.PMC3629381.pdf
"To view a copy of this license, visit http://creativecommons.org/licenses/by-nc-sa/3.0/",Non-OADS,/arxiv_data1/oa_pdf/b0/7f/mi201289a.PMC3629381.pdf
"To view a copy of this license, visit http://creativecommons.org/licenses/by-nc-sa/3.0/Serotonin modulation and inhibition J Macoveanu et al 1005 Neuropsychopharmacology",Non-OADS,/arxiv_data1/oa_pdf/9b/96/npp2012264a.PMC3629389.pdf
"To view a copy of this license, visit http://creativecommons.org/licenses/by-nc-nd/3.0/ Supplementary Information accompanies the paper on the Neuropsychopharmacology website (http://www.nature.com/npp)Fluoxetine-induced cortical neurogenesis K Ohira et al 920 Neuropsychopharmacology",Non-OADS,/arxiv_data1/oa_pdf/a0/aa/npp20132a.PMC3629401.pdf
"To view a copy of this license, visit http://creativecommons.org/licenses/by-nc-nd/3.0/Visual responses and GABA SD Muthukumaraswamy et al 1112 Neuropsychopharmacology",Non-OADS,/arxiv_data1/oa_pdf/77/a3/npp20139a.PMC3629410.pdf
"To view a copy of thislicense, visit http://creativecommons.org/licenses/by-nc-sa/3.0/ How to cite this article: Falzarano, D. et al.",Non-OADS,/arxiv_data1/oa_pdf/8b/95/srep01686.PMC3629412.pdf
"To view a copy of thislicense, visit http://creativecommons.org/licenses/by-nc-nd/3.0/ How to cite this article: Watabe, M. et al.",Non-OADS,/arxiv_data1/oa_pdf/f9/38/srep01685.PMC3629414.pdf
Additional information Supplementary information accompanies this paper at http://www.nature.com/ scientificreports Competing financial interests: The authors declare no competing financial interests.,Non-OADS,/arxiv_data1/oa_pdf/6c/81/srep01687.PMC3629416.pdf
"To view a copy of this license, visit http://creativecommons.org/licenses/by-nc-nd/3.0/ How to cite this article: Duan, H. et al.",Non-OADS,/arxiv_data1/oa_pdf/6c/81/srep01687.PMC3629416.pdf
Pixel density in each spot of the array was quantified using ImageJ 1.44o software (http://rsb.info.nih.gov/ij/features.html).,OADS,/arxiv_data1/oa_pdf/c0/46/bjc2013102a.PMC3629417.pdf
Supplementary Information accompanies this paper on British Journal of Cancer website (http://www.nature.com/bjc)CD24 and tumour therapy BRITISH JOURNAL OF CANCER www.bjcancer.com | DOI:10.1038/bjc.2013.102 1459,Non-OADS,/arxiv_data1/oa_pdf/c0/46/bjc2013102a.PMC3629417.pdf
http://www.R-project.org).,Non-OADS,/arxiv_data1/oa_pdf/ff/78/bjc2013106a.PMC3629420.pdf
Supplementary Information accompanies this paper on British Journal of Cancer website (http://www.nature.com/bjc)BRITISH JOURNAL OF CANCER Competing mortality analysis for bladder cancer 1540 www.bjcancer.com | DOI:10.1038/bjc.2013.106,Non-OADS,/arxiv_data1/oa_pdf/ff/78/bjc2013106a.PMC3629420.pdf
"Ministry of Labour, Available at: http://www.regjeringen.no/en/dep/ad/doc/ veiledninger_brosjyrer/2011/the-norwegian-social-insurance-scheme-20.html?id=636557.",Non-OADS,/arxiv_data1/oa_pdf/11/35/bjc2013107a.PMC3629421.pdf
"NIS, Available at: http://www.nav.no/ English/Membership+in+The+National+Insurance+Scheme.",Non-OADS,/arxiv_data1/oa_pdf/11/35/bjc2013107a.PMC3629421.pdf
"National Cancer Institute, Available at: http://seer.cancer.gov/.",Non-OADS,/arxiv_data1/oa_pdf/11/35/bjc2013107a.PMC3629421.pdf
"The Norwegian Labour and Welfare Administration (2012) NAV , Available at: http://www.nav.no/English.",Non-OADS,/arxiv_data1/oa_pdf/11/35/bjc2013107a.PMC3629421.pdf
"World Health Organization: Geneva, Switzerland, Available at: http://www.who.int/classifications/icd/.",Non-OADS,/arxiv_data1/oa_pdf/11/35/bjc2013107a.PMC3629421.pdf
"We designed specific primers using Primer-BLAST (NCBI, http://www.ncbi.nlm.nih.gov/tools/primer-blast/).",OADS,/arxiv_data1/oa_pdf/a4/82/bjc2013108a.PMC3629422.pdf
"Available from http://globocan.iarc.fr, accessed on 15/October/2012.",Non-OADS,/arxiv_data1/oa_pdf/71/a2/bjc2013109a.PMC3629423.pdf
Supplementary Information accompanies this paper on British Journal of Cancer website (http://www.nature.com/bjc)Reasons patients take part in trials BRITISH JOURNAL OF CANCER www.bjcancer.com | DOI:10.1038/bjc.2013.113 1407,Non-OADS,/arxiv_data1/oa_pdf/94/53/bjc2013113a.PMC3629425.pdf
Available at http://www.socialstyrelsen.se/Lists/Artikelkatalog/Attachments/18204/2010–12–17.pdfaccessed 31 August 2011.,Non-OADS,/arxiv_data1/oa_pdf/71/9f/bjc2013119a.PMC3629428.pdf
org/licenses/by-nc-sa/3.0/ Supplementary Information accompanies this paper on British Journal of Cancer website (http://www.nature.com/bjc)Treatment and survival in Swedish RCC patients BRITISH JOURNAL OF CANCER www.bjcancer.com | DOI:10.1038/bjc.2013.119 1549,Non-OADS,/arxiv_data1/oa_pdf/71/9f/bjc2013119a.PMC3629428.pdf
Lentiviral vectors encoding shRNAs specific for EpCAM as well as control GFP sequences are part of The RNAi Consortium shRNA Library (http://www.broadinstitute.org/rnai/trc).,OADS,/arxiv_data1/oa_pdf/52/79/bjc201380a.PMC3629430.pdf
The black rectangular frame in each schematic represents potential E2F1-binding sites analysed with the Transcription Element Search System (at http://www.cbil.upenn.edu/cgi-bin/tess/tess?RQ ¼SEA-FR-Query) by entering human E2F1 accession number (TRANSFAC) T01542 in the factor filter option.,OADS,/arxiv_data1/oa_pdf/97/79/bjc201381a.PMC3629431.pdf
Supplementary Information accompanies this paper on British Journal of Cancer website (http://www.nature.com/bjc)BRITISH JOURNAL OF CANCER STS and EST in NSCLC 1424 www.bjcancer.com | DOI:10.1038/bjc.2013.84,Non-OADS,/arxiv_data1/oa_pdf/d5/82/bjc201384a.PMC3629433.pdf
Available at http://www.icr.ac.uk/research/team_leaders/Houlston_Richard/Houlston_Richard_RES/NSCCG/ 23438.pdf.,Non-OADS,/arxiv_data1/oa_pdf/0a/ca/bjc201391a.PMC3629434.pdf
Available at http://www.ncin.org.uk/collecting_and_using_data/national_cancer_data_repository/default.aspx.,Non-OADS,/arxiv_data1/oa_pdf/0a/ca/bjc201391a.PMC3629434.pdf
Supplementary Information accompanies this paper on British Journal of Cancer website (http://www.nature.com/bjc)Sunitinib plus gemcitabine for advanced solid tumours BRITISH JOURNAL OF CANCER www.bjcancer.com | DOI:10.1038/bjc.2013.96 1401,Non-OADS,/arxiv_data1/oa_pdf/35/4d/bjc201396a.PMC3629436.pdf
"Data were obtained from all 17 US cancer registries participating in the SEER programme using SEER*Stat version 7.0.5 under a data user agreement (http://seer.cancer.gov/seerstat, access date: 23 January 2012).",OADS,/arxiv_data1/oa_pdf/8f/1e/bjc201397a.PMC3629437.pdf
"Information on the prevalence of selected lifestyle factors for cancer and the use of CRC screening tests (colonoscopy and faecal occult blood testing) were derived from the 2009 California Health Interview Survey (CHIS) data using the askCHIS tool (http://ask.chis.ucla.edu/main/default.asp, access date: 17 February 2012).",OADS,/arxiv_data1/oa_pdf/8f/1e/bjc201397a.PMC3629437.pdf
"To view a copy of this license, visit http://creativecommons.org/licenses/by-nc-nd/3.0/ How to cite this article: Krumme, C., Llorente, A., Cebrian, M., Pentland, A.(S.)",Non-OADS,/arxiv_data1/oa_pdf/31/8b/srep01645.PMC3629735.pdf
Additional information Supplementary information accompanies this paper at http://www.nature.com/ scientificreports Competing financial interests: The authors declare no competing financial interests.,Non-OADS,/arxiv_data1/oa_pdf/1f/1b/srep01650.PMC3629736.pdf
"To view a copy of thislicense, visit http://creativecommons.org/licenses/by-nc-nd/3.0/ How to cite this article: Sun, Q., Haynes, K.F.",Non-OADS,/arxiv_data1/oa_pdf/1f/1b/srep01650.PMC3629736.pdf
Tremor Other Hyperkinet Mov 2013;3: http://tremorjournal.org/article/view/103 * To whom correspondence should be addressed.,Non-OADS,/arxiv_data1/oa_pdf/ca/39/tre-03-103-3713-1.PMC3629860.pdf
"1 Characterized as idiopathic and congenital, MEM has also been diagnosed in association with acoustic trauma, hemifacial spasm, andFreely available online Tremor and Other Hyperkinetic Movements http://www.tremorjournal.orgThe Center for Digital Research and ScholarshipColumbia University Libraries/Information Services1",Non-OADS,/arxiv_data1/oa_pdf/ca/39/tre-03-103-3713-1.PMC3629860.pdf
"The clicking remained the mostEllenstein A, Yusuf N, Hallett M Middle Ear Myoclonus: Perspective from Neurology Tremor and Other Hyperkinetic Movements http://www.tremorjournal.orgThe Center for Digital Research and ScholarshipColumbia University Libraries/Information Services2",Non-OADS,/arxiv_data1/oa_pdf/ca/39/tre-03-103-3713-1.PMC3629860.pdf
"Although not typicallydiscussed in the context of normal sound perception, the cochlea also has a second, pliable window in the middle ear, the oval window,Middle Ear Myoclonus: Perspective from Neurology Ellenstein A, Yusuf N, Hallett M Tremor and Other Hyperkinetic Movements http://www.tremorjournal.orgThe Center for Digital Research and ScholarshipColumbia University Libraries/Information Services3",Non-OADS,/arxiv_data1/oa_pdf/ca/39/tre-03-103-3713-1.PMC3629860.pdf
"(Modified from Gray’s Anatomy, plates 915, 907, 102879).Ellenstein A, Yusuf N, Hallett M Middle Ear Myoclonus: Perspective from Neurology Tremor and Other Hyperkinetic Movements http://www.tremorjournal.orgThe Center for Digital Research and ScholarshipColumbia University Libraries/Information Services4",Non-OADS,/arxiv_data1/oa_pdf/ca/39/tre-03-103-3713-1.PMC3629860.pdf
"While tensor tympani movement may cause some cases of MEM tinnitus 1,5,41and tensor veli palatini is widely cited as the primary muscle involved in EPT tinnitus,2,42,43movement of other palatal andMiddle Ear Myoclonus: Perspective from Neurology Ellenstein A, Yusuf N, Hallett M Tremor and Other Hyperkinetic Movements http://www.tremorjournal.orgThe Center for Digital Research and ScholarshipColumbia University Libraries/Information Services5",Non-OADS,/arxiv_data1/oa_pdf/ca/39/tre-03-103-3713-1.PMC3629860.pdf
"52Myoclonus can be evaluatedEllenstein A, Yusuf N, Hallett M Middle Ear Myoclonus: Perspective from Neurology Tremor and Other Hyperkinetic Movements http://www.tremorjournal.orgThe Center for Digital Research and ScholarshipColumbia University Libraries/Information Services6",Non-OADS,/arxiv_data1/oa_pdf/ca/39/tre-03-103-3713-1.PMC3629860.pdf
"Likewise, some cases of MEM tinnitus couldbe due to invoked physiologic tremor of the tensor tympani orstapedius muscles, which are located near the middle meningeal andMiddle Ear Myoclonus: Perspective from Neurology Ellenstein A, Yusuf N, Hallett M Tremor and Other Hyperkinetic Movements http://www.tremorjournal.orgThe Center for Digital Research and ScholarshipColumbia University Libraries/Information Services7",Non-OADS,/arxiv_data1/oa_pdf/ca/39/tre-03-103-3713-1.PMC3629860.pdf
"Rather than representing a single disorder, MEM tinnitus likely reflects aEllenstein A, Yusuf N, Hallett M Middle Ear Myoclonus: Perspective from Neurology Tremor and Other Hyperkinetic Movements http://www.tremorjournal.orgThe Center for Digital Research and ScholarshipColumbia University Libraries/Information Services8",Non-OADS,/arxiv_data1/oa_pdf/ca/39/tre-03-103-3713-1.PMC3629860.pdf
"Otolaryngol Head Neck Surg 2012;146:698– 706, doi: http://dx.doi.org/10.1177/0194599811434504.",Non-OADS,/arxiv_data1/oa_pdf/ca/39/tre-03-103-3713-1.PMC3629860.pdf
"Neurology 1991;41:1677–1679, doi: http://dx.doi.org/10.1212/WNL.41.10.1677.",Non-OADS,/arxiv_data1/oa_pdf/ca/39/tre-03-103-3713-1.PMC3629860.pdf
"Otolaryngol Head Neck Surg 2003;128:441, doi: http://dx.doi.org/10.",Non-OADS,/arxiv_data1/oa_pdf/ca/39/tre-03-103-3713-1.PMC3629860.pdf
"Dent Clin North Am 2007;51:225–243,viii–ix, doi: http://dx.doi.org/10.1016/j.cden.2006.",OADS,/arxiv_data1/oa_pdf/ca/39/tre-03-103-3713-1.PMC3629860.pdf
"Br J Oral Surg 1964;2:28–32, doi: http://dx.doi.org/10.1016/S0007-117X(64)80004-4.",OADS,/arxiv_data1/oa_pdf/ca/39/tre-03-103-3713-1.PMC3629860.pdf
"Clin Neurol Neurosurg 2011;113: 57–58, doi: http://dx.doi.org/10.1016/j.clineuro.2010.07.022.",OADS,/arxiv_data1/oa_pdf/ca/39/tre-03-103-3713-1.PMC3629860.pdf
"Parkinsonism Relat Disord 2007;13:254–256, doi: http://dx.doi.org/10.",Non-OADS,/arxiv_data1/oa_pdf/ca/39/tre-03-103-3713-1.PMC3629860.pdf
"Otol Neurotol 2003;24: 714–716, doi: http://dx.doi.org/10.1097/00129492-200309000-00003.",Non-OADS,/arxiv_data1/oa_pdf/ca/39/tre-03-103-3713-1.PMC3629860.pdf
"J Laryngol Otol 1987;101:1230–1234, doi: http://dx.doi.org/10.1017/S0022215100103573.",Non-OADS,/arxiv_data1/oa_pdf/ca/39/tre-03-103-3713-1.PMC3629860.pdf
"Hear Res 2005;206:200–226, doi: http://dx.doi.org/10.1016/j.heares.2005.02.013.",OADS,/arxiv_data1/oa_pdf/ca/39/tre-03-103-3713-1.PMC3629860.pdf
"Otol Neurotol 2007;28:178–184, doi: http://dx.doi.org/10.1097/MAO.",Non-OADS,/arxiv_data1/oa_pdf/ca/39/tre-03-103-3713-1.PMC3629860.pdf
"Neuropharmacology 2011;60:774–779, doi: http://dx.doi.org/ 10.1016/j.neuropharm.2010.12.021.",Non-OADS,/arxiv_data1/oa_pdf/ca/39/tre-03-103-3713-1.PMC3629860.pdf
"Neuron 2011;69: 33–43, doi: http://dx.doi.org/10.1016/j.neuron.2010.12.002.",OADS,/arxiv_data1/oa_pdf/ca/39/tre-03-103-3713-1.PMC3629860.pdf
"Curr Neurol Neurosci Rep 2001;1:492–499, doi: http://dx.doi.org/10.1007/s11910-001-0112-9.",Non-OADS,/arxiv_data1/oa_pdf/ca/39/tre-03-103-3713-1.PMC3629860.pdf
"doi.org/10.3988/jcn.2009.5.1.11.Middle Ear Myoclonus: Perspective from Neurology Ellenstein A, Yusuf N, Hallett M Tremor and Other Hyperkinetic Movements http://www.tremorjournal.orgThe Center for Digital Research and ScholarshipColumbia University Libraries/Information Services9",Non-OADS,/arxiv_data1/oa_pdf/ca/39/tre-03-103-3713-1.PMC3629860.pdf
"Acta Otorrinolaringol Esp 2007;58:426–433, doi: http://dx.doi.",Non-OADS,/arxiv_data1/oa_pdf/ca/39/tre-03-103-3713-1.PMC3629860.pdf
"Acta Otorrinolaringol Esp 2009;61:26–33, doi: http://dx.doi.",Non-OADS,/arxiv_data1/oa_pdf/ca/39/tre-03-103-3713-1.PMC3629860.pdf
"Trends Amplif 2010;14:170–191, doi: http://dx.doi.org/10.1177/1084713810381771.",OADS,/arxiv_data1/oa_pdf/ca/39/tre-03-103-3713-1.PMC3629860.pdf
"J Laryngol Otol 1986;100:529–531, doi: http://dx.doi.org/10.1017/ S002221510009962X.",Non-OADS,/arxiv_data1/oa_pdf/ca/39/tre-03-103-3713-1.PMC3629860.pdf
"Acta Otolaryngol 2002;122:504–509, doi: http://dx.doi.org/10.1080/ 00016480260092309.",Non-OADS,/arxiv_data1/oa_pdf/ca/39/tre-03-103-3713-1.PMC3629860.pdf
"IEEE Trans Biomed Eng 1990;37:525–531, doi: http://dx.doi.org/10.1109/10.55644.",OADS,/arxiv_data1/oa_pdf/ca/39/tre-03-103-3713-1.PMC3629860.pdf
"Br J Anaesth 2002;88:389–393, doi: http://dx.doi.org/10.1093/bja/88.3.389.",Non-OADS,/arxiv_data1/oa_pdf/ca/39/tre-03-103-3713-1.PMC3629860.pdf
"Korean J Otorhinolaryngol-Head Neck Surg 2010; 53:578–581, doi: http://dx.doi.org/10.3342/kjorl-hns.2010.53.9.578.",Non-OADS,/arxiv_data1/oa_pdf/ca/39/tre-03-103-3713-1.PMC3629860.pdf
"Bilateral objective tinnitus secondary to congenital middle-ear myoclonus.J Laryngol Otol 2005;119:489–491, doi: http://dx.doi.org/10.1258/002221505 4273223.",Non-OADS,/arxiv_data1/oa_pdf/ca/39/tre-03-103-3713-1.PMC3629860.pdf
"Mov Disord 1994;9:676–678, doi: http://dx.doi.org/10.1002/mds.870090615.44.Jamieson DR, Mann C, O’Reilly B, Thomas AM.",OADS,/arxiv_data1/oa_pdf/ca/39/tre-03-103-3713-1.PMC3629860.pdf
"Neurology 1996;46:1168– 1169, doi: http://dx.doi.org/10.1212/WNL.46.4.1168.",Non-OADS,/arxiv_data1/oa_pdf/ca/39/tre-03-103-3713-1.PMC3629860.pdf
"Brain 1994;117:775–788, doi: http://dx.doi.org/10.1093/brain/117.",Non-OADS,/arxiv_data1/oa_pdf/ca/39/tre-03-103-3713-1.PMC3629860.pdf
"Ther Adv Neurol Disord 2011;4:47–62, doi: http://dx.doi.org/10.1177/1756285610395653.",Non-OADS,/arxiv_data1/oa_pdf/ca/39/tre-03-103-3713-1.PMC3629860.pdf
"Mov Disord 1999;14:689–693, doi: http://dx.doi.",OADS,/arxiv_data1/oa_pdf/ca/39/tre-03-103-3713-1.PMC3629860.pdf
"Am J Otolaryngol 2008;31:91–95, doi: http://dx.doi.org/10.1016/j.amjoto.2008.11.",OADS,/arxiv_data1/oa_pdf/ca/39/tre-03-103-3713-1.PMC3629860.pdf
"Mov Disord 1998; 13:2–23, doi: http://dx.doi.org/10.1002/mds.870131303.",OADS,/arxiv_data1/oa_pdf/ca/39/tre-03-103-3713-1.PMC3629860.pdf
"Mov Disord 1998;13: 43–48, doi: http://dx.doi.org/10.1002/mds.870131308.",OADS,/arxiv_data1/oa_pdf/ca/39/tre-03-103-3713-1.PMC3629860.pdf
"Lancet Neurol 2004;3:598–607, doi: http://dx.doi.org/10.1016/ S1474-4422(04)00880-4.",Non-OADS,/arxiv_data1/oa_pdf/ca/39/tre-03-103-3713-1.PMC3629860.pdf
"Functional anatomy of the mandibular nerve: consequences of nerve injury and entrapment.Clin Anat 2011;24:143–150, doi: http://dx.doi.org/10.1002/ca.21089.",Non-OADS,/arxiv_data1/oa_pdf/ca/39/tre-03-103-3713-1.PMC3629860.pdf
"Int Rev Neurobiol 2007;79:621–631, doi: http://dx.doi.org/10.1016/S0074- 7742(07)79027-X.",OADS,/arxiv_data1/oa_pdf/ca/39/tre-03-103-3713-1.PMC3629860.pdf
"Otol Neurotol 2012;33:267–269, doi: http://dx.doi.org/10.1097/MAO.0b013e 318241c25d.",Non-OADS,/arxiv_data1/oa_pdf/ca/39/tre-03-103-3713-1.PMC3629860.pdf
"Ann Neurol 1978;4: 97–103, doi: http://dx.doi.org/10.1002/ana.410040202.",Non-OADS,/arxiv_data1/oa_pdf/ca/39/tre-03-103-3713-1.PMC3629860.pdf
"J Neurol Neurosurg Psychiatry 1986;49:58–63, doi: http://dx.doi.org/ 10.1136/jnnp.49.1.58.",Non-OADS,/arxiv_data1/oa_pdf/ca/39/tre-03-103-3713-1.PMC3629860.pdf
"Hum Mutat 2009;30:530–536, doi: http://dx.doi.org/10.1002/humu.",Non-OADS,/arxiv_data1/oa_pdf/ca/39/tre-03-103-3713-1.PMC3629860.pdf
"20925.Ellenstein A, Yusuf N, Hallett M Middle Ear Myoclonus: Perspective from Neurology Tremor and Other Hyperkinetic Movements http://www.tremorjournal.orgThe Center for Digital Research and ScholarshipColumbia University Libraries/Information Services10",Non-OADS,/arxiv_data1/oa_pdf/ca/39/tre-03-103-3713-1.PMC3629860.pdf
"J Neurol 2007;254:569–574, doi: http://dx.doi.org/10.1007/s00415-006-0348-z.",Non-OADS,/arxiv_data1/oa_pdf/ca/39/tre-03-103-3713-1.PMC3629860.pdf
"Eur Arch Otorhinolaryngol 2009;266: 137–141, doi: http://dx.doi.org/10.1007/s00405-008-0714-9.",Non-OADS,/arxiv_data1/oa_pdf/ca/39/tre-03-103-3713-1.PMC3629860.pdf
"Microsurgery 2010;30:565–568, doi: http://dx.doi.org/10.",Non-OADS,/arxiv_data1/oa_pdf/ca/39/tre-03-103-3713-1.PMC3629860.pdf
"Nat Rev Neurosci 2008;9:222–234, doi: http://dx.doi.org/10.1038/nrn2337.",Non-OADS,/arxiv_data1/oa_pdf/ca/39/tre-03-103-3713-1.PMC3629860.pdf
"Mov Disord 2011;26:958–967, doi: http://dx.doi.org/10.1002/mds.23572.",OADS,/arxiv_data1/oa_pdf/ca/39/tre-03-103-3713-1.PMC3629860.pdf
"Neurobiol Dis2011;42:177–184, doi: http://dx.doi.org/10.1016/j.nbd.2010.08.025.",OADS,/arxiv_data1/oa_pdf/ca/39/tre-03-103-3713-1.PMC3629860.pdf
"J Neurol Neurosurg Psychiatry 2011;82:892–898, doi: http://dx.doi.org/10.",Non-OADS,/arxiv_data1/oa_pdf/ca/39/tre-03-103-3713-1.PMC3629860.pdf
"Muscle Nerve 1996;19:431–437, doi: http://dx.doi.org/10.1002/mus.880190403.70.Ross MH, Charness ME, Lee D, Logigian EL.",OADS,/arxiv_data1/oa_pdf/ca/39/tre-03-103-3713-1.PMC3629860.pdf
"Muscle Nerve 1995;18:606–611, doi: http://dx.doi.",Non-OADS,/arxiv_data1/oa_pdf/ca/39/tre-03-103-3713-1.PMC3629860.pdf
"Fortschr Neurol Psychiatr 2007;75:331–342, doi: http://dx.doi.org/10.1055/s-2006-944310.",Non-OADS,/arxiv_data1/oa_pdf/ca/39/tre-03-103-3713-1.PMC3629860.pdf
"Parkinsonism Relat Disord 2009;15:592–597, doi: http://dx.doi.org/10.1016/j.parkreldis.2009.02.010.",OADS,/arxiv_data1/oa_pdf/ca/39/tre-03-103-3713-1.PMC3629860.pdf
"Curr Neurol Neurosci Rep 2006;6:269–271, doi: http://dx.doi.org/10.1007/s11910- 006-0015-x.",Non-OADS,/arxiv_data1/oa_pdf/ca/39/tre-03-103-3713-1.PMC3629860.pdf
"Mov Disord 2006;21:274–276, doi: http://dx.doi.org/10.1002/ mds.20731.",OADS,/arxiv_data1/oa_pdf/ca/39/tre-03-103-3713-1.PMC3629860.pdf
"Psychosomatics 2011;52:109–116, doi: http://dx.doi.org/10.1016/j.",OADS,/arxiv_data1/oa_pdf/ca/39/tre-03-103-3713-1.PMC3629860.pdf
"Mov Disord 2011;26: 1844–1850, doi: http://dx.doi.org/10.1002/mds.23830.",Non-OADS,/arxiv_data1/oa_pdf/ca/39/tre-03-103-3713-1.PMC3629860.pdf
"Philadelphia: Lea & Febiger; 1918. www.bartleby.com/107/.Middle Ear Myoclonus: Perspective from Neurology Ellenstein A, Yusuf N, Hallett M Tremor and Other Hyperkinetic Movements http://www.tremorjournal.orgThe Center for Digital Research and ScholarshipColumbia University Libraries/Information Services11",Non-OADS,/arxiv_data1/oa_pdf/ca/39/tre-03-103-3713-1.PMC3629860.pdf
Tremor Other Hyperkinet Mov 2013;3: http://tremorjournal.org/ article/view/147 * To whom correspondence should be addressed.,Non-OADS,/arxiv_data1/oa_pdf/2e/88/tre-03-147-3163-2.PMC3629861.pdf
"A synchronous tremor was registered in all three muscles, but itFreely available online Tremor and Other Hyperkinetic Movements http://www.tremorjournal.orgThe Center for Digital Research and ScholarshipColumbia University Libraries/Information Services1",Non-OADS,/arxiv_data1/oa_pdf/2e/88/tre-03-147-3163-2.PMC3629861.pdf
Slow orthostatic tremor Tremor and Other Hyperkinetic Movements http://www.tremorjournal.orgThe Center for Digital Research and ScholarshipColumbia University Libraries/Information Services2,Non-OADS,/arxiv_data1/oa_pdf/2e/88/tre-03-147-3163-2.PMC3629861.pdf
"Arch Neurol 1984;41:880–881, doi: http://dx.doi.org/10.1001/archneur.1984.04050190086020.",Non-OADS,/arxiv_data1/oa_pdf/2e/88/tre-03-147-3163-2.PMC3629861.pdf
"Mov Disord 2004;19:788–795, doi: http://dx.doi.org/10.1002/mds.20132.",OADS,/arxiv_data1/oa_pdf/2e/88/tre-03-147-3163-2.PMC3629861.pdf
"Mov Disord 2005;20: 1455–1461, doi: http://dx.doi.org/10.1002/mds.20588.",OADS,/arxiv_data1/oa_pdf/2e/88/tre-03-147-3163-2.PMC3629861.pdf
"Mov Disord 2012;27:1567–1569, doi: http://dx.doi.org/10.1002/mds.",OADS,/arxiv_data1/oa_pdf/2e/88/tre-03-147-3163-2.PMC3629861.pdf
"Mov Disord 2009;24:1550–1553, doi: http://dx.doi.org/10.",Non-OADS,/arxiv_data1/oa_pdf/2e/88/tre-03-147-3163-2.PMC3629861.pdf
"Acta Neurol Scand 1989;79:119–122, doi: http://dx.doi.org/10.1111/j.1600-0404.1989.tb03722.x.",OADS,/arxiv_data1/oa_pdf/2e/88/tre-03-147-3163-2.PMC3629861.pdf
"Mov Disord 2007;22:2063–2069, doi: http://dx.doi.org/10.1002/mds.21651.",OADS,/arxiv_data1/oa_pdf/2e/88/tre-03-147-3163-2.PMC3629861.pdf
"Neurology 2007;68:1826–1830, doi: http://dx.doi.org/10.1212/01.wnl.0000260225.46732.af.Slow orthostatic tremor Coffeng SM et al.",Non-OADS,/arxiv_data1/oa_pdf/2e/88/tre-03-147-3163-2.PMC3629861.pdf
Tremor and Other Hyperkinetic Movements http://www.tremorjournal.orgThe Center for Digital Research and ScholarshipColumbia University Libraries/Information Services3,Non-OADS,/arxiv_data1/oa_pdf/2e/88/tre-03-147-3163-2.PMC3629861.pdf
Tremor Other Hyperkinet Mov 2013;3: http://tremorjournal.org/article/view/140 * To whom correspondence should be addressed.,Non-OADS,/arxiv_data1/oa_pdf/68/51/tre-03-140-2921-1.PMC3629862.pdf
"5,6 The specific aim of this report is to compare symptom improvement and tolerability associated with a single injection of incobotulinumtoxinA forFreely available online Tremor and Other Hyperkinetic Movements http://www.tremorjournal.orgThe Center for Digital Research and ScholarshipColumbia University Libraries/Information Services1",Non-OADS,/arxiv_data1/oa_pdf/68/51/tre-03-140-2921-1.PMC3629862.pdf
"Among previously treated subjects, the mean improvements in TWSTRS total score at Week 4, Week 8, and the final visit was superior to that for placebo at all time points for both dose groups (Table 2 and Figure 2b).Fernandez HH, Pappert EJ, Comella CL IncobotulinumtoxinA Use in Cervical Dystonia Tremor and Other Hyperkinetic Movements http://www.tremorjournal.orgThe Center for Digital Research and ScholarshipColumbia University Libraries/Information Services2",Non-OADS,/arxiv_data1/oa_pdf/68/51/tre-03-140-2921-1.PMC3629862.pdf
"Table 1.Subjects’ Demographic and Baseline Cervical Dystonia Characteristics by Treatment Group and Treatment History (ITT Population) IncobotulinumtoxinA 120 U GroupIncobotulinumtoxinA 240 U GroupPlacebo Group Toxin- Naı¨ve N531Previously Treated 547Toxin-Naı ¨ve N531Previously Treated N 550Toxin- Naı¨ve N528Previously Treated N546 Sex, n (% of subgroup) Females 21 (67.7) 30 (63.8) 23 (74.2) 31 (62.0) 17 (60.7) 32 (69.6)Males 10 (32.3) 17 (36.2) 8 (25.8) 19 (38.0) 11 (39.3) 14 (30.4) Age, mean (SD) 50.9 (11.9) 54.0 (11.2) 50.9 (12.1) 54.7 (12.1) 51.5 (10.5) 53.0 (11) Race, n (% of subgroup) White 31 (100) 43 (91.5) 28 (90.3) 46 (92.0) 24 (85.7) 41 (89.1) Hispanic or Latino 0 3 (6.4) 2 (6.5) 3 (6.0) 2 (7.1) 0 Black 0 0 1 (3.2) 1 (2.0) 2 (7.1) 2 (4.3)Other 0 1 (2.1) 0 0 0 3 (6.5) Weight (lb), median 161.9 191.0 158.1 161.0 165.0 164.0 BMI (kg/m 2), median 24.7 28.7 24.7 24.3 27.4 26.8 Estimated duration of CD (months), median72.0 92.0 60.0 102.0 60.0 122.5 Toxin injections since first diagnosis, (number) mean (SD)n/a 13.3 (12.4) n/a 17.7 (17.1) n/a 15.5 (11.4) Time since most recent toxin injection (months), mediann/a 3.6 n/a 4.0 n/a 3.9 Botulinum toxin type and mean doses of last injection prior to study entry OnabotulinumtoxinA Mean (SD) 219.4 (74.4) 222.8 (78.3) 232.5 (72.4) #120 U n/a 7 (17.5) n/a 6 (14.0) n/a 4 (10.5) .120 U to 180 U n/a 3 (7.5) n/a 3 (7.0) n/a 4 (10.5) .180 U n/a 30 (75.0) n/a 34 (79.1) n/a 30 (79.0) RimabotulinumtoxinB Mean (SD) 12000 (500) 10875 (2250.0) 10200 (2049.4) #6,000 U n/a 0 n/a 0 n/a 0 .6,000 U to 12,000 U n/a 2 (66.7) n/a 4 (100.0) n/a 5 (100.0) .12,000 U n/a 1 (33.3) n/a 0 n/a 0IncobotulinumtoxinA Use in Cervical Dystonia Fernandez HH, Pappert EJ, Comella CL Tremor and Other Hyperkinetic Movements http://www.tremorjournal.orgThe Center for Digital Research and ScholarshipColumbia University Libraries/Information Services3",Non-OADS,/arxiv_data1/oa_pdf/68/51/tre-03-140-2921-1.PMC3629862.pdf
"Figure 1.Subject Disposition.Fernandez HH, Pappert EJ, Comella CL IncobotulinumtoxinA Use in Cervical Dystonia Tremor and Other Hyperkinetic Movements http://www.tremorjournal.orgThe Center for Digital Research and ScholarshipColumbia University Libraries/Information Services4",Non-OADS,/arxiv_data1/oa_pdf/68/51/tre-03-140-2921-1.PMC3629862.pdf
"Placebo 0.006 0.035 0.185 ,0.001 n/a n/a 120 U vs. 240 U 0.215 0.397 n/a n/a n/a n/aIncobotulinumtoxinA Use in Cervical Dystonia Fernandez HH, Pappert EJ, Comella CL Tremor and Other Hyperkinetic Movements http://www.tremorjournal.orgThe Center for Digital Research and ScholarshipColumbia University Libraries/Information Services5",Non-OADS,/arxiv_data1/oa_pdf/68/51/tre-03-140-2921-1.PMC3629862.pdf
"Previously Toxin-Treated Subjects.ap,0.05 treatment group versus placebo;bp.0.05 120 U versus 240 U;cp,0.05 120 U versus 240 U; p-value: Analysis of Covariance (ANCOVA) – change from baseline in TWSTRS total score; missing values replaced by baseline value [full model].Fernandez HH, Pappert EJ, Comella CL IncobotulinumtoxinA Use in Cervical Dystonia Tremor and Other Hyperkinetic Movements http://www.tremorjournal.orgThe Center for Digital Research and ScholarshipColumbia University Libraries/Information Services6",Non-OADS,/arxiv_data1/oa_pdf/68/51/tre-03-140-2921-1.PMC3629862.pdf
"Abbreviations: N/n, total subject population/subset of total subject population; %, percentage; U, units.IncobotulinumtoxinA Use in Cervical Dystonia Fernandez HH, Pappert EJ, Comella CL Tremor and Other Hyperkinetic Movements http://www.tremorjournal.orgThe Center for Digital Research and ScholarshipColumbia University Libraries/Information Services7",Non-OADS,/arxiv_data1/oa_pdf/68/51/tre-03-140-2921-1.PMC3629862.pdf
"Mov Disord 1988;3:188–194, http://dx.doi.org/10.1002/mds.870030302.",OADS,/arxiv_data1/oa_pdf/68/51/tre-03-140-2921-1.PMC3629862.pdf
"Phys Ther 2007;87:1511–1526, http://dx.doi.org/10.2522/ptj.20060272.",Non-OADS,/arxiv_data1/oa_pdf/68/51/tre-03-140-2921-1.PMC3629862.pdf
"Eur J Neurol 2011;18:5–18, http://dx.doi.org/ 10.1111/j.1468-1331.2010.03042.x.",Non-OADS,/arxiv_data1/oa_pdf/68/51/tre-03-140-2921-1.PMC3629862.pdf
"Neurology 2006;67:2230–2232, http://dx.doi.org/10.1212/01.wnl.0000249310.25427.f2.",Non-OADS,/arxiv_data1/oa_pdf/68/51/tre-03-140-2921-1.PMC3629862.pdf
"Toxicon 2009;54:697– 701, http://dx.doi.org/10.1016/j.toxicon.2009.03.010.",OADS,/arxiv_data1/oa_pdf/68/51/tre-03-140-2921-1.PMC3629862.pdf
"J Neurol Sci 2011;308:103–109, http://dx.doi.org/10.1016/j.jns.2011.05.041.",OADS,/arxiv_data1/oa_pdf/68/51/tre-03-140-2921-1.PMC3629862.pdf
"Management of spasticity associated pain with botulinum toxin A. J Pain Symptom Manage 2000;20:44–49, http://dx.doi.org/10.1016/S0885-3924(00)00146-9.",Non-OADS,/arxiv_data1/oa_pdf/68/51/tre-03-140-2921-1.PMC3629862.pdf
"Mov Disord 2012; under consideration.Fernandez HH, Pappert EJ, Comella CL IncobotulinumtoxinA Use in Cervical Dystonia Tremor and Other Hyperkinetic Movements http://www.tremorjournal.orgThe Center for Digital Research and ScholarshipColumbia University Libraries/Information Services8",Non-OADS,/arxiv_data1/oa_pdf/68/51/tre-03-140-2921-1.PMC3629862.pdf
"Kang, M. LeDoux, K. Levin, P. LeWitt, A. Nicholas, R.Rodnitzky, A. Sahay, H. Schwartz, B. Scott, K. Sethi, J. Shahed,D .S i l v e r ,C .S i n g e r ,L .S t r u c k ,W .S u n t e r ,D .T r u o n g ,A .V a s q u e z ,M. Watts.IncobotulinumtoxinA Use in Cervical Dystonia Fernandez HH, Pappert EJ, Comella CL Tremor and Other Hyperkinetic Movements http://www.tremorjournal.orgThe Center for Digital Research and ScholarshipColumbia University Libraries/Information Services9",Non-OADS,/arxiv_data1/oa_pdf/68/51/tre-03-140-2921-1.PMC3629862.pdf
Tremor Other Hyperkinet Mov 2013;3: http://tremorjournal.org/article/view/152 * To whom correspondence should be addressed.,Non-OADS,/arxiv_data1/oa_pdf/7e/fa/tre-03-152-3638-4.PMC3629863.pdf
"9,10Freely available online Tremor and Other Hyperkinetic Movements http://www.tremorjournal.orgThe Center for Digital Research and ScholarshipColumbia University Libraries/Information Services1",Non-OADS,/arxiv_data1/oa_pdf/7e/fa/tre-03-152-3638-4.PMC3629863.pdf
"Over the next 18 years, several studiesemployed VBM to attempt to verify these findings and further probeTable 1.Dystonia Classification Classification Body of distribution Focal Segmental Generalized Age of onset Early onset ( ,26 years of age) Late onset ( ,30–50 years of age) Etiology Primary torsion +/ 2tremor SecondaryDystonia-plus syndrome Heredodegenerative Feature of another neurological conditionRamdhani RA, Simonyan K. Structural imaging of primary dystonia Tremor and Other Hyperkinetic Movements http://www.tremorjournal.orgThe Center for Digital Research and ScholarshipColumbia University Libraries/Information Services2",Non-OADS,/arxiv_data1/oa_pdf/7e/fa/tre-03-152-3638-4.PMC3629863.pdf
"When the VBM processing steps with the use of SPM8 software were held constant, an increase in theStructural imaging of primary dystonia Ramdhani RA, Simonyan K. Tremor and Other Hyperkinetic Movements http://www.tremorjournal.orgThe Center for Digital Research and ScholarshipColumbia University Libraries/Information Services3",Non-OADS,/arxiv_data1/oa_pdf/7e/fa/tre-03-152-3638-4.PMC3629863.pdf
"- Putamen --- SD Simonyan and Ludlow 201240 (25 AD, 15 AB)56.9 L. M1/S1, supramarginal gyrus, putamen, R. IFG, B/L CBLPos.- R. IFG, L. CBL NR HD Egger et al., 2007 9 (DYT1) 39.8 R GP --- --- Draganski et al., 200922 DYT1 (11 MN, 11NMN)B/L putamen (NMN.MN)Inv., putamen Abbreviations: AB, abductor; ACC, anterior cingulate cortex; AD, adductor; B/L, bilateral; Caud, caudate nucleus; CBL, cerebellum; IFG, inferior frontal gyrus; G P, globus pallidus; M1, primary motor cortex; MN, manifesting; MD, musician’s dystonia; NMN, non-manifesting; Inf., inferior; Inv., inverse; NR, no relationship; STL, superior t emporal lobe; STG, superior temporal gyrus; S1, primary somatosensory cortex; OFC, orbitofrontal cortex; OC, occipital cortex; RH, right-handed; Pos., positive; WC, writer’s cramp; L, left; R, right; (- --), no dataRamdhani RA, Simonyan K. Structural imaging of primary dystonia Tremor and Other Hyperkinetic Movements http://www.tremorjournal.orgThe Center for Digital Research and ScholarshipColumbia University Libraries/Information Services4",Non-OADS,/arxiv_data1/oa_pdf/7e/fa/tre-03-152-3638-4.PMC3629863.pdf
"The color bar representsFvalues and reflects the significance of changes in patients compared to controls.Structural imaging of primary dystonia Ramdhani RA, Simonyan K. Tremor and Other Hyperkinetic Movements http://www.tremorjournal.orgThe Center for Digital Research and ScholarshipColumbia University Libraries/Information Services5",Non-OADS,/arxiv_data1/oa_pdf/7e/fa/tre-03-152-3638-4.PMC3629863.pdf
"The red arrows indicate the over-segmented primary motor cor tex and basal ganglia.Ramdhani RA, Simonyan K. Structural imaging of primary dystonia Tremor and Other Hyperkinetic Movements http://www.tremorjournal.orgThe Center for Digital Research and ScholarshipColumbia University Libraries/Information Services6",Non-OADS,/arxiv_data1/oa_pdf/7e/fa/tre-03-152-3638-4.PMC3629863.pdf
"Ex vivo DTI revealed reduced FA in the superior cerebellar tract, the white matter underlying theStructural imaging of primary dystonia Ramdhani RA, Simonyan K. Tremor and Other Hyperkinetic Movements http://www.tremorjournal.orgThe Center for Digital Research and ScholarshipColumbia University Libraries/Information Services7",Non-OADS,/arxiv_data1/oa_pdf/7e/fa/tre-03-152-3638-4.PMC3629863.pdf
"- MD in Thal.--- HD Carbon et al., 200412 (DYT1) 44.1 Dec. SMC --- --- Carbon et al., 20087 (4 DYT1, 3 DYT6)29.3 Dec. – Dorsal pontine BS, SMC, --- --- --- Cheng et al., 20126 (DYT6) Dec. - SMC Inc. – SLF and CST --- --- Van de Meer et al., 201216 (DYT11)43.5 Inc. – R. STN, RN Dec. –subgyral SMC; STN --- --- Abbreviations: BS, brainstem; BLS, blepharospasm; Caud., caudate; CD, cervical dystonia; CC, corpus callosum; CR, corona radiata; Dec., decreased; FHD, focal han d dystonia; HD, hereditary dystonia; IC, internal capsule; Inc., increased; NR, no relationship; NS, no significance; Ped, peduncle; PFC, prefrontal cortex; RN, red nucleus; SD, spasmodic dysphonia; SMA–supplementary motor area; SMC, sensorimotor cortices; SLF, superior longitudinal fasciculus; STN, subthalamic nucleus; Thal., thalamus; (---), no data.Ramdhani RA, Simonyan K. Structural imaging of primary dystonia Tremor and Other Hyperkinetic Movements http://www.tremorjournal.orgThe Center for Digital Research and ScholarshipColumbia University Libraries/Information Services8",Non-OADS,/arxiv_data1/oa_pdf/7e/fa/tre-03-152-3638-4.PMC3629863.pdf
"Nat Rev Neurosci 2008;9:222–234, doi: http://dx.doi.org/10.1038/nrn2337.",Non-OADS,/arxiv_data1/oa_pdf/7e/fa/tre-03-152-3638-4.PMC3629863.pdf
"Lancet Neurol 2006;5: 780–790, doi: http://dx.doi.org/10.1016/S1474-4422(06)70547-6.",Non-OADS,/arxiv_data1/oa_pdf/7e/fa/tre-03-152-3638-4.PMC3629863.pdf
"N Engl J Med 2006;355:818–829, doi: http://dx.doi.org/10.1056/NEJMra055549.",OADS,/arxiv_data1/oa_pdf/7e/fa/tre-03-152-3638-4.PMC3629863.pdf
"Mov Disord 2011;26:947– 957, doi: http://dx.doi.org/10.1002/mds.23759.",OADS,/arxiv_data1/oa_pdf/7e/fa/tre-03-152-3638-4.PMC3629863.pdf
"Lancet Neurol 2002;1:316–325, doi: http://dx.doi.org/10.1016/S1474- 4422(02)00137-0.",Non-OADS,/arxiv_data1/oa_pdf/7e/fa/tre-03-152-3638-4.PMC3629863.pdf
"Nat Genet 2013;45:88–92, doi: http://dx.doi.org/10.",Non-OADS,/arxiv_data1/oa_pdf/7e/fa/tre-03-152-3638-4.PMC3629863.pdf
"Ann Neurol 2012;71:458–469, doi: http://dx.doi.org/ 10.1002/ana.23547.",Non-OADS,/arxiv_data1/oa_pdf/7e/fa/tre-03-152-3638-4.PMC3629863.pdf
"Brain 1985;108:463–483, doi: http://dx.doi.org/ 10.1093/brain/108.2.463.",Non-OADS,/arxiv_data1/oa_pdf/7e/fa/tre-03-152-3638-4.PMC3629863.pdf
"Mov Disord 2002;17:S49–S62, doi: http://dx.doi.org/10.1002/mds.10142.",OADS,/arxiv_data1/oa_pdf/7e/fa/tre-03-152-3638-4.PMC3629863.pdf
"Ann Neurol 2004;56:595–599, doi: http://dx.doi.org/10.1002/ana.",OADS,/arxiv_data1/oa_pdf/7e/fa/tre-03-152-3638-4.PMC3629863.pdf
"Neurobiol Dis2011;42:177–184, doi: http://dx.doi.org/10.1016/j.nbd.2010.08.025.",OADS,/arxiv_data1/oa_pdf/7e/fa/tre-03-152-3638-4.PMC3629863.pdf
"Brain 2003;126:2586–2596, doi: http://dx.doi.org/10.1093/brain/awg273.Structural imaging of primary dystonia Ramdhani RA, Simonyan K. Tremor and Other Hyperkinetic Movements http://www.tremorjournal.orgThe Center for Digital Research and ScholarshipColumbia University Libraries/Information Services9",Non-OADS,/arxiv_data1/oa_pdf/7e/fa/tre-03-152-3638-4.PMC3629863.pdf
"Mov Disord 2003;18:605–622, doi: http://dx.doi.org/10.",OADS,/arxiv_data1/oa_pdf/7e/fa/tre-03-152-3638-4.PMC3629863.pdf
"Brain 2010;133: 690–700, doi: http://dx.doi.org/10.1093/brain/awq017.",OADS,/arxiv_data1/oa_pdf/7e/fa/tre-03-152-3638-4.PMC3629863.pdf
"Lancet Neurol 2011;10:1074–1085, doi: http://dx.doi.org/10.1016/S1474- 4422(11)70232-0.",Non-OADS,/arxiv_data1/oa_pdf/7e/fa/tre-03-152-3638-4.PMC3629863.pdf
"J Neurosci 2009;29:9740–9747, doi: http://dx.doi.org/10.1523/JNEUROSCI.2300-09.2009.",Non-OADS,/arxiv_data1/oa_pdf/7e/fa/tre-03-152-3638-4.PMC3629863.pdf
"NeuroImage 1995;2:244–252, doi: http://dx.doi.org/10.1006/ nimg.1995.1032.",Non-OADS,/arxiv_data1/oa_pdf/7e/fa/tre-03-152-3638-4.PMC3629863.pdf
"NeuroImage 2000;11:805–821, doi: http://dx.doi.org/10.1006/nimg.2000.",OADS,/arxiv_data1/oa_pdf/7e/fa/tre-03-152-3638-4.PMC3629863.pdf
"NeuroImage 2001;14:21–36, doi: http://dx.doi.org/10.",Non-OADS,/arxiv_data1/oa_pdf/7e/fa/tre-03-152-3638-4.PMC3629863.pdf
"NeuroImage 2001;13:623–631, doi: http://dx.doi.org/10.1006/nimg.2000.0734.",OADS,/arxiv_data1/oa_pdf/7e/fa/tre-03-152-3638-4.PMC3629863.pdf
"NeuroImage 2005;26:839– 851, doi: http://dx.doi.org/10.1016/j.neuroimage.2005.02.018.",OADS,/arxiv_data1/oa_pdf/7e/fa/tre-03-152-3638-4.PMC3629863.pdf
"NeuroImage 1997;6:209–217, doi: http://dx.doi.org/ 10.1006/nimg.1997.0290.",Non-OADS,/arxiv_data1/oa_pdf/7e/fa/tre-03-152-3638-4.PMC3629863.pdf
"Neurology 1998;51:819–824, doi: http://dx.doi.org/10.1212/WNL.51.",Non-OADS,/arxiv_data1/oa_pdf/7e/fa/tre-03-152-3638-4.PMC3629863.pdf
"J Neurol Neurosurg Psychiatry 2006;77: 1017–1020, doi: http://dx.doi.org/10.1136/jnnp.2005.087148.",Non-OADS,/arxiv_data1/oa_pdf/7e/fa/tre-03-152-3638-4.PMC3629863.pdf
"Mov Disord 2007;22:1117–1123, doi: http://dx.doi.org/10.1002/mds.21495.",OADS,/arxiv_data1/oa_pdf/7e/fa/tre-03-152-3638-4.PMC3629863.pdf
"Mov Disord 2011;26:1907–1912, doi: http://dx.doi.org/10.1002/mds.23724.",Non-OADS,/arxiv_data1/oa_pdf/7e/fa/tre-03-152-3638-4.PMC3629863.pdf
"Transl Neurodegener 2012;1:12, doi: http://dx.doi.org/10.1186/2047-9158-1-12.",Non-OADS,/arxiv_data1/oa_pdf/7e/fa/tre-03-152-3638-4.PMC3629863.pdf
"Neurology 2003; 61:1228–1231, doi: http://dx.doi.org/10.1212/01.WNL.0000094240.93745.83.",Non-OADS,/arxiv_data1/oa_pdf/7e/fa/tre-03-152-3638-4.PMC3629863.pdf
"NeuroImage 2009;47:1141–1147, doi: http://dx.doi.org/10.1016/j.",OADS,/arxiv_data1/oa_pdf/7e/fa/tre-03-152-3638-4.PMC3629863.pdf
"Ann Neurol 2004;55:736–739, doi: http://dx.doi.org/10.1002/ana.20113.",OADS,/arxiv_data1/oa_pdf/7e/fa/tre-03-152-3638-4.PMC3629863.pdf
"Mov Disord 2007;22:1538– 1542, doi: http://dx.doi.org/10.1002/mds.21619.",OADS,/arxiv_data1/oa_pdf/7e/fa/tre-03-152-3638-4.PMC3629863.pdf
"Neurology 2007;69:376– 380, doi: http://dx.doi.org/10.1212/01.wnl.0000266591.49624.1a.",Non-OADS,/arxiv_data1/oa_pdf/7e/fa/tre-03-152-3638-4.PMC3629863.pdf
"Cereb Cortex 2012;22:417–425, doi: http://dx.doi.org/10.",OADS,/arxiv_data1/oa_pdf/7e/fa/tre-03-152-3638-4.PMC3629863.pdf
"Ann NY Acad Sci 2009;1156:260–293, doi: http://dx.doi.org/10.1111/j.1749-6632.2009.04420.x.",OADS,/arxiv_data1/oa_pdf/7e/fa/tre-03-152-3638-4.PMC3629863.pdf
"Nature 2004;427: 311–312, doi: http://dx.doi.org/10.1038/427311a.",Non-OADS,/arxiv_data1/oa_pdf/7e/fa/tre-03-152-3638-4.PMC3629863.pdf
"NeuroImage 2009;48:585–589, doi: http://dx.doi.org/10.1016/j.neuroimage.2009.07.009.",OADS,/arxiv_data1/oa_pdf/7e/fa/tre-03-152-3638-4.PMC3629863.pdf
"NeuroImage 2011;54:32– 41, doi: http://dx.doi.org/10.1016/j.neuroimage.2010.08.013.",OADS,/arxiv_data1/oa_pdf/7e/fa/tre-03-152-3638-4.PMC3629863.pdf
"Nature 2004;431:782–788, doi: http://dx.doi.org/10.1038/ nature03012.",Non-OADS,/arxiv_data1/oa_pdf/7e/fa/tre-03-152-3638-4.PMC3629863.pdf
"Science 2005;310:805–810, doi: http://dx.doi.org/10.1126/science.1112070.",Non-OADS,/arxiv_data1/oa_pdf/7e/fa/tre-03-152-3638-4.PMC3629863.pdf
"47.Holtmaat A, Wilbrecht L, Knott GW, Welker E, Svoboda K. Experience-dependent and cell-type-specific spine growth in the neocortex.Nature 2006;441:979–983, doi: http://dx.doi.org/10.1038/nature04783.",OADS,/arxiv_data1/oa_pdf/7e/fa/tre-03-152-3638-4.PMC3629863.pdf
"NeuroImage 2001;14:723–735, doi: http://dx.doi.org/10.1006/nimg.2001.0861.Ramdhani RA, Simonyan K. Structural imaging of primary dystonia Tremor and Other Hyperkinetic Movements http://www.tremorjournal.orgThe Center for Digital Research and ScholarshipColumbia University Libraries/Information Services10",Non-OADS,/arxiv_data1/oa_pdf/7e/fa/tre-03-152-3638-4.PMC3629863.pdf
"Magn Reson Med 1994;31:394–400, doi: http://dx.doi.org/10.1002/ mrm.1910310408.",Non-OADS,/arxiv_data1/oa_pdf/7e/fa/tre-03-152-3638-4.PMC3629863.pdf
"Neurotherapeutics 2007;4:316–329, doi: http://dx.doi.org/10.1016/j.",OADS,/arxiv_data1/oa_pdf/7e/fa/tre-03-152-3638-4.PMC3629863.pdf
"J Neurol Neurosurg Psychiatry 2005;76:1591–1593, doi: http://dx.doi.org/10.1136/jnnp.2004.",Non-OADS,/arxiv_data1/oa_pdf/7e/fa/tre-03-152-3638-4.PMC3629863.pdf
"Eur J Neurol 2008;15:185–189, doi: http://dx.doi.org/10.1111/j.1468-1331.2007.",Non-OADS,/arxiv_data1/oa_pdf/7e/fa/tre-03-152-3638-4.PMC3629863.pdf
"Mov Disord 2007;22:1110– 1116, doi: http://dx.doi.org/10.1002/mds.21295.",OADS,/arxiv_data1/oa_pdf/7e/fa/tre-03-152-3638-4.PMC3629863.pdf
"PLOS ONE 2012;7:e31654, doi: http://dx.doi.org/10.1371/journal.pone.0031654.",Non-OADS,/arxiv_data1/oa_pdf/7e/fa/tre-03-152-3638-4.PMC3629863.pdf
"Arch Neurol 2009;66: 502–508, doi: http://dx.doi.org/10.1001/archneurol.2009.8.",Non-OADS,/arxiv_data1/oa_pdf/7e/fa/tre-03-152-3638-4.PMC3629863.pdf
"Brain 2008;131:447–459, doi: http://dx.doi.org/10.1093/ brain/awm303.",Non-OADS,/arxiv_data1/oa_pdf/7e/fa/tre-03-152-3638-4.PMC3629863.pdf
"Ann Neurol 2004;56:283–286, doi: http://dx.doi.org/10.1002/ana.20177.",OADS,/arxiv_data1/oa_pdf/7e/fa/tre-03-152-3638-4.PMC3629863.pdf
"Mov Disord 2008;23:234–239, doi: http://dx.doi.org/10.1002/mds.21806.60.Cheng FB, Wan XH, Feng JC, et al.",OADS,/arxiv_data1/oa_pdf/7e/fa/tre-03-152-3638-4.PMC3629863.pdf
"Subcellular distribution of THAP1 and alterations in the microstructure of brain white matter in DYT6 dystonia.Parkinsonism Relat Disord 2012;18:978–982, doi: http://dx.doi.org/10.1016/j.",Non-OADS,/arxiv_data1/oa_pdf/7e/fa/tre-03-152-3638-4.PMC3629863.pdf
"Brain 2011;134:1416–1427, doi: http://dx.doi.org/10.1093/brain/awr060.",Non-OADS,/arxiv_data1/oa_pdf/7e/fa/tre-03-152-3638-4.PMC3629863.pdf
"Mov Disord 2012;27:1666–1672, doi: http://dx.doi.org/10.1002/mds.",OADS,/arxiv_data1/oa_pdf/7e/fa/tre-03-152-3638-4.PMC3629863.pdf
"Ann Neurol 1995;38:139–140, doi: http://dx.doi.org/10.1002/ana.410380203.",Non-OADS,/arxiv_data1/oa_pdf/7e/fa/tre-03-152-3638-4.PMC3629863.pdf
"Brain 2009;132:2327–2335, doi: http://dx.doi.org/10.1093/brain/ awp156.",Non-OADS,/arxiv_data1/oa_pdf/7e/fa/tre-03-152-3638-4.PMC3629863.pdf
"J Neuroscience 2006;26:716–721, doi: http://dx.doi.org/10.1523/ JNEUROSCI.3948-05.2006.",Non-OADS,/arxiv_data1/oa_pdf/7e/fa/tre-03-152-3638-4.PMC3629863.pdf
"Neurobiol Dis 2011;42:202–209, doi: http://dx.doi.org/10.1016/j.nbd.",OADS,/arxiv_data1/oa_pdf/7e/fa/tre-03-152-3638-4.PMC3629863.pdf
"Neurobiol Dis 2011; 42:148–151, doi: http://dx.doi.org/10.1016/j.nbd.2011.01.012.Structural imaging of primary dystonia Ramdhani RA, Simonyan K. Tremor and Other Hyperkinetic Movements http://www.tremorjournal.orgThe Center for Digital Research and ScholarshipColumbia University Libraries/Information Services11",Non-OADS,/arxiv_data1/oa_pdf/7e/fa/tre-03-152-3638-4.PMC3629863.pdf
Tremo r Other Hyperkinet Mov 2013;3: http://tremorjournal.org/article/view/150 * To whom correspondence should be addressed.,Non-OADS,/arxiv_data1/oa_pdf/4f/5c/tre-03-150-3598-2.PMC3629864.pdf
"Statistical significance was set at p ,0.05.Freely available online Tremor and Other Hyperkinetic Movements http://www.tremorjournal.orgThe Center for Digital Research and ScholarshipColumbia University Libraries/Information Services1",Non-OADS,/arxiv_data1/oa_pdf/4f/5c/tre-03-150-3598-2.PMC3629864.pdf
"Although idiopathic PD cannotTable 1.Comparison of the Clinical Characteristics between the Two Groups Developed Parkinsonism (n510)Did Not Develop Parkinsonism (n512)p Value Leg dystonia with levodopa response 7 (70%) 2 (16%) 0.02 Family history of Parkinson’s disease or tremor5 (50%) 3 (25%) 0.22 Type of dystonia (action/rest) 7 (70%)/3 (30%) 7 (58%)/5 (42%) 0.57 Gender (F/M) 9 (90%)/1 (10%) 8 (66%)/4 (33%) 0.19 Age of onset (years; range) 49 (22–75) 53 (31–71) 0.59 Table 2.Summary of the Clinical Characteristics between the Two Groups Developed Parkinsonism (n510)Did Not Develop Parkinsonism (n512) Median follow-up period (years; range) 2 (0.5–22) 1 (0.5–9) Median time from leg dystonia onset to Parkinsonism (years; range) 1 (0.5–3) NA Median effective levodopa dose (mg; range) 600 (350–800) NA Developed corticobasal syndrome 2 0Chang FCF, Josephs KA Levdopa, Adult-onset Lower Limb Dystonia and PD Tremor and Other Hyperkinetic Movements http://www.tremorjournal.orgThe Center for Digital Research and ScholarshipColumbia University Libraries/Information Services2",Non-OADS,/arxiv_data1/oa_pdf/4f/5c/tre-03-150-3598-2.PMC3629864.pdf
"Table 3.Data Collected From All Subjects Case Develop PD (Time to Diagnosis)Develop Corticobasal Syndrome (Time to Diagnosis)Age OnsetType Sex Levodopa Response (Dose per Day)Anticholinergic Response?Family History of PD or Tremor?Years of Follow- upResponse to Other Medications/Other 1 No No 59 Action F No (75 mg) Not tried No 9 2 No No 55 Rest M No Not tried No 3 3 No No 64 Action F No No No 5 Responded to baclofen but not to clonazepam 4 No No 71 Rest F No (1500 mg)No No 1 Responded to botulinum toxin Ainjection 5 No No 31 Action F No (750 mg) Yes (12 mg) No 0.56 No No 57 Rest F No (300 mg) Not tried No 8 Responded to pramipexole 1 mg/day,baclofen and botulinumtoxin A injection 7 No No 63 Rest M No Not tried Yes 18 No No 43 Action M No (300 mg) Not tried No 0.5 Long distance runner 9 No No 40 Action F Yes (300 mg) Not tried No 2 Long distance runner 10 No No 36 Action F No (600 mg) Not tried No 2 Long distance runner11 No No 61 Action M No (900 mg) Not tried Yes 1 12 No No 55 Rest F Yes (750 mg) Not tried No 1 Responded to ropinirole 13 No Yes (8 years) 37 Action F No (750 mg) Yes No 814 No Yes (2 years) 60 Rest F No Not tried No 2 Did not respond botulinum toxin Ainjection 15 Yes (0.5 years later)No 22 Rest F Yes (800 mg) Not tried Yes 0.5Levdopa, Adult-onset Lower Limb Dystonia and PD Chang FCF, Josephs KA Tremor and Other Hyperkinetic Movements http://www.tremorjournal.orgThe Center for Digital Research and ScholarshipColumbia University Libraries/Information Services3",Non-OADS,/arxiv_data1/oa_pdf/4f/5c/tre-03-150-3598-2.PMC3629864.pdf
"Table 3.Continued Case Develop PD (Time to Diagnosis)Develop Corticobasal Syndrome (Time to Diagnosis)Age OnsetType Sex Levodopa Response (Dose per Day)Anticholinergic Response?Family History of PD or Tremor?Years of Follow- upResponse to Other Medications/Other 16 Yes (0.5 years later)No 51 Action M Yes (750 mg) Not tried No 11 Responded to botulinum toxin A injection 17 Yes (1 year later)No 73 Rest F Yes (600 mg) Not tried Yes 2 Responded to clonazepam, no benefitbaclofen 30 mg 18 Yes (1 year later)No 41 Action F Not tried Not tried No 1 19 Yes (2 years later)No 75 Action F Yes (300 mg) Not tried No 8 20 Yes (2 years)No 43 Action F Yes (600 mg) Not tried Yes 1 21 Yes (2 years)No 45 Action F Yes (500 mg) Yes (4 mg) Yes 2 Did not respond baclofen 60 mg 22 Yes (3 years later)No 43 Action F Yes (750 mg) Not tried Yes 22 Responded to pramipexole 3 mg Abbreviations: PD, Parkinson’s Disease.Chang FCF, Josephs KA Levdopa, Adult-onset Lower Limb Dystonia and PD Tremor and Other Hyperkinetic Movements http://www.tremorjournal.orgThe Center for Digital Research and ScholarshipColumbia University Libraries/Information Services4",Non-OADS,/arxiv_data1/oa_pdf/4f/5c/tre-03-150-3598-2.PMC3629864.pdf
"Neurology 1987;37:1009–1011, doi: http://dx.doi.org/10.1212/WNL.",Non-OADS,/arxiv_data1/oa_pdf/4f/5c/tre-03-150-3598-2.PMC3629864.pdf
"Parkinsonism Relat Disord 2008;14:613–619, doi: http://dx.doi.org/10.1016/j.parkreldis.2008.01.012.",OADS,/arxiv_data1/oa_pdf/4f/5c/tre-03-150-3598-2.PMC3629864.pdf
"Mov Disord 2006;21:767–771, doi: http://dx.doi.org/10.1002/ mds.20794.",OADS,/arxiv_data1/oa_pdf/4f/5c/tre-03-150-3598-2.PMC3629864.pdf
"Ann Neurol 2003; 54:283–286, doi: http://dx.doi.org/10.1002/ana.10675.",OADS,/arxiv_data1/oa_pdf/4f/5c/tre-03-150-3598-2.PMC3629864.pdf
"Neurology 2005;65: 87–95, doi: http://dx.doi.org/10.1212/01.wnl.0000167546.39375.82.",Non-OADS,/arxiv_data1/oa_pdf/4f/5c/tre-03-150-3598-2.PMC3629864.pdf
"Brain 2003;126:1279–1292, doi: http://dx.doi.org/ 10.1093/brain/awg142.",Non-OADS,/arxiv_data1/oa_pdf/4f/5c/tre-03-150-3598-2.PMC3629864.pdf
"J Neurol Sci 2006;251:73–76, doi: http://dx.doi.org/10.1016/j.jns.2006.09.003.",OADS,/arxiv_data1/oa_pdf/4f/5c/tre-03-150-3598-2.PMC3629864.pdf
"Neurology 2002;59:1974–1976, doi: http://dx.doi.org/10.1212/01.WNL.0000037484.28297.66.",Non-OADS,/arxiv_data1/oa_pdf/4f/5c/tre-03-150-3598-2.PMC3629864.pdf
"Mov Disord 2007;22:1229–1238, doi: http://dx.doi.org/10.1002/mds.21505.Levdopa, Adult-onset Lower Limb Dystonia and PD Chang FCF, Josephs KA Tremor and Other Hyperkinetic Movements http://www.tremorjournal.orgThe Center for Digital Research and ScholarshipColumbia University Libraries/Information Services5",Non-OADS,/arxiv_data1/oa_pdf/4f/5c/tre-03-150-3598-2.PMC3629864.pdf
"However, evaluation of the methodsshows that there is still room for improvement in the named-entity recognition and that a larger and more robust corpus isneeded to achieve a better performance for event extraction.Database URL : http://www.cellfinder.org/ ............................................................................................................................... ............................................................................................................................... ............................... Introduction Biomedical literature curation is the process of automatic- ally and/or manually compiling biological data from scien- tific publications and making it available in a structured and comprehensive way.",Non-OADS,/arxiv_data1/oa_pdf/ba/af/bat020.PMC3629873.pdf
"This is an Open Access article distributed under the terms of the Creative Commons Attribution Non-Commercial License (http://creativecommons.org/licenses/by-nc/3.0/), which permits non-commercial re-use, distribution, and reproduction in any medium, provided the original work is properly cited.",Non-OADS,/arxiv_data1/oa_pdf/ba/af/bat020.PMC3629873.pdf
"We present the first description of the curation pipeline for the CellFinder database (http://www.cellfinder.org/),a repository of cell research, which aims to integrate data derived from many sources, such as literature curation and microarray data.",OADS,/arxiv_data1/oa_pdf/ba/af/bat020.PMC3629873.pdf
"It is based on a novel ontology [Cell:Expression, Localization, Development, Anatomy (CELDA)(http://cellfinder.org/about/ontology)], which allows stand-ardization and integration to other available ontologieson the cell and anatomy domains.",OADS,/arxiv_data1/oa_pdf/ba/af/bat020.PMC3629873.pdf
"Curation is carried out for full text documents available at the PubMed Central Open Access (PMC OA) subset (http://www.ncbi.nlm.nih.gov/pmc/tools/openftlist/), and manual intervention from curators iscurrently only necessary for querying new documents forcuration and validation of the derived biological processes.",OADS,/arxiv_data1/oa_pdf/ba/af/bat020.PMC3629873.pdf
Pre-processing Full texts documents were first split by sentences using the OpenNLP toolkit (http://opennlp.apache.org/) and thenparsed by the Brown Laboratory for LinguisticInformation Processing (BLLIP) parser (https://github.com/dmcc/bllip-parserV) ( 45) (also known as McClosky-Charniak parser).,OADS,/arxiv_data1/oa_pdf/ba/af/bat020.PMC3629873.pdf
Dependencytrees were built using the Stanford parser (http://nlp.stan- ford.edu/software/lex-parser.shtml).,OADS,/arxiv_data1/oa_pdf/ba/af/bat020.PMC3629873.pdf
"Cell lines are recognized based on the version 4.0 of Cellosaurus (ftp://ftp.nextprot.org/pub/current_release/con-trolled_vocabularies/ cellosaurus.txt), a manually curatedvocabulary of cell lines provided by the Swiss Institute ofBioinformatics.",OADS,/arxiv_data1/oa_pdf/ba/af/bat020.PMC3629873.pdf
Terms from the list are matched against the fulltext using Lingpipe (http://alias-i.com/lingpipe/).,OADS,/arxiv_data1/oa_pdf/ba/af/bat020.PMC3629873.pdf
"CUI terms are also mapped to other ontol- ogies and terminologies supported by UMLS, but not byCellFinder, such as the CRISP Thesaurus (http://www.nlm.",Non-OADS,/arxiv_data1/oa_pdf/ba/af/bat020.PMC3629873.pdf
"Event extraction Results from sentence splitting, tokenization, part-of-speech tagging, parsing, dependency tags and namedentities are integrated into the so-called ‘Interaction XML’file format (https://github.com/jbjorne/TEES/wiki/TEES- Overview) ( 58) used by the Turku Event Extraction System (TEES) ( 59).",OADS,/arxiv_data1/oa_pdf/ba/af/bat020.PMC3629873.pdf
"The validated data, one file per snippet in the Bionotate’sXML format, is available for download at the CellFinder website (http://cellfinder.org/about/annotation/).",OADS,/arxiv_data1/oa_pdf/ba/af/bat020.PMC3629873.pdf
"This is an Open Access article distributed under the terms of the Creative Commons Attribution Non-Commercial License (http://creativecommons.org/licenses/by-nc/3.0/), which permits unrestricted non-commercial use, distribution, and reproduction in any medium, provided the original work is properly cited.",Non-OADS,/arxiv_data1/oa_pdf/0a/41/bjs138.PMC3629874.pdf
"Data analysis Data were analyzed in custom written routines using IDL (ITT VIS), R (http://www.r-project.org), and LibreOffice (http://www.libreoffice.org).",OADS,/arxiv_data1/oa_pdf/0a/41/bjs138.PMC3629874.pdf
http://www.diss.fu-berlin.de/diss/receive/FUDISS_thesis_000000001732.,Non-OADS,/arxiv_data1/oa_pdf/0a/41/bjs138.PMC3629874.pdf
"This is an Open Access article distributed under the terms of the Creative Commons Attribution License (http://creativecommons.org/licenses/by- nc/3.0/), which permits non-commercial reuse, distribution, and reproduction in any medium, provided the original work is properly cited.",Non-OADS,/arxiv_data1/oa_pdf/93/eb/mds614.PMC3629894.pdf
"This is an Open Access article distributed under the terms of the Creative Commons Attribution License (http://creativecommons.org/licenses/by- nc/3.0/), which permits non-commercial use, distribution, and reproduction in any medium, provided the original work is properly cited.",Non-OADS,/arxiv_data1/oa_pdf/47/59/mds647.PMC3629900.pdf
http://www.who.int/mediacentre/factsheets/ fs297/en/index.html .,Non-OADS,/arxiv_data1/oa_pdf/47/59/mds647.PMC3629900.pdf
Cancer facts & ﬁgures 2011. http://www.cancer.org/ acs/groups/content/@epidemiologysurveilance/documents/document/acspc- 029771.pdf .,Non-OADS,/arxiv_data1/oa_pdf/47/59/mds647.PMC3629900.pdf
"Non-small cell lung cancer, version 2.2012. http://www.nccn.org/ professionals/physician_gls/f_guidelines.asp#nscl .",Non-OADS,/arxiv_data1/oa_pdf/47/59/mds647.PMC3629900.pdf
Rattner; Email: barbara@landesbioscience.com Submitted: 10/31/12; Accepted: 10/31/12http://dx.doi.org/10.4161/trns.22760Transcription in the Chloroplast:  It’s Not That Simple  pp.,Non-OADS,/arxiv_data1/oa_pdf/77/16/tran-3-271.PMC3630179.pdf
"www.landesbioscience.com  T ranscription  273Transcription 3:6, 273-276; November/December 2012; © 2012 Landes Bioscience Poi NT-of-View PoiNT-of-View Keywords:  Elongator, transcription   elongation, tRNA modification Submitted: 06/28/12Revised: 07/17/12Accepted: 07/17/12http://dx.doi.org/10.4161/trns.21525 *Correspondence to: Christoph W. Müller;   Email: cmueller@embl.deThe conserved multisubunit Elongator  complex was initially described as  an RNA polymerase II (RNAP II) asso - ciated transcription elongation factor but, since, has been shown to be involved in a variety of different cellular activi - ties.",OADS,/arxiv_data1/oa_pdf/60/7e/tran-3-273.PMC3630180.pdf
Nat Struct Mol Biol 2012; 19:314-20; PMID:22343726; http://dx.doi.org/10.1038/nsmb.2234.,OADS,/arxiv_data1/oa_pdf/60/7e/tran-3-273.PMC3630180.pdf
EMBO J 2001; 20:1993-2003; PMID:11296232; http://dx.doi.org/10.1093/emboj/20.8.1993.,OADS,/arxiv_data1/oa_pdf/60/7e/tran-3-273.PMC3630180.pdf
"RNA 2005; 11:424-36; PMID:15769872; http://dx.doi.org/10.1261/rna.7247705.in the Elp456 ATPase sites, located on  the outside of the inter-subunit interfaces, would induce conformational changes in the distant tRNA binding loops, located in the central cavity, allowing the release of a tRNA molecule.",Non-OADS,/arxiv_data1/oa_pdf/60/7e/tran-3-273.PMC3630180.pdf
Mol Microbiol 2006; 59:795-806; PMID:16420352; http://dx.doi.org/10.1111/j.1365-2958.2005.04989.x.,OADS,/arxiv_data1/oa_pdf/60/7e/tran-3-273.PMC3630180.pdf
Science 2011; 332:1089-92; PMID:21527678; http://dx.doi.org/10.1126/science.1205358.,OADS,/arxiv_data1/oa_pdf/60/7e/tran-3-273.PMC3630180.pdf
J Mol Biol 2012; 416:467-85; PMID:22227389; http://dx.doi.org/10.1016/j.jmb.2011.12.048.,OADS,/arxiv_data1/oa_pdf/60/7e/tran-3-273.PMC3630180.pdf
Cell Reports 2012; 1:424-33; PMID:22768388; http://dx.doi.org/10.1016/j.cel - rep.2012.04.001.,OADS,/arxiv_data1/oa_pdf/60/7e/tran-3-273.PMC3630180.pdf
J Biol Chem 2012; 287:21501-8; PMID:22556426; http://dx.doi.org/10.1074/jbc.M112.341560.,OADS,/arxiv_data1/oa_pdf/60/7e/tran-3-273.PMC3630180.pdf
Curr Opin Struct Biol 2011; 21:240-8; PMID:21282052; http://dx.doi.org/10.1016/j.sbi.2011.01.002.,OADS,/arxiv_data1/oa_pdf/60/7e/tran-3-273.PMC3630180.pdf
J Biol Chem 2001; 276:32743-9; PMID:11435442; http://dx.doi.org/10.1074/jbc.M105303200.,OADS,/arxiv_data1/oa_pdf/60/7e/tran-3-273.PMC3630180.pdf
Nature 1998; 395:292-6; PMID:9751059; http://dx.doi.org/10.1038/26254.,OADS,/arxiv_data1/oa_pdf/60/7e/tran-3-273.PMC3630180.pdf
Mol Microbiol 2002; 43:783-91; PMID:11929532; http://dx.doi.org/10.1046/j.1365-2958.2002.02794.x.,Non-OADS,/arxiv_data1/oa_pdf/60/7e/tran-3-273.PMC3630180.pdf
J Biol Chem 2003; 278:956-61; PMID:12424236; http://dx.doi.org/10.1074/jbc.M210060200.,OADS,/arxiv_data1/oa_pdf/60/7e/tran-3-273.PMC3630180.pdf
Mol Microbiol 2009; 73:869-81; PMID:19656297; http://dx.doi.org/10.1111/j.1365-2958.2009.06811.x.,Non-OADS,/arxiv_data1/oa_pdf/60/7e/tran-3-273.PMC3630180.pdf
PLoS Genet 2011; 7:e1002258; PMID:21912530; http://dx.doi.org/10.1371/journal.pgen.1002258.18.,Non-OADS,/arxiv_data1/oa_pdf/60/7e/tran-3-273.PMC3630180.pdf
Hum Mol Genet 2009; 18:472-81; PMID:18996918; http://dx.doi.org/10.1093/hmg/ddn375.,Non-OADS,/arxiv_data1/oa_pdf/60/7e/tran-3-273.PMC3630180.pdf
Eur J Hum Genet 2009; 17:1171-81; PMID:19172991; http://dx.doi.org/10.1038/ejhg.2008.267.,OADS,/arxiv_data1/oa_pdf/60/7e/tran-3-273.PMC3630180.pdf
Trends Neurosci 2010; 33:249-58; PMID:20227117; http://dx.doi.org/10.1016/j.tins.2010.02.003.,OADS,/arxiv_data1/oa_pdf/60/7e/tran-3-273.PMC3630180.pdf
Mol Cell 1999; 3:109-18; PMID:10024884; http://dx.doi.org/10.1016/S1097-2765(00)80179-3.,OADS,/arxiv_data1/oa_pdf/60/7e/tran-3-273.PMC3630180.pdf
Cell 2005; 122:517-27; PMID:16122420; http://dx.doi.org/10.1016/j.cell.2005.06.026.,OADS,/arxiv_data1/oa_pdf/60/7e/tran-3-273.PMC3630180.pdf
Mol Cell 2002; 9:799-809; PMID:11983171; http://dx.doi.org/10.1016/S1097-2765(02)00502-6.,OADS,/arxiv_data1/oa_pdf/60/7e/tran-3-273.PMC3630180.pdf
Mol Cell 2004; 14:457-64; PMID:15149595; http://dx.doi.org/10.1016/S1097-2765(04)00239-4.,OADS,/arxiv_data1/oa_pdf/60/7e/tran-3-273.PMC3630180.pdf
Nature 2012; 484:386-9; PMID:22446626; http://dx.doi.org/10.1038/nature10925.,Non-OADS,/arxiv_data1/oa_pdf/60/7e/tran-3-273.PMC3630180.pdf
J Biol Chem 2002; 277:3047-52; PMID:11714725; http://dx.doi.org/10.1074/jbc.M110445200.,OADS,/arxiv_data1/oa_pdf/60/7e/tran-3-273.PMC3630180.pdf
PLoS Genet 2010; 6:e1000820; PMID:20107598; http://dx.doi.org/10.1371/journal.pgen.1000820.,Non-OADS,/arxiv_data1/oa_pdf/60/7e/tran-3-273.PMC3630180.pdf
Mol Microbiol 2002; 45:817-26; PMID:12139626; http://dx.doi.org/10.1046/j.1365-2958.2002.03055.x.,OADS,/arxiv_data1/oa_pdf/60/7e/tran-3-273.PMC3630180.pdf
RNA 2008; 14:2183-94; PMID:18755837; http://dx.doi.org/10.1261/rna.1184108.,OADS,/arxiv_data1/oa_pdf/60/7e/tran-3-273.PMC3630180.pdf
RNA 2005; 11:1648-54; PMID:16244131; http://dx.doi.org/10.1261/rna.2172105.4.,OADS,/arxiv_data1/oa_pdf/60/7e/tran-3-273.PMC3630180.pdf
Mol Microbiol 2010; 76:1082-94; PMID:20398216; http://dx.doi.org/10.1111/j.1365-2958.2010.07163.x.,OADS,/arxiv_data1/oa_pdf/60/7e/tran-3-273.PMC3630180.pdf
PLoS Genet 2009; 5:e1000561; PMID:19593383; http://dx.doi.org/10.1371/journal.pgen.1000561.,Non-OADS,/arxiv_data1/oa_pdf/60/7e/tran-3-273.PMC3630180.pdf
Genetics 2011; 187:1067-75; PMID:21288872; http://dx.doi.org/10.1534/genet - ics.110.123893.,OADS,/arxiv_data1/oa_pdf/60/7e/tran-3-273.PMC3630180.pdf
J Neurochem 2010; 115:493-504; PMID:20626565; http://dx.doi.org/10.1111/j.1471-4159.2010.06892.x.,Non-OADS,/arxiv_data1/oa_pdf/60/7e/tran-3-273.PMC3630180.pdf
Mol Microbiol 2010; 76:1065-9; PMID:20398217; http://dx.doi.org/10.1111/j.1365-2958.2010.07162.x.,Non-OADS,/arxiv_data1/oa_pdf/60/7e/tran-3-273.PMC3630180.pdf
Curr Opin Cell Biol 2007; 19:331-6; PMID:17466506; http://dx.doi.org/10.1016/j.ceb.2007.04.005.,OADS,/arxiv_data1/oa_pdf/60/7e/tran-3-273.PMC3630180.pdf
Neuron 2011; 72:776-88; PMID:22153374; http://dx.doi.org/10.1016/j.neu - ron.2011.10.010.,OADS,/arxiv_data1/oa_pdf/60/7e/tran-3-273.PMC3630180.pdf
Mol Cell 1999; 4:123-8; PMID:10445034; http://dx.doi.org/10.1016/S1097-2765(00)80194-X.,OADS,/arxiv_data1/oa_pdf/60/7e/tran-3-273.PMC3630180.pdf
Cell 2009; 136:551-64; PMID:19185337; http://dx.doi.org/10.1016/j.cell.2008.11.043.,OADS,/arxiv_data1/oa_pdf/60/7e/tran-3-273.PMC3630180.pdf
Mol Cell 2005; 17:841-53; PMID:15780940; http://dx.doi.org/10.1016/j.mol - cel.2005.02.018.,OADS,/arxiv_data1/oa_pdf/60/7e/tran-3-273.PMC3630180.pdf
PLoS Genet 2009; 5:e1000684; PMID:19834596; http://dx.doi.org/10.1371/journal.pgen.1000684.,Non-OADS,/arxiv_data1/oa_pdf/60/7e/tran-3-273.PMC3630180.pdf
Nature 2010; 463:554-8; PMID:20054296; http://dx.doi.org/10.1038/nature08732.,OADS,/arxiv_data1/oa_pdf/60/7e/tran-3-273.PMC3630180.pdf
Mol Cell 2006; 24:139-48; PMID:17018299; http://dx.doi.org/10.1016/j.mol - cel.2006.07.031.,OADS,/arxiv_data1/oa_pdf/60/7e/tran-3-273.PMC3630180.pdf
Am J Hum Genet 2001; 68:753-8; PMID:11179021; http://dx.doi.org/10.1086/318808.,OADS,/arxiv_data1/oa_pdf/60/7e/tran-3-273.PMC3630180.pdf
"Transcription 3:6, 290-294; November/December 2012; © 2012 Landes Bioscience Poi NT-of-View 290 T ranscription  V olume 3 i ssue 6Keywords:  chloroplast, nucleoid, PEP,  NEP, pTAC Abbreviations:  PEP, plastid encoded  plastid RNA polymerase; NEP, nuclear  encoded plastid RNA polymerase; ChIP, chromatin immunoprecipitation; pTAC, plastid transcriptionally active chromo - some; CRS1, chloroplast RNA splicing 1; WHY1, whirly 1; GUN1, genome uncoupling 1; SiR, sulfite reductase; SWIB, SWI/SNF complex B; PEND, plastid envelope DNA-binding protein; MFP1, MAR binding filament-like  protein 1 Submitted: 07/31/12Revised: 08/10/12Accepted: 08/10/12http://dx.doi.org/10.4161/trans.21810 *Correspondence to: Takashi Shiina;   Email: shiina@kpu.ac.jpChloroplasts in land plants have a  small genome consisting of only  100 genes encoding partial sets of pro - teins for photosynthesis, transcription and translation.",Non-OADS,/arxiv_data1/oa_pdf/2a/b9/tran-3-290.PMC3630183.pdf
Nucleic Acids Res 2008; 36:5152-65; PMID:18676978; http://dx.doi.org/10.1093/nar/gkn492.,OADS,/arxiv_data1/oa_pdf/2a/b9/tran-3-290.PMC3630183.pdf
Dev Cell 2004; 6:229-40; PMID:14960277; http://dx.doi.org/10.1016/S1534-5807(04)00028-0.,OADS,/arxiv_data1/oa_pdf/2a/b9/tran-3-290.PMC3630183.pdf
Cell 2010; 141:1230-40; PMID:20603003; http://dx.doi.org/10.1016/j.cell.2010.05.007.,OADS,/arxiv_data1/oa_pdf/2a/b9/tran-3-290.PMC3630183.pdf
Science 2007; 316:715-9; PMID:17395793; http://dx.doi.org/10.1126/science.,OADS,/arxiv_data1/oa_pdf/2a/b9/tran-3-290.PMC3630183.pdf
Nat Rev Microbiol 2010; 8:185-95; PMID:20140026; http://dx.doi.org/10.1038/nrmicro2261.,OADS,/arxiv_data1/oa_pdf/2a/b9/tran-3-290.PMC3630183.pdf
Protoplasma 1997; 200:163-73; http://dx.doi.org/10.1007/BF01283292.,Non-OADS,/arxiv_data1/oa_pdf/2a/b9/tran-3-290.PMC3630183.pdf
Int Rev Cytol 2003; 232:217-62; PMID:14711120; http://dx.doi.org/10.1016/S0074-7696(03)32006-6.,OADS,/arxiv_data1/oa_pdf/2a/b9/tran-3-290.PMC3630183.pdf
J Biol Chem 2002; 277:24399-404; PMID:11997391; http://dx.doi.org/10.1074/jbc.M201714200.,OADS,/arxiv_data1/oa_pdf/2a/b9/tran-3-290.PMC3630183.pdf
Plant Cell 2012; 24:3060-73; doi: http://dx.doi.org/10.1105/tpc.112.099721.,OADS,/arxiv_data1/oa_pdf/2a/b9/tran-3-290.PMC3630183.pdf
Nucleic Acids Res 2003; 31:5175-85; PMID:12930969; http://dx.doi.org/10.1093/nar/gkg693.,Non-OADS,/arxiv_data1/oa_pdf/2a/b9/tran-3-290.PMC3630183.pdf
Plant Physiol 2012; 158:156-89; PMID:22065420; http://dx.doi.org/10.1104/pp.111.188474.6.,Non-OADS,/arxiv_data1/oa_pdf/2a/b9/tran-3-290.PMC3630183.pdf
Plant Physiol 2006; 142:993-1003; PMID:16963522; http://dx.doi.org/10.1104/pp.106.085043.,Non-OADS,/arxiv_data1/oa_pdf/2a/b9/tran-3-290.PMC3630183.pdf
Plant Cell 2008; 20:856-74; PMID:18441214; http://dx.doi.org/10.1105/tpc.107.055202.,OADS,/arxiv_data1/oa_pdf/2a/b9/tran-3-290.PMC3630183.pdf
Plant Cell 2006; 18:176-97; PMID:16326926; http://dx.doi.org/10.1105/tpc.105.036392.,OADS,/arxiv_data1/oa_pdf/2a/b9/tran-3-290.PMC3630183.pdf
Plant J 2004; 38:923-39; PMID:15165185; http://dx.doi.org/10.1111/j.1365-313X.2004.02094.x.,OADS,/arxiv_data1/oa_pdf/2a/b9/tran-3-290.PMC3630183.pdf
Nucleic Acids Res 1988; 16:8411-31; PMID:2843817; http://dx.doi.org/10.1093/nar/16.17.8411.,OADS,/arxiv_data1/oa_pdf/2a/b9/tran-3-290.PMC3630183.pdf
Cell 1987; 51:1145-57; PMID:3690662; http://dx.doi.org/10.1016/0092-8674(87)90600-3.,OADS,/arxiv_data1/oa_pdf/2a/b9/tran-3-290.PMC3630183.pdf
Plant Mol Biol 1994; 25:69-81; PMID:8003698; http://dx.doi.org/10.1007/BF00024199.,Non-OADS,/arxiv_data1/oa_pdf/2a/b9/tran-3-290.PMC3630183.pdf
Biochemistry 1976; 15:3039-45; PMID:821516; http://dx.doi.org/10.1021/bi00659a016.,Non-OADS,/arxiv_data1/oa_pdf/2a/b9/tran-3-290.PMC3630183.pdf
Plant Physiol 1982; 69:1205-11; PMID:16662371; http://dx.doi.org/10.1104/pp.69.5.1205.,Non-OADS,/arxiv_data1/oa_pdf/2a/b9/tran-3-290.PMC3630183.pdf
"Plant Mol Biol 2011; 76:235-49; PMID:21107995; http://dx.doi.org/10.1007/s11103-010-9714-4.NEP type novel plastid RNA polymerase  likely enabled a transcriptional switching system in chloroplasts, which allows selec - tive transcription of a set of housekeep - ing genes in non-photosynthetic tissues, such as roots and flowers.",Non-OADS,/arxiv_data1/oa_pdf/2a/b9/tran-3-290.PMC3630183.pdf
Plant Mol Biol  1992; 19:149-68; PMID:1600166; http://dx.doi.,OADS,/arxiv_data1/oa_pdf/2a/b9/tran-3-290.PMC3630183.pdf
DNA Res 1996; 3:109-36; PMID:8905231; http://dx.doi.org/10.1093/dnares/3.3.109.,OADS,/arxiv_data1/oa_pdf/2a/b9/tran-3-290.PMC3630183.pdf
Plant Physiol 1998; 118:9-17; PMID:9733521; http://dx.doi.org/10.1104/pp.118.1.9.,Non-OADS,/arxiv_data1/oa_pdf/2a/b9/tran-3-290.PMC3630183.pdf
Int Rev Cytol 2005; 244:1-68; PMID:16157177; http://dx.doi.org/10.1016/S0074-7696(05)44001-2.,OADS,/arxiv_data1/oa_pdf/2a/b9/tran-3-290.PMC3630183.pdf
Plant Biotechnol 2009; 26:57-66; http://dx.doi.org/10.5511/plantbio - technology.26.57.,OADS,/arxiv_data1/oa_pdf/2a/b9/tran-3-290.PMC3630183.pdf
"5,6 Biofilms  are notorious for forming on various implanted medical devices, including catheters, pacemakers, heart valves, dentures and pros - thetic joints, which provide a surface and sanctuary for biofilm  *Correspondence to: Clarissa J. Nobile; Email: Clarissa.Nobile@ucsf.edu Submitted: 08/29/12; Revised: 09/15/12; Accepted: 09/18/12http://dx.doi.org/10.4161/trans.22281Candida albicans  is a commensal microorganism of the human  microbiome; it is also the most prevalent fungal pathogen of  humans.",Non-OADS,/arxiv_data1/oa_pdf/a1/e1/tran-3-315.PMC3630188.pdf
"This information will provide new insight for understanding biofilms in more detail and may lead to improvements in preventing and treating biofilm-based infections in the future.A sticky situation Untangling the transcriptional network controlling biofilm  development in Candida albicans Emily P. Fox1,2 and Clarissa J. Nobile1,* 1Department of Microbiology and Immunology; University of California-San Francisco; San Francisco, CA USA; 2Tetrad Program; Department of Biochemistry and Biophysics;  University of California-San Francisco; San Francisco, CA USA Keywords:  transcriptional regulation, transcription networks, biofilm development, Candida albicans growth.7,8 The human health consequences of device-associated  infections can be severe and often life-threatening.6 Estimates by the NIH in PA-03-047 indicate that biofilms in  general (including both bacterial and fungal biofilms) are respon - sible for over 80% of all microbial infections (http://grants.nih.",Non-OADS,/arxiv_data1/oa_pdf/a1/e1/tran-3-315.PMC3630188.pdf
Clin Infect Dis 2004; 38:161-89; PMID:14699449; http://dx.doi.org/10.1086/380796.,OADS,/arxiv_data1/oa_pdf/a1/e1/tran-3-315.PMC3630188.pdf
T rends Microbiol 2001; 9:327-35; PMID:11435107; http://dx.doi.org/10.1016/S0966-842X(01)02094-7.,OADS,/arxiv_data1/oa_pdf/a1/e1/tran-3-315.PMC3630188.pdf
T rends Microbiol 1998; 6:468-70; PMID:10036723; http://dx.doi.org/10.1016/S0966-842X(98)01407-3.,OADS,/arxiv_data1/oa_pdf/a1/e1/tran-3-315.PMC3630188.pdf
Science 1999; 284:1318-22; PMID:10334980; http://dx.doi.org/10.1126/science.284.5418.1318.,OADS,/arxiv_data1/oa_pdf/a1/e1/tran-3-315.PMC3630188.pdf
Clin Infect Dis 2001; 33:1387-92; PMID:11565080; http://dx.doi.org/10.1086/322972.,OADS,/arxiv_data1/oa_pdf/a1/e1/tran-3-315.PMC3630188.pdf
Clin Microbiol Rev 2002; 15:167-93; PMID:11932229; http://dx.doi.org/10.1128/CMR.15.2.167-193.2002.8.,Non-OADS,/arxiv_data1/oa_pdf/a1/e1/tran-3-315.PMC3630188.pdf
Clin Microbiol Rev 2004; 17:255-67; PMID:15084500; http://dx.doi.org/10.1128/CMR.17.2.255-267.2004.,OADS,/arxiv_data1/oa_pdf/a1/e1/tran-3-315.PMC3630188.pdf
T rends Microbiol 2003; 11:30-6; PMID:12526852; http://dx.doi.org/10.1016/S0966-842X(02)00002-1.,OADS,/arxiv_data1/oa_pdf/a1/e1/tran-3-315.PMC3630188.pdf
Clin Infect Dis 1995; 20:1531-4; PMID:7548504; http://dx.doi.org/10.1093/cli-nids/20.6.1531.,Non-OADS,/arxiv_data1/oa_pdf/a1/e1/tran-3-315.PMC3630188.pdf
J Med Microbiol 1999; 48:671-9; PMID:10403418; http://dx.doi.org/10.1099/00222615-48-7-671.,Non-OADS,/arxiv_data1/oa_pdf/a1/e1/tran-3-315.PMC3630188.pdf
J Bacteriol 2001; 183:5385-94; PMID:11514524; http://dx.doi.org/10.1128/JB.183.18.5385-5394.2001.,Non-OADS,/arxiv_data1/oa_pdf/a1/e1/tran-3-315.PMC3630188.pdf
Curr Biol 2005; 15:1150-5; PMID:15964282; http://dx.doi.org/10.1016/j.cub.2005.05.047.16.,OADS,/arxiv_data1/oa_pdf/a1/e1/tran-3-315.PMC3630188.pdf
PLoS Pathog 2010; 6:e1000828; PMID:20360962; http://dx.doi.org/10.1371/journal.ppat.1000828.,Non-OADS,/arxiv_data1/oa_pdf/a1/e1/tran-3-315.PMC3630188.pdf
Oral Surg Oral Med Oral Pathol Oral Radiol Endod 2004; 98:53-9; PMID:15243471; http://dx.doi.org/10.1016/j.tripleo.2003.04.002.,Non-OADS,/arxiv_data1/oa_pdf/a1/e1/tran-3-315.PMC3630188.pdf
Infect Immun 2004; 72:6023-31; PMID:15385506; http://dx.doi.org/10.1128/IAI.72.10.6023-6031.2004.,Non-OADS,/arxiv_data1/oa_pdf/a1/e1/tran-3-315.PMC3630188.pdf
Antimicrob Agents Chemother 2004; 48:1727-32; PMID:15105127; http://dx.doi.org/10.1128/AAC.48.5.1727-1732.2004.,Non-OADS,/arxiv_data1/oa_pdf/a1/e1/tran-3-315.PMC3630188.pdf
Cell 2012; 148:126-38; PMID:22265407; http://dx.doi.org/10.1016/j.cell.2011.10.048.,OADS,/arxiv_data1/oa_pdf/a1/e1/tran-3-315.PMC3630188.pdf
Plant  Physiol Biochem 2010; 48:506-12; PMID:20159658; http://dx.doi.org/10.1016/j.plaphy.2010.01.017.,OADS,/arxiv_data1/oa_pdf/a1/e1/tran-3-315.PMC3630188.pdf
Int J Biochem Cell Biol 2010; 42:39-51; PMID:19643201; http://dx.doi.org/10.1016/j.biocel.2009.07.009.,OADS,/arxiv_data1/oa_pdf/a1/e1/tran-3-315.PMC3630188.pdf
Appl Environ Microbiol 2002; 68:5459-63; PMID:12406738; http://dx.doi.org/10.1128/AEM.68.11.5459-5463.2002.,OADS,/arxiv_data1/oa_pdf/a1/e1/tran-3-315.PMC3630188.pdf
Methods Mol Biol 2011; 692:219-33; PMID:21031315; http://dx.doi.org/10.1007/978-1-60761-971-0_16.,Non-OADS,/arxiv_data1/oa_pdf/a1/e1/tran-3-315.PMC3630188.pdf
Mol Microbiol 2006; 62:100-19; PMID:16987174; http://dx.doi.org/10.1111/j.1365-2958.2006.05367.x.,Non-OADS,/arxiv_data1/oa_pdf/a1/e1/tran-3-315.PMC3630188.pdf
Genes Dev 2002; 16:3017-33; PMID:12464632; http://dx.doi.org/10.1101/gad.1039602.,OADS,/arxiv_data1/oa_pdf/a1/e1/tran-3-315.PMC3630188.pdf
Eukaryot Cell 2007; 6:2122-38; PMID:17905926; http://dx.doi.org/10.1128/EC.00327-07.,Non-OADS,/arxiv_data1/oa_pdf/a1/e1/tran-3-315.PMC3630188.pdf
Blood 2012; 120:1473-84; PMID:22740448; http://dx.doi.org/10.1182/blood-2011-12-395335.,Non-OADS,/arxiv_data1/oa_pdf/a1/e1/tran-3-315.PMC3630188.pdf
T rends Genet 2011; 27:141-8; PMID:21295369; http://dx.doi.org/10.1016/j.tig.2011.01.001.,OADS,/arxiv_data1/oa_pdf/a1/e1/tran-3-315.PMC3630188.pdf
FEMS Microbiol Lett 2002; 214:95-100; PMID:12204378; http://dx.doi.org/10.1111/j.1574-6968.2002.tb11330.x.,OADS,/arxiv_data1/oa_pdf/a1/e1/tran-3-315.PMC3630188.pdf
Eukaryot Cell 2010; 9:1531-7; PMID:20709787; http://dx.doi.org/10.1128/EC.00111-10.35.,Non-OADS,/arxiv_data1/oa_pdf/a1/e1/tran-3-315.PMC3630188.pdf
Mol Microbiol 2000; 38:435-45; PMID:11069668; http://dx.doi.org/10.1046/j.1365-2958.2000.02132.x.,OADS,/arxiv_data1/oa_pdf/a1/e1/tran-3-315.PMC3630188.pdf
PLoS Comput Biol 2009; 5:e1000279; PMID:19180182; http://dx.doi.org/10.1371/journal.pcbi.1000279.,Non-OADS,/arxiv_data1/oa_pdf/a1/e1/tran-3-315.PMC3630188.pdf
Curr Biol 2008; 18:1017-24; PMID:18635358; http://dx.doi.org/10.1016/j.cub.2008.06.034.,OADS,/arxiv_data1/oa_pdf/a1/e1/tran-3-315.PMC3630188.pdf
Eukaryot Cell 2006; 5:1604-10; PMID:17030992; http://dx.doi.org/10.1128/EC.00194-06.,Non-OADS,/arxiv_data1/oa_pdf/a1/e1/tran-3-315.PMC3630188.pdf
PLoS Pathog 2006; 2:e63; PMID:16839200; http://dx.doi.org/10.1371/journal.ppat.0020063.,Non-OADS,/arxiv_data1/oa_pdf/a1/e1/tran-3-315.PMC3630188.pdf
Microbiology 2010; 156:3645-59; PMID:20705663; http://dx.doi.org/10.1099/mic.0.043851-0.,Non-OADS,/arxiv_data1/oa_pdf/a1/e1/tran-3-315.PMC3630188.pdf
Microbiology 2005; 151:1051-60; PMID:15817774; http://dx.doi.org/10.1099/mic.0.27696-0.,Non-OADS,/arxiv_data1/oa_pdf/a1/e1/tran-3-315.PMC3630188.pdf
J Biol Chem 1996; 271:6298-305; PMID:8626424; http://dx.doi.org/10.1074/jbc.271.11.6298.,OADS,/arxiv_data1/oa_pdf/a1/e1/tran-3-315.PMC3630188.pdf
FEMS Microbiol Rev 1995; 16:53-75; PMID:7888172; http://dx.doi.org/10.1111/j.1574-6976.1995.tb00155.x.,Non-OADS,/arxiv_data1/oa_pdf/a1/e1/tran-3-315.PMC3630188.pdf
Infect Immun 2009; 77:1596-605; PMID:19188358; http://dx.doi.org/10.1128/IAI.01452-08.,Non-OADS,/arxiv_data1/oa_pdf/a1/e1/tran-3-315.PMC3630188.pdf
J Infect Dis 2009; 200:307-13; PMID:19527170; http://dx.doi.org/10.1086/599838.,Non-OADS,/arxiv_data1/oa_pdf/a1/e1/tran-3-315.PMC3630188.pdf
EMBO J 2002; 21:5448-56; PMID:12374745; http://dx.doi.org/10.1093/emboj/cdf507.21.,OADS,/arxiv_data1/oa_pdf/a1/e1/tran-3-315.PMC3630188.pdf
PLoS Genet 2009; 5:e1000783; PMID:20041210; http://dx.doi.org/10.1371/journal.pgen.1000783.,Non-OADS,/arxiv_data1/oa_pdf/a1/e1/tran-3-315.PMC3630188.pdf
Mol Microbiol 2011; 80:995-1013; PMID:21414038; http://dx.doi.org/10.1111/j.1365-2958.2011.07626.x.,Non-OADS,/arxiv_data1/oa_pdf/a1/e1/tran-3-315.PMC3630188.pdf
PLoS Pathog 2012; 8:e1002525; PMID:22359502; http://dx.doi.org/10.1371/journal.ppat.1002525.,Non-OADS,/arxiv_data1/oa_pdf/a1/e1/tran-3-315.PMC3630188.pdf
Eukaryot Cell 2004; 3:536-45; PMID:15075282; http://dx.doi.org/10.1128/EC.3.2.536-545.2004.,Non-OADS,/arxiv_data1/oa_pdf/a1/e1/tran-3-315.PMC3630188.pdf
Mol Microbiol 2004; 53:969-83; PMID:15255906; http://dx.doi.org/10.1111/j.1365-2958.2004.04185.x.,OADS,/arxiv_data1/oa_pdf/a1/e1/tran-3-315.PMC3630188.pdf
PLoS Biol 2009; 7:e1000133; PMID:19529758; http://dx.doi.org/10.1371/journal.pbio.1000133.,Non-OADS,/arxiv_data1/oa_pdf/a1/e1/tran-3-315.PMC3630188.pdf
Mol Microbiol 2011; 79:940-53; PMID:21299649; http://dx.doi.org/10.1111/j.1365-2958.2010.07504.x.,Non-OADS,/arxiv_data1/oa_pdf/a1/e1/tran-3-315.PMC3630188.pdf
Genome Res 2012; 22:1668-79; PMID:22955979; http://dx.doi.org/10.1101/gr.127761.111.,OADS,/arxiv_data1/oa_pdf/a1/e1/tran-3-315.PMC3630188.pdf
Cell Stem Cell 2010; 7:532-44; PMID:20887958; http://dx.doi.org/10.1016/j.stem.2010.07.016.,OADS,/arxiv_data1/oa_pdf/a1/e1/tran-3-315.PMC3630188.pdf
Cell 2011; 144:940-54; PMID:21414485; http://dx.doi.org/10.1016/j.cell.2011.01.032.,OADS,/arxiv_data1/oa_pdf/a1/e1/tran-3-315.PMC3630188.pdf
Science 2001; 293:880-3; PMID:11486091; http://dx.doi.org/10.1126/science.1061320.,OADS,/arxiv_data1/oa_pdf/a1/e1/tran-3-315.PMC3630188.pdf
Genes Dev 2006; 20:435-48; PMID:16449570; http://dx.doi.org/10.1101/gad.1389306.,OADS,/arxiv_data1/oa_pdf/a1/e1/tran-3-315.PMC3630188.pdf
Genes Dev 2009; 23:1351-63; PMID:19487574; http://dx.doi.org/10.1101/gad.1781909.,OADS,/arxiv_data1/oa_pdf/a1/e1/tran-3-315.PMC3630188.pdf
"This is an Open Access article distributed under the terms of the Creative Commons Attribution License (http://creativecommons.org/licenses/by-nc/3.0/), which permits non-commercial use, distribution, and reproduction in any medium, provided the original work is properly cited.",Non-OADS,/arxiv_data1/oa_pdf/f6/eb/aet005.PMC3630285.pdf
"THE KOREAN SOCIETY FOR REPRODUCTIVE MEDICINE  1 ORIGINAL ARTICLE http://dx.doi.org/10.5653/cerm.2013.40.1.1 pISSN 2233-8233 · eISSN 2233-8241Clin Exp Reprod Med 2013;40(1):1-6 Nuclear localization of Obox4 is dependent on its  homeobox domain  Geon Tae Park, Kyung-Ah Lee Department of Biomedical Science, College of Life Science, CHA University, Seoul, Korea Objective:  Oocyte-specific homeobox 4 ( Obox4 ) is preferentially expressed in oocytes and plays an important role in the completion of meio - sis of oocytes.",Non-OADS,/arxiv_data1/oa_pdf/db/7f/cerm-40-1.PMC3630287.pdf
"This is an Open Access article distributed under the terms of the Creative Commons Attribution  Non-Commercial License (http://creativecommons.org/licenses/by-nc/3.0/) which permits unrestricted non-commercial use, distribution, and reproduction in any medium, provided the original work is properly cited.",Non-OADS,/arxiv_data1/oa_pdf/db/7f/cerm-40-1.PMC3630287.pdf
" http://dx.doi.org/10.5653/cerm.2013.40.1.1 Clin Exp Reprod Med 2013;40(1):1-6 2a phosphodiesterase inhibitor, which maintains an intact GV state [6].",Non-OADS,/arxiv_data1/oa_pdf/db/7f/cerm-40-1.PMC3630287.pdf
"To further investigate the elements necessary and sufficient for nu - clear localization in the HD, we performed sequence analysis using the PSORTII prediction program (http://psort.hgc.jp).",OADS,/arxiv_data1/oa_pdf/db/7f/cerm-40-1.PMC3630287.pdf
" http://dx.doi.org/10.5653/cerm.2013.40.1.1 Clin Exp Reprod Med 2013;40(1):1-6 4there is a region responsible for nuclear localization of Obox4 throu - ghout the entire HD, although a certain motif cannot yet be specified.",OADS,/arxiv_data1/oa_pdf/db/7f/cerm-40-1.PMC3630287.pdf
" http://dx.doi.org/10.5653/cerm.2013.40.1.1 Clin Exp Reprod Med 2013;40(1):1-6 6from the nucleus to the cytoplasm (Figure 3), suggesting that the  Obox4 HD would not have contained the nuclear export signal or  that it had been broken by deletion analysis.",OADS,/arxiv_data1/oa_pdf/db/7f/cerm-40-1.PMC3630287.pdf
"THEKOREAN SOCIETY FORREPRODUCTIVE MEDICINE  12 ORIGINALARTICLE http://dx.doi.org/10.5653/cerm.2013.40.1.12 pISSN2233-8233·eISSN2233-8241ClinExpReprodMed2013;40(1):12-22 Altered expression of norepinephrine transporter  and norepinephrine in human placenta cause   pre-eclampsia through regulated trophoblast invasion  Kyu-Hwan Na1, Jong Ho Choi1, Chun-Hyung Kim2, Kwang-Soo Kim2, Gi Jin Kim1 1Department of Biomedical Science, CHA University, Seoul, Korea; 2Molecular Neurobiology Lab, McLean Hospital, Harvard Medical School, Belmont, USA Objective:  We investigated the norepinephrine transporter (NET) expression in normal and pre-eclamptic placentas and analyzed the invasion  activity of trophoblastic cells based on norepinephrine (NE)-NET regulation.",Non-OADS,/arxiv_data1/oa_pdf/9b/45/cerm-40-12.PMC3630288.pdf
"This is an Open Access article distributed under the terms of the Creative Commons Attribution  Non-Commercial License (http://creativecommons.org/licenses/by-nc/3.0/) which permits unrestricted non-commercial use, distribution, and reproduction in any medium, provided the original work is properly cited.",Non-OADS,/arxiv_data1/oa_pdf/9b/45/cerm-40-12.PMC3630288.pdf
 http://dx.doi.org/10.5653/cerm.2013.40.1.12 Clin Exp Reprod Med 2013;40(1):12-22 144.,OADS,/arxiv_data1/oa_pdf/9b/45/cerm-40-12.PMC3630288.pdf
 http://dx.doi.org/10.5653/cerm.2013.40.1.12 Clin Exp Reprod Med 2013;40(1):12-22 16Results 1.,OADS,/arxiv_data1/oa_pdf/9b/45/cerm-40-12.PMC3630288.pdf
 http://dx.doi.org/10.5653/cerm.2013.40.1.12 Clin Exp Reprod Med 2013;40(1):12-22 18mock group ( p<0.05) (Figure 3B).,OADS,/arxiv_data1/oa_pdf/9b/45/cerm-40-12.PMC3630288.pdf
" http://dx.doi.org/10.5653/cerm.2013.40.1.12 Clin Exp Reprod Med 2013;40(1):12-22 20Thus, we analyzed the phosphorylated PI3K/AKT and STAT3 path - ways and MMP-2 and MMP-9 activity in HTR-8/SVneo cells based on  the alteration of NE-NET expression.",OADS,/arxiv_data1/oa_pdf/9b/45/cerm-40-12.PMC3630288.pdf
 http://dx.doi.org/10.5653/cerm.2013.40.1.12 Clin Exp Reprod Med 2013;40(1):12-22 22Stress hormone-mediated invasion of ovarian cancer cells.,Non-OADS,/arxiv_data1/oa_pdf/9b/45/cerm-40-12.PMC3630288.pdf
"THE KOREAN SOCIETY FOR REPRODUCTIVE MEDICINE  23 ORIGINAL ARTICLE http://dx.doi.org/10.5653/cerm.2013.40.1.23 pISSN 2233-8233 · eISSN 2233-8241Clin Exp Reprod Med 2013;40(1):23-28 The utility of sperm DNA damage assay using  toluidine blue and aniline blue staining in routine semen analysis Hee-Sun Kim1,2, Moon Joo Kang1,2, Sung Ah Kim1,2, Sun Kyung Oh1,2, Hoon Kim2,3, Seung-Yup Ku2,3, Seok Hyun Kim2,3,  Shin Yong Moon2,3, Young Min Choi2,3 1IVF Laboratory, Department of Obstetrics and Gynecology, Seoul National University Hospital, Seoul; 2Institute of Reproductive Medicine and  Population, Medical Research Center, Seoul National University, Seoul; 3Department of Obstetrics and Gynecology, Seoul National University College of  Medicine, Seoul, Korea  Objective:  The aim of the present study was to examine the relationship among male age, strict morphology, and sperm chromatin structure  and condensation.",Non-OADS,/arxiv_data1/oa_pdf/04/a8/cerm-40-23.PMC3630289.pdf
"This is an Open Access article distributed under the terms of the Creative Commons Attribution  Non-Commercial License (http://creativecommons.org/licenses/by-nc/3.0/) which permits unrestricted non-commercial use, distribution, and reproduction in any medium, provided the original work is properly cited.",Non-OADS,/arxiv_data1/oa_pdf/04/a8/cerm-40-23.PMC3630289.pdf
" http://dx.doi.org/10.5653/cerm.2013.40.1.23 Clin Exp Reprod Med 2013;40(1):23-28 24ture assay, comet assay, and terminal deoxynucleotidyl transferase- mediated deoxyuridine triphosphate nick end labeling (TUNEL) as - say have been investigated.",OADS,/arxiv_data1/oa_pdf/04/a8/cerm-40-23.PMC3630289.pdf
" http://dx.doi.org/10.5653/cerm.2013.40.1.23 Clin Exp Reprod Med 2013;40(1):23-28 26Sperm chromatin condensation was negatively correlated with strict  morphology in the overall strict morphology ( r=-0.219, p=0.0029).",OADS,/arxiv_data1/oa_pdf/04/a8/cerm-40-23.PMC3630289.pdf
Available from: http://www.who.int/reproductivehealth/publi - cations/infertility/9789241547789/en/index.html.,Non-OADS,/arxiv_data1/oa_pdf/04/a8/cerm-40-23.PMC3630289.pdf
 http://dx.doi.org/10.5653/cerm.2013.40.1.23 Clin Exp Reprod Med 2013;40(1):23-28 28142-7.,OADS,/arxiv_data1/oa_pdf/04/a8/cerm-40-23.PMC3630289.pdf
"THE KOREAN SOCIETY FOR REPRODUCTIVE MEDICINE  29 ORIGINAL ARTICLE http://dx.doi.org/10.5653/cerm.2013.40.1.29 pISSN 2233-8233 · eISSN 2233-8241Clin Exp Reprod Med 2013;40(1):29-32 Natural conception rate following laparoscopic  surgery in infertile women with endometriosis Hye Jun Lee1, Jae Eun Lee2, Seung-Yup Ku2,3, Seok Hyun Kim2,3, Jung Gu Kim2, Shin Yong Moon2,3, Young Min Choi2,3 1Maria Fertility Hospital, Seoul; 2Department of Obstetrics and Gynecology, Seoul National University College of Medicine, Seoul; 3Clinical Research  Institute, Seoul National University, Seoul, Korea Objective:  To investigate the influence of laparoscopic surgery on the natural conception rate in infertile women with endometriosis during  the first year after the operation.",Non-OADS,/arxiv_data1/oa_pdf/48/1e/cerm-40-29.PMC3630290.pdf
"This is an Open Access article distributed under the terms of the Creative Commons Attribution  Non-Commercial License (http://creativecommons.org/licenses/by-nc/3.0/) which permits unrestricted non-commercial use, distribution, and reproduction in any medium, provided the original work is properly cited.",Non-OADS,/arxiv_data1/oa_pdf/48/1e/cerm-40-29.PMC3630290.pdf
 http://dx.doi.org/10.5653/cerm.2013.40.1.29 Clin Exp Reprod Med 2013;40(1):29-32 30and most of the conceptions took place during the first 3 months  postoperatively [9].,Non-OADS,/arxiv_data1/oa_pdf/48/1e/cerm-40-29.PMC3630290.pdf
 http://dx.doi.org/10.5653/cerm.2013.40.1.29 Clin Exp Reprod Med 2013;40(1):29-32 32global fertility outcome but was associated with a higher complica - tion rate.,Non-OADS,/arxiv_data1/oa_pdf/48/1e/cerm-40-29.PMC3630290.pdf
"THE KOREAN SOCIETY FOR REPRODUCTIVE MEDICINE  33 BRIEF COMMUNICATION http://dx.doi.org/10.5653/cerm.2013.40.1.33 pISSN 2233-8233 · eISSN 2233-8241Clin Exp Reprod Med 2013;40(1):33-37 Autophagy-related protein LC3 and Beclin-1 in the  first trimester of pregnancy Barbara Chifenti1*, Maria Teresa Locci1*, Gloria Lazzeri1, Mariangela Guagnozzi1, Dino Dinucci2, Federica Chiellini2,  Maria Elena Filice3, Maria Giovanna Salerno4, Lorella Battini4   1Department of Translational Research on New Technologies in Medicine and Surgery, University of Pisa Medical School, Pisa; 2BIOlab, Department of  Chemistry and Industrial Chemistry, University of Pisa, Pisa; 3Anatomy and Pathology Department, Section 2 Santa Chiara Hospital-University Health  Care System, Pisa; 4Obstetrics and Gynecology Unit 2, Santa Chiara Hospital-University Health Care System, Pisa, Italy Autophagy is a degradation process that acts in response to environmental stressors.",Non-OADS,/arxiv_data1/oa_pdf/7c/36/cerm-40-33.PMC3630291.pdf
"This is an Open Access article distributed under the terms of the Creative Commons Attribution  Non-Commercial License (http://creativecommons.org/licenses/by-nc/3.0/) which permits unrestricted non-commercial use, distribution, and reproduction in any medium, provided the original work is properly cited.",Non-OADS,/arxiv_data1/oa_pdf/7c/36/cerm-40-33.PMC3630291.pdf
" http://dx.doi.org/10.5653/cerm.2013.40.1.33 Clin Exp Reprod Med 2013;40(1):33-37 34to be a haploinsufficient tumor suppressor, being monoallelically de- leted in some tumors such as those of the breast, ovarian, and pros - tate [5-7].",Non-OADS,/arxiv_data1/oa_pdf/7c/36/cerm-40-33.PMC3630291.pdf
 http://dx.doi.org/10.5653/cerm.2013.40.1.33 Clin Exp Reprod Med 2013;40(1):33-37 36by immunofluorescence and western blotting analysis.,OADS,/arxiv_data1/oa_pdf/7c/36/cerm-40-33.PMC3630291.pdf
http://dx.doi.org/10.5301/JBM.2012.,OADS,/arxiv_data1/oa_pdf/7c/36/cerm-40-33.PMC3630291.pdf
THEKOREAN SOCIETY FORREPRODUCTIVE MEDICINE  38 CASEREPORT http://dx.doi.org/10.5653/cerm.2013.40.1.38 pISSN2233-8233·eISSN2233-8241ClinExpReprodMed2013;40(1):38-41 Ovarian stimulation and liver dysfunction: Is a clinical  relationship possible?,Non-OADS,/arxiv_data1/oa_pdf/e2/1f/cerm-40-38.PMC3630292.pdf
"At admission, she reported general malaise and non-specific  Received: Sep25,2012 ∙Revised: Nov23,2012 ∙Accepted: Dec5,2012 Corresponding author: Emilio Giugliano Department ofBiomedical Sciences andAdvanced Therapies, University of Ferrara, Corso Giovecca 183,44121 Ferrara, Italy Tel:+390-532236297 Fax:+390-532203844 E-mail: doctorgiugli@hotmail.it This is an Open Access article distributed under the terms of the Creative Commons Attribution  Non-Commercial License (http://creativecommons.org/licenses/by-nc/3.0/) which permits unrestricted non-commercial use, distribution, and reproduction in any medium, provided the original work is properly cited.",Non-OADS,/arxiv_data1/oa_pdf/e2/1f/cerm-40-38.PMC3630292.pdf
 http://dx.doi.org/10.5653/cerm.2013.40.1.38 Clin Exp Reprod Med 2013;40(1):38-41 40bosis and liver tissue ischemia.,Non-OADS,/arxiv_data1/oa_pdf/e2/1f/cerm-40-38.PMC3630292.pdf
"THEKOREAN SOCIETY FORREPRODUCTIVE MEDICINE  42 CASEREPORT http://dx.doi.org/10.5653/cerm.2013.40.1.42 pISSN2233-8233·eISSN2233-8241ClinExpReprodMed2013;40(1):42-46 Successful birth with preimplantation genetic  diagnosis using single-cell allele-specific PCR and sequencing in a woman with hypochondroplasia due to FGFR3  mutation (c.1620C>A, p.N540K) Kyung Eui Park1, Sung Ah Kim1,2, Moon Joo Kang1,2, Hee Sun Kim1,2, Sung Im Cho3, Kyoung Won Yoo3, So Yeon Kim3,4,  Hye Jun Lee1, Sun Kyung Oh1,2, Moon-Woo Seong3, Seung-Yup Ku1,2, Jong Kwan Jun1, Sung Sup Park3, Young Min Choi1,2,  Shin Yong Moon1,2 1Department of Obstetrics and Gynecology, Seoul National University Hospital, Seoul National University College of Medicine, Seoul; 2Institute of  Reproductive Medicine and Population, Medical Research Center, Seoul National University, Seoul; 3Laboratory Medicine, Seoul National University  Hospital, Seoul National University College of Medicine, Seoul; 4Department of Laboratory Medicine, National Medical Center, Seoul, Korea Hypochondroplasia (HCH) is an autosomal dominant inherited skeletal dysplasia, usually caused by a heterozygous mutation in the fibroblast  growth factor receptor 3 gene ( FGFR3 ).",Non-OADS,/arxiv_data1/oa_pdf/fe/f1/cerm-40-42.PMC3630293.pdf
"This is an Open Access article distributed under the terms of the Creative Commons Attribution  Non-Commercial License (http://creativecommons.org/licenses/by-nc/3.0/) which permits unrestricted non-commercial use, distribution, and reproduction in any medium, provided the original work is properly cited.",Non-OADS,/arxiv_data1/oa_pdf/fe/f1/cerm-40-42.PMC3630293.pdf
" http://dx.doi.org/10.5653/cerm.2013.40.1.42 Clin Exp Reprod Med 2013;40(1):42-46 44buffer, 200 μM dNTP , 10% DMSO, 0.4 μM of each inner primer (Table  1), and 1.25 U Taq DNA polymerase.",OADS,/arxiv_data1/oa_pdf/fe/f1/cerm-40-42.PMC3630293.pdf
 http://dx.doi.org/10.5653/cerm.2013.40.1.42 Clin Exp Reprod Med 2013;40(1):42-46 462009;26:263-71.,OADS,/arxiv_data1/oa_pdf/fe/f1/cerm-40-42.PMC3630293.pdf
"THE KOREAN SOCIETY FOR REPRODUCTIVE MEDICINE  7 ORIGINAL ARTICLE http://dx.doi.org/10.5653/cerm.2013.40.1.7 pISSN 2233-8233 · eISSN 2233-8241Clin Exp Reprod Med 2013;40(1):7-11 Fertilization and pregnancy potential of immature  oocytes from stimulated intracytoplasmic sperm injection cycles Seung Bi Shin1, Jae Won Cho1, Sun-Hee Lee1, Kwang Moon Yang2, Chun Kyu Lim1, Hyoung-Song Lee1 1Laboratory of Reproductive Biology and Infertility, 2Department of Obstetrics and Gynecology, Cheil General Hospital and Women’s Healthcare Center,  Kwandong University College of Medicine, Seoul, Korea Objective:  We evaluated the fertilization potential of immature oocytes obtained from controlled ovarian hyperstimulation cycles of patients  undergoing ICSI.",Non-OADS,/arxiv_data1/oa_pdf/39/a2/cerm-40-7.PMC3630294.pdf
"Immature oocytes released from ovarian folli - cles were shown to have the potential for spontaneous maturation in  vitro and subsequent development in different mammalian species, Received: Feb 8, 2013 ∙ Revised: Mar 4, 2013 ∙ Accepted: Mar 5, 2013 Corresponding author:  Hyoung-Song Lee Laboratory of Reproductive Biology and Infertility, Cheil General Hospital and Women’s Healthcare Center, Kwandong University College of Medicine, 17 Seoae-ro 1-gil, Jung-gu, Seoul 100-380, KoreaTel: +82-2-2000-7592 Fax: +82-2-2265-5621 E-mail: cghivf999@gmail.com This is an Open Access article distributed under the terms of the Creative Commons Attribution  Non-Commercial License (http://creativecommons.org/licenses/by-nc/3.0/) which permits unrestricted non-commercial use, distribution, and reproduction in any medium, provided the original work is properly cited.",Non-OADS,/arxiv_data1/oa_pdf/39/a2/cerm-40-7.PMC3630294.pdf
 http://dx.doi.org/10.5653/cerm.2013.40.1.7 Clin Exp Reprod Med 2013;40(1):7-11 8including humans [9].,OADS,/arxiv_data1/oa_pdf/39/a2/cerm-40-7.PMC3630294.pdf
 http://dx.doi.org/10.5653/cerm.2013.40.1.7 Clin Exp Reprod Med 2013;40(1):7-11 10in the number of embryos derived from immature oocytes cannot  be efficiently translated into pregnancy and live births.,Non-OADS,/arxiv_data1/oa_pdf/39/a2/cerm-40-7.PMC3630294.pdf
"Though this study was retrospective cohort COMMENTARY Open Access Received: February 13, 2013    Revised: February 27, 2013 Accepted: February 27, 2013 Correspondence:  Ki Baik Hahm Digestive Disease Center, CHA Bundang Medical Center, CHA University and  CHA Cancer Prevention Research Center, CHA Cancer Institute, 59 Yatap-ro,  Bundang-gu, Seongnam 463-712, KoreaTel: +82-31-780-5220, Fax: +82-31-780-5219, E-mail:  hahmkb@cha.ac.kr cc This is an Open Access article distributed under the terms of the Creative  Commons Attribution Non-Commercial License (http://creativecommons.org/ licenses/by-nc/3.0) which permits unrestricted non-commercial use, distribution,  and reproduction in any medium, provided the original work is properly cited.Print ISSN 2234-2400 / On-line ISSN 2234-2443 http://dx.doi.org/10.5946/ce.2013.46.2.111 Endoscopically Diagnosed Gastric Cancers: Looking Alike,   but Behave Differently Won Hee Kim and Ki Baik Hahm Digestive Disease Center, CHA Bundang Medical Center, CHA University, Seongnam, Korea See “Early Gastric Cancer-Like Advanced Gastric Cancer versus Advanced Gastric Cancer-Like Early Gastric Cancer” by  Hyun Sik Park, Sun-Y oung Lee, Sung Noh Hong, et al., on page 155-160",Non-OADS,/arxiv_data1/oa_pdf/69/20/ce-46-111.PMC3630301.pdf
"Correct classification of the type V pit pattern is essential, as it can suggest the pres -COMMENTARY Open Access Received: February 25, 2013    Revised: March 5, 2013 Accepted: March 5, 2013 Correspondence:  Yang Suh Ku Department of Gastroenterology, Gachon University Gil Medical Center, Ga - chon University of Medicine and Science, 21 Namdong-daero 774beon-gil,  Namdong-gu, Incheon 405-760, KoreaTel: +82-32-460-3778, Fax: +82-32-460-3408, E-mail:  yskoo@hanmail.net cc This is an Open Access article distributed under the terms of the Creative  Commons Attribution Non-Commercial License (http://creativecommons.org/ licenses/by-nc/3.0) which permits unrestricted non-commercial use, distribution,  and reproduction in any medium, provided the original work is properly cited.Print ISSN 2234-2400 / On-line ISSN 2234-2443 http://dx.doi.org/10.5946/ce.2013.46.2.113 Clinical Usefulness of Magnifying Chromoendoscopy and   Magnifying Narrow Band Imaging Endoscopy for Predicting   the Submucosal Invasion of Early Colorectal Cancers Kwang An Kwon and Yang Suh Ku Department of Gastroenterology, Gachon University Gil Medical Center, Gachon University of Medicine and Science, Incheon, Korea See “Diagnostic Accuracy and Interobserver Agreement in Predicting the Submucosal Invasion of Colorectal Tumors Using  Gross Findings, Pit Patterns, and Microvasculatures” by Hye Jung Choi, Bo-In Lee, Hwang Choi, et al., on page 168-171",Non-OADS,/arxiv_data1/oa_pdf/f9/48/ce-46-113.PMC3630302.pdf
"This heterogeneity accounts for inaccurate results of EUS-FNA par -COMMENTARY Open Access Received: February 13, 2013    Revised: February 26, 2013 Accepted: February 26, 2013 Correspondence:  Woo Jin Lee Pancreatobiliary Cancer Clinic, Center for Liver Cancer, National Cancer Cen - ter, 323 Ilsan-ro, Ilsandong-gu, Goyang 410-769, Korea Tel: +82-31-920-1612, Fax: +82-31-920-1138, E-mail:  lwj@ncc.re.kr cc This is an Open Access article distributed under the terms of the Creative  Commons Attribution Non-Commercial License (http://creativecommons.org/ licenses/by-nc/3.0) which permits unrestricted non-commercial use, distribution,  and reproduction in any medium, provided the original work is properly cited.Print ISSN 2234-2400 / On-line ISSN 2234-2443 http://dx.doi.org/10.5946/ce.2013.46.2.116 Endoscopic Ultrasound Elastography for Pancreatic Cancer   Diagnosis: A Step Forward?",Non-OADS,/arxiv_data1/oa_pdf/7a/75/ce-46-116.PMC3630303.pdf
DOI: http://dx.doi.org/0.1016/j.gie.2012.09.035.,OADS,/arxiv_data1/oa_pdf/7a/75/ce-46-116.PMC3630303.pdf
DOI: http://dx.doi.org/10.1007/s10620-012-2428-5.,Non-OADS,/arxiv_data1/oa_pdf/7a/75/ce-46-116.PMC3630303.pdf
"Key Words :  High-definition colonoscopy; Narrow band imaging; Colorectal polyps; Optical diagnosisOpen Access Received:  December 19, 2012    Revised:  January 3, 2013 Accepted:  January 7, 2013 Correspondence:  Hyung Wook Kim Department of Internal Medicine, Pusan National University School of Medi - cine, 49 Busandaehak-ro, Yangsan 626-815, Korea Tel: +82-55-360-1534, Fax: +82-55-360-1536  E-mail:  mdkhwook@gmail.com cc This is an Open Access article distributed under the terms of the Creative  Commons Attribution Non-Commercial License (http://creativecommons.org/ licenses/by-nc/3.0) which permits unrestricted non-commercial use, distribution,  and reproduction in any medium, provided the original work is properly cited.Print ISSN 2234-2400 / On-line ISSN 2234-2443 http://dx.doi.org/10.5946/ce.2013.46.2.118",Non-OADS,/arxiv_data1/oa_pdf/5f/ef/ce-46-118.PMC3630304.pdf
"Key Words :  Narrow band imaging; Optical diagnosis; Diminutive polypsOpen Access Received:  February 26, 2013    Revised:  March 11, 2013 Accepted:  March 11, 2013 Correspondence:  Amit Rastogi Division of Gastroenterology, Department of Medicine, Kansas City V A Medi - cal Center, University of Kansas School of Medicine, 4801 Linwood Boule - vard, Kansas City, MO 64128, USA Tel: +1-816-922-4737, Fax: +1-816-922-4737  E-mail:  amitr68@hotmail.com cc This is an Open Access article distributed under the terms of the Creative  Commons Attribution Non-Commercial License (http://creativecommons.org/ licenses/by-nc/3.0) which permits unrestricted non-commercial use, distribution,  and reproduction in any medium, provided the original work is properly cited.Print ISSN 2234-2400 / On-line ISSN 2234-2443 http://dx.doi.org/10.5946/ce.2013.46.2.120FOCUSED REVIEW SERIES:  Optical Diagnosis and New Management Strategy of Colorectal Polyps",Non-OADS,/arxiv_data1/oa_pdf/2d/e2/ce-46-120.PMC3630305.pdf
"Key Words :  Electronic chromoendoscopy; Colonoscopy; Polypectomy; Narrow band imaging;   Preservation and incorporation of valuable endoscopic innovationOpen Access Received:  January 28, 2013    Revised:  February 13, 2013 Accepted:  February 13, 2013 Correspondence:  Cesare Hassan Division of Gastroenterology, Ospedale Nuovo Regina Margherita Hospital,  Via E. Morosini 30, I-00153 Rome, Italy Tel: +39-3387922296, Fax: +39-3387922296, E-mail:  cesareh@hotmail.com cc This is an Open Access article distributed under the terms of the Creative  Commons Attribution Non-Commercial License (http://creativecommons.org/ licenses/by-nc/3.0) which permits unrestricted non-commercial use, distribution,  and reproduction in any medium, provided the original work is properly cited.Print ISSN 2234-2400 / On-line ISSN 2234-2443 http://dx.doi.org/10.5946/ce.2013.46.2.130 INTRODUCTION Any decision-making process in clinical medicine may be  simplified in a series of sequential steps that cumulatively lead  to a clinical diagnosis or intervention.",Non-OADS,/arxiv_data1/oa_pdf/8c/63/ce-46-130.PMC3630306.pdf
"Key Words :  Colorectal subumucosal carcinoma; Invasion depth; Pit pattern; Narrow band imaging; Magnifying colonoscopyOpen Access Received:  February 13, 2013    Revised:  March 8, 2013 Accepted:  March 8, 2013 Correspondence:  Shinji Tanaka Department of Endoscopy, Hiroshima University Hospital, 1-2-3 Kasumi, Min - ami-ku, Hiroshima 734-8551, Japan Tel: +81-257-5538, Fax: +81-253-2930, E-mail:  colon@hiroshima-u.ac.jp cc This is an Open Access article distributed under the terms of the Creative  Commons Attribution Non-Commercial License (http://creativecommons.org/ licenses/by-nc/3.0) which permits unrestricted non-commercial use, distribution,  and reproduction in any medium, provided the original work is properly cited.Print ISSN 2234-2400 / On-line ISSN 2234-2443 http://dx.doi.org/10.5946/ce.2013.46.2.138 INTRODUCTION The progress in endoscopy, from forceps biopsy to pit pat - tern-based diagnosis using magnifying observation and opti - cal diagnosis using image-enhanced endoscopy such as nar - row band imaging (NBI), has led the changes in the clinical  and pathological diagnosis of colorectal tumors.",Non-OADS,/arxiv_data1/oa_pdf/04/25/ce-46-138.PMC3630307.pdf
DOI: http://dx.doi.org/10.1007/ s00384-012-1612-6.,Non-OADS,/arxiv_data1/oa_pdf/04/25/ce-46-138.PMC3630307.pdf
"Key Words :  Capsule endoscopy; Bowel preparation; GuidelineOpen Access Received: February 28, 2012    Revised: April 24, 2012 Accepted: April 24, 2012 Correspondence:  Jeong Seop Moon Department of Internal Medicine, Inje University Seoul Paik Hospital, Inje Uni - versity College of Medicine, 9 Mareunnae-ro, Jung-gu, Seoul 100-032, Korea Tel: +82-2-2270-0012, Fax: +82-2-2279-4021, E-mail:  moonjs2@unitel.co.kr cc This is an Open Access article distributed under the terms of the Creative  Commons Attribution Non-Commercial License (http://creativecommons.org/ licenses/by-nc/3.0) which permits unrestricted non-commercial use, distribution,  and reproduction in any medium, provided the original work is properly cited.Print ISSN 2234-2400 / On-line ISSN 2234-2443 http://dx.doi.org/10.5946/ce.2013.46.2.147",Non-OADS,/arxiv_data1/oa_pdf/a4/89/ce-46-147.PMC3630308.pdf
Key MeSH terms used (http://www.nlm.nih.gov/mesh/MBrowser.html) were “capsule endoscopy” and “bowel preparation.,Non-OADS,/arxiv_data1/oa_pdf/a4/89/ce-46-147.PMC3630308.pdf
"The meta-analyses were performed using the Co - chrane Review tool ReVman version 5.1 (The Cochrane Col-laboration, Copenhagen, Denmark; http://ims.cochrane.org/revman).",OADS,/arxiv_data1/oa_pdf/a4/89/ce-46-147.PMC3630308.pdf
"Key Words :  Early gastric cancer; Advanced gastric cancer; Gastrointestinal endoscopyOpen Access Received:  April 11, 2012    Revised:  June 7, 2012 Accepted:  June 22, 2012 Correspondence:  Sun-Y oung Lee Department of Internal Medicine, Konkuk University School of Medicine, 120  Neungdong-ro, Gwangjin-gu, Seoul 143-729, Korea Tel: +82-2-2030-7747, Fax: +82-2-2030-7748, E-mail:  sunyoung@kuh.ac.kr cc This is an Open Access article distributed under the terms of the Creative  Commons Attribution Non-Commercial License (http://creativecommons.org/ licenses/by-nc/3.0) which permits unrestricted non-commercial use, distribution,  and reproduction in any medium, provided the original work is properly cited.Print ISSN 2234-2400 / On-line ISSN 2234-2443 http://dx.doi.org/10.5946/ce.2013.46.2.155 See commentary on page 111-112",Non-OADS,/arxiv_data1/oa_pdf/4a/b1/ce-46-155.PMC3630309.pdf
"Key Words :  Esophageal achalasia; Peroral endoscopic myotomy; High resolution manometryOpen Access Received:  September 3, 2012    Revised:  October 4, 2012 Accepted:  October 11, 2012 Correspondence:  Joo Y oung Cho Institute for Digestive Research, Digestive Disease Center, Department of In - ternal Medicine, Soonchunhyang University Hospital, Soonchunhyang Uni - versity College of Medicine, 59 Daesagwan-ro, Yongsan-gu, Seoul 140-743,  Korea Tel: +82-2-709-9581, Fax: +82-2-709-9696, E-mail:  cjy6695@dreamwiz.com cc This is an Open Access article distributed under the terms of the Creative  Commons Attribution Non-Commercial License (http://creativecommons.org/ licenses/by-nc/3.0) which permits unrestricted non-commercial use, distribution,  and reproduction in any medium, provided the original work is properly cited.Print ISSN 2234-2400 / On-line ISSN 2234-2443 http://dx.doi.org/10.5946/ce.2013.46.2.161",Non-OADS,/arxiv_data1/oa_pdf/c8/32/ce-46-161.PMC3630310.pdf
"Key Words :  Colorectal neoplasms; Colonoscopy; Neoplasm stagingOpen Access Received: May 28, 2012    Revised: October 24, 2012 Accepted: October 24, 2012 Correspondence:  Bo-In Lee Division of Gastroenterology, Department of Internal Medicine, Incheon St.  Mary’s Hospital, The Catholic University of Korea, 56 Dongsu-ro, Bupyeong-gu,  Incheon 403-720, KoreaTel: +82-32-280-5052, Fax: +82-32-280-5987, E-mail:  gidoc4u@catholic.ac.kr cc This is an Open Access article distributed under the terms of the Creative  Commons Attribution Non-Commercial License (http://creativecommons.org/ licenses/by-nc/3.0) which permits unrestricted non-commercial use, distribution,  and reproduction in any medium, provided the original work is properly cited.Print ISSN 2234-2400 / On-line ISSN 2234-2443 http://dx.doi.org/10.5946/ce.2013.46.2.168 See commentary on page 113-115",Non-OADS,/arxiv_data1/oa_pdf/d1/2b/ce-46-168.PMC3630311.pdf
"Key Words :  Elasticity imaging techniques; Endosonography; PancreasOpen Access Received: April 17, 2012    Revised: June 15, 2012 Accepted: June 17, 2012 Correspondence:  Y oung Deok Cho Institute for Digestive Research, Soonchunhyang University Hospital, Soonc - hunhyang University College of Medicine, 59 Daesagwan-ro, Yongsan-gu,  Seoul 140-743, KoreaTel: +82-2-709-9691, Fax: +82-2-709-9696, E-mail:  ydcho@schmc.ac.kr cc This is an Open Access article distributed under the terms of the Creative  Commons Attribution Non-Commercial License (http://creativecommons.org/ licenses/by-nc/3.0) which permits unrestricted non-commercial use, distribution,  and reproduction in any medium, provided the original work is properly cited.Print ISSN 2234-2400 / On-line ISSN 2234-2443 http://dx.doi.org/10.5946/ce.2013.46.2.172 See commentary on page 116-117",Non-OADS,/arxiv_data1/oa_pdf/18/1b/ce-46-172.PMC3630312.pdf
"Key Words :  Enteritis cystica profunda; Choledochal cyst; Ampulla of Vater; DuodenumOpen Access Received:  February 29, 2012    Revised:  April 9, 2012 Accepted:  April 16, 2012 Correspondence:  Sang Wook Park Department of Internal Medicine, Kwangju Christian Hospital, 37 Yangnim- ro, Nam-gu, Gwangju 503-715, Korea Tel: +82-62-650-5023, Fax: +82-62-650-5277, E-mail:  kch20113@hanmail.net cc This is an Open Access article distributed under the terms of the Creative  Commons Attribution Non-Commercial License (http://creativecommons.org/ licenses/by-nc/3.0) which permits unrestricted non-commercial use, distribution,  and reproduction in any medium, provided the original work is properly cited.Print ISSN 2234-2400 / On-line ISSN 2234-2443 http://dx.doi.org/10.5946/ce.2013.46.2.178",Non-OADS,/arxiv_data1/oa_pdf/d3/0b/ce-46-178.PMC3630313.pdf
"Key Words :  Esophageal neoplasms; Endosonography; Endoscopic resection; RecurrenceOpen Access Received: February 28, 2012    Revised: April 3, 2012 Accepted: May 17, 2012 Correspondence:  Gwang Ha Kim  Department of Internal Medicine, Pusan National University School of Medi - cine and Biomedical Research Institute, Pusan National University Hospital,  179 Gudeok-ro, Seo-gu, Busan 602-739, KoreaTel: +82-51-240-7869, Fax: +82-51-244-8180, E-mail:  doc0224@pusan.ac.kr cc This is an Open Access article distributed under the terms of the Creative  Commons Attribution Non-Commercial License (http://creativecommons.org/ licenses/by-nc/3.0) which permits unrestricted non-commercial use, distribution,  and reproduction in any medium, provided the original work is properly cited.Print ISSN 2234-2400 / On-line ISSN 2234-2443 http://dx.doi.org/10.5946/ce.2013.46.2.182",Non-OADS,/arxiv_data1/oa_pdf/72/a7/ce-46-182.PMC3630314.pdf
"Key Words :  Fibrovascular; Polyps; Stomach; MelenaOpen Access Received:  February 14, 2012    Revised:  May 30, 2012 Accepted:  June 20, 2012 Correspondence:  Seung Goun Hong Department of Internal Medicine, SAM Medical Center, 9 Samdeok-ro, Man - an-gu, Anyang 430-733, Korea Tel: +82-31-467-9114, Fax: +82-31-449-0151, E-mail:  perm@naver.com cc This is an Open Access article distributed under the terms of the Creative  Commons Attribution Non-Commercial License (http://creativecommons.org/ licenses/by-nc/3.0) which permits unrestricted non-commercial use, distribution,  and reproduction in any medium, provided the original work is properly cited.Print ISSN 2234-2400 / On-line ISSN 2234-2443 http://dx.doi.org/10.5946/ce.2013.46.2.186",Non-OADS,/arxiv_data1/oa_pdf/bf/36/ce-46-186.PMC3630315.pdf
"Key Words :  Hypopharyngeal neoplasms; Carcinoma, squamous cell; Endoscopic mucosal resectionOpen Access Received:  February 6, 2012    Revised:  June 27, 2012 Accepted:  June 29, 2012 Correspondence:  Joo Y oung Cho Digestive Disease Center, Soonchunhyang University Hospital, Soonchunhy - ang University College of Medicine, 59 Daesagwan-ro, Yongsan-gu, Seoul  140-743, Korea Tel: +82-2-709-9202, Fax: +82-2-709-9696, E-mail:  cjy6695@dreamwiz.com cc This is an Open Access article distributed under the terms of the Creative  Commons Attribution Non-Commercial License (http://creativecommons.org/ licenses/by-nc/3.0) which permits unrestricted non-commercial use, distribution,  and reproduction in any medium, provided the original work is properly cited.Print ISSN 2234-2400 / On-line ISSN 2234-2443 http://dx.doi.org/10.5946/ce.2013.46.2.189",Non-OADS,/arxiv_data1/oa_pdf/7b/9e/ce-46-189.PMC3630316.pdf
"Key Words :  Xanthogranulomatous inflammation; Terminal ileum; NeoplasmsOpen Access Received:  May 15, 2012    Revised:  July 31, 2012 Accepted:  July 31, 2012 Correspondence:  Y ong Cheol Jeon Department of Internal Medicine, Hanyang University Guri Hospital, Han - yang University College of Medicine, 153 Gyeongchun-ro, Guri 471-701, Korea Tel: +82-31-560-2227, Fax: +82-31-555-2998, E-mail:  ycjeon@hanyang.ac.kr cc This is an Open Access article distributed under the terms of the Creative  Commons Attribution Non-Commercial License (http://creativecommons.org/ licenses/by-nc/3.0) which permits unrestricted non-commercial use, distribution,  and reproduction in any medium, provided the original work is properly cited.Print ISSN 2234-2400 / On-line ISSN 2234-2443 http://dx.doi.org/10.5946/ce.2013.46.2.193",Non-OADS,/arxiv_data1/oa_pdf/d0/82/ce-46-193.PMC3630317.pdf
"Key Words :  Neoplasm metastasis; Esophageal neoplasms; Squamous cell carcinomaOpen Access Received:  May 30, 2012    Revised:  August 29, 2012 Accepted:  October 23, 2012 Correspondence:  Jae Y oung Jang Division of Gastroenterology and Hepatology, Department of Internal Medi - cine, Kyung Hee University Medical Center, Kyung Hee University School of  Medicine, 23 Kyungheedae-ro, Dongdaemun-gu, Seoul 130-872, Korea Tel: +82-2-958-8200, Fax: +82-2-968-1848, E-mail:  jyjang@khu.ac.kr cc This is an Open Access article distributed under the terms of the Creative  Commons Attribution Non-Commercial License (http://creativecommons.org/ licenses/by-nc/3.0) which permits unrestricted non-commercial use, distribution,  and reproduction in any medium, provided the original work is properly cited.Print ISSN 2234-2400 / On-line ISSN 2234-2443 http://dx.doi.org/10.5946/ce.2013.46.2.197",Non-OADS,/arxiv_data1/oa_pdf/30/50/ce-46-197.PMC3630318.pdf
"BRIEF REPORT Balloon Catheter Assisted Biliary Stent Insertion Chang-Il Kwon and Kwang Hyun Ko Digestive Disease Center, CHA Bundang Medical Center, CHA University, Seongnam, KoreaOpen Access Received: July 2, 2012    Revised: September 27, 2012 Accepted: September 27, 2012 Correspondence:  Kwang Hyun Ko Digestive Disease Center, CHA Bundang Medical Center, CHA University, 59  Yatap-ro, Bundang-gu, Seongnam 463-712, Korea Tel: +82-31-780-5220, Fax: +82-31-780-5219, E-mail:  bluehipp@cha.ac.kr cc This is an Open Access article distributed under the terms of the Creative  Commons Attribution Non-Commercial License (http://creativecommons.org/ licenses/by-nc/3.0) which permits unrestricted non-commercial use, distribution,  and reproduction in any medium, provided the original work is properly cited.Print ISSN 2234-2400 / On-line ISSN 2234-2443 http://dx.doi.org/10.5946/ce.2013.46.2.201",Non-OADS,/arxiv_data1/oa_pdf/0e/cb/ce-46-201.PMC3630319.pdf
Additional information Supplementary information accompanies this paper at http://www.nature.com/ scientificreports Competing financial interests: A.O.,Non-OADS,/arxiv_data1/oa_pdf/3e/05/srep01664.PMC3630328.pdf
"To view a copy of this license, visit http://creativecommons.org/licenses/by-nc-nd/3.0/ How to cite this article: Su, T. et al.",Non-OADS,/arxiv_data1/oa_pdf/3e/05/srep01664.PMC3630328.pdf
"Korean Journal of Urology ⒸThe Korean Urological Association, 2013 213 Korean J Urol 2013;54:213-219www.kjurology.org http://dx.doi.org/10.4111/kju.2013.54.4.213 Review Article Current Status of 5 α-Reductase Inhibitors in Prostate Disease  Management Dong Il Kang, Jae Il Chung Department of Urology, Inje University Busan Paik Hosp ital, Inje University College of Medicine, Busan, Korea The key enzyme in the androgen synthesi s and androgen receptor pathways is 5 α-re- ductase (5-AR), which occurs as three isoen zymes.",Non-OADS,/arxiv_data1/oa_pdf/11/81/kju-54-213.PMC3630338.pdf
"Keywords:  5-alpha reductase inhibitor; Hemospermia; Prostatic hyperplasia;  Prostate  neoplasms This is an Open Access article distributed under the te rms of the Creative Commons Attribution Non-Commercial  License (http://creativecommons.org /licenses/by-nc/3.0) which permit s unrestricted non-commercial use,  distribution, and reproduction in any medium, provided the original work is properly cited.Article History: received 12 March, 2013 accepted 21 March, 2013 Corresponding Author: Jae Il Chung Department of Urology, Inje  University Busan Paik Hospital, Inje University College of  Medicine, 75 Bokji-ro, Busanjin-  gu, Busan 614-735, KoreaTEL: +82-51-890-6384 FAX: +82-51-892-2728 E-mail: prosdoc@hanmail.net INTRODUCTION Benign prostatic hyperplasia (BPH) and prostate cancer  are the most common diseases of men, and the incidence of these diseases increases with age.",Non-OADS,/arxiv_data1/oa_pdf/11/81/kju-54-213.PMC3630338.pdf
Available from: http://www.uroweb.org/guidelines/online-guidelines/.,Non-OADS,/arxiv_data1/oa_pdf/11/81/kju-54-213.PMC3630338.pdf
Avaiable from:  http://www.nice.org.uk/nicemedia/live/12984/48557/48557.pdf.,Non-OADS,/arxiv_data1/oa_pdf/11/81/kju-54-213.PMC3630338.pdf
Available  from: http://www.fda.gov/Drugs/DrugSafety/ucm258314.htm.,Non-OADS,/arxiv_data1/oa_pdf/11/81/kju-54-213.PMC3630338.pdf
Avaiable from:  http://www.auanet.org/conte nt/media/pcredinh.pdf.,Non-OADS,/arxiv_data1/oa_pdf/11/81/kju-54-213.PMC3630338.pdf
"Korean Journal of Urology ⒸThe Korean Urological Association, 2013 220 Korean J Urol 2013;54:220-228www.kjurology.org http://dx.doi.org/10.4111/kju.2013.54.4.220 Review Article Citation Analysis of the Korean Journal of Urology From Web of  Science, Scopus, Korean Medical Citation Index, KoreaMed Synapse, and Google Scholar Sun Huh Department of Parasitology and Institute of Medical Education, Hallym University College of Medicine, Chuncheon, Korea The Korean Journal of Urology  began to be published exclusively in English in 2010  and is indexed in PubMed Central/PubMed.",Non-OADS,/arxiv_data1/oa_pdf/da/48/kju-54-220.PMC3630339.pdf
"Keywords:  Analysis; Bibliometrics; Database; Korea This is an Open Access article distributed under the te rms of the Creative Commons Attribution Non-Commercial  License (http://creativecommons.org /licenses/by-nc/3.0) which permit s unrestricted non-commercial use,  distribution, and reproduction in any medium, provided the original work is properly cited.Article History: received 22 February, 2013 accepted 19 March, 2013 Corresponding Author: Sun HuhDepartment of Parasitology and  Institute of Medical Education,  Hallym University College of Medicine, 1 Hallimdaehak-gil,  Chuncheon 200-702, Korea  TEL: +82-33-248-2652FAX: +82-33-241-1672 E-mail: shuh@hallym.ac.kr INTRODUCTION The Korean Journal of Urology  (KJU) is the official English-  language open access journal of the Korean Urological Association.",Non-OADS,/arxiv_data1/oa_pdf/da/48/kju-54-220.PMC3630339.pdf
Available from: http://www.webofknowledge.com/wos/.,Non-OADS,/arxiv_data1/oa_pdf/da/48/kju-54-220.PMC3630339.pdf
Available from: http://www.scopus.com/.,Non-OADS,/arxiv_data1/oa_pdf/da/48/kju-54-220.PMC3630339.pdf
Available from: http://scimagojr.com/.,Non-OADS,/arxiv_data1/oa_pdf/da/48/kju-54-220.PMC3630339.pdf
Avail able from: http://komci.org/.,Non-OADS,/arxiv_data1/oa_pdf/da/48/kju-54-220.PMC3630339.pdf
"Korean Journal of Urology ⒸThe Korean Urological Association, 2013 229 Korean J Urol 2013;54:229-233www.kjurology.org http://dx.doi.org/10.4111/kju.2013.54.4.229 Urological Oncology The Establishment of K-CaP (the Multicenter Korean Prostate  Cancer Database) Dong Hoon Lee, Seung Hwan Lee, Koon Ho Rha, In Young Choi1, Ji Youl Lee2, Sae Woong Kim2,  Sangchul Lee3, Sung Kyu Hong3, Seok-Soo Byun3, In Gab Jeong4, Jun Hyuk Hong4, Choung-Soo Kim4,  Hwang Gyun Jeon5, Hyun Moo Lee5, Byung Ha Chung  Department of Urology, Urological Science Institute, Yonsei University College of Medicine, Seoul, 1Graduate School of Management and  Policy, The Catholic University of Korea, Seoul, 2Department of Urology, Seoul St. Mary’s Hospital, The Catholic University of Korea College  of Medicine, Seoul, 3Department of Urology, Seoul National University Bundang Hospital, Seongnam, 4Department of Urology, Asan  Medical Center, University of Ulsan College of Medicine, Seoul, 5Department of Urology, Samsung Medical Center, Sungkyunkwan  University School of Medicine, Seoul, Korea Purpose:  The purpose of this article was to announce the establishment of the multi- center Korean Prostate Cancer  Database (K-CaP) and to provide urologists with details  about K-CaP’s methodology.",Non-OADS,/arxiv_data1/oa_pdf/79/cb/kju-54-229.PMC3630340.pdf
"Keywords:  Database; K-CaP; Korea; Prostate neoplasms This is an Open Access article distributed under the te rms of the Creative Commons Attribution Non-Commercial  License (http://creativecommons.org /licenses/by-nc/3.0) which permit s unrestricted non-commercial use,  distribution, and reproduction in any medium, provided the original work is properly cited.Article History: received 2 May, 2012 accepted 10 July, 2012 Corresponding Author: Byung Ha Chung Department of Urology, Yonsei  University College of Medicine, 50 Yonsei-ro, Seodaemun-gu,  Seoul 120-752, Korea TEL: +82-2-2019-3470FAX: +82-2-3462-8887 E-mail: chung646@yuhs.ac INTRODUCTION The prevalence of prostate cancer in Korea quadrupled be- tween 2002 and 2008, with the highest increased incidence rate in total forms of malignan cy [1].",Non-OADS,/arxiv_data1/oa_pdf/79/cb/kju-54-229.PMC3630340.pdf
"SUPPLEMENTARY MATERIALS Scan this QR code to see the supplementary materials, or  visit http://kjurology.org/src/sm/kju-54-229-s001.pdf.REFERENCES  1.",Non-OADS,/arxiv_data1/oa_pdf/79/cb/kju-54-229.PMC3630340.pdf
Available from: http://kostat.go.kr/portal/english/index.action.,Non-OADS,/arxiv_data1/oa_pdf/79/cb/kju-54-229.PMC3630340.pdf
"Korean Journal of Urology ⒸThe Korean Urological Association, 2013 234 Korean J Urol 2013;54:234-238www.kjurology.org http://dx.doi.org/10.4111/kju.2013.54.4.234 Urological Oncology Can Diffusion-Weighted Magnetic Resonance Imaging Predict a  High Gleason Score of Prostate Cancer?",Non-OADS,/arxiv_data1/oa_pdf/64/c1/kju-54-234.PMC3630341.pdf
"Keywords:  Diffusion magnetic resonance imaging; Neoplasm grading; Prostatic neoplasms This is an Open Access article distributed under the te rms of the Creative Commons Attribution Non-Commercial  License (http://creativecommons.org /licenses/by-nc/3.0) which permit s unrestricted non-commercial use,  distribution, and reproduction in any medium, provided the original work is properly cited.Article History: received 24 August, 2012 accepted 4 October, 2012 Corresponding Author: Katsumi Shigemura Department of Urology, Kobe University Graduate School of  Medicine, 7-5-1, Kusunoki-cho,  Chuo-ku, Kobe 650-0017, JapanTEL: +81-78-382-6155 FAX: +81-78-382-6169 E-mail: yutoshunta@hotmail.co.jp INTRODUCTION Magnetic resonance imaging (MRI) for prostate cancer (PC)  diagnosis was previously mainly performed with conven-tional T2-weighted imaging (WI), and the quality for this pur-pose is in general limited to staging for organ-confined PC or the presence of extracapsular extension and seminal vesicle invasion.",Non-OADS,/arxiv_data1/oa_pdf/64/c1/kju-54-234.PMC3630341.pdf
"Korean Journal of Urology ⒸThe Korean Urological Association, 2013 239 Korean J Urol 2013;54:239-243www.kjurology.org http://dx.doi.org/10.4111/kju.2013.54.4.239 Lasers in Urology Application of the Modified Clavien Classification System to 120W  Greenlight High-Performance System Photoselective Vaporization of the Prostate for Benign Prostatic Hyperplasia: Is It Useful for Less-Invasive Procedures?",Non-OADS,/arxiv_data1/oa_pdf/cd/cc/kju-54-239.PMC3630342.pdf
"Keywords:  Complications; Lasers; Prostatic hy perplasia; Transurethral resection of  prostate; Transurethral vaporesection of prostate This is an Open Access article distributed under the te rms of the Creative Commons Attribution Non-Commercial  License (http://creativecommons.org /licenses/by-nc/3.0) which permit s unrestricted non-commercial use,  distribution, and reproduction in any medium, provided the original work is properly cited.Article History: received 27 August, 2012 accepted 20 October, 2012 Corresponding Author: Hwancheol Son Department of Urology, SMG-SNU Boramae Medical  Center, 20 Boramae-ro 5-gil,  Dongjak-gu, Seoul 156-707, Korea  TEL: +82-2-870-2391 FAX: +82-2-870-3863E-mail: volley@snu.ac.kr INTRODUCTION Although many variables must be considered in the quality  assessment of surgical outcom es, previous investigations  have shown that the Clavien classification system (CCS) for the evaluation of postoperative complications has been accepted since 1992 as a desi rable, standardized platform of accuracy and reliability for comparing surgical outcomes  among different inst itutions, surgeons, or operative tech- niques [1].",Non-OADS,/arxiv_data1/oa_pdf/cd/cc/kju-54-239.PMC3630342.pdf
"Korean Journal of Urology ⒸThe Korean Urological Association, 2013 244 Korean J Urol 2013;54:244-248www.kjurology.org http://dx.doi.org/10.4111/kju.2013.54.4.244 Laparoscopy/Robotics A Comparative Study of Laparoendoscopic Single-Site Surgery  Versus Conventional Laparoscopy for Upper Urinary Tract Malignancies Jongchan Kim, Ho Song Yu1, Kang Su Cho, Woong Kyu Han, Won Sik Ham Department of Urology, Urological Science Institut e, Yonsei University College of Medicine, Seoul, 1Department of Urology, Chonnam  National University Hospital, Chonnam National  University Medical School, Gwangju, Korea Purpose:  The proper indication fo r laparoendoscopic single-sit e surgery (LESS) in urol- ogy is still under debate, especially for ma lignant diseases.",Non-OADS,/arxiv_data1/oa_pdf/75/c2/kju-54-244.PMC3630343.pdf
"Keywords:  Laparoscopy; Nephrectomy; Renal cell carcinoma; Ureteral neoplasms This is an Open Access article distributed under the te rms of the Creative Commons Attribution Non-Commercial  License (http://creativecommons.org /licenses/by-nc/3.0) which permit s unrestricted non-commercial use,  distribution, and reproduction in any medium, provided the original work is properly cited.Article History: received 21 April, 2012 accepted 10 September, 2012 Corresponding Author: Won Sik HamDepartment of Urology, Yonsei  University College of Medicine,  50 Yonsei-ro, Seodaemun-gu,  Seoul 120-749, Korea TEL: +82-2-2228-2313 FAX: +82-2-312-2538E-mail: uroham@yuhs.ac INTRODUCTION During the last 10 years, the transition from conventional  laparoscopy (CL) to laparoen doscopic single-site surgery  (LESS) as a step toward scar-free surgery may represent a paradigm shift in reconstr uctive and extirpative sur- geries in many surgical fields .",Non-OADS,/arxiv_data1/oa_pdf/75/c2/kju-54-244.PMC3630343.pdf
"Korean Journal of Urology ⒸThe Korean Urological Association, 2013 249 Korean J Urol 2013;54:249-251www.kjurology.org http://dx.doi.org/10.4111/kju.2013.54.4.249 Voiding Dysfunction Homogeneity Among the Korean International Prostate Symptom  Score Questionnaires Used in Real Practice Jae Heon Kim, Seung Whan Doo, Won Jae Yang, Yun Seob Song Department of Urology, Soonchunhyang University Seoul Hospital, Soonchunhyang University College of Medicine, Seoul, Korea Purpose:  We analyzed whether any problems existed in terms of the homogeneity of  the Korean International Prostate Symptom Score (IPSS) questionnaire used in real  practice.",Non-OADS,/arxiv_data1/oa_pdf/1a/9f/kju-54-249.PMC3630344.pdf
"Keywords:  Questionnaires; Reproducibility of results This is an Open Access article distributed under the te rms of the Creative Commons Attribution Non-Commercial  License (http://creativecommons.org /licenses/by-nc/3.0) which permit s unrestricted non-commercial use,  distribution, and reproduction in any medium, provided the original work is properly cited.Article History: received 9 October, 2012 accepted 9 November, 2012 Corresponding Author: Won Jae YangDepartment of Urology,  Soonchunhyang University Seoul  Hospital, Soonchunhyang University College of Medicine,  59 Daesagwan-ro, Yongsan-gu,  Seoul 140-743, Korea TEL: +82-2-709-9378 FAX: +82-2-709-9272 E-mail: wonjya@schmc.ac.kr  INTRODUCTION Questionnaires are one of the most commonly used techni- ques for collecting health-relat ed information in clinical  studies because of their ease and simplicity of use.",Non-OADS,/arxiv_data1/oa_pdf/1a/9f/kju-54-249.PMC3630344.pdf
"We are indebted to Sun-Hwa Kim and the business staff  of Sales Unit I team of Astellas Pharma Korea, Inc. for col-lecting data.SUPPLEMENTARY MATERIALS Scan this QR code to see the supplementary materials, or  visit http://kjurology.org/src/sm/kju-54-249-s001.pdf.",Non-OADS,/arxiv_data1/oa_pdf/1a/9f/kju-54-249.PMC3630344.pdf
"Korean Journal of Urology ⒸThe Korean Urological Association, 2013 252 Korean J Urol 2013;54:252-257www.kjurology.org http://dx.doi.org/10.4111/kju.2013.54.4.252 Endourology/Urolithiasis Diosmin Reduces Calcium Oxalate Deposition and Tissue  Degeneration in Nephrolithiasis in Rats: A Stereological Study Ali Noorafshan, Saied Karbalay-Doust, Fatemeh Karimi  Histomorphometry and Stereology Research Center, Shiraz University of Medical Sciences, Shiraz, Iran Purpose:  Kidney stones (nephrolithiasis) are a widespread disease.",Non-OADS,/arxiv_data1/oa_pdf/36/ac/kju-54-252.PMC3630345.pdf
"Keywords:  Calcium oxalate; Diosmin;  Nephrolithiasis; Stereology This is an Open Access article distributed under the te rms of the Creative Commons Attribution Non-Commercial  License (http://creativecommons.org /licenses/by-nc/3.0) which permit s unrestricted non-commercial use,  distribution, and reproduction in any medium, provided the original work is properly cited.Article History: received 2 May, 2012 accepted 3 July, 2012 Corresponding Author: Saied Karbalay-Doust Histomorphometry and  Stereology Research Center,  Shiraz University of Medical Sciences, Zand Ave., Shiraz  71348, Iran TEL: +98-711-2304372FAX: +98-711-2304372 E-mail: karbalas@sums.ac.ir INTRODUCTION Diosmin is a member of the citrus flavonoid family and is  a modified form of hesperidin [1-4].",Non-OADS,/arxiv_data1/oa_pdf/36/ac/kju-54-252.PMC3630345.pdf
"Korean Journal of Urology ⒸThe Korean Urological Association, 2013 258 Korean J Urol 2013;54:258-262www.kjurology.org http://dx.doi.org/10.4111/kju.2013.54.4.258 Endourology/Urolithiasis Optimal Management of Lower Polar Calyceal Stone 15 to 20 mm Naveed Haroon, Syed M Nazim, M Hammad Ather Department of Surgery, Aga Khan University, Karachi, Pakistan Purpose:  To compare the stone clearance rate, e fficiency quotient (EQ), and early com- plications of shock wave li thotripsy (SWL) and percutaneo us nephrolithotomy (PCNL)  for solitary lower-pole renal stones measuring 15 to 20 mm.",Non-OADS,/arxiv_data1/oa_pdf/73/0c/kju-54-258.PMC3630346.pdf
"Keywords:  Lithotripsy; Percutaneous nephrostomy; Renal calculi This is an Open Access article distributed under the te rms of the Creative Commons Attribution Non-Commercial  License (http://creativecommons.org /licenses/by-nc/3.0) which permit s unrestricted non-commercial use,  distribution, and reproduction in any medium, provided the original work is properly cited.Article History: received 16 February, 2011 accepted 13 August, 2012 Corresponding Author: M Hammad AtherDepartment of Surgery, Aga  Khan University, PO Box 3500,  Stadium Road, Karachi 74800, Pakistan TEL: +92-213-4864778 FAX: +92-213-4934294Email: hammad.ather@aku.edu INTRODUCTION The optimal management of lowe r-pole calculi has been un- der debate, and the ideal trea tment remains controversial  [1].",Non-OADS,/arxiv_data1/oa_pdf/73/0c/kju-54-258.PMC3630346.pdf
Available  from: http://www.uroweb.org/g ls/pdf/18_Urolithiasis.pdf.,Non-OADS,/arxiv_data1/oa_pdf/73/0c/kju-54-258.PMC3630346.pdf
"Korean Journal of Urology ⒸThe Korean Urological Association, 2013 263 Korean J Urol 2013;54:263-265www.kjurology.org http://dx.doi.org/10.4111/kju.2013.54.4.263 Male Infertility Klinefelter Syndrome Diagnosed by Prenatal Screening Tests in  High-Risk Groups  Dae Gi Jo, Ju Tae Seo, Joong Shik Lee, So Yeon Park1, Jin Woo Kim1  Department of Urology, 1Laboratory of Medical Genetics, Cheil General Hospital & Women 's Healthcare Center, Kwandong University  College of Medicine, Seoul, Korea Purpose:  Klinefelter syndrome is a chromosomal di sorder present in 1 out of 400 to 1,000  male newborns in Western populations.",Non-OADS,/arxiv_data1/oa_pdf/1d/79/kju-54-263.PMC3630347.pdf
"Keywords:  Karyotype; Klinefelter sy ndrome; Male infertility  This is an Open Access article distributed under the te rms of the Creative Commons Attribution Non-Commercial  License (http://creativecommons.org /licenses/by-nc/3.0) which permit s unrestricted non-commercial use,  distribution, and reproduction in any medium, provided the original work is properly cited.Article History: received 31 August, 2012 accepted 24 December, 2012 Corresponding Author: Ju Tae Seo  Department of Urology, Cheil  General Hospit al & Women's  Healthcare Center, Kwandong  University College of Medicine,  17 Seoae-ro 1-gil, Jung-gu, Seoul 100-380, Korea TEL: +82-2-2000-7585 FAX: +82-2-2000-7787E-mail: jtandro@cgh.co.kr INTRODUCTION Klinefelter syndrome was first described in 1942 as an en- docrine disorder caused by a supernumerary X chromo-some that is characterized by gynecomastia, small testes, absent spermatogenesis, normal to moderately reduced Leydig cell function, and increased secretion of follicle-sti-mulating hormone [1,2].",Non-OADS,/arxiv_data1/oa_pdf/1d/79/kju-54-263.PMC3630347.pdf
"Korean Journal of Urology ⒸThe Korean Urological Association, 2013 266 Korean J Urol 2013;54:266-270www.kjurology.org http://dx.doi.org/10.4111/kju.2013.54.4.266 Basic and Translational Research Expression of Aquaporin-3 in Ipsilateral Rat Kidney With  Unilateral Partial Ureteral Obstruction Ji Yong Lee, Ju Hyun Shin, Ki Hak Song, Jae Sung Lim, Chong Koo Sul Department of Urology, Chungnam National University School of Medicine, Daejeon, Korea  Purpose:  Aquaporin (AQP), a protein located in the cellular membrane, allows rapid  passage of water across the cell membrane.",Non-OADS,/arxiv_data1/oa_pdf/55/46/kju-54-266.PMC3630348.pdf
"Keywords:  Aquaporin 3; Ureteral obstruction This is an Open Access article distributed under the te rms of the Creative Commons Attribution Non-Commercial  License (http://creativecommons.org /licenses/by-nc/3.0) which permit s unrestricted non-commercial use,  distribution, and reproduction in any medium, provided the original work is properly cited.Article History: received 7 September, 2012 accepted 2 November, 2012 Corresponding Author: Ki Hak SongDepartment of Urology,  Chungnam National University  School of Medicine, 266 Munhwa-ro, Jung-gu, Daejeon  301-747, Korea TEL: +82-42-280-7777FAX: +82-42-257-0966 E-mail: urosong@cnu.ac.kr  INTRODUCTION Urinary tract obstruction is a serious and common clinical  condition associated with increased intraluminal pressure in the ureter and renal tubule s that can cause renal paren- chymal damage through a series  of direct and indirect ef- fects [1].",Non-OADS,/arxiv_data1/oa_pdf/55/46/kju-54-266.PMC3630348.pdf
"Korean Journal of Urology ⒸThe Korean Urological Association, 2013 271 Korean J Urol 2013;54:271-273www.kjurology.org http://dx.doi.org/10.4111/kju.2013.54.4.271 Case Report Lung Metastasis of Ta Bladder Cancer: A Case Report and  Literature Review Takeshi Sano, Shinshichi Hamada1, Takao Haitani, Masakazu Nakashima2, Yoichiro Kajita,  Yasumasa Shichiri  Departments of Urology and 1Pathology, Otsu Municipal Hospital, Otsu, 2Department of Urology, Kyoto Un iversity Graduate School of  Medicine, Kyoto, Japan A 66-year-old man with a history of multip le transurethral resections for recurrent  bladder tumors, staged as Ta according to the Internationa l Union Against Cancer stag- ing guidelines, presented with a complaint of dry cough.",Non-OADS,/arxiv_data1/oa_pdf/c7/08/kju-54-271.PMC3630349.pdf
"Keywords:  Indirect fluorescent antibody techni que; Solitary pulmonary nodule;  Urinary bladder neoplasms  This is an Open Access article distributed under the te rms of the Creative Commons Attribution Non-Commercial  License (http://creativecommons.org /licenses/by-nc/3.0) which permit s unrestricted non-commercial use,  distribution, and reproduction in any medium, provided the original work is properly cited.Article History: received 28 October, 2011 accepted 29 December, 2011 Corresponding Author: Takeshi Sano Department of Urology, Otsu  Municipal Hospital, 2-9-9 Motomiya, Otsu 520-0804, Japan TEL: +81-77-522-4607 FAX: +81-77-521-5414E-mail: sanotake@kuhp.kyoto-u.",Non-OADS,/arxiv_data1/oa_pdf/c7/08/kju-54-271.PMC3630349.pdf
"Korean Journal of Urology ⒸThe Korean Urological Association, 2013 274 Korean J Urol 2013;54:274-276www.kjurology.org http://dx.doi.org/10.4111/kju.2013.54.4.274 Case Report Malacoplakia of the Epididymis Yu Jin Kang, Sung Woo Kim1, Kyung Seop Lee, Ki Ho Kim Departments of Urology and 1Radiology, Dongguk University College of Medicine, Gyeongju, Korea Malacoplakia is a chronic inflammatory dise ase.",Non-OADS,/arxiv_data1/oa_pdf/5a/bb/kju-54-274.PMC3630350.pdf
"Keywords:  Epididymis; Malacoplakia This is an Open Access article distributed under the te rms of the Creative Commons Attribution Non-Commercial  License (http://creativecommons.org /licenses/by-nc/3.0) which permit s unrestricted non-commercial use,  distribution, and reproduction in any medium, provided the original work is properly cited.Article History: received 10 August, 2011 accepted 22 September, 2011 Corresponding Author: Ki Ho Kim Department of Urology, Dongguk  University College of Medicine,  123 Dongdae-ro, Gyeongju 780-714, Korea TEL: +82-54-770-8265 FAX: +82-54-771-0769E-mail: honda400@dreamwiz.com FIG.",Non-OADS,/arxiv_data1/oa_pdf/5a/bb/kju-54-274.PMC3630350.pdf
"Korean Journal of Urology ⒸThe Korean Urological Association, 2013 277 Korean J Urol 2013;54:277www.kjurology.org http://dx.doi.org/10.4111/kju.2013.54.4.277 Letter Letter to the Editor: Is Routine Screening Necessary for Renal Cell  Carcinoma in End-Stage Renal Disease Patients?",Non-OADS,/arxiv_data1/oa_pdf/ca/5f/kju-54-277.PMC3630351.pdf
"Korean Journal of Urology ⒸThe Korean Urological Association, 2013 278 Korean J Urol 2013;54:278-279www.kjurology.org http://dx.doi.org/10.4111/kju.2013.54.4.278 Letter  The Authors Reply: Renal Cell Carcinoma in Kidney Transplant  Recipients and Dialysis Patients Hyung Ho Lee, Woong Kyu Han Department of Urology, Urologic Sc ience Institute, Yonsei University College of Medicine, Seoul, Korea This is an Open Access article dist ributed under the terms of the Creative Commons Attribution Non-Commercial  License (http://creativeco mmons.org/licenses/by-nc/3.",Non-OADS,/arxiv_data1/oa_pdf/fa/b9/kju-54-278.PMC3630352.pdf
"Based on the combined errors of all steps,the overall accuracy of this analysis lies within a factor of ca 2–3.Supplementary data Supplementary data are available at The EMBO Journal Online (http://www.embojournal.org).",OADS,/arxiv_data1/oa_pdf/32/75/emboj201352a.PMC3630355.pdf
Access codes The EM maps of the FLCC and CC elastase complexes are deposited in the EMD data bank (http://www.ebi.ac.uk/pdbe/) under the acces-sion codes EMD-2232 and EMD-2233.Supplementary data Supplementary data are available at The EMBO Journal Online (http://www.embojournal.org).,OADS,/arxiv_data1/oa_pdf/57/52/emboj201358a.PMC3630358.pdf
To view acopy of this licence visit http://creativecommons.org/ licenses/by-nc-nd/3.0/.Type IV secretion core complex structure A Rivera-Calzada et al 1204 The EMBO Journal VOL 32 |NO 8 |2013 &2013 European Molecular Biology Organization,Non-OADS,/arxiv_data1/oa_pdf/57/52/emboj201358a.PMC3630358.pdf
"G&I    Genomics & InformaticspISSN 1598-866X  eISSN 2234-0742 Genomics Inform  2013;11(1):1 http://dx.doi.org/10.5808/GI.2013.11.1.1 EDITORIAL *Corresponding author:  Tel: +82-2-820-0457, Fax: +82-2-824-4383, E-mail: sskimb@ssu.ac.kr Copyright © 2013 by the Korea Genome Organization CC It is identical to the Creative Commons Attribution Non-Commercial License (http://creativecommons.org/licenses/by-nc/3.0/).Editor’s Introduction to This Issue Sangsoo Kim* School of Systems Biomedical Science, Soongsil University, Seoul 156-743, Korea The theme of this issue’s review articles is epigenomics － one of the hot topics in genome sciences.",Non-OADS,/arxiv_data1/oa_pdf/2b/55/gni-11-1.PMC3630379.pdf
"G&I    Genomics & InformaticspISSN 1598-866X eISSN 2234-0742 Genomics Inform  2013;11(1):15-23 http://dx.doi.org/10.5808/GI.2013.11.1.15 ORIGINAL ARTICLE Received January 21, 2013; Revised February 8, 2013; Accepted February 14, 2013 *Corresponding author:  Tel: +82-31-725-8376, Fax: +82-31-725-8350, E-mail: kbkwack@cha.ac.kr Copyright © 2013 by the Korea Genome Organization CC It is identical to the Creative Commons Attribution Non-Commercial License (http://creativecommons.org/licenses/by-nc/3.0/).Association between Interferon-Inducible Protein 6  (IFI6) Polymorphisms and Hepatitis B Virus Clearance Geun-Hee Park1, Kyoung-Yeon Kim1, Sung Won Cho2, Jae Youn Cheong2,  Gyeong Im Yu3, Dong Hoon Shin3, Kyu Bum Kwack1* 1Department of Biomedical Science, College of Life Science, CHA University, Seongnam 463-836, Korea,  2Department of Gastroenterology, Genomic Research Center for Gastroenterology, Ajou University School of Medicine, Suwon  442-749, Korea, 3Department of Preventive Medicine, Keimyung University School of Medicine, Daegu 700-712, Korea CD8+ T cells are key factors mediating hepatitis B virus (HBV) clearance.",Non-OADS,/arxiv_data1/oa_pdf/5f/63/gni-11-15.PMC3630380.pdf
"Single nucleotide polymorphism (SNP) selection and  genotyping In the discovery stage, six SNPs were selected from a  public SNP database (http://www.ncbi.nlm.nih.gov/snp/)  for the genotyping assay: 1) polymorphic in Chinese and Japanese; 2) tag SNPs in Asian; 3) might have functionality  in protein or expression level.",Non-OADS,/arxiv_data1/oa_pdf/5f/63/gni-11-15.PMC3630380.pdf
"The Plink program  was used to confirm the results and permutation test (n = 100,000; http://pngu.mgh.harvard.edu/~purcell/plink/).",OADS,/arxiv_data1/oa_pdf/5f/63/gni-11-15.PMC3630380.pdf
"The binding of  several transcription factors, including isoforms of the glucocorticoid receptor α, STAT4, v-ets erythroblastosis  virus E26 oncogene homolog 1 (ETS1), and ETS2, to the  protective allele (C) was predicted by ALLGEN PROMO (version 3.0.2; http://alggen.lsi.upc.es/cgi-bin/promo_v3/  promo/promoinit.cgi?dirDB=TF_8.3) [27].",Non-OADS,/arxiv_data1/oa_pdf/5f/63/gni-11-15.PMC3630380.pdf
"G&I    Genomics & InformaticspISSN 1598-866X  eISSN 2234-0742 Genomics Inform  2013;11(1):2-6 http://dx.doi.org/10.5808/GI.2013.11.1.2 REVIEW ARTICLE Received January 25, 2013; Revised February 18, 2013; Accepted February 21, 2013 *Corresponding author:  Tel: +82-42-350-4327, Fax: +82-42-350-4310, E-mail: jungkyoon@kaist.ac.kr Copyright © 2013 by the Korea Genome Organization CC It is identical to the Creative Commons Attribution Non-Commercial License (http://creativecommons.org/licenses/by-nc/3.0/).ENCODE: A Sourcebook of Epigenomes and  Chromatin Language  Maryam Yavartanoo1, Jung Kyoon Choi1,2* 1Department of Bio and Brain Engineering, KAIST, Daejeon 305-701, Korea,  2Genome Institute of Singapore, Singapore 138672, Singapore  Until recently, since the Human Genome Project, the general vi ew has been that the majority of the human genome is  composed of junk DNA and has little or no selective advantag e to the organism.",Non-OADS,/arxiv_data1/oa_pdf/58/cf/gni-11-2.PMC3630381.pdf
"For this project, an international group  of 442 members from 32 institutions studied 147 different  types of cells with 24 types of different experiments (http://www.genome.gov/ENCODE) [3, 4].",OADS,/arxiv_data1/oa_pdf/58/cf/gni-11-2.PMC3630381.pdf
The ENCODE website at the University of  California Santa Cruz (UCSC) genome browser (http:// encodeproject.org or http://genome.ucsc.edu/ENCODE)  provides information about how to access the data.,OADS,/arxiv_data1/oa_pdf/58/cf/gni-11-2.PMC3630381.pdf
"G&I    Genomics & InformaticspISSN 1598-866X  eISSN 2234-0742 Genomics Inform  2013;11(1):24-33 http://dx.doi.org/10.5808/GI.2013.11.1.24 ORIGINAL ARTICLE Received January 30, 2013; Revised February 20, 2013; Accepted February 22, 2013 *Corresponding author:  Tel: +82-42-879-8540, Fax: +82-42-879-8519, E-mail: deepreds@kribb.re.kr †These two authors contributed equally to this work.",Non-OADS,/arxiv_data1/oa_pdf/a6/48/gni-11-24.PMC3630382.pdf
"Copyright © 2013 by the Korea Genome Organization CC It is identical to the Creative Commons Attribution Non-Commercial License (http://creativecommons.org/licenses/by-nc/3.0/).Bioinformatics Interpretation of  Exome Sequencing: Blood Cancer Jiwoong Kim1†, Yun-Gyeong Lee1,2†, Namshin Kim1,2* 1Korean Bioinformation Center, Korea Research Institute of Bioscience and Biotechnology, Daejeon 305-806, Korea,  2Department of Bioinformatics, University of Science and T echnology, Daejeon 305-806, Korea We had analyzed 10 exome sequencing data and single nucleot ide polymorphism chips for blood cancer provided by the  PGM21 (The National Project for Personalized Genomic Medicine) Award program.",Non-OADS,/arxiv_data1/oa_pdf/a6/48/gni-11-24.PMC3630382.pdf
"SNP, single nucleotide polymorphism; LOH, loss of heterozygosity; SCNA, so- matic copy-number alterations; SCHALE, somatic copy-number and heterozygosity alteration estimation; NS/SS/I, nonsense, splice-site,or coding indel mutations.Toolkit, and the high-quality reads were aligned to the  human reference genome (hg19, http://genome.ucsc.edu)  using BWA (http://bio-bwa.sourceforge.net/) [1] with de-fault parameteres.",OADS,/arxiv_data1/oa_pdf/a6/48/gni-11-24.PMC3630382.pdf
"The mutation set  was annotated using a custom-made script with refSeq, SIFT (http://sift.jcvi.org/), MutationAssessor, phyloP46way (ver- tebrate), dbSNP 137 [3], in-house Korean variation data- base, etc.",OADS,/arxiv_data1/oa_pdf/a6/48/gni-11-24.PMC3630382.pdf
"Homology modeling was  performed using MODELLER (http://salilab.org/modeller)  with the templates 1LWD for IDH2, 3KSY for RASGEF1B,",OADS,/arxiv_data1/oa_pdf/a6/48/gni-11-24.PMC3630382.pdf
The structural images were drawn using PyMOL (http://www.pymol.org/).,OADS,/arxiv_data1/oa_pdf/a6/48/gni-11-24.PMC3630382.pdf
"We had  removed all variants from dbSNP and an in-house Korean  database that showed polymorphisms or normal variants,  because they can be putatively functionally neutral, even if they are discovered as somatic mutations.We had downloaded the COSMIC (http://www.sanger.ac.",Non-OADS,/arxiv_data1/oa_pdf/a6/48/gni-11-24.PMC3630382.pdf
"Dat a were analyzed through the use of Ingenity Pathway Analysis (IPA) (IngenuityⓇ Systems, http://www.ingenuity.com) [8].",OADS,/arxiv_data1/oa_pdf/a6/48/gni-11-24.PMC3630382.pdf
"Data were analyzed  through the use of Ingenity Pathway Analysis (IPA) (IngenuityⓇ Systems, http://www.ingenuity.com) [8].",OADS,/arxiv_data1/oa_pdf/a6/48/gni-11-24.PMC3630382.pdf
INTS6 is  expressed in blood; many expressed sequence tags (ESTs)  were found in INTS6 in UniGene (http://www.ncbi.,OADS,/arxiv_data1/oa_pdf/a6/48/gni-11-24.PMC3630382.pdf
"Network and pathway analyses Using 26 genes, we had used IPA (http://www.ingenuity.",OADS,/arxiv_data1/oa_pdf/a6/48/gni-11-24.PMC3630382.pdf
Available from: http://www.ingenuity.com/.,Non-OADS,/arxiv_data1/oa_pdf/a6/48/gni-11-24.PMC3630382.pdf
"G&I    Genomics & InformaticspISSN 1598-866X  eISSN 2234-0742 Genomics Inform  2013;11(1):34-37 http://dx.doi.org/10.5808/GI.2013.11.1.34 ORIGINAL ARTICLE Received January 18, 2013; Revised February 15, 2013; Accepted February 20, 2013 *Corresponding author:  Tel: +82-2-2072-3079, Fax: +82-2-743-3079, E-mail: ssysmc@snu.ac.kr  Copyright © 2013 by the Korea Genome Organization CC It is identical to the Creative Commons Attribution Non-Commercial License (http://creativecommons.org/licenses/by-nc/3.0/).Effects of Somatic Mutations Are Associated with SNP  in the Progression of In dividual Acute Myeloid  Leukemia Patient: The Two-Hit Theory Explains  Inherited Predisposition to Pathogenesis Soyoung Park1, Youngil Koh1,2, Sung-Soo Yoon1,2,3* 1Cancer Research Institute, Seoul National University College of Medicine, Seoul 110-799, Korea,  2Department of Internal Medicine, Seoul National University Hospital,  Seoul National University College of Medicine, Seoul 110-799, Korea,  3Clinical Research Institute, Seoul National University Hospital, Seoul 110-799, Korea This study evaluated the effects of somatic mutations and si ngle nucleotide polymorphisms (SNPs) on disease progression  and tried to verify the two-hit theory in cancer pathogenesis.",Non-OADS,/arxiv_data1/oa_pdf/ba/93/gni-11-34.PMC3630383.pdf
Filtering and annotation of SNVs and indels were performed using  ANNOVAR (http://www.openbioinformatics.org/annovar/).,OADS,/arxiv_data1/oa_pdf/ba/93/gni-11-34.PMC3630383.pdf
"G&I    Genomics & InformaticspISSN 1598-866X eISSN 2234-0742 Genomics Inform  2013;11(1):38-45 http://dx.doi.org/10.5808/GI.2013.11.1.38 ORIGINAL ARTICLE Received January 28, 2013; Revised February 15, 2013; Accepted February 22, 2013 *Corresponding author:  Tel: +82-2-740-8920, Fax: +82-2-747-8928, E-mail: juhan@snu.ac.kr Copyright © 2013 by the Korea Genome Organization CC It is identical to the Creative Commons Attribution Non-Commercial License (http://creativecommons.org/licenses/by-nc/3.0/).Annotation of Genes Having Candidate Somatic  Mutations in Acute My eloid Leukemia with  Whole-Exome Sequencing Using Concept  Lattice Analysis Kye Hwa Lee, Jae Hyeun Lim, Ju Han Kim* Division of Biomedical Informatics, Seoul National University Biomedical Informatics (SNUBI) and Systems Biomedical  Informatics National Core Research Center, Seoul National University College of Medicine, Seoul 110-799, Korea In cancer genome studies, the annotation of newly detected oncogene/tumor suppressor gene candidates is a challenging  process.",Non-OADS,/arxiv_data1/oa_pdf/68/46/gni-11-38.PMC3630384.pdf
Avail- able from: http://picard.sourceforge.net/.,Non-OADS,/arxiv_data1/oa_pdf/68/46/gni-11-38.PMC3630384.pdf
"G&I    Genomics & InformaticspISSN 1598-866X eISSN 2234-0742 Genomics Inform  2013;11(1):46-51 http://dx.doi.org/10.5808/GI.2013.11.1.46 ORIGINAL ARTICLE Received January 23, 2013; Revised February 13, 2013; Accepted February 18, 2013 *Corresponding author:  Tel: +82-33-248-2691, Fax: +82-33-248-2693, E-mail jwpark@hallym.ac.kr Copyright © 2013 by the Korea Genome Organization CC It is identical to the Creative Commons Attribution Non-Commercial License (http://creativecommons.org/licenses/by-nc/3.0/).Genetic Risk Prediction for Normal-Karyotype Acute  Myeloid Leukemia Using Whole-Exome Sequencing Seong Gu Heo, Eun Pyo Hong, Ji Wan Park* Department of Medical Genetics, Hallym University College of Medicine, Chuncheon 200-702, Korea Normal-karyotype acute myeloid leukemia (NK-AML) is a highly malignant an d cytogenetically heterogeneous hematologic  cancer.",Non-OADS,/arxiv_data1/oa_pdf/64/2c/gni-11-46.PMC3630385.pdf
"Statistical analysis We performed logistic regression analyses between the  somatic mutations and NK-AML using PLINK/SEQ v0.08  (http://atgu.atgu.mgh.harvard.edu/plinkseq), which pro- vides powerful utilities in variant call format (vcf) for ana- lyzing whole- exome and -genome data.",OADS,/arxiv_data1/oa_pdf/64/2c/gni-11-46.PMC3630385.pdf
"G&I    Genomics & InformaticspISSN 1598-866X  eISSN 2234-0742 Genomics Inform  2013;11(1):52-54 http://dx.doi.org/10.5808/GI.2013.11.1.52 APPLICATION NOTE Received November 23, 2012; Revised January 17, 2013; Accepted February 4, 2013 *Corresponding author:  Tel: +82-2-880-4674, Fax: +82-2-873-2317, E-mail: yonglee@snu.ac.kr Copyright © 2013 by the Korea Genome Organization CC It is identical to the Creative Commons Attribution Non-Commercial License (http://creativecommons.org/licenses/by-nc/3.0/).Eukaryotic DNAJ/K Database: A Comprehensive  Phylogenomic Analysis Platform for the DNAJ/K Family Kyeongchae Cheong1,2, Jaehyuk Choi3, Jaeyoung Choi1,2,  Jongsun Park1, Suwang Jang1, Yong-Hwan Lee1,2,3,4* 1Fungal Bioinformatics Laboratory, Seoul National University, Seoul 151-921, Korea,  2Department of Agricultural Biotechnology, Seoul National University, Seoul 151-921, Korea,  3Center for Fungal Pathogenesis, Seoul National University, Seoul 151-921, Korea,  4Center for Fungal Genetic Resources, Seoul National University, Seoul 151-921, Korea Proteins in DNAJ/K families are ubiqui tous, from prokaryotes to eukaryotes, and function as molecular chaperones.",Non-OADS,/arxiv_data1/oa_pdf/39/50/gni-11-52.PMC3630386.pdf
"Keywords: database, HSP40 heat-shock proteins, HSP70 heat-shock proteins Availability: All data described in this study can be browsed on the EDD website at http://edd.snu.ac.kr/.",OADS,/arxiv_data1/oa_pdf/39/50/gni-11-52.PMC3630386.pdf
All protein sequences  of the 339 genomes deposited in the Comparative Fungal  Genomics Platform (CFGP; http://cfgp.snu.ac.kr) [16] were filtered according to the following description.,OADS,/arxiv_data1/oa_pdf/39/50/gni-11-52.PMC3630386.pdf
"G&I    Genomics & InformaticspISSN 1598-866X  eISSN 2234-0742 Genomics Inform  2013;11(1):55-57 http://dx.doi.org/10.5808/GI.2013.11.1.55 APPLICATION NOTE Received December 5, 2012; Revised January 10, 2013; Accepted January 18, 2013 *Corresponding author:  Tel: +1-214-633-2005, Fax: +1-214-648-5814, E-mail: Hyun.Kim@UTsouthwestern.edu Copyright © 2013 by the Korea Genome Organization CC It is identical to the Creative Commons Attribution Non-Commercial License (http://creativecommons.org/licenses/by-nc/3.0/).siMacro: A Fast and Easy Data Processing Tool for  Cell-Based Genomewide siRNA Screens Nitin Kumar Singh1, Bo Yeun Seo2, Mathukumalli Vidyasagar1,  Michael A. White2, Hyun Seok Kim2* 1Department of Bioengineering, University of T exas at Dallas, Richardson, TX 75080, USA,  2Department of Cell Biology, University of T exas Southwestern Medical Center, Dallas, TX 75390, USA Growing numbers of studies employ cell lin e-based systematic short interfering RNA (siRNA) screens to study gene functions  and to identify drug targets.",Non-OADS,/arxiv_data1/oa_pdf/61/36/gni-11-55.PMC3630387.pdf
"Keywords: high-throughput screening assays, RNA interference  Availability: siMacro, source code, and manuals are available at the Sourceforge website: http://www.sourceforge.",OADS,/arxiv_data1/oa_pdf/61/36/gni-11-55.PMC3630387.pdf
"G&I    Genomics & InformaticspISSN 1598-866X  eISSN 2234-0742 Genomics Inform  2013;11(1):58 http://dx.doi.org/10.5808/GI.2013.11.1.58 ERRATUM 58 www.genominfo.orgERRATUM: Figure Legend Correction Characteristics in Molecular Vibrational Frequency  Patterns between Agonists and Antagonists of  Histamine Receptors S. June Oh Department of Pharmacology, Inje University College of Medicine, Busan 614-735, Korea http://dx.doi.org/10.5808/GI.2012.10.2.128 Genomics Inform 2012;10(2):128-132 The legend of Figure 1 was given incorrectly.",Non-OADS,/arxiv_data1/oa_pdf/92/26/gni-11-58.PMC3630388.pdf
"G&I    Genomics & InformaticspISSN 1598-866X  eISSN 2234-0742 Genomics Inform  2013;11(1):7-14 http://dx.doi.org/10.5808/GI.2013.11.1.7 REVIEW ARTICLE Received January 30, 2013; Revised February 20, 2013; Accepted February 21, 2013 *Corresponding author:  Tel: +82-43-719-8888, Fax: +82-43-719-8908, E-mail: jbbae72@gmail.com Copyright © 2013 by the Korea Genome Organization CC It is identical to the Creative Commons Attribution Non-Commercial License (http://creativecommons.org/licenses/by-nc/3.0/).Perspectives of International Human  Epigenome Consortium Jae-Bum Bae* Division of Structural and Functional Genomics, Center for Genome Sciences,  Korea National Institute of Health, Cheongwon 363-951, Korea As the International Human Epigenome Cons ortium (IHEC) launched officially at the 2010 Washington meeting, a giant step  toward the conquest of unexplored regions of the human genome has begun.",Non-OADS,/arxiv_data1/oa_pdf/91/de/gni-11-7.PMC3630389.pdf
Available from: http://www.roadmapepigenomics.org.,OADS,/arxiv_data1/oa_pdf/91/de/gni-11-7.PMC3630389.pdf
Available from: http://www.IHEC-epigenomes.net.,OADS,/arxiv_data1/oa_pdf/91/de/gni-11-7.PMC3630389.pdf
Available from: http://www.blue-print-epigenome.eu/.,Non-OADS,/arxiv_data1/oa_pdf/91/de/gni-11-7.PMC3630389.pdf
"Published by Oxford University Press on behalf of the British Society for Rheumatology This is an Open Access article distributed under the terms of the Creative Commons Attribution Non-Commercial License (http://creativecommons.or g/licenses/by-nc/3.0/), which permits unrestricted non-commercial use, distribution, and reproduction in any medium, provided the original work is properly cited.RHEUMATOLOGYRheumatology 2013;52:839 /C150846 doi:10.1093/rheumatology/kes378 Advance Access publication 3 January 2013 CLINICAL SCIENCE",Non-OADS,/arxiv_data1/oa_pdf/bc/36/kes378.PMC3630394.pdf
"The DAS28-CRP scores for each patient werecalculated using the following formula from the DAS web- site (http://www.das-score.nl/): DAS28 /C04ðCRPÞ¼0:56/C3sqrtðTJC28 Þþ0:28/C3sqrtðSJC28 Þ þ0:36/C3ln CRP þ1 ðÞ þ 0:014/C3GHþ0:96: Disease activity based on the DAS28-CRP was classified as high (DAS28-CRP >4.09), moderate (DAS28-CRP 2.67 /C1504.09) or low (DAS28-CRP 2.32 /C1502.67) and patients with DAS28-CRP scores <2.32 were considered to be in remission according to the adjusted thresholds described by Inoue et al.",OADS,/arxiv_data1/oa_pdf/bc/36/kes378.PMC3630394.pdf
"This is an Open Access article distributed under the terms of the Creative Commons Attribution Non-Commercial License (http://creativecommons.or g/licenses/by-nc/3.0/), which permits unrestricted non-commercial use, distribution, and reproduction in any medium, provided the original work is properly cited.RHEUMATOLOGYRheumatology 2013;52:944 /C150950 doi:10.1093/rheumatology/kes400 Advance Access publication 21 January 2013CLINICAL SCIENCE",Non-OADS,/arxiv_data1/oa_pdf/7d/0a/kes400.PMC3630395.pdf
SUPPLEMENTARY MATERIAL  is linked to the online version of the paper at  http://www.nature.com/cpt ACKNOWLEDGMENTS We are grateful to the patients and their caregivers.,Non-OADS,/arxiv_data1/oa_pdf/1a/b7/clpt201326a.PMC3630454.pdf
<http://www.who.int/ malaria/publications/atoz/9789241563697/en/index.html> (2008).,Non-OADS,/arxiv_data1/oa_pdf/1a/b7/clpt201326a.PMC3630454.pdf
<http://www.who.int/malaria/publications/atoz/9789241547925/en/index.html> (2011).,Non-OADS,/arxiv_data1/oa_pdf/1a/b7/clpt201326a.PMC3630454.pdf
"To view a copy of this license,  visit http://creativecommons.org/licenses/by-nc-nd/3.0/ 450 VOLUME 93 NUMBER 5 | MAy 2013 | www.nature.com/cpt",Non-OADS,/arxiv_data1/oa_pdf/1a/b7/clpt201326a.PMC3630454.pdf
"To view a copy of this license, visit http://creativecommons.org/licenses/by-nc-nd/3.0/ Supplementary Information accompanies the paper on the Oncogene website (http://www.nature.com/onc)Immune surveillance of senescent cells A Sagiv et al 1977 &2013 Macmillan Publishers Limited Oncogene (2013) 1971 – 1977",Non-OADS,/arxiv_data1/oa_pdf/dd/04/onc2012206a.PMC3630483.pdf
MiR-497 downregulates IGF1-R One of the predicted common targets of miR-15/16/195/424/497 family members is IGF1-R (http://www.targetscan.org; http:// www.ebi.ac.uk/enright-srv/microcosm/htdocs/targets/v5).,Non-OADS,/arxiv_data1/oa_pdf/d4/d3/onc2012214a.PMC3630484.pdf
"To view a copy of this license, visit http://creativecommons.org/licenses/by-nc-nd/3.0/ Supplementary Information accompanies the paper on the Oncogene website (http://www.nature.com/onc)miR-497 regulates IGF1-R in colorectal cancer ST Guo et al 1920 Oncogene (2013) 1910 – 1920 &2013 Macmillan Publishers Limited",Non-OADS,/arxiv_data1/oa_pdf/d4/d3/onc2012214a.PMC3630484.pdf
"To view a copy of this license, visit http://creativecommons.org/licenses/by-nc-sa/3.0/ Supplementary Information accompanies the paper on the Oncogene website (http://www.nature.com/onc)B-Raf controls a network of microRNAs in melanoma KL Couts et al 1970 Oncogene (2013) 1959 – 1970 &2013 Macmillan Publishers Limited",Non-OADS,/arxiv_data1/oa_pdf/d4/e0/onc2012209a.PMC3630485.pdf
Available at http://www.cdc.gov/hai/ outbreaks/meningitis.html (accessed 29 November 2012).,Non-OADS,/arxiv_data1/oa_pdf/ce/63/emi20135a.PMC3630490.pdf
Available at http://www.promedmail.org (accessed 29 November 2012).,Non-OADS,/arxiv_data1/oa_pdf/ce/63/emi20135a.PMC3630490.pdf
Available at http://web.oie.int/eng/normes/mmanual/2008/pdf/2.03.04_AI.pdf (accessed 17 January 2013).,Non-OADS,/arxiv_data1/oa_pdf/15/5c/emi20137a.PMC3630491.pdf
Available at http://www.waddensea-secretariat.org/news/news/Seals/Annual-reports/Trilateral%20Seal%20Counts%20Report_2011.pdf.,Non-OADS,/arxiv_data1/oa_pdf/f8/68/emi20132a.PMC3630493.pdf
"To view a copy of this license, visit http://creativecommons.org/licenses/by-nc-nd/3.0Prevalence of phocine distemper virus antibodies R Bodewes et al 5 Emerging Microbes and Infections",Non-OADS,/arxiv_data1/oa_pdf/f8/68/emi20132a.PMC3630493.pdf
"3, Issue 4      http://www.thno.org 239 TThheerraannoossttiiccss   2013; 3(4):239-248.  doi: 10.7150/thno.5113  Research Paper  Multicolor Upconversion Nanoparticles for Protein  Conjugation  Stefan Wilhelm1, Thomas Hirsch1, Wendy M. Patterson1, Elisabeth Scheucher2, Torsten Mayr2, Otto S.  Wolfbeis1,  1.",Non-OADS,/arxiv_data1/oa_pdf/b6/b8/thnov03p0239.PMC3630524.pdf
This is  an open-access article distributed under the terms of the Creative Commons License  (http://creativecommons.org/  licenses/by-nc-nd/3.0/).,Non-OADS,/arxiv_data1/oa_pdf/b6/b8/thnov03p0239.PMC3630524.pdf
"3, Issue 4    http://www.thno.org 240 ferred to an activator ion (e.g., Er3+ or Tm3+) via a  non-radiative, resonant energy transfer process.",Non-OADS,/arxiv_data1/oa_pdf/b6/b8/thnov03p0239.PMC3630524.pdf
"3, Issue 4    http://www.thno.org 241 luminescence emission after 980-nm laser excitation.",Non-OADS,/arxiv_data1/oa_pdf/b6/b8/thnov03p0239.PMC3630524.pdf
"3, Issue 4    http://www.thno.org 242 emulsion after 30 minutes of sonication, which was  supplemented with 60 µL (0.27 mmol) of TEOS and  kept for 24 hours at room temperature under mag- netic stirring (600 rpm).",Non-OADS,/arxiv_data1/oa_pdf/b6/b8/thnov03p0239.PMC3630524.pdf
"3, Issue 4    http://www.thno.org 243 can be seen in Figure 1B.",Non-OADS,/arxiv_data1/oa_pdf/b6/b8/thnov03p0239.PMC3630524.pdf
"3, Issue 4    http://www.thno.org 244   Figure 2 .",Non-OADS,/arxiv_data1/oa_pdf/b6/b8/thnov03p0239.PMC3630524.pdf
"3, Issue 4    http://www.thno.org 245   Figure 4 .",Non-OADS,/arxiv_data1/oa_pdf/b6/b8/thnov03p0239.PMC3630524.pdf
"3, Issue 4    http://www.thno.org 246 nm³.",OADS,/arxiv_data1/oa_pdf/b6/b8/thnov03p0239.PMC3630524.pdf
"3, Issue 4    http://www.thno.org 247 In order to quantitatively verify the functionality  of protein-reactive nanoparticles, their binding to  surface-immobilized BSA was monitored by SPR  measurements in real time.",OADS,/arxiv_data1/oa_pdf/b6/b8/thnov03p0239.PMC3630524.pdf
"3, Issue 4    http://www.thno.org 248                                                                                                  17  Shao H, Min C, Issadore D, Lion g M, Yoon TJ, Weissleder R, Lee H.  Magnetic nanoparticles and microN MR for diagnostic applications.",Non-OADS,/arxiv_data1/oa_pdf/b6/b8/thnov03p0239.PMC3630524.pdf
"3, Issue 4       http://www.thno .org 249  TThheerraannoossttiiccss   2013; 3(4):249-257. doi: 10.7150/ thno .5432   Research Paper   Stem Cell Labeling using Polyethylenimine Conjugated  (α-NaYbF4:Tm3+)/CaF2 Upconversion Nanoparticles   Liang Zhao1,3,*, Artem Kutikov2,*, Jie Shen1, Chunying Duan3, Jie Song2 and Gang Han1  1.",Non-OADS,/arxiv_data1/oa_pdf/cf/3a/thnov03p0249.PMC3630525.pdf
This is an open -access article distributed under the terms of the Creative Commons License (http://creativecommons.org/   licenses/by -nc-nd/3.0/).,Non-OADS,/arxiv_data1/oa_pdf/cf/3a/thnov03p0249.PMC3630525.pdf
"3, Issue 4    http://www.thno .org 250  [1], cardiovascular disease  [2], spinal- cord injuries  [3]  and cancers  [4].",Non-OADS,/arxiv_data1/oa_pdf/cf/3a/thnov03p0249.PMC3630525.pdf
"3, Issue 4    http://www.thno .org 251  based on our previously reported approach [17] .",Non-OADS,/arxiv_data1/oa_pdf/cf/3a/thnov03p0249.PMC3630525.pdf
"3, Issue 4    http://www.thno .org 252  Cytotoxicity of PEI -UCNPs   Passage 1 rMSCs were seeded onto 96 -well tissue  culture plates (15,625/cm2 or 5,000/well) and cu l- tured for 24 -h prior to the addition of PEI -UCNPs (0,  20, 50 and 100 µg/mL).",Non-OADS,/arxiv_data1/oa_pdf/cf/3a/thnov03p0249.PMC3630525.pdf
"3, Issue 4    http://www.thno .org 253  tential measurement of the PEI -UCNPs further co n- firmed the presence of a PEI surface coating with a  positive potential of app roximately +17.8 mV(i.e., in comparison with -31 mV of PAA -UCNPs), which  would be suitable for binding with negatively  charged cell surfaces.",Non-OADS,/arxiv_data1/oa_pdf/cf/3a/thnov03p0249.PMC3630525.pdf
"3, Issue 4    http://www.thno .org 254  PEI-UCNP cellular uptake and cytotoxicity   In order to determine the optimal time and n a- noparticle concentration for stem cell labeling, rMSCs  were treated with different concentrations of  PEI-UCNPs (0, 20, 50, or 100 µg/ml) for 4 h and 24 h.  After incubation, the cells were washed and imaged  using a 2 -photon microscope.",Non-OADS,/arxiv_data1/oa_pdf/cf/3a/thnov03p0249.PMC3630525.pdf
"3, Issue 4    http://www.thno .org 255  Exocytosis of PEI -UCNPs from labeled rMSCs   One pote ntial challenge for in vivo tracking of  UCNP -labeled stem cells is the possibility that the  uptaken nanoparticles could be exocytosed overtime,  leading to the unintended labeling of other su r- rounding cells.",Non-OADS,/arxiv_data1/oa_pdf/cf/3a/thnov03p0249.PMC3630525.pdf
"3, Issue 4    http://www.thno .org 256    Figure 5.",Non-OADS,/arxiv_data1/oa_pdf/cf/3a/thnov03p0249.PMC3630525.pdf
"3, Issue 4    http://www.thno .org 257  coupled PEI coating (PEI -UCNPs) and their validation  for stem cell labeling applications.",Non-OADS,/arxiv_data1/oa_pdf/cf/3a/thnov03p0249.PMC3630525.pdf
This is an open -access article distributed under the terms of the Creative Commons License (http://creativecommons.org/   licenses/by -nc-nd/3.0/).,Non-OADS,/arxiv_data1/oa_pdf/9b/01/thnov03p0258.PMC3630526.pdf
Numerous biological models have been used for  toxicological assessments 10 Zebrafish were selected  for this experiment because of their widespread use in   Ivyspring    International Publisher     http://www.thno .org,Non-OADS,/arxiv_data1/oa_pdf/9b/01/thnov03p0258.PMC3630526.pdf
"), 2 μL RNA, 1 μL random    http://www.thno .org",OADS,/arxiv_data1/oa_pdf/9b/01/thnov03p0258.PMC3630526.pdf
http://www.thno .org,Non-OADS,/arxiv_data1/oa_pdf/9b/01/thnov03p0258.PMC3630526.pdf
The zeta -potential values of the three    http://www.thno .org,Non-OADS,/arxiv_data1/oa_pdf/9b/01/thnov03p0258.PMC3630526.pdf
http://www.thno .org,Non-OADS,/arxiv_data1/oa_pdf/9b/01/thnov03p0258.PMC3630526.pdf
http://www.thno .org,Non-OADS,/arxiv_data1/oa_pdf/9b/01/thnov03p0258.PMC3630526.pdf
Toxicity a s-   http://www.thno .org,Non-OADS,/arxiv_data1/oa_pdf/9b/01/thnov03p0258.PMC3630526.pdf
2010; 100: 218- 228.    http://www.thno .org,Non-OADS,/arxiv_data1/oa_pdf/9b/01/thnov03p0258.PMC3630526.pdf
2008; 29: 1179.     http://www.thno .org,Non-OADS,/arxiv_data1/oa_pdf/9b/01/thnov03p0258.PMC3630526.pdf
This is an open -access article distributed under the terms of the Creative Commons License (http://creativecommons.org/   licenses/by -nc-nd/3.0/).,Non-OADS,/arxiv_data1/oa_pdf/7f/40/thnov03p0267.PMC3630527.pdf
This is an open- access article distributed under the terms of the Creative Commons License (http://creativecommons.org/   licenses/by-nc -nd/3.0/).,Non-OADS,/arxiv_data1/oa_pdf/ab/6d/thnov03p0275.PMC3630528.pdf
This is an open -access article distributed under the terms of the Creative Commons License (http://creativecommons.org/   licenses/by -nc-nd/3.0/).,Non-OADS,/arxiv_data1/oa_pdf/c5/bf/thnov03p0282.PMC3630529.pdf
In   Ivyspring    International Publisher     http://www.thno .org,Non-OADS,/arxiv_data1/oa_pdf/c5/bf/thnov03p0282.PMC3630529.pdf
http://www.thno .org,Non-OADS,/arxiv_data1/oa_pdf/c5/bf/thnov03p0282.PMC3630529.pdf
As shown in Figure    http://www.thno .org,Non-OADS,/arxiv_data1/oa_pdf/c5/bf/thnov03p0282.PMC3630529.pdf
http://www.thno .org,Non-OADS,/arxiv_data1/oa_pdf/c5/bf/thnov03p0282.PMC3630529.pdf
"Near the metal surface,    http://www.thno .org",Non-OADS,/arxiv_data1/oa_pdf/c5/bf/thnov03p0282.PMC3630529.pdf
http://www.thno .org,Non-OADS,/arxiv_data1/oa_pdf/c5/bf/thnov03p0282.PMC3630529.pdf
1985: 274 -760.    http://www.thno .org,Non-OADS,/arxiv_data1/oa_pdf/c5/bf/thnov03p0282.PMC3630529.pdf
This is an open- access article distributed under the terms of the Creative Commons License (http://creativecommons.org/  licenses/by-nc -nd/3.0/).,Non-OADS,/arxiv_data1/oa_pdf/27/63/thnov03p0289.PMC3630530.pdf
Available from: http://www.fda.gov/downloads/Drugs/.../ Guidances/ucm070246.pdf [Last accessed 2012  Mar 21].,Non-OADS,/arxiv_data1/oa_pdf/9c/54/IJPhS-74-312.PMC3630726.pdf
Available from: http://www.salud.gob.mx/unidades/cofepris/cis/ tramites/regmed/pdf/NOM_177.pdf [Last accessed 2012  Mar 22].,Non-OADS,/arxiv_data1/oa_pdf/9c/54/IJPhS-74-312.PMC3630726.pdf
Available from: http://www.fda.gov/downloads/Drugs/Guidance TABLE  5: DISSOLUTION KINETIC PARAMETERS OF  SUSPENSION AND TABLETS OF IBP pHSuspension Order and k units Tablets Order and k units 7.2 0.08977 1 (1/min) 0.04131 1 (1/min) 6.8 0.12069 1 (1/min) 0.00628 1 (1/min) 4.5 0.06176 1 (1/min) 0.05792 0 (% dissolved/min) 1.2 0.1246 0 (% dissolved/min) 0.03528 0 (% dissolved/min) k is dissolution constant.,Non-OADS,/arxiv_data1/oa_pdf/9c/54/IJPhS-74-312.PMC3630726.pdf
Available from: http://en.wikipedia.org/wiki/Gulf_of_Mannar_Marine_ National_Park.,Non-OADS,/arxiv_data1/oa_pdf/d7/6f/IJPhS-74-331.PMC3630728.pdf
Database URL: http://rgd.mcw.edu ............................................................................................................................... ............................................................................................................................... ............................... Introduction Rat models have been used for many decades to study physiological and pathological processes.,OADS,/arxiv_data1/oa_pdf/82/f3/bat015.PMC3630803.pdf
Those projects include the PhysGenProgram for Genomic Applications (PGA) ( 3) (http://pga.mcw.edu) and the National BioResource Program in Japan (NBRP) ( 4) (http://www.anim.med.kyoto-u.ac.jp/nbr/).,Non-OADS,/arxiv_data1/oa_pdf/82/f3/bat015.PMC3630803.pdf
"This is an Open Access article distributed under the terms of the Creative Commons Attribution Non-Commercial License (http://creativecommons.org/licenses/by-nc/3.0/), which permits unrestricted non-commercial use, distribution, and reproduction in any medium, provided the original work is properly cited.",Non-OADS,/arxiv_data1/oa_pdf/82/f3/bat015.PMC3630803.pdf
The PhenoMiner data are accessed through RGD’s pheno-types and models portal (http://rgd.mcw.edu/phenotypes/).,OADS,/arxiv_data1/oa_pdf/82/f3/bat015.PMC3630803.pdf
The CMO was developed partly as an offshoot of the develop- ment of the Vertebrate Trait Ontology (VT) from the AnimalTrait Ontology (http://www.animalgenome.org/bioinfo/projects/ato/) ( 8).,OADS,/arxiv_data1/oa_pdf/82/f3/bat015.PMC3630803.pdf
"The Ontology forBiomedical Investigations (http://obi-ontology.org/page/Main_Page) has partial overlap of terminology with the MMO and XCO, but it was decided that new ontologies created in-house and specifically for methods and condi-tions of quantitative phenotype data would be the mostefficient way to proceed.",Non-OADS,/arxiv_data1/oa_pdf/82/f3/bat015.PMC3630803.pdf
"Beyond the bulk loading of large data sets and the initial manual curation initiative, manual literature curation willcontinue, as well as the uploading of phenotype datadirectly to RGD by rat researchers who wish to make theirdata publicly available (http://rgd.mcw.edu/wg/home/phenominer-data-upload).",Non-OADS,/arxiv_data1/oa_pdf/82/f3/bat015.PMC3630803.pdf
"Required ontologies/vocabularies for PhenoMiner annotations, URLs for available download sites for those ontologies/ vocabularies and relevant literature references Curation categoryOntology/ vocabularyOBO file downloads References Experiment name—physiological VT ftp://rgd.mcw.edu/pub/ontology/vertebrate_trait/ http://purl.bioontology.org/ontology/VT Experiment name—pathological RDO ftp://rgd.mcw.edu/pub/ontology/disease/ ( 8) Rat strain RS ftp://rgd.mcw.edu/pub/ontology/rat_strain/ http://purl.bioontology.org/ontology/RS Clinical measurement CMO ftp://rgd.mcw.edu/pub/ontology/clinical_measurement/ http://purl.bioontology.org/ontology/CMO(5) Measurement method MMO ftp://rgd.mcw.edu/pub/ontology/measurement_method/ http://purl.bioontology.org/ontology/MMO(5) Experimental condition XCO ftp://rgd.mcw.edu/pub/ontology/experimental_condition/ http://purl.bioontology.org/ontology/XCO(5) All ontologies listed here can be browsed in RGD’s ontology browser (http://rgd.mcw.edu/rgdweb/ontology/search.html) ( 9).",Non-OADS,/arxiv_data1/oa_pdf/82/f3/bat015.PMC3630803.pdf
"Internally, RGD has implemented an ontology development process similar to the SourceForge (http://sourceforge.net/projects/geneontology/) term request tracker system that the Gene Ontology Consortium ( 14) has used for years.",OADS,/arxiv_data1/oa_pdf/82/f3/bat015.PMC3630803.pdf
"For XCO terms that are chemical names, an xref (cross-reference tothe same or similar information) to the appropriate ChEBI (Chemical Entities of Biological Interest) (http://www.ebi.ac.",Non-OADS,/arxiv_data1/oa_pdf/82/f3/bat015.PMC3630803.pdf
"Beyond the PhenoMiner project at RGD, the CMO, MMO and XCO have been used in a human clinicaldata project (COVER) (http://cover.wustl.edu/Cover/) andthe VT and CMO have been used to annotate animalQTLs in the Animal QTLdb (http://www.animalgenome.org/bioinfo/projects/ato/main.html) ( 8).",OADS,/arxiv_data1/oa_pdf/82/f3/bat015.PMC3630803.pdf
"Both the bulk-loaded, high-throughput data and manu- ally curated literature data are available in the PhenoMiner end-user interface (http://rgd.mcw.edu/phenotypes/) wherestudies across many rat strains, methods and conditionscan be compared.",OADS,/arxiv_data1/oa_pdf/82/f3/bat015.PMC3630803.pdf
Database URL : http://pfam.sanger.ac.uk/ ............................................................................................................................... ............................................................................................................................... ............................... Introduction The sequencing of the human genome ( 1) and large-scale projects such as ENCODE ( 2) have provided access to a more complete and reliable list of human protein-coding genes than was previously available.,Non-OADS,/arxiv_data1/oa_pdf/9c/ef/bat023.PMC3630804.pdf
"This is an Open Access article distributed under the terms of the Creative Commons Attribution Non-Commercial License (http://creativecommons.org/licenses/by-nc/3.0), which permits unrestricted non-commercial use, distribution, and reproduction in any medium, provided the original work is properly cited.",Non-OADS,/arxiv_data1/oa_pdf/9c/ef/bat023.PMC3630804.pdf
"Methods Human, Saccharomyces cerevisiae and Escherichia coli proteomes We downloaded the UniProtKB/Swiss-Prot-reviewed pro- tein sequences for Homo sapiens (taxonomic identifier 9606; 20 234 sequences), S. cerevisiae strain ATCC 204508 /S288c (taxonomic identifier 559292; 6621 sequences) and E. coli strain K12 (taxonomic identifier 83333; 4431 se- quences) from the UniProt website (http://www.uniprot.",OADS,/arxiv_data1/oa_pdf/9c/ef/bat023.PMC3630804.pdf
We refer to these as the ‘uncovered regions’.HMMER3 phmmer (http://hmmer.janelia.org/) searchesagainst UniProtKB release 2012_06 were run using the un-covered regions as query and both domain and sequence E-value inclusion thresholds of 10 /C03.,OADS,/arxiv_data1/oa_pdf/9c/ef/bat023.PMC3630804.pdf
SUPERFAMILY and Gene3D coverage of the human proteome We downloaded the file of UniProtKB Gene3D data from ftp://ftp.biochem.ucl.ac.uk/pub/gene3d_data/v11.0.0/uniprot_ ............................................................................................................................... ............................................................................................................................... ...............................,OADS,/arxiv_data1/oa_pdf/9c/ef/bat023.PMC3630804.pdf
"Coiled-coiland low-complexity regions were predicted using defaultparameters with ncoils (http://www.russelllab.org/cgi-bin/coils/coils-svr.pl) and SEG ( 12), respectively.",OADS,/arxiv_data1/oa_pdf/9c/ef/bat023.PMC3630804.pdf
"To betterunderstand how these 24 896 regions related to eachother, we ran phmmer (http://hmmer.janelia.org/) all versus all to detect similarity between them, and used the program MCL ( 10) to cluster them based on E-values (Methods).",OADS,/arxiv_data1/oa_pdf/9c/ef/bat023.PMC3630804.pdf
"To view a copy of this license, visit http://creativecommons.org/licenses/by-nc-nd/3.0Expecting unexpected virus diseases CR Howard and NF Fletcher 11 Emerging Microbes and Infections",Non-OADS,/arxiv_data1/oa_pdf/57/fd/emi201247a.PMC3630908.pdf
"To view a copy of this license, visit http://creativecommons.org/licenses/by-nc-nd/3.0 Amplitude3432 2288 11444576 0.00 Mass (kDa)A28G24C16T18P.",Non-OADS,/arxiv_data1/oa_pdf/c5/7c/emi201249a.PMC3630909.pdf
Avail ableat http://www.who.in t/tb/publications/20 08/en/index.html (accessed 13March 2012).,Non-OADS,/arxiv_data1/oa_pdf/93/6f/emi201218a.PMC3630910.pdf
"To view a copy of this license, visit http://creativecommons.org/licenses/by-nc-nd/3.0Emerging Microbes and Infections (2012) 1, e1; doi:10.1038/emi.2012.13 /C2232012 SSCC.",Non-OADS,/arxiv_data1/oa_pdf/05/af/emi201213a.PMC3630911.pdf
Available at http://www.cdc.gov/ncidod/biotech/strep/types_emm103- 124.htm (accessed 31 January 2012).,OADS,/arxiv_data1/oa_pdf/3e/e1/emi20129a.PMC3630912.pdf
Clin Infect Dis 2011; 52: 988–994.Streptococcus pyogenes and scarlet fever SSY Wong and KY Yuen 7 Emerging Microbes and Infectionshttp://www.bacterio.cict.fr/s/streptococcus.html,Non-OADS,/arxiv_data1/oa_pdf/3e/e1/emi20129a.PMC3630912.pdf
"Available at http://www.promedmail.org (accessed 31 January 2012)65 Centre for Health Protection, Department of Health.",Non-OADS,/arxiv_data1/oa_pdf/3e/e1/emi20129a.PMC3630912.pdf
Available at http://www.chp.,Non-OADS,/arxiv_data1/oa_pdf/3e/e1/emi20129a.PMC3630912.pdf
Available at http://www.hpa.org.uk/ webc/HPAwebFile/HPAweb_C/1194947358374 (accessed 2 January 2012).,Non-OADS,/arxiv_data1/oa_pdf/3e/e1/emi20129a.PMC3630912.pdf
Available at http://www.nhmrc.gov.au/_files_nhmrc/publications/ attachments/ch43poster4.pdf (accessed 2 January 2012).,Non-OADS,/arxiv_data1/oa_pdf/3e/e1/emi20129a.PMC3630912.pdf
Available at http://www.who.int/entity/tb/publications/global_report/2011/ gtbr11_full.pdf.,OADS,/arxiv_data1/oa_pdf/e8/6c/emi201221a.PMC3630913.pdf
Available at http://www.stoptb.org/ assets/documents/global/plan/TB_GlobalPlanToStopTB2011-2015.pdf.,Non-OADS,/arxiv_data1/oa_pdf/e8/6c/emi201221a.PMC3630913.pdf
Available at http://www.un.org/millennium/declaration/ares552e.pdf.,Non-OADS,/arxiv_data1/oa_pdf/e8/6c/emi201221a.PMC3630913.pdf
Available at http://www.who.int/tb/features_archive/operational_research_priorities/ en/index.html.,OADS,/arxiv_data1/oa_pdf/e8/6c/emi201221a.PMC3630913.pdf
Available at http://policycures.org/publications.html.,Non-OADS,/arxiv_data1/oa_pdf/e8/6c/emi201221a.PMC3630913.pdf
Available at http://www.niaid.nih.gov/topics/tuberculosis/research/documents/ mdrxdrresearchagenda.pdf.,Non-OADS,/arxiv_data1/oa_pdf/e8/6c/emi201221a.PMC3630913.pdf
Available at http://www.gatesfoundation.org/global-health/ Documents/tuberculosis-strategy.pdf.,Non-OADS,/arxiv_data1/oa_pdf/e8/6c/emi201221a.PMC3630913.pdf
Available at http://cptrinitiative.org/ (accessed 1 June 2012).,Non-OADS,/arxiv_data1/oa_pdf/e8/6c/emi201221a.PMC3630913.pdf
Available at http://www.niaid.nih.gov/labsandresources/restructuring(accessed 14 February 2012).,OADS,/arxiv_data1/oa_pdf/e8/6c/emi201221a.PMC3630913.pdf
Available athttp://www.niaid.nih.gov/labsandresources/resources (accessed 1 June 2012).,OADS,/arxiv_data1/oa_pdf/e8/6c/emi201221a.PMC3630913.pdf
"To view a copy of this license, visit http://creativecommons.org/licenses/by-nc-nd/3.0Passive immunity to infection PJ Lachmann 5 Emerging Microbes and Infections",Non-OADS,/arxiv_data1/oa_pdf/dc/10/emi20122a.PMC3630915.pdf
"For example, in March 1999, avian IAV H9N2 was seen to infect two persons in Hong Kong, resulting in mild influenza.41In 2003, another avian IAV subtype H7N7 was reported to infect 89 humans with one death during a fowl plague outbreak in the Netherlands.42Furthermore, the highly pathogenic avian influenza A virus (HPAI) H5N1 has become a continuing threat to public health worldwide since its first report in 2003.43As of 20th January 2012, 582 cases of H5N1 have been reported to theWorld Health Organization with a mortality rate approaching 60% (http://www.who.int/influenza/hu man_animal_interface/EN_GIP_ 20120120Cumulative NumberH5N1cases.pdf).",Non-OADS,/arxiv_data1/oa_pdf/f3/19/emi20121a.PMC3630917.pdf
"To view a copy of this license, visit http://creativecommons.org/ licenses/by-nc-nd/3.0Figure 2 Phylogenetic analysis of HCoV-EMC.",Non-OADS,/arxiv_data1/oa_pdf/4b/05/emi201245a.PMC3630921.pdf
"Available at http://www.rsu.ac.th/medtech/files/CLSI%202011.pdf 24 Endimiani A, Carias LL, Hujer AM et al .",OADS,/arxiv_data1/oa_pdf/66/fa/emi201237a.PMC3630922.pdf
"To view a copy o f this license, visit http:// creativecommons.org/licenses/by-nc-nd/3.0 Supplementary Information accompanies the paper on Emerging Microbes and Infections ’s website (http://www.nature.com/EMI).Novel IncX3 plasmid carrying blaNDM-1 in China PL Ho et al 6 Emerging Microbes and Infections",Non-OADS,/arxiv_data1/oa_pdf/66/fa/emi201237a.PMC3630922.pdf
"To view a copy of this license, visit http://creativecommons.org/licenses/by-nc-nd/3.0Plague vaccines VA Feodorova and VL Motin 5 Emerging Microbes and Infections",Non-OADS,/arxiv_data1/oa_pdf/84/aa/emi201234a.PMC3630923.pdf
"However, such studies are con- sidered by the National Science Advisory Board for Biosecurity (NSABB) as ‘dual use research’, a biological research with legitimate scientific purpose that may be misused to pose a biologic threat to public health and/or national security (http://oba.od.nih.gov/ biosecurity/biosecurity.html).",Non-OADS,/arxiv_data1/oa_pdf/24/06/emi201239a.PMC3630924.pdf
"The panel reversed course on 29–30 March 2012, and recommended full publication of the two revised manuscripts (http://news.sciencemag.o rg/scienceinsider/2012/03/breaking- news-nsabb-reverses-pos.html) and the papers were finally published inNature3and Science4recently.",Non-OADS,/arxiv_data1/oa_pdf/24/06/emi201239a.PMC3630924.pdf
"6The objective of biosecurity is to prevent loss, theft or misuse of microorganisms, biological materials and research-related information (http://www.cdc.gov/biosafety/publications/bmbl5).",Non-OADS,/arxiv_data1/oa_pdf/24/06/emi201239a.PMC3630924.pdf
"8Following suggestions are made for the researchers who are working on these new pathogens: (i) they must be well trained and proficient in handling such dangerous materials safely; (ii) they should make a detailed risk assessment under the direction of the InstitutionalBiosafety Committees consisting of biological safety professionals before starting to work on the infectious agents, analyze the worst casescenarios that may occur and prepare a strategy to mitigate the impact of the negative event if it happens; (iii) they should strictly follow the safety procedures and manage the research materials by adherence to appropriate materials managementprocedures; (iv) they should report to their supervisors or bio-safety officials immediately if they encounter a dangerous situ-a t i o no ri d e n t i f yan e wp a t h o g e nw ith significantly increased human transmissibility and/or virulence; and (v) they must estab- lish material accountability procedures to track the inventory,storage, use, transfer and dest ruction of dangerous biological materials and assets when no longer needed (http://www.cdc.",Non-OADS,/arxiv_data1/oa_pdf/24/06/emi201239a.PMC3630924.pdf
"For example, experiments using research-laboratory-scale quantities of Human Immunodeficiency Virus, a blood-borne virus, can be performed ina biosafety level-2, rather than biosafety level-3 facility (http://www.cdc.gov/biosafety).",Non-OADS,/arxiv_data1/oa_pdf/24/06/emi201239a.PMC3630924.pdf
"Splice site prediction wt and mutant NS gene sequences, from A/Hong Kong/1/1968 (H3N2) were run through ASSP 25(Alternative Splice Site Predictor) using acceptor and donor site cut-off values of 7 and 9, respectively (http://www.es.embnet.org/ ,mwang/assp.html).",OADS,/arxiv_data1/oa_pdf/a0/0b/emi201238a.PMC3630925.pdf
"To view a copy of this license, visit http://creativecommons.org/licenses/by-nc-sa/3.0Non-structural protein 3, novel influenza A virus protein M Selman et al.",Non-OADS,/arxiv_data1/oa_pdf/a0/0b/emi201238a.PMC3630925.pdf
(http://www.ncbi.nlm.nih.gov/).,OADS,/arxiv_data1/oa_pdf/73/be/emi201222a.PMC3630932.pdf
"Open reading frames (ORFs) weredetermined using the ORF Finder program, which is accessiblethrough the National Center for Biotechnology Information (http://www.ncbi.nlm.nih.gov/gorf/gorf.html), and conformed to the codonusage table for Escherichia coli .",OADS,/arxiv_data1/oa_pdf/73/be/emi201222a.PMC3630932.pdf
Searches for homologous DNA and protein sequences were conducted with the BLAST software againstthe non-redundant GenBank database (http://www.ncbi.nlm.nih.gov/blast/blast/).,OADS,/arxiv_data1/oa_pdf/73/be/emi201222a.PMC3630932.pdf
"To view a copy of this license, visit http:// creativecommons.org/licenses/by-nc-nd/3.0 Supplementary Information for this article can be found on Emerging Microbes and Infections ’ website (http://www.nature.com/EMI/)A new oacgene identified in S. flexneri serotype 1b QZ Sun et al 7 Emerging Microbes and Infections",Non-OADS,/arxiv_data1/oa_pdf/73/be/emi201222a.PMC3630932.pdf
Potential strategies to mitigate the transmission of influ-enza A viruses between pigs and people are available from severalsources including The Ohio State University’s Animal Influenza Ecology and Epidemiology Research Program website (http://vet.osu.,Non-OADS,/arxiv_data1/oa_pdf/85/53/emi201233a.PMC3630945.pdf
Available at http://www.cidrap.umn.edu/cidrap/content/influenza/swineflu/ news/aug1612variant.html (accessed 22 August 2012) 17 Anonymous.,Non-OADS,/arxiv_data1/oa_pdf/85/53/emi201233a.PMC3630945.pdf
Available at http://www.cdc.gov/flu/ spotlights/more-h3n2v-cases-reported.htm (accessed 22 August 2012).,Non-OADS,/arxiv_data1/oa_pdf/85/53/emi201233a.PMC3630945.pdf
"Available at http://www.cidrap.umn.edu/cidrap/content/influenza/swineflu/news/aug0712swine.html (accessed 23 August 2012) 29 Ito T, Couceiro JN, Kelm S et al.",Non-OADS,/arxiv_data1/oa_pdf/85/53/emi201233a.PMC3630945.pdf
ClustalW 27w a su s e dt oa l i g na n dg e n e r a t ea g u i d et r e ef o rt h eF A S T As e q u e n c e s .N e i g h b o r - j o i n i n gp h y l o g e n e t i ct r e e s followed by bootstrap analysis of 1000 replicates were created usingSplitsTree 28and graphically edited with TreeDyn.29The Neighbor-join- ing phylogenetic tree for Canadian epidemic strains isolated 2006–2011 was exported to Path-O-Gen v1.3 (http://tree.bio.ed.ac.uk/software/ pathogen) and a linear regression plot for isolation date versus root-to-tip distance was generated as described by Mutreja et al.,OADS,/arxiv_data1/oa_pdf/5c/80/emi201313a.PMC3630956.pdf
"This is an Open Access article distributed under the terms of the Creative Commons   Attribution License (http://creativecommons.org/licenses/by-nc/3.0/), which permits   non-commercial re-use, distribution, and reproduction in any medium, provided the original  work is properly cited.",Non-OADS,/arxiv_data1/oa_pdf/bd/ad/dxt006.PMC3631001.pdf
Available at: http://www.clinicaltrials.gov/ ct2/show/NCT00943826 .Conflict of Interest Olivier L. Chinot has been a paid consultant for F. Hoffmann-La Roche and received honoraria from Astra-Zeneca and MSD.,Non-OADS,/arxiv_data1/oa_pdf/ee/e5/11910_2013_Article_347.PMC3631110.pdf
http://www.cbtrus.org/2011-NPCR-SEER/WEB- 0407-Report-3-3-2011.pdf .,Non-OADS,/arxiv_data1/oa_pdf/ee/e5/11910_2013_Article_347.PMC3631110.pdf
"Retrieved from http://www.R-project.org Rakoczy, H., Tomasello, M., & Striano, T. (2004).",Non-OADS,/arxiv_data1/oa_pdf/63/ef/13415_2013_Article_151.PMC3631111.pdf
"To view a copy of this license, visit http://creativecommons.org/licenses/by-nc-nd/3.0/ Supplementary Information accompanies the paper on the Oncogene website (http://www.nature.com/onc)Mechanism of radioresistance of perinecrotic cells Y Zhu et al 2068 Oncogene (2013) 2058 – 2068 &2013 Macmillan Publishers Limited",Non-OADS,/arxiv_data1/oa_pdf/7a/a3/onc2012223a.PMC3631307.pdf
"To view a copy of this license, visit http://creativecommons.org/licenses/by-nc-nd/3.0/ Supplementary Information accompanies the paper on the Oncogene website (http://www.nature.com/onc)WNT signalling activation in the stomach S Radulescu et al 2057 &2013 Macmillan Publishers Limited Oncogene (2013) 2048 – 2057",Non-OADS,/arxiv_data1/oa_pdf/c5/f9/onc2012224a.PMC3631308.pdf
"This is an Open Access article distributed under the terms of the Creative Commons Attribution License (http://creativecommons.org/licenses/ by-nc/3.0/), which permits non-commercial use, distribution, and reproduction in any medium, provided the original work is properly cited.",Non-OADS,/arxiv_data1/oa_pdf/68/aa/mct051.PMC3631335.pdf
"This is an Open Access article distributed under the terms of the Creative Commons Attribution License (http://creativecommons.org/licenses/ by-nc/3.0/), which permits non-commercial use, distribution, and reproduction in any medium, provided the original work is properly cited.",Non-OADS,/arxiv_data1/oa_pdf/e7/da/mct059.PMC3631343.pdf
"In the absence of a sequenced genome forMiscanthus , primers were designed from the Sorghum bicolour (sorghum) and Zea mays (maize) cDNA libraries available from the NCBI website ( http://www.ncbi.nlm.nih.gov/ ; see Table S2).",Non-OADS,/arxiv_data1/oa_pdf/e7/da/mct059.PMC3631343.pdf
Annotated sequences in sorghum and maize are available for allgenes tested from the NCBI database ( http://www.ncbi.nlm.,OADS,/arxiv_data1/oa_pdf/e7/da/mct059.PMC3631343.pdf
"ACKNOWLEDGEMENTS The authors gratefully acknowledge funding support from the BBSRC Sustainable Bioenergy Centre (BSBEC) grant (BB/G016216/1) working within the BSBEC BioMASSProgramme ( http://www.bsbec-biomass.org.uk/ ) of the centre, the BBSRC Bioenergy & Biorenewables Institute StrategicProgramme Grant (BBS/E/W/00003134) and Ceres Inc.",Non-OADS,/arxiv_data1/oa_pdf/e7/da/mct059.PMC3631343.pdf
BMC Plant Biology 11: 12.http://dx.doi.org/10.1186/1471-2229-11-12 .,Non-OADS,/arxiv_data1/oa_pdf/e7/da/mct059.PMC3631343.pdf
http://dx.doi.org/10.1371/journal.pone.0033821 .,Non-OADS,/arxiv_data1/oa_pdf/e7/da/mct059.PMC3631343.pdf
BMC Genomics 9: 434. http://dx.doi.org/10.1186/1471-2164-9-434 .,OADS,/arxiv_data1/oa_pdf/e7/da/mct059.PMC3631343.pdf
http://ecdc.europa.eu/610 Eur J Pediatr (2013) 172:601 –612,Non-OADS,/arxiv_data1/oa_pdf/7a/be/431_2012_Article_1924.PMC3631514.pdf
http://www.ema.europa.eu/ docs/en_GB/document_library/EPAR_-_Public_assessment_report/ human/002226/WC500127664.pdf .,Non-OADS,/arxiv_data1/oa_pdf/7a/be/431_2012_Article_1924.PMC3631514.pdf
"Health Protection Agency, London 2006. http://www.hpa- bioinformatics.org.uk/euib is/documents/2006_meningo.pdf .",Non-OADS,/arxiv_data1/oa_pdf/7a/be/431_2012_Article_1924.PMC3631514.pdf
http://www.fda.gov/BiologicsBloodVaccines/Vaccines/ ApprovedProducts/ucm252511.htm .,Non-OADS,/arxiv_data1/oa_pdf/7a/be/431_2012_Article_1924.PMC3631514.pdf
http://www.fda.gov/BiologicsBloodVaccines/Vaccines/ ApprovedProducts/ucm201342.htm .Accessed 19 July 2012 58.,Non-OADS,/arxiv_data1/oa_pdf/7a/be/431_2012_Article_1924.PMC3631514.pdf
http://seer.cancer.gov/ statfacts/html/breast.html .,Non-OADS,/arxiv_data1/oa_pdf/d7/65/10549_2013_Article_2447.PMC3631516.pdf
http://packageinserts.bms.com/pi/pi_taxol.pdf .,Non-OADS,/arxiv_data1/oa_pdf/d7/65/10549_2013_Article_2447.PMC3631516.pdf
"This is an Open Access article distributed under the terms of the Creative Commons Attribution Non-Commercial License (http://creativecommons.or g/licenses/by-nc/3.0/), which permits unrestricted non-commercial use, distribution, and reproduction in any medium, provided the original work is properly cited.European Heart Journal (2013) 34, 1233–1244 doi:10.1093/eurheartj/ehr445",Non-OADS,/arxiv_data1/oa_pdf/22/e5/ehr445.PMC3631523.pdf
"To view a copy of this license, visithttp://creativecommons.org/licenses/by-nc-nd/3.0/AL Furmanski et al.",Non-OADS,/arxiv_data1/oa_pdf/cd/bd/jid2012492a.PMC3631608.pdf
"To view a copy of this license, visithttp://creativecommons.org /licenses/by-nc-nd/3.0/FS y e d et al.",Non-OADS,/arxiv_data1/oa_pdf/78/bb/jid2012483a.PMC3631609.pdf
http://dx.doi.org/10.1128 /mBio.00103-13 .,Non-OADS,/arxiv_data1/oa_pdf/f4/ab/mBio.00225-13.PMC3631614.pdf
http://dx.doi.org/10 .1128/mBio.00103-13 .,Non-OADS,/arxiv_data1/oa_pdf/8f/33/mBio.00245-13.PMC3631615.pdf
Additional information Supplementary information accompanies this paper at http://www.nature.com/ scientificreports Competing financial interests: The authors declare no competing financial interests.,Non-OADS,/arxiv_data1/oa_pdf/55/16/srep01694.PMC3631765.pdf
"To view a copy of this license, visit http://creativecommons.org/licenses/by-nc-nd/3.0/ How to cite this article: Yang, Y. et al.",Non-OADS,/arxiv_data1/oa_pdf/55/16/srep01694.PMC3631765.pdf
Additional information Supplementary information accompanies this paper at http://www.nature.com/ scientificreports Competing financial interests: The authors declare no competing financial interests.,Non-OADS,/arxiv_data1/oa_pdf/19/b9/srep01691.PMC3631766.pdf
"To view a copy of this license, visit http://creativecommons.org/licenses/by-nc-sa/3.0/ How to cite this article: Chang, X., Xu, T., Li, Y.",Non-OADS,/arxiv_data1/oa_pdf/19/b9/srep01691.PMC3631766.pdf
"To view a copy of this license, visit http://creativecommons.org/licenses/by-nc-sa/3.0/ How to cite this article: Kawasaki, M., Yamada, Y., Ushiku, Y., Miyauchi, E. & Yamaguchi, Y. Inter-brain synchronization during coordination of speech rhythm in human-to-human social interaction.",Non-OADS,/arxiv_data1/oa_pdf/2f/ca/srep01692.PMC3631767.pdf
Additional information Supplementary information accompanies this paper at http://www.nature.com/ scientificreports Competing financial interests: The authors declare no competing financial interests.,Non-OADS,/arxiv_data1/oa_pdf/a0/f8/srep01693.PMC3631768.pdf
"To view a copy of thislicense, visit http://creativecommons.org/licenses/by-nc-nd/3.0/ How to cite this article: Huang, Z.W.",Non-OADS,/arxiv_data1/oa_pdf/a0/f8/srep01693.PMC3631768.pdf
We further evaluated whether the identified cancer specific isoforms comprise a functional open reading frame (ORF) by aligning the RNA of the novel isoforms against the human ORFeome 8.1 (http://horfdb.dfci.harvard.edu/).,Non-OADS,/arxiv_data1/oa_pdf/9a/d0/srep01689.PMC3631769.pdf
"Additionally, for consistency checking and independent validation we used an in-house built program (http://genomics.jhu.edu/software/ASproFile/) to compare the exon models between isoforms assembled with the program cufflinks for the normal and cancer samples (as mentioned earlier, only the isoforms that are similar to reference and isoforms that comprise novel splice junctions were considered), and determine the splicing differences indicative of exon inclusion,exclusion, alternative 5 9,39, and intron retention events.",OADS,/arxiv_data1/oa_pdf/9a/d0/srep01689.PMC3631769.pdf
"GO and IPA analysis .To associate cellular functions with the set of differential splicing, pre-RNA expression, promoter switching and genes, we used Database for Annotation, Visualization and Integrated Discovery (DAVID http://david.abcc.ncifcrf.gov/) and ingenuity pathway analysis (IPA, Ingenuity HSystems, www.ingenuity.com).",OADS,/arxiv_data1/oa_pdf/9a/d0/srep01689.PMC3631769.pdf
Additional information Supplementary information accompanies this paper at http://www.nature.com/ scientificreports Competing financial interests: The authors declare no competing financial interests.,Non-OADS,/arxiv_data1/oa_pdf/9a/d0/srep01689.PMC3631769.pdf
"To view a copy of thislicense, visit http://creativecommons.org/licenses/by-nc-nd/3.0/ How to cite this article: Eswaran, J. et al.",Non-OADS,/arxiv_data1/oa_pdf/9a/d0/srep01689.PMC3631769.pdf
Additional information Supplementary information accompanies this paper at http://www.nature.com/ scientificreports Competing financial interests: This work is part of a patent application by CIC bioGUNE.,Non-OADS,/arxiv_data1/oa_pdf/aa/ee/srep01690.PMC3631770.pdf
"To view a copy of this license, visit http://creativecommons.org/licenses/by-nc-sa/3.0/ How to cite this article: Da Silva-Ferrada, E. et al.",Non-OADS,/arxiv_data1/oa_pdf/aa/ee/srep01690.PMC3631770.pdf
Additional information Supplementary information accompanies this paper at http://www.nature.com/ scientificreports Competing financial interests: The authors declare no competing financial interests.,Non-OADS,/arxiv_data1/oa_pdf/23/81/srep01697.PMC3631771.pdf
"To view a copy of thislicense, visit http://creativecommons.org/licenses/by-nc-nd/3.0/ How to cite this article: Shen, D.W. et al.",Non-OADS,/arxiv_data1/oa_pdf/23/81/srep01697.PMC3631771.pdf
"We downloaded bioreaction databases for Ma 2003 and Zeng2011 29,30from http://www.tuharburg.de, and the iAF1260 Escherichia coli reconstruction31from the BiGG database32.",OADS,/arxiv_data1/oa_pdf/5c/28/srep01695.PMC3631772.pdf
"To view a copy of this license, visit http://creativecommons.org/licenses/by-nc-nd/3.0/ How to cite this article: Pah, A.R., Guimera `, R., Mustoe, A.M. & Amaral, L.A.N.",Non-OADS,/arxiv_data1/oa_pdf/5c/28/srep01695.PMC3631772.pdf
"Korean J Thorac Cardiovasc Surg 2013;46:104-110 □ Clinical Research  □ http://dx.doi.or g/10.5090/k jtcs.2013.46.2.104 ISSN: 2233-601X (Print)   ISSN: 2093-6516 (Online) − 104 −Department of Thoracic and Cardi ovascular Surgery, Asan Medical  Center, University of Ulsan College of Medicine Received: August 7, 2012, Revised: October 17, 2012, Accepted: October 18, 2012 Corresponding author: Sung-Ho Jung, Department of Thoracic and C ardiovascular Surgery, Asan Medical Center, University of Ulsan  College  of Medicine, 88 Olympic-ro 43-gil, Songpa-gu, Seoul 138-736, Ko rea (Tel) 82-2-3010-3584 (Fax) 82-2-3010-6966 (E-mail) csjung@amc.s eoul.kr  C The Korean Society for Thoracic and Cardiovascular Surgery.",Non-OADS,/arxiv_data1/oa_pdf/3f/b0/kjtcs-46-104.PMC3631783.pdf
"Korean J Thorac Cardiovasc Surg 2013;46:111-116 □ Clinical Research  □ http://dx.doi.or g/10.5090/k jtcs.2013.46.2.111 ISSN: 2233-601X (Print)   ISSN: 2093-6516 (Online) − 111 −1Department of Thoracic and Cardiovascular Surgery, 2Cardiovascular Center and Cardiovascular Research Institute, De partment of Internal  Medicine, Seoul National Universi ty Hospital, Seoul National Un iversity College of Medicine †This article was presented at the 43th Annual Meeting of The Ko rean Society for Thoracic and Ca rdiovascular Surgery, Gwangju, Korea,  November 6 –8, 2011.",Non-OADS,/arxiv_data1/oa_pdf/e7/50/kjtcs-46-111.PMC3631784.pdf
"Korean J Thorac Cardiovasc Surg 2013;46:117-123 □ Clinical Research  □ http://dx.doi.or g/10.5090/k jtcs.2013.46.2.117 ISSN: 2233-601X (Print)   ISSN: 2093-6516 (Online) − 117 −Department of Thoracic and Cardiovascular Surgery, 1Research Institute of Clinical M edicine, Chonbuk National Unive rsity Medical School,  2Wonkwang University School of Medicine †A  p a r t  o f  t h i s  a r t i c l e  w a s  p r e s e n t e d  a t  t h e  4 1 s t  A u t u m n  A c a d e m i c Meeting of the Korean Society for Thoracic and Cardiovascular  S u r g e r y .",Non-OADS,/arxiv_data1/oa_pdf/35/ad/kjtcs-46-117.PMC3631785.pdf
"Korean J Thorac Cardiovasc Surg 2013;46:124-129 □ Clinical Research  □ http://dx.doi.or g/10.5090/k jtcs.2013.46.2.124 ISSN: 2233-601X (Print)   ISSN: 2093-6516 (Online) − 124 −Department of Thoracic and Cardi ovascular Surgery, Dong-A Unive rsity Medical Center, Dong-A University College of Medicine †This article was presented at the 43th autumn scientific meetin g of The Korean Society for Thoracic and Cardiovascular Surgery .",Non-OADS,/arxiv_data1/oa_pdf/20/95/kjtcs-46-124.PMC3631786.pdf
"Korean J Thorac Cardiovasc Surg 2013;46:130-134 □ Clinical Research  □ http://dx.doi.or g/10.5090/k jtcs.2013.46.2.130 ISSN: 2233-601X (Print)   ISSN: 2093-6516 (Online) − 130 −Department of Thoracic and Cardi ovascular Surgery, Samsung Chan gwon Hospital, Sungkyunkwan University School of Medicine Received: May 25, 2012, Revised: August 23, 2012, Accepted: Aug ust 24, 2012 Corresponding author: Joung Hun Byun, Department of Thoracic and  Cardiovascular Surgery, Samsung Changwon Hospital, Sungkyunkwa n  University School of Medicine, 158 Paryong-ro, Masanhoewon-gu, Changwon 630-723, Korea (Tel) 82-55-290-1151 (Fax) 82-55-290-6785 (E-mail) jhunikr@nave r.com  C The Korean Society for Thoracic and Cardiovascular Surgery.",Non-OADS,/arxiv_data1/oa_pdf/2d/07/kjtcs-46-130.PMC3631787.pdf
"Korean J Thorac Cardiovasc Surg 2013;46:135-137 □ Case Report  □ http://dx.doi.or g/10.5090/k jtcs.2013.46.2.135 ISSN: 2233-601X (Print)   ISSN: 2093-6516 (Online) − 135 −Departments of 1Cardiology and 2Cardiovascular Surgery, Erzurum Region Training and Research Ho spital Received: August 16, 2012, Revised: October 18, 2012, Accepted:  October 18, 2012 Corresponding author: Mustafa Yolcu, Department of Cardiology, E rzurum Bolge Egitim ve Arast ırma Hastanesi, Kardiyoloji Klinigi, 25100,  Palandoken, Erzurum, Turkey (Tel) 90-442-319-18-00 (Fax) 90-442-232-64-05 (E-mail) yolcudoc tor@gmail.com  C The Korean Society for Thoracic and Cardiovascular Surgery.",Non-OADS,/arxiv_data1/oa_pdf/a8/68/kjtcs-46-135.PMC3631788.pdf
"Korean J Thorac Cardiovasc Surg 2013;46:138-141 □ Case Report  □ http://dx.doi.or g/10.5090/k jtcs.2013.46.2.138 ISSN: 2233-601X (Print)   ISSN: 2093-6516 (Online) − 138 −Departments of 1Thoracic and Cardiovascular Surgery, 2Radiology and Research Institute of Radiology, and 3Pathology, Asan Medical Center,  University of Ulsan College of Medicine Received: August 22, 2012, Revised: October 8, 2012, Accepted: October 9, 2012 Corresponding author: Sung-Ho Jung, Department of Thoracic and C ardiovascular Surgery, Asan Medical Center, University of Ulsan  College  of Medicine, 88 Olympic-ro 43-gil, Songpa-gu, Seoul 138-736, Ko rea (Tel) 82-2-3010-5990 (Fax) 82-2-3010-6966 (E-mail) ctsjungsh@ha nmail.net  C The Korean Society for Thoracic and Cardiovascular Surgery.",Non-OADS,/arxiv_data1/oa_pdf/79/63/kjtcs-46-138.PMC3631789.pdf
"Korean J Thorac Cardiovasc Surg 2013;46:142-145 □ Case Report  □ http://dx.doi.or g/10.5090/k jtcs.2013.46.2.142 ISSN: 2233-601X (Print)   ISSN: 2093-6516 (Online) − 142 −Department of Thoracic and Cardi ovascular Surgery, Samsung Medi cal Center, Sungkyunkwan University School of Medicine Received: August 20, 2012, Revised: October 13, 2012, Accepted:  October 17, 2012 Corresponding author: Kiick Sung, Department of Thoracic and Car diovascular Surgery, Samsung Medical Center, Sungkyunkwan Unive rsity  School of Medicine, 81 Irwon-ro, Gangnam-gu, Seoul 135-710, Kor ea (Tel) 82-2-3410-6541 (Fax) 82-2-3410-0089 (E-mail) kiick.sung@s amsung.com  C The Korean Society for Thoracic and Cardiovascular Surgery.",Non-OADS,/arxiv_data1/oa_pdf/c5/65/kjtcs-46-142.PMC3631790.pdf
"Korean J Thorac Cardiovasc Surg 2013;46:146-149 □ Case Report  □ http://dx.doi.or g/10.5090/k jtcs.2013.46.2.146 ISSN: 2233-601X (Print)   ISSN: 2093-6516 (Online) − 146 −Department of Thoracic and Cardiovascular Surgery, Haeundae Pai k Hospital, Inje University College of Medicine Received: October 8, 2012, Revis ed: November 29, 2012, Accepted : December 3, 2012 Corresponding author: Hee Jae Ju n, Department of Thoracic and Ca rdiovascular Surgery, Haeundae Paik Hospital, Inje University C ollege of  Medicine, 875 Haeun-daero, Haeundae-gu, Busan 612-862, Korea (Tel) 82-51-797-3131 (Fax) 82-51-797-3101 (E-mail) cs523@dreamw iz.com  C The Korean Society for Thoracic and Cardiovascular Surgery.",Non-OADS,/arxiv_data1/oa_pdf/92/8c/kjtcs-46-146.PMC3631791.pdf
"Korean J Thorac Cardiovasc Surg 2013;46:150-152 □ Case Report  □ http://dx.doi.or g/10.5090/k jtcs.2013.46.2.150 ISSN: 2233-601X (Print)   ISSN: 2093-6516 (Online) − 150 −1Department of Thoracic and Cardiovascular Surgery, Samsung Medi cal Center, Sungkyunkwan Uni versity School of Medicine, 2Department of  Thoracic and Cardiovascular Surgery, Institute of Health Scienc es, Gyeongsang National University School of Medicine, ³Department of  Pathology, Gyeongsang National University School of Medicine Received: October 4, 2012, Revis ed: October 18, 2012, Accepted:  O c t o b e r  1 8 ,  2 0 1 2 Corresponding author: Chung Eun Lee, Department of Thoracic and Cardiovascular Surgery, Gyeongsan g National University Hospital ,  Gyeongsang National University School of Medicine, 79 Gangnam-r o, Jinju 660-702, Korea (Tel) 82-55-750-8124 (Fax) 82-55-750-8138 (E-mail) ilikerem@han mail.net  C The Korean Society for Thoracic and Cardiovascular Surgery.",Non-OADS,/arxiv_data1/oa_pdf/d3/b9/kjtcs-46-150.PMC3631792.pdf
"Korean J Thorac Cardiovasc Surg 2013;46:153-155 □ Case Report  □ http://dx.doi.or g/10.5090/k jtcs.2013.46.2.153 ISSN: 2233-601X (Print)   ISSN: 2093-6516 (Online) − 153 −Department of Thoracic and Cardiovascular Surgery, 1Seoul National University Hospita l, Seoul National University C ollege of Medicine, 2Asan  Medical Center, University of Ulsan College of Medicine Received: May 8, 2012, Revised: September 22, 2012, Accepted: O ctober 8, 2012 Corresponding author: Chang Hyun Kang, Department of Thoracic an d Cardiovascular Surgery, Seoul National University Hospital, S eoul  National University College of Medicine, 101 Daehak-ro, Jongno- gu, Seoul 110-744, Korea (Tel) 82-2-2072-3010 (Fax) 82-2-764-3664 (E-mail) chkang@snu.ac .kr  C The Korean Society for Thoracic and Cardiovascular Surgery.",Non-OADS,/arxiv_data1/oa_pdf/50/d9/kjtcs-46-153.PMC3631793.pdf
"Korean J Thorac Cardiovasc Surg 2013;46:156-158 □ Case Report  □ http://dx.doi.or g/10.5090/k jtcs.2013.46.2.156 ISSN: 2233-601X (Print)   ISSN: 2093-6516 (Online) − 156 −Department of Thoracic and Cardi ovascular Surgery, Seoul Nation al University Hospital, Seoul National University College of Me dicine Received: September 20, 2012, Revised: October 10, 2012, Accept ed: October 15, 2012 Corresponding author: Young Tae Kim, Department of Thoracic and Cardiovascular Surgery, Seoul National University Hospital, Seo ul National  University College of Medicine, 101 Daehak-ro, Jongno-gu, Seoul  110-744, Korea (Tel) 82-2-2072-3161 (Fax) 82-2-765-7117 (E-mail) ytkim@snu.ac.",Non-OADS,/arxiv_data1/oa_pdf/ec/31/kjtcs-46-156.PMC3631794.pdf
"Korean J Thorac Cardiovasc Surg 2013;46:159-161 □ Case Report  □ http://dx.doi.or g/10.5090/k jtcs.2013.46.2.159 ISSN: 2233-601X (Print)   ISSN: 2093-6516 (Online) − 159 −Department of Thoracic and Cardiovascular Surgery, 1Inje University Busan Paik Hospi tal, Inje University College of  Medicine, 2Inje University  Haeundae Paik Hospital, Inje U niversity College of Medicine, 3Department of Pathology, Inje University Busan Paik Hospital, I nje University  College of Medicine Received: July 18, 2012, Revised: August 17, 2012, Accepted: Au gust 21, 2012 Corresponding author: Kwang-Hyun Cho, Department of Thoracic and  Cardiovascular Surgery, Inje University Busan Paik Hospital, I nje  University College of Medicine, 75 Bokji-ro, Busanjin-gu, Busan  614-735, Korea (Tel) 82-51-890-6834 (Fax) 82-51-891-1297 (E-mail) ctsckh@inje.",Non-OADS,/arxiv_data1/oa_pdf/c5/4b/kjtcs-46-159.PMC3631795.pdf
"Korean J Thorac Cardiovasc Surg 2013;46:162-163 □ Brief Communication  □ http://dx.doi.or g/10.5090/k jtcs.2013.46.2.162 ISSN: 2233-601X (Print)   ISSN: 2093-6516 (Online) − 162 −Private practice Received: August 30, 2012, Revised: September 21, 2012, Accepte d: October 8, 2012 Corresponding author: Shailendra Kapoor, Private practice, Chica go, IL, USA (Tel) 1-865-345-2345 (Fax) 1-865-657-6767 (E-mail) shailendraka poor@yahoo.com  C The Korean Society for Thoracic and Cardiovascular Surgery.",Non-OADS,/arxiv_data1/oa_pdf/80/9d/kjtcs-46-162.PMC3631796.pdf
"Korean J Thorac Cardiovasc Surg 2013;46:93-97 □ Clinical Research  □ http://dx.doi.or g/10.5090/k jtcs.2013.46.2.93 ISSN: 2233-601X (Print)   ISSN: 2093-6516 (Online) − 93 −Department of Thoracic and Cardi ovascular Surgery, Asan Medical  Center, University of Ulsan College of Medicine Received: August 27, 2012, Revised: October 9, 2012, Accepted: October 9, 2012 Corresponding author: Jae Won Lee, Department of Thoracic and Ca rdiovascular Surgery, Asan Medical Center, University of Ulsan College of  Medicine, 88 Olympic-ro 43-gil, Songpa-gu, Seoul 138-736, Korea (Tel) 82-2-3010-3580 (Fax) 82-2-3010-6966 (E-mail) jwlee@amc.se oul.kr  C The Korean Society for Thoracic and Cardiovascular Surgery.",Non-OADS,/arxiv_data1/oa_pdf/3b/89/kjtcs-46-93.PMC3631797.pdf
"Korean J Thorac Cardiovasc Surg 2013;46:98-103 □ Clinical Research  □ http://dx.doi.or g/10.5090/k jtcs.2013.46.2.98 ISSN: 2233-601X (Print)   ISSN: 2093-6516 (Online) − 98 −Department of Thoracic and Cardi ovascular Surgery, Samsung Medi cal Center, Sungkyunkwan University School of Medicine Received: August 13, 2012, Revised: October 17, 2012, Accepted:  October 17, 2012 Corresponding author: Tae-Gook Jun, Department of Thoracic and C ardiovascular Surgery, Samsung Medical Center, Sungkyunkwan Uni versity  School of Medicine, 81 Irwon-ro, Gangnam-gu, Seoul 135-710, Kor ea (Tel) 82-2-3410-3484 (Fax) 82-2-3410-0089 (E-mail) tgjunsmc@gma il.com  C The Korean Society for Thoracic and Cardiovascular Surgery.",Non-OADS,/arxiv_data1/oa_pdf/7d/3c/kjtcs-46-98.PMC3631798.pdf
http://archiviostorico.corriere.it/2002/ottobre/13/una_ma-lattia_rovino_voce_della_co_0_0210134315.shtml.,Non-OADS,/arxiv_data1/oa_pdf/af/d4/0392-100X-33-67.PMC3631811.pdf
Clinical otolaryngology  [original manuscript] 2012; 03.11.2012:[Available from:  http://onlinelibrary.wiley.com/doi/10.1111/coa.12043/ pdf.,Non-OADS,/arxiv_data1/oa_pdf/c2/d1/0392-100X-33-36.PMC3631816.pdf
See http://creativecommons.org/ licenses/by-nc-nd/3.0/ for details.,Non-OADS,/arxiv_data1/oa_pdf/78/18/1283.PMC3631817.pdf
See http://creativecommons.org/ licenses/by-nc-nd/3.0/ for details.,Non-OADS,/arxiv_data1/oa_pdf/fe/71/1102.PMC3631818.pdf
Available from http://www.nap.edu/ catalog.php?re- cord_id=12584.,OADS,/arxiv_data1/oa_pdf/fe/71/1102.PMC3631818.pdf
This article contains Supplementary Data online at http://care.diabetesjournals.org/lookup/suppl/doi:10 .2337/dc12-0712/-/DC1.,Non-OADS,/arxiv_data1/oa_pdf/e7/dd/1297.PMC3631819.pdf
See http://creativecommons.org/ licenses/by-nc-nd/3.0/ for details.,Non-OADS,/arxiv_data1/oa_pdf/e7/dd/1297.PMC3631819.pdf
"Corresponding author: Shintaro Kinugawa, tuckahoe@med.hokudai.ac.jp.Received 18 June 2012 and accepted 29 October 2012.DOI: 10.2337/dc12-1161This article contains Supplementary Data online at http://care.diabetesjournals.org/lookup/suppl/doi:10 .2337/dc12-1161/-/DC1.",Non-OADS,/arxiv_data1/oa_pdf/6a/e7/1341.PMC3631820.pdf
See http://creativecommons.org/ licenses/by-nc-nd/3.0/ for details.,Non-OADS,/arxiv_data1/oa_pdf/6a/e7/1341.PMC3631820.pdf
This article contains Supplementary Data online at http://care.diabetesjour nals.org/lookup/suppl/ doi:10.2337/dc12-1871/-/DC1.,Non-OADS,/arxiv_data1/oa_pdf/25/08/1088.PMC3631821.pdf
"UMIN CTR C000000222 for the Japan Diabetes Complica- tions Study and UMIN 000000890 for the Japanese Elderly Diabetes Intervention Trial, www.umin.ac.jp/ctr/.This article contains Supplementary Data online at http://care.diabetesjournals.org/lookup/suppl/doi:10 .2337/dc12-0958/-/DC1.",Non-OADS,/arxiv_data1/oa_pdf/b7/f9/1193.PMC3631823.pdf
See http://creativecommons.org/ licenses/by-nc-nd/3.0/ for details.,Non-OADS,/arxiv_data1/oa_pdf/b7/f9/1193.PMC3631823.pdf
"A web application for the JJ risk en- gine, which works in both Windows and Macintosh environments, is available athttp://www.biostatistics.jp/prediction/jjre.",OADS,/arxiv_data1/oa_pdf/b7/f9/1193.PMC3631823.pdf
Available from http://www.jds.or.jp/jds_or_jp0/uploads/photos/813.pdf.,Non-OADS,/arxiv_data1/oa_pdf/b7/f9/1193.PMC3631823.pdf
Available from http://www.nice.org.,Non-OADS,/arxiv_data1/oa_pdf/b7/f9/1193.PMC3631823.pdf
See http://creativecommons.org/ licenses/by-nc-nd/3.0/ for details.,Non-OADS,/arxiv_data1/oa_pdf/eb/3f/1290.PMC3631825.pdf
See http://creativecommons.org/ licenses/by-nc-nd/3.0/ for details.,Non-OADS,/arxiv_data1/oa_pdf/0a/e4/1172.PMC3631826.pdf
Available from http://www.health.alberta.ca/AHCIP/ premium-subsidy.html.,Non-OADS,/arxiv_data1/oa_pdf/0a/e4/1172.PMC3631826.pdf
See http://creativecommons.org/licenses/by-nc-nd/3.0/ for details.,Non-OADS,/arxiv_data1/oa_pdf/5d/29/e69.PMC3631827.pdf
See http://creativecommons.org/ licenses/by-nc-nd/3.0/ for details.,Non-OADS,/arxiv_data1/oa_pdf/74/0b/1406.PMC3631828.pdf
Availablefrom http://www.usrds.org/2010/view/v2_11.asp.,Non-OADS,/arxiv_data1/oa_pdf/74/0b/1406.PMC3631828.pdf
See http://creativecommons.org/ licenses/by-nc-nd/3.0/ for details.,Non-OADS,/arxiv_data1/oa_pdf/c6/37/1254.PMC3631829.pdf
See http://creativecommons.org/ licenses/by-nc-nd/3.0/ for details.,Non-OADS,/arxiv_data1/oa_pdf/93/c2/1095.PMC3631831.pdf
"NCT00509262, clinicaltrials.gov.This article contains Supplementary Data online at http://care.diabetesjournals.org/lookup/suppl/doi:10 .2337/dc12-1365/-/DC1.",Non-OADS,/arxiv_data1/oa_pdf/37/c1/1067.PMC3631833.pdf
See http://creativecommons.org/ licenses/by-nc-nd/3.0/ for details.,Non-OADS,/arxiv_data1/oa_pdf/37/c1/1067.PMC3631833.pdf
See http://creativecommons.org/ licenses/by-nc-nd/3.0/ for details.,Non-OADS,/arxiv_data1/oa_pdf/9b/f8/1236.PMC3631834.pdf
See http://creativecommons.org/ licenses/by-nc-nd/3.0/ for details.,Non-OADS,/arxiv_data1/oa_pdf/68/45/1377.PMC3631836.pdf
See http://creativecommons.org/ licenses/by-nc-nd/3.0/ for details.,Non-OADS,/arxiv_data1/oa_pdf/88/cc/1272.PMC3631837.pdf
Available from http://www.plosone.org/article/info%3Adoi%2F10.1371%2Fjournal.pone.0015568 7.,Non-OADS,/arxiv_data1/oa_pdf/88/cc/1272.PMC3631837.pdf
See http://creativecommons.org/ licenses/by-nc-nd/3.0/ for details.,Non-OADS,/arxiv_data1/oa_pdf/82/97/1200.PMC3631838.pdf
"Corresponding author: Latha P. Palaniappan, lathap@pamfri.org.Received 19 May 2012 and accepted 24 October 2012.DOI: 10.2337/dc12-0951This article contains Supplementary Data online at http://care.diabetesjournals.org/lookup/suppl/doi:10 .2337/dc12-0951/-/DC1.",Non-OADS,/arxiv_data1/oa_pdf/bf/05/1215.PMC3631839.pdf
See http://creativecommons.org/ licenses/by-nc-nd/3.0/ for details.,Non-OADS,/arxiv_data1/oa_pdf/bf/05/1215.PMC3631839.pdf
Available from http://www.epic.com.,Non-OADS,/arxiv_data1/oa_pdf/bf/05/1215.PMC3631839.pdf
"Corresponding author: Majken K. Jensen, mkjensen@hsph.harvard.edu.Received 7 August 2012 and accepted 28 October 2012.DOI: 10.2337/dc12-1591This article contains Supplementary Data online at http://care.diabetesjournals.org/lookup/suppl/doi:10 .2337/dc12-1591/-/DC1.",Non-OADS,/arxiv_data1/oa_pdf/c7/a7/1222.PMC3631840.pdf
See http://creativecommons.org/ licenses/by-nc-nd/3.0/ for details.,Non-OADS,/arxiv_data1/oa_pdf/c7/a7/1222.PMC3631840.pdf
See http://creativecommons.org/ licenses/by-nc-nd/3.0/ for details.,Non-OADS,/arxiv_data1/oa_pdf/95/b1/1126.PMC3631842.pdf
"NCT00513630, clinicaltrials.gov.This article contains Supplementary Data online at http://care.diabetesjournals.org/lookup/suppl/doi:10 .2337/dc12-0719/-/DC1.",Non-OADS,/arxiv_data1/oa_pdf/45/01/1304.PMC3631843.pdf
See http://creativecommons.org/ licenses/by-nc-nd/3.0/ for details.,Non-OADS,/arxiv_data1/oa_pdf/45/01/1304.PMC3631843.pdf
See http://creativecommons.org/ licenses/by-nc-nd/3.0/ for details.,Non-OADS,/arxiv_data1/oa_pdf/56/92/1335.PMC3631844.pdf
See http://creativecommons.org/ licenses/by-nc-nd/3.0/ for details.,Non-OADS,/arxiv_data1/oa_pdf/c1/e6/1361.PMC3631845.pdf
"ChiCTR-OCC-11001422, www.chictr.org.This article contains Supplementary Data online at http://care.diabetesjournals.org/lookup/suppl/doi:10 .2337/dc12-0940/-/DC1.",Non-OADS,/arxiv_data1/oa_pdf/ff/7c/1074.PMC3631846.pdf
See http://creativecommons.org/ licenses/by-nc-nd/3.0/ for details.,Non-OADS,/arxiv_data1/oa_pdf/ff/7c/1074.PMC3631846.pdf
Web site: http://professional.diabetes.org/ce.,Non-OADS,/arxiv_data1/oa_pdf/a7/45/1430.PMC3631847.pdf
"Other Events 10th Annual Nutrition & Health Conference 13–15 May 2013 Sheraton Seattle HotelSeattle, WashingtonWeb site: http://www.nutritionandhealthconf.org 81st Congress of the European Atherosclerosis Society 2–5 June 2013 Lyon, FranceWeb site: www.kenes.com/eas2013 E-mail: eas@kenes.com Diabetes Innovation 2013 3–5 October 2013 Omni Shoreham HotelWashington, DCWeb site: http://www.diabetesinnovation.org E-mail: nancy.felsheim@joslin.harvard.edu8th World Congress on Developmental Origins of Health and Disease 17–20 November 2013 SUNTEC SingaporeWeb site: http://www.dohad2013.org 7th International Conference on Advanced Technologies and Treatments for Diabetes 5–8 February 2014 Vienna, AustriaWeb site: www.kenes.com/attd2014 E-mail: attd@kenes.com 1430 DIABETES CARE,VOLUME 36, M AY2013 care.diabetesjournals.org",Non-OADS,/arxiv_data1/oa_pdf/a7/45/1430.PMC3631847.pdf
See http://creativecommons.org/ licenses/by-nc-nd/3.0/ for details.,Non-OADS,/arxiv_data1/oa_pdf/da/8b/1117.PMC3631848.pdf
Available from http://www.nice.org.uk/ guidance/TA60.,Non-OADS,/arxiv_data1/oa_pdf/da/8b/1117.PMC3631848.pdf
"Available from http://phi.uhce.ox.ac.uk/Table 4dRelationship between DSQOLS subscales and presence of complications (database study) Complications present Complications absent t, df, and P n Mean (SD) n Mean (SD) Social aspects 379 72.9 (20.2) 484 77.6 (18.4) t= 3.6, df = 861, P,0.001 Fear of hypoglycemia 379 64.2 (25.4) 484 68.4 (23.0) t= 2.5, df = 770, P,0.05 Dietary restrictions 377 65.1 (23.0) 485 64.8 (24.7) t=22.0, df = 832, NS Physical complaints 379 64.3 (23.4) 484 70.8 (20.3) t= 4.3, df = 751, P,0.001 Anxiety about future 378 40.7 (26.3) 485 47.3 (25.9) t= 3.7, df = 861, P,0.001 Daily hassles 379 55.6 (25.4) 486 53.9 (24.8) t=21.0, df = 862, NS DSQOLS total score 377 64.3 (19.1) 482 68.1 (18.0) t= 3.0, df = 857, P,0.01 Treatment satisfaction (PWTSS) 383 56.9 (13.2) 495 59.3 (14.3) t= 2.6, df = 850, P,0.01 1124 DIABETES CARE,VOLUME 36, M AY2013 care.diabetesjournals.orgDSQOLS in U.K. English",Non-OADS,/arxiv_data1/oa_pdf/da/8b/1117.PMC3631848.pdf
Available from http://www.dh.gov.uk/en/publicationsandstatistics/publications/publicatio nspolicyandguidance/ dh_4002951.,Non-OADS,/arxiv_data1/oa_pdf/da/8b/1117.PMC3631848.pdf
Available fromhttp://www.who.int/substance_abuse/ research_tools/translation/en/.,Non-OADS,/arxiv_data1/oa_pdf/da/8b/1117.PMC3631848.pdf
Available from http://www.deakin.edu.au/research/acqol/instruments/wellbeing_index.htm.,OADS,/arxiv_data1/oa_pdf/da/8b/1117.PMC3631848.pdf
See http://creativecommons.org/ licenses/by-nc-nd/3.0/ for details.,Non-OADS,/arxiv_data1/oa_pdf/02/8a/1209.PMC3631849.pdf
Centers for Dis-ease Control and Prevention 12 A.D. May24Available from: URL: http://apps.nccd.,Non-OADS,/arxiv_data1/oa_pdf/02/8a/1209.PMC3631849.pdf
See http://creativecommons.org/ licenses/by-nc-nd/3.0/ for details.,Non-OADS,/arxiv_data1/oa_pdf/60/17/1229.PMC3631850.pdf
"Corresponding author: Susan M. Mason, n2sma@channing.harvard.edu.Received 6 June 2012 and accepted 15 October 2012.DOI: 10.2337/dc12-1082This article contains Supplementary Data online at http://care.diabetesjournals.org/lookup/suppl/doi:10 .2337/dc12-1082/-/DC1.",Non-OADS,/arxiv_data1/oa_pdf/67/2e/1159.PMC3631851.pdf
See http://creativecommons.org/ licenses/by-nc-nd/3.0/ for details.,Non-OADS,/arxiv_data1/oa_pdf/67/2e/1159.PMC3631851.pdf
Available from http://www.hsph.harvard.,Non-OADS,/arxiv_data1/oa_pdf/67/2e/1159.PMC3631851.pdf
Available from http://www.diabetes.org/diabetes-basics/ diabetes-statistics/.,Non-OADS,/arxiv_data1/oa_pdf/67/2e/1159.PMC3631851.pdf
